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THE LIMAX TEST. A NEW LIVER FUNCTION
TEST FOR PREDICTION OF POSTOPERATIVE
OUTCOME IN LIVER SURGERY
M. Stockmann1, J. Lock1, B. Riecke1, M. Fricke1, S. Lehmann1,
S. Niehues2, P. Martus3, P. Neuhaus1
1. Dept. of General, Visceral and Transplantation Surgery Campus
Virchow Clinic
2. Department of Radiology
3. Institute for Biostatistics and Clinical Epidemiology, Germany
Background and aims: Accurate determination of liver function
is a challenging task in perioperative patient evaluation and mon-
itoring. Liver failure is a major cause of mortality after hepatec-
tomy. Residual liver function is an important prognostic
parameter but could not be calculated accurately till today. The
LiMAx test can assess maximal liver function capacity based on
13C-methacetin kinetics. The aim of this study was the technical
and diagnostic evaluation of the LiMAx test in hepatectomy.
Methods: Sixty-four patients undergoing hepatectomy were ana-
lyzed in a prospective study. Patients were investigated pre- and
postoperatively at different points with the LiMAx test. Analysis
of liver volume was carried out with preoperative CT and intra-
operative volumetry. Perioperative factors associated with mor-
bidity and mortality were analyzed. Cut-off values of the LiMAx
test were calculated by receiver operating characteristic.
Results: The residual LiMAx showed an excellent linear correla-
tion with residual liver volume (r=0.94, p<0.001) after hepatec-
tomy. The multivariate analysis revealed LiMAx on first
postoperative day as the only predictor of liver failure (p=0.003)
and mortality (p=0.004). AUROC for the prediction of liver fail-
ure and mortality by the LiMAx test was both 0.99. Volume/func-
tion analysis by combination of CT and LiMAx allows an accurate
calculation of residual liver function in the preoperative evalua-
tion (r=0.85, p<0.001).
Conclusions: The LiMAx test enables a more effective and risk-
related patient evaluation in liver surgery. The residual liver func-
tion is the major factor influencing the clinical outcome after
hepatectomy, and its quantity can be calculated preoperatively by
the new LiMAx test in combination with CT volumetry.
PL 02
PROSPECTIVE VOLUMETRIC ASSESSMENT
OF THE LIVER REMNANT ON THE PERSONAL
COMPUTER
S. Dello, J. Stoot, R. van Dam, J. van der Vorst, J. Bloemen,
M. van de Poll, M Bemelmans, S. Olde Damink, C. Dejong
Surgery Maastricht University Medical Center, The Netherlands
Introduction: A small remnant liver volume is an important risk
factor for post-hepatectomy liver failure. The utility of existing
professional image-processing software is often limited by costs,
lack of flexibility and specific hardware requirements such as
coupling to a CT-scanner. ImageJ is a free, open-source Java-
based image processing software programme developed by the
National Institute of Health (NIH). We aimed to study the accu-
racy of ImageJ for CT-volumetric analysis of the liver in a
prospective setting on a Personal Computer in patients undergo-
ing major liver resection.
Methods: Between January and November 2008, 12 patients (7
male: 5 female) scheduled for major liver resection (≥ 3 seg-
ments) were included. The median age was 60.5 (48-78) years.
ImageJ was downloaded from http://rsb.info.nih.gov/ij, DICOM
images were opened in ImageJ. Liver, tumour and future resec-
tion specimen were manually outlined directly on every slice. Sev-
eral plug-ins were downloaded to reduce time consumption.
Volumes of resection specimens measured with ImageJ were
compared with the actual weights of the liver specimens removed
during surgery.
Results: There was an excellent correlation between volumes cal-
culated prospectively with ImageJ and actual measured weights of
resection specimens (r²=0.59, p<0.005). Mean total liver volume
was 1774 (118) mls, mean resection volume was 1059 (74) mls,
mean tumour volume was 9 (3) mls. The average time needed for
an analysis was 20.5 (15-29) minutes.
Conclusion: ImageJ can be used accurately for hepatic CT-vol-
umetry on a Personal Computer in a prospective setting. This ap-
plication brings CT-volumetry to the surgeons desktop at no
expense.
PL 03
ADDITION OF BEVACIZUMAB TO
NEOADJUVANT THERAPY MAY INCREASE
RESECTABILITY RATE WITHOUT SIGNIFICANT
MORBIDITY IN PATIENTS WITH INITIALLY
NON-RESECTABLE COLORECTAL LIVER
METASTASES
R. Troisi 1, B. Van Den Bossche 1, S. Laurent 2, I. Deroo 2,
F. Berrevoet 1, L. Libbrecht 3, B. De Hemptinne 1
1. HB Surgery Ghent University Hospital & Medical School
2. Abdominal Oncology, Ghent University Hospital & Medical School
3. Pathology, Ghent University Hospital & Medical School, Belgium
Background: Patients with colorectal liver metastases (CRM)
and initially non resectable metastases might benefit from pre-
operative chemotherapy (CTX). Bevacizumab (BV) seems to im-
prove outcomes in patients with CRM but may induce
chemotoxicity with increased perioperative morbidity.
Methods: From June 2007 to November 2008, 38 patients with
non resectable CRM, received BV based CTX regimen (Fol-
fox/Folfiri). CTX was administered bi-weekly until 6 cycles. The
sixth cycle did not include BV resulting in 5 w between the last ad-
ministration and liver resection (LR).
Results: After a mean time of 6.6 ± 3.3 w with BV, 18/38 (47%)
patients became resectable and underwent LR (objective re-
sponse to neoadjuvant CTX on PET-CT or histology). Down-
staging of CRM was observed in 33% of cases whereas 1 patient
was considered not resectable at laparotomy.
Seven patients (41%) underwent a major hepatectomy whereas
minor and wedge resections were done in 7 and 3 other respec-
tively. Neither increased per operative bleeding nor wound heal-
ing complication were recorded. No postoperative mortality
occurred and 2/17 (12%) major complications were recorded (in-
traabdominal abscess and postoperative bleeding). Radical re-
section (R0) was achieved in 12/17 (71%) patients. After a
median FU of 5.75 m (range 1-18) all patients are alive. CRM re-
currence has been recorded in 5/17(29%) (2/5 with R0 resection).
Conclusions: Bevacizumab-based CTX regimen in patients with
initially non resectable CRM allowed surgery in 47% of cases,
with 71% R0 resection rate and without increased complication
rate. A longer FU is needed to understand the significance of
downsizing and its impact on disease-free survival.
PL 04
LIVER RESECTION FOR COLORECTAL
METASTASES: RESULTS AND PROGNOSTIC
FACTORS AFTER 10 YEARS OF FOLLOW-UP
C. Pulitano 1, L. Aldrighetti 2, R. Parks 1, S. Wigmore 1,
G. Ferla 2, J. Garden 1
1. Clinical and Surgical Sciences (Surgery), University of
Edinburgh, Royal Infirmary Edinburgh, UK
2. Liver Unit, Department of Surgery, Scientific Institute
San Raffaele, Vita-Salute San Raffaele University, Milan, Italy
IRCCS San Raffaele Hospital – Milan – Italy
Background: During the last 20 years, resection of colorectal liver
metastases (CLM) in selected patients has became the standard
of care, with 5-year survival between 20 and 55%. Although a sub-
stantial number of actual 5-year survivors are being reported after
resection, 5-year survival rates may be inadequate to evaluate
surgical outcomes, because a significant number of patients ex-
perience a recurrence at some point.
Aim: To analyze long-term results and prognostic factors of liver
resection for CLM in patients with a complete 10-year follow-up.
Methods: Between 1985-1998, 309 patients who underwent liver
resection for CLM were identified from an bi-institutional data-
base. Postoperative deaths were excluded. Clinicopathologic
prognostic factors were analyzed using univariate and multivari-
ate analyses.
Results: There were 301 consecutive patients identified with 10-
year follow-up.
Five- and 10-year survival rates were 28.5% and 18.7%, respec-
tively. No patient experienced a disease-specific death after 10
years of survival. In contrast, 32% of the 5-year survivors suffered
a cancer-related death. Multivariate analysis evidenced four in-
dependent negative prognostic factors of survival: >3 metastases
(P < 0.001), positive surgical margin (P < 0.001), tumor size >5
cm (P < 0.001) and CRS >2.
Conclusions: Five-year survival rates are not adequate to evalu-
ate surgical outcome of patients with CLM. Approximately one
third of actual 5-year survivors experience cancer-related death,
whereas patients who survive 10 years appear to be cured of their
disease. The presence of >3 metastases, positive surgical margin,
large tumor size >5 cm, and CRS >2 were associated to un-
favourable long-term survival.
PL 05
PREDICTING PATIENT SURVIVAL AFTER
PANCREATICODUODENECTOMY FOR
MALIGNANCY - A HISTOPATHOLOGICAL
CRITERIA BASED ON PERINEURAL
INFILTRATION AND LYMPHOVASCULAR
INVASION
R. Padbury 1, M. Bhandari 1, D. Astill 2, T. Wilson 1, L, Kow 1,
M. Brooke-Smith 1, J. Toouli 1, J. Chen 1
1. Department of Surgery Flinders Medicxal Centre
2. Department of Anatomical Pathology Flinders Medical Centre,
Australia
An accurate and simple prognostic criteria based on histopathology
following pancreaticoduodenectomy would be helpful in considering
adjuvant therapy. This study analysed the histological parameters in-
fluencing outcome following pancreaticoduodenectomy.
Method: 110 pancreaticoduodenectomies were performed from
1998 to 2008. The median age was 69(20-89). The median follow-
up was 4.9 years. 87%(96) were performed for malignancies and
the rest(n=14) for benign aetiologies. Of the 96 malignancies, 60
were pancreatic adenocarcinoma, the rest were ampullary(14),
cholangio(9), duodenal(9) carcinomas & others. Statical analysis
was performed using log rank and Cox regression multivariate
analysis(SPSS® version 11.5.0).
Results: Patient who had malignancies resected had 1, 3 & 5 year
survival of 70%, 46% & 41% respectively. The 1, 3, 5 year sur-
vival for periampullary cancers other than pancreatic adenocar-
cinoma were 83%, 69% & 61% respectively compared with
pancreatic adenocarcinoma of 62%, 31% & 27% respec-
tively(P<0.003). Poor tumour differentiation(P<0.02), tumour
size > 3cm(P<0.04), margin ≤ 2mm(P< 0.02), nodal involve-
ment (P<0.003), perineural invasion(P<0.0001) and lymphovas-
cular invasion(P<0.003) were associated with poorer prognosis.
In multivariate analysis, perineural(P<0.03) & lymphovascular
(P=0.05) invasion were significant factors influencing outcome.
If both these factors were negative, the 5 year survival was 77%
compared with 15% if both parameters were positive(P<0.0001).
For the subgroup of pancreatic adenocarcinoma, those that were
negative for both factors had a 5 year survival of 71% compared
with 16% for those that were both positive(P<0.02).
Conclusion: A histolopathological criteria based on perineural
and lymphovascular invasion is highly significant in predicting 5
year outcome for pancreaticoduodenectomy for periampullary
and pancreatic malignancies.
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GROWTH RATE OF SEROUS CYSTIC TUMORS
OF THE PANCREAS: ANALYSIS OF SERIAL
MAGNETIC RESONANCE IMAGING IN 56
PATIENTS
G. Malleo 1, R. Salvia 2, S. Crippa 2, S. Partelli 2, R. Rossini 2,
C. Bassi 2
1. Department of Surgical and Gastroenterological Sciences;
General Surgery B, “G.B. Rossi” Hospital, University of Verona, Italy
2. Department of Surgery University of Verona, Italy
Background: The management of pancreatic serous cystic tumors
(SCTs) is currently under debate. It has been shown that SCTs > 4 cm
in diameter are more likely to be symptomatic and that their growth
rate is significantly faster than lesions < 4 cm. Resection has been thus
recommended, regardless of symptoms, for SCT > 4 cm (1).
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Aim: To estimate SCTs growth rate using magnetic resonance
imaging and test whether a diameter of 4 cm is a reliable cut-off
size above which to recommend resection.
Methods: Serial MR/MRCP films were analysed for 56 patients.
Tumor size was calculated as previously described: tumor volume
was estimated using the formula π/6 x (d1 x d2 x d3), where d is
diameter. When fewer than three diameters were available the
formula was modified as follows: π/6 x (d12 x d2) or π/6 x (d13).
Tumor volume growth (doubling time [DT]) was estimated using
the Schwartz equation: DT = [(ln2) (t2 – t1)]/ln(v2/v1), where t
is time and v is volume (1).
Results: A significant difference in growth rate between tumors
< 4 cm at the diagnosis (0.096 cm/year) and tumors > 4 cm (0.42
cm/year) was observed (p <0.01). However, growth rates were
overall much slower than those reported by Tseng and co-wor-
kers (0.48 cm/year vs 1.98 cm/year respectively) (1).
Conclusions: Our results come from the analysis of a single ima-
ging modality, with a consistently larger patient cohort than pre-
viously reported. Although lesions > 4 cm grow significantly
faster, SCTs seem in general to grow much slower than expected,
so that in asymptomatic patients with a lesion larger than 4 cm
an aggressive policy could not always be justified. To wait (for
symptoms) and see (imaging) still represents – in our opinion –
the most reliable policy.
References: Tseng JF, Warshaw AL, Sahani DV, et al. Serous
cystadenoma of the pancreas: tumor growth rates and recom-
mendations for treatment. Ann Surg 2005; 242:413-419.
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IMPACT OF PANCREATIC LEAK ON LONG
TERM SURVIVAL AFTER WHIPPLES
RESECTION FOR PANCREATIC DUCTAL
ADENOCARCINOMA
F. Ausania, A. Jah, N. Jamieson, E. Huguet, R. Praseedom
Hepatobiliary Unit Addenbrooke’s Hospital, UK
Background: Although pancreatic leak following pancreatico-
duodenectomy (PD) has a major impact on post-operative mor-
tality, its effect on long term survival, particularly with regards to
cancer recurrence is unclear.
Aim: To compare the long term outcome in patients with or with-
out pancreatic leak after PD for pancreatic ductal adenocarcinoma.
Methods: Details of all the patients who underwent PD for pan-
creatic ductal adenocarcinoma between June 2002 and June 2007
were obtained from a prospectively held database. Pancreatic
leak was defined as drain fluid amylase level more than three
times the serum level for more than 3 days post-operatively. All
patients were considered for recruitment in to ESPAC III trial
and followed up for life. Long term survival of patients with and
without leaks were compared using Kaplan-Meier curves and sig-
nificance was measured using log-rank test.
Results: A total of 144 patients underwent PD of which 47 had
post-resection histological diagnosis of pancreatic ductal adeno-
carcinoma. There was no 30-day mortality. Median follow-up was
30.8 months. Pancreatic leak occurred in 9 patients (19%). The
overall survival of patients with and without pancreatic leaks was
not statistically different at 1 year (66% vs. 81%, p 0.38), 2 years
(22% vs. 55%, p 0.06) and 3 years (22% vs. 15%, p 0.58) respec-
tively. Similarly, there was no significant difference in disease-
free survival at 1, 2 and 3 years.
Conclusions: Pancreatic leak following PD does not significantly
impact on the long term outcome of patients with pancreatic duc-
tal adenocarcinoma.
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RESECTION OF HILAR
CHOLANGIOCARCINOMA WITH LEFT
HEPATECTOMY FOLLOWING PREOPERATIVE
EMBOLIZATION OF PROPER HEPATIC
ARTERY. A NEW APPROACH FACILITATING
SAFE R0-RESECTION
Y. Yasuda 1, P. Larsen 2, T. Ishibashi 1, K. Yamashita 1,
H. Toei 3, K. Tamada 4, H. Nagai 1
1. Dept. of Gastroenterology and General Surgery Jichi Medical
University, Japan
2. Department of Surgery and Transplantation Rigshospitalet,
University of Copenhagen, Denmark
3. Dept. of Radiology Jichi Medical University, Japan
4. Dept. of Internal Medicine and Gastroenterology Jichi Medical
University, Japan
Background: Right or right extended hepatectomy including cau-
date lobe, is the preferred treatment of Hilar Cholangiocarci-
noma(HC). A 5-year survival up to 60 % can be obtained by this
procedure if R0-resection is obtained. In rare cases a left sided
liver resection is necessary to obtain radical resection. The close
relationship between right hepatic artery and the HC in these
cases often precludes R0-resection or involves difficult vascular
reconstruction. We theorized that preoperative embolization of
proper hepatic artery would induce development of arterial col-
laterals transversing the hepatic suspensory ligaments, taking over
arterial supply of the liver, thus facilitating safe R0 resection of
the HC, as the proper and right hepatic artery could be totally re-
sected without vascular anastomosis.
Aim: To demonstrate the efficacy of preoperative embolization of
proper hepatic artery in patients with HC requiring a left sided
hepatectomy.
Methods: In HC patients, considered to have a left hepatic lo-
bectomy on the basis of the extent of tumor spread and in whom
preoperative work up revealed possible tumor invasion of the
right hepatic artery, a transcatheter arterial embolization (TAE)
of the proper hepatic artery or the left and right hepatic arteries
was performed Only the main stem of the hepatic artery at the
porta hepatis was occluded, avoiding embolization of the perip-
heral segments of the artery. The TAE was done with coils, fol-
lowed by pieces of Spongel if vascular occlusion was inadequate.
2-3 weeks later left sided hepatectomy with resection of all por-
tal structures except portal vein was performed, followed by bili-
ary Roux-en-Y reconstruction.
Results: Of the 43 patients operated for HC at our department in
the period 2000 to 2005, 6 patients fulfilled the criteria for preo-
perative embolization of the proper hepatic artery. After 2-3
weeks arterial flow signals could be detected in the liver by dop-
pler sonography in all 6 patients and surgery could be performed.
Patient characteristics and results according to table 1. No pa-
tient died during surgery or had local recurrence. All complicati-
ons were managed successfully by percutaneous drainage
procedures. 2 patients (33%) are still alive with no recurrence
more than 4 years after surgery.
Summary: Resection of Hilar Cholangiocarcinoma with left he-
patectomy following preoperative embolization of proper hepatic
artery is a promising new approach facilitating safe R0-resection
of this technically demanding group of patients, giving them the
chance of cure.
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SURVIVAL AFTER LIVER TRANSPLANTATION
FOR HEPATOCELLULAR CARCINOMA IN THE
MELD SYSTEM ERA
G. Tsoulfas, T. Kawai, D. Ko, N. Elias, A. Cosimi, M. Hertl
Harvard Medical School Massachusetts General Hospital
Background: The effect of the model for end-stage liver disease
(MELD) system on the post-transplant survival of patients with
hepatocellular carcinoma (HCC) has not been fully elucidated.
Objective: To review the results of LT for HCC at Massachusetts
General Hospital over a period of 10 years, with special empha-
sis on the effect of the MELD system since its implementation
date of February, 2002.
Methods: Retrospective review of 48 patients who underwent LT
for HCC between 1995 and 2005. Outcome measures included
demographics, tumor stage at explant, patient survival (Kaplan-
Meier), and tumor recurrence.
Results: On pathologic review of the explanted liver, 17% of pa-
tients were classified as stage I; 38% stage II; 21% stage III; and
22% stage IV.
The overall actual survival rate was 80% at 1-year, 75% at 3-year,
50% at 5-year and 40% at 10-year. Overall tumor recurrence was
12.5%, with average time to recurrence 410 days. As seen in the
figure survival rates were higher after the MELD system com-
pared to before (3-year survival 60% before MELD vs. 80% after
MELD). This was an effect of the extra points assigned for HCC,
as there was no difference in the calculated MELD scores (16 vs.
18) or the stages between the pre- and post-MELD era patients.
Furthermore, recurrence decreased from 21% to 6.9%. Other
findings included no effect on survival of pretreatment for HCC.
Conclusion: We showed a beneficial effect of the MELD system on
survival after LT for HCC, and a decrease in the recurrence rate.
Table 1. Patient characteristics and results
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NERVE STIMULATOR GUIDED THORACIC
PARAVERTEBRAL NERVE BLOCK:
AN ANAESTHETIC APPROACH FOR OPEN
CHOLECYSTECTOMY IN PATIENTS WITH
SEVERE CARDIOPULMONARY DISEASE.
I. Serpetinis 1, L. Baltatzi 1, E. Basiakou 1, K. Avgerinos 2,
A. Kouta 1. C. Dervenis 2
1. Department of Anaesthesia Konstantopoulion General Hospital
2. Kostantopouleio-Agia Olga Hospital, 1st Surgical Department-
Liver surgical unit, Athens, Greece
Background: The purpose of this study was to assess the safety
and efficacy of thoracic paravertebral block (TPNB) as an anaes-
thetic technique for open cholecystectomy in patients ASA III-IV.
Methods: In 12 patients (9 males and 3 females) nerve stimula-
tor guided TPNB was performed at T5-T9 levels, after light in-
travenous sedation. For postoperative analgesia a catheter was
placed at T7 level. Operating time was recorded as well as any
intra-operative incidents, especially related to anaesthesia. Time
for completion and full onset of TPVB was 18 ± 7 minutes and
17 ± 5 minutes respectively. During the surgical procedure light
intravenous analgesia was given (remifentanyl 1-2µg/Kg/h), when
needed. Any anaesthetic complication, as well as pain, were as-
sessed with follow up and the visual analogue scale (VAS) at 0, 4,
8, and 24 h post-operatively. The surgical indications were: gall
bladder empyema or hydrops, previous multiple episodes of pan-
creatitis or cholecystitis. The surgical procedures were performed
by the same surgical team. Average operative time was 73 ± 17
minutes.
Results: No conversion to general anaesthesia was required, and
no major event was recorded during the procedure. No patient
complained of headache, nausea or vomiting intra-operatively.
All patients were breathing spontaneously and hemodynamic sta-
bility was maintained during the procedure. Postoperatively, the
VAS at 0, 4,8 and 24 was 1, 2, 1 and 1 respectively.
Conclusions: Thoracic paravertebral block could be a safe and
efficient alternative anaesthetic method in ASA III-IV patients
undergoing open cholecystectomy.
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LIVER RESECTION FOR MULTINODULAR
HEPATOCELLULAR CARCINOMA. LESSION
LEARN FROM OBSERVATIONAL STUDY ON 464
PATIENTS
R. Andrea1, P. Silvia1, C. Franco2, C. Iacono1, V. Alessandro1,
P. Gianluca1, L. Marta2, P. Stefano2, G. Alfredo1
1. General Surgery A Department of surgical an gastroenterological
sciences
2. Internal Medicine Department of internal medicine, Desenzano
Hospital
ABSTRACT BODY:
Background and Objective: The role of liver resection of multin-
odular hepatocellular carcinoma (HCC) is still controversial. The
aim of this study is to evaluate the results of surgical resection in
patients with multinodular HCC.
Methods:464 patients with HCC treated from 1991 to 2007 were
included into this study. According to the tumor stage and de-
gree of liver impairment patients were submitted to surgical re-
section (LR) or local ablative therapy (LAT) or
chemoembolization. Eighty-eight patients were excluded from
treatment and best supportive therapy (ST) was applied. All the
patients included into the study had no evidence of distant metas-
tases. Eight patients submitted to liver transplantation were ex-
cluded from the statistical analysis.
Results: Median follow up time for surviving was 25 months
(range 1-155. Two hundred and eighty-three patients were in
Child-Pugh class A, 161 in class B and 20 in class C. Two-hun-
dred and seventy-one patients had single HCC, 121 patients had
two or three HCCs, and 72 more than three HCCs. 136 (30 %)
patients were submitted to LR, 232 (51 %) to LAT and 88 (19.0
%) to ST Median survival time for all patients was 30.4 months
(95% CI 24-36). Median survival time was 57 months for LR, 30
for LAT and 8 for ST, with a 5 year survival of 47 %, 20 % and 2.5
% respectively (p=0.001). Overall survival was significantly
shorter in patients with multiple HCCs compared to single HCC
with a median survival time of 39, 36, 18 and 11 months for pa-
tients with single HCC, with 2 HCCs, with 3 HCCs and with more
than 3 HCCs respectively (p=0.001). Survival for patients with
single HCC was significantly longer in patients submitted to LR
compare to LAT and ST with a median survival time of 57, 37
and 14 months respectively (p=0.001). Also in patients with
multinodular HCCs (2-3 HCCs) LR showed best results with a
median survival time of 59 months compared to 22 and 8 months
for LAT and ST respectively (p=0.001). In patients with more
than 3 HCCs LR did not showed different results compared to
LAT and ST with a median survival time of 10, 29 and 10 months
respectively.
Conclusions: The present study shows that multinodular HCCs
(2-3 nodules) can benefit from LR compared to LAT or ST. In
patients with more than 3 HCCs LR seems to have similar results
of LAT.
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POOR CORRELATION AMONG EXPERTS
PATHOLOGISTS IN INTERPRETING LIVER
STEATOSIS? 20 -YEARS OF MISLEADING DATA!
A. El-Badry1, S. Breitenstein1, W. Jochum2, K. Washington3,
V. Paradis4, L. Rubbia-Brandt5, M. Puhan6, K. Slancamenac1,
R. Graf1, P. Clavien1
1. Department of Visceral and Transplantation Surgery University
Hospital Zurich, Switzerland
2. Department of Pathology University Hospital Zurich,
Switzerland
3. Department of Pathology University Medical Center
Nashville, USA
4. Department of Pathology Beaujon Hospital Paris, France
5. Department of Pathology University Hospital of Geneva,
Switzerland
6. Department of Epidemiology Johns Hopkins University, USA
Background: Most surgeons consider liver steatosis as a major
risk factor for liver surgery. The current standard is microscopic
evaluation by pathologists, although consistency in such evalua-
tion remains unclear. Computerized image analysis (CIA) is a
novel approach to objectively assess the degree of hepatic steato-
sis. The aim of this study was to test the consistency of histologi-
cal assessment of hepatic steatosis among expert pathologists and
(CIA).
Methods: High resolution images of hematoxylin and eosin
stained sections of resected liver parenchyma from 46 consecutive
patients, initially diagnosed with liver steatosis, were blindly as-
sessed by four expert pathologists in liver disease from different
institution (France, Switzerland and USA). Standardized defini-
tions of various histological parameters were applied. The sec-
tions were also evaluated by CIA. The inter-observer agreement
among pathologists was evaluated using interclass correlation co-
efficients.
Results: Among pathologists, the number of patients with steato-
sis < 5%, 5-30%, >30-60% & >60% ranged from 9-12, 21-26, 6-
10 and 3-6, respectively. The correlation index for micro- macro-
and total steatosis was poor, respectively, 0.22, 0.55 and 0.57 (>
0.7 indicates acceptable agreement). Very poor conformity was
also observed among three pathologists and CIA regarding total
steatosis (correlation index: 0.22, 0.82, 0.28 and 0.38).
Conclusion: Quantification of hepatic steatosis in histological
sections is strongly observer-dependent, not reproducible, and
does not correlate with CIA. None of the evaluations convinc-
ingly correlated with postoperative complications. Current stan-
dards of assessment, previous published data and the clinical
relevance of liver steatosis for liver surgery must be challenged.
Novel tools for convincing investigation must be developed.
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patients following resection.
Methods: The frequency of specific lymphocyte subsets within
tumour and macroscopically normal adjacent liver tissue, and pe-
ripheral blood was determined using flow cytometry in 14 patients
undergoing surgical resection of colorectal liver metastases.
Results: After a median follow up of 22 (13-26) months 3 patients
survived free of disease, 4 patients survived with recurrent dis-
ease and 7 patients died of disease. T cells were the dominant
tumour infiltrating lymphocyte (51.9 (37.1- 79.3)% T cells, 17.0
(6.02-21.1)% NK cells) whereas in liver they were in similar
proportions to NK cells (39.0 (23.5-70.6) T cells, 41.7(7.9-62.6)%
NK cells). The percentage of T cells in the livers was 69.53
(54.13-70.6)% in the disease free survivors, 36.06 (34.27-51.6)%
in those surviving with recurrence and 38.49 (23.54-42.3)% in
those who had died. A less marked trend was seen in the metas-
tases (70.18 (68.1-74.9)% v 67.02 (54.7-79.3)% v 57.4 (37.1-
46.7)% respectively). Analysis of the NK cell numbers and other
immunological parameters within the metastases, liver and pe-
ripheral blood appeared not to correlate with patient outcomes.
Conclusions: This pilot study suggests that the immunological re-
sponse to CRLM within the liver may be an important determi-
nant of survival after resectional surgery. A larger study which
includes examination of T cell subsets is ongoing.
Reference: 1. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A,
Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A,
Wind P, Zinzindohoué F, Bruneval P, Cugnenc PH, Trajanoski Z,
Fridman WH, Pagès F. Type density and location of immune cells
within human colorectal tumours predict clinical outcome.
Science 2006; 313: 1960-4.
O 05
ASCITES AFTER LIVER RESECTION IS NOT
ONLY ASSOCIATED WITH LIVER FAILURE
M. Lesurtel, W. Andraus, M. Zappa, O. Farges, J. Belghiti
Department of HPB Surgery Beaujon’s hospital
Background: Postoperative ascites can occur after hepatectomy in
non-cirrhotic patients and may increase postoperative morbidity.
Aim: To provide the features of natural history of ascites after
liver resection and to determine the risk factors.
Methods: The postoperative fluid output was prospectively
recorded in 100 consecutive patients who underwent a liver re-
section (60% major hepatectomy). All patients had systematic
abdominal drainage until postoperative day 8. Postoperative as-
cites was arbitrarily defined as a daily output greater than 500 mL
for at least one day between postoperative day 3 and 8. Uni and
multivariate analysis were performed to identify risk factors for
postoperative ascites.
Results: The incidence of postoperative ascites was 29%. Its out-
put was maximum at postoperative day 6. The rate of cirrhosis
was similar in patients with or without ascites (10% vs. 17%,
p=0.2). The factors associated with postoperative ascites in uni-
variate analysis were peroperative fluid infusion (p=0.005), in-
flow occlusion (p=0.04), blood loss (p=0.04) and peroperative
transfusion (p=0.03). On multivariate analysis, only peroperative
fluid infusion was a significant predictor of postoperative ascites.
Ascites was not significantly associated with liver failure (3.4%
vs. 0%, p=0.3), kidney failure (3.4% vs. 8.5%, p=0.3) or mortal-
ity (3.4% vs. 0%, p=0.3) compared with patients without ascites,
respectively. However, the hospital stay was significantly longer in
case of postoperative ascites (20 vs. 12 days, p=0.007).
Conclusions: Ascites after liver resection is not restricted to cir-
rhotic patients. It is also dependant on peroperative mechanistic
factors like fluid infusion.
O 03
PARTIAL LIVER RESECTION FOR HCC
IN PATIENTS WITH GOOD LIVER FUNCTION
CAN CHALLENGE LT
J. Belghiti, A. Herrero, C. Pulitano, O. Farges, A. Sauvanet,
F. Dondéro, D. Sommacale
Departement of HPB Surgery Beaujon’s hospital
Background: Indications of partial liver resection for HCC was
challenged by the increasing use of liver transplantation (LT) dur-
ing the last ten years, in a context of lack of graft.
Objective: The aim of this study was to evaluate, in patients with
good liver function, the outcome after partial resection for HCC.
Methods: From 1990 to 2007, 609 resections in 556 patients with
good liver function (Child A) were analyzed in two consecutive
periods (before and after 2000).Chronic liver disease (CLD) was
present in 367 (66%) patients, including 229 with cirrhosis asso-
ciated with HCV (n=141), HBV (n=114), alcohol (n=60) and
cryptogenic (n=65). Major liver resection was performed in 275
patients, 53 underwent second resection and 43 patients were
transplanted after recurrence.
Results: As shown in the table below, patients resected in the sec-
ond period were older with larger size tumors and underwent
more often major resection, mortality decreased significantly
(7.9% vs. 3.3%) and 5 years survival increased dramatically from
44% to 74%.
Conclusions: Results showed that partial liver resection for HCC
in patients with good liver function can challenge LT. Better pa-
tient selection and preparation, including PVE, resulted in a low
mortality. The 5 years survival of 74% resulted from operative
technical changes, especially oncological surgical approach, spe-
cific aggressive management of recurrence including liver trans-
plantation, and the control of the underlying disease with better
medical treatment.
O 04
T CELL INFILTRATION OF LIVER BEARING
COLORECTAL METASTASES (CRLM) MAY
PREDICT OUTCOME AFTER RESECTION:
A PILOT STUDY
S. Pugh, M. Abu Hilal, N. Pearce, S. Khakoo, J. Primrose
Southampton University Hospital, Southampton UK
Background: The type and density of lymphocytes infiltrating pri-
mary colorectal cancers has been shown to predict survival (1).
We have previously demonstrated that whereas there was defi-
cient recruitment of innate immune cells to CRLM, T cells were
prevalent.
Aim: In this pilot study we have correlated the immune cell mi-
lieu within the CRLM and adjacent liver with the outcome in the
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CTCs were localized to the hepatic portal-systemic macrocircu-
lation with significantly greater numbers than in the systemic vas-
culature. Importantly, the lungs filtered 99% of CTCs from the
liver, with only less than 1% entering the systemic circulation.
Surgical procedures led to a statistically significant fall in CTCs at
all sites measured (p<0.03). Conversely, RFA was associated
with an increase in CTCs in peripheral circulation (p<0.04). Re-
duction in CTCs was strongly correlated with reduction in tumor
markers.
Conclusions: Surgical procedures but not RFA decreases CTC
levels. In patients with colorectal liver metastases, CTCs are lo-
calized to the hepatic and pulmonary macrocirculations. This may
explain why metastases outside of the liver and lungs are infre-
quently observed in cancer.
O 08
IMPACT OF PORTAL VEIN EMBOLIZATION
ON LONG-TERM SURVIVAL AFTER MAJOR
HEPATECTOMY FOR COLORECTAL LIVER
METASTASES
D. Wicherts, R. de Haas, P. Andreani, D. Sotirov, C. Salloum,
D. Castaing, R. Adam, D. Azoulay
Centre Hépato-Biliaire Hôpital Paul Brousse
Background: Portal vein embolization (PVE) increases the re-
sectability of initially unresectable colorectal liver metastases
(CLM) due to a too small remnant liver. However, long-term out-
come of these patients remains unclear.
Aim: To evaluate long-term survival in patients with CLM that
underwent major hepatectomy following PVE.
Methods: Patients that underwent major hepatectomy for CLM
between January 1990 and January 2006 were selected. Patients
treated by PVE before hepatectomy were compared with PVE
naïve patients.
Results: Of 364 included patients, 67 (18%) underwent PVE be-
fore hepatectomy and 297 (82%) were resected without PVE.
Thirty-two other PVE patients did not undergo resection and
were excluded. Resected PVE patients more often had >3 liver
metastases (68% vs 41%) (P<0.001), that were more frequently
bilobar (78% vs 56%) (P<0.001). PVE patients underwent more
extended hepatectomies (63% vs 19%) (P<0.001). Postoperative
mortality rate was 2% (1/67) in the PVE group, and morbidity
occurred in 55% of patients versus 41% in the control group
(P=0.04). Overall 3- and 5-year survivals were 44% and 21% for
resected PVE patients, and 61% and 47% for resected PVE naïve
patients (P=0.001). All 32 PVE patients that did not undergo he-
patectomy died within 3 years. Multivariate analysis identified ex-
trahepatic disease, preoperative chemotherapy, and PVE as
independent prognostic factors of poor survival.
Conclusions: PVE increases the resectability rate of patients with
advanced CLM by 18%. Together with a significantly higher long-
term survival than for nonresected patients, these results confirm
the important value of PVE in the current management of pa-
tients with CLM.
O 06
EMBOLIZATION VERSUS LIGATION OF THE PORTAL
VEIN TO INDUCE HYPERTROPHY OF THE FUTURE
REMNANT LIVER IN A RABBIT MODEL
J. van den Esschert1, W. de Graaf1, K. van Lienden2,
T. van Gulik1
1. Surgery AMC
2. Radiology AMC
Background: Portal vein embolization (PVE) and portal vein lig-
ation (PVL) are two methods to increase the future remnant liver
(FRL) preoperatively in case the FRL is considered too small.
Aim: To assess if PVE is superior to PVL for induction of a hy-
pertrophy response.
Methods: Female New Zealand White rabbits of 3kg were allo-
cated to PVE or PVL (n=10/group). The portal vein branches to
the cranial liver lobes were occluded, which acount for ±80% of
the total liver. Occlusion of the portal vein was assessed by por-
tography. Regeneration of the FRL was measured using CT-vol-
umetry. A multiphasic CT-scan was performed the day before
PVE in all rabbits. This imaging procedure was repeated at day 3
and 7 (subgroup A, n=5) and at day 10 and 14 (subgroup B, n=5),
after which the rabbits were sacrificed. Liver weight was measured
and tissue samples were taken. Liver function and damage pa-
rameters were assessed at several time points. Paraffin embedded
liver tissue was stained for hepatocyte proliferation (Ki-67).
Results: There was a significant difference in hypertrophy re-
sponse in favour of PVE. When the separate time points were
analysed, a significant difference was found on day 10 and 14
(p<0.05). A higher number of proliferating hepatocytes was
found in the FRL 7 days after PVE compared to PVL (p<0.05).
Liver damage was minimal and liver function was preserved in
both procedures.
Conclusion: PVE is superior to PVL in terms of inducing hyper-
trophy response.
O 07
IMPACT OF SURGICAL AND RADIOLOGICAL
INTERVENTIONS ON CIRCULATING
TUMOUR CELLS IN COLORECTAL LIVER
METASTASES
L .Jiao, N. Tsim, N. Johnson, N. Habib, C. Coombes,
J. Stebbing
Imperial College London Hammersmith Hospital
Background: There is limited data on the impact of differing in-
terventions on circulating tumor cells (CTCs), nor their com-
partmentalization in different anatomical vascular sites.
Aims: To examine the impact of interventions on CTCs and cor-
relate this with clinical outcome.
Methods: CTCs from consecutive patients with colorectal liver
metastases were quantified prior to and immediately after open
surgery, laparoscopic resection, open or percutaneous radiofre-
quency ablation (RFA). For individuals undergoing open surgery,
either hepatic resections or open RFA, CTCs were examined in
both systemic and portal circulation by measuring CTCs in sam-
ples derived from peripheral vein, peripheral artery, the portal
and the hepatic veins. Tumor markers were also assessed before
and after intervention.
Results:A total of 29 consecutive patients with colorectal liver metas-
tases were included with a median age of 55 (range 30 – 88 years).
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O 09
HEPATIC PREPARATION DURING
COLORECTAL RESECTION IN A TWO-STAGE
HEPATECTOMY STRATEGY FOR BILOBAR
SYNCHRONOUS METASTASES:
M. KarouI1, L. Vigano2, P. Goyer1, A. Ferrero3, A. Laurent2,
N. Russolillo3, C. Tayar1, F. BrunettiI1, l. Capussotti3,
D. CherquiI2
1. HPB and Digestive Surgery Hôpital Henri Mondor,
Créteil, France
2. Dept of surgery hopital henri mondor creteil france
3. HPB Unit Ospedale Mauriziano
Background: Resectability of bilobar liver metastases (LM) can
be increased by two-stage hepatectomies. In LM synchronous to
colorectal cancer (CRC), first-stage hepatectomy can be simul-
taneous to colorectal resection.
Aim: To analyze outcomes of this strategy.
Methods: Between 2000 and 2007, 25 patients with bilobar LM
with CRC in situ have been scheduled for a two-stage hepatec-
tomy. Their outcomes have been reviewed.
Results: 1st stage: All cases had CRC resection with left liver
clearance. Portal vein (PV) ligature was performed in 11 (44%)
cases. Mortality was nil and morbidity was 24%. Anastomotic leak
occurred in 3 (12%) patients (2 with PV ligature).
17 (68%) patients received interval chemotherapy and 3 (12%)
PV embolization.
2nd stage: 21 (84%) completed the two-stage procedure (4 had
neoplastic progression). Mortality and morbidity were 5% and
33%, including 3 liver dysfunctions, 1 bile leak and 1 PV throm-
bosis (dead patient). Radical resection rate was 86%.
Three-year overall and disease-free survival rates for patients who
completed the procedure were 75.5% and 38.5%. Disease-free
survival was reduced in patients with extrahepatic disease (1-year
0% vs 58% p=0.029), but their survival was better than patients
who did not complete the two-stage procedure (3-year 66.7% vs
0%, p=0.007).
Conclusions: Two-stage hepatectomy with liver preparation si-
multaneous with colorectal resection is safe and feasible. More
than three fourth of patients who completed the procedure are
alive at 3 years from the second hepatectomy. Even if increased
recurrence rate occurred in patients with extrahepatic disease,
completion of the two-stage procedure offered improved survival.
O 11
OVERWEIGHT AND FATTY PANCREAS
INCREASE THE RISK OF PANCREATIC
FISTULA FOLLOWING PANCREATICODUO-
DENECTOMY
S. Gaujoux1, A. Cortes1, A. Couvelard2, G. Nagarajan1,
S. Noulet1, L. Clavel3, P. Lévy4, A. Sauvanet2, J. Belghiti2
1. HPB Surgery Hospital Beaujon
2. Pathology Hospital Beaujon
3. INSEE Paris
4. Gastroenterology Hospital Beaujon
Background: The only commonly accepted risk factor of pancre-
atic fistula (PF) following pancreaticoduodenectomy (PD) is the
soft consistency of the pancreatic remnant, despite its subjective
evaluation.
Aims: To determine the influence of Body Mass Index (BMI),
pancreatic fatty infiltration and fibrosis on pathological exami-
nation, apart from the other commonly accepted risk factors, on
the risk of PF following PD.
Methods: One hundred consecutive patients, prospectively col-
lected, underwent PD. On the pancreatic margin, a score of fi-
brosis and fatty infiltration, were assessed by a pathologist
unaware of the postoperative course.
Results: PF occurred in 31% of cases. In univariate analysis, male
gender, age over 58 years, BMI ≥ 25 kg/m², preoperative high
blood pressure, surgery for non-IPMN disease and ampullary car-
cinoma, operative time, blood loss, soft consistency of the pan-
creatic remnant, absence of pancreatic fibrosis and presence of
fatty infiltration were associated with a higher risk of PF. In mul-
tivariate analysis, only BMI ≥ 25 kg/m², absence of pancreatic fi-
brosis and presence of fatty pancreas were significant predictors
of PF. A score based on the number of risk factors present, iso-
late subgroups carrying a risk of PF ranging from 7% (no risk fac-
tor) to 78% (3 risk factors).
Conclusions: Identification of high BMI, fatty pancreas and ab-
sence of pancreatic fibrosis as risk factors of PF allows a more
precise and objective prediction of PF than the consistency of
pancreatic remnant alone. A predictive score based on these 3
factors could help to tailor preventive measures to this group of
patients.
O 10
ADJUVANT INTRA-ARTERIAL CHEMOTHERAPY
AND RADIOTHERAPY VERSUS SURGERY
ALONE IN RESECTABLE PANCREATIC AND
PERIAMPULLARY CANCER. A PROSPECTIVE
RANDOMISED CONTROLLED TRIAL
M. Morak1, A. van der Gaast2, L. Incrocci3, H. van Dekken4,
J. Hermans5, J. Jeekel1, W. Hop6, G. Kazemier1, C. van Eijck1
1. Dep Surgery Erasmus Medical Centre
2. Dep Oncology Erasmus Medical Centre
3. Dep Radiotherapy Erasmus Medical Centre
4. Dep Pathology Erasmus Medical Centre
5. Dep Radiology Erasmus Medical Centre
6. Dep Statistics Erasmus Medical Centre
Background: Success of surgical treatment for pancreatic and pe-
riampullary cancer is often limited due to locoregional recurrence
and/or the development of distant metastases.
Objective: Survival benefit of celiac axis infusion and radiother-
apy (CAI/RT) versus observation following resection of pancre-
atic or periampullary cancer was investigated.
Methods: In a randomized controlled trial, 120 consecutive pa-
tients with histopathologically proven pancreatic or periampullary
cancer received either adjuvant treatment consisting of intra-ar-
terial mitoxantrone, 5-FU, leucovorin and cisplatinum in combi-
nation with 30x 1.8 Gray radiotherapy or no adjuvant treatment.
Treatment efficacy was stratified for tumour type (pancreatic vs.
periampullary tumours).
Results: After surgery, 59 patients were randomized to CAI/RT
and 61 to observation. CAI/RT did not result in overall survival
benefit (median 19 vs. 18 months). Time to progressive disease
was longer after CAI/RT (12 months) than after observation (7
months; p=0.027). Patients with periampullary tumours devel-
oped significantly less liver metastases after CAI/RT (log-rank
p<0.02) without effect on local recurrence. Nonetheless, there
was no significant effect on overall survival in these patients (log-
rank p=0.12). In patients with pancreatic cancer, CAI/RT had
no significant effect on local recurrence (log-rank p=0.13) nei-
ther on the development of liver metastases (log-rank p=0.66)
and consequently, no effect on overall survival.
Conclusion: This adjuvant treatment schedule results in a pro-
longed time to progression. For periampullary tumours, CAI/RT
induced a significant reduction in the in the development of liver
metastases, with a possible effect on overall survival. Especially in
these tumours, CAI/RT might prove beneficial in larger groups
and further research is warranted.
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O 12
MAIN-DUCT AND COMBINED IPMNS ARE THE
SAME CLINICAL ENTITY AND DISTINCT FROM
BRANCH-DUCT IPMNS
S. Crippa1, C. Fernandez-del Castillo2, R. Salvia1,
D. Finkelstein3, C. BasiiI1, I. Dominguez2, M. Falconi1,
M. Mino-Kenudson4, P. Capelli5, G. Lauwers4, S. Thayer2,
S. Partelli1, P. PederzoliI1, A. Warshaw2
1. Department of Surgery University of Verona
2. Massachusetts General Hospital, Boston, USA Dept of Surgery
3. Massachusetts General Hospital, Boston, USA Dept od Biostatistics
4. Massachusetts General Hospital, Boston, USA Dept of Pathology
5. Pathological Dept Verona University
Background & Aims: Intraductal papillary mucinous neoplasms
(IPMNs) of the pancreas comprise main-duct (MD), branch-duct
(BD) and combined types. The aim of this study was to evaluate
the clinico-epidemiological characteristics and prognosis of a
large series of patients with IPMNs, to elucidate differences
among the three types.
Methods: 389 patients who underwent pancreatic resection for
IPMN were identified.
Results: 159 (41%) patients had BD-IPMNs, 149 (38%) combi-
ned-IPMNs, and 81 (21%) MD-IPMNs. MD- and combined
IPMNs occurred more frequently in males (56%) while BD-
IPMNs in females (57%) (p<0.05). All IPMNs subtypes were ge-
nerally located in the proximal pancreas. Incidental diagnosis was
more common in BD-IPMNs (34.5%) than in MD- (13.5%) and
combined (19%) ones (p=0.001). Prevalence of adenoma was
44% in BD-, 11% in MD- and 8% in combined-IPMNs
(p=0.0001). The rate of invasive cancer was 11% in BD-IPMNs
but 42% and 48% in combined- and MD-IPMNs (p=0.0001). Pa-
tients with combined and MD-IPMNs with invasive cancer were
older than those with noninvasive tumors -suggesting tumor pro-
gression- while this age difference was not found in BD-IPMNs.
5-year DSS was 100% for patients with noninvasive BD-IPMNs
and combined-IPMNs and 95% for patients with noninvasive
MD-IPMNs; 5-year DSS was 56%, 51%, and 64%, for BD-
IPMNs, MD-IPMNs, and combined-IPMNs with invasive cancer.
Conclusion: BD-IPMNs have a specific profile, likely represent-
ing a specific entity. Combined-IPMNs show close overlapping in
regard to clinico-pathological-epidemiological characteristics
with MD-IPMNs, and should be considered an extension of MD-
IPMNs to the branch-ducts. These two subtypes show a more ag-
gressive biological behavior.
O 13
THE QUANTIFICATION OF DELAYED
GASTRIC EMPTYING IN PANCREATIC
SURGERY
G. van Samkar1, M. Lemmers2, W. Eshuis2, O. Busch2,
R. Bennink3, M. Hollmann2, M. Dijkgraaf4, D. Gouma3
1. Anesthesiology AMC, University of Amsterdam
2. Department of surgery Academic Medical Center
3. Nuclear Medicine MC, University of Amsterdam
4. Clinical Epidemiology MC, University of Amsterdam
Background: Delayed gastric emptying (DGE) is a common com-
plication after pancreatic surgery. The International Study Group
of Pancreatic surgery (ISGPS) published a consensus definition
that defines DGE by clinical criteria. It has been suggested that
diagnosis of DGE requires objectivation by a diagnostic test.
Quantitative assay is possible with gastric emptying scintigraphy.
Aim: To compare gastric emptying scintigraphy results to post-
operative incidence of DGE according to the ISGPS definition.
Methods: In 41 patients who underwent exploration for pancre-
atic or periampullary tumor, 27 pancreatoduodenectomies (PD)
and 14 double bypass procedures (DBP) were performed. Solid
phase gastric emptying scintigraphy was performed in all patients
on the 1st preoperative and 7th postoperative day. Postoperative
incidence of DGE according to the ISGPS definitions was com-
pared to scintigraphy results.
Results: Total postoperative incidence of DGE was 54% (grade
A/B/C: 20/17/17%), equally distributed between PD and DBP
groups. Preoperative scintigraphy showed normal emptying. At
postoperative scintigraphy, median post-/preoperative ratio of
half emptying time (“T½-ratio”) in patients grouped by grade of
DGE was 2.0 (no DGE), 3.3 (grade A), 5.6 (grade B) and 6.3
(grade C). Median postoperative residual activity at t=2h
(“RA120”) in these groups was 37% (no DGE), 30% (grade A),
91% (grade B) and 99% (grade C).
Conclusion: T½-ratio and postoperative RA120 show a correla-
tion with severity of DGE, especially with clinically relevant
ISGPS grades B and C. Gastric emptying scintigraphy on the 7th
postoperative day therefore may predict duration and severity of
DGE and thus play a role in its management.
Reference: Delayed gastric emptying (DGE) after pancreatic sur-
gery: a suggested definition by the International Study Group of
Pancreatic Surgery (ISGPS). Wente MN, Bassi C, Dervenis C,
Fingerhut A, Gouma DJ, Izbicki JR, Neoptolemos JP, Padbury
RT, Sarr MG, Traverso LW, Yeo CJ, Büchler MW.
Surgery. 2007 Nov;142(5):761-8.
O 14
DIFFERENTIAL EXPRESSION OF MITOCHON-
DRIAL MEMBRANE COMPLEXES IN BENIGN
AND MALIGNANT PERIAMPULLARY EPITHE-
LIUM: A POTENTIAL TARGET FOR DRUG
THERAPY?
M. Aloysius1, A. Zaitoun2, M. Ilyas2, B. Rowlands1, D. Lobo1
1. Division of Gastrointestinal Surgery Nottingham Digestive
Diseases Centre Biomedical Research Unit
2. Department of Pathology Nottingham Digestive Diseases Centre
Biomedical Research Unit
Background: Mitocans, or drugs that block the electron trans-
port chain by inhibiting mitochondrial membrane complexes
(MMCs-I, II, III, IV and V) are potential therapeutic agents for
cancer. However, the expression of MMCs in benign and malig-
nant periampullary epithelium is not known.
Aim: To investigate the expression of MMCs I, III, IV and V in
peri-ampullary cancers, chronic pancreatitis, normal pancreas
and to evaluate its potential clinical significance.
Methods: The expression of MMCs I, III, IV and V was analyzed
using immunohistochemistry of formalin-fixed human pancreatic
tissue constructed into tissue microarrays (TMAs). The study was
performed on tissue obtained from 126 consecutive patients un-
dergoing pancreatic resection at one centre.
Results: Of the 126 patients, 104 had cancer and 22 had chronic
pancreatitis. Normal pancreatic tissue was obtained from the re-
section specimens, adjacent to areas of cancer or chronic pan-
creatitis in 30 patients. Sixty one metastatic lymph nodes from 61
patients were also studied. Immunohistochemical analysis of
MMCs III, IV and V in a range of periampullary tumours,
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showed a significantly higher (p<0.05, ANOVA) expression in
periampullary cancer compared with chronic pancreatitis or nor-
mal pancreatic tissue. High expression of MMC I and V appear
to confer a survival advantage to patients. This may in part relate
to lower expression of these MMCs in poorly differentiated tu-
mours compared to well and moderately differentiated tumours.
Conclusion: Differential immunohistochemical expression of
MMCs III, IV and V in periampullary cancers compared with be-
nign pancreatic tissue may render them potentially attractive for
anti-cancer drug therapy with mitocans.
O 15
PANCREATIC SURGERY FOR METASTATIC
RENAL CELL CARCINOMA; ANALYSIS OF 397
CASES.
P. Tanis, N. van der Gaag, O. Busch, T. van Gulik, D. Gouma
Surgery Academic Medical Center
Background: Patients with pancreatic metastases from renal cell
carcinoma (RCC) may benefit from surgical treatment.
Aim: to determine population characteristics and clinical out-
come of patients with pancreatic RCC metastases.
Methods: Systematic search of literature revealed 322 surgically
treated and 75 non-surgically treated patients after exclusion of
not individually documented cases. Ten patients were surgically
treated at our centre. Actuarial survival probabilities were deter-
mined by Kaplan-Meier analysis of the pooled data and prog-
nostic factors by log-rank test and Cox proportional hazards
regression.
Results: Pancreatic metastases were solitary in 65%, synchro-
nously identified in 9%, symptomatic in 58% and preceded
and/or accompanied by extra-pancreatic disease in 22% in the re-
section group; these percentages were 60%, 3%, 60% and 58% in
the no resection group, respectively. In hospital mortality after
pancreatic surgery for RCC metastasis was 3%. Disease-free sur-
vival was 76% and 57% at two and five-year after resection with
corresponding overall survival probabilities of 81% and 73%, re-
spectively. Extra-pancreatic disease was the only significant pre-
dictor for disease-free survival after pancreatic resection
(P=0.001), whereas a symptomatic RCC metastasis was the only
significant factor for overall survival (P=0.031). Two and five-
year overall survival was 41% and 14% in the no resection group.
Conclusions: Pancreatic surgery for RCC metastases in selected
patients resulted in 74% actuarial five-year overall survival as
found by pooled analysis from published cases. Neo-adjuvant
treatment using novel systemic agents may extend indications for
surgery by down staging and adjuvant treatment may further im-
prove outcome in patients at high risk of recurrence.
O 16
AMYLASE VALUE IN DRAINS FOR EVIDENCED
BASED FAST TRACK IN PANCREATIC
SURGERY: RESULTS OF RANDOMIZED
CLINICAL TRIAL
E. Molinari1, C. Bassi2, R. Salvia2, G Butturini2, S Crippa2,
G Malleo2, P Pederzoli2
1. Surgical and Gastroenterological Department University of
Verona Policlinico G.B Rossi
2. Department of Surgery University of Verona
Background: In a previous study (1) we showed that the Amy-
lase Value in Drains (AVD) after pancreatic resection was a pre-
dictive factor of pancreatic fistula (PF) development; in fact AVD
in post-operative day one (POD1) >5000 U/L is the only signifi-
cant predictive factor of PF(p<0.0001), therefore we established
this cut-off as the “reference point”.
Aim: To demonstrate that early removal of drains reduces com-
plications in pancreatic resective surgery.
Methods: we planned a randomized clinical trial in patients un-
dergoing to pancreatic surgery.The cases with “low risk” (AVD in
POD1 £ 5000 U/L) were randomized to remove drains on POD3
(Group A) versus on POD 5/6 (Group B) that was our usual re-
moving time. Between March 2007 to April 2008 we prospectively
randomized all 114 patients with AVD in POD1< 5000 U/L, in
Group A (n=57) and in Group B (n=57). The outcome of the
two groups was than compared.
Results: The two groups were homogeneous for sex, age, nutri-
tional status of the patients , type of resection, tissue texture.
There was no mortality. 15 patients had abdominal complications
in Group B (23%) whereas 1 in Group A ( p=0.001; OR 11); 13
PF (22%) in Group B versus 1 in Group A (P=0.002; OR: 7), 15
(23%) fluid collections versus 1 (p=0.001; OR 12).The pul-
monary complications were higher in Group B ( p=0.007). In
multivariate analysis the predicting risk factors of PF was type of
randomization (delayed removal drains in POD5/6) with p=0.003
(OR: 24.3)
Conclusions: when AVD in POD1 is £ 5000 U/L after pancreatic
resection, the “early drains removal” (POD3) significantly de-
creases the rate of abdominal and pulmonary complications,
leading to a safe “fast track” policy.
1. Molinari et al Ann Surg. 2007;246:281-7
O 17
PROPHYLACTIC PANCREATICODUO-
DENECTOMY FOR ADVANCED DUODENAL
ADENOMATOSIS IN FAMILIAL
ADENOMATOUS POLYPOSIS
J. Skipworth1, C. Morkane1, M. Deheragoda2, D. Raptis1,
C. Imber1, S. Olde Damink1, M. Malago1, R. Phillips3, S. Clark3,
A. Shankar1
1. Department of HPB Surgery University College London Hospital
2. Department of Pathology University College London Hospital
3. The Polyposis Registry St. Mark’s Hospital, Harrow
Background: Patients with familial adenomatous polyposis
(FAP) develop duodenal polyps that may progress to malignancy,
via the adenoma-carcinoma sequence. In 2002, this centre re-
ported data on 16 FAP patients who underwent prophylactic duo-
denal resection for duodenal polyps. We now present the
extended results, which represents the largest series of pancre-
aticoduodenectomy for FAP ever reported.
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particular pancreatic fistula, were not significantly different in the
two groups. Median follow-up was 55 months (range 14-187).
There were no differences in terms of quality of life. However,
the rate of both exocrine and endocrine insufficiency was signif-
icantly higher in patients with COP (steatorrhea 20% versus
11.1%, p=0.05; postoperative diabetes 10% versus 4.6%,
p=0.02).
Conclusions: SCTs of the pancreas are frequently associated with
COP, especially when maximum tumor diameter is > 5cm. Once
signs of COP have developed, long-term impairment of pancre-
atic functions following resection is significantly higher. Accord-
ingly, evidence of COP at presentation or during follow-up may
represent an additional parameter for recommending surgical re-
section.
Methods: We performed a retrospective case-notes review of all
patients undergoing prophylactic duodenal resection, for ad-
vanced duodenal adenomatosis, in 1 centre. Data collected in-
cluded demographics, resection type, Spigelman staging,
morbidity and mortality. Data for 4 patients were incomplete.
Results: 33(19F:14M) FAP patients underwent prophylactic sur-
gical resection for advanced duodenal adenomatosis (Spigelman
stage III and IV) between January 1994-November 2008. Mean
patient age was 48.8 years and median hospital stay 26 days.
Available data revealed that 28 pancreaticoduodenectomies and
1 local excision+cholecystectomy were performed. Peri-opera-
tive mortality was 2(6.1%): both patients dying from multi-organ
failure following re-operation for haemorrhage. Major compli-
cations occurred in 14(42.4%) patients and included 4 anasto-
motic leaks, 3 enterocutaneous fistulae, 1 primary haemorrhage,
2 secondary haemorrhages (1 necessitating gastroduodenal ar-
tery embolisation), 2 thromboembolic events, 1 lymphatic leak
and 1 chylous ascites. Postoperative histology revealed 6(18.2%)
pre-operatively undetected ampullary/duodenal cancers–
4(66.7%) of these patients have subsequently died.
Conclusion: Prophylactic pancreaticoduodenectomy is associated
with significant morbidity and mortality; however, FAP patients
with advanced duodenal polyposis have a significant risk of ma-
lignant transformation and some have undetected malignancy.
Thus, the identification of FAP patients requiring surgical inter-
vention for high-risk of duodenal malignant transformation re-
mains challenging.
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CHRONIC OBSTRUCTIVE PANCREATITIS
ASSOCIATED WITH SEROUS CYSTIC
TUMORS OF THE PANCREAS: A NEW
ISSUE TO BE EXPLORED
A. Esposito, R. Salvia, G. Malleo, S. Crippa, S. Partelli,
M. Massignani, C. Bassi
General Surgery B Department of Surgical and Gastroenterologica
Sciences, University of Verona, Italy
Background: The association between chronic obstructive pan-
creatitis (COP) and serous cystic tumors (SCTs) of the pancreas
has not been investigated so far.
Aim: To estimate the prevalence of COP after resection for SCTs
and evaluate its association with (i) tumor size, (ii) postoperative
complications and (iii) long-term pancreatic exocrine and en-
docrine function.
Methods: Pancreatic resection margins of 65 consecutive patients
operated for SCTs were analyzed. COP was classified in four
stages (focal, mild, moderate and severe) according to the degree
of fibrosis, acinar atrophy and main pancreatic duct diameter.
Clinical data, morbidity and mortality were retrieved from our
database. Quality of life was evaluated by EORTC QLQ-C30 and
by an Institutional questionnaire focused on exocrine and en-
docrine pancreatic function.
Results: COP was found in 11 out of 65 (17%) patients and clas-
sified as focal in 2 cases (18.2%), mild in 2 cases (18.2%), mod-
erate in 3 cases (22.3%) and severe in 4 cases (36.3%). It was
mainly associated with lesions in the head/uncinate process (8
[72.7%] versus 3 lesions [27.3%] in the body/tail). Median age of
patients with COP was significantly higher than patients without
COP (59 yrs versus 49 years, p=0.05). Also, tumor size was sig-
nificantly greater in COP group (median diameter 5.1 cm versus
3.7 cm, p=0.026). No significant difference in main pancreatic
duct diameter was found. Postoperative complications, and in
examination in the initial staging of a CC were reviewed retro-
spectively. Only patients with CC proven by histopathology were
included. All patients underwent a PET/CT and a standard work-
up imaging including CT-scan and/or MRI. Tumour, distant and
regional metastases were collected and analysed with each imaging.
Results: Twenty-one patients were included. There were 15 males
and 5 females. There were 8 intrahepatic, 9 hilar and 4 main bile
duct CC. Thirteen patients had preoperative MRI. PET/CT, CT-
scan and MRI detected 80, 80 and 92% of biliary tumours. Sen-
sibility of PET/CT in the assessment of the tumour in
intra-hepatic, hilar and main bile duct was 88%, 67% and 100%
respectively. Sensibility and specificity of PET/CT and CT-scan in
the assessment of regional lymph node involvement were 38 and
89%, and 38 and 67% respectively. The PET/CT and CT were
false-negative regarding the lymph node involvement in 5 pa-
tients. PET/CT was more accurate than CT-scan to find distant
metastases with a sensibility and specificity of 78 and 100%, ver-
sus 56 and 100% respectively.
Conclusion: PET/CT improves the results and impacts on the
management in CC compared with other imaging modalities
(intra-hepatic and main bile duct CC). PET/CT is highly sensi-
tive and specific for the detection of distant metastases.
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INTRAOPERATIVE CHOLANGIOGRAPHY(IOC)
UTILISATION AND MANAGEMENT OF GALL
BLADDER DISEASE: THE RESULTS OF A
NATION WIDE QUESTIONNAIRE SURVEY IN
THE UNITED KINGDOM AND IRELAND
P. Sanjay, L. Colombo, C. Kulli, F. Polignano, I. Tait
Ninewells Hospital and Medical School, United Kingdom
Background: There is debate on optimal techniques that reduce
bile duct injury during LC.
Aim: A national survey of AUGIS members was carried out to
determine current surgical practice and use of intra-operative
cholangiography (IOC).
Methods: An anonymous postal survey was sent to all 417 mem-
bers. Data on Grade of surgeon, place of work (DGH, Teaching),
subspecialty, number LC/yr, use of IOC, critical view, and man-
agement of stones detected during surgery were collated.
Results: There was a 36% (152/417) response - 134 (88%) from
consultant surgeons: 36 – HPB, 106 – UGI; 64 – DGH & 88 –
teaching hospital. 38% performed > 100 LC/yr, 36% 50-100
LC/yr, and 22% 25-50 LC/yr. IOC was routine for 24%; and se-
lective for 72%. Critical view of Calots triangle was advocated by
82%. 39% recommend IOC, and 23% pre-operative MRCP when
dilated CBD is noted on ultrasound. When CBD stones are iden-
tified on IOC - 61% perform laparoscopic CBD exploration
(LCBDE), 25% advise post-op ERCP, and 13% perform either
LCBDE or ERCP. Overall 89% (n=134) recommend index
cholecystectomy for acute pathology, and this is more likely in a
teaching hospital setting (p=0.003). Routine IOC and Laparo-
scopic CBD exploration is more likely in a university hospital
(p<0.05)
Conclusions: 24% of specialist GI surgeons recommend routine
O 19
LAPAROENDOSCOPIC RENDEZ VOUS FOR
THE TREATMENT OF CHOLECYSTO-
CHOLEDOCHOLITHIASIS: INTERIM ANALYSIS
OF A CONTROLLED RANDOMIZED TRIAL
G. Tzovaras, I. Baloyiannis, D. Symeonides, G. Paroutoglou, C.
Rizos, A. Psychos, A. Kapsoritakis, S. Potamianos
University Hospital of Larissa, Greece
Background: The ideal management of concomitant cholelithiasis
and choledocholithiasis remains controversial. Although data from
the litereature support the one stage approach (laparoscopic chole-
cystectomy and common bile duct exploration) the two stage ap-
proach (ERCP followed by laparoscopic cholecystectomy) is more
popular between surgeons worldwide. Intraoperative ERCP during
laparoscopic cholecystectomy using the so called laparoendoscopic
rendez vous technique is an alternative one stage management of
concomitant cholelithiasis and cholelithiasis,
Aim: to compare laparoendoscopic rendez vous with the standard two
stage approach for the management of cholecysto-choledocholithia-
sis. This is an interim analysis of a controlled randomized trial.
Methods: One hundred patients with symptomatic cholecysto-
choledocholithiasis were randomized to undergo either la-
paroendoscopic rendez vous (n: 50) or ERCP and CBD clearance
followed by laparoscopic cholecystectomy (n:50). Both elective
and emergency cases were included in the trial. Primary endo-
point was to detect difference in hospital stay and secondary end-
points were to detect differences in morbidity, failure rate,
incidence of hyperamylasemia and severe pancreatitis.
Results: The median total hospital stay was significantly lower
for the laparoendoscopic group: 4 days compared to the two stage
group: 5.5 days (p=0.0004). Morbidity did not differ between the
laparoendoscopic group (14%) and the two stage approach
(12%) (P= not significant). The failure rate was 6% for the la-
paroendoscopic group and 10% for the two stage approach (P=
not significant). Hyperamylasemia detected in 7 patients of the la-
paroendoscopic group and 15 patients of the two stage group
(P=0.08) but the median value of amylase was significantly lower
in the laparoendoscopic rendez vous (65 vs 91, p= 0.02)
Conclusion: The results of the interim analysis of this trial suggest
that the laparoendoscopic rendez vous procedure is a safe ap-
proach resulting in shorter hospital stay.
O 20
IMPACT OF PET-SCAN IN MANAGEMENT
OF CHOLANGIOCARCINOMA
J. Morvan1, F. Demuynck2, D. Fuks1, C. Brochart1, C. Sabbagh3,
T. Yzet2, M. Meyer1, J. Regimbeau1
1. Federation of Digestive Diseases Amiens North Hospital
2. Department of Radiology Amiens North Hospital
Aim: The aim of the study was to evaluate PET/CT for detection
and staging of cholangiocarcinoma (CC). We compared accuracy
of PET/CT with contrast-enhanced CT and/or RMI and evalu-
ated the impact of PET/CT on management.
Methods: From 2004 and 2008, patients who underwent PET/CT
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IOC, and 39% recommend IOC when a dilated CBD is noted on
pre-operative US. Routine IOC and laparoscopic CBD explo-
ration is recommended by University hospital surgeons, whereas
ERCP extraction of CBD stones is common practice in district
general hospitals.
O 22
ESTABLISHMENT OF A HEPATO-
PANCREATICO-BILIARY (HPB) PROGRAM
AT A LARGE VOLUME INSTITUTION:
IMPACT ON PATIENT OUTCOME
A. Prabhu, S. Smeaton, J. Norton, A. Lincourt, S. Rucho,
J. Martinie, T. Heniford, D. Iannitti
Carolinas Medical Center, Charlotte U.S.A
Background: HPB procedures have improved outcomes when
performed at high-volume centers.
Aims: To demonstrate improved outcomes in HPB procedures after
establishment of a specialist HPB program at a high volume center
Methods: A comprehensive HPB program consisting of two fel-
lowship trained HPB surgeons was developed in 2006. Patients
undergoing HPB procedures between 2001-2003 and 2006-2008
were reviewed. An ordinal complexity scale (1 though 5) was de-
veloped to stratify cases with higher scores correlating with higher
complexity. Peri- and post-operative data was collected. Standard
statistical methods were used. Results: 337 HPB procedures were
evaluated, 126 cases from 2001-2003 and 212 cases from 2006-
2008. From 2006-2008, 159 cases were performed by 2 HPB sur-
geons, and 53 cases by transplant or oncologic surgeons. Overall,
21 cases were complexity level 1, 125 were level 2, 117 were level
3, and 20 were level 4 or 5. Only four complexity >4 were per-
formed pre-HPB. LOS was shorter for HPB surgeons (12vs.7
days, p<0.0001). HPB surgeons had lower mean EBL for com-
plexity levels 1 (74cc vs. 519cc, p=0.03), 2 (429cc vs. 721cc, p =
0.005), and 3 (640cc vs. 1767cc, p = 0.01). Operating times were
shorter for HPB surgeons for complexity levels 2 (182vs.216 min-
utes, p = 0.03) and 3 (270 vs. 549 minutes, p = 0.01).
Conclusion: Establishment of a comprehensive HPB program at
a large, single institution has allowed for better patient outcomes:
shorter length of stay, shorter operating times, and lower blood
loss with an increase in complexity of cases being performed.
O 23
COMPARATIVE REVIEW OF LITIGATION
COSTS RELATED TO BILE DUCT INJURIES
DURING LAPAROSCOPIC CHOLECYSTECTOMY:
THE MORE WESTERLY THE MORE EXPENSIVE
E. Ypsilantis1, N. Pawa2, M. Tutton2, R. Motson2
1. Queen Elizabeth Hospital, King’s Lynn
2. Colchester University Hospital, Colchester,
UK Colchester Hospital
Background: Bile duct injury (BDI) is a sinister complication of
laparoscopic biliary surgery, incurring not only dismal clinical
consequences for patients but also significant medico-legal costs
for hospital institutions.
Aims: This retrospective review aims to reveal the litigation cost im-
plications of iatrogenic laparoscopic BDI for NHS hospitals in the
UK, in comparison to the international status quo. Methods: All the
claims on the NHS Litigation Authority (NHSLA) database related
to iatrogenic BDI between 2002 and 2007 were analysed and com-
pared to international data from the pertinent literature.
Results: CBD injuries were the commonest (n=70 or 44.6%) of
the claims associated with laparoscopic cholecystectomy. Dam-
ages were paid in 36 of the 49 closed cases, suggesting a 73% com-
pensation rate, higher than the average 49% concerning the total
3,870 claims related to general surgery during the same period.
The total costs paid mounted to £1,955,265 (average
£391,053/year, with median compensation £27,500/case (range
£3,000 - £300,000/case). Similar study from The Netherlands
(n=88 cases of laparoscopic BDI between1994-2006) revealed
that lower compensations are being paid (median £8,200, range
£13 - £46,000) with liability being acknowledged less frequently
(paid/closed ratio 18%). On the contrary, studies from the United
States demonstrate higher compensation rates (86%) and higher
damage costs paid (average compensation ranging between
£128,400 and £304,000).
Conclusion: Iatrogenic laparoscopic BDI is considered as negli-
gence, with significant clinical and litigation repercussions. The
UK arbitration systems lead to high likelihood of admitting med-
ical liability, with compensation costs lying between the extremes
of the USA and European models.
O 24
EFFECTIVENESS OF PROPHYLACTIC
TREATMENT WITH ANTIIOTICS DURING
CHOLECSYCTECTOMY
B. Darkahi1, G. Sabdblom2, S. Wollert2, M. Ljungdahl2,
H. liljeholm1, B. Karlson2, P. Videhult3, I. Rasmusen2
1. Surgery Lassaretet Enköping
2. Surgery Uppsala University
3. surgery Ersta Stockholmm, Sweden
Background: Antibiotics are often given prophylactically during
cholecystecomy, despite the absence of randomised controlled trials
showing any benefit on the postoperative course. To explore the risk
of postoperative infections in a population-based cohort of patients
operated for gallstone disease and to compare the infection rate be-
tween patients who received antibiotic prophylaxis with those who
did not a prospective population-based study was performed.
Methods: All surgical procedures for gallstone disease performed
in the Uppsala county; Sweden, were registered prospectively
2003-2005. Data included indication for surgery, approach, pro-
phylactic treatment with antibiotics and postoperative adverse
events. Complicated procedures were defined as operations for
which acute cholecystitis, exploration of the common bile duct or
gallbladder perforation was recorded.
Results: Altogether 1199 patients underwent cholecystectomy.
Prophylactic antibiotic treatment was given to 755 patients
(63%). Only 19 infectious complications were recorded (1.6%).
Thirteen (68%) of the infections occurred in patients undergo-
ing complicated surgical procedures. Minor infections were
recorded in 12 patients (1.0%) and major infections, including
intraabdominal abscesses, pneumonia and urosepsis, were
recorded in 7 patients (0.6%). Infections were recorded for 4
(0.5%) of the patients receiving antibiotics and 15 (4.3%) of those
who did not (p<0.05). None of the patients receiving antibiotics
had any major infection. Complicated procedures, including sur-
gery for cholecystitis, were performed in 248 patients. Of these,
194 received antibiotics and 54 did not. Infections occurred in
one (1,9%) of the complicated procedures not receiving antibi-
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otics and in 12 (6,2%) not receiving antibiotics.
Conclusion: These data do not support prophylactic treatment
with antibiotics to patients undergoing uncomplicated cholecys-
tectomy. However, for patients with complicating factors, such as
acute cholecystitis or jaundice, prophylactic antibiotics may be
warranted. The benefit from antibiotic prophylaxis in high-risk
patients should be assessed in randomized controlled trials be-
fore definite conclusions can be drawn. Furthermore, the reduced
risk for infections has to be weighed against the risk of the risk of
promoting the spread of drug-resistant bacteria.
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GANGRENOUS CHOLECYSTITIS (GC):
RISK FACTORS AND MANAGEMENT BY
URGENT LAPAROSCOPIC CHOLECYSTECTOMY
(LC)
P. Sanjay, J. Moore, E. Saffouri, M. Thaha, D. Smith
Ninewells Hospital and Medical School, United Kingdom
Background: Morbidity with GC remains high necessitating
prompt recognition and early intervention. The study aimed to
analyse the risk factors for GC and to describe the clinical out-
comes following surgical management of GC
Methods: Of the 917 consecutive patients needing emergency
LC, sub-group of GC (histological diagnosis) was identified and
analysed for the study outcomes. Comparisons were made with
the non-gangrenous group.
Results: 115 (12%) patients were diagnosed with GC. The me-
dian age was 67 years (range19-89), M: F ratio1:1.5. Male gender
was associated with increased incidence of GC compared to non
gangrenous group, 40% vs. 27%, P=0.008. No significant differ-
ence was noted in the operating time between the gangrenous
and non gangrenous group (120 vs 115 mins, P=0.12). 44 (38%)
patients required conversion to open cholecystectomy compared
to 109 (13%) in the non gangrenous group (P=0.0001). The post-
operative stay was longer in gangrenous group compared to non
gangrenous group, 4 vs. 1 day, P=0.001. However total hospital
stay was similar between the 2 groups (6 vs. 5 days, P=0.06). The
postoperative stay was longer in patients requiring conversion to
open cholecystectomy (6 vs.3 days, P=<0.001) No bile duct in-
juries were noted in the study group. Age >65, white cell count
of >15 and CRP >50 at admission predicted gangrenous chole-
cystitis at admission on multivariate analysis.
Conclusion: Index laparoscopic cholecystectomy for gangrenous
cholecystitis is feasible, however is associated with higher con-
version rates. Duration of surgery is not significantly prolonged
and it can be performed with low morbidity, short hospital stay.
O 26
SYSTEMIC REVIEW OF CHOLECYSTOSTOMIES
A .Winbladh, P. Sandström, P. Gullstrand, J. Svanvik
Dep of surgery Inst of clinical and experimental medicine, Sweden
Percutaneous cholecystostomy (PC) is an established low-mor-
tality treatment option for the elderly and critically ill with acute
cholecystitis. The primary aim of this review is to see if there is
any evidence in the literature to recommend PC rather than
cholecystectomy for acute cholecystitis in the elderly population.
Method: In April 2007, a systemic electronic database search was
performed on the matter of PC and cholecystectomy in the eld-
erly population. After exclusions, 53 studies remained comprising
1918 patients Three papers are randomized controlled trials
(RCT), but none compare the outcome of PC versus cholecys-
tectomy. Nineteen papers on mortality after cholecystectomy in
patients older than 65 years were identified.
Results: Successful intervention was seen in 85.6% of patients
with acute cholecystitis. 40% of the patients treated with PC were
later cholecystectomized with a mortality rate of 1.96%. Proce-
dure mortality was 0.36%, but the 30-day mortality rate was 15.4
% for patients treated with PC and 4.5% for those treated with
acute cholecystectomy (p<0.001).
Conclusion: There are no controlled studies evaluating the out-
come of PC vs. cholecystectomy and the papers reviewed are evi-
dence grade C. It is not possible to make decisive recommendations
regarding treatment by the use of PC or cholecystectomy in the eld-
erly or critically ill with acute cholecystitis. Low mortality rates after
cholecystectomy in elderly patients with acute cholecystitis have
been reported in recent years and therefore we believe it is time
launch a randomized controlled study to address this issue.
O 27
INDEX LAPAROSCOPIC CHOLECYSTECTOMY
(LC) DURING FIRST ADMISSION PROVIDES AN
EXCELLENT TRAINING OPPURTUNITY IN
EMERGENCY GENERAL SURGERY
P. Sanjay, J. Moore, E. Saffouri, F. Polignano, C. Kulli, I. Tait
Ninewells Hospital and Medical School, United Kingdom
Background: There is minimal data on the outcome of early la-
paroscopic cholecystectomy (LC) for acute gall bladder disease
when performed by trainees.
Aim: This study assesses the outcomes of a policy of same ad-
mission LC incorporated into a surgical training programme in a
major teaching hospital.
Methods: 447 LCs performed over a 3-year period were reviewed.
The indications, operating surgeon, operating time, use of IOC,
conversion rates, reasons for conversion and post operative stay
were analysed. Multivariate analysis of reasons for conversion was
performed.
Results: 150 LCs were performed by consultants and 297 by reg-
istrars; 67 were performed by year 1-3 specialist registrars (SpR)
and 230 by year 4-6 SpRs. The indications were biliary colic
(n=7), acute cholecystitis (n=180), chronic cholecystitis (n=260),
carcinoma (n=1). No difference was found in demographics, op-
erating time (105 mins Vs 115 mins), use of IOC (34% Vs 29%;
P=0.2) and postoperative stay (2 days Vs 1 day) between con-
sultants and registrars. The conversion rates were higher for
consultants compared to registrars (29 (19%) Vs 28 (9%),
P=0.004). The overall conversion rate was 11%. There were no
bile duct injuries. Predictors for conversion were CRP >50 at ad-
mission and acute cholecystitis.
Conclusion: In a teaching hospital setting most acute admission
LCs (66%) were performed by trainees. A step-wise training pro-
gramme with active consultant supervision results in low mor-
bidity, low conversion rates, and a short postoperative stay for
acute gall bladder disease. This model of same admission chole-
cystectomy provides a good training opportunity in emergency
general surgery.
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THE IMPACT OF NEOADJUVANT
CHEMOTHERAPY ON HEPATIC RESECTION
SERVICE PROVISION
P. Scriven1, H. Katsarelis2, J. Ritchie1, G. Leslie2, G. Irving2,
M. Peterson2, I. Cameron2
1. University of Sheffield
2. STH Foundation Trust
Introduction: Following the EORTC trial there is debate as to
whether chemotherapy before liver resection should be intro-
duced as a standard management strategy in all cases of re-
sectable colorectal cancer liver metastases. Anecdotally,
resections on patients who have undergone pre op chemotherapy
are felt to suffer from more complications than those who have
had no chemotherapy. We have performed a service evaluation
to assess if any differences relevant to service provision exist be-
tween patients having major hepatectomy for colorectal cancer
metastases after 6 cycles of oxaliplatin chemotherapy and those
having resection without chemotherapy.
Methods: Retrospective analysis of departmental database and
case note review of all patients undergoing major resection (>3
segments) for colorectal liver metastases from May 2004 to De-
cember 2007
Results: 48 patients underwent resection without chemotherapy
and 33 patients underwent 6 cycles of oxaliplatin chemotherapy
prior to resection. The chemotherapy group had a significantly
longer operation time (276 mins vs. 200mins p=<0.05), larger
intra-operative blood loss (1542ml vs. 676ml p=<0.05), a greater
requirement for blood and blood products and significantly more
post operative complications (47% vs. 16% p=<0.05) than the
no chemotherapy group. The chemotherapy group had a longer
total inpatient stay (16 vs 13.7 days p=<0.05), there was no sig-
nificant difference in mortality.
Conclusion: Resection of colorectal cancer metastases following
oxaliplatin chemotherapy potentially has significant impact on
service provision with resections taking longer and having an in-
creased overall cost through increased requirement for blood,
blood products and more post operative complications.
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IMPACT OF EXPERTISE IN LIVER SURGERY
ON LONG-TERM OUTCOME AFTER
SIMULTANEOUS RESECTIONS OF
COLORECTAL CANCER AND
SYNCHRONOUS LIVER METASTASES
F. Ardito, F. Giuliante, M. Vellone, M. Giordano,
G. Ranucci, I. Giovannini, G. Nuzzo
Catholic University-School of Medicine Hepatobiliary
Surgery Unit
Background: About 50% of all resectable patients have synchro-
nous colorectal liver metastases (SCRLM). Recent studies have
shown that simultaneous colorectal and liver resection (SIMRES)
is feasible and safe even when this implicates major hepatectomy.
Aim: To evaluate the impact of specialization in liver surgery on
long-term outcome after SIMRES for SCRLM.
Methods: Between January 1992 and June 2008, 127 patients with
SCRLM were managed in our tertiary care unit. Fifty-eight pa-
tients underwent SIMRES: 35 underwent SIMRES locally
(Group A), while 23 were referred for liver recurrence after SIM-
RES performed elsewhere in low-volume centers (Group B). The
groups were compared, with Kaplan-Meier assessment of long-
term outcome.
Results: Group A and B matched for age, sex, site/stage of pri-
mary tumor, and number, size and location of SCRLM. The rate
of major liver resection was higher in Group A vs B (28.6% vs
8.7%, p=ns). After a mean follow-up of 28 months, all Group B
patients had liver recurrence (median disease-free survival 12
months). The rate of liver recurrence on the surgical margin was
lower in Group A vs B (2.9% vs 73.9%, p<0.001). Five-year dis-
ease-free survival was higher in Group A vs B (27.1% vs 0.0%,
p<0.001).
Conclusions: To our knowledge this is the first study addressing
long-term outcome after SIMRES according to expertise of the
surgeon in liver surgery. It suggests that, although SIMRES can
be performed with low operative risk also in non-specialized set-
tings, the long-term results are better when the complete opera-
tion is performed by an experienced hepatic surgeon.
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LAPAROSCOPIC LIVERRESECTIONS OF SOLID
TUMOURS IN THE NETHERLANDS:
A COMPARATIVE STUDY OF INITIAL
EXPERIENCE
J. Stoot1, I. Limantoro2, R. van Dam1, O. Busch3,
R. van Hillegersberg4, K. De Jong5, A. Rijcken6, G. Kazemier7,
M. Bemelmans1, K. Dejong2
1. Surgery Maastricht University Medical Center
2. Department of Surgery MUMC
3. Department of Surgery AMC
4. Surgical Oncology University Medical Centre Utrecht
5. Department of Surgery UMCG
6. Department of Surgery Amphia Hospital Breda
7. Dep Surgery Erasmus Medical Centre
Background: The purpose of this study was to report the initial
experience with laparoscopic liver resections in the Netherlands.
We analysed the feasibility, safety and the outcome of these pro-
cedures.
Methods: Patients undergoing laparoscopic left lateral sec-
tionectomy in the Netherlands in the years 2000 to 2008 were in-
cluded. This group of patients was matched in the proportion of
1:3, with a group of patients undergoing the same type of liver re-
section as an open procedure in the same era. Primary outcome
of the study was hospital length of stay. Secondary outcomes were
complications (including mortality and conversion rates), dura-
tion of operation time and blood loss. Data are means + SEM.
Results: The laparoscopic approach for hepatic left lateral sec-
tionectomy was performed in thirty patients in 6 centres in the
Netherlands (group I, age 50 [3] years). In the open group, ninety
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patients were matched for the same type of resection and age
(group II, age 52 [2] years). Hospital length of stay was 6.0 [0.4]
days in group I versus 8.1 [0.4] days in group II (p < 0.0001). No
statistical differences were observed in complications between the
two groups. Blood loss was 289 [99] mls and operation time 160
[13] minutes in the laparoscopic group versus 603 [96] mls and
229 [11] minutes in the open group (p<0.001 and p<0.001, re-
spectively).
Conclusion: Implementation of laparoscopic liver resection in
the Netherlands seems feasible and safe. It can result in compa-
rable morbidity and a shorter hospital length of stay.
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DIFFERENTIAL EXPRESSION OF
EPITHELIAL-MESENCHYMAL
TRANSITION- RELATED GENE MARKERS
BETWEEN PRIMARY COLORECTAL
CARCINOMAS AND LIVER METASTASES
R. Argent1, P. Clarke1, V. Green1, Y. Yin1, D. Lobo2,
K. Shepherd2, P. King3, M. Page3, A. Grabowska1, S. Watson1
1. Division of Pre-Clinical Oncology University of Nottingham
2. Division of Surgical Sciences University of Nottingham
3. Oncology Research and Development OrthoBiotech
Background: Epithelial-mesenchymal transition (EMT) is a de-
velopmental process which is frequently activated during car-
cinogenesis resulting in metastatic spread. EMT activation
downregulates E-cadherin expression leading to increased motil-
ity and gain of a more mesenchymal phenotype.
Aim: To assess the expression of EMT-associated genes in col-
orectal carcinomas (CRCs) and liver metastases (LMs).
Methods: Human primary CRC (n=9) and LM (n=19) samples
were obtained under full ethical approval from Queen’s Medical
Centre, Nottingham, UK. Samples were stored in RNAlater prior
to RNA extraction, cDNA synthesis, and real-time quantitative
PCR to determine expression levels of EMT markers (Snail, Slug,
Zeb1, E-cadherin), mesenchymal markers (N-cadherin, vimentin,
s100a4), as well as the c-Met receptor, hepatocyte growth factor
(HGF) and TGFβ1, relative to the housekeeping gene hypoxan-
thine-guanine phosphoribosyltransferase. A student’s t-test was
used for statistical analysis.
Results: Snail (p=0.015), vimentin (p<0.002), s100a4 (p<0.01)
and TGFβ1 (p=0.011) were significantly upregulated in LMs
compared to normal liver, whereas N-cadherin (p=0.0006) was
significantly down-regulated. In CRCs, c-Met (p<0.01) expres-
sion was significantly increased compared to normal colonic mu-
cosa, whereas Slug (p=0.011), Zeb1 (p=0.029), and vimentin
(p=0.038) expression were significantly downregulated. E-cad-
herin expression was significantly decreased in CRCs (p<0.01),
but not liver metastases (p=0.15). Comparison of expression of
EMT markers between CRCs and LMs showed that HGF
(p=0.001), N-cadherin (p=0.001), Snail (p=0.02), Slug
(p=0.011), Zeb1 (p=0.011), vimentin (p=0.002), and TGFβ1
(p=0.003) were all significantly upregulated in LM tissue.
Conclusion: EMT markers were significantly increased in LMs
compared to CRCs. Snail, vimentin, and TGFβ1 provide the best
markers for LM.
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THE VALUE OF MODEL FOR END-STAGE
LIVER DISEASE SCORE IN PREDICTING
OUTCOME AFTER HEPATECTOMY FOR
HEPATOCELLULAR CARCINOMA IN
CIRRHOTIC PATIENTS
A. Bakogiannis, S. Delis, D. Kelgiorgi, C. Agalianos,
D. Karakaxas, K. Athanassiou, C. Dervenis
Kostantopouleio-Agia Olga Hospital 1st surgical department-
Liver surgical unit
Introduction:Model for end-stage liver disease (MELD) score was in-
troduced as an index of hepatic function reserve in cirrhotic patients.
Aims and methods: To evaluate the ability of MELD score in
predicting postoperative morbidity and mortality, hospital stay,
recurrence and 5-year survival in cirrhotic patients undergoing
hepatectomy for hepatocellular carcinoma (HCC). We retro-
spectively examined the clinical records of all patients with HCC
and histologically proven cirrhosis, managed surgically between
01/2002 and 01/2007. Preoperative MELD score was calculated
and associated with postoperative outcome.
Results: Seventy nine patients(61 men, 18 women, all Child A) were
included. MELD score ranged from 6 to 18. MELD score was≤9 in
46 patients (58,2%)(GroupA) and >9 in 33 patients
(41.8%)(GroupB). Twenty one patients(MELD≤9, n=14;
MELD>9, n=7) underwent major hepatic resections(≥3 segments)
and 58 patients(MELD≤9, n=37; MELD>9, n=21) had minor he-
patic resections. Overall postoperative mortality and morbidity rate
were 0% and 38.3% respectively. Twenty two per cent of patients
with MELD≤9(n=9) and 64,3% of patients with MELD>9(n=18)
developed at least 1 complication(p=0,01). Median hospital stay for
patients with MELD≤9 was 6,9 days(range 6-15), while for
MELD>9 was 14.6 days (range 9-28)(p=0,02). Recurrence devel-
oped in 60% of cases and mostly affected the group with MELD >9
(79%)(p<0,05). The five year survival was 55% for Group A and
41% for Group B(p>0,05). Disease free survival was 25 months(15-
28) in Group A and 14 months (10-22) in group B(p=0,002).
Conclusion: MELD score can predict the good risk Child A pa-
tients with cirrhosis and should be used to select the best candi-
dates for hepatectomy.
References: 1.Teh SH, Christein J, Donohue J, et al. Hepatic resec-
tion of hepatocellular carcinoma in patients with cirrhosis: Model of
End-Stage Liver Disease (MELD) score predicts perioperative mor-
tality.J Gastrointest Surg. 2005;9(9):1207-15; discussion 1215.
2.Chen TW, Chu CM, Yu JC, et al. Comparison of clinical stag-
ing systems in predicting survival of hepatocellular carcinoma pa-
tients receiving major or minor hepatectomy.Eur J Surg Oncol.
2007 ;33(4):480-7.
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SEROTONIN SUPPRESSES AUTOPHAGY
IN HUMAN HEPATOCELLULAR CANCER
CELLS
C. Soll1, M. Riener2, W. Moritz1, P. Wild2, J. Jang1, R. Graf3,
P. Clavien3
1. Department of Surgery
2. Department of Pathology
3. Department of Visceral and Transplantation Surgery,
University Hospital Zurich, Switzerland
Background: Autophagy is a type of programmed altruistic cell
death induced by withdrawal of nutrients. It is a mechanism by
Abstracts 17
which cells defend against temporal loss of nutrient supply re-
sulting in either survival or controlled death. Nutrient depletion
is also encountered by cancer cells which require continues an-
giogenesis to promote growth. A putative growth factor is sero-
tonin which supports liver regeneration and may also be
involved in cancer growth.
Aim: To test whether serotonin is involved in hepatocellular car-
cinoma (HCC).
Methods: Proliferation and survival assays were performed with
hepatocellular cancer cell lines (Huh7, HepG2, and Hep3B). Im-
munoblots were used to identify involved ignalling pathways. A
tissue micro array of 168 patients with HCC was used to validate
the in vitro findings.
Results: Hepatocellular carcinoma (HCC) cell lines were ex-
posed to serotonin. No significant mitogenic activity was found,
however, in serum-free medium, serotonin prevented cell death.
This effect was abolished with specific antagonists against the
5HT2B serotonin receptor. Electron microscopy revealed sero-
tonin-dependent inhibition of autophagosome formation. In the
presence of rapamycin, an inhibitor of mTOR and inducer of au-
tophagy, serotonin mediated phosphorylation of p70S6K and 4E-
BP1, two downstream targets of mTOR that facilitate protein
synthesis and cell cycle progression. Expression of the 5HT2B
serotonin receptor and LC3, a marker for autophagy, was con-
firmed in human hepatocellular carcinoma. The 5HT2B sero-
tonin receptor correlated with the expression of phosphorylated
p70S6K.
Conclusion: The study provides evidence that serotonin and au-
tophagy are involved in the biology of hepatocellular cancer.
Serotonin bypasses mTOR signalling and inhibits autophagy. The
5HT2B receptor may be a target for HCC.
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EFFECTS OF CETUXIMAB AND BEVACIZUMAB
ON CLINICAL, BIOLOGICAL AND
HISTOLOGICAL OUTCOME AFTER
HEPATECTOMY FOR COLORECTAL
METASTASIS: A CASE-CONTROL STUDY
F. Panaro, S. Casnedi, I. Zeca, M. Mahfud, M. Chenard-Neu,
D. Jaeck, P. Bachellier, P. Pessaux
Objective: To analyse, the effects of the preoperative targeted
therapy (cetu and beva) on outcome after liver resection for col-
orectal liver metastases (CLM).
Background: Hepatotoxicity of irinotecan and oxaliplatin has
been reported. The effect of bevacizumab (beva) and cetuximab
(cetu) on the non tumoral liver parenchyma needs further evalu-
ation.
Patients and Methods: Between January 2005 and December
2007, patients receiving preoperatively cetu (n=15) or beva
(n=21) were respectively matched to a control group of patients
who did not receive targeted therapy. They were matched on the
basis of age, sex, body mass index, extent of hepatectomy, and
type and number of cycles of neoadjuvant chemotherapy. Liver
function tests, postoperative outcome and histopathology of the
resected liver were compared.
Results: Mortality was nil. Postoperative morbidity, particularly
perioperative bleeding, was similar in both groups. In the group
beva, liver function tests showed high serum bilirubin level on
postoperative day 1(POD) (p=0.001) and POD 3 (p=0.01), high
serum AST on POD 1 (p=0.004), and low prothrombin time on
POD 5 (p=0.02), compared to control group. In both groups,
cetu and beva, the postoperative peaks of GGT and ALP were
statistically higher than in the control groups. Interestingly, the
prevalence of sinusoidal injury and fibrosis was lower in patients
receiving cetu (p=0.04) while the prevalence of steato-hepatitis
was lower in patients receiving beva (p=0.04).
CONCLUSION: The addition of cetu or beva to chemotherapy
regimens does not increase the morbidity rate after hepatectomy
for CLM. The pathological examination did not show additional
injury to the non tumoral liver parenchyma. This study could sug-
gest a protective effect of the targeted therapy on the non tumoral
liver parenchyma.
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HEPATIC RESECTION FOR HEPATOCELLULAR
CARCINOMA IN THE BARCELONA-CLINIC-
LIVER-CANCER CLASSIFICATION: ANALYSIS
OF A PROSPECTIVE COHORT OF RESECTED
PATIENTS
M. Donadon, F. Procopio, M. Cimino, A. Palmisano, D. Del
Fabbro, F. Botea, M. Montorsi, G. Torzilli
Third Department of General Surgery University of Milan, IRCCS
Istituto Clinico Humanitas, Rozzano, Milan, Italy
Background: For patients with hepatocellular carcinoma (HCC)
in classes B and C of the Barcelona-Clinic-Liver-Cancer classifi-
cation (BCLC) palliation is the only feasible approach. However,
some authors reported survival benefit after surgery even in more
advanced patients. We prospectively evaluated the short- and
long-term outcome of patients resected for HCC based on a se-
lection process, in which the BCLC B and C classes were not con-
traindicated.
Methods: Patients were selected for surgery based on pres-
ence/absence of ascites, serum bilirubin level and expected rem-
nant liver volume. Esophageal varices were not a contraindication
once eradicated endoscopically. Surgical strategy was based on
the relationship between the tumor and the intrahepatic vascular
structures at intraoperative ultrasonography (IOUS). Mortality,
morbidity, rate of cut-edge local recurrences, and long-term out-
come were evaluated. A P<0.05 was considered statistically sig-
nificant.
Results: One-hundred-seventy-three patients underwent surgery
and 165 (95%) were resected: 93 (56%) were BCLC stage 0-A, 39
(24%) B, and 33 (20%) C. The BCLC C class was, in all patients,
due to macroscopic vascular invasion. The overall morbidity rate
was 22%. Major morbidity occurred in 7 (5 liver failures – 3 mild,
2 moderate, 1 severe – 1 reoperation, and 2 thoracentesis) pa-
tients (5%). The 30-, and 90-day postoperative mortality were 1%
(2 patients), and 2% (3 patients), respectively. Surgical clearance
was achieved in all cases without local recurrence. After a me-
dian follow-up of 26 months (rage 6-117) for BCLC 0-A, B, and
C the 3-year overall survival was respectively: 89%; 62%; 52%
(P=0.001). The 3-year disease-free survival was respectively:
37%; 34%; 41% (P=0.853) (P=0.409).
Conclusions: This study showed that hepatic resection might
offer survival benefits for patients with HCC in BCLC class B and
C when resection is feasible and safe under strict IOUS guidance.
These results should induce to reconsider the BCLC treatment
recommendations.
© The Authors
Journal Compilation © 2009 Hepato-Pancreato-Biliary Association, HPB, 11 (Suppl. 2), 1-172
18 Abstracts
© The Authors
Journal Compilation © 2009 Hepato-Pancreato-Biliary Association, HPB, 11 (Suppl. 2), 1-172
O 36
QUALITY OF LIFE AFTER LIVER RESECTION –
A SINGLE CENTRE ANALYSIS
H. Bruns1, L. Fischer1, K. Krätschmer1, U. Hinz1, A. Brechtel2,
M. Keller2, M. Büchler1, P. Schemmer1
1. Ruprecht-Karls-University/Dept. of Surgery
2. Ruprecht-Karls-University/Dept. of Psychosomatic Medicine
Objective: Postoperative quality of life (QoL) is considered to
being as important as disease-free and overall survival; however,
there are few studies on QoL after liver resection. Thus, this study
was designed to evaluate QoL after curative liver resection and
identify variables associated with decreased QoL.
Design and Patients: From October 2001 to July 2004, 323 pa-
tients underwent liver resection in our institution. 3-36 months
after discharge, 188 patients were disease free. QoL was assessed
using the Short Form (SF)-12 Health Survey with mental and
physical component scales (SF-12 MCS and PCS), supplemented
with generic questions concerning pain and liver specific items.
Results: 68% (128/188) returned the questionnaire (completed
in 75% (96/128) of cases). Median SF-12 PCS and MCS were 46.7
(interquartile range 34.2-53.9) and 54.1 (42.8-58.2). 50% were
pain free with a median symptom score of 1.75 (1.38-2.13). PCS
was higher after major hepatectomy (57% (55/96)) compared to
minor resection (p<0.01). QoL was not affected by sex but by age
compared to the general German population. MCS was higher
after liver surgery for metastatic disease (55.9 (47.5-58.8)) com-
pared to primary carcinoma (49.6 (36.5-55.1)) and benign disease
(49.2 (37.7-56.3)) (p<0.05). There was no correlation between
length of postoperative period and QoL. Pain, deficiencies in
everyday life and a high symptom score significantly decreased
MCS and PCS.
Conclusions: The vast majority of patients were only marginally
affected even after major liver resection; however, complications
that are considered as minor were associated with decreased SF-
12 MCS and PCS and therefore need careful attention.
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INVASIVE INTRADUCTAL PAPILLARY
MUCINOUS CARCINOMAS OF THE PANCREAS
PREDICTORS OF SURVIVAL AND THE ROLE
OF LYMPH NODE RATIO
S. Partelli1, R. Salvia1, W. Mantovani2, C. Fernandez del Castillo3,
C. Bassi1, S. Crippa1, A. Warshaw3, P. Pedrzoli1
1. Department of Surgery University of Verona
2. Department of Medicine and Public Health University of Verona
3. Department of Surgery Harvard University
Introduction: Intraductal papillary mucinous neoplasms (IPMNs)
are an increasingly well-recognized group of pancreatic neoplasms.
The presence or absence of lymph node metastases is known to be an
important prognostic factor for patients with invasive intraductal pap-
illary carcinoma (I-IPMC). The role of lymph node ratio (LNR) in
the outcome after surgery for I-IPMC is unknown.
Methods: The combined databases from the Massachusetts Gen-
eral Hospital and the Policlinico G.B.Rossi, University of Verona
were queried. We retrospectively reviewed clinical and patho-
logical data of all patients with resected, pathologically con-
firmed, I-IPMC between 1990 and 2007. Univariate and
multivariate analysis were performed.
Results: I-IPMCs were diagnosed in 104 patients (55 males and
49 females), median age was 69 year. Recurrent disease was iden-
tified in 41 patients (39,4%) and the median 5-year disease spe-
cific survival (DSS) was (61.3%). The median number of
resected/evaluated nodes was 15 (range 5-60). There were 60
(57,7%) patients who had negative lymph nodes (N0), whereas
44 (42,3%) had lymph node metastases (N1). Patients with lymph
node metastases had a shorter 5-year DSS (31%) compared with
patients with negative lymph nodes (80%; p<0,05) As the LNR
increased, 5-year DSS decreased (LNR = 0, 87,6%; LNR > 0 to
0.2, 39,7%; LNR > 0.2 ,16,7%; P <0.05). On multivariate analy-
sis LNR and a familial history of pancreatic cancer were signifi-
cant predictors of survival (P <0,05.).
Conclusions: After resection for I-IPMC of the pancreas, LNR
and a familial history of pancreatic cancer are the most powerful
predictors of survival.
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INFECTED PANCREATIC NECROSIS -
FAVOURABLE OUTCOME ASSOCIATED WITH
WIDE-BORE CT-GUIDED PERCUTANEOUS
DRAINAGE, CRITICAL CARE AND DEFERRED
NECROSECTOMY
J. Conneely1, S. Shine2, M. Doyle1, H. Fenlon2,
M. MacNicholas2, F. Colreavy3, D. Phelan3, G. McEntee1
1. Dept of Surgery Mater Misericordiae University Hospital
2. Dept of Radiology Mater Misericordiae University Hospital
3. Dept of Critical Care Medicine Mater Misericordiae University
Hospital
Background: The role and timing of surgery in severe acute
pancreatitis remain controversial. Despite development of minimally
invasive techniques, multiple procedures are common and morbidity
and mortality remain high. We postulated that sepsis-control
facilitating deferral of surgery would improve outcomes.
Methods: From 1999 to 2007 all patients with infected pancreatic
necrosis (IPN) were managed with wide-bore radiologic drainage
and critical care management. Disease severity was serially
assessed using APACHE II and Sepsis-related Organ Failure
Assessment. Necrosectomy was performed when there was
clinical and radiological evidence of disease resolution.
Results: 51 patients were admitted with severe acute pancreatitis.
Six patients had sterile necrosis and were managed conservatively. 45
developed IPN. Critical Care management and wide-bore radiologic
drainage yielded a significant reduction in disease severity indices;
APACHE II: peak 11 (range 2-24) vs. pre-op 6 (1-15) (p < 0.001);
SOFA: 3 (0-12) vs. 1 (0-7) (p = 0.01). Necrosectomy was delayed to
a median 45 days (range 24-112) post onset. 2 patients (4%) died
post-operatively. Enteric fistula was encountered in one patient
(2%) and 1 patient required reoperation (2%).
Conclusions: We demonstrate that wide-bore percutaneous
drainage, coupled with critical care management achieves significant
improvement in physiological and radiological parameters, facilitat-
ing deferred surgery, ultimately reducing morbidity and mortality
(4%). Non-operative clearance of infection supports the hypothesis
that some IPN patients may be suitable for non-surgical management.
Recent publications claiming best-practice outcomes do not achieve
mortality/complication rates comparable to our series.
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EARLY AND LATE COMPLICATIONS IN
SPLEEN PRESERVING DISTAL PANCREATEC-
TOMY WITH SPLENIC VESSELS SACRIFICE.
A SINGLE CENTRE EXPERIENCE
M. Inama1, G. Butturini1, R. Manfredi2, G. Melotti3, M. Piccoli3,
R. Salvia4, C. Bassi4, P. Pederzoli4
1. Surgical and Gastroenterological Dept Verona University
2. Radiological Dept Verona University
3. Surgical Dept Modena Hospital
4. Department of Surgery University of Verona
Background: During distal pancreatectomy it is possible to pre-
serve the spleen with the sacrifice of the splenic vessels (SVS) or
with their preservation ( SVP). Early and late complications of
SVS are not well known yet.
Aim: The aim of this study was to review our experience with SVS
spleen preserving operation.
Methods: All data regarding operative procedures and outcome
of patients undergone to SVS spleen preserving distal pancrea-
tectomy (group 1) were prospectively recorded since 2002. 13 pa-
tients undergone to SVP operation in the same period were
enrolled as control group (group 2). All patients had blood test,
MSCT or MRI with follow-up ended on June 2008.
Results:Among 7 patients in group 1, one underwent to splenectomy
for splenic infarction on 3rd post-operative day; one patient with an un-
eventful postoperative course died for lung cancer during the follow
up. As regard the 5 patients still alive, 3 have gastric varices associated
to thrombocytopenia in 2 of them. All patients are asymptomatic. In
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group 2, two patients developed gastric varices with thrombocytope-
nia and both had had a complicated post-operative course with 1 ab-
dominal collection and 1 pancreatic fistula.
Conclusions: In our experience, SVS spleen preserving distal
pancreatectomy had determined complications such as spleen in-
farction and perigastric varices associated to thrombocytopenia.
This technique should not be applied as routine procedure.
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CROSSING THE RUBICON - WHEN
PANCREATIC RESECTION WITH CURATIVE
INTENT ENDS IN AN R2 STATUS
M. Bockhorn1, G. Cataldegirmen1, A. Marx2, C. Burdelski1,
J. Vashist1, J. R. Izbicki1, E. F. Yekebas1
1. University Hospital General-, Visceral- and Thoracic Surgery
2. University Hospital Institute of Pathology
Background: To analyse the impact of pancreatitis-mimicking,
concomitant alterations on intraoperative assessment of curative
resectability, the anatomical site of irresectability and outcome
after non-intentional R2 resection in pancreatic cancer.
Methods:From 1099 patients subjected to pancreatic resection for can-
cer, 40 (4%) underwent R2 resection (group A). The site where tumors
turned to be irresectable and the coincident presence of potentially mis-
leading, fibro-desmoplasticalterationswereanalyzed.Outcomeafter re-
section was compared with 40 bypass patients matched for age, gender,
histopathology, and the use of additive chemotherapy (group B).
Results: R2 resection was due to misjudgement regarding re-
sectability in 38 patients (95%) and to uncontrollable hemorrhage in
2 patients (5%). Group A patients had significantly longer operative
times (P<0.0001), required more blood units (P<0.0001), and had
longer hospital stay than group B patients (P=0.049). Despite a sig-
nificantly higher relaparotomy rate of 20% (n=8) in group A vs. 5%
(n=2) in group B, perioperative mortality was equal (n=2, each).
Median survival was 11.5 months in group A and 7.5 months in group
B (p=0.014). “Pancreatitis”-like lesions were assessed in 70%
(n=28/40, Group A) and 25% (10/40, Group B; P=0.014). The su-
perior mesenteric artery proximal to its jejunal branches was the most
likely site of irresectability (60%), followed by its peripheral course
(22.5%) and the lower aspects of the celiac trunk (17.5%).
Conclusions: Concomitant “pancreatitis-like” alterations ham-
per the assessment of local resectability in pancreatic cancer. Al-
though palliative resection results in elevated perioperative
morbidity compared to bypass procedures, mortality is equal,
while survival is prolonged.
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DOWNSTAGING AFTER RADIOFREQUENCY
ABLATION IN LOCALLY ADVANCED
PANCREATIC CANCER
I. Frigerio1, R. Girelli1, A. Giardino1, R. Salvia2, M. Bacchion2,
C. BassiI2
1. General Surgeon Casa di Cura Pederzoli
2. Department of Surgery University of Verona
Introduction: Feasibility and safety of radiofrequency ablation
(RFA) of locally advanced pancreatic cancer (LAPC) has been
recently reported by our own institution (1); long term effect is
still under study. Here we present the preliminary data regarding
the local effect of RFA.
Matherials and Methods: Fifty patients with hystologically
proven LAPC were treated with US-guided RFA during laparo-
tomy. One month after surgery, all the patients were checked with
a CT scan and clinical evaluation, then received a combination
of chemo-radiotherapy. Upon the opinion of the oncologist we
re-evaluate for surgery all the patients with a significant mass re-
duction proved with CT, MRI or PET-CT.
Results: The mean age of the 50 consecutive patients treated
within 21 months was 69 years. Forty five patients received the
above mentioned combined treatment. Six out of 45 (13,3%)
were proposed to our re-evaluation after the treatment because
of a significant reduction or radiological “absence” of disease.
Tumour location was the head in 2 pts and the body-tail in 4 pts
(mean size 36mm). Two out of six (33%) underwent to re-la-
parotomy and the tumour was resected with left pancreatectomy
(LP) in one case and pancreaticoduodenectomy (PD) in the
other. At first operation the tumour infiltrated the celiac trunk
and SMA respectively. A third patient with a tumour of the head
went back to O.R. one month after RFA for a benign stenosis of
duodenum and was found resectable by the same surgeon. His-
tology of the specimen could not find any tumoural cell (T0, N0)
in the patient who received LP and found microscopic neoplastic
foci in the other two. All the resections were R0. The other 4 pa-
tients with instrumental downstaging refused the second look and
are still alive, “progression free” and in good conditions. The
mean follow up of these 7 patients is 17 months.
Conclusions: The combination of RFA and chemo-radiotherapy
is an interesting option for a multidisciplinary treatment of lo-
cally advanced pancreatic cancer.
Girelli R. et al. Radiofrequency ablation for locally advanced
pancreatic cancer. A phase II study on 50 consecutive patients.
(Submitted).
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THE MTOR-INHIBITOR RAD001 INDUCES
AUTOPHAGY AND APOPTOSIS IN PANCREATIC
CARCINOMA AND SUPRESSES TUMOR
GROWTH
M. Bartel1, A. Sommer1, S. Serba1, N. Brady2, J. Schmidt1,
A. Märten1
1. University of Heidelberg, Department of Surgery
2. 3Department of Theoretical Bioinformatics, German Cancer
Research Center
Background/Aim: The purpose of the present study was to in-
vestigate the effect of the mTOR inhibitor RAD001 on apopto-
sis and autophagy in cancer cell lines, as well and to how it is
connected to tumor growth in vivo.
Methods: Human pancreatic carcinoma cells were treated under
standard conditions and under nutrient deprivation with RAD001
and/or gemcitabine. Mice were implanted orthotopically with syn-
geneic cells and treated at different time-points. Autophagy was
assessed by Western blot detection of LC3.
Results: In pancreatic carcinoma cell lines RAD001 significantly in-
duced both apoptosis and autophagy to a greater extent than gemc-
itabine. Nutrient deprivation yielded similar results as gemcitabine;
however treatment with RAD001 had no additive effect. In vivo,
RAD001 and gemcitabine each affected tumor growth independently
of tumor size. However, significance was only reached when used as
in combination. Autophagy in the tumor mass was detected after
treatment with RAD001 in small and medium sized tumors. Inter-
estingly, anti-CD31 staining of tumors showed that mean vessel den-
sity was significantly decreased in the tumors of RAD001-treated
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ical trials addressing the issue (irrespective of sample size; language
or publication status; aetiology; or type of operation) were included.
Two authors independently assessed trials for inclusion and inde-
pendently extracted the data. The data was analysed with both the
fixed-effect and the random-effects models. Risk ratio (RR) or mean
difference (MD) with 95% confidence intervals (CI) were calculated
based on available case analysis. Sub-group analysis was based on
the aetiology of the disease and procedure performed.
Results: Seventeen trials involving 2143 patients were included.
There was no difference in the peri-operative mortality, re-opera-
tion, anastamotic leak, post-operative pancreatitis, or hospital stay
between the groups. The incidence of pancreatic fistula was lower
in the somatostatin analogues group (RR 0.62, 95% CI 0.51 to 0.76).
However, there was no difference in clinically significant pancreatic
fistulas between the groups. The hospital stay was shorter in the so-
matostatin analogues group in patients undergoing resections for
malignancy (MD -7.57 days, 95% CI -11.29 to -3.84). None of the
other subgroups had any benefit from somatostatin analogues.
Conclusions: Use of somatostatin analogues is of minimal benefit
overall. However, the incidence of pancreatic fistula is reduced; and
so is the hospital stay in patients undergoing pancreatic resections for
malignancy. Further low bias-risk trials are necessary.
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EFFECTIVENESS OF THE INTERNATIONAL
STUDY GROUP OF PANCREATIC FISTULA
DEFINITION: RESULTS IN 147 CONSECUTIVE
PATIENTS
D. Daskalaki1, G. Butturini2, E. Molinari1, S. Crippa2,
C. Bassi2, P. Pederzoli2
1. Surgical and Gastroenterological Department University
of Verona Policlinico G.B Rossi
2. Department of Surgery University of Verona
Background: The reported rates of postoperative pancreatic fistula
(POPF) largely vary, because of the lack of one common definition.
The aim of this study is to affirm the validity of the International
Study Group of Pancreatic Fistula (ISGPF) definition.
Methods: A retrospective study on 755 patients who underwent pan-
creaticoduodenectomy in our Clinic between November 1996 and
October 2006. 147 patients (19.5%) have developed a POPF ac-
cording to a previously applied definition. ISGPF definition was ret-
rospectively used in order to define the grading of this complication.
Results: Grade A fistula occurred in 19% of all cases and had no
clinical impact. Grade B was the most frequent type of fistula
(70.7%) and was successfully managed with conservative therapy or
mini-invasive procedures. Grade C (8.8%) was associated to severe
clinical complications and required invasive therapy. Pulmonary
complications were statistically higher in the group B and C rather
than the group A POPFs (p<0.005; OR: 8). Patients with carcinoma
of the ampullary region had a higher incidence of POPF, with a pre-
dominance of grade A (p=0.036). Increasing fistula grades have
higher economic impact on the healthcare system ( 11.654, 25.698,
59.492 for grade A, B and C respectively, p<0.001).
Conclusions: POPF doesn’t always determine a substantial change
of the postoperative management. Clinically relevant fistulas can be
treated conservatively in most cases. Higher fistula severity corre-
sponds to increased costs. The grading system proposed by the
ISGPF allows a correct stratification of the complicated patients,
based on the real clinical and economic impact of the POPF.
mice compared to the tumors of control animals.
Conclusion: The results of this study indicate a therapeutic potential
of RAD001 against pancreatic carcinoma, specifically in combina-
tion with standard chemotherapy. Autophagy and apoptosis could be
activated in parallel by the same agent and are not antagonists. Fur-
thermore, RAD001 has a negative impact on vascularization.
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IN-HOSPITAL MORTALITY DECREASED
SIGNIFICANTLY AFTER REGIONALIZATION
OF PANCREATIC SURGERY IN THE
SOUTH-EAST OF THE NETHERLANDS
S. Nienhuijs1, H. Rutten1, E. Luiten2, O. Repelaer van Driel3,
P. Reemst3, V. Lemmens4, I. De Hingh1
1. Catharina Ziekenhuis Eindhoven
2. St Anna Ziekenhuis Geldrop
3. MMC-Veldhoven
4. Comprehensive Cancer Centre South
Background: In the south of The Netherlands, surgery for pan-
creatic and peri-ampullary cancer used to be performed in low-
volume hospitals (<5 resections/year). In 2005, the
Comprehensive Cancer Centre South (CCCS) reported the
clearly unsatisfying results of this practice. This stimulated the re-
gionalization of pancreatic surgery by 3 collaborating surgical
units into one non-academic teaching hospital. As the impact on
surgical outcome of such an initiative has not been reported yet,
the results are reviewed.
Methods: All patients in the regionalized cohort group (Oct 05-
Dec 08) operated with curative intent for a (peri-)pancreatic
tumor were followed prospectively. Their outcome was compared
to the reported CCCS cohort group (Jan 95-Dec 00).
Results: Since the regionalization the number of annually treated pa-
tients increased from 10 to 41, making a total of 90 patients. The in-
hospital mortality rate was 3.3% (3/90). Almost one-third (n=29) of
the tumours was peroperatively deemed locally advanced or metas-
tasised and a palliative procedure was performed. In 61 patients
(68%) a resection was performed. Their outcomes were a mortality
rate of 4.9%, complication rate of 48% and re-intervention rate of
23%. These results were lower than the previously reported ones
(24% (p<0.001), 72% and 38% respectively.
Conclusion: After regionalization of pancreatic surgery in the south-
east of The Netherlands the in-hospital mortality decreased signifi-
cantly from an unacceptable 24% in 2000 to 4.9% in 2008. These data
underline the recommendations of various experts advocating that
centralisation of pancreatic surgery improves the standard of care.
O 44
A SYSTEMATIC REVIEW OF RANDOMISED
CLINICAL TRIALS OF PROPHYLACTIC
SOMATOSTATIN ANALOGUES IN
PANCREATIC SURGERY
R. Koti, K. Gurusamy, V. Alberto, G. Fusai, B. Davidson
Surgery Royal Free Hospital and UCL School of Medicine
Background: Routine use of somatostatin analogues in pancre-
atic surgery is controversial.
Aim: To determine if somatostatin analogues should be used rou-
tinely in pancreatic surgery.
Methods: Cochrane trials register, Medline, Embase, and other jour-
nal databases were searched until November 2008. Randomised clin-
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LIVER RESECTION PRIOR
TRANSPLANTATION FOR HCC:
OUTCOME OF SIXTY SIX PATIENTS
F. Dondéro, G. Liddo, D. Sommacale, S. Dokmak,
A. Sauvanet, F. Durand, C. Francoz, J. Belghiti
HBP Surgery, Hospital Beaujon, Clichy France
Background: Liver resection (LR) for hepatocellular carcinoma
(HCC) in patients eligible for liver transplantation (LT) is in-
creasingly used.
Aims: To analyze the outcome of a series of 66 patients who un-
derwent LR prior LT for HCC.
Methods: From 1999 to 2007, among 216 patients who under-
went LT for HCC, 66 (31%) had previous liver resection. This
group with secondary LT was compared to 150 who underwent
primary LT.
Results: These two groups (secondary LT and primary LT) were
similar concerning age (54±8 vs 53±7 years), etiology of cirrho-
sis, within Milano criteria (86% vs 78%) and use of partial grafts.
The two groups showed no difference in blood loss (2021±2065
vs 1672±1928 mL) and operative time (536±145 vs 538±139
min) (p=NS). Secondary LT was associated with 30 days mortal-
ity of 8%. This rate was similar to the 30 days mortality of the 150
patients with primary LT (10%). The 3 and 5 years survival was
respectively 83% and 80% after secondary LT and 75% and 73%
after primary LT (p=NS).
Conclusion: This study confirms that LR doesn’t increase the op-
erative risk of LT, nor impair the long term survival in patients
with HCC. The main problem remains to define whether the in-
dication of this resection is as a bridge, a selection or an initial
treatment with LT as a salvage procedure in case of recurrence.
O 47
PORTAL VEIN THROMBOSIS AND LIVER
TRANSPLANTATION: EVOLUTIONS DURING
10-YEARS EXPERIENCE AT THE UNIVERSITY
OF BOLOGNA
M. Ravaioli, M. Zanello, G. Grazi, G. Ercolani1, M. Cescon,
M. Del Gaudio, G. Vetrone, A. Dazzi, F. Tuci, C. Zanfi,
P. Di Gioia, A. Lauro, M. Vivarelli, A .Pinna
Hospital Sant’Orsola, Bologna, Italy
Background: portal vein thrombosis (PVT) may be a contraindi-
cation to liver transplantation (LT).
Aim: to review 10-years experience on LT and PVT.
Methods: patients with PVT intra-operatively confirmed during
1998-2008 (1st era 1998-2002; 2nd era 2003-2008), formed the study
group (PVT), sub-classified according to Yerdel classification:
partial PVT (grade 1-2) and complete PVT (grade 3-4). Patients
without PVT was the control group (non-PVT).
Results: among 889 consecutive LTs, we diagnosed 91 PVT (10.2%):
51 partial PVT (56%) and 40 total PVT (44%). The rate of complete
PVT increased from 1st to 2nd era (2.2% vs. 6.7%, p<0.005).
At multivariate analysis, previous shunt surgery or splenectomy,
hepatocellular carcinoma histological-proven and cirrhosis alco-
hol-related were independently related to the presence of PVT.
PVT were treated with thrombectomy in 53 cases (58%), anasto-
mosis to spleno-mesenteric confluence in 23 (25%), jumping graft
in 6 (7%), cavo-portal hemitransposition in 6 (7%) and anasto-
mosis to varix in 3 (3%).
There were not any intra-operative differences among PVT and
non-PVT groups. Mortality was comparable (6,6% vs. 5,8%),
such as 1- and 5-years patient survival (85% and 68% vs. 86% and
73%) and graft survival (79% and 60% vs. 78% and 66%). The
rate of re-PVT was different: 6.6% PVT vs. 0.6% non-PVT,
p=0.0001.
Post-operative outcome was similar between partial and complete
PVT, which showed different patient survival from 1st to 2nd era:
57% vs. 89% at 1-year, p<0.05.
Conclusions: LT is safe and with satisfactory outcome in patients
with partial and complete PVT.
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EXPANDING THE LIVER DONOR POOL BY
USING EXTENDED CRITERIA DONOR LIVER
GRAFTS: RESULTS OF A SINGLE CENTER
I. Petridis1, S. Gruttadauria2, D. Biondo1, R. Jones2, M. Spada2,
D. Cintorino1, S. Li Petri1, F. Di Francesco1, T. Dominioni1,
G. Vizzini2, B. Gridelli2
1. Istituto Mediterraneo Trapianti e Terapie ad Alta Specializ-
zazione- University of Pittsburgh Medical Center in Italy,
Palermo Italy.
2. Thomas Starzl Transplantation Institute, University of Pitts-
burgh Medical Center, Pittsburgh, PA, USA
Introduction: Disparity between demand and donor supply is a
major problem in liver transplantation. Use of hepatic grafts from
extended criteria donors (ECD) is a way for expanding donor pool.
Aim: With this study we present the results of our 5-years expe-
rience by using ECD in liver transplantation.
Materials and Methods: 198 deceased-donor liver transplants
(LTx), performed between June 2003 and March 2008, were in-
cluded in the present study and were divided into 2 groups: Stan-
dard (S) and Non-Standard (NS). In the first group, 87 patients
received a liver procured from an ideal donor and in the second
group 111 patients received an organ from an ECD.
Marginal liver donor criteria included obesity, age, steatosis, long
intensive care unit stay, hypotensive episodes, use of inotropic
drug, long cold ischemia time, Na >155.
Patients in the NS group were further divided into 2 subgroups:
NS1 group, with 70 pt receiving a graft with < 2 risk factors and
NS2 group, in which 41 received a graft with > 3 risk factors.
Results: There was no statistically significant difference in the
prevalence of biliary/vascular complications or HCV recurrence and
incidence of acute and chronic rejection between S vs. NS group.
No difference was seen in terms of patient and graft survival in
the first three months post-OLTx in both groups.
1 and 5 year patient survival in the S vs NS group were respec-
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tively 95.06% vs 83.04% and 93.39% vs 76.34% (p 0.005). Graft
survival between two groups was 92.75% vs. 78.44% (p0.01) after
1 year from OLTx and 89.41% vs. 70.19% (p0.004) after 5 years
respectively.
During first year post-OLTx, more deaths occurred in the NS vs.
S group (17 vs 4). During the five years of follow-up, the overall
number of deaths was reduced in both groups, with no statisti-
cally significant difference (4 vs 1).
Number of risk factors do not affect 1-year and 5-year patient
(p=0.37) and graft survival (p=0.12) between NS1 and NS2 sub-
groups.
Conclusions: ECD liver grafts can safely be used and allows re-
cipients on the waiting list to have a greater chance of being trans-
planted. High rate mortality seen during the first 12 months
post-OLTx suggests a careful selection and use of the ECD.
O 49
ONE THOUSAND LIVER TRANSPLANTS FROM
A SINGLE EUROPEAN CENTER
M. Caralt, A. Escartín, J. Lázaro, I. Bilbao, L. Blanco,
C. Dopazo, J. Bueno, J. Ortega, C. Venturi, R. Charco
Hpb Surgery and Liver Transplant, Hospital Vall d’Hebron,
Barccelona, Spain
Aim: To analize changes over time in donors, recipients and re-
sults of a series of 1000 liver transplants(LT) performed in our
center.
Patients and Methods: Between 1985-2007,1000 LT were per-
formed(789 adults,211 children). We have compared the first 100
LT with the last 200 among adults,and the first 100 with the last
100 among children.
Results:
Adults: Donors in the last period were older (30 years(r:7-64) vs
54.5 years(r:7-83),p<0.001)). The main cause of death during the
1stperiod was traffic accident(47%) and cerebrovascular disease in
the 2ndperiod(54.9%).
Recipients were older (53.5 years(r:16-66) vs 57.4 years(r:20-
69),p<0.001) and had more comorbidity in the 2ndperiod (DM
14%vs29.5%, HTA 6%vs14.3%;p<0.05). In the last period, there
were more patients with HCC (14%vs27.5%,p<0.005) and pa-
tients HIV+started to be transplanted. In the 1stperiod, the sur-
gical technique used was: Piggy-Back technique(45%),
by-pass(33%) and classical(22%),(p<0.001). In the 2ndperiod,the
Piggy-Back technique was used in all patients. Initially, the T-tube
was used in 46% and in the 2ndperiod scarcely(6.6%),(p<0.05).
One-,3- and 4-year actuarial patient survival in the first and last
period was 64%,50%,48% vs 86%,78%,75%, respec-
tively,(p<0.05).
Children: During the last period, transplanted children were
younger: 1.3 years(r:0.08-16.5) vs 4 years(r:0.6-15),(p<0.05).
There were no differences in weight: 15kg(r:4.4-68) vs 10kg(r:2.5-
78). The main reason for transplantation was biliary duct atresia
in both groups. In the last group, more partial grafts were used
(17%vs44.1%,p<0.05): less reduced grafts (15%vs20.4%), but
more “split” (2%vs19.4%) and the beginning of the living
donor(p<0.05).
Conclusions: Despite the use of older donors,partial grafts,more
comorbidity and extreme ages, survival has improved throughout
the years.
O 50
LIVER TRANSPLANTATION - BILIARY
COMPLICATIONS
B. Dorobantu, E. Matei, V. Brasoveanu, D. Hrehoret1,
M. Boros1, S. Dima, I. Popescu
Fundeni Clinical Institute, Bucharest, Romania
Introduction: Early and late biliary complications still remain the
Achille’s heel of the liver transplantation, leading to increased
morbidity with a reported negative incidence up to 64% in adult
living donor liver transplantation (ALDLT).
Materials and methods: We reviewed 152 transplants in 144 pa-
tients who underwent liver transplantation between April 2000
and June 2008. Whole and partial liver transplants were 101 and
51 respectively (41 from living donors and 10 cadaveric split and
reduced livers). We compared recipient’s outcomes and biliary
complications in these two groups to assess the impact of trans-
plant type.
Results: Mean follow-up was 792 days (range, 1-2985 days), the
patient overall survival rate was 72.2 %( 1year survival = 76.1%
and 5ys survival = 68.6%). Forty recipients (27.8%) died and 8
(5.5%) were retransplanted. Forty-nine biliary complications
were present in 38 (26.3%) cases, 29 biliary leakages, 19 biliary
stenosis and 1 lithiasis.
Conclusions: The transplantation program from Fundeni Clini-
cal Institute is complex with all types of liver transplantation, both
in adults and children and combined as well. The high incidence
of biliary complications is associated with partial liver grafts.
Along with the increase of liver transplantation procedures and
experience of surgical team, improved results are expected.
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EVALUATION OF ADJUVANT TREATMENT
WITH SORAFENIB AFTER OLT FOR HCC
BEYOND MILAN CRITERIA. PRELIMINARY
RESULTS
D. Giakoustidis1, N. Antoniadis1, G. Tsoulfas1, S. Iosifidou1,
N. Ouzounidis1, G. Imvrios1, T. Vassiliadis4, K. Patsiaoura3,
I. Goulis2, I. Fouzas1, E. Katsika4, E. Katsiki3, D. Vrochides1,
A. Giakoustidis1, A. Tsitlakidis1, P. Agorastou2,
V. Pappanikolaou2, E. Akriviadis6, D. Takoudas1
1. Department of Transplantation Surgery, Aristotle University
of Thessaloniki, Greece Hippokratio General Hospital
2. Department of Internal Medicine, Aristotle University of
Thessaloniki, Greece Hippokratio General Hospital
3. Department of Pathology Aristotle University
4. Department of Anesthesiology Aristotle University
Background: Liver transplantation (OLT) is considered as one
of the optimum treatment modalities for HCC. Milan criteria
have shown excellent results in terms of long term and disease-
free survival. Pre-transplant imaging techniques frequently un-
derstage patients with HCC, as evidenced by the final explant
pathology. Sorafenib is a new targeted therapy for advanced
HCC.
Objective: To evaluate Sorafenib as an adjuvant treatment in pa-
tients transplanted for HCC outside Milan criteria.
Material and Methods: From January 2007 to December 2008,
75 patients underwent liver transplantation in our centre. HCC
was the principal diagnosis in 17 patients and out of these, 6 pa-
tients were either beyond Milan criteria or presented with, or de-
veloped metastatic disease later on. These patients were treated
with Sorafenib as adjuvant treatment and were on an mTor in-
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hibitor for immunosuppression maintenance.
Results: Patient and graft survival were both 7.5 months (2-21m),
mean aFP was 2223 ng/ml (3.7-11000). Secondary disease was
HBV in 4 patients, HBV + ALD in 1 patient and ALD in 1 pa-
tient. One patient presented with recurrence 3 months after liver
transplantation and 2 patients developed metastastes in bones
and lungs respectively. There were episodes of acute rejection in
2 patients treated with steroids boluses. Maintenance immuno-
suppression was mTor plus Calcineurin inhibitors in 5 patients
and 1 patient was converted from mTor to MMF due to acute re-
jection.
Conclusions: Preliminary results showed that adjuvant treatment
with Sorafenib after OLT is likely to slow progression of the dis-
ease and a trend to extend survival.
O 52
130 LIVER TRANSPLANTATIONS FOR
FULMINANT HEPATIC FAILURE RESULTS
OF A HIGH VOLUME CENTER
P. Fikatas, F. Ulrich, J. Lee, S. Chopra, A. Pascher,
O. Guckelberger, G. Puhl, U. Neumann, P. Neuhaus,
J. Pratschke
Dept. of General, Visceral and Transplantation Surgery
Campus Virchow Clinic
Purpose: Fulminant hepatic failure (FHF) is an uncommon and
life-threatening clinical syndrom. Despite impovements in med-
ical therapy, orthotopic liver transplantation (OLTX) remains
treatment of choise. Since now, only few investigations have been
published in this field. Purpose of this analysis was to present the
postranplant outcomes in patients with of a high volume trans-
plantation center.
Patients and Methods: This retrospective analysis included 135
patients with FHF who underwent OLTX between 1988 and
2007. Etiology of FHF, patients demographic variables and lab-
oratory values were analyzed and compared with postranplant
outcome. Postoperative liver specific values were collected.
Results: In the cohort of 135 transplantated patients, 44 (32.6%)
were males and 91 (67.4%) females with a mean age 32±17 years
at time of transplantation. In most instances cause of FHF re-
mained unclear (44%) followed by hepatitis B infection (22.2%)
and drug-induced hapatic failure (13.3%). The mean waiting time
for a suitable graft was 2±2 days. Cold and warm ischemia time
were 525±174 min und 44±13 min respectively. Nine graft
showed initial non-function. The mean hospital-stay was 47±32
days . The 1 year survival was 82%. Gender and etiology of FHF
did not correlate with posttransplant outcome (p=NS). At the
14th POD the patients had following laboratory values: bilirubin
8,9±9 IU/L, INR 1.16±0.23 und ALT 92±81 IU/L.
Conclusions: This analysis demonstrates that OLTX due to FHF
has a 1-year survival over 80% with excellent postoperative graft
function. Because of this positive results, OLTX represents the
best therapeutic option for patients with irreversible FHF.
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THE LONG-TERM SURVIVAL OF LIVER
TRANSPLANT RECIPIENTS FOR HEPATITIS
B AND D CIRRHOSIS IS INCREASED WHEN
HEPATOCELLULAR CANCER IS PRESENT
G. Imvrios1, D. Vrochides1, V. Papanikolaou1, I. Fouzas1,
N. Antoniadis1, D. Giakoustidis1, A. Ntinas1, D. Kardasis1,
E. Akriviadis2, T. Vasiliadis2, I. Goulis2, E. Katsika3,
G. Moutsianos3, K. Patsiaoura4, G. Tsoulfas5, N. Ouzounidis1,
P. Agorastou3, D. Takoudas2
1. Organ Transplant Unit Aristotle University
2. Department of Internal Medicine Aristotle University
3. Department of Anesthesiology Aristotle University
4. Department of Pathology Aristotle University
5. Harvard Medical School Massachusetts General Hospital
Introduction: In contrast to immunocompetent patients, indi-
viduals with multiple hepatitis virus infections have an improved
outcome after liver transplantation. However, the effect of he-
patocellular cancer (HCC) in patients transplanted for hepatitis
B and D virus (HB/DV) cirrhosis is not well studied.
Purpose: To study the long-term survival outcomes of patients
who underwent liver transplantation for HB/DV cirrhosis with
and without HCC.
Methods: A total of 231 primary, adult, single-organ liver trans-
plants were performed from 1990 to 2007. HB/DV was the cause
of cirrhosis in 15.6% (n=36) of the patients. Nine patients died
during the first three postoperative months from surgical com-
plications. The rest 27 comprised the study group. Median fol-
low-up was 1515 days.
Results: Study group mean patient survival was 3760 days (95%
CI: 3013, 4507). Six patients (22.2%) were diagnosed with HCC
in the liver explant. Mean patient survival was 3011 days (95%
CI: 2344, 3679) and 4036 days (95% CI: 3002, 5070) for recipi-
ents without and with HCC respectively. The incidence of acute
cellular rejection was 14.3% and 16.7% for HB/DV patients with-
out and with HCC respectively (p=0.659). The incidence of mi-
crobial infections was 61.9% and 33.3% in patients without and
with HCC respectively (p=0.219). HCC has not recurred in any
of the six patients.
Conclusions: Mean long-term survival after liver transplantation
for HB/DV and HCC surpasses 11 years. The superior survival
of HCC patients is difficult to explain. The increased number
(almost double) of microbial infections in the non-HCC popula-
tion might be held accountable.
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BILIARY TRACT COMPLICATIONS AFTER
ORTHOTOPIC LIVER TRANSPLANTATION:
DO THEY STILL REMAIN THE ACHILLES
HEEL?
N. Vassos, T. Foertsch, A. Perrakis, V. Schellerer, P. Klein,
H. Werner, V. Muller
Surgical Department University of Erlangen-Nuremberg
Background/Aim: Biliary tract complications, once considered as
the technical “Achilles heel” of orthotopic liver transplantations
(OLTx), continue to be a challenging problem and a major cause
of morbidity and mortality despite advances in surgical tech-
niques, immunosuppression and postoperative management. The
aim of this study was to document the clinical presentation and
management of biliary complications (BC) after OLTx our center
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Methods: The clinical data of 229 patients (pts) undergoing 245
OLTx over a twelve year period were collected and analyzed ret-
rospectively. Reconstructions of biliary tract were included chole-
dochocholedochostomy (CDC) with or without a T-tube and
choledochojejunostomy (RCDJ). BC were suspected on clinical
and biochemical parameters and confirmed using imaging tech-
niques and their risk was related to the technique of biliary re-
construction and the use of a biliary T-tube drain. The average
follow-up was 50 months (range: 12-98 months).
Results: BC occurred after 60 OLTx (24,5%), including anasto-
mosis leak (5,5%) and T-tube drain leak (2,5%), anastomosis
(11%) and intrahepetic strictures (5,5%). One third of them oc-
curred in the early postoperative period and the rest during the
follow-up. The end-to-end CDC without a T tube is associated
with the lowest incidence of BC. The BC following RCDJ were
considerably less (7/45, 15,5%) than these following CDC
(53/200, 26,5%). Biliary strictures presented later than leaks and
their treatment lasted 10 times longer. Endoscopic treatment was
used as primary therapy in 81% of cases following CDC, primary
surgical intervention was only used in 19%, whereas this method
was more frequent after RCDJ.
Conclusion: BC after OLTx are difficult to treat and the early
one can have a negative impact on patient survival. They can be
avoided with the correct reconstruction, the sufficient and not-
stressed anastomosis suture line and the good arterial flow. Their
management is discussed with interventional radiology and en-
doscopic techniques emerging as the preferred treatment option,
obviating the need for surgery in a selected part of patients, es-
pecially in those with RCDJ.
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TUMOR RECURRENCE AFTER
HEPATECTOMY FOR COLORECTAL LIVER
METASTASES: THE NEED FOR NEW
PREDICTIVE FACTORS?
S. Marinakis, V. Lucidi, A .Buggenhout, B. Nebbot
J. Van Laethem, V. Donckier
Hopital Erasme, Universite Libre de Bruxelles
Background: Progresses in the multimodal management of pa-
tients with colorectal liver metastases (CRLM) justify reevaluat-
ing prognostic factors for surgical decision.
Aim: To review prognostic factors for morbidity, mortality and
survival after hepatectomy for CRLM.
Methods: Sixty-one patients undergoing a first liver resection for
CRLM were reviewed. Classical factors and 2 prognostic scores
were evaluated; Score I: node-positive primary tumor, disease-
free interval<12 months, CRLM number>1, tumor>5cm,
CEA>200ng/ml (Fong, Ann Surg 1999) and Score II: inflamma-
tory response to tumor, CRLM number>8 (Malik, Ann Surg
2007). Univariate and multivariate comparisons were made using
chi square, Fischer’s exact tests and Cox model. Predictive values
of scores I and II were analyzed with Wilcoxon-Mann-Withney test.
Results: Seventy% of CRLM were synchronous, 63% multiple,
30% bilobar. Eighty-four% of the patients received preoperative
chemotherapy (response: 84%). Twelve% had 2-steps hepatec-
tomy, 12% had a combined Radiofrequency. Operative mortality
and morbidity were 3 and 30%. One-year overall and disease-free
survivals were 92 and 47% and 2-years 89 and 30% respectively.
Tumor>50mm and 2-steps hepatectomy were the only prognos-
tic factors for operative morbidity. Node-positive primary tumor,
CRLM number, bilobar distribution, increased CEA and associ-
ated Radiofrequency were significantly correlated with tumor re-
currence in univariate but not in multivariate analyses. Score I
was predictive for tumor recurrence (most discriminative score:
2, p=0.001). Score II was not predictive.
Conclusion: None of the classical predictive factors was signifi-
cant in multivariate analysis. Despite efficient neoadjuvant
chemotherapy, a preoperative Score I>2 remains associated with
high short-term tumor recurrence rate, underlying its potential
role for therapeutic decision.
References:
1. Y. Fong, J. Fortner, R. Sun, M. Brennan, L. Blumgart, Clin-
inical Score for Predicting Recurrence After Hepatic Resection
for Metastatic Colorectal Cancer, Ann Surg 1999;230: 309-321
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LIVER RESECTION IN OBESE PATIENTS:
RESULTS OF A CASE-CONTROL STUDY
L. VIigano, A. Laurent, C. Tayar, D. Cherqui
Dept of Surgery Hopital Henri Mondor Creteil France
Objectives: To analyze outcomes of obese patients (BMI>30
kg/m2) undergoing hepatectomy.
Background data: Obesity is increasing worldwide. It is com-
monly considered to be associated with increased operative risk.
No data are available about short-term results after liver resection.
Methods: 85 obese patients (median BMI 32.6 kg/m2 (31-62.4))
undergoing hepatectomy (1998-2008) were matched 1:2 with 170
non obese patients (BMI 24.5 kg/m2 (16.9-28.9). Matching crite-
ria were diagnosis, ASA score, liver fibrosis score, type of resec-
tion, and Child score in cirrhotic patients. Main diagnoses were
HCC (35%), colorectal metastases (29%), biliary tumors (14%)
and benign lesion (13%). Patients characteristics were similar ex-
cept for higher rate of females in obese group. Steatosis > 30%
was more frequent in obese patients (28% vs 4%, p<0.001). 49%
of patients underwent major hepatectomy.
Results: Operative time, blood loss and transfusion rate were
similar. Overall mortality was 2.4% in both groups. Causes of
death were 1 liver failure in a cirrhotic and 1 Roux loop necrosis
in a Klatskin in obese patients, and 2 liver failures (1 cirrhotic and
1 Klatskin), 1 PV portal thrombosis in a cirrhotic, 1 pulmonary
failure, in non obese patients. Morbidity was higher in obese pa-
tients (32.9% vs 21.2%,p<0.05). Grade II morbidity was in-
creased in obese patients (14% vs 1.8%,p=0.0002); it was mainly
related to abdominal wall complications (9.4% vs 1.8%,p=0.002).
No difference of grade III-IV morbidities was found. Hospital
stay was similar. Stratification according to major hepatectomies,
cirrhosis, steatosis > 30%, or diabetes showed the same results.
Stratification according to BMI (<25,25-30,>30), showed an in-
crease in overall and infectious complications (19%, 24%, 33%
and 11%, 15%, 19%, respectively, ns).
Conclusions: Obese patients have increased postoperative mor-
bidity after liver resection. This is due to minor complications.
Grade III-IV morbidity and mortality rates are similar to those of
no obese patients, even in cirrhotic patients and after major he-
patectomies.
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THE EFFECT OF U-74389G LAZAROID ON
RECOVERY OF THE LIVER AFTER ACUTE
LIVER ISCHEMIA-REPERFUSION INJURY IN
AN EXPERIMENTAL SWINE MODEL
S. Vernadakis1, A. Tsaroucha2, K. Papadopoulos2,
S. Adamopoulos2, A. Papalois3, K. Simopolos2
1. Department of General, Visceral and Transplantation Surgery
University Hospital Essen, Germany
2. 2nd Department of Surgery Medical School, Democritus
University of Thrace, Alexandroupolis, Greece.
3. Experimental–Research Center Elpen Pharmaceuticals, Athens,
Greece
Background: The potential of U-74389G in attenuating liver
damage after ischemia and reperfusion of the liver was studied
in a swine model.
Materials and Methods: Eighteen pigs, weighting 28-35 kg, were
used in the study. The animals were divided into three experi-
mental groups: Group A (control group): Ischemia time 30min
and reperfusion for 120min (with tissue and blood sampling at
both 60min (A-60) and 120min (A-120)); Group B: Ischemia time
30min, U-74389G intraportal injection, reperfusion for 60min;
and Group C: Ischemia time 30min, U-74389G intraportal injec-
tion, reperfusion for 120min. The dose of U-74389G adminis-
tered was 10 mg/kg animal body weight. Anesthesia was induced
with propofol, pancuronium, and fentanyl. Surgery was per-
formed through a midline laparotomy. The portal vein and the
common hepatic artery were isolated and prepared for occlusion.
Results: Histopathological evaluation revealed a statistically sig-
nificant difference in portal infiltration in the liver tissue between
control group A-60 and group B (P = 0.01), and between control
group A-120 and group C (P = 0.002). Hemodynamic and meta-
bolic data in the control and therapy groups at 0, 30, 60, and
120min were not statistically significantly different. Tissue mal-
ondialdehyde levels were statistically significantly different.
Tumor necrosis factor-alpha values were statistically significantly
different between groups A-60 and B but not between groups A-
120 and C.
Conclusions: Based on the histological data and the reduction of
the malondialdehyde and tumor necrosis factor-alpha levels, ad-
ministration of U-74389G in ischemia-reperfusion injury of the
liver in a swine model has potential in attenuating liver damage.
O 58
CORRELATION BETWEEN POSTOPERATIVE
INFECTIVE COMPLICATIONS AND
LONG-TERM OUTCOMES FOLLOWING
HEPATIC RESECTION FOR COLORECTAL
LIVER METASTASIS
S. Farid, A. Aldouri, G. Morris-Stiff, A. Khan, G. Toogood, P.
Lodge, R. Prasad
Department of Organ Transplantation St James University
Hospital
Background: The impact of postoperative morbidity, and in par-
ticular infective complications on long-term outcomes following
hepatic resection for colorectal liver metastasis (CRLM) is not
widely published.
Objective: To evaluate the effect of postoperative complications
(POC) on disease recurrence and overall survival in patients un-
dergoing hepatic resection for CRLM.
Methods: All patients undergoing hepatic resection for CRLM
from January 1993 and March 2007 were identified, and postop-
erative complications analyzed. Patients who died of postopera-
tive complications within 30 days of surgery were excluded form
the study. Complications were further classified into infective and
non-infective complication groups and the primary end points of
the study were disease free survival (DFS) and overall survival
(OS) at 5 years.
Result: A total of 702 patients underwent hepatic resection in the
study period. Median follow up was 38 months. Operative mor-
bidity and mortality were 28% and 3.6% respectively. The total
number of patients with complications was 194 (28%) and 504
(72%) without. The 5 year DFS and OS for those with and with-
out complications were; 13% vs. 26% (p <0.001) and 24% vs.
37% (p<0.001) respectively. Multivariate analysis showed in-
flammatory response to tumour (IRT) score, blood transfusion,
tumour number > 8 and postoperative sepsis to be independent
factors associated with DFS and IRT, tumour number >8, and
postoperative sepsis to be independent predictors for OS.
Conclusions: Postoperative complications influence long-term
outcomes in hepatic resection for CRLM. Specifically, postoper-
ative sepsis is an independent predictor of disease free and over-
all survival. Thorough preoperative optimisation, meticulous
surgical technique and careful management in the postoperative
period may reduce the incidence of these complications and in-
fluence long-term outcomes.
O 59
GENETIC REGULATION IN THE TERMINATING
PHASE OF LIVER REGENERATION
I. Nygaard1, K. Mortensen2, L. Conley3, J Hedegaard3,
T. Kalstad1, P. Sorensen3, C. Bendixen3, A. Revhaug2
1. Laboratory of Surgical Research, Institute of Clinical Medicine
University of Tromso, Norway
2. Department of Digestive Surgery University Hospital of
Northern-Norway
3. Department of Genetics and Biotechnology, Research Centre
Foulum, Faculty of Agricultural Sciences University of Aarhus,
Denmark
Background: The liver regeneration process terminates when the
normal liver-mass/body-weight ratio of 2.5% has been re-estab-
lished.
Aims: We aimed to illuminate the genetic interactions between
genes regulating the cell cycle and apoptosis, and to clarify the
role of TGF-β signalling in the terminating phase of liver regen-
eration.
Methods: Twelve pigs were randomised to either 60% liver re-
section (n=4), sham operation (n=4) or control animals (n=4).
Liver biopsies were taken at the time of resection, after three
weeks and upon termination the sixth week. Global gene expres-
sion profiles in the biopsies were explored with microarray analy-
sis using 27000 pig oligo microarray slides representing
approximately 20000 porcine genes.
Results: A total of 609 genes found differentially expressed when
comparing resection, sham and control animals. There was a clear
dominance of genes regulating apoptosis towards the end of re-
generation, compared to the sham and control groups. Caspase
Recruitment Domain-Containing Protein 11 (CARD11) was
upregulated six weeks after liver resection, suggesting the in-
volvement of the caspase system at this time. Zinc Finger Protein
(ZNF490) gene, with a potential negative effect on cell cycle pro-
gression and promotion of apoptosis, was only up regulated at
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three and six weeks after liver resection indicating a central role
at this time. TGF-β was not found.
Conclusions: CARD 11 and ZNF490 appear to play a central
role in the termination of liver regeneration in the present study.
The lack of TGF-β could indicate that signaling by TGF-β is not
required for termination of liver regeneration.
O 60
INFLUENCE OF PREOPERATIVE
CHEMOTHERAPY AND HEPATIC HISTOLOGY
ON OUTCOME FOLLOWING EXTENDED
HEPATECTOMY
C. Neal, C. Mann, E. Porter, A. McGregor, G. Garcea,
A. Dennison, D. Berry
1. University of Leicester Leicester General Hospital
Background: Preoperative factors, particularly chemotherapy
use, have been associated with histological abnormalities in the
non-tumour-bearing liver (NTBL) of patients undergoing hepatic
resection. The effects of hepatic injury on liver remnant function
and patient outcome are expected to be most pertinent following
extended hepatic resection, but have yet to be specifically ex-
plored.
Aims: The aim of this study was to explore correlations between
preoperative factors, NTBL histology and outcome in patients
undergoing extended hepatectomy.
Methods: Data on consecutive patients undergoing extended he-
patectomy between 2000 and 2005 were identified from a
prospective database. Preoperative variables (including
chemotherapy use/regime and body mass index [BMI]), and intra-
operative variables were recorded. Blinded pathological review
of the NTBL was performed using established criteria for steato-
sis, steatohepatitis, fibrosis, sinusoidal injury and necrosis. Asso-
ciations between chemotherapy use, liver injury and
postoperative outcome were determined using the Chi-squared
and Fisher’s exact tests.
Results: 77 patients underwent extended hepatectomy over the
study period. In patients undergoing resection of colorectal liver
metastases (n=51), use of oxaliplatin-based chemotherapy was
associated with the development of sinusoidal injury (P=0.04).
Patient BMI, but not chemotherapy use, correlated with the pres-
ence of steatosis (P=0.02) and steatohepatitis (P=0.03).
Chemotherapy use showed no association with adverse outcome
following hepatectomy, but the presence of steatohepatitis was
associated with the development of major postoperative morbid-
ity (P=0.03). Other histological abnormalities in the NTBL
showed no association with outcome following extended hepate-
ctomy.
Conclusions: Steatohepatitis, but not sinusoidal injury, in the
NTBL is associated with adverse outcome following extended he-
patectomy.
O 61
MAJOR LIVER RESECTION FOR COLORECTAL
METASTASES IS FACILITATED BY THE
LAPAROSCOPIC APPROACH OF
COLORECTAL CANCER
S. Dokmak, Y. Panis, C. Hatwell, B. Aussilhou, F. Bretagnol,
O. Farges, J. Belghiti
Department of HBP Surgery, Hospital Beaujon, Clichy France
Backround: Combined simultaneous major liver and colorectal
cancer resection for synchronous Colorectal liver metastases
(CRLM) still remains controversial because of the higher risk of
morbidity and the necessity of adequate abdominal approach for
both liver and colorectal resection. Laparoscopy may be benefi-
cial in terms of operative results and could facilitate surgically
this combined procedure.
Aim: The aim of this study was to describe this new approach and
to report the surgical outcome of these patients.
Methods and Patients: From 2005 to 2008, 280 patients were
operated at Beaujon Hospital for CRLM. Among them 12 un-
derwent combined open right hepatectomy with colorectal cancer
resection by laparoscopy. There were 10 men with a mean age of
57 ± 10 years. Colorectal cancer was resected by laparoscopic ap-
proach with lateral ileostomy and extraction of the specimen by
small subcostal incision, which was extended for the liver ap-
proach. Liver transaction was achieved with intermittent pedicle
clamping if necessary. All patients had preoperative chemother-
apy. Two patients underwent portal vein embolisation because
the remnant liver was < 35%.
Results: There was no postoperative death. The mean operative
time was 420 ±102mn and the mean blood loss for the liver re-
section was 420ml (range: 200-750). Two patients (17%) were
transfused. Morbidity was observed in 4/12 (42%) patients in-
cluding one patient with hepatic insufficiency related to
chemotherapy induced liver injury and another developed bil-
iary fistula necessitating percutaneous drainage. No colorectal
fistula was observed. The Mean hospital stay was 12 days (range:
7-60). Postoperative Adjuvant chemotherapy was started at a
mean of 35 days (range: 27-9). Ileostomy closure was performed
at 6-8 weeks postoperatively.
Conclusions: This combined approach is safe, allowing the liver
surgeon to choose the best abdominal approach for the liver re-
section. These results are comparable to isolated major liver re-
section and better than the cumulative 2 steps operation for
CRLM in terms of operative time and hospital stay.
O 62
THE COSTS OF POSTOPERATIVE LIVER
FAILURE AFTER HEPATECTOMY AND
PREVENTIVE STRATEGIES IN A PROSPECTIVE
PILOT STUDY
J. Lock1, M. Stockmann1, T. Reinhold3, P. Neuhaus1
1. Dept. of General, Visceral and Transplantation Surgery Campus
Virchow Clinic
2. PhD Institute for Social Medicine, Epidemiology, and Health
Economics
Background and aims: Postoperative liver failure (PLF) is a se-
vere complication after hepatectomy and associated with a high
mortality. No economic data concerning hepatectomy and PLF
are available in literature. The aim of this study is the explorative
description of the economic burden of PLF in liver surgery. Po-
tential preventive strategies are presented.
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Methods: Economic data of 48 study patients were retrieved from
our hospital’s medical controlling office. All types of costs were
collected individually for every case in an electronic database for
internal accounting. The cost difference between PLF and regu-
lar progression was compared using ANCOVA. Liver function
and volume were determined perioperatively by the LiMAx test
(a new intravenous 13C- methacetin breath test) and computed
tomography. A predicted LiMAx for the liver function after sur-
gery was preoperatively calculated by volume/-function analysis.
Results: Forty-five patients underwent major hepatectomy
(mostly Klatskin tumor; n=27). Eight patients of this selected se-
ries developed PLF; seven of them deceased during hospitaliza-
tion. The mean attributable costs of PLF were 56,219 Euro
(82,199 Euro [95%CI 42,812 to 121,586] vs. 25,980 Euro [95%CI
9,559 to 42,401]; p=0.013). Intensive care was responsible for
more than 50% of the costs. Patients suffering from PLF showed
critically reduced LiMAx values after surgery. (61 µg/kg/h vs. 122
µg/kg/h; p<0.0001) A linear correlation between total costs and
LiMAx after surgery (r=-0,618; p<0,0001) and the predicted
value (r=-0,446; p=0,008) was demonstrated.
Conclusions: PLF is a relevant economic and medical problem
and underlines the necessity for improved preoperative planning and
patient selection. The LiMAx test can quantify liver function and has
the potential to decrease the incidence and mortality of PLF.
O 63
FEASIBILITY AND OUTCOMES OF LIVER
RESECTION FOR COLORECTAL LIVER
METASTASES IN OLDER PATIENTS
N. de Liguori Carino, B. van Leeuwen, P. Ghaneh,
A. Wu, R. Audisio, G. Poston
Hepatobiliary Unit University Hospital Aintree, Liverpool,UK
Introduction: 76% of all patients with a newly diagnosed col-
orectal tumour are between 65 and 85 years old. A substantial
proportion will develop colorectal liver metastases, for which re-
section is the only cure.
Aims: To investigate the feasibility, short and long terms out-
comes of liver resection for colorectal liver metastases in elderly
patients.
Methods: Between 1990 and April 2007 data were prospectively
collected on patients over 70 years old who underwent a liver re-
section for colorectal liver metastases at our Hepatobiliary Unit.
Results: 181 liver resections were performed in 178 consecutive
patients. Median age was 74 years. 34 patients (18,8%) received
neoadjuvant chemotherapy(FOLFOX) prior to liver surgery and
a majority (57,5%) of liver resections involved more than three
Couinaud’s segments. Median in hospital stay was 13 days, 70
(38,5%) patients had perioperative complications and overall in
hospital mortality was 4,9 % (9 patients). Median follow-up was
17,5 months (range 1-120). Overall- and disease free survival rates
at 1, 3 and 5 years were 86,1%, 43,2% and 31,5%, and 65,8%,
26% and 16% respectively. Neoadjuvant chemotherapy and he-
patic pedicle clamping did not significantly influence overall and
disease free median survival(p>0.05).
In multivariate analysis only the occurrence of postoperative
complications was predictive of overall and disease free survival.
Conclusions: Liver resection for colorectal liver metastases in
elderly patients is safe and may offer long time survival to a sub-
stantial percentage of patients. We strongly recommend consid-
ering senior patients for surgical treatment whenever possible.
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O 64
IMPROVED LONG-TERM SURVIVAL AFTER
RADICAL RESECTION FOR GALLBLADDER
CANCER
T. Underwood, J. Holley, J. Primrose
Southampton University Hospital, Southampton
Background: Gallbladder cancer is an aggressive malignancy with
historically poor long-term survival. The role of radical resection
for gallbladder cancer remains an area of debate. We present the
long-term results of all patients treated for gallbladder cancer at
a tertiary referral centre between 1998 and 2008.
Aims: To assess the impact of radical resection on the long-term
survival from gallbladder cancer in a single institution.
Methods: Records of all patients with gallbladder cancer were re-
viewed. Details including patient demographics, operative details,
TNM tumour stage, the incidence and location of residual/additional
tumour discovered at re-resection and outcome were recorded and
analysed. Patient survival was analysed by the Kaplan-Meier method
and log-rank was used to compare between curves.
Results: 50 patients were treated for carcinoma of the gallblad-
der during the study period. The median age at presentation was
68 and 70% were female. Overall 5 year survival was 22% with a
median life expectancy of 46 months. 19 patients presented with
incidental cancers, of which 7 went onto re-resection. No patients
with incidental T2 tumours had residual tumour in the liver at the
time of re-resection, whereas all those with T3 tumours did. 4
patients had residual lymph node disease only (one T1b, two T2
and one T3 tumour). Radical surgery for T1b/T2/T3 disease led
to a significant increase in median life expectancy from 15 months
to 49 months (p=0.02).
Conclusions: Radical resection for gallbladder cancer signifi-
cantly improves survival and should be considered for all patients
with muscle invasive tumours.
O 65
BILIARY DRAINAGE, PHOTODYNAMIC
THERAPY AND CHEMOTHERAPY FOR
UNRESECTABLE CHOLANGIOCARCINOMA
WITH JAUNDICE
D. Fuks1, E. Bartoli2, R. Delcenserie2, T. Yzet3, P. Celice2,
C. Sabbagh1, D. Chatelain4, N. Cheron2, J. Joly2, J. Dupas2,
J. Regimbeau1
1. Department of Digestive disease Amiens North Hospital
2. Department of Gastroenterology Amiens North Hospital
3. Department of Radiology Amiens North Hospital
4. Department of Pathology Amiens North Hospital
Background: The combination of photodynamic therapy (PDT)
and biliary stenting seems to be beneficial in the palliative treat-
ment of unresectable cholangiocarcinoma (CC). The aim of the
present study was to assess the accuracy of PDT in a single centre.
Methods: From 2000 to 2007, 150 patients were managed for CC.
Fourteen selected patients (with jaundice related to unresectable
CC) underwent PDT and biliary stenting (± chemotherapy). For
PDT, Photofrin was injected intravenously 2 days before intralu-
minal photoactivation. In the event of malignant progression,
PDT was repeated. The outcome parameters were overall sur-
vival, jaundice, pruritus and quality of life.
Results Thee was 8 men and 6 women (median age: 67±10).
Non-resectability was related to a low Karnofski index (n=2),
peritoneal carcinomatosis (n=4), vascular involvement (n=3), in-
vasion of hepatoduodenal ligament (n=2) and an under-sized
liver remnant (n=3). Biliary stenting was efficient (≥50% total
bilirubin) in 78.5% of cases. Eight patients developed cholangitis
and one patient died of severe cholangitis. The mean number of
PDT procedures was 2 (1-4). Six (43%) patients needed ≥2 pro-
cedures. The median time interval between 2 PDT procedures
was 4.1 months. No severe toxicity was noted. PDT improved the
Karnofski index in 64% of cases. Six (42.8%) patients received
concomitant chemotherapy (gemcitabine in all cases). The me-
dian survival time was 418±310 days (13.7 months). The 3, 6 and
12-month survival rates were 85%, 77% and 77% respectively.
Conclusion These results confirm the beneficial effect of biliary
drainage, PDT and chemotherapy for unresectable CC in se-
lected patients with jaundice.
O 66
THE IMPACT OF LAPAROSCOPY AND
LAPAROSCOPIC ULTRASOUND ON THE
MANAGEMENT OF PERIHILAR
CHOLANGIOCARCINOMA
K. Srensen, C. Fristrup, H. Nielsen, M. Mortensen, T. Pless
Department of Surgery Odense University Hospital
Background: Selecting patients with perihilar cholangiocarci-
noma for surgery is still a challenge despite the evolution in im-
aging in the recent years and the disease is often diagnosed in an
advanced stage. Unnecessary laparotomy increases morbidity and
mortality, thus augmenting the overall poor prognosis.
Aim: To evaluate the role of laparoscopy with laparoscopic ul-
trasound (LAP/LUS) in the assessment of respectability in pa-
tients with perihilar cholangiocarcinoma.
Methods: The medical records of patients who underwent
lap/LUS with perihilar cholangiocarcinoma between 01.01.1998
and 31.12.2007 were reviewed. The results of preoperative eval-
uation with CT/MR, EUS and lap/LUS were analysed and com-
pared with the intraoperaitve and pathology findings.
Results: 50 patients were eligible. Mean age 66 years. All under-
went a complete staging Lap/LUS, and a non-resectable lesion
was detected in 16 patients. Thus, the impact of LAP/LUS was
32% (16/50), but an additional 14 patients had non-resectable or
disseminated disease found during surgery. The remaining 20 pa-
tients underwent resection.
Conclusion: Lap/ LUS identified 16 non-resectable patients
(32%) who avoided unnecessary laparotomy. Laparoscopy and
laparoscopic ultrasound should be considered an integrated part
of the preoperative evaluation of patients with perihilar cholan-
giocarcinoma.
O 67
REVISION SURGERY FOR INCIDENTAL
CARCINOMA GALL BLADDER: THE TATA
MEMORIAL HOSPITAL EXPERIENCE
M. D’ Souza1, G. Nagarajan2, S. Ing;e1, P. Shukla1,
S. Shrikhande1
1. Tata Memorial Hospital
2. HPB Surgery Hospital Beaujon
Background: The extent of resection for gall bladder cancer has
been extensively debated due to the poor prognosis. A large num-
ber of gall bladder cancers are still incidentally detected on
histopathology after simple cholecystectomy.
Aim: To evaluate the efficacy of re-resection in this group of pa-
tients.
Methods: We retrospectively analysed prospectively collected
data of 42 patients who underwent re- resection for incidentally
detected gall bladder cancer between 2005-07 (T2 and beyond).
All patients underwent biochemical and radiological investiga-
tions to rule out metastatic disease. Surgery involved complete
lymphadenectomy of the porta and retropancreatic region, cystic
duct stump resection and a 2 cm wedge excision of liver at the
gall bladder fossa. Demographic data, post-operative course and
histopathology were recorded.
Results: Of the 42 patients, prior cholecystectomy in 35 was la-
paroscopic. Pre-operative imaging identified localized disease in
only 2 of these patients. Mean duration between cholecystectomy
and re- resection was 3.5 months.
All 42 patients underwent R0 resection. One patient had an intra-
operative caval injury. Two had post-operative wound infections.
There were no other morbidity or mortality.
Final histopathology showed residual disease in 9 patients (21%).
3 patients had nodal disease alone, 4 had disease in the liver
wedge while 2 had disease in both the liver wedge and nodes.
Conclusion: Re-resection after a simple cholecystectomy in gall
bladder cancer, stageT2 and above is therapeutic and also pro-
vides accurate staging. This facilitates prognostication and also
identifies patients who would benefit from adjuvant treatment.
O 68
SURGICAL MANAGEMENT, MORBIDITY AND
PROGNOSTIC FACTORS OF SURVIVAL IN 68
CONSECUTIVE PATIENTS WITH HILAR
CHOLANGIOCARCINOMA (KLATSKIN TUMOR)
R. Troisi1, S. Laurent2, I. Deroo2, F. Berrevoet4, M. Peeters2,
L. Libbrecht3, X. Rogiers1, B. De Hemptinne2
1. HB Surgery Ghent University Hospital & Medical School
2. Abdominal Oncology UZ Ghent
3. Pathology UZ Ghent
Background: This study was conceived to assess multimodal
treatment including surgical approach and to determine postop-
erative morbidity, mortality rate and prognostic factors for long-
term survival.
Methods: From May 1992 to December 2006, 68 patients with a
Klatskin tumor were evaluated in our institution. Clinicopatho-
logical data were analyzed and univariate and multivariate analy-
ses carried out to determine significant prognostic factors
affecting morbidity and mortality. Mean age was of 53.4 ± 12
years. M/F ratio was of 46/22.
Results: After a median FU of 28 months (1-84), 11/68(16%) of
patients were non resectable (group A) and treated with pal-
liative transtumoral stenting. The other 57 patients (group B)
underwent surgery: n=5 for BIsmuth type II; n=20 for type IIIa;
n=23 for type IIIb and n=9 for type IV. Median survival was of
6 months in non resected patients vs. 32 months in group B
(p=0.001). R0 resection was achieved in 41/57(72%) patients.
Median survival was of 48 m in R0 vs. 10 m in R1-R2 resection
(p=0.003). In-hospital mortality was of 3.5%. Overall morbidity
rate was of 35%. Factors related to a shorter survival were iden-
tified as: lymphatic and perineural invasiveness, R1-2 resection,
AJCC stage. Overall 3 & 5 y patient survival was of 45%
and 22% respectively.
Conclusions: Surgical approach for Klatskin tumor is the only
chance for long-term survivals with acceptable surgical mortality
rate. In our experience, radical oncological surgery was possible
in more than 70% of cases leading to a significant survival. Per-
ineural and lymphatic involvement combined to a “non- R0” re-
section correlated with shorter survivals.
O 69
NINE YEAR EXPERIENCE OF AGGRESSIVE
RESECTION OF CHOLANGIOCARCINOMA:
RESULTS FROM A UNITED KINGDOM
NON-TRANSPLANT CENTRE
C. Briggs1, C. Mann1, C. Pattenden2, C. Neal1, A. Dennison2,
D. Berry2
1. University of Leicester Leicester General Hospital
2. Leicester Teaching Hospitals, Leicester General Hospital
Background and Aims: Cholangiocarcinoma is an aggressive ma-
lignancy with poor overall survival. We aimed to examine the re-
sults of resection of cholangiocarcinoma in our UK tertiary
referral unit to evaluate whether an aggressive approach is justi-
fied.
Methods: Data from our retrospective database of all patients di-
agnosed with cholangiocarcinoma between July 1995 and De-
cember 2004 was reviewed. Patients undergoing laparotomy were
included. Demographics, peri-operative variables and outcomes
were examined.
Results: Eighty two patients were identified. There were 40 males
and 42 females, with a mean age of 64 years (37-84 yrs). Forty
four patients (54%) underwent pre-operative staging laparoscopy
(37 with ultrasound). Anatomical locations: Intrahepatic = 10
(12%), Klatskin / Hilar = 38 (48%), Gallbladder = 4 (5%), Mid
bile duct = 9 (11%), Distal bile duct = 20 (24%). Twenty nine pa-
tients were inoperable at laparotomy (35%). There were 31 major
hepatectomies(38%), 13 pancreaticoduodenectomies (16%), and
9 radical excisions of the biliary tree (11%). Mean operating time
was 301 minutes (70-630 mins). There were 35 complications
(morbidity 43%) in 25 patients (Respiratory 7, hepatic failure 5,
cardiac 4, collection 4, anastamotic leak 3, wound infection 2, sep-
sis 2, renal failure 2, peptic ulcer 2, DVT / PE 2, UTI 1, bleeding
1). Mortality was 11%. Mean post operative stay was 23 days (3-
155). Survival at 1, 3 and 5 years for resected patients was 70%,
37% and 35% respectively.
Conclusions: Aggressive surgical resection of cholangiocarci-
noma requires major surgical approaches and carries high mor-
bidity and mortality. However, an aggressive approach is justified
as reasonable survival rates can be achieved.
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O 70
TREATMENT FOR PATIENTS WITH
UNRESECTABLE ADVANCED CARCINOMA OF
BILIARY TRACT- FIRST LINE CHEMOTHERAPY
OF SCISPLATIN, COMBINED SURGERY AND
SECOND LINE CHEMOTHERAPY OF
GEMCITABINE
Z. Morise, A. Sugioka, Y. Tanahashi, Y. Okabe
Department of surgery Fujita Health University School of Medicine
Introduction: Adenocarcinomas of biliary tract still remain a
major challenge. We herein evaluate the results of 12 consecu-
tive patients with unresectable advanced carcinoma of biliary
tract treated with our treatment strategy.
Methods: 8 patients with intrahepatic cholangiocarcinoma (ICC)
and 1 with extrahepatic cholangiocarcinoma (ECC), and 3 with
gallbladder carcinoma (GBC) were employed. They all had far-
advanced diseases, out of surgical indication (8 with extra-hepatic
distant metastases and 4 with extended invasions to the biliary
tree). They were 4 males and 8 females, and 48 to 78 (median:
69.5) years old.
They all were applied to the chemotherapy of S1/cisplatin. The
protocol of the therapy is 3 week-period of oral S-1 combined
with 2 intravenous administrations of CDDP, followed by two
weeks intermission. 4 out of the patients underwent combined
surgical resection. 2nd line chemotherapy of gemcitabine was em-
ployed for 6 patients without early death or combined surgery .
Results: The median survival time of the patients was 15.9
months. With the first line S1/CDDP therapy, 6 patients had PR
(response rate, 50.0%) and 4 had SD response (disease control
rate, 83.3%). Two patients with PD response died within 3
months. Two patients with combined surgical resection after good
response of S1/CDDP survived more than 3 years. 2nd line
chemotherapy of gemcitabine was well tolerable after the failure
of 1st line therapy.
Conclusion: S1/Cdbp therapy for biliary carcinoma showed con-
siderable anti-cancerous effects. Employing combined surgical
resection and 2nd line chemotherapy of gemcitabine may prolong
the prognosis of the patients.
O 71
RESPONSIVENESS OF SF-36 AND FACTORS
INFLUENCING IMPROVEMENT OF
HEALTH-RELATED QUALITY OF LIFE IN
A COHORT UNDERGOING
CHOLECYSTECTOMY
S. Pålsson1, G. Sandblom1, I. Rasmussen2, P. Lundström3,
J. Östergren3
1. Surgery University Hospital of Lund, Sweden
2. Surgery University Hospital of Uppsala, Sweden
3. Surgery Mora Hospital, Sweden
Background and aim: Gallstone surgery is one of the most com-
mon surgical procedures in Sweden. In order to assess the impact
on quality of life from gallstone surgery, a reliable instrument
with sufficient responsiveness is required.
Materials and methods: The Swedish Register for Gallstone Sur-
gery and ERCP (GallRiks) was founded in May 2005, with the
aim of registering indications, complications, results and quality
of life outcome of gallstone surgery. By the end of 2007, the reg-
ister covered 56 hospitals. Altogether 8804 cholecystectomies and
5042 ERCP have been registered. As a pilot study SF-36 has been
filled in prior to surgery and 6-9 months postoperatively at some
of the units. Four of these hospitals were chosen for this study.
Expected SF-36 scores were determined from the age- and gen-
der-matched population. Linear mMultivariate regression analy-
sis was performed to assess which factors had the greatest impact
on the responsiveness.
Results: Out of 206 operated patients, 148 responded to the SF-
36 questionnaire prior to and 6-9 months post surgery, yielding
a response rate of 72% (= 148/206). Standardizsed response
means ranged from 0.20 to 0.82 for the SF-36 sub scores. The
highest responsiveness was seen for bodily pain. Prior to surgery,
all sub scores were significantly lower than in the general popu-
lation (all p<0.05). Six months after surgery, all sub scores were
equal to or higher than the expected except for general health
(p<0.05). Low age, laparoscopic surgery and cholecystitis, pan-
creatitis or jaundice as indication for surgery were found to be
associated with significantly higher improvement of physical com-
ponent summary in multivariate linear regression analysis (all
p<0.05).
Conclusion: SF-36 is a useful instrument for measuring the im-
pact of gallstone surgery on quality of life. Good quality requires
careful consideration of indication for surgery as well as use of
adequate technique.
O 72
HOSPITAL COST CATEGORIES IN THE
MANAGEMENT OF COMMON BILE DUCT
STONES
R. Hompes, K. Vromman, R. Aerts, C. Verslype,
W Van Steenbergen, B. Topal
University hospital Leuven, Belgium
Aims: In the era of cost-conscious healthcare, hospitals are focus-
ing on costs. Analysis of hospital costs per cost category may provide
indications for potential cost saving measures in the management of
common bile duct stones (CBDS) and gallbladder in situ.
Methods: Between October 2005 and September 2006, 49 con-
secutive patients suffering from CBDS underwent either a 1-stage
procedure (laparoscopic common bile duct exploration (LCBDE)
with stone clearance and cholecystectomy (LCCE)) or a 2-stage
procedure (endoscopic retrograde cholangiopancreatography
with sphincterotomy and stone clearance (ERCP/ERS) followed
by LCCE). Costs were defined in different cost categories for
each activity centre and were linked to the individual patient via
the ‘bill of activities’. Postoperative (4) and/or pot-ERCP (3)
complications were excluded from cost-analysis. Only patients
with an uneventful post-procedural course were considered for
cost-analysis.
Results: Costs per patient were significantly (p<0.0001) different
between 1-stage vs. 2-stage procedures with respect to total hos-
pital costs (2180 vs 3958 ), consumables (501 vs 1202 ), indirect
costs (238 vs 495 ), and para-medical personnel costs (820 vs 1563
; p 0.0004). Also the length of hospital stay (LOS) was signifi-
cantly (p<0.0001) different between patients treated via a 1-stage
vs. 2-stage procedure, i.e. 2 (0-6) vs. 8 (3-18) days, respectively.
Conclusion: In the management of patients with CBDS and gall-
bladder in situ a 1-stage procedure is associated with significantly
less costs as compared to a 2-stage procedure. From an econom-
ical point of view these patients should preferably be treated via
a 1-stage procedure as long as safety and efficacy of this approach
are provided.
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SHORT-TERM OUTCOME FOLLOWING OPEN
AND LAPAROSCOPIC SEGMENT II/III-LIVER
RESECTION
O. Villanger, B. RØsok, A. Rosseland, A. Kazaryan,
I. Pavlik Manrangos, Ø. Mathisen, B. Edwin
Rikshospitalet University Hospital, Norway
Background: Laparoscopic approach has been our preferred op-
tion last ten years for left lateral hepatic lobectomy. Segment
II/III resections is a standarized procedure for comparing con-
ventional and laparoscopic technique. Few studies have com-
pared short-term outcome of the laparoscopic approach to that of
conventional technique.
Aim: To compare short-term outcome of the two approaches.
Methods: 14 segment II/III resections by conventional surgery
were compared to 27 similar resections performed laparoscopi-
cally from January 2000 to December 2008. The median age was
65 years (27-81) in the group with conventional approach and 65
years (23-81) in the laparoscopic group. Our material include 12
malign and 3 benign tumors in the conventional- technique group,
and 21 malign and 6 benign tumors in the laparoscopic group.
Results: No perioperative mortality occurred. The median op-
eration time was 190 minutes (95-245) after conventional surgery
and 170 minutes (100-357) by the laparoscopic approach. The
median perioperative bleeding was 500 ml (400-500) by conven-
tional technique compared to 200 ml (0-2000) in the laparoscopic
group. We experienced very few perioperative complications in
both groups. None of the procedures in the laparoscopic group
were converted to open surgery. The median postoperative stay
in hospital was 6 days (4-10) after conventional surgery and 3 (1-
10) in patients operated laparoscopically. The median follow up
was 46 months (14-96) by conventional surgery and 40 months
(1-79) by laparoscopic approuch.
Conclusion: Short-term outcome of laparoscopic left lateral he-
patic lobectomy is comparable or even better to that of conven-
tional surgery, with the additional benefits from minimal invasive
therapy.
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REMNANT LIVER VOLUME TO BODY WEIGHT
RATIO 0.5%: A CRITICAL CUTOFF
S. Truant1, E. BoleslawskI1, G. Sergent2, L. Gambiez1, F. Pruvot1
1. Service de Chirurgie Digestive et Transplantations
CHRU LILLE
2. Service de radiologie CHRU LILLE
Background: Before extended hepatectomy ³5 segments in nor-
mal liver, the remnant liver volume (RLV) measurement is usu-
ally calculated as a ratio to total liver volume (RLV-TLV), with
a minimum tolerable RLV-TLV of 20-25%. Extrapolating the
model of living donor liver transplantation, we previously showed
that the RLV/body weight ratio (RLVBWR) was more accurate
in assessing the functional limit of hepatectomy 1.
O 73
EARLY RECURRENCE AFTER RESECTION
FOR HCC IN NON-CIRRHOTIC LIVERS
WITHOUT UNDERLYING VIRAL HEPATITIS
AND OUTCOMES
N. de Liguori Carino1, S. Farid2, N. Khan2, A. Young2,
G. Toogood3, R. Prasad2, P. Lodge3
1. Hepatobiliary Unit University Hospital Aintree,Liverpool,UK
2. St James University Hospital
3. Department of Organ Transplantation St James University
Hospital
Introduction/Aim: Early recurrence (ER) (<1yr) after liver re-
section for HCC remains an important prognostic factor of long-
term outcome. However studies reporting the impact in patients
with non-cirrhotic liver and without underlying viral hepatitis re-
main limited. We evaluate factors associated within this group
and report long-term outcomes.
Methods: A review of the departmental database was performed
to identify patients undergoing resection for non-cirrhotic HCC
without viral hepatitis during February 1994 - August 2007. Pa-
tients were divided into Group 1: Early Recurrence (<1yr) and
Group 2: Disease Free Survival (DFS) >1yr. Demographic data,
laboratory and histopathology findings were assessed. Overall
survival was analysed using Kaplan Meir survival curves and com-
pared by log rank.
Results: A total of 69 patients were identified with median age at
diagnosis of 65 years (range: 15-85years). Median follow-up post-
resection was 30 months (range: 6-152 months). ER occurred in
32 patients (48%) and 34 patients (52%) with DFS >1yr. 3 pa-
tients (4.4%) were excluded from analysis because of death within
30-days of resection. Comparison revealed significant differences
between rates of microvascular invasion (75% vs. 43% p=0.04),
and positive resection margins (47% vs. 14%, p=0.004) in ER
group. Overall 1 and 2 year survival was significantly poorer in
ER compared to those with DFS >1yr; 54% vs. 97% (p=0.002)
and 11% vs. 92% (p<0.001) respectively. P<0.001
Conclusion: ER (<1yr) for HCC in non-cirrhotic livers without
underlying viral hepatitis is an important cause of patient death
within 2 years of resection similar to reported outcomes in cir-
rhotic HCC. Vascular invasion and positive resection margins are
important factors associated with ER.
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significantly associated with recurrence; however, random sur-
vival forests suggested large prediction errors associated with this
endpoint.
CONCLUSION: The preoperative factors BMI<30, abdominal
pain, serum CA19-9 level, and serum neutrophil count were as-
sociated with poor survival after PD for PC. Prediction models
for recurrence were limited by large prediction errors. These
models may prove useful for tailoring neoadjuvant therapy and
timing operative treatment for PC.
O 77
TWO STAGE LIVER RESECTION: A SENSIBLE
APPROACH TO BILOBAL LIVER METASTASES?
N. Tsim, A. Healey, C. Lowdell, H. Wasan, P. Tait,
J. Jackson, N. Habib, L. Jiao
Hammersmith Hospital Imperial College London
Background: Only 10-20% of patients with colorectal liver metas-
tases (CLM) are suitable for liver resection. Patients are excluded
due to extensive bilobar disease, or insufficient future liver rem-
nant (FLR). The technique of two staged liver resection (2-SLR)
with portal vein embolization (PVE) can increase the number of
patients eligible for resection.
Aims: To assess the outcome of patients undergoing two-stage
liver resection (2-SLR) for colorectal liver metastases (CLM).
Methods: Between 2001 and 2008, patients with multiple CLM
considered suitable for 2-SLR were recruited. Stage 1 resection
involved resection of metastasis in the left lobe of liver +/- ra-
diofrequency ablation (RFA) which was followed by right PVE
inducing hypertrophy in FLR. The second stage of liver resection
ensues with right or extended right hepatectomy to remove all
metastases.
Results: 28 consecutive patients with median age of 61 (range 36-
82) underwent liver resection. 22 patients (78.6%) completed 2-
SLR. Stage 2 was abandoned in 6 patients due to progressive
disease. There was no perioperative mortality and one major
complication of persistent bile leak requiring percutaneous
drainage. 5 patients later developed recurrence in the liver and
underwent further RFA with good outcome. Median follow-up
after 2-SLR was 20 months (IQR 12-24 months). Overall survival
after curative resection was 100%, 76%, 50% at 1, 2, and 3 years,
respectively. The median survival rate was significantly less in
those with non-curative resection (p = 0.04).
Conclusion: This study confirms the safety and benefits of 2-SLR
in patients with CLM where previously would be unsuitable for
resection.
O 78
A NOVEL1.8 MM TRANSCUTANEOUS ANTENNA
FOR USE WITH A 2.45 GHZ MICROWAVE
ABLATION SYSTEM: IN-VIVO STUDY IN LIVER,
KIDNEY & LUNG
S. Smeaton, J. Martinie, J. Heath, D. Iannitti
Carolinas Medical Center, Charlotte, U.S.A.
Background: Microwave ablation of solid hepatic lesions with a
2.45 GHz system has previously been limited in application due
to the larger 5mm diameter antenna. We demonstrate efficacy
Objective: reappraisal of the critical cut-off value of RLVBWR in
a prospective series of right extended hepatectomy.
Methods: From September 2000 to October 2008, the RLV was
measured using computed tomography in 45 patients with non-
cirrhotic liver. We successively studied the impact of RLV-TLV
(<= or > 20%) and of RLVBWR (<= or >0.5% and 0.45%) on
postoperative outcome.
Results:
* prothrombin time < 50% and total serum bilirubin level >
50µmol/L >POD 4
Conclusion: The RLVBWR with a cut-off value of 0.5% consti-
tuted a critical point for patient course.
1. Truant S, Remnant liver volume to body weight ratio > or
=0.5%: A new cut-off to estimate postoperative risks after extended
resection in noncirrhotic liver. Jan; 204: 22-33; JACS 2007.
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PREOPERATIVE PREDICTION MODELS FOR
DEATH AND RECURRENCE FOLLOWING
PANCREATODUODENECTOMY FOR
PANCREATIC CANCER
J. Barton1, T. Schnelldorfer1, C. Lohse2, M. Huebner2,
F. Que1, K. Reid-Lombardo1, D. Nagorney1, M. Farnell1,
M. Kendrick1
1. Department of Surgery Mayo Clinic, Rochester,
2. Department of Biostatistics Mayo Clinic, Rochester, U.S.A.
BACKGROUND: A significant number of patients undergo re-
section of pancreatic adenocarcinoma (PC) while undetectable
micrometastatic disease is present. Typical image-based methods
of preoperative assessment do not reveal micrometastatic disease.
AIM: To develop prediction models for recurrence and death
using common preoperative features in patients undergoing pan-
creatoduodenectomy (PD) for PC.
METHODS: We identified 219 patients treated with PD at Mayo
Clinic between 1997 and 2007 with complete data for our factors
of interest which included age, sex, BMI, jaundice, abdominal
pain, weight loss, tumor size on computed tomography, serum
CA19-9 level, and serum counts of platelets, neutrophils, and lym-
phocytes. Platelet-to-lymphocyte and neutrophil-to-lymphocyte
ratios were calculated and used as additional features of interest.
Associations of preoperative features with death and recurrence
were assessed using univariate and multivariable Cox propor-
tional hazards regression models and random survival forests.
RESULTS: BMI<30, abdominal pain, serum CA19-9 level, and
serum neutrophil count were associated with an increased risk of
death in a multivariable setting (all p<0.03); the predictive value
of these variables was confirmed by random survival forests. After
adjusting for serum CA19-9 level (p=0.02), no other feature was
© The Authors
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LAPAROSCOPIC APPROACH FOR RESECTION
OF HEPATOCARCINOMA IN CIRRHOTIC
PATIENTS: A CASE-CONTROL STUDY
E. Boleslawski1, F. Bouras2, S. Truant1, P. Zerbib2, F. Pruvot1
1. Service de Chirurgie Digestive et Transplantations CHRU LILLE
2. Chirurgie Digestive et Transplantations CHRU DE LILLE
Introduction: Laparoscopic approach for resection of hepato-
carcinoma has proved to be feasible in cirrhotic patients but there
is no comparative study versus open hepatectomy in this indica-
tion. The aim of this case-control study was to determine the im-
pact of laparoscopy on postoperative morbidity and quality of
resection.
Patients and Methods: from 2002 à 2008, 55 cirrhotic patients
with hepatocarcinoma underwent a laparoscopic (n=25) or open
(n=30) liver resection of up to 2 segments. Demographic and pe-
rioperative datas were compared between the two groups.
Results: Both groups were comparable on preoperative datas as
well as number of resected liver segments. Postoperative mortal-
ity was 2% (one patient in the open group). There was no differ-
ence concerning duration of surgery, morbidity and resection
margins. Intraoperative red blood cells transfusions were less fre-
quent in the laparoscopic group.
Conclusion: laparoscopic approach does not increase mor-
bimortality after resection of hepatocarcinoma in cirrhotic pa-
tients and should be considered especially in patients eligible for
liver transplantation.
based on volume of thermocoagulation in in-vivo porcine liver,
kidney and lung for a novel internally cooled 1.8mm diameter
transcutanous antenna.
Methods: Microwave ablations were made in in-vivo porcine
liver, kidney and lung using a 2.45 GHz Sulis V system with a
1.8mm diameter transcutaneous antenna (Microsulis, UK). Tis-
sue was then sectioned along the plane of the needle and the di-
ameter (perpendicular to needle) and length (parallel to needle)
of the observed thermocoagulation zone measured. The volume
was then calculated as that of a prolate ellipsoid using the for-
mula 4/3πr2(L/2). Dose response curves were made for each tis-
sue type.
Results: 53 ablations were made in liver, kidney and lung of four
animals. Energy output ranged from 6.0 kJ (50 watts X 120 sec)
to 61.2 kJ (170 watts X 360 sec). For each tissue an increase in en-
ergy corresponded to an increase in volume roughly a curvilinear
fashion (Fig 1, 2, 3). Maximum volumes in for each tissue were
21.1 cm3 in kidney, 18.7 cm3 in liver, and 13.1 cm3 in lung.
Conclusions: The 1.8mm transcutaneous antenna provides an ad-
equate dose response to achieve clinically useful ablation volumes
in porcine liver, kidney and lung. Clinical trials in humans via la-
paroscopic and percutaneous approaches are planned.
Fig 1: KIDNEY
Fig 2: LIVER
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overall mean postoperative hospital stay was 8.4 ± 2.5 days
(range 3 – 15). The actuarial overall 5-year survival and disease
free survival were 57 (95% confidence interval [CI], 33–92) and
33 percent (95% confidence interval [CI], 13–62) respectively.
Tumor grade(OR: 5.6 [95% CI]: 1.4–22, p= .013) and microvas-
cular invasion (OR: 12 [95% CI]: 1.4–103, p= .020) for survival
and either gender (OR: 1.5 [95% CI]: 0.4–5.1, p= .021) and sur-
gical margin (OR: 1.5 [95% CI]: 1.5–14, p= .005) for disease free
survival were identified as independent prognostic predictors.
Conclusion: This study confirmed feasibility and safety of la-
paroscopic liver resection even in cirrhotic patients, and proved
that LLR can warrant long term outcome similar to those re-
ported with the traditional open approach.
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OXALIPLATIN HEPATIC ARTERIAL INFUSION
AFTER RESECTION OF HEPATIC METASTASES
FROM COLORECTAL CANCER IN PATIENTS
WITH HIGH RISK OF HEPATIC RECURRENCE
D. Goéré1, S. Bonnet1, D. Malka2, I. Deshais1, T. de Baere3,
V. Boige2, C. Dromain3, M. Ducreux2, D. Elias1
1. Surgical Oncology Institut Gustave Roussy
2. Medical Oncology Institut Gustave Roussy
3. Radiology Institut Gustave Roussy
Introduction: We previously reported the efficacy (response rate,
64%) of hepatic arterial infusion (HAI) of oxaliplatin plus intra-
venous (IV) fluorouracil (FU) and leucovorin (LV) in patients
(pts) with colorectal liver-only metastases (CRLM). Whether this
combination chemotherapy may be effective after complete re-
section of CRLM in pts at high risk of hepatic recurrence is un-
known.
Methods: In this single-center study, we retrieved from our
prospective surgical database all consecutive pts who underwent
complete resection of ≥ 4 CRLM followed by six-month
chemotherapy with HAI oxaliplatin (100 mg/m²) plus IV
LV5FU2 (HAI group), and compared them to controls matched
for the following criteria: complete resection of ≥ 4 CRLM, post-
operative chemotherapy with IV FOLFOX or FOLFIRI, and
postoperative follow-up ≥ 3 years (IV group).
Results: The HAI group consisted of 16 pts, and the IV group of
59 pts. The two groups did not differ regarding age, sex, charac-
teristics of the primary tumor or CRLM (number, synchronous or
not onset, unilobar or bilobar liver involvement), serum carci-
noembryonic antigen levels, and preoperative chemotherapy.
Four pts in the HAI group received less than 6 cycles, due to tox-
icity (n = 2) or catheter obstruction (n = 2). With a median fol-
low-up of 75 months, 3-year overall survival did not significantly
differ between HAI and IV groups (63% vs 57%, p = 0.64). The
3-year progression-free survival (PFS) was better in the HAI
group (47% vs 38%, p = 0.04). Hepatic (p = 0.06), but not ex-
trahepatic 3-year PFS, tended to be higher in the HAI group com-
pared to the IV group.
Conclusions: HAI oxaliplatin plus IV FU/LV after complete re-
section of ≥ 4 CRLM may prolong PFS as compared to IV FOL-
FOX or FOLFIRI in patients at high risk of intrahepatic
recurrence, with an acceptable toxicity. Future studies combin-
ing HAI oxaliplatin and intensified IV chemotherapy are needed
to achieve an increase in OS.
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LAPAROSCOPIC LIVER RESECTION FOR
HEPATOCELLULAR CARCINOMA ON
CIRRHOSIS: LONG-TERM RESULTS
G. Belli, P. Limongelli, C. Fantini, A. Dagostino, L. Cioffi,
G. Russo, A. Belli
Loreto Nuovo Hospital S.Maria Loreto Nuovo Hospital
Naples - Dept of General and HPB Surgery
Background: Few data regarding the long term survival or pat-
tern of recurrence after laparoscopic liver resection for HCC on
cirrhosis have been reported so far.
Methods: Morbidity and mortality rate, and factors affecting
overall and disease free survival were analyzed in 54 patients un-
dergoing laparoscopic liver resection for HCC on cirrhosis.
Results: Morbidity rate was 20% (12/54) whereas there was only
1 death (1.8 %). Reoperation was required in 2 patients. The
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EXTERNAL DRAINAGE OF THE PANCREATIC
DUCT FOR HIGH-RISK PANCREATIC
ANASTOMOSIS: A CASE-CONTROL STUDY
G. Balzano, G. Capretti, A. Zerbi, C. Ridolfi, N. Pecorelli,
D. Valerio
Pancreas Unit, Dept. of Surgery S. Raffaele Scientific Institute,
Milan, Italy
Background: External drainage of the pancreatic duct has been
suggested to reduce pancreatic fistula (PF) rate after pancreati-
coduodenctomy (PD).
Aim: To compare the outcome of patients undergoing PD with
high-risk pancreas treated with or without external stenting.
Methods: Retrospective evaluation of prospectively collected data.
Between 2000 and 2008 598 patients underwent PD; 186 of them
(32.7%) had high-risk pancreatic remnant (duct ≤ 3mm, soft tex-
ture) and were evaluated in the present study. 93 patients were
treated by external drainage of the pancreatic duct (5-8 Fr. silicon
catheter), whereas 93 patients had no stent. The choice of external
drainage was made according to surgeon preference. Primary end-
points were incidence and severity of PF ( ISGPF definition).
Results: Mean duct diameter was 2.12 mm in the stent group and
2.49 mm in no-stent group (p<0.01). PF rate was higher in the
stent group (p<0.01): incidence of PF in stent group was 59.1%
(grade A 63.6%; grade B 20%; grade C 16.3%), in no-stent group
it was 38.7% (grade A 52.7%; , B 13.9%; C 33.3%). In the multi-
variate analysis external stent and young age were significant pre-
dictors of PF. Mortality was 4.3% and 5.3%. After 7 days from
operation only 33.3% of patients with external stent had a daily
pancreatic drainage >100 ml.
Conclusions: Despite the possible selection bias regarding the
use of stent in higher-risk patients, external drainage of pancre-
atic duct seems detrimental in high-risk anastomosis. This could
be explained by the frequent obstructed flow of the external stent.
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THE TWO-WEEK TARGET FOR
LAPAROSCOPIC CHOLECYSTECTOMY
FOLLOWING ACUTE PANCREATITIS IS
FEASIBLE AND COST EFFECTIVE
S. Monkhouse, E. Court, I. Dash, N. Coombs
Surgery Great Western Hospital, Swindon
Introduction: The British Society of Gastroenterology acute pan-
creatitis guidelines1 recommend that all patients with biliary pan-
creatitis should undergo cholecystectomy within two weeks. The
aim of this study is to assess whether these guidelines are feasible
and cost-effective.
Methods: The notes of every patient admitted with gallstone pan-
creatitis between 2006 and 2008 were reviewed. Details of hospi-
tal re-admissions for subsequent pancreatitis were noted together
with the additional investigations, length of stay, time to chole-
cystectomy, and complications. The costs of each re-admission
and the costs of a dedicated operating list were provided by two
independent directorate accountants.
Results: During the two-year period, 153 patients (75 male) were
admitted with gallstone pancreatitis. The mean age was 55 years.
Twenty-one patients (13.7%) had further attacks requiring 40 re-
admissions to hospital. There were no deaths. The additional hos-
pital costs due to the readmitted patients was £171,130:
Bed-occupancy for 234 bed-nights £58,500; Investigations
£20,830; and 153 laparoscopic cholecystectomies on an existing the-
atre list £91,800. The estimated cost to staff a half-day theatre list
every fortnight, to perform 153 laparoscopic cholecystectomies, is
£167,800. Implementation of the guidelines would save £3,330.
Conclusions: There are clear benefits in developing a dedicated
theatre for emergency cholecystectomy operations after gallstone
pancreatitis, including safety advantages for patients and the pro-
vision of training opportunities for junior staff. We have shown
that it is economically viable and cost-neutral as the costs of re-
admissions and ad-hoc operating are balanced by the costs of a
dedicated theatre list in the long-term. The savings made in pro-
viding this service would be approximately £1.665 each year.
References: 1. UK Working Party on Acute Pancreatitis. UK Guide-
lines for the management of acute pancreatitis. Gut 2005:54;1-9
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IS LAPAROSCOPY A FAVORABLE METHOD
TO TREAT NEUROENDOCRINE PANCREATIC
TUMORS?
I. Pavlik Marangos, A. Kazaryan, E. Pomianowska,
A. Rosseland, B. Røsok, I. Gladhaug, Ø. Mathisen, B. Edwin
Rikshospitalet University Hospital, Norway
Background: Neuroendocrine tumors of the pancreas are un-
common but can be distressing due to excessive secretion of reg-
ulatory peptides. Surgery is the only radical method of treatment
for these patients.
Aim: To evaluate surgical outcomes of laparoscopic approach.
Methods: A total of 45 patients/ 47 procedures were included
from March 1997 to December 2008. All patients were staged
with preoperative CT and/or MR scans and intraoperative endo-
scopic ultrasound. There were19 insulinomas, 4 gastrinomas, 2
VIPomas, 2 glucagonomas and 18 non-functional neoplasmas.
Results: Following laparoscopic procedures were performed: dis-
tal pancreatectomy with splenectomy (n=18), spleenpreserving
(n=14), local enucleation (n=7), other type of resections (n=2).
Two re-resections were performed after 2 and 3 years after the
first operation. Three patients required conversion (6.4 %) to an
open procedure due to necessity of performing other type of re-
section and three patients were found inoperable.
The median operative time was 185 (60-375) min. Median post-
operative stay was 5(2-20) days. Postoperative morbidity was 29%
(fistulas 15%). There was no mortality.
For patients with malignant tumors (n=22) mean follow-up is
48±8 (SE) months, mean survival is 100±16,9 months, 3- and 5-
year survival 100% and 60% respectively.
Conclusions: Laparoscopic treatment of neuroendocrine tumors
is feasible, can be performed with minimum morbidity and giving
to the patient all benefits of the laparoscopic surgery.
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SIC3B AS AN EARLY MARKERS FOR
PANCREATIC ADENOCARCINOMA IS
DETECTABLE UP TO FOUR MONTHS PRIOR
TO RADIOLOGICAL EVIDENCE
A. Märten2, M. Büchler2, W. Werft1, M. Wente1, J. Schmidt2
1. German Cancer Research Institute, Heidelberg 2Division of
Biostatistics
2. University of Heidelberg Department of Surgery
Background: Pancreatic adenocarcinoma is recognized as an ag-
gressive tumour, yet it still lacks specific markers. Resection of-
fers the only potential cure, and earlier diagnosis could benefit
many patients. The complement system is activated by the bin-
ding of auto-antibodies on the tumour. The cleavage product C3b
could be detected in its inactivated form in plasma (siC3b).
Methods: 232 plasma samples from subjects with adjuvant treat-
ment after resection, from healthy volunteers and from vulnera-
ble patients were collected prospectively and analyzed for siC3b.
Every three months, patients underwent imaging and the results
from siC3b ELISA were categorized according to radiological-
defined recurrence within four months after blood withdrawal.
Furthermore, factors of the complement system were analyzed
on tumour cells and in urine.
Findings: The most important finding was that up to four months
prior to radiological defined recurrence, siC3b plasma level is inc-
reased with an AUC of 0.85 which could be further increased by
combining it with CA 19.9 (AUC = 0.92). Complement regulatory
proteins are highly expressed on pancreatic carcinoma cells and
detectable in patient’s urine; CD59 expression is further increased
after incubation with plasma from pancreatic carcinoma patients.
Tumours express the C3b-cleavage products iC3b and C3dg.
Interpretation: In summary, screening for siC3b in subjects with
an increased risk for PDAC allows for early detection with high
sensitivity, as siC3b plasma levels are increased up to four months
prior to radiological evidence. Sensitivity could be further inc-
reased by combining this approach with CA 19.9. The mode of
action could be explained by up-regulated complement regula-
tory proteins.
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MIDDLE-PRESERVING PANCREATECTOMY
FOR MULTICENTRIC BODY-SPARING LESIONS
OF THE PANCREAS
S. Partelli, R. Salvia, L. Boninsegna, C. Bassi, P. Pederzoli,
M. Falconi
Department of Surgery University of Verona
Background: The appropriate surgical approach of a pancreatic
multifocal disease that skips the body of the gland, still remains
unknown.
Aim: To analyze a parenchyma-sparing surgical technique con-
sisting of a middle-preserving pancreatectomy (MPP) evaluating
feasibility, safety, oncological and functional outcome.
Patients and Methods: Between 1999 and 2007 five patients un-
derwent to MPP. Pathological, perioperative and follow up data
were analyzed.
Results: Three patients were male and 2 female with a median
age of 35 years (28-70 years). Two patients with a MEN1 syn-
drome were affected by multiple non functioning endocrine tu-
mors (NFET) of the pancreas; in the remaining patients the
preoperative diagnosis was multifocal intraductal papillary mu-
cinous neoplasms (IPMNs). In all the patients the lesions were
localized in the head and tail of the pancreas sparing the pancre-
atic body. The median operative time was 365 minutes (range
330-440 minutes). Postoperative mortality was nil and the post-
operative course was uneventful in 4 cases and complicated in 1.
The median postoperative stay was 10 days (range 7-16 days).
Overall, two patients developed both a well-controlled insulin de-
pendent diabetes and exocrine insufficiency soon after the oper-
ation, one patient developed only exocrine insufficiency. At a
median follow up of 14 months (8-112 months) all the patients
are alive and free of disease.
Conclusion: MPP is a safe and feasible procedure; this operation
is associated with a low risk of developing metabolic disorders
and we recommend this operation in young patients affected by
body-sparing multifocal lesions of the pancreas when surgery is
indicated.
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NASO-JEJUNAL NUTRITION STRATEGIES
IN CHRONIC PANCREATITIS
J. Skipworth1, D. Raptis1, C. Imber2, S. Olde Damink3,
M. Malago2, A. Shankar2
1. University College London Department of Surgery
and Interventional Science
2. University College London Hospital, NHS Foundation
Trust Department of Hepatobiliary and Pancreatic Surgery
3. Surgery Maastricht University Medical Center
Background/Aims: Patients with chronic pancreatitis (CP) often
suffer from nutritional deterioration and weight loss. We aimed
to assess a programme of home-based, naso-jejunal (N-J) nutri-
tion in CP patients with acute complications.
Methods: All CP patients acutely admitted and fed via the N-J
route, between January 2004 and December 2007, were assessed
by retrospective case-notes review. Indications for radiologically-
guided NJ-catheter insertion included inability to tolerate oral
feeding/ingest sufficient oral calories; or the presence of gross
weight loss/acute complications. All patients were discharged
home with ongoing N-J nutrition.
Results: 58 (35M:23F) patients were included in the study. Me-
dian patient age was 46 years (20-67 years) and median follow-
up 16 months (3-36 months). Median discharge date was the 14th
day (8-74 days) and N-J nutrition was continued for a median of
47 days (28-139 days). 42 (72%) patients reported their tolerance
of the feed as ‘excellent/good’ and 46 patients (79%, p=0.0003)
reported complete resolution of their abdominal pain and cessa-
tion of opioid intake. Median weight gain at 6 weeks following
N-J cessation was 1 kg (-34 kg-+27 kg). 12 (21%) patients re-
ported recurrence of pain during the follow-up period (median 4
months (1-25 months)). Complications were minor and infre-
quent (diarrhoea 14 (24%), tube blockage 11 (19%) or displace-
ment 10 (17%), nausea 9 (16%)).
Conclusion: NJ nutrition, commenced in hospital and continued
at home, is safe, well tolerated and contributes to pain-relief. It
helps to maintain weight during the acute phase of disease and
can be used as a bridging strategy to avoid surgery/intervention.
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pared to 15 (4 -28) for non-CL {p = 0.003, unpaired
t-test}. MCT diet was used for median 16 days (range: 11- 32) in
CL patients as compared to median 10 days (4- 21) of EN in non
CL patients. The mean duration of hospital stay in the CL group
was significantly longer than in the non CL group {21 versus 15
days, p = 0.047 (t- test)}. The post operative complication rate
was similar to both the groups.
Conclusion: The incidence of chyle leak after major pancreatic
resection is high. It is associated with more extensive resections
and extended lymphadenectomy. It substantially increases the du-
ration of enteral feeding and subsequent hospitalization and costs.
O 90
VOLATILE ORGANIC COMPOUNDS IN
ALVEOLAR AIR FOR THE DIAGNOSIS OF
PANCREATIC NEOPLASMS
G. Butturini1, A. Princivalle2, R. Micciolo3, F. Zarantonello1,
A. Caletti1, C. Bassi1, S. Praun4, J. Villinger4, P. Pederzoli1,
L. Perbellini2
1. Surgical and Gastroenterological Dept Verona University
2. Verona University Medicine and Public Health Dept.
3. Trento University Faculty of Economics
4. V&F medical Development
Background: Malignant tumors are associated to oxidative
processes leading to a specific pattern of volatile organic com-
pounds (VOCs) in the expired alveolar air as demonstrated for
lung and breast cancer.
Aim: To study the presence of VOCs in the breath of patients
with pancreatic ductal adenocarcinoma.
Patients and Methods: 31 patients suffering from cyto-histolog-
ically proven pancreatic ductal adenocarcinomas and 43 age–
matched control subjects provided alveolar air samples. Clinical
data including Ca 19/9 were prospectively collected. VOCs were
measured in each sample using a highly sensitive mass-spectrom-
eter. A logistic regression was employed to find a subset of the
variables which was able to predict the probability of being a case.
Results: Among 87 VOCs found in the analysis, six variables re-
sulted significantly and independently associated with the prob-
ability of being a case with a sensitivity and a specificity of 77.4
and 86% respectively. They were M29formyl, propene, formalde-
hyde, NH
3
and two molecules identified by their molecular
weight: M106 and M110.
Conclusions: The sensitivity and specificity of variables measured
in the alveolar air and selected for the identification of the duc-
tal cancer are comparable to that of Ca 19-9, the bio-marker used
in diagnosis and monitoring of malignant pancreatic diseases; but
in this case it is overcame the limit of the absence of Ca 19-9 in
people with Lewis b blood group antigens.
1. Phillips M, Cataneo RN, Cummin AR, et al. Detection of Lung
Cancer with volatile markers in the breath. Chest Jun
2003;123:2115-23.
2. Di Natale C, Macagnano A, Martinelli E, et al. Lung cancer
identification by the analysis of breath by means of an array of
non-selective gas sensors. Biosens Bioelectron 2003;10:1209-18.
3. Phillips M, Cataneo RN, Ditkoff BA, et al. Volatile markers of
breast cancer in the breath. Breast J 2003;3:184-91. Erratum in:
Breast J 2003;4:345.
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A PROSPECTIVE STUDY TO EVALUATE
CONTRAST-ENHANCED ULTRASOUND IN
STAGING ADVANCED PANCREATIC CANCER:
COMPARISON WITH STAGING
LAPAROSCOPY
G. Butturini1, M. DOnofrio2, C. Cena3, N. Faccioli2,
G. Armatura3, R. Salvia3, C. Bassi3, P. Pederzoli3
1. Surgical and Gastroenterological Dept Verona University
2. Radiological Dept Verona University
3. Surgical Dept Verona University
Background: Most patients suffering from pancreatic ductal ade-
nocarcinoma have unresectable disease at diagnosis and despite
the pre-operative work-up, a good proportion of them is still un-
derstaged because of very small nodules in the liver or on the
peritoneal surface. Contrast-enhanced ultrasonography repre-
sents a new tool that may help improve the detection of liver
metastases in patients with pancreatic cancer. The aim of this
paper was to demonstrate the utility of contrast-enhanced ultra-
sonography in staging patients with pancreatic cancer, compared
to conventional ultrasonography and laparoscopy.
Patients and methods: 19 patients considered unresectable at
preoperative staging underwent laparoscopy in order to obtain
cyto-hystological definition or to detect metastases. All of them
also underwent contrast-enhanced ultrasonography. They were
compared with a control group previously studied with la-
paroscopy and only conventional ultrasonography.
Results: In the study group contrast enhanced ultrasonography
failed to correctly stage the cancer in 4/19 patients (21%). When
compared to control group, the re-staging rate was lower but not
statistically significant (21% vs 37%, p= 0.47).
Conclusion: Contrast-enhanced ultrasonography is a useful tool
in staging pancreatic cancer but laparoscopy still maintains the
highest sensitivity and specificity as an all in one procedure to
stage and to characterize these patients.
O 89
CHYLE LEAK AFTER MAJOR PANCREATIC
RESECTIONS: RISK FACTORS AND IMPACT
ON OUTCOME
G. Jain, A. Hemandas, I. Panagiotopoulou, M. Zuccaro,
P. Neil, C. D. Johnson, A. .Mohammed
Southampton General Hospital, Southampton, UK
Background: Chyle leak forms small proportion of morbidities
following pancreatic
surgery. The impact of chyle leak on the outcome of these pa-
tients has not been
previously discussed.
Aim: This study aims to determine the incidence of chyle leak,
associated risk factors, its influence onoutcome and hospital stay
in a large current series of pancreatic resections.
Method: Data were collected retrospectively from all pancreatic
resections performed in 2007.
Results: Among 81 pancreatic resections (62 Whipple’s proce-
dures, 7 total pancreatectomies 3 median pancreatectomies, 9 dis-
tal pancreatectomies) 10 (12.6 %) patients developed chyle leak
(CL). Seven of these patients had Whipple’s procedure, while 3
patients had total pancreatectomy. Of 12 patients who had ex-
tended lymphadenectomy, 6 developed a chyle leak. The median
number of lymph nodes removed was 22 (13- 38) for CL com-
V 01
THE LATERAL LAPAROSCOPIC
APPROACH TO LESIONS IN THE
POSTERIOR HEPATIC SEGMENTS
A. Gumbs 1, B. Gayet 2
1. Columbia University, New York, USA
2. Institut Mutualiste Montsouris
Introduction: Since the first report of a laparoscopic liver resec-
tion in 1992, laparoscopic resection of anterior hepatic segments
has become increasingly more common in the surgical treatment
of both benign and malignant tumors. The minimally invasive ap-
proach to lesions in the posterior segments, however, is still only
being currently performed in highly specialized centers. Although
some authors believe that laparoscopy is contraindicated for the
posterior hepatic segments, we use a lateral approach for resec-
tions in these segments.
Methods: This video will illustrate the pertinent issues regarding
instrument selection, trochar placement, intra-operative monitoring
and steps necessary to perform laparoscopic resection of the poste-
rior hepatic segments using totally laparoscopic techniques. The he-
patic inflow is approached with patients in a modified partial left
lateral with the surgeon between the legs. The hepatic outflow is
then controlled laterally if not already done so retro-hepatically with
the surgeon standing to the right of the patient.
Results: We have safely performed this procedure in > 25 pa-
tients with a 5% rate of major morbidity and 0% mortality. Av-
erage margin is > 10mm for malignant lesions. Long-term results
are similar to our open patients.
Conclusions: Minimally invasive techniques for lesions in the
deep hepatic segments are feasible, and high volume centers that
specialize in these procedures can have results similar to histori-
cal open series. The Lateral Laparoscopic Approach to hepatic
lesions in the posterior segements of the liver should currently
only be performed by surgeons with expertise in laparoscopy and
hepatobiliary surgery.
V 02
THE ANTERIOR APPROACH TECHNIQUE AND
HANGING LIVER MANEUVER IN PATIENTS
WITH COLORECTAL LIVER METASTASES
M. Koch, N. Rahbari, J. Schmidt, M. Buechler, J. Weitz
University of Heidelberg Department of Surgery, Germany
Surgical hepatic resection remains the treatment of choice in pa-
tients with colorectal liver metastases. The anterior approach has
been described as a new and useful technique in liver surgery
demonstrating a potential prognostic benefit in patients with
HCC. For safe performance of the anterior approach technique
the hanging liver maneuver seems to be very helpful.
In this video and presentation, we will show the anterior approach
technique and hanging liver maneuver. Furthermore, we will
present our ongoing clinical trial comparing anterior approach
with conventional resection for right or extended right hepatec-
tomy in patients with colorectal liver metastases.1
1 Schmidt T*, Koch M*, Antolovic D, Reissfelder C, Schmitz-
Winnenthal FH, Rahbari NN, Schmidt J, Seiler CM, Büchler
MW, Weitz J.
Influence of two different resection techniques (conventional
liver resection versus anterior approach) of liver metastases from
colorectal cancer on hematogenous tumor cell dissemination –
prospective randomized multicenter trial.
BMC Surg 2008 Mar5;8:6
V 03
LIVER HANGING MANEUVER ALLOWS
COMPLEX HEPATIC RESECTION BY UPPER
MIDLINE INCISION
G. Liddo, G. Nagarajan, J. Belghiti
HPB Surgery Hospital Beaujon, France
Background: The goals of safe major hepatectomies for malig-
nancies can be achieved by the anterior approach. This technique
allows minimal mobilization of the tumorous liver and excellent
exposure of the anterior aspect of the vena cava (IVC) thereby re-
ducing the length of the abdominal incision. These aspects are
facilitated by the hanging maneuver (HM).
Procedure: 71 year old woman with a 12 cm right intrahepatic
cholangiocarcinoma involving IVC and right portal vein up to
main portal vein (MPV) bifurcation was operated through an
upper midline incision. The hanging maneuver was performed
with the upper end of the tape passed behind the middle and the
left hepatic vein trunk over the Arantius ligament. The lower end
was passed between right and left portal pedicle. The portal bi-
furcation was resected and an end to end anastomosis between
left portal vein and MPV was performed. A right hepatectomy
with segment 1 resection was done. A total caval clamping ex-
cluding the middle and left hepatic veins allowed caval exclusion
with caval shunting through the left liver. The cuff of the vena
cava involved by the tumor was removed. The right liver was mo-
bilized and removed.
Blood loss 1 liter. Operating time 7 hours.
Conclusion: Anterior approach with HM allows safe complex he-
patic procedures even by upper midline incision.
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V 04
SURGICAL TREATMENT FOR RECURRENT
HEPATIC HYDATID CYST RUPTURED INTO
THE RETROHEPATIC INFERIOR VENA CAVA
WITH THROMBOSIS UP TO THE RIGHT ATRIUM
E. Vicente 1, Y. Quijano 1, R. D az Conradi 1, H. Dur n 1,
C. Loinaz 1, M. Marcello 1, E. Esteban 1, P. Galindo 1,
Mart nez Gil 2, A. Carbajo 3, P. Hidalgo 4, E. Garc a 5
1. General Surgery Service Hospital Madrid Norte Sanchinarro
2. Intensive Care Unit Hospital Madrid Norte Sanchinarro
3. Anesthesiology Service Hospital Madrid Norte Sanchinarro
4. Radiology Service Hospital Madrid Norte Sanchinarro
5. Pathology Service Hospital Madrid Norte Sanchinarro,
Centro Oncol gico Clara Campal. Universidad San Pablo CEU,
Facultad de Medicina, Spain
We present an unusual but severe complication of a hepatic hy-
datid cyst: spontaneous rupture into the retrohepatic inferior
vena cava (IVC) accompanied with intravascular thrombus ex-
tended to the right atrium.
Historically, the potentially high operative morbidity rate and
presumed poor prognosis for this situation have discouraged ag-
gressive surgical treatment. However, the absence of any other
effective treatments, the refinement of surgical technique and
better criteria for patients selection have led to a more frequent
and safe use of resection.
Five years after non radical surgical treatment, a 62 year old man
was diagnosed of recurrent hydatid cyst located in segment I ad-
jacent to the inferior vena cava. Chest radiographs reveal multi-
ple and bilateral pulmonary cysts. Ultrasonography, CT and MRI
demonstrated a thrombus extending into retrohepatic,
supraphrenic-intrapericardial IVC and right atrium.
The video shows the preoperative workup to evaluate the location
of the cyst, the vascular invasion and the extent of thrombus, as
well as the surgical procedure. Through a bilateral subcostal la-
parotomy, total cystoperiystectomy and resection of retrohepatic
IVC was performed with total liver vascular exclusion. The trans-
abdominal and transpericardial approach to the intrapericardial
IVC and right atrium avoided median sternotomy. Intravascular
trombectomy with intraoperative transesophageal echocardio-
gram was performed. Three years after the operation, the patient
remains alive and well without evidence of hydatid disease re-
currence.
V 05
ROBOTIC-ASSISTED LAPAROSCOPIC
ENUCLEATION OF A PANCREATIC
ENDOCRINE TUMOR AND
CHOLECYSTECTOMY
J. Martinie, M. Meadows, S. Padma, S. Smeaton, D. Iannitti
Carolinas Medical Center, Charlotte, U.S.A.
Objective: To demonstrate the use of the daVinci® surgical ro-
botic system (Intuitive Surgical, Sunnyvale, California), to per-
form enucleation of a pancreatic endocrine tumor and
cholecystectomy.
Background: Pancreatic endocrine tumors (PET’s) arise prima-
rily in the pancreatic parenchyma and are generally considered
to be less-aggressive tumors when compared to the much more
common adenocarcinomas. Enucleation of small PET’s has been
demonstrated to be a safe and effective treatment due to the low
incidence of malignancy and lymphatic invasion.
Case Report: A 57 year old male who presented with sympto-
matic gallstones, but was also found to have an incidental, non-
functional PET on abdominal CT scan. Diagnosis was confirmed
on endoscopic ultrasound fine needle aspiration. He elected to
have his gallbladder and pancreatic tumor removed simultane-
ously, and for this reason, we elected to use the daVinci® robot
to assist with the procedure. A total of five ports were used, one
camera port, three 8mm robotic arm ports, and an assistants port
site. The combined procedure was completed laparoscopically
and the patient was discharged home post-operatively the same
day. Pathology confirmed the diagnosis of a benign PET.
Conclusions: The technique of laparoscopic enucleation for pan-
creatic endocrine tumors has been previously described. We have
attempted to explore the application of the daVinci® surgical
robot system to minimally invasive pancreatic procedures, in-
cluding distal pancreatectomies, enucleations, and hepaticoje-
junostomies. This case demonstrates the application of the
robotic system to assist the surgeon to perform delicate pancre-
atic enucleations.
V 06
SURGERYFORHILARCHOLANGIOCARCINOMA:
A VIDEO OF PARENCHYMA-CONSERVING
LIVER RESECTION
D. Raptis1, C. Imber2, J. Skipworth1, S. Olde Damink3,
A. Shankar2, M. Malago2
1. University College London Department of Surgery and
Interventional Science, UK
2. University College London Hospital, NHS Foundation, UK
Trust Department of Hepatobiliary and Pancreatic Surgery
3. Surgery Maastricht University Medical Center, The Netherlands
Background: Major liver resections have improved the re-
sectability rate of hilar cholangiocarcinomas, but morbidity and
mortality remain significantly high. The aim of this study was to
demonstrate the value of the parenchyma-conserving liver resec-
tion in hilar cholangiocarcinoma.
Patients and Methods: A video of a parenchyma-conserving liver
resection for hilar cholangiocarcinoma of a patient, previously
deemed inoperable in an other institution, will be presented fo-
cusing on the value of pre-operative assessment, transection tech-
nique and postoperative care in the resection margins, morbidity
and mortality.
Conclusions: Parenchyma-conserving liver resection in hilar
cholangiocarcinoma is feasible even in patients deemed inoper-
able by several other institutions. Outcomes include a high clear
margins rate with low morbidity and mortality rates.
V 07
TECHNIQUE TO TREAT
THORACOSCOPICALLY THE
INTRACTABLE PANCREATIC PAIN
G. Ayiomamitis, H. Abbas, B. Ammori
Manchester Royal Infirmary, UK
The management of pain due to chronic pancreatitis, advanced or
unresectable upper abdominal malignancies needs a multidisci-
plinary approach. In patients with chronic pancreatitis, surgical
drainage or resection of the diseased pancreas should be consid-
ered. However, the pain relief achieved with direct pancreatic
© The Authors
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surgery is often non-durable. Percutaneous celiac plexus block
has its role, but the efficacy of this procedure is variable and is
generally short-lived. More recently, new techniques such as bi-
lateral thoracoscopic splanchnotomy and endoscopic ultrasound-
guided coeliac plexus block have emerged as efficient alternatives
in quality of life improvement.
In this video, we demonstrate our technique of bilateral thoraco-
scopic splanchnotomy. This employs two 5-mm ports on either
side with division of the greater and lesser splanchnic nerves using
hook-diathermy. No chest drains are employed and the median
operating time is 40 minutes.
V 08
ZERO BLOOD LOSS RIGHT
HEMIHEPATECTOMY
A Karamarkovic
Center for Emergency Surgery, Clinical Center of Serbia
and School of Medicine, University of Belgrade
Liver resections have long been regarded as one of the most dif-
ficult and challenging operations in abdominal surgery. As a re-
sult of improvement in surgical technique, better knowledge of
the internal liver anatomy, development of new technological de-
vices in transection of liver parenchyma in the last decade, liver
resections with minimally blood loss became a “standard” in the
era of modern hepatic surgery.
Video represents our bloodless surgical technique during the
right hemi-hepatectomy. Liver mobilization with VCI dissection
and exposure, extrahepatic outflow venous control, intermittent
inflow vascular occlusion, anterior and posterior intrahepatic ap-
proach to the vascular control of the appropriate Hepatic pedicle,
technique of parenchymal transection with CUSA dissector and
use of vascular staplers in division of hepatic pedicles and hepatic
veins were shown.
V 09
LAPAROSCOPIC ENUCLEATION OF
MUCINOUS CYSTIC NEOPLASM (MCN) OF
THE MID PANCREAS IN A YOUNG WOMAN
C. VanCOtt, R. Zuckerman, S. Helton
Hospital of Saint Raphael, Newhaven, U.S.A.
Background: Pancreatic MCNs are increasingly being diagnosed
at an early age in women. The risk of malignancy is associated
with. Observation is a rational approach for patients in whom
the risk of malignancy is low (size < 3 cm, age < 50, no internal
polypoid projections from the cyst wall) but is not an attractive
option for young women. Patients would prefer not to undergo a
distal or subtotal pancreatectomy for a mid-body benign pancre-
atic MCN in order to avoid the risk of diabetes. For this reason,
enucleation of these lesions is an attractive option. However, enu-
cleation of pancreatic tumors > 2 cm is associated with an inci-
dence of pancreatic fistula approaching 25%.
Methods: We present a video showing the diagnostic work up
(CT, MRI, EUS guided aspiration) treatment (laparoscopic enu-
cleation) and follow up of a patient to illustrate important points
of clinical decision making and treatment of asymptomatic mid
body pancreatic MCN in a 24 year old woman.
Results: Operation lasted 90 min. Patient had a self limiting Stage
I pancreatic fistula and returned to work on post operative day # 7.
Conclusions: Laparoscopic enucleation of small MCN is a good
alternative to open pancreatectomy. While this approach is as-
sociated with the risk for a pancreatic fistula it is likely to be of
low severity and the benefits of a minimally invasive surgical ap-
proach can still be realized.
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TECHNIQUE OF STAPLER HEPATECTOMY
J. Weitz, P. Schemmer, M. Koch, J. Schmidt, M. Büchler
University of Heidelberg Department of Surgery, Germany
Liver resection remains the preferred technique for treatment of be-
nign and malignant diseases of the liver. Several techniques of
parenchymal transsection have been described in the literature. Liver
resection with vascular staplers for dissection of hepatic parenchyma
is a relatively new but safe and fast dissection technique in major
liver surgery (e.g. hepatectomy) being feasible in a routine clinical
setting.1 In this video we will demonstrate our routine technique of
stapler hepatectomy for right and left hepatectomy.
1 Schemmer P, Bruns H, Weitz J, Schmidt J, Büchler MW. Liver
transection using vascular stapler: a review. HPB (Oxford)
2008;10:249-52.
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LIVER SEGMENTECTOMY VI (MODIFIED
TAKASAKI TECHNIQUE)
M. Oliveira, R. Melo, M. Almeida, M. Sacchetti, E. Martins,
J. Costa-Maia
Uindade HBPE - Serviço de Cirurgia Geral Hospital S. Joao,
Portugal
Introduction: Ken Takasaki has described a liver resection tech-
nique based on a 3-sector segmentation according to portal
branch distribution with “en bloc” glissonian control at the sec-
ondary branches of the portal triad. This anatomical concept
bears a close relation to Claude Couinaud’s segmentation and
constitutes the base of our current practice in anatomical liver
surgery. Takasaki’s original technique has been adapted in our
practice, mainly by modifying the “en bloc” vascular isolation into
individual dissection and clamping of the arterial and portal sec-
ondary branches at the hilar plate.
Case presentation: The authors present the technique in a liver
segmentectomy VI for secondary tumor, in a 68 year-old male
patient.
The most significant phases of the operation (hilar dissection and
vascular control, definition of the resection area, parenchymal
transection and liver surface treatment) are highlighted in this
video.
V 12
LEFT HEPATECTOMY FOR CAVERNOUS
HEMANGIOMA UNDER SELECTIVE HEPATIC
VEINS EXCLUSION
R. Bracco, J. Grondona, J. Rastrilla, R. Sarquis
UNACIR HPB, Argentina
Background: cavernous hemangioma ( CH) is the most common be-
nign liver tumor. However surgical treatment is occasionally indi-
cated. Progressive enlargement, pain requiring permanent employ-
ment of analgesia, rupture and bleeding and uncertain diagnosis are
usually reasons for operating on patients bearing this tumor.
Aim: to show a complex surgical approach in a symptomatic 41
y.o female with a 9 cm in diameter , central ,deeply located, cav-
ernous hemangioma.
Method: the video shows preoperative images , an arterial em-
bolization carried out prior to decide surgery and the main sur-
gical steps with the addition of a computed animation.
A left hepatectomy under selective hepatic veins exclusion al-
lowed a bloodless and safe operation for this benign tumor.
Results: in the postoperative period the patient had mild ascitis
and colonic dilatation that spontaneously remitted. On postop-
erative 9th day she was discharged. After a one year follow up the
patient’s right upper quadrant pain was relieved.
Summary: surgery for CH should be very carefully indicated, es-
pecially in difficult located lesions and must be operated by a
team trained in complex liver procedures.
References: 1) Trastek V. Cavernous Hemangiomas of the liver:
resect or observe. Am J Surg Vol 145, 1983, 49-53
2) Bornman P . Giant Hepatic hemangiomas: diagnostic and ther-
apeutic dilemmas. Surgery Vol 101 N 4, 1987, 445-449
3) Kim D. Cavernous Hemangioma presenting as Budd Chiari
Syndrome. JACS Vol 200 N 3 2005 470-471
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MODIFIED APPLEBY OPERATION FOR
PANCREATIC BODY CARCINOMA WITH
CELIAC AXIS INVOLVEMENT
E. Vicente1, Y. Quijano1, P. Galindo1, R. D az Conradi1,
H. Dur n1, C. Loinaz1, M. Marcello1, E. Esteban1,
J. Villanueva2, C. Sanz3, M. Allona4, A. Su rez Gauthier5,
L. Ugidos6, M. Garc a Aranda7, M. Rodr guez8
1. General Surgery Service Hospital Madrid Norte Sanchinarro
2. Intensive Care Unit Hospital Madrid Norte Sanchinarro
3. Anesthesiology Service Hospital Madrid Norte Sanchinarro
4. Radiology Service Hospital Madrid Norte Sanchinarro
5. Pathology Service Hospital Madrid Norte Sanchinarro
6. Oncology Service Hospital Madrid Norte Sanchinarro
7. Radiotherapy Service Hospital Madrid Norte Sanchinarro
8. Gastroenterology Service Hospital Madrid Norte Sanchinarro.
Centro Oncol gico Clara Campal. Universidad San Pablo CEU,
Facultad de Medicina, Spain
Locally advanced cancer of the pancreatic body is still associated
with a low resectability and dismal prognosis despite of the devel-
opment of surgical technique. Involvement of major vessels such
as the common hepatic artery (CHA) and celiac axis (CA) is the
main reason for unresectability. In patients with locally advanced
pancreatic carcinomas with celiac axis involvement, resection of
the involved arteries can increase resectability and thus might im-
prove prognosis and quality of life (excellent pain control). A 49-
year-old woman was studied because of persistent epigastric and
back pain, as well as weight loss. Contrast-enhanced computed
tomography showed a tumor, 4 cm in diameter, in the body of the
© The Authors
Journal Compilation © 2009 Hepato-Pancreato-Biliary Association, HPB, 11 (Suppl. 2), 1-172
© The Authors
Journal Compilation © 2009 Hepato-Pancreato-Biliary Association, HPB, 11 (Suppl. 2), 1-172
pancreas with encasement of the CA and CHA. En bloc subtotal
pancreatectomy with splenectomy and resection of the CA was
performed. The stomach was preserved. Surgical margins were
free of tumor. Intraoperative Doppler ultrasonography meas-
urement of the hepatic arterial flow was obtained before and after
clamping of the CA. No significant change in the color and ten-
sion of the liver was observed. The hepatic arterial flow via the
pancreatic arcade from the SMA was sufficient and no re-arteri-
alization of the liver was performed.
The patient had an uneventful postoperative course and was dis-
charged on postoperative day 12. 34 months after the operation,
the patient is free from epigastric and back pain, without evidence
of tumoral recurrence.
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LAPAROSCOPIC DISTAL PANCRE-
ATOSPLENECTOMY AND LAPAROSCOPIC
DISTAL PANCREATECTOMY WITH
PRESERVATION OF THE SPLENIC VESSELS
G. Belli, C. Fantini, A. DAgostino, A. Belli, P. Limongelli,
L. Cioffi, G. Russo
Loreto Nuovo Hospital S.Maria Loreto Nuovo Hospital Naples -
Dept of General and HPB Surgery, Italy
Background: Laparoscopic distal pancreatectomy is progressively
gaining popularity and its feasibility and safety has been demon-
strated by vorious series.
Aim: The aim of this video is to focus on the technical aspects
and differences between laparoscopic distal pancreato-splenec-
tomy ( indicated in the case of aggressive malignant neoplasms )
and spleen preserving distal pancreatectomy with conservation
of the splenic artery and vein. (indicated in the case of benign or
borderline malignant tumors).
Methods: A case of pancreatic adenocarcinoma and a case of
pancreatic insulinoma both localized in the tail of the pancreas
are compared analyzing the differences in the surgical techniques.
Conclusions: Laparoscopic distal pancreatectomy is feasible and
safe. Both pancreato-splenectomy and spleen preserving proce-
dures are technically demanding. In the case of adenocarcinoma
it is necessary to pay attention to infiltrations to adjacent organs
or vascular structure as the celiac axis.; when preservation of the
splenic vessels is performed preventive control at the origin is
suggestable and a meticulous and fine dissection is mandatory to
avoid massive bleeding.
V 15
SEVERE IATROGENIC BILIARY LESIONS:
SURGICAL REPAIR
M. Filauro, D. Dedola.F. Belli S. Cappato
General and Hepatobiliopancreatic surgery Unit Galliera Hospital,
Genoa-Italy
Iatrogenic biliary lesions represent a complex and challenging
surgical problem. Large part of these lesions occur during chole-
cystectomy With the large spreading of laparoscopic cholecys-
tectomy in the last decades, the frequency of iatrogenic lesions
of the bile duct have increase (0,5 %).
Different kinds of bile duct injury are described during cholecys-
tectomy and they have been recently classified by Strasberg in
eight types which include also the Bismuth classification .
The majority of bile duct injuries seen with laparoscopic chole-
cystectomy can either be prevented or minimized if the surgeon
adheres to a simple and basic rule of biliary surgery: no structure
is ligated or divided until it is clearly identified. The proper use of
intra-operative cholangiography may identify an impendig injury
before the level of injury is extended: early recognition with an
immediate conversion to an open procedure and prompt repair
can result in a significant decreased morbidity, mortality, length
of hospitalization and cost saving ;unfortunately injury is recog-
nized during the laparoscopic procedure only in about 30 % of
the cases.
We present the case a 69 years old patient operated in an other
hospital for cholelitiasis: the video show the dramatic sequences
of the severe lesions, with transection of the biliary confluence
and biliary duct of segment 6 and 7 (with an anatomical varia-
tion:separated confluence in the upper part of CBD).
Patient was admitted in our Unit with fever and biliary fistula.
The video shows the reconstruction of CBD and biliary flow of
Segm.6 and 7 by bilioenteric anastomosis, using also CUSA for
precise dissection of the biliary stump.Anastomosis were stented
by Volker and Rodney-Smith technique.
The postoperative course was uneventfull and the patient is fine
without signs of cholangitis after 2 years from reconstruction.
V 16
TOTALLY LAPAROSCOPIC RIGHT
HEPATECTOMY WITH ANTERIOR APPROACH
D. Cherqui, L. Vigano
Department of Surgery, Hospital HENRI MONDOR,
Creteil, France
The video shows a totally laparoscopic right hepatectomy with
anterior approach for symptomatic hepatic nodule in a 61 year-
old woman.
In May 2008, the patient presented with acute abdominal pain.
Abdominal CT scan and MRI showed a 60 mm nodule in seg-
ment 8 with intralesional necrosis and hemorrhage. Radiological
diagnosis was liver adenoma or HCC. AFP was 3 ng/mL and liver
function tests were normal. Laparoscopic liver resection was
planned.
The patient was placed in the supine position, with lower limbs
apart. The surgeon was between the legs with one assistant on
each side. Five port sites were placed.
After cholecystectomy, cystic duct stump was pulled to expose the
hepatic pedicle. Right hepatic artery was taped and divided be-
tween non-absorbable locking clips. Right portal branch was then
dissected and taped.
After left portal branch identification, right portal branch was su-
tured by TA linear stapler and divided between non-absorbable
locking clips. Incision of the Glisson’s capsule was conducted
along the ischemic line. Harmonic scalpel was used for transec-
tion of the superficial part of the liver parenchyma, while ultra-
sonic dissector with spray monopolar coagulation was used for
deeper transection. Hepatic veins from segment 5 and 8 were iso-
lated and divided between clips. The hilar plate was identified.
To improve its exposure, section of some accessory hepatic veins
and transection of segment 1 were performed. Hilar plate in-
cluding the right bile duct was then dissected and divided by lin-
ear stapler. Parenchymal transection was completed with
exposure of the anterior aspect of the inferior vena cava. The
right hepatic vein was taped and divided by linear stapler as well
as the hepatocaval ligament. Right hepatectomy was completed
by mobilization of the specimen from the diaphragm. The speci-
men was then placed in a plastic bag and extracted through an 8
cm supra-pubic horizontal incision. Remnant liver was fixed in
© The Authors
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anatomic position by falciform ligament reconstruction with clips.
Operative time was 240 minutes. No pedicle clamping was
needed. Blood loss was 100 mL and no transfusions were re-
quired. Postoperative course was uneventful and the patient was
discharged on postoperative day 5.
Diagnosis at final pathology was hepatic angiomyolipoma.
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PANCREATIC HEAD RESECTION EN BLOC
WITH SUPERIOR MESENTERIC VEIN AND
RIGHT HEPATIC ARTERY FOR A SOLID-
CYSTIC PANCREATIC TUMOR
E. Vicente1, Y. Quijano1, H. Durán1, C. Loinaz1,
M. Marcello1, E. Esteban1, P. Galindo1, R. Díaz Conradi1,
L. Córdoba2, B. Álvarez3, A. Muro4, E. Conde5, A. Cubillo6,
C. Rubio7, S. Prados8
1. General Surgery Service Hospital Madrid Norte Sanchinarro
2. Intensive Care Unit Hospital Madrid Norte Sanchinarro
3. Anesthesiology Service Hospital Madrid Norte Sanchinarro
4. Radiology Service Hospital Madrid Norte Sanchinarro
5. Pathology Service Hospital Madrid Norte Sanchinarro
6. Oncology Service Hospital Madrid Norte Sanchinarro
7. Radiotherapy Service Hospital Madrid Norte Sanchinarro
8. Gastroenterology Service Hospital Madrid Norte Sanchinarro.
Centro Oncol gico Clara Campal. Universidad San Pablo CEU,
Facultad de Medicina, Spain
Solid-cystic tumors of the pancreas are relatively rare, usually pre-
senting as large asymptomatic masses about 15 cm in diameter
with frequent involvement of regional vascular structures. An in-
creasing resectability rate in hepato-biliary and pancreatic tumors
with vascular involvement is being achieved due to recent ad-
vances in surgical technique. An acceptable early and late mor-
bidity and mortality rates have been obtained.
A huge pancreatic head tumor more than 15 cm in diameter pre-
sented in a 51 year-old woman. A radical surgical treatment was pos-
sible by means of a pancreatoduodenectomy associated to superior
mesenteric vein and right hepatic artery resection. Vascular recon-
struction was performed with an end-to-end anastomosis of both the
superior mesenteric vein and right hepatic artery. A microsurgery
procedure was necessary to perform the arterial reconstruction.
The video shows the preoperative workup evaluating the extent of
the tumor and its vascular invasion as well as the surgical procedure.
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TOTALLY TRASNUMBILICAL LAPAROSCOPIC
CHOLECYSTECTOMY
A. Gumbs, L. Milone, P. Sinha, M. Bessler
Columbia University, New York, U.S.A.
Introduction: With the advent of Natural Orifice Transluminal En-
doscopic Surgery (NOTES), and the acknowledged limitations of
the current technology, Laparo-Endoscopic Single-Site (LESS) sur-
gery has emerged as a viable and more widely applicable minimally
invasive technique. Presented here are the steps necessary to per-
form totally transumbilical laparoscopic cholecystectomy (TTLC).
Methods: To perform TTLC we make a 2 cm incision through
the umbilicus until the fascia is identified. Using 3 separate fas-
cial sites, three 5mm reusable trocars are placed after pneu-
moperitoneum to 15 torr is obtained using the Veress needle.
Intra-abdominal visualization should be obtained with a 5 mm
deflecting laparoscope. Because only 2 other instruments are
used, it is imperative to grasp the gallbladder in the “sweet spot,”
to enable the exposure of both the Triangle of Calot and retract
the cystic duct off of the common bile duct.
Results: At our institution 10 patients have been enrolled in an
IRB-approved study to evaluate the safety and efficacy of this
technique. Procedures average 65 minutes (range= 51-147) all
patients were discharged home in less than 20 hours. To date, one
wound infection and no hernias have developed.
Conclusion: TTLC is feasible and safe. Although single ports are
coming on the market, enabling so-called SPA surgery, the TTLC
technique obviates the need for this device and may help reduce
costs. The use of a deflecting scope and an articulating instru-
ment greatly reduces the “learning curve,” of this procedure and
should be used in the beginning of one’s experience, in particular.
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LAPAROSCOPIC TOTAL
DUODENOPANCREATECTOMY FOR
NTRADUCTAL PAPILLARY MUCINOUS TUMOR
A. Sa Cunha, A. Rault, D. Collet, B. Masson
CHU BORDEAUX, France
Total pancreatectomy was performed due to massive involvement
of the entire pancreas by intraductal papillary mucinous tumor
in 67-year old women.
The dissection and transaction phase was performed laparoscop-
ically. Spleen and splenic vessels were preserved. The reconstruc-
tion phase was accomplished through a minilaparotomy (8 cm).
Postoperative course was uneventful and patient discharged on 7
post operative day.
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GALLBLADDER CARCINOMA WITH
INVOLVEMENT OF MAIN AND LEFT PORTAL
VEIN: RADICAL APROACH WITH DOUBLE
PORTAL RESECTION AND NO GRAFTING
INTERPOSITION
E. Vicente1, Y. Quijano1, C. Loinaz1, M. Marcello1,
E. Esteban1, P. Galindo1, R. Díaz Conradi1, H. Durán1,
B. Morató2, A. López3, U. López de la Guardia4,
A. Suárez Gauthier5, J. Rodríguez6, O. Hernando7,
G. López-Nava8
1. General Surgery Service Hospital Madrid Norte Sanchinarro
2. Intensive Care Unit Hospital Madrid Norte Sanchinarro
3. Antesthesiology Service Hospital Madrid Norte Sanchinarro
4. Radiology Service Hospital Madrid Norte Sanchinarro
5. Pathology Service Hospital Madrid Norte Sanchinarro
6. Oncology Service Hospital Madrid Norte Sanchinarro
7. Radiotherapy Service Hospital Madrid Norte Sanchinarro
8. Gastroenterology Service Hospital Madrid Norte Sanchinarro.
Centro Oncol gico Clara Campal. Universidad San Pablo CEU,
Facultad de Medicina, Spain
Gallbladder carcinoma is the most common cancer of the biliary
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tract. Radical resection of the tumor has been suggested to im-
prove survival.
Our patient was a 63-year-old woman with gallbladder carcinoma
causing painless obstructive jaundice. Percutaneous transhepatic
cholangiogram revealed a total obstruction of the common bil-
iary duct, close to the confluence of right and left bile ducts. Con-
trast-enhanced CT scan showed no infiltration of the liver,
absence of disseminated disease and no evidence of vascular en-
casement.
Through a bilateral subcostal laparotomy, a radical cholecystec-
tomy with bile duct resection, segmental liver resection and re-
gional lymphadenectomy was performed. During the
hepatoduodenal ligament dissection, a double encasement of the
portal vein was demonstrated (main and left portal vein in its
junction with the right portal vein). Segmental resection of ex-
trahepatic portal vein and intrahepatic left portal vein were per-
formed with a double primary end-to-end anastomosis. In the
final part of the dissection, an encasement of the aberrant right
hepatic artery arising from the superior mesenteric artery was ob-
served, so we decided to complete a right liver resection.
The patient was discharged after an uncomplicated postopera-
tive course. Thirty months after surgery, the patient died due to
intraperitoneal recurrence.
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ENSEAL BIPOLAR CUTTING DEVICE
ENABLES SAFE AND BLOODLESS HEPATIC
SUBSEGMENTECTOMY
S. Helton, C. VanCOtt, R. Zuckerman
Hospital of Saint Raphael, Newhaven, U.S.A.
Background: A number of thermal energy devices have been de-
veloped in the past few years that enable bloodless hepatic
parenchymal transaction. The most recent bipolar vessel sealing
and cutting instrument to be FDA approved for surgical division
of blood vessels up to 7 mm is the Enseal Bipolar Vessel Sealer.
Aim: To explore the utility and safety of using the Enseal device
to perform a variety of liver resections.
Methods: Retrospective review of 10 patients undergoing liver
resection using Enseal device for parenchymal transaction. Video
presentation of technique in different liver resections will be il-
lustrated.
Results: The Enseal device performed extremely well in open and
laparoscopic liver resections. Vessel sealing up to 7 mm was per-
formed without bleeding and quickly. The instrument was partic-
ularly useful for performing large subsegmentectomy, was not
adversely influenced by fatty or fibrotic liver tissue and can be used
nicely with water jet dissector. Care must be taken in using the de-
vice on caudate veins to avoid tears. Costs are equal or less than
other bipolar devices currently being used for liver resection.
Conclusion: The Enseal device is safe and cost effective for per-
forming open and laparoscopic liver resection. Subsegmental la-
paroscopic liver resection is very safe using this device.
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THE USE OF A MECHANICAL LITHOTRIPSY
DEVICE AS AN ADJUNCT TO LAPAROSCOPIC
COMMON BILE DUCT (CBD) EXPLORATION
FOR LARGE IMPACTED STONES
S. Robinson1, A. Al-Mukhtar1, M. Nayar2, K. Oppong2,
R. Charnley1, S. White1
1. Department of HPB/Transplant Surgery Freeman Hospital
2. Department of Gastroenterology Freeman Hospital, UK
Background: Laparoscopic CBD exploration is an accepted al-
ternative in preference to laparoscopic cholecystectomy com-
bined with either pre or post ERCP. Recent UK guidelines
recommend laparoscopic CBD exploration in specialist centres
for patients with CBD stones undergoing laparoscopic cholecys-
tectomy. Commonly stones are retrieved using a choledocoscope
and dormier basket technique, however this technique can prove
inadequate for the management of particularly large stones im-
pacted at the ampulla.
Method: A Standard laparoscopic cholecystectomy with on table
cholangiogram (OTC) via the cystic duct is performed. Where
the OTC suggests an impacted large stone then a choledochotomy
is made and the findings confirmed on choledochoscopy. Where
it proves impossible to remove the stone with a dormier basket
then the stone can be crushed using a Mechanical Lithotriptor
(Boston Scientific). Whilst it is not possible to pass this device
along the channel of a choledochoscope, as it is too wide, it can
be inserted into the abdomen through a 5mm port and then passed
into the CBD through the choledochotomy alongside the chole-
dochoscope. The stone is then grasped under direct vision and
crushed into small fragments which can then be extracted with
ease. After confirming that the duct is clear the choledochotomy
is closed either over a T-tube or by primary closure.
Discussion: Our method for managing impacted CBD stones
with a mechanical lithotripsy device provides an acceptable al-
ternative to open surgery and ERCP with its associated risks.
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LAPAROSCOPIC AND OPEN APPROACH FOR
SYNCHRONOUS COLORECTAL LIVER
METASTASES
F. Ratti1, C. Pulitanò1, E. Guzzetti1, F. Cipriani1, S. Di Palo2,
D. Parolini2, L. Aldrighetti3, C. Staudacher2, G. Ferla3
1. General and Specialistic Surgery Department – UOC Hepatobil-
iary Surgery IRCCS San Raffaele Hospital – Milan – Italy
2. General and Specialistic Surgery Department – UOC Gastroin-
testinal Surgery IRCCS San Raffaele Hospital – Milan – Italy
3. Liver Unit, Department of Surgery, Scientific Institute San Raf-
faele, Vita-Salute San Raffaele University, Milan, Italy IRCCS San
Raffaele Hospital – Milan – Italy
BACKGROUND: Almost 30% of patients with colorectal can-
cer have synchronous liver metastases on presentation. Com-
bined resection remains controversial because of the risk of
morbidity and necessity of a curative abdominal approach to war-
rant liver resection. [1,2]
AIM: The aim of this study was to evaluate the outcome of si-
multaneous resection of colorectal cancer WITH synchronous
liver metastasis, comparing results of laparoscopic colonic re-
section + open liver resection and open colonic resection.
PATIENTS: Between January 2004 and December 2008, thirty
patients underwent simultaneous resection of colorectal cancer
with synchronous liver metastasis at San Raffaele Hospital. Nine
patients underwent OPEN hepatic resection and laparoscopic
colorectal resection (LPS Group) and were retrospectively com-
pared with twenty-one patients who underwent synchronous open
hepatic and colorectal resection (Open Group).
Groups were compared in terms of demographic data, concomi-
tant diseases, stage of disease, associated surgical procedures and
use of previous chemoradiotherapy. The outcome was evaluated
in terms of length of operation, number of nodes, intraoperative
blood loss, postoperative stay and complications.
RESULTS: Patients were homogeneously distributed into
groups. The were no significant differences in terms of length of
operation, number of nodes, intraoperative blood loss and post-
operative complications. Postoperative stay was significantly
shorter in LPS group than in Open (9 ± 2,06 vs. 15,21 ± 5,72; P
0,04).
CONCLUSIONS: Laparoscopic colorectal resection in patients
undergoing simultaneous open resection of colorectal cancer and
synchronous liver metastasis is a safe and attractive surgical op-
tion.
[1] Reddy SK, Zorzi D, Lum YW, Barbas AS, Pawlik TM, Ribero
D, Abdalla EK, Choti MA, Kemp C, Vauthey JN, Morse MA,
White RR, Clary BM
Timing of Multimodality therapy for resectable synchronous col-
orectal liver metastases: a retrospective multi-institutional analy-
sis
Ann Surg Oncol. 2008 Nov 1. [Epub ahead of print]
[2] Lim SB, Choi HS, Jeong SY, Park JG.
Feasibility of laparoscopic techniques as the surgical approach of
choice for primary colorectal cancer: an analysis of 570 consecu-
tive cases.
Surg Endosc. 2008 Dec;22(12):2588-95. Epub 2008 Mar 6.
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INFLUENCE OF ESTROGEN ON THE EARLY
RECOVERY OF HEPATOBILIARY SECRETORY
FUNCTION AFTER ISCHEMIA/REPERFUSION
INJURY IN RATS
F. Ponds1, A. de Vries1, R. Padbury2, R. Porte3, V. Nieuwenhuijs3,
G. Barritt4
1. Departments of Medical Biochemistry and Surgery Flinders Med-
ical Centre
2. Department of Surgery Flinders Medical Centre
3. Department of Surgery University Medical Centre Groningen
4. Department of Medical Biochemistry Flinders Medical Centre
Background Ischemia/reperfusion injury (I/R injury) is a major
problem in liver surgery, which causes liver dysfunction and liver
failure after transplantation or hepatectomy. Recent studies have
shown gender-related differences in I/R injury, in which estrogen
is suggested as a ‘survival factor’ for hepatic cells through various
pathways (1).
Aim The aim of this study was to investigate the influence of es-
trogen during the early recovery of hepatobiliary secretory func-
tion after I/R injury of the liver.
Methods A rat model of segmental (60-70%) I/R was used, in
which 60 minutes of ischemia was induced followed by 90 min-
utes of reperfusion. Male (M) and female (F) Sprague Dawley
rats (n = 32) were randomly pre-treated 24 hours prior to I/R
with a s.c. injection of ethanol-oil (M and F Control), 17β-estra-
diol (M-E2), estrogen receptor antagonist ICI 182,780 (F-ICI) or
ICI 182,780 plus 17β-estradiol (F-ICI/E2). Bile flow, ALT, biliru-
bine and histology were analyzed, using One-Way ANOVA (Post
Hoc Bonferroni).
Results Female rats appeared to have a significantly better re-
covery compared to male rats, reflected by the initial degree of
bile flow recovery, area under the curve of bile flow and levels of
ALT (P<0.05). No significant differences were found between
the other groups.
Conclusions Gender appeared to have a significant effect on the
early recovery of hepatobiliary secretory function after liver I/R
injury. However this effect cannot be explained by estrogen me-
diated pathways.
References
1. Eckhoff DE, Bilbao G, Frenette L et al. Surgery 132(2):302-
9, 2002.
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HEPATOBILIARY TRANSPORT REGULATION
IN THE DEVELOPMENT OF MURINE BILIARY
ATRESIA
H. Yang1, T. Plösch2, T. Lisman3, A. Gouw4, R. Porte5,
H. Verkade6, J. Hulscher1
1. Pediatric Surgery University Medical Center Groningen
2. Pediatric Research Labarotory University Medical Center Groningen
3. Surgical Research Labarotory University Medical Center Groningen
4. Department of Pathology University Medical Center Groningen
5. Hepatobiliary Surgery University Medical Center Groningen
6. Pediatric Gastroenterology University Medical Center Groningen,
The Netherlands
Background: The murine model of biliary atresia is rotavirus in-
duced CD4+ Th1 cell mediated inflammation of bile ducts fol-
lowed by progressive biliary obstruction with extrahepatic
cholestasis and liver injury. Little is known about the role of in-
trahepatic cholestasis and the regulation of hepatobiliary trans-
porters in this model.
Aim: To determine changes in hepatobiliary transporters in rela-
tion inflammation and/or extrahepatic cholestasis in the devel-
opment of biliary atresia.
Methods: In murine biliary atresia, mRNA expression of hepato-
biliary transporters, nuclear receptors and inflammatory cy-
tokines were determined by QPCR at 7-days, 14-days and 18-days
after inoculation and compared to control group. Total liver bile
salts and serum bilirubin were assessed. Liver inflammation and
damage were investigated histologically. Independent-sample t
test was used to compare between groups.
Results: Seven days after inoculation, cholestasis occurred. De-
spite high bile acids concentration, both canalicular and basolat-
eral hepatobiliary transporters were down-regulated, with a
decline of nuclear receptors. This was paralleled by an increase in
expression of inflammatory cytokines. At 14 days, hepatobiliary
transporters and nuclear receptors remained downregulated. The
percentage of conjugated bilirubin started to increase remark-
ably, as extrahepatic biliary obstruction occurred. At 18 days, he-
patobiliary transporters expression remained low, nuclear
receptors tended to return to normal, while inflammatory cy-
tokines decreased. Moreover, histology demonstrated progres-
sive inflammation, bile duct damage and ductular proliferation.
Conclusion: Intrahepatic cholestasis due to inflammation-induced
down-regulation of basolateral and canalicular hepatobiliary
transporters is an early event in the development of biliary atre-
sia. Intrahepatic cholestasis contributes to the development of
jaundice and occurs before extrahepatic biliary obstruction.
P 004
VIRTUAL LIVER RESECTION AND CT
VOLUMETRY WITH OPEN SOURCE OSIRIX
3D PACS
J. van der Vorst1, R. van Dam1, I. Hollander1, S. Read2, J. Bloemen1,
S. Dello1, M. Bemelmans1, S. Olde Damink3, C. Dejong1
1. Surgery MUMC+
2. Radiology UCLH
3. Surgery MUMC+/UCLH
Background: Small and less functioning remnant livers resulting
from extended indications for liver resection (LR) and use of
chemotherapy in colorectal cancer liver metastasis (CRCLM)
lead to an increased risk for post resectional liver failure (PLF).
To reduce this risk in patients undergoing LR, preoperative eval-
uation of remnant liver volume (RLV) may be valuable. The
open-source Osirix PAC system for Apple Mac OS is available to
perform CT volumetries, allowing surgeons to predict the RLV
themselves.
Aim: To assess the accuracy of Osirix CT Volumetry to predict liver
resection specimen volume and RLV in patients undergoing LR.
Methods: In 25 patients who underwent LR for CRCLM, preop-
erative 4phase liver CT-scans were analysed by two observers,
blinded for each others results. The total liver and resection spec-
imen were manually outlined in all slices. Total volume, resec-
tion volume and RLV were calculated by Osirix . The resection
volumes were compared with prospectively collected resection
weights obtained immediately after LR.
Results: 25 patients with a median age of 60 (34-77) years were
included. The mean total liver volume measured was 1732mls.
The mean virtual resection volume measured was 965mls. The
mean resection weight was 817 gram. A significant correlation
between weight and volume (R2= 0.944, p<0.0001, fig.1) was
found. The Bland-Altman plot showed a small inter-observer
variability (SD=84.3mls) and a intra class correlation coefficient
of 0.984 (CI: 0.965-0.993, p<0.0001, fig.2).
Conclusion: Osirix CT volumetry is highly accurate in predicting
resection volume and RLV.
P 005
THE HEPATICA STUDY: HEPATIC RESECTION
WITH ADJUVANT THERAPY IN COLORECTAL
CARCINOMA
N. Snoeren1, E. Voest2, I. Borel Rinkes1, R. van Hillegersberg1
1. Surgical Oncology University Medical Centre Utrecht
2. Medical Oncology University Medical Centre Utrecht, The Netherlands
Background: Long term survival of patients with metastasized
colorectal cancer has only been achieved in patients who could
undergo radical surgical resection of metastases. Unfortunately
60%-70% of the patients will develop local or distant recurrences.
Aim: This study aims to achieve an improved disease free survival for
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patients after resection of colorectal liver metastases by adding the an-
giogenesis inhibitor bevacizumab to an adjuvant regimen of CAPOX.
Methods/Design: The Hepatica study is a 2- arm, multicentre,
randomized, comparative efficacy and safety study. Patients will
be assessed no more than 8 weeks before surgery with CT chest,
CT abdomen with and CEA measurement. Patients will be ran-
domized after resection to receive CAPOX and Bevacizumab or
CAPOX alone between 4 and 8 weeks after metastasectomy. Pa-
tients will be assessed before randomization, before cycle 1 of ad-
juvant treatment and after cycle 4 and 8. Further assessment for
recurrence/new occurrence of colorectal cancer and survival is to
be performed every 3 months after cycle 8 for the first 2 years and
thereafter every 6 months until 5 years after surgery. The primary
endpoint is disease free survival. Secondary endpoints are over-
all survival, safety and quality of life.
Results: The Hepatica study is approved in 24 centres, of which
two Swedish centres.
Currently 30 patients are enrolled in the Hepatica study. Safety
and adverse events will be presented.
Conclusion: The HEPATICA study is designed to demonstrate a
DFS benefit by adding bevacizumab to an adjuvant regime of CAPOX
in patients with radically resected colorectal liver metastases.
P 006
UNICENTRIC SURGICAL EXPERIENCE OF 120
PATIENTS WITH SINGLE AND MULTIPLE
HEPATOCELLULAR ADENOMA. A MORE
CONSERVATIVE APPROACH
S. Dokmak1, V. Paradis2, V. Vilgrain3, A. Sauvanet1, O. Farges1,
D. Valla4, P. Bedossa2, J. Belghiti1
1. HBP Surgery Beaujon Hospital
2. Pathology Beaujon Hospital
3. Radiology Beaujon Hospital
4. Hepatology Beaujon Hospital, France
Background: Hepatocellular adenoma (HA) carries a risk of
bleeding and malignant transformation justifying resection for
many authors. Multiple forms are difficult to manage.
Aim: to study their characteristics, risk of complications and sur-
gical outcome in these patients.
Patients and methods: Between 1990 and 2004, 120 patients were
operated, including 109 females and 59 with multiple HA. All HA
> 3 cm were resected. 117 underwent partial liver resection and
3 with multiple malignant HA had transplantation. The mean fol-
low-up was of 70 months.
Results: No difference was observed between patients with single
or multiple HA. Haemorrhagic and malignant HA were observed
in 25 (21%) and 12 (10%) cases respectively. 5/9 of men had ma-
lignant HA (45%). Analysis of 386 HA showed a clear relation-
ship between the size and the risk of complications. All malignant
HA and 23 haemorrhagic (92%) were > 5cm. No recurrence was
observed in the 9 patients with single malignant HA treated by
partial resection, while the 3 transplanted patients with multiple
malignant HA died from malignant recurrence within 2 years. In
benign HA, progression was observed in 7 (6.6%) cases while 4
(10%) patients out of 39 with residual HA experienced tumour
regression. No complication occurred in patients with residual
HA or during pregnancy.
Conclusions: HA should be managed according to the size and
not to the number. In men, HA should be resected whatever the
size. Partial liver resection is a safe treatment of HA > 5 cm.
There is no indication for liver transplantation. Females with HA
< 5 cm can be safely observed.
P 007
LAPAROSCOPIC LIVER RESECTION:
HUNDRED AND TWENTY CONSECUTIVE
RESECTIONS
M. Abu Hilal, N. Pearce
Southampton University Hospital, UK
Aim We present and discuss our results of a consecutive series of
over 120 laparoscopic liver resections between August 2003 and
October 2008.
Methods patients were identified as suitable for a laparoscopic
approach by our hepato-biliary multi-disciplinary team. The in-
dications included 78 with a known liver cancer and 42 with po-
tential malignant liver lesions.
Results 107 had a complete laparoscopic procedure; 40 left lat-
eral sectionectomies, 22 right hemi-hepatectomies, 6 left hemi-
hepatectomies, 3 trisegmentectomies, 17 bisegmentectomies, 10
segmental resections and 9 non-anatomical wedge excisions.
in the remaining 13, the procedure was converted for haemosta-
sis or to ensure good surgical oncology.
Histologically: 60% were malignant, of these 70% colorectal
metastasis, 14% hepatocellular carcinoma and 7% neuro-en-
docrine metastasis. Mean size of lesions was 27mm and mean
clearance margin was 13mm. There were three R1 resections.
Average length of stay was 3.3 days with a range of 1-9 days.
There were no thirty-day mortalities; two patients had post-op-
erative haemorrhage requiring further laparoscopic intervention.
Conclusion
Laparoscopic liver resection can be a safe and oncologically
sound alternative to conventional open liver resection when per-
formed in a suitable tertiary referral centre with the backup of a
good HPB MDT.
P 008
RISK OF BLEEDING IN LAPAROSCOPIC
LIVER SURGERY
M. Abu Hilal, T. Underwood, M. Taylor, N. Pearce
Southampton University Hospital, UK
Introduction: Laparoscopic liver surgery is now gaining accept-
ance, however obtaining haemostasis continues to present a
major challenge. Bleeding is associated with increased overall
morbidity and mortality. We present the results of all patients
who underwent laparoscopic liver resection between August 2003
and December 2007 with reference to control of bleeding.
Methods: Patients were identified from a prospective surgical
database that was cross referenced with the theatre database, the
pathology reporting database and the blood transfusion labora-
tory.
Results: 78 patients underwent laparoscopic liver resection dur-
ing the study period (32 (41%) male, 46 (59%) female, median
age 65). 53.8% were performed for cancer. Median operating
time was 177 minutes. Median hospital stay was 3 days (range 1-
9 days). Median blood loss was 150 mls (range 15-1500 mls) and
4 cases were converted to open to control haemorrhage (5%).
Only 2 patients required intra-operative blood transfusion.
Discussion: Our experience of laparoscopic liver resection shows
it to be a safe procedure associated with low morbidity and short
hospital stays. An intimate knowledge of modern approaches to
laparoscopic haemostasis is required for successful laparoscopic
liver resection and these will be discussed using intra-operative
video clips from the case series.
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REPERFUSION INJURY TO STEATOTIC
RAT LIVERS AFTER TRANSPLANTATION
CAN BE ATTENUATED WITH A MODIFIED
HTK SOLUTION
P. Schemmer1, Q. Liu2, A. Nickkholgh2, H. Bruns2, E. Mohr2,
C. Flechtenmacher3, M. Zorn4, M. Büchler2, U. Rauen5
1. University of Heidelberg Department of Surgery
2. Ruprecht-Karls-University/Dept. of Surgery
3. Ruprecht-Karls-University/Dept. of Pathology
4. Ruprecht-Karls-University/Dept. of Internal Medicine
5. University Hospital Essen, Germany
Background: Ischemia/reperfusion injury (IRI) is still an obsta-
cle especially in fatty livers. Most recently a modified histidine-
tryptophan-ketoglutarate (HTK) solution, Custodiol-N, has been
developed. This solution contains N-acetyl-histidine as buffer, the
amino acids aspartate, glycine, alanine, and arginine to limit is-
chemic injury and to improve reperfusion and the iron chelators
deferoxamine and LK 614 to inhibit cold-induced cell injury. This
study was designed to test the effects of Custodiol-N on IRI to
fatty livers in a rat liver transplantation model.
Methods: Moderate steatosis was induced by a single dose of
ethanol (8 g/kg BW) to female Sprague-Dawley (SD) donor rats
20h before organ harvest. Livers were harvested and cold stored
at 4°C for 8 hours with either HTK solution or Custodiol-N be-
fore transplantation. Serum transaminases and histology were
compared at 1h, 8h and 24h after reperfusion (n=8 animals per
group). Survival was compared after 7 days.
Results: Custodiol-N significantly improved permanent survival
from 12.5% in controls to 87.5% after 7 days. Further, Custodiol-
N decreased the release of AST, ALT and LDH to up to 25%
(e.g. AST after 24h 14456 ± 11493 vs. 4584 ± 2340) of controls
(p<0.05). These results were confirmed by histology.
Conclusions: These results clearly demonstrate that Custodiol-
N is superior to the traditional HTK solution in experimental
fatty liver transplantation.
P 010
RADIOLOGICAL ESTIMATION OF SIZE IN
LIVER TUMORS WHICH UNDERWENT
HEPATECTOMY: IS IT RELIABLE?
F. Botea1, M. Marconi1, D. Poretti2, V. Pedicini2, F. Lutman2,
L. Balzarini2, M. Roncalli3, M. Montorsi1, G. Torzilli1
1. 3rd, Department of Surgery University School of Medicine – Hu-
manitas Clinical Institute IRCCS, Rozzano, Milan, Italy
2. Department of Radiology Humanitas Clinical Institute IRCCS,
Rozzano, Milan, Italy
3. Department of Pathology University School of Medicine – Hu-
manitas Clinical Institute IRCCS, Rozzano, Milan, Italy
Background. Liver tumor size is an important parameter for ther-
apeutical indications and results in colorectal liver metastasis
(CLM) and hepatocarcinoma (HCC).
Aims. To study the accuracy of preoperative imaging to measure
liver tumors by assessing the differences between the size meas-
urements at radiology (RS) and pathology (PS).
Methods. Radiological and pathological tumor measurements in
102 consecutive patients operated in our institution for liver tu-
mors (39 patients for CLM and 63 patients for HCC) for a total
of 147 tumors (69 CLM and 78 HCC) were analyzed.
Results. The radiological measurement was performed by MRI
in 50 tumors (40 CLM in 23 cases and 10 HCC in 9 cases) and by
CT in 97 tumors (29 CLM in 16 cases and 68 HCC in 54 cases).
Mean time from CT/MRI to surgery was 11.5 days (median 15;
range: 1-21) for CLM and 16.7 days (median 14; range: 1-45) for
HCC. The mean difference between PS and RS was 0.4 cm
(p<0.001) and -0.3 cm (p<0.01) for CLM and HCC, respectively.
PS was bigger than RS in 60.9% of CLM, while in 59% of HCC
was smaller than RS.
Conclusion. CT and MRI significantly underestimate the diam-
eter of metastatic nodules and overestimates the size of HCC le-
sions. This finding has a potential consequence especially in
treatment selection for percutaneous ablation techniques and has
to be taken into consideration when evaluating and comparing
the results of various classifications or treatments of liver tumors.
P 011
LONG-TERM OUTCOMES AFTER HEPATIC
RESECTION FOR COLORECTAL METASTASES
IN YOUNG PATIENTS
R. de Haas, D. Wicherts, C. Salloum, P. Andreani, R. Adam,
D. Castaing, D. Azoulay
Centre Hépato-Biliaire Hôpital Paul Brousse, France
Background: Long-term outcomes after hepatectomy for col-
orectal liver metastases (CLM) in relatively young patients are
still unknown.
Aim: To evaluate long-term outcomes in patients <40 years, and
to compare them with patients older than 40 years.
Methods: All consecutive patients who underwent hepatectomy
for CLM at our hospital between 1990 and 2006 were included in
the study. Patients <40 years were compared with all other pa-
tients treated during the same period. Overall (OS), progression-
free (PFS), and disease-free survival rates (DFS) were
determined, and prognostic factors were identified.
Results: In total, 806 patients underwent hepatectomy for CLM,
of whom 56 (7%) were aged <40 years. Among the young pa-
tients, more CLM were present at diagnosis which were more
often diagnosed synchronous to the primary tumor. Five-year OS
was 33% in young patients, compared with 51% in older patients
(P=0.12). Five-year PFS was 2% in young patients, compared
with 16% in older patients (P<0.001). DFS were comparable be-
tween both groups (17%vs23%, P=0.10). At multivariate analy-
sis, age <40 years was identified as an independent predictor of
poor PFS.
Conclusions: In young patients, metastatic colorectal cancer
seems to be more aggressive with a trend to lower OS, more dis-
ease recurrences, and a significantly shorter progression-free
time-interval after hepatectomy. However, DFS were comparable
between young and older patients, owing to an aggressive multi-
modality treatment approach, consisting of chemotherapy and re-
peat surgery. Therefore, physicians should recognize the poor
outcome of CLM in young patients and should consider an ag-
gressive approach to diagnosis and early treatment.
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P 012
LONG TERM RESULTS FOR LIVER
RESECTION AND TRANSPLANTATION FOR
PRIMARY CARCINOID TUMOR OF THE LIVER
N. de Liguori Carino1, S. Fenwick2, G. Toogood2, K. Prasad2,
S. Pollard2, J. Lodge2
1. Hepatobiliary Unit University Hospital Aintree, Liverpool,UK
2. HPB and Transplant Unit St James’s University Hospital, UK
Objective: To discuss the clinical course, management and long
term follow-up of primary carcinoid tumor of the liver treated
with liver resection(LR) and transplantation(OLT).
Methods: Between March 1994 and December 2008, we treated
11 patients (4 male, 7 female) with primary hepatic carcinoid tu-
mors. Treatment was by LR in 8 patients, OLT in 3 and living re-
lated liver transplantation (LRLT) in 1. One patient underwent
both resection and transplantation.
Results: The diagnosis was con rmed histologically in the absence
of an alternative primary site. Protocol follow-up was based on
serial total body CT scan, Octreoscan and tumor markers. Fol-
low-up ranged from 10 to 168 months. Only one patient died of
recurrent disease within 5 months. Three patients had recurrence
while six patients remain alive and disease free at 10, 12, 35, 116,
120, 127 and 130 and months respectively.
Conclusions: This series is the largest reported and the only one
to include OLT, including LRLT, as a treatment option. Exclu-
sion of extrahepatic primary and long-term follow-up is essential
for diagnosis of primary carcinoid of the liver. The mainstay of
treatment should be liver resection, although liver transplanta-
tion may be considered in selected patient. A radical surgical ap-
proach is warranted as this disease carries a better prognosis than
for other primary hepatic tumors and for secondary hepatic car-
cinoids.
P 013
ACTIVATION OF THE HEDGEHOG SIGNAL
TRANSDUCTION PATHWAY DURING
DEVELOPING BILIARY ATRESIA IN MICE
H. Yang1, T. Lisman2, A. Gouw3, R. Porte4, H. Verkade5,
J. Hulscher1
1. Pediatric Surgery University Medical Center Groningen
2. Surgical Research Labarotory University Medical Center Groningen
3. Department of Pathology University Medical Center Groningen
4. Section of Hepatobiliary Surgery and Liver Transplantation Uni-
versity Medical Center Groningen
5. Pediatric Gastroenterology University Medical Center Groningen,
The Netherlands
Background: Hedgehog (Hh) signaling is involved in the fibro-
proliferative response in liver injury. We hypothesized that Hh
signaling is also involved in the fibro-proliferative response dur-
ing the development of biliary atresia.
Aim: To determine the activity of Hh signaling during the pro-
gression of biliary atresia in a mouse model.
Methods: In the mouse model of biliary atresia, levels of inflam-
matory cytokines in the liver, CK19 (cholangiocyte marker),
genes involved in the Hh pathway (Ihh, Shh, Ptc and Gli-2) and
the presence of activated myofibroblasts (using aSMA) were as-
sessed using qPCR at 7, 14 and 18 days and compared to a con-
trol group. Liver injury and proliferative response were
investigated histologically. Mann-Whitney test was used to com-
pare between groups.
Results: Seven days after inoculation, there was severe inflam-
mation but no increase of mRNA levels of Ck19 or Hh genes. At
14 days, the mRNA level of CK19, Hh ligand Ihh (but not Shh)
and Hh receptor Ptc started to increase while inflammatory mark-
ers decreased. At 18 days, there was a statistically significant in-
crease in CK19, Ihh and Ptc mRNA levels. The level of a-SMA
seemed to increase, but without statistical significance. Histology
demonstrated progressive liver damage, ductular reaction and
proliferation over time.
Conclusion: In the mouse model, there is no involvement of Hh
signaling at the early inflammatory stage of biliary atresia devel-
opment. However, there is activation of Hh signaling during the
fibroproliferative phase.
P 014
GLISSONEAN APPROACH FOR ANATOMICAL
LIVER RESECTIONS
V. Vishnevsky1, M. Efanov1, R. Ikramov2, V. Egorov2,
T. Shevchenko2, O. Melehina2
1. Vishnevsky Institute of Surgery
2. V.A.Vishnevsky Institute of Surgery, Moscow, Russia
BACKGROUND. Anatomical liver resections are considered as
the most effective procedure to achieve R-0 resection. It is not
still clear enough what the technique is the most effective and
safe for anatomical partial hepatectomy. AIM of the study was to
estimate results of anatomical liver resections performed by pos-
terior approach with precise atraumatic isolation of glissonean
pedicles. METHODS. We have been applying atraumatic glis-
sonean approach for right lobe segmental anatomical liver resec-
tions since 2007. Twenty four patients underwent liver resections
according to such a technique. The indications were liver col-
orectal metastases (18), HCC (3), gallbladder cancer (1), hae-
mangiomas (5). Short term results of segmental resections were
estimated in patients with colorectal metastases included 24 pa-
tients with anterior approach and 10 patients with posterior ap-
proach. RESULTS. All anatomical segmental resections with
glissonean approach were performed without Pringle maneuver
( <0.05). There were no differences in bloodloss, duration of op-
eration and postoperative hospital stay, morbidity. Glissonean
approach allowed to perform radical resection in patients with
multiply of large tumors located near hepatic hilum and liver
function deterioration. Patients underwent anatomical posterior
liver resections with glissonean approach for malignant lesions
are followed up for 3-12 months. No one has relapse of disease in
the liver resection zone. CONCLUSION. Anatomical posterior
liver resections by glissonean pedicle approach are reliable pro-
cedures for complete removing of affected part of the liver ac-
cording to its real borders.
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SHOULD OCTOGENARIANS BE DENIED
ACCESS TO SURGERY FOR LIVER CANCER?
ANALYSIS OF A SINGLE CENTRE EXPERIENCE
E. Guzzetti1, C. Pulitan 1, F. Cipriani1, F. Ratti1, L. Aldrighetti2,
M. Catena1, R. Finazzi1, G. Ferla2
1. General and Specialistic Surgery Department – UOC Hepatobil-
iary Surgery IRCCS San Raffaele Hospital – Milan – Italy
2. Liver Unit, Department of Surgery, Scientific Institute San Raf-
faele, Vita-Salute San Raffaele University, Milan, Italy IRCCS San
Raffaele Hospital – Milan – Italy
Background: With a progressively ageing population, increasing
number of elderly patients will and be referred for hepatic resec-
tion.
Aim: The aim of this study was to assess the safety of hepatic re-
sections in octogenarians patients.
Patients: Between February 1990 and October 2008, 539 patients
underwent hepatic resection at S.Raffaele Hospital – Milan.
Twenty-seven patients ≥80 years (Over-80 Group) were com-
pared with 115 patients between 70 and 80 years of age (70-80
Group), and with 397 patients <70 years of age (control Group).
Indications for resection, concomitant diseases, previous ab-
dominal surgery, type of resection, associated surgical proce-
dures, use/length of portal clamping, intra-operative blood losses
and transfusions, and length of operation were preliminarily com-
pared. The outcome was evaluated in terms of post-operative
mortality, morbidity, transfusions, postoperative hospitalization.
Results: When compared with the 70-80 Group and with the Con-
trol Group, the Over-80 Group included more HCC (51.9% vs.
39.5% and 21.8%, P:0.001), chronic liver disease/hepatic cirrho-
sis (46.2% vs. 41.5% and 25.9%, P:0.002), concomitant disease
(76.9% vs. 66.4% and 43.1% P:0.000), and previous abdominal
surgery (65.4% vs. 61.7% and 48.1%, P:0.017). The ASA score
was significantly superior in the Over-80 Group (P:0.001). As re-
gard the intraoperative outcome, the Over-80 Group had an in-
creased need of packed red blood cells (53.8% vs. 38.7 and 29.9,
P:0.017). There were no significant differences in perioperative
mortality, postoperative morbidity, requirement of postoperative
transfusions and hospitalization.
Conclusions: Hepatic resections in octogenarian patients may be
carried out relatively safely provided that an accurate preopera-
tive selection of the patient is performed. [1-3]
1. Aldrighetti L, Arru M, Catena M, et al.: Liver Resections in
Over-75-Year-Old Patients: Surgical Hazard or Current Prac-
tice? J Surg Oncol 2006;93:186-193.
2. Fortner JG, Lincer RM: Hepatic resection in the elderly. Ann
Surg 1990;211:141-145.
3. Mann CD, Neal CP, Pattenden CJ, et al.: Major resenction of
hepatic colorectal liver metastases in elderly patients - An ag-
gressive approach is justified. EJSO 2008;34:428-432.
P 016
LAPAROSCOPIC LEFT HEPATECTOMY BY
COMBINED USE OF ULTRASONIC DISSECTOR
AND HARMONIC SCALPEL
L. Aldrighetti1, E. Guzzetti2, C. Pulitan 2, M. Catena2,
M. Paganelli2, G. Ferla1
1. Liver Unit, Department of Surgery, Scientific Institute San Raf-
faele, Vita-Salute San Raffaele University, Milan, Italy IRCCS San
Raffaele Hospital – Milan – Italy
2. General and Specialistic Surgery Department – UOC Hepatobil-
iary Surgery IRCCS San Raffaele Hospital – Milan – Italy
Background Laparoscopic liver surgery is gaining wider and
clearer acceptance as therapeutic modality for liver lesions. The
ideal technique for dissection of liver parenchyma has not been
yet defined.
Aim This video presents laparoscopic hepatectomy performed by
combined use of ultrasonic dissector and harmonic scalpel (Sono-
Surg System, Olympus, Tokyo, Japan).
Methods Continuous 12 mmHg pneumoperitoneum is induced
and a 4 trocar configuration is used. Hepatic pedicle is dissected
and left hepatic artery and left portal vein are sectioned using a
linear stapler. Transection line, along Cantlie line, is shown by is-
chemic demarcation of the left liver.
The ultrasonic dissector is used to fracture hepatocytes along the
proposed line of division, leaving intact veins, arteries and bile
ducts crossing the line of division. Blood vessels up to 4 mm in
diameter are coagulated in 4-5 s using harmonic scalpel and
larger vessels up to 15 mm and biliary branches are sealed with ti-
tanium clips. Left hepatic vein is sectioned with a transparenchy-
mal approach using a linear stapler. Autologous fibrine glue is
apposed on transection line at the end of resection.
Results Operating time was 340 min. Intraoperative blood loss was
100 ml. Portal clamping was not used. Postoperative course was
regular and the patient was discharged in post-operative day 5.
Conclusions Laparoscopic liver surgery by combined use of ul-
trasonic dissector and harmonic scalpel can represent a safe and
effective technique for liver resections.
P 017
MELD SCORE IN EVALUATING THE
FUNCTIONAL RESULT OF PREOPERATIVE
PORTAL VEIN EMBOLIZATION(PVE) IN
PATIENTS WITH PRIMARY OR SECONDARY
LIVER TUMORS
A. Bakoyiannis, S. Delis, C. Avgerinos, N. Papaspirou,
A. Sofianidis, C. Dervenis
1st Surgery Department Konstantopouleio-Agia Olga Hospital,
Athens, Greece
INTRODUCTION: PVE is used before liver resection, to in-
crease the future liver remnant(FLR). The assumption has been
that larger volume seen in the FLR after PVE correlates with in-
creased function and therefore post-resection liver dysfunction
can be minimized.
AIMS AND METHODS: To identify if PVE induced liver hy-
pertrophy correlates with functional improvement assessed with
MELD score and what is the impact on postoperative course.
From 2002 to 2007, fourteen patients underwent PVE before ex-
tended hepatic resections. Resections were performed to treat
colorectal liver metastases(n = 9), hepatocellular carcinoma(n =
4), and peripheral cholangiocarcinoma(n = 1).
MELD score was calculated prior and six weeks after PVE.
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RESULTS: Following PVE, FLR was increased in all patients
from 47 ± 6% to 53 ±7%. MELD score was decreased after PVE
in seven(50%) patients(Group A) and was not changed in the re-
maining seven(50%) patients(Group B). In group A, mortality
was zero. Following resection, two group A patients developed
pleural effusion. In group B one patient died one month postop-
eratively due to liver failure. Two group B patients developed
pleural effusion, one developed hepatic abscess and two devel-
oped biliary fistula. Statistical analysis revealed that decrease in
MELD score after PVE correlates with more favourable outcome
regarding morbidity(p= 0.005) and mortality(p=0.04). In median
15 month follow up(range 3–59 months), six patients are alive and
free of recurrence.
CONCLUSION: PVE effect is visualized with MELD score be-
fore and after PVE. Stable value of MELD score after PVE is a
negative prognostic factor for postoperative outcome.
REFERENCES:
1. Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jack-
son J, et al. Preoperative portal vein embolization for major
liver resection: a meta-analysis.
Ann Surg. 2008 Jan;247(1):49-57.
2. Hemming AW, Reed AI, Howard RJ, Fujita S, Hochwald SN,
Caridi JG, et al. Preoperative portal vein embolization for ex-
tended hepatectomy.
Ann Surg. 2003 May;237(5):686-91
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ESTIMATION OF FUNCTIONAL LIVER
RESERVE IN PATIENTS WITH
HEPATOCELLULAR CARCINOMA IN
CIRRHOSIS: THE VALUE OF PREOPERATIVE
CHOLINESTERASIS
M. Donadon1, F. Procopio1, M. Cimino1, A. Palmisano1,
D. Del Fabbro1, F. Botea2, M. Montorsi2, G. Torzilli2
1. Third Department of General Surgery University of Milan,
IRCCS Istituto Clinico Humanitas, Rozzano, Milan, Italy
2. 3rd, Department of Surgery University School of Medicine – Hu-
manitas Clinical Institute IRCCS, Rozzano, Milan, Italy
Background. Estimation of functional liver reserve in patients
with hepatocellular carcinoma (HCC) in cirrhosis is of paramount
importance to properly select candidates for surgical resection.
Together with the value of bilirubin, the presence/absence of as-
cites and esophageal varices, and the rate of residual liver vol-
ume, which are our current parameters to measure functional
liver reserve, we sought to investigate the value of preoperative
cholinesterasis (CHE) in predict postoperative adverse outcome
after hepatic resection for HCC.
Methods. We reviewed the records of 165 consecutive patients
who underwent hepatic resection for HCC at our Unit. The value
of preoperative CHE was analyzed against the occurrence of
postoperative adverse events. Receiver–operator characteristic
curve analysis was used to identify cut-off values of CHE that pre-
dicted adverse outcome. P<0.05 was considered statistically sig-
nificant.
Results. Forty-three (26%) of 165 patients had complications, of
which 29 (16%) were liver-related. Major morbidity occurred in
7 patients (5%) [5 liver failures – 3 mild, 2 moderate, 1 severe –
1 reoperation, and 2 thoracentesis]. The 30-, and 90-day postop-
erative mortality were 1% (2 patients), and 2% (3 patients), re-
spectively. A value of CHE less than 5900 UI/L had a sensitivity
of 73% and a specificity of 67% in predicting liver-related post-
operative complications (P=0.003). Overall and major compli-
cations were significantly greater in patients with a CHE value
less than 5900 UI/L.
Conclusions. The value of CHE contributes important informa-
tion in predict postoperative adverse outcome after hepatic re-
section for HCC. Thus, it should be included in the selection
process of candidates to surgery for such disease.
P 019
N-ACETYLCYSTEIN INFUSION PROTECTS
AGAINST SEGMENTAL ISCHEMIA-
REPERFUSION INJURY IN THE PIG LIVER
A. Winbladh1, L. Trulsson2, P. Sandström1, P. Gullstrand1
1. Dep of surgery Inst of clinical and experimental medicine
2. Institution of clinical and experimental medicine, University
hospital, Linköping, Sweden
Introduction: N-Acetylcystein (NAC) is known to have antioxi-
dant effects and have been used in various ischemia-reperfusion
injury (IRI) models as well as clinically. Our primary aim was to
see the effect of NAC on segmental liver IRI in vivo.
Method: 8 landrace pigs received a bolus of NAC 150 mg/kg and
infusion 50 mg/kg/h (group A), 8 pigs served as controls (group B)
and three were sham-operated (group C). Group A and B had
liver segment 4 clamped for 80 minutes. Reperfusion was fol-
lowed for 6 hours with laser Doppler flowmetry. Microdialysate,
tissue and blood samples were obtained.
Results: Microdialysis revealed lower levels of lactate (5.2 vs. 7.6
mM), glucose (11.9 vs. 15.6 mM) and pyruvate (4 vs. 21 mM) in
group A vs. group B (p<0.05). In all animals total antioxidative
capacity increased throughout the experiment from 0.4 to 1.4 mM
(p<0.01) and oxidative stress decreased (4.0 to 2.3 mM p<0.01),
but no differences were seen between the groups. There were no
changes in glutathione (GSH/GSSG), nitrite/nitrate levels, nor
were there any differences in apoptosis (Caspase or DNA-frag-
mentation). At histology the density of polymorph nuclear leuko-
cytes was higher in group B compared to group A (p<0.05).
Conclusion: NAC protects the liver against IRI, most likely by
reducing the recruitment of leukocytes to the injured liver. The
effect of NAC seems to reduce anaerobic glucose metabolism.
Further analyses will be made this winter to elucidate the mech-
anisms of NAC.
P 020
HEPATIC MICROWAVE ABLATION IN AN
EXTRACORPOREALLY HAEMOPERFUSED
LIVER MODEL: A DOSE RESPONSE STUDY
S. Ong1, G. Gravante1, R. Sorge2, M. Metcalfe1, A. Dennison1,
D. Lloyd1
1. University Hospitals of Leicester NHS Trust, United Kingdom
2. University of Tor Vergata, Rome
Objective: The aim of this study was to evaluate the relationship
between the delivered microwave dose during hepatic ablation in
a normothermic, autologous haemoperfused ex vivo model.
Materials and Methods: Microwave ablations were carried out at
power settings of 50, 70 and 90 watts (Groups A, B and C re-
spectively) for a fixed period of 2 minutes. The dimensions of the
lesions generated were calculated and evaluated against the
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amount of microwave energy that had been delivered.
Results: The radii, areas and volumes of the lesions increase sig-
nificantly with increasing power of microwave applied (p<0.05).
The lesions consisted of a centre necrotic zone and a peripheral
transitional zone and adopted an ellipsoidal shape consistent with
those previously described in the literature.
Conclusion: Hepatic microwave experiments using an ex vivo per-
fused liver model produced a dose-response curve similar to that
found in in vivo experiments and can be employed for future stud-
ies of hepatic ablation avoiding the need for live animal studies.
P 021
SUCCESSFUL LONG TERM OUTCOME OF
LIVER RESECTION AS PART OF
ONCOSURGICAL TREATMENT OF
METASTATIC MELANOMA
M. Caralt, J. Martí, G. Sapisochín, J. Fuster, I. Bilbao,
C. Fondevila, J. Lázaro, J. García-Valdecasas, R. Charco
HPB Surgery and Liver Transplant Hospital Vall d Hebron, Spain
Backround: Classicaly, patients with metastatic melanoma have
very poor outcome despite new therapies. However,recent stud-
ies suggest that liver resection may improve patient survival
Aims: To analize the outcome of patients undergoing liver re-
section for metastatic melanoma.
Patients and Methods: Patient selection criteria were: good per-
formance status,the feasibility of a complete and safe surgical
procedure, and absence of uncontrolled extrahepatic metas-
tases.Data was collected prospectively and analyzed retrospec-
tively.
Results: Between 1994 and 2007 13 liver resections were per-
formed. Median follow-up was 60.7 months (r:0.5-103.5). Median
age at liver surgery was 48 years (r:25-68). The primary tumor was
ocular in 5 patients (38.5%), cutaneous in 6 (84.6%) and un-
known in 2 (15.4%). Among patients with cutaneous melanoma,
40% had stage T1, 60% stage T2 and axillary lymph nodes were
positive in 20% Two patients had synchronous metastases
(15.4%) and 11 methachronous (84.6%). Eight patients (61.5%)
underwent a major hepatectomy and 5 a minor hepatectomy.
Postoperative morbidity was 38.5% (biliary leak, abdominal ab-
scess, pneumonia) and one patient died of a brain hemorrage
during the postoperative stay. After the liver surgery, only 4 pa-
tients (30.8%) received systemic adjuvant therapy. All patients
except one developed recurrence: 11 patients systemic recurrence
(84.6%) and 5 hepatic receurrence (38.5%). Treatment of liver
recurrence was: systemic therapy in 3 patients, readiofrequency in
1 and no treatment in 1. Median time of hepatic reccurrence was
12.9 months (r:2.8-62.7). One-, 3-, and 5-year actuarial patient
survival was 69%,52% and 52%.
Conclusions: Liver resection of metastatic melanoma may im-
prove survival in selected patients.
P 022
PORTAL VEIN EMBOLIZATION FOR
EXTENDED HEPATECTOMY:METASTASES DO
BETTER THAN PRIMARY LIVER TUMOURS
S. Vyas, S. Partelli, Lykoudis P. C. Bent, A. Abraham,
R. Hutchins, S. Bhattacharya, D. Low, T. Fotheringham,
H. Kocher
Hepato Biliary and Pancreatic Surgery Unit and Interventional
Radiology, Barts and the London HPB Centre, Royal London
Hospital, Whitechapel, London, UK
Background and Aims: Hepatic resection offers the best survival
advantage for liver tumours. Portal vein embolization (PVE) in-
duces contra-lateral liver hypertrophy to facilitate an extended
hepatectomy. We analysed data on PVE and extended hepatec-
tomy on overall outcomes including success of PVE, feasibility of
resections, operative morbidity and survival.
Methods: A retrospective analysis of data collected prospectively
on 33 patients (2004-2008) selected for PVE. Survival curves were
estimated by the Kaplan-Meier (Breslow) method. Significance
was defined as p < 0.05.
Results: 31 patients had successful PVE. Patients were dis-
charged uneventfully in a median of 1 day. 24 patients underwent
surgery. Significant hypertrophy of residual liver was noted from
a median of 230.15 mls (pre-embolization) to 428.50 mls (post-
embolization) (p<0.0001, Wilcoxon signed rank test). 16 patients
had liver resections with a single mortality (6.25%) and 56.25%
morbidity. The median hospital stay was 17.5 days. 14 patients
had R0 resections, 2 patients had R1 resections. The median
overall survival was 14(95%CI 7.8-20.2) months. Patients who un-
derwent surgical resection had a median disease specific survival
of 33 (95%CI 4-62) months against a median survival of 8.6(95%
CI 0-19.9) months for patients without resection (p = 0.14). For
patients with primary liver tumours, the median disease-specific
survival was 7.9 (95%CI 4.5-11.3) months against a median sur-
vival of 19.7(95%CI 0-42.2) months for patients with liver metas-
tases (p=0.07).
Conclusion: PVE is a safe procedure and when applied selec-
tively, facilitates complete tumour resection offering the best
chance of cure, especially for liver metastasis.
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INFERIOR VENA CAVA RESECTIONS FOR
RADICAL TREATMENT OF PRIMARY AND
SECONDARY TUMORS
E. Vicente1, Y. Quijano1, M. Marcello1, E. Esteban1, P. Galindo1,
R. Díaz Conradi1, H. Durán1, C. Loinaz1, L. Córdoba2,
J. Mart nez Rom n3, A. Muro4, E. García5, J. Rodríguez6,
C. Rubio7, S. Prados8
1. General Surgery Service Hospital Madrid Norte Sanchinarro
2. Intensive Care Unit Hospital Madrid Norte Sanchinarro
3. Anesthesiology Service Hospital Madrid Norte Sanchinarro
4. Radiology Service Hospital Madrid Norte Sanchinarro
5. Pathology Service Hospital Madrid Norte Sanchinarro
6. Oncology Service Hospital Madrid Norte Sanchinarro
7. Radiotherapy Service Hospital Madrid Norte Sanchinarro
8. Gastroenterology Service Hospital Madrid Norte Sanchinarro.
Centro Oncol gico Clara Campal. Universidad San Pablo CEU,
Facultad de Medicina, Spain
BACKGROUND: Regional invasion or compression of the in-
ferior vena cava (IVC) are often associated with tumors of the
liver, biliary tract, pancreas, retroperitoneum and kidney.
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AIM: Our experience, technical considerations and results for
IVC resections in selected cases of locally advanced tumors are
presented.
PATIENTS: 23 patients underwent IVC resections (17 circum-
ferential and 5 partial) to obtain R0 surgery. Primary diseases:
liver metastasis from colon cancer (8), intrahepatic cholangio-
carcinoma (1), hydatid cyst (2), renal carcinoma (4), IVC tumoral
thrombosis after renal carcinoma relapse (3), tumoral thrombus
into IVC + liver infiltration (segment VI) (1), IVC primary tu-
mors (2), adrenal carcinoma (2). Locations: level I (renal veins)
(10), level II (retrohepatic IVC) (4), level III (hepatic veins and
atrium) (9). Associated resections: right hepatectomy (5), right
hepatectomy extended to segment IV (4), hepatic segmentectomy
(segment VI) (1), nephrectomy (4), nephrectomy + adrenalec-
tomy (2), and total cystopericystectomy (2) one of them with IVC
and atrium trombectomy and nephrectomy. Hepatic veins (8) and
renal veins bifurcation (8) were resected when necessary. Pros-
thetic replacement was performed in 14 patients with reimplan-
tation of left hepatic vein in 1 patient.
RESULTS: General and vascular resection-related morbidity,
early and late graft patency, graft thrombosis incidence, mortal-
ity and survival are presented. Techniques of venous control, he-
patic vascular exclusion, hepatic and renal veins reconstruction,
prosthetic replacement and arterio-venous fistulae are also anal-
ized.
DISCUSSION: IVC resection can be performed in selected cases
with low risk of morbimortality. Pre and intraoperative evalua-
tion to determine the extent of tumor are imperative.
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HEPATIC ARTERY ANEURYSMS (HAAS):
ROLE OF INTERVENTIONAL RADIOLOGY
P. Alexey, T. Pavel
Research Center of Radiology and Surgical Technologies, Russia
Purpose. To analyze the first clinical experience of new treatment
for locally advanced unresectable pancreatic cancer.
Material and methods. After experimental study, we performed
21 TAOCE in 10 pts with histologically proven adenocarcinoma
of the pancreatic head ( T3-4 N 0-2 M0 ). We used redistribu-
tion technique as follows: Selective catheterization and distal em-
bolization of the gastroduodenal artery ( GDA ) was performed
with steel coils. Then TAOCE of proximal branches of GDA su-
plying tumor was made using bolus injection of 200 - 400mg/sq.m.
Gemcitabine, emulsified in 3-5ml Lipidiol Ultrafluid. Subcuta-
neous injections of Octreotide 0,1mg x 3 was used during four
days as a prophylaxe of pancreatitis.
The follow-up included clinical observation, ultrasound exami-
nation and computer tomography or magnetic resonance imag-
ing. TAOCEs were repeated with 1-2 month interval.
Results: There were no treatment-related complications. The
post-embolization syndrome included upper abdominal pains
and nausea. These symptoms disappeared within 2 days of symp-
tomatic therapy.
Now, four pts showed decrease of tumors size and improvement
of general condition during 2-12 mo after the beginning of treat-
ment, and five pts showed stabilization of tumor growth for 3
to 6 mo. However, one patient died from tumor progressions in
6 mo.
Conclusion: Transcatheter arterial oily chemoembolization is a
well-tolerated procedure and can cause partial tumor response
in some patients with locally advanced unresectable pancreatic
head carcinoma.
ID N 2964 7819
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HEPATIC RESECTION FOR NON-COLORECTAL
NON-NEUROENDOCRINE METASTATIC
TUMORS: EXPERIENCE FROM A REGIONAL
ANTICANCER CENTER
D. Korkolis1, C. Aggeli1, H. Zerbinis1, E. Gontikakis1,
G. Plataniotis1, D. Dimitroulopoulos2, D. Xinopoulos2,
P. Vassilopoulos1
1. First Department of Surgery Hellenic Anticancer Institute, “Saint
Savvas”Hospital, Athens, Greece
2. Department of Gastroenterology Hellenic Anticancer Institute,
“Saint Savvas”Hospital, Athens, Greece
Background: The clinical importance of aggressive surgical treat-
ment for hepatic metastases originating from non-colorectal non-
neuroendocrine (NCNE) primary tumors remains controversial.
Aim: The retrospective evaluation of the role of liver resection
for NCNE metastatic disease in a regional cancer center.
Materials and Methods: Between June 2004 and December 2008,
32 consecutive patients suffering from NCNE metastases, were sur-
gically treated for cure. These were 13 men and 19 female with a
mean age of 62 years (range 18-72) at the time of surgery. In 5 pa-
tients (16%) synchronous metastatic disease was found and treated.
Hepatic metastases were solitary in 61% and unilateral in 86%. Pri-
mary tumor sites were: Breast CA in 10 (30%), Ovarian CA in 5
(16%), Malignant melanoma in 4 (12%), Gastric CA in 3 (9%),
Renal CA in 3 (9%), Testicular CA in 3 (9%), Pancreatic CA in 2
(6%), Lung CA in 1 (3%), and Anal CA in 1 patient (3%). 12 major
hepatectomies and 20 minor resections were performed. An R0 on-
cologic resection was achieved in 28 (87%) patients.
Results: There was no perioperative mortality. Postoperative
complications (20%) included biliary injury in 1 patient, abscess
formation in 1 , pneumonia in 1, wound infection in 2 and sterile
intraabdominal/pleural effusions in 2 patients. All of them were
conservatively treated. With a follow-up period ranging from 6
to 50 months, median survival rate for the entire group was 23
months. Survival was significantly longer for metastases of breast
and urogenital origin (p<0.01). Curative R0 resection, metachro-
nous disease, disease-free interval longer than 12 months, pre-
operative response to chemotherapy and absence of extrahepatic
disease were statistically significant factors associated with in-
creased survival (p<0.05). The extent of liver resection and as-
sociated morbidity were not predictive of outcome.
Conclusions: In a highly selected group of patients, hepatic re-
section for non-colorectal non-neuroendocrine metastatic disease
is an effective treatment which may offer a significant advantage
in overall survival.
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FORMATION OF INTRAHEPATIC VENOUS
COLLATERALS IN LEFT LOBE REMNANTS:
ANALYSIS OF COMPUTED TOMOGRAPHY
DATA IN A REGENERATION STUDY
A. Schenk1, M. Hindennach1, A. Radtke2, M. Malag 3,
C. Broelsch2, S. Kinner2, T. Schroeder2, H. Peitgen1
1. Fraunhofer MEVIS, Bremen, Germany
2. University Hospital Essen, Germany
3. University College Hospital London, UK
BACKGROUND: In live donor liver transplantations, middle
hepatic vein (MHV) tributaries are ligated in graft or remnant
and induce the risk of hepatic venous congestion, decreased re-
generation and delayed recovery of liver function [1].
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AIM/OBJECTIVE: To study liver regeneration and the forma-
tion of intrahepatic venous collaterals by evaluating hepatic veins
in pre- and postoperative multiphase computed tomography (CT)
data.
METHODS: Computer-assisted analysis of preoperative CT data
was performed comprising the three-dimensional reconstruction
of liver and vascular systems. Right grafts including the MHV
were resected virtually in a technique following the course of this
vein [2] and potentially outflow obstructed tributaries were iden-
tified. CT data of the regenerating remnant at day 10 and 3, 6 and
12 months post transplantation was analysed, aligned and dis-
played simultaneously with preoperative images and 3D recon-
structions. Vascular growth, volume regeneration and formation
of collaterals were evaluated for 16 donors.
RESULTS: Eleven of 16 donors (69%) developed collaterals be-
tween MHV tributaries and draining veins of the left lobe. The
connecting veins were not found in the first postoperative scan
but were visible in the CT data 3 months after LDLT. No forma-
tion of collaterals was found in five donors. Growth of segment
IV was decreased compared to that of left lateral segments inde-
pendent of collateral formation.
CONCLUSIONS: Software-assisted analysis of CT data allows
for a reliable detection of hepatic vein collaterals in computed
tomography data and evaluation of local volume growth.
REFERENCES
[1] Scatton O, Plasse M, Dondero F, Vilgrain V, Sauvanet A, Bel-
ghiti J. Impact of localized congestion related to venous depriva-
tion after hepatectomy. Surgery 143(4):483-9, 2008.
[2] Malago M, Molmenti EP, Paul A, Nadalin S, Lang H, Radtke
A, et al. Hepatic venous outflow reconstruction in right live donor
liver transplantation. Liver Transpl. 11:364–5, 2005.
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VIRTUAL HEPATOBILIARY SURGERY AND ITS
OPERATIVE IMPLEMENTATION THROUGH
NAVIGATION TECHNIQUES
G. Stavrou1, S. Weber2, N. Wendt3, C. Hansen3, K. Oldhafer1
1. Department of General, Visceral and Thoracic Surgery Celle Gen-
eral Hospital
2. Chair for Micro- and Medical Device Technology (MiMed) Tech-
nical University Munich
3. Center for Medical Diagnostic Systems and Visualization (MeVis)
University of Bremen
Backround: Concepts of approaching liver tumours have changed
over the last years. Nowadays the limiting factor of resectability
is the amount of liver parenchyma remaining after an operation.
Modern imaging techniques, especially 3D analysis of vascular
territories have led to advances in understanding functional
anatomy of the liver. We can actually perform the resections vir-
tually and understand the consequences of different resection
strategies on the vasculature of the liver remant, therefore al-
lowing more advanced and complex resections without risking
postoperative liver failure.
Aim of the Study/Method: Current research focuses on transfer-
ring the virtual plan to the operation site. This is made possible
by using stereotactic navigation techniques combined with dy-
namic intraoperative ultrasound. Landmark structures in the liver
are identified and stereotactically registered into the virtual plan.
It is now possible to perform the resection with a stereotactically
registered dissection device according to the virtual operation
plan.
Results: During this study conducted by a research consortium*
we have performed 6 successful resections in our department
using the method, in one case, we managed to resect a non-visi-
ble, non palpaple tumour, that could not have been resected oth-
erwise.
Summary: Intraoperative navigation in liver surgery is one of the
most challenging fields today. Though some issues as the dynamic
deformation of the organ during the operation have not been
completely solved yet, we can present a working solution for the
implementation of virtual resection planning into the actual op-
eration.
* Project Somit-Fusion (funded by the BMBF): MeVis Research
Bremen, MiMed Munich, Clinical Partners
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THE VALUE OF THE ULTRASONIC SURGICAL
ASPIRATOR IN LIVER TRANSECTION: A
META-ANALYSIS AND SYSTEMATIC REVIEW
OF THE LITERATURE
F. Prete1, D. Raptis2, J. Skipworth2, B. Singh1, D. Dhar1,
S. Olde Damink3, C. Imber4, A. Shankar4, M. Malago4
1. University College Hospital Department of Hepatopancreatico-
biliary Surgery
2. University College London, Department of Surgery and Interven-
tional Science
3. Surgery Maastricht University Medical Center
4. University College London Hospital, NHS Foundation Trust De-
partment of Hepatobiliary and Pancreatic Surgery
INTRODUCTION: Inconsistent and limited data exist concern-
ing the optimal surgical technique for liver parenchymal transec-
tion during hepatic resection. Further, clear definitions of the role
of each technique are also lacking. We aimed to address these is-
sues by specifically assessing the role of ultrasonic aspirator-aided
liver dissectors (UAD) in hepatic transection.
MATERIALS AND METHODS: A comprehensive review of
electronic databases, including Medline, EMBASE, the
Cochrane Database and Science Citation Index, was undertaken
using the search terms ‘liver’, ‘hepatic’, ‘resection’, ‘transection’,
‘dissection’, ‘techniques’, ‘CUSA’, ‘ultrasonic dissector’, ‘aspira-
tor’ and ‘cavitron’, in various combinations. All identified original
articles, studies, randomized controlled trials (RCT), and reviews
were subsequently individually appraised and all relevant articles
classified according to the level of evidence they provide (Oxford
Centre for Evidence-based Medicine). We specifically assessed
the association of UAD with peri-operative blood loss, resection
time and margins, post-operative morbidity and mortality, and
cost-effectiveness.
RESULTS: Out of 9633 screened articles, 82 described the use of
UAD in liver resections. Of these, 17 studies comparing UAD
with other techniques of liver parenchymal transection, includ-
ing 4 RCTs, entered into meta-analysis. The statistical analysis
showed nonsignificant differences between UAD and other tran-
section techniques (clamp crushing, water-jet, microwave coagu-
lation, ultrasonic scalpel) in terms of intraoperative blood loss (8
eligible studies, mean 42.56 ml, [-256.04, 341.15] 95% CI,
p=0.78), resection-related blood loss (4 eligible studies, mean
0.71 ml/cm2, [-0.86, 2.27] 95% CI, p=0.38), operative time (6 el-
igible studies, 10.72 min, [-10.31, 31.76] 95% CI, p=0.32) and pe-
rioperative complications (7 eligible studies, odds ratio 1.08 [0.76,
1.54], p=0.67).
CONCLUSION: No single technique in this study clearly
emerged as the optimal standard for liver parenchymal transec-
tion. Overall, UAD appeared well comparable to other estab-
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lished techniques of liver transection, in terms of perioperative
blood loss, operative time, with no added perioperative compli-
cations.
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TUMOUR SIZE OF 10 CM IS NOT A
CONTRAINDICATION FOR SURGICAL
RESECTION OF HCC
S. Farid1, G. Morris-Stiff1, G. Toogood2, P. Lodge2, R. Prasad1
1. St James University Hospital
2. Department of Organ Transplantation St James University Hos-
pital, UK
Introduction: The role of surgery in HCCs greater than 10 cm is
controversial with some centres reporting inferior outcomes for
these large tumours. We present a Western experience of surgi-
cal resection in patients with HCC’s greater than 10 cm
Methods: A prospectively maintained departmental database was
analysed to include all HCC resections in our institution between
February 1994 and August 2007. The Kaplan-Meier method was
utilised to analyse disease-free survival (DFS) and overall sur-
vival (OS). A multi-variate analysis was performed by Cox re-
gression (Step-wise forward model) for variables reaching
significance on univariate analysis.
Results: A total of 94 patients underwent hepatic resection dur-
ing the study period. Median follow up was 28 months. There
were 43 patients with a tumour >10 cm in diameter and 51 pa-
tients with smaller HCCs. There were significantly fewer patients
with cirrhosis in large HCC tumours (>10cm) than smaller tu-
mours; 7% vs 23%, p<0.001. The overall 5-year DFS and OS
were 28% and 36% respectively. Patients with tumour >10 cm
and < 10 cm had 5-year DFS rates of 14% versus 18 % (p=0.471)
and OS rates of 20% versus 22% (p=0.130). Multivariate analy-
sis revealed that only multiple tumours, high pre-operative neu-
trophil to lymphocyte ratio (>5:1) and vascular invasion to be
independent factors associated with DFS.
Conclusions: A tumour size > 10 cm does not present a con-
traindication to hepatic resection for HCC and other factors re-
lated to tumour biology including the presence of cirrhosis need
to be considered in determining resectability.
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HEPATIC RESECTION FOR HCC IN ELDERLY
PATIENTS
S. Farid1, G. Toogood2, P. Lodge2, R. Prasad1
1. St James University Hospital
2. Department of Organ Transplantation St James University Hos-
pital, UK
Introduction/Aim: The western experience of hepatocellular car-
cinoma (HCC) resection in elderly patients continues to increase.
We present a single centre experience of HCC resection in pa-
tients aged over 70 years.
Method: A review of the departmental database was performed
to identify all patients undergoing resection for HCC and divided
into two groups; Group A - < 70 years and Group B > 70 years
old during the period February 1994 and August 2007. The Ka-
plan-Meier method was utilised to analyse disease-free survival
(DFS) and overall survival (OS). A multi-variate analysis was per-
formed by Cox regression (Step-wise forward model) for prog-
nostic variables reaching significance on univariate analysis.
Results: Of 96 surgically resected HCC, 57 (60%) were in pa-
tients in Group A (<70 years) and 37 (40%) in Group B
(>70yrs). Median follow up was 30 months. There was no signif-
icant difference in tumour characteristics, parenchyma status,
AFP expression, extent of resection, use of blood transfusion,
postoperative complications and resection margin involvement.
Overall 1 & 5 year disease free (DFS) and survival (OS) of the
study group was 73%, 52%, 80% and 55% respectively. No sig-
nificant difference observed in DFS at 5years between Group A
(77%) vs. Group B (63%), p= 0.524 but OS at 5 years was infe-
rior in elderly patients compared to those aged less than 70 years;
36% vs. 60% p=0.018. Only multiple and involved resection mar-
gins were independent prognostic factors for poor long-term out-
comes in multivariate analysis.
Conclusions: Selected elderly patients (>70yrs) with HCC ben-
efit disease free survival from resection as much as younger pa-
tients Postresection longterm prognosis in the elderly was
determined by the presence of multiple tumors and involved re-
section margins.
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THE RELATIONSHIP BETWEEN
PREOPERATIVE PHYSIOLOGY AND
LONG-TERM SURVIVAL FOLLOWING
RESECTION OF COLORECTAL LIVER
METASTASES
C. Neal1, C. Mann1, N. Johnson2, G. Garcea2, C. Pattenden2,
A. Dennison3, D. Berry3
1. University of Leicester Leicester General Hospital
2. Department of Hepatobiliary and Pancreatic Surgery Leicester
General Hospital
3. Leicester Teaching Hospitals, Leicester General Hospital, UK
BACKGROUND: Preoperative patient physiology, determined
using the physiology component of the Physiological and Opera-
tive Severity Score for the Enumeration of Mortality and Mor-
bidity (POSSUM) score, was recently shown to independently
predict overall, cancer-specific and disease-free survival following
resection of primary colorectal cancer (CRC).
AIM: The aim of this study was to determine whether patient
physiology predicts long-term survival following resection of col-
orectal liver metastases (CLM).
METHODS: Data on patients undergoing resection of CLM be-
tween January 2000 and December 2004 were obtained from a
prospective database. Preoperative variables, including the Clin-
ical Risk Score (CRS) and POSSUM score were recorded. POS-
SUM physiology scores were analysed following division into
established groupings (11-14, 15-20, >20). Variables were com-
pared to overall and disease-free survival by entry into a Kaplan-
Meier model and application of the log rank test. Independent
prognostic significance was determined by Cox regression analy-
sis, including all variables with P<0.10 on univariate analysis.
RESULTS: 148 patients underwent hepatic resection for CLM
over the study period and were eligible for inclusion. Median fol-
low-up was 38 months. Median preoperative POSSUM physiol-
ogy score was 15 (range 12-31). On univariate analysis, patients
with POSSUM physiology scores >20 demonstrated trends to-
wards poorer overall and disease-free survival that lacked signif-
icance (P=0.11 and P=0.078). On multivariable analysis,
increasing CRS was the only variable independently associated
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with both overall and disease-free survival (P=0.017 and
P=0.006).
CONCLUSIONS: In contrast to evidence for primary CRC,
these data suggest that preoperative physiology is not a useful
predictor of long-term survival in patients with resectable CLM.
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PERI-OPERATIVE MORBIDITY DOES NOT
PREDICT LONG-TERM OUTCOME
FOLLOWING HEPATECTOMY FOR
COLORECTAL LIVER METASTASES
C. Mann1, C. Neal1, C. Briggs1, C. Maratos2, A. Khanna2,
M. Metcalf2, A. Dennison2, D. Berry2
1. University of Leicester Leicester General Hospital
2. Leicester Teaching Hospitals, Leicester General Hospital, UK
Introduction – Hepatectomy, when feasible, is the most effective
treatment for colorectal liver metastases, but can be associated
with significant post-operative morbidity. It has recently been re-
ported that peri-operative morbidity has a detrimental effect on
long-term oncological outcome. The aim of this study was to val-
idate this finding in a United Kingdom population.
Methods – All patients undergoing hepatectomy for colorectal
liver metastases between January 2000 and December 2005 at a
single tertiary hepatobiliary referral unit in the United Kingdom
were included. Patients were identified from our multi-discipli-
nary team Hepatobiliary database. All resections were per-
formed with curative intent. Data collected included
demographics, short-term outcomes, and long-term outcomes.
Patients who died of peri-operative complications were excluded
from analysis. Survival was analysed using log-rank analysis.
Results – 174 patients underwent resection during this period,
62% of whom underwent major resections. 106 were male, with
a mean age of 61 years (range 32–79). 42% received systemic
chemotherapy prior to resection. 54 patients suffered peri-oper-
ative complications (31%). The overall median follow-up was 36
months. The 5-year overall and disease-free survival rates were
36.6% and 25.3% respectively (median 34 months and 15
months). There was no significant difference in either overall or
disease-free survival between patients who suffered post-opera-
tive complications and those who did not.
Conclusions – The results from this study do not support other
data in the literature. Whilst every effort should be made to re-
duce peri-operative morbidity, these data suggest that this cohort
of patients should not be considered as higher oncological risk.
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THREE SURGEON TECHNIQUE FOR LIVER
TISSUE DISSECTION: TOWARDS REAL
BLOODLESS HEPATECTOMY
A. Petrou, M. Kontos, K. Bramis, E. Prassas,
I. Papaconstantinou, A. Papalambros, N. Basios, I. Griniatsos,
E. Pikoulis, E. Felekouras
A Department of Surgery University of Athens Laiko General Hos-
pital, Greece
Background: Bleeding during hepatectomy remains a major
cause of mortality despite recent developments in surgical and
anesthetic techniques. Up to date, there is no single surgical de-
vice that combines, efficient haemostasis, safety for the adjacent
vital structures during parenchymal division.
Aim: To present the Three Surgeon Technique (3ST), a novel
method parenchymal dissection for major hepatectomies and
compare it with our standard RFA – assisted technique (already
published).
Methods: Forty-three patients, who underwent major liver re-
section, were divided in two groups. Twenty-one of them (group
A) underwent 22 RFA-assisted liver resections and 22 (group B)
underwent 24 hepatectomies with the 3ST. 3ST combines the use
of Saline-cooled radiofrequency coagulation device (SC) and the
Ultrasonic Aspirator (UA) in hilar dissection/glissonean ap-
proach with radiofrequency ablation (RFA) for hepatic parenchy-
mal transection.
Results: Blood transfusion was necessary in 14 and 7 patients in
group A and B respectively (p=0,022), with an average of 1.6 and
0.7 units of red blood cells (p=0,018). Pringle maneuver was used
in two and none cases, hemi-selective vascular inflow occlusion in
13 and 10 cases for groups A and B respectively. The mean time
of parenchymal dissection was 92, 38 and 87 min in Group A and
B, respectively.
Conclusions: The 3ST method is a novel reliable and safe alter-
native that reduces blood transfusion although is not faster. The
financial cost needs to be examines considering the cost of blood
transfusion and morbidity expenses
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EXTENDED LIVER RESECTION FOR
POLYCYSTIC LIVER DISEASE: A
CHALLENGING PROCEDURE WITH
EXCELLENT LONG TERM RESULTS
C. Hubert1, B. Aussilhou1, A. Herrero1, A. Sauvanet1,
O. Farges1, V. Paradis2, J. Belghiti1
1. Departement of HPB Surgery Beaujon’s hospital
2. Pathology Beaujon Hospital, France
Objectives: The aim of this study was to report the largest pub-
lished unicentric series of extended resection for highly sympto-
matic adult polycystic liver disease (APLD).
Background data: Highly symptomatic APLD is usually treated
by liver transplantation. Extended liver resection, which is per-
formed in very few centers, remains debatable in terms of oper-
ative difficulties, perioperative course and long-term results.
Methods: Since 1995, we prospectively selected 43 patients with
highly symptomatic APLD to perform a liver resection ≥2 seg-
ments associated with fenestration of the spared sectors. They
were aged from 31 to 72 years including 40 females and were clas-
sified as Grade II GIGOT in 70% and Grade III in 30%. A vol-
umetry of the future remnant liver (FRL) was measured
preoperatively. Perioperative outcome and long-term follow-up
were assessed. The analysis of the non-cystic parenchyma paid at-
tention to document vascular changes and fibrosis.
Results: Intraoperative blood loss was 800 cc (range 50-4317) and
19 (44%) were transfused. One (2%) patient died 4 months after re-
section. Significant morbidity was 42% including ascites (n=18),
bile leak (n=9), hemorrhage (n=9) and liver insufficiency (n=3).
Among these patients who had significant complications, the FRL
was <20% in 55% (vs. 38% in the patients with no complication, p
<0.05) and the histological changes (including fibrosis) were pres-
ent in 37% (vs. 17%, ns). A lower morbidity was significantly en-
countered in left hepatectomies (n=17) versus right (n=26)
(morbidity 41 vs. 72%, p=0.034). Long term follow-up (median 36
months) showed that 85% of the patients were symptom-free.
Conclusions: Extended hepatic resection for symptomatic APLD
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offers excellent long-term outcome with acceptable morbidity.
Factors predictive of perioperative morbidity include a right-
sided hepatectomy, a future liver remnant <20% and possibly
presence of parenchymal alterations in the remnant liver sug-
gesting that measures to optimize these conditions may further
improve the outcome.
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SAFETY AND PROGNOSTIC ROLE OF
REGIONAL LYMPHADENECTOMY FOR
PRIMARY LIVER TUMORS AND METASTATIC
COLORECTAL TUMORS
M. Ravaioli, G. L. Grazi, G. Ercolani, M. Cescon, A. Dazzi,
C. Zanfi, P. Di Gioia, M. Del Gaudio, A. Cucchetti,
G. Vetrone, M. Zanello, F. Tuci, M. Vivarelli, A. Lauro,
V. Bertuzzo, G. Ramacciato, C. Morelli, A. D. Pinna
Department of Surgery and Organ Transplantation, Sant’Orsola-
Malpighi Hospital, University of Bologna, Italy.
Background: the routine regional lymphadenectomy for col-
orectal liver metastases and primary liver tumors, but not extra-
hepatic bile duct cancer, is debated.
Methods: during 2001-2005, we performed a prospective trial
where regional lymphadenectomy of the hepato-duodenal liga-
ment and common hepatic artery was performed in group R+LN
and not applied in group R-LN.
Results: the pre-operative clinical features of patients were com-
parable among groups such as the operative data. There were 106
(67%) male, the median age was 66 years, 124 cases had single le-
sion (77%) and the median diameter was 4 cm. The type of le-
sion was: 77 (48%) colorectal liver metastasis (M-CR), 75 (46%)
hepatocellular carcinoma (HCC) and 10 (6%) cholangiocellular
carcinoma (CCC). In the R+LN group, the mean number of
lymph nodes removed was 6.7 ± 4.8 (range 3-26) and 7 cases
(8.6%) presented lymph node metastasis.
After a median follow-up of 3.5 years and considering all patients
there was no difference in the post-operative course and follow-
up.
M-CR patients showed comparable hospital mortality (R+LN
0% vs. R-LN 2.6%) and morbidity (R+LN 17.9% vs. R-LN
21.1%), but R+LN had higher disease free-survival at 5 years
(33% vs. 16%, p<0.05). HCC cases in R+LN group presented
higher hospital mortality and morbidity (13.5% vs. 0% and 64%
vs. 36%, p<0.05 for both) without any improved 5-years disease
free-survival (34% vs. 33%).
Conclusion: routine regional lymphadenectomy should be per-
formed for colorectal liver metastases and avoided in patients
with hepatocellular carcinoma.
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EXTENDED LIVER RESECTIONS FOR
ADVANCED DISEASE IN COLORECTAL LIVER
METASTASIS: IS IT WORTHWHILE?
L. Benhaim, A. Kraemer, E. Buc, S. Dokmak, O. Farges,
J. Belghiti
Departement of HPB Surgery Beaujon’s Hospital, France
Background and aims: Chemotherapy and progresses in surgery
lead to enlarge indications of liver resection for colorectal liver
metastasis (CRLM). Since the benefit of extended resection for
advanced disease has not been established, we aimed to assess
risks and benefits of such procedure. We compared also patients
operated with and without preoperative portal vein occlusion
(PVO) to determine the oncological risk of induced liver hyper-
trophy which is still much debated.
Methods: From 2003 to 2007, among 345 patients who under-
went liver resection for CRLM, 44 (13%) patient’s responders to
chemotherapy with bilobar tumors involving at least 5 segments.
Preoperative parenchymal hypertrophy was required before com-
plete resection in 25 cases (PO+); this group was compared to
19 (PO-) cases immediately resected.
Results: Disease tend to be more severe in the PO+ group with
more synchronous (23 vs 13), a higher number of tumors (9.47 vs
6.94) but received preoperatively the same number of cycles (12.7
vs 11.38) and had the same involvement of 6 segments (31% vs
36%). In the PO+ group, complete surgical treatment was not
possible in 8 (32%) patients. Postoperative mortality (1 vs 1) and
morbidity rate (47% vs 58%) were similar in the two groups. One
and 3-years survival tend to be higher (p=0. 12) in the PO+
group (93.3% vs. 81.4%) and (44.4% vs. 30.8%) respectively. Sim-
ilarly, the one (42% vs. 10%) and 3 years (15, 6% vs. 0%) disease
free survival was also higher in the PO+ group (p=0.24). In the
two groups, all patients with more than 6 liver segments involved
by CRLM metastasis had a recurrence before the first year what-
ever the group.
Conclusions: Extended liver resections for CRLM are safely fea-
sible with a 40% 3-years survival and a 10% 3 years disease free
survival. There is no adverse effect of PVO on the overall sur-
vival and disease free survival (on the contrary). In case of more
than 6 segments invaded the resection must be carefully consider
regarding to systematic and early recurrences.
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MICROWAVE HEPATIC TUMOR ABLATION
WITH 915 MHZ VS 2.45 GHZ: A CASE MATCHED
COMPARISON
D. Iannitti, S. Smeaton, E. Kubec, J. Martinie
MD Carolinas Medical Center, Charlotte, USA
BACKGROUND: Microwave ablation of hepatic tumors has
been performed primarily in the United States with a 915 MHz
system. 2.45 GHz systems have been used in the UK and Japan.
This is the first study comparing outcomes between the 915 MHz
and 2.45 GHz system as measured by required treatment time
and presence of residual tumor.
METHODS: Patients with solid liver lesions were treated with a
2.45GHz MWA system with a single 5.6mm diameter surgical an-
tennae (Microsulis, Denmead, UK). These were then case
matched with patients previously receiving treatment with a 915
MHz MWA system (ValleyLab, Boulder, CO) with three 13
gauge 22cm surgical antennae in a clustered array. Data for the
number of treatments, time of each treatment, and power meas-
ured in watts were collected. Follow up CT with contrast at 30
days was examined for presence residual tumor. A number of out-
come measures and complication rates were recorded.
RESULTS: 40 patients (20 from each system) were treated for
either primary or secondary lesions of the liver. The treatment
time required for similar sized lesions was less for the 2.45 GHz
system compared with the 915 MHz system. Evidence of resid-
ual tumor and complication rates were similar (Table 1).
CONCLUSIONS: 915 MHz and 2.45 GHz microwave ablation
systems are equally efficacious in thermocoagulating hepatic tu-
mors in this case matched series. Time to treat and number of ap-
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GUT MUCOSAL BARRIER IMPAIRMENT IN A
SWINE MODEL OF POSTHEPATECTOMY
LIVER FAILURE; A STUDY OF THE IMPACT
OF PERITONEAL ALBUMIN DIALYSIS UPON
INTESTINAL MUCOSA
G. Defterevos1, K. Nastos1, N. Papoutsidakis1, K. Kalimeris2,
A. Papalois3, G. Agrogiannis4, K. Pavlakis4, A. Mikrova1,
T. Nomikos5, N. Arkadopoulos1, V. Smyrniotis1
1. Aretaieion Hospital, Athens, Greece
2. Attikon Hospital, Athens, Greece
3. Elpen Pharma, Greece
4. Athens University, Medical School, Greece
5. Harokopeion University
Background Extensive hepatic resections and liver transplanta-
tion involve portal triad occlusion (Pringle’s manoeuvre), thus,
inevitably, hepatic ischemia-reperfusion (I-R) injury has become
a common complication in liver surgery. The aim of the present
study is to investigate the presence of remote injury to the intes-
tinal mucosa and the effect of peritoneal albumin dialysis, a ther-
apeutic modality applied to support liver function, to attenuate
this injury.
Materials-Methods A porcine model of acute liver failure, con-
sisting of prolonged (2,5hrs) hepatic ischemia and subsequent
reperfusion in combination with extended (70-75%) hepatec-
tomy, was employed. Fourteen Landrace pigs (30-35kg) were ran-
domly assigned into 2 groups which underwent a 6-hour session
of peritoneal dialysis with albumin-rich (albumin group, n=7
pigs) and albumin-free solution (control group, n=7 pigs).
Results Levels of endotoxin, ammonia, lactate and malondialde-
hyde (MDA) in portal circulation were significantly diminished
(p=0.033, p=0.007, p=0.046 and p=0.002, respectively) in the
therapeutic group after completion of the dialysis session. Sys-
temic endotoxin levels were also substantially reduced (p=0.02)
after therapy. Tonometric evaluation of intramucosal pH and
PCO
2
gap displayed significantly decreased intestinal mucosal
perfusion in controls (p=0.005, p=0.008, respectively); increased
intestinal tissue MDA, nitric oxide and protein carbonyl levels in
control group signify oxidative damage. Albumin dialysis resulted
in less pronounced histological injury, as well.
Conclusions Many lines of evidence imply that intestinal mucosa
suffers moderate oxidative injury after hepatic ischemia-reperfu-
sion as a part of a systemic inflammatory response, which is ef-
fectively attenuated by peritoneal albumin dialysis, possibly as a
result of albumin’s antioxidant and anti-inflammatory properties
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MAJOR HEPATECTOMIES IN THE EDERLY
J. Contis1, K. Karapanos1, G. Fragoulidis2, G. Vassilikostas1,
V. Smyrniotis1, D. Voros1
1. Univ. of Athens Med School Aretaieion Hospital
2. 2nd Department of Surgery, Experimental-Reasearch Department,
University of Athens, Aretaieion Hospital, Athens
Background: Curative liver resection has been accepted as the
only chance of long-term survival for patients with primary and
metastatic liver cancer.
Aim: Faced with an increasing number of elderly patients pre-
sented with hepatic malignancies, we studied old age defined as
70 years or older as a prognostic factor for the early outcome of
major hepatectomies.
Methods: We performed a retrospective review of a consecutive
plications per lesion is less in the 2.45 GHz system.
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LIVER RESECTION OF METASTASES
SYNCHRONOUS TO RECTAL TUMOR:
THE PROGNOSTIC ROLE OF PRIMARY TUMOR
L. Vigano1, M. Karoui2, A. Ferrero1, F. Brunetti2, N. Russolillo1,
C. Tayar2, A. Laurent2, D. Cherqui2, L. Capussotti1
1. HPB and Digestive surgery, Ospedale Mauriziano, Torino, Italy
2. HPB and Digestive Surgery, Hôpital Henri Mondor, Créteil,
France
Background: Management of synchronous liver metastases (LM)
is debated. No analysis focused on LM synchronous to rectal can-
cer (RC) and their specific issues (radiotherapy, operative mor-
bidity and pelvic recurrence risk).
Aim: To evaluate outcomes of surgery for LM synchronous to
RC.
Methods: Outcomes of 72 patients undergoing liver resection for
LM synchronous to RC between 2000 and 2007 were reviewed.
Results: Radiotherapy was performed in 4 cases (5.6%) and
radio-chemotherapy in 13 (18.1%). 52 patients (72.2%) received
chemotherapy before hepatectomy.
38 patients (53%) underwent simultaneous rectal-hepatic resec-
tion (83% excluding referred patients). Overall mortality and
morbidity were 1.4% and 43%. Morbidity was not increased in
simultaneous group (42%).
Three-/5-year overall and disease-free survival rates were
73%59% and 53%/45%. 42 patients (60%) had recurrence; 68%
had recurrence resection. Pelvic recurrence occurred in 7 (10%)
cases (5.8% in radiotherapy/radio-chemotherapy group); only in
3 cases radical reresection was possible.
At multivariate analysis, LM>5 cm and low RC were independ-
ent prognostic factors of overall (p=0.035 and p=0.003) and dis-
ease-free survival (p=0.006 and p=0.002). In low RC, 50% of
cases had extra-hepatic recurrence (vs 30% in upper-mild RC)
and no recurrence was resectable.
Conclusions: Simultaneous resection of RC and LM is safe and
feasible without increased morbidity. After radical resection, half
of patients are alive and disease-free at 3 years. Low RC is asso-
ciated to increased extra-hepatic recurrence rate. Pelvic recur-
rence incidence is similar to non metastatic RC and few
reresections are possible. Radiotherapy should be systematically
evaluated even in metastatic patients.
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hours (p<0,01). Systemic and portal endotoxin levels were sig-
nificantly decreased in both treatment groups 24 hours after
reperfusion (p<0,05 and p<0,01). Portal pressure did not have
significant differences between the three groups.
CONCLUSIONS: Major hepatectomy was followed by moder-
ate to severe IMI and increased bacterial translocation. Bioarti-
ficial liver and desferrioxamine attenuated IMI and improved gut
barrier function. The above treatments seem to improve intes-
tinal barrier function, possibly implying a preventive effect in the
development of postoperative acute liver failure derived MODS.
P 042
PERITONEAL ALBUMIN DIALYSIS IS
ASSOCIATED WITH NEUROLOGICAL
IMPROVEMENT IN PIGS WITH ACUTE LIVER
FAILURE
G. Defterevos1, K. Nastos1, N. Papoutsidakis1, K. Kalimeris3,
T. Nomikos 6, P. Korkolopoulou4, G. Agrogiannis4,
S. Panagiotopoulos5, A. Mikrovas1, A. Papalois2,
N. Arkadopoulos1, V. Smyrniotis1
1. Experimental Surgical Center, 2nd Department of Surgery, Medical
School, University of Athens, Aretaieion Hospital, Athens, Greece
2. Experimental Research Center of ELPEN-Pharma, Athens,
Greece
3. 2nd Department of Anesthesiology, Medical School, University
of Athens, Attikon Hospital, Greece
4. Department of Pathology, Medical School, University of Athens,
Greece
5. Department of Surgery, Agrinio General Hospital, Greece
6. Department of Nutrition, Harokopeio University of Athens,
Greece
Background: Raised intracranial pressure (ICP) and cerebral
edema are common complications of Acute Liver Failure (ALF),
worsening patient’s final outcome. The aim of our study was to in-
vestigate whether peritoneal dialysis (PD), in a porcine model of
ALF using an albumin-rich solution, would attenuate the rise in
ICP and ameliorate hepatic encephalopathy
Methods: Landrace pigs were assigned into a therapeutic (or al-
bumin, n=7) group, in which the peritoneal solution was albu-
min-rich, and in a control (n=7) group; ALF was induced by
extensive (70%-75%) hepatectomy and, subsequently, superim-
posed ischemia (for 2,5 hours) and reperfusion of the liver rem-
nant. In both groups, PD was performed 6 hours after ALF onset
and ended after a 6-hour session.
Results: ICP, Cerebral Perfusion Pressure(CPP), arterial ammonia
and lactate rose significantly over the 12-hour observation period
in the control group, in comparison with the albumin group, in
which PD resulted in attenuation (almost normalization) of the in-
creased ICP, ammonia and lactate levels, whereas CPP merely im-
proved. Percentage change in S-100b and Neuron-Specific-Enolase
levels after albumin PD was statistically significant (p=0.028 and
p=0,017, respectively). Tissue MDA levels tended to significantly
decrease (p=0.071) after therapy, whereas, histopathologically,
brain inflammatory cell infiltration and cerebral edema significantly
decreased in the albumin-treated ALF group.
Conclusion: Peritoneal albumin dialysis has unequivocally de-
creased ICP in our animal ALF model and partly prevented pro-
gression of underlying brain tissue damage. Albumin’s
antioxidant properties, and its potential scavenging role con-
cerning substances that contribute in hepatic encephalopathy,
had probably a crucial impact on the overall neurologic im-
provement.
series of patients who underwent a major hepatectomy to study
old age (>70 years) as a risk factor regarding outcome. All pa-
tients undergoing major liver resection (defined as three seg-
ments or more) from January 2001 to December 2005 were
included. Patients were studied in two groups: 70 years of age and
older (54 patients, 70-90. mean 75 years) and less than 70 years
old (138 patients) .Early outcomes were analyzed.
Results: Elderly patients had a 5,5% mortality (3 deaths due to
MI, hemorrhage and liver failure respectively) and a 15% rate of
major complications ( biliary leak 7 patients, re-operation for
bleeding one patient) while their mean hospital stay was 10,9
days (3-50 days). There was no statistical difference in the inci-
dence of perioperative complication and death rate compared to
younger patients who suffered a 4.3% mortality and 16.6% mor-
bidity rate. Their mean hospital stay was 11.3%, also not statisti-
cal different.
Conclusions: Major liver resections can be safely performed in
elderly (70 years of age or older) with early results similar to those
in younger patients. Age by itself cannot be considered as a con-
traindication for surgery in the elderly patients who could bene-
fit from a liver resection.
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ATTENUATION OF INTESTINAL MUCOSA
INJURY FOLLOWING MAJOR HEPATECTOMY
WITH BIOARTIFICIAL LIVER AND IRON
CHELATING THERAPY
C. Nastos1, N. Arkadopoulos1, C. Kalimeris2, N. Papoutsidakis1,
G. Defterevos1, E. Kalogeropoulou3, A. Pafiti1, L. Zerva3,
D. Kipriotis1, C. Kostopangiotou1, C. Polizois1, G. Kabouroglou1,
G. Fragoulidis1, A. Papalois4, G. Kostopanagiotou2, V. Smirniotis1
1. 2nd Department of Surgery, Experimental-Reasearch Department,
University of Athens, Aretaieion Hospital, Athens
2. 2nd Department of Anesthesiology, University of Athens, Attikon
Hospital, Athens
3. Department of Biopathology, Attikon Hospital
4. Experimental–Research Center Elpen Pharmaceuticals, Athens,
Greece
AIM: Evaluation of the role of bioartificial liver (BAL) and des-
ferrioxamine treatment in the prevention of intestinal mucosa in-
jury after major hepatectomy.
METHODS: 18 female pigs were subjected to major hepatec-
tomy 60-70%, performed using the Pringle manouvre. To avoid
splachnic congestion and direct damage to the intestine, a side-to-
side portacaval shunt was constructed prior to hepatectomy. He-
patectomy was followed with a 150 minute ischemic period and 24
hours of reperfusion of the liver. Animals were randomly divided
into three groups. In group A (control) no treatment was in-
volved. In group B (BAL), animals received a 6 hour session of
bioartificial liver support starting 6 hours after reperfusion. In
group C (DFX) 3gr of desferrioxamine were intravenously in-
fused starting from ischemia, until the end of the experiment. In-
testinal microscopy was used to evaluate intestinal mucosal injury
(IMI). Bacterial translocation (BT) was assessed by quantitative
blood cultures and the levels of endotoxin in systematic and por-
tal circulation. Portal pressure was monitored in both groups. Sta-
tistical analysis was done using ANOVA.
RESULTS: IMI was significantly reduced in both treatment
groups (p<0,05). Quantitative blood bacterial cultures in portal
circulation showed fewer CFU/ml after 12 hours in both groups
and after 24 hours in the BAL group (p<0,05). Fewer CFU/ml
were also seen in the BAL group in systemic circulation at 24
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STANDARDIZED RADIOFREQUENCY ASSISTED
LIVER RESECTION FOR COLORECTAL LIVER
METASTASES
P. Bulajic, M. Milicevic, D. Basaric, D. Galun
First Surgical Clinic, Clinical center of Serbia
The aim of this video is to display the feasibility and efficiency of
a standardized radiofrequency assisted transection technique per-
formed during atypical liver resections for colorectal liver metas-
tases.
The highlights of this technique are:
a.) delineating topographical characteristics off the metastases
and their relation to the hepatic veins and Glissonian pedicles
by intraoperative ultrasonography; b.) designing the oncologically
radical
and tissue sparing transection plain, according to CT and intra-
operative ultrasonography findings; c.)a stay suture is placed
through metastasis to facilitate transection (traction and coun-
tertraction); d.) resection begins by desiccation of the liver
parenchyma at the point nearest to the presumed inflow routes at
least 1 cm away of metastases (20-30 mm long and 8-10 mm vide
cylindrical area of liver tissue) and immediate cut along the probe
through desiccated tissue by scalpel or scissors; e.) resection of
the liver is continued along transection plane by repeating desic-
cation and cutting sequences; f.) since transection is performed
through desiccated tissue the operative filed is free of blood and
transection is performed under direct visual guidance. g.)Surgical
margin (the margin left in situ on the remaining liver) is uniformly
desiccated. h.) hepatic inflow (Pringle’s maneuver) and outflow
occlusion, low central venous pressure anesthesia and the Tren-
delenburg position (patient in 15o head down position) were not
used at the time of liver parenchymal transaction. i.)Topical he-
mostatic agents were not used during and after liver resection.
The radiofrequency assisted liver resection performed in stan-
dardized manner: spare healthy liver parenchyma, ensures free
tumor margins and avoids blood loss.
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NEW CONCEPT OPERATION BY BENEFICIAL
GASTRORENAL SHUNT PRESERVING
DEVASCULIZATION IN THE UPPER STOMACH
FOR ESOPHAGOGASTRIC VARICES
H. Oya, Y. Sato, S. Yamamoto, T. Kobayashi, Y. Hara,
T. Watanabe, H. Kokai, K. Hatakeyama
Division of Digestive and General Surgery, Niigata University Grad-
uate School of Medical and Dental Sciences, Niigata, Japan
Background: Selective shunts such as distal splenorenal shunt
(DSRS) or left gastric vena caval shunt are the effective surgical
procedure for intractable esophagogastric varices. However, se-
lective shunt is hard for patients of poor hepatic function due to
its surgical stress. Spontaneous gastrorenal shunt preserving
devasculization in the upper stomach is a useful new method for
esophagogastric varices because of its simplicity using existing
shunt for drainage vein to vena cava.
Methods: New technique applied for three cases with intractable
esophagogastric varices and concomitant spontaneous gastrore-
nal shunt. Spontaneous gastrorenal shunt was proved by preop-
erative enhanced CT and angiography. All gastrorenal shunt as
drainage passed from the fundal varicous vein to the left renal
vein through the retroperitoneal root. Therefore, azygoportal dis-
connection was made by the dissection of the left gastric artery
and vein, the posterior artery and vein, and the short gastric ar-
tery and vein as supply. As a result, the gastrorenal shunt as “a
beneficial shunt” was preserved.
Results: Operation time was 225-301 minutes. Operative blood
loss was 166-640 ml. Hepatic encephalopathy after operation did
not occur in any case. Postoperative endoscopy revealed that the
risky varices improved extremely. Enhanced CT showed pre-
served gastrorenal shunt and disappearance of esophagogastric
varices.
Conclusions: This surgical procedure, which simply disconnects
between portal vein and varices, and preserves spontaneous ben-
eficial gastrorenal shunt, is expected as selective shunt such as
DSRS or left gastric vena caval shunt. Operation time can be
shorter than other selective shunts. Moreover, difficult technique
of producing new shunt is unnecessary.
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PATIENT AND HISTOLOGICAL FACTORS
INFLUENCING PRIMARY HEPATOCYTE
ISOLATION FROM SURGICALLY RESECTED
TISSUE
C. Pattenden1, C. Neal2, E. Porter1, S. Kingston3, D. Berry2,
A. MacGregor4, A. Dennison5
1. Department of Hepatobiliary and Pancreatic Surgery Leicester
General Hospital
2. Leicester General Hospital
3. UK Human Tissue Bank De Montfort University, Leicester
4. Leicester Royal Infirmary
5. University Hospitals of Leicester NHS Trust, United Kingdom
Studies of the effects of patient factors and histological abnor-
malities in non-tumour-bearing liver (NTBL) upon hepatocyte
isolation from tissue immediately post-hepatectomy have yielded
conflicting results. These correlations are pertinent to function
of the hepatic remnant and to attempts to culture hepatocytes for
use in biomedical applications. The aim was to explore correla-
tions between patient factors, NTBL histology and yield and via-
bility of hepatocytes isolated from NTBL in patients undergoing
hepatectomy.
PATIENTS AND METHODS: Informed consent was obtained
from patients undergoing hepatic resection between 2003 and
2005 with LREC approval. Patient factors and intraoperative
variables were recorded.
Following surgical excision of tissue, hepatocyte isolation was per-
formed using a two-stage collagenase digestion. Viability was as-
sessed using the Trypan blue exclusion test.
Blinded pathological review of the NTBL was performed using
established criteria for steatosis, steatohepatitis, fibrosis, sinu-
soidal injury and necrosis. Associations between patient factors,
liver injury and hepatocyte yield/function were determined using
the Chi-squared, Fisher’s exact and Mann-Whitney U tests.
RESULTS: 55 consecutive patients were included. No correla-
tion between patient factors and outcome or histology was
demonstrated. Cellular ballooning (a feature of steatohepatitis)
was significantly associated with decreased percentage digest
(P=0.047), but not viability. Other histological abnormalities
showed no correlation with isolation outcome.
Hepatocyte viability (per gram of tissue) showed no association
with initial tissue mass used for isolation, but was significantly as-
sociated with both total mass of digested tissue (P=0.013) and
the percentage of tissue successfully digested (P=0.002).
CONCLUSION: Neither patient factors nor histological out-
comes affect hepatocyte viability following hepatectomy.
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CYTOKINES CHANGES OBTAINED DURING
THE ISCHAEMIA-REPERFUSION INJURY
ELICITED BY EX-VIVO PERFUSED PORCINE
LIVERS
G. Gravante1, S. Ong1, M. Metcalfe1, R. Sorge2, G. Sconnocchia,
D. Lloyd1, A. Dennison1
1. University Hospitals of Leicester NHS Trust, United Kingdom
2. University of Tor Vergata, Rome
Objective: To evaluate the degree of inflammatory response gen-
erated by extracorporeal normothermic autologous hemoperfu-
sion of porcine livers.
Methods: Livers explanted from 7 pigs were perfused extracor-
poreally at 39 C with autologous blood. Serum samples were ob-
tained hourly until six hours from reperfusion and assayed for 9
different cytokines.
Results: A significant increase in IL-6 and IL-8 was noted fol-
lowing reperfusion (p<0.001), while the other cytokines showed
non significant variations over time. Both cytokines manifested a
sigmoid increase.
Conclusion: The ex-vivo model excludes the liver from the influ-
ence of factors such as hormones, autonomic nervous system or
regulatory substances produced elsewhere, allowing a clearer in-
terpretation of changes occurred. In such organ the
ischemia/reperfusion injury produced significant changes in IL-6
and IL-8 only, suggesting that these two cytokines are directly
produced by the liver after the reperfusion took place.
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SIMULTANEOUS RESECTIONS FOR
COLORECTAL CANCER AND LIVER
METASTASES. REVIEW OF SINGLE
INSTITUTION RESULTS
D. Fern ndez1, C. Vaccaro2, J. Salceda1, R. Sanchez Claria1,
J. Pekolj1, E. de Santiba es3
1. HPB section Hospital Italiano Buenos Aires
2. Colorectal section Hospital Italiano Buenos Aires
3. Surgery and Liver Transplant Unit Hospital Italiano Buenos
Aires, Argentina
Background: the optimal surgical strategy for the treatment of
synchronous resecable colorectal liver metastasis has not been
defined. The aim of this study was to review our experience and
outcomes with synchronous colorectal metastasis and to define
the safety of simultaneous resection.
Study design: Between June 1982 and June 2006 752 patients un-
derwent liver resection for colorectal metastases. Liver resection
was performed simultaneously with colorectal resection in 185
cases 24,6% (median age 63, range 16-86; 33.6% female). Clinic,
pathologic, operative, perioperative and oncologic outcomes
were reviewed.
Results: The median follow up was 35.5 months (r:16-83). Me-
dian hospitalization time was 8 days (r: 4-24). The median surgi-
cal time was 4 hours (r: 2-8). The Pringle maneuver was used
during liver resections in 36-185 patients (19.2%), with a median
time of 18.75 minutes (range. 5-45). During surgery, 62/185 pa-
tients (33.5%) required red blood cell transfusion and 25/185
(13.5%) required frozen fresh plasma, with a median of 2.1 IU
(range: 1-5) and 2.1 IU (range: 1-4) respectively. Morbidity was
21.3% and there were two postoperative deaths (within 30 days of
surgery). Recurrence occurred in 119/185 patients (63%). Sites
of recurrence were hepatic in 98 cases (52%), lung in 43 (22%),
peritoneal in 16 (8.5%), abdominal wall in 3 (1.6%), bone in 4
patient (2.1%) and 1 suprarenal recurrence. Overall survival time
(OST) at 3 and 5 years was 60.1%, 36.1% respectively, whereas
disease-free survival (DFS) at 3 and 5 years was 37.8% and
27.9%, respectively.
The node stage, CEA level, number of metastases, size and trans-
fusion were associated with prognosis.
The OST and DFS were statistically shorter in patients with a
more advanced node stage according to the TNM classification.
Patients with N0 had an OST at 3 and 5 year 56.8% and 44.8%
months, those with N1 had 65.9 and 41.5 months and patients
with N2 had 50.4 and 9.2 months respectively (p<0.02); the DFS
at 3 and 5 years was 38.7 and 30.3 months, 44.9 and 33.8 months
and 17.8 and 11.9 months respectively (p: 0.008). The OST and
DFS at 3 and 5 year when CEA was normal was 95 and 82% but
was 53 and 19% when was elevated more than 20 ng/dl (p:0.01).
The OST and DFS at 3 and 5 year for tumor less than 5 cm was
63 and 27 months and 39 and 28 months respectively, whereas for
tumors more than 5 cm the OST and DSF was 41 and 27 months
and 21 and 20 months (p:0.05). The OST at 3 and 5 year when
patient had less than two metastases was 41 and 21 months ver-
sus 26 and 14 months for patients with 3 or more respectively
(p<0.03). Also blood cell or plasma transfusion was associated
with prognosis. The OST at 3 and 5 years was 65.6% and 39.4%
when patients had no transfusion and was 50% and 29.8% when
received transfusion (p:0.04), the DFS at 3 and 5 years was 40%
and 30.1% versus 29.9% and 17.7% respectively (p:0.05).
Positive node status and high CEA level were statistically signif-
icant, associated with worse prognosis in both univariate and mul-
tivariate analysis. The number ol liver metastases more than 2,
tumors greater than 5 cm and transfusions also were statistically
significant associated with worse prognosis but only in univariate
analysis.
Conclusion: simultaneous colon and liver resection is safe and
efficient in the treatment of patients with colorectal cancer and
synchronous metastasis when is performed by a trained team,
avoiding a second laparotomy, with a low mortality and morbid-
ity rate and good results in the oncologic long term outcomes.
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RISK ANALYSIS FOR EXTENDED LIVER
SURGERY: COMBINATION OF VIRTUAL
RESECTION WITH INDIVIDUAL SUPPLY
AND DRAINAGE TERRITORIES
A. Schenk1, S. Zidowitz1, M. Hindennach1, C. Hansen2,
H. Peitgen1
1. Fraunhofer MEVIS, Bremen, Germany
2. Center for Medical Diagnostic Systems and Visualization (MeVis)
University of Bremen, Germany
Background: Liver surgery for extended tumour resections or live
donor transplantations often affects important vein tributaries.
In performing the resection, areas of the liver supplied and/or
drained by these vascular structures bear the risk of functional
loss or delayed regeneration.
Objectives: To optimize the computer-assisted planning of liver
surgery by adding a dedicated risk analysis of different resection
strategies that consider the patient’s individual vascular systems.
Methods: Based on radiological data (CT or MRI), all relevant
structures, i.e. liver, portal and hepatic veins, artery, and bile
ducts are reconstructed three-dimensionally. Resection lines are
drawn virtually and free-form on the liver surface or around tu-
mours and can be adapted in 3D but also on the 2D image slices.
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All vascular structures affected by the virtual resection are de-
termined automatically and the dependent supplying and drain-
ing regions with their respective volumes are computed and
displayed in 2D and 3D.
Results: Compared to the computation of supplying territories
following Couinaud’s scheme and the subdivision of the liver tak-
ing into account the three hepatic veins and accessory inferior
veins, our approach provides the individual resection plan with
additional information. It enables the surgeon not only to con-
sider the patient’s anatomy but also to assess the tributary risk of
all potentially ligated vascular structures.
Conclusion: The computer-assisted analysis of the individual re-
section plane allows for a more precise estimation of liver terri-
tories at risk and enables for the optimization of the surgical
strategy.
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RADIOFREQUENCY ABLATION OF
UNRESECTABLE LIVER TUMORS: FACTORS
ASSOCIATED WITH INCOMPLETE ABLATION
OR LOCAL RECURRENCE
A. Ayav1, L. Robert1, F. Marchal1, C. Bazin2, L. Brunaud1,
P. Boissel1, L. Bresler1
1. Dept of Surgery Nancy
2. Dept of Radiology Nancy, France
Introduction: Radiofrequency ablation (RFA) can be used to
treat unresectable liver tumors. However, there is a risk of either
incomplete ablation (IA) and/ or local recurrence (LR). In order
to assess factors associated with IA or LR, we retrospectiveley re-
viewed a series of patient that underwent RFA for unresectable
hepatic tumors.
Materiel and Methods: From January 2000 to March 2007, 311
lesions were treated in 163 patients. Patients, tumors details and
results were analysed retrospectively. Multivariate analysis was
performed to assess risk factors for IA or LR.
Results: Tumor pathology was 132(42%) hepatocellular carci-
noma (HCC) and 179(58%) colorectal liver metastases (CLM).
Mean tumor size was 24(±13) mm. 226 tumors were treated per-
cutaneously, and 85 by open approach (associated with liver re-
section in 42 cases). There was no mortality. Morbidity rate was
26%, of whom 9% were major complications (Clavien III and
IV). IA was present in 14% of cases and an extra 18,6% devel-
opped LR. Mean follow-up was 29 months. On multivariate
analysis, factors associated with IA were : tumor pathology
(HCC vs CLM, p=0.01), tumor size (>30mm vs <30mm,
p=0.004), approach (percutaneous vs open, p=0.0001). Factor
associated with LR was tumor size (>30mm vs <30mm, p=0.01).
Tumor location into the liver, proximity with bile ducts, vessels
and caspule were also analysed, and none of these items were as-
sociated IA or LR
Conclusion: Radiofrequency ablation for unresectable liver tu-
mors is most effective when treating small (<30mm). The risk of
incomplete ablation is higher when treating HCC percutaneously,
compared to CLM treated by open approach.
P 050
TRADITIONAL CLUMP CRUSHING
TECHNIQUE VERSUS LIGASURE VESSEL
SEALING SYSTEM IN LIVER RESECTION
M. Garancini, I. Mattavelli, F. Romano, L. Gianotti,
L. Degrate, R. Caprotti, A. Nespoli, F. Uggeri
Department of Surgery, San Gerardo Hospital, Italy
Background: Intra-operative blood loss and post-operative bile
leakage are major complications of liver surgery and their reduc-
tion is a major concern for hepatic surgeon.
Employment of new devices and application of new technologies
might be useful for liver surgeon to improve surgical outcomes.
Aims: The aim of this study was to compare the use of traditional
clump crushing technique versus a Bipolar Vessel Sealing Device
(LigaSure) for parenchymal transection.
Methods: A retrospective trial was performed to compare the
two techniques. From January 2003 to June 2008 a total of 100
consecutive patients underwent elective liver resection: 60 hepa-
tectomies were carried out using traditional clump crushing while
40 hepatectomies using LigaSure. Statistical significance was de-
fined as P<0,05.
Results: The two groups were well-matched for baseline and sur-
gical characteristics.
There was no statistically significant difference between clump
crushing group and LigaSure group in mortality (1,66% vs 2,5%),
mean operation time (192±75 min vs 206±70 min), mean blood
loss (900±500 ml vs 1124±406 ml), transfusion rate (48% vs
60,5%), mean transfusion units per patient (3,9±3,7 vs 3,9±2,5),
total morbility rate (26,6% vs 31,5%), bile leakage rate (5% vs
2,5%) and mean hospital stay (16±11 days vs 14±9 days). Post-
operative peak of transaminases , pseudocholinesterase and γGT
were statistically higher in LigaSure group meanwhile albumin
levels was statistically lower in LigaSure group.
Conclusions: LigaSure System and traditional clump crushing
are similar techniques in terms of major outcomes; Ligasure Sys-
tem seems to be correlated with an increased tissue damage at
the cut surface.
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RADICAL AND CONSERVATIVE RESECTION
FOR CENTRALLY LOCATED LIVER TUMORS
F. Botea1, F. Procopio2, A. Palmisano2, D. Del Fabbro2,
M. Cimino2, M. Donadon2, M. Montorsi1, G. Torzilli1
1. 3rd, Department of Surgery University School of Medicine – Hu-
manitas Clinical Institute IRCCS, Rozzano, Milan, Italy
2. Third Department of General Surgery University of Milan, IRCCS
Istituto Clinico Humanitas, Rozzano, Milan, Italy
Background. For liver tumors located in the adjacency of 1st/2nd
order portal branches major hepatectomy are usually performed,
sacrificing a large amount of functioning parenchyma, with sub-
sequent higher risk of postoperative liver failure and mortality.
Aims. To avoid major hepatectomies for centrally located liver
tumors using intraoperative ultrasound (IOUS) guided tech-
niques.
Methods. Out of 262 consecutive patients operated for 138 liver
tumors (median 2; mean 3.5; range 1-18), 40 patients had 47 cen-
trally located tumors. Twenty-three patients (with 24 central tu-
mors) had hepatocellular carcinoma and 17 patients (with 23
central tumors) had colorectal cancer liver metastases. Surgical
strategy was based on tumor-vessel relationship at IOUS and on
findings at IOUS color-Doppler.
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Results. Rate of major hepatectomies (more than 3 adjacent seg-
ments) was 10% (overall) and 7.5% (due to central tumors). In-
hospital mortality at 30- and 90-days was 0 and 2.5%, respectively.
The overall morbidity rate was 22.5%, while major complication
rate was 2.5%. The median hospital stay was 10 days (mean 11.5;
range 8–44). Blood transfusions were administered in 22.5% of
patients. After a mean follow-up of 12.6 months (median 20;
range 6-51), 7 patients died for systemic recurrence, 22 patients
are alive and disease-free, and 9 are alive with new liver lesions.
No cut-edge liver recurrences were observed.
Conclusions. IOUS-guided resection based on strict criteria al-
lows safe and effective surgical treatment for patients with cen-
trally located liver tumors, avoiding major liver resections in most
of them.
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SAFETY AND EFFECTIVENESS OF
SYSTEMATIC LONG-TERM DRAINS
MAINTENANCE AFTER HEPATIC RESECTION
M. Donadon1, F. Procopio1, M. Cimino1, A. Palmisano1,
D. Del Fabbro1, F. Botea2, M. Montorsi2, G. Torzilli2
1. Third Department of General Surgery University of Milan, IRCCS
Istituto Clinico Humanitas, Rozzano, Milan, Italy
2. 3rd, Department of Surgery University School of Medicine – Hu-
manitas Clinical Institute IRCCS, Rozzano, Milan, Italy
Background. The routine use of abdominal drains after hepatic
resection is a matter of debate as well as its long-term mainte-
nance. However, undetected bile leakage may be the source of
major morbidity, which may require interventional procedures or
even reoperations. The aim of this study was to investigate the
safety and effectiveness of the systematic long-term drains main-
tenance after hepatic resection for liver tumors.
Methods. We reviewed the records of 327 consecutive patients
who underwent hepatic resection at our Unit based on the same
prospective selection process. One-hundred-sixty-eight patients
(52%) had hepatocellular carcinoma, 105 (32%) had colorectal
liver metastases, and 54 (16%) had other malignancies. Each pa-
tient had abdominal drains placement, and those drains were
maintained for at least 7 days after surgery. The bilirubin con-
centration was systematically sampled in the drain in 3rd, 5th, and
7th postoperative day (POD)
Results. The median number of drains per patient was 2 (range
1-5). The 90-days mortality was 1%. The overall morbidity rate
was 17% and major morbidity occurred in 6%. The trend of the
bilirubin concentration showed that the bilirubin significantly in-
creased between the 3rd and the 5th POD (P<0.001), and then
significantly decreased at the 7th POD (P<0.001). Eight patients
(2%) had biliary fistula, which was conservatively treated by drain
maintenance. Only one patient (0.3%) required a percutaneous
drainage for a fluid collection developed after drains removal. No
infections or others drains-related complications occurred.
Conclusions. The late onset of biliary fistula justify the long-term
maintenance of drains after hepatic resection for liver tumors,
which is a safe and effective method in reducing the rate of un-
detected abdominal collections and in preventing postoperative
morbidity and mortality.
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GUIDANCE FOR DEVELOPMENT OF A
HIGH-QUALITY SURGICAL SERVICE FOR
HILAR CHOLANGIOCARCINOMA IN A
REGIONAL HEPATOBILIARY SURGERY
SERVICE
S. Jegatheeswaran, A. Sheen, A. Siriwardena
Hepatobiliary Surgery Unit, Manchester Royal Infirmary, Manches-
ter, UK
Introduction: Hilar cholangiocarcinoma (Klatskin tumour) pres-
ents a difficult surgical challenge. This study reports the devel-
opment of a surgical service for treatment of Klatskin tumours
within a regional Hepatobiliary (HPB) service.
Methods: Patients referred to a regional HPB service for treat-
ment of hilar cholangiocarcinoma are divided into two groups:
Group A patients from 2000-2004; Group B 2004-08. In the sec-
ond period there was an aggressive pro-active care policy com-
prising: obligatory percutaneous drainage of future remnant liver
± additional PTC of obstructed hemi-liver; MR angiography to
assess vasculature combined with radical surgery: station 12 hilar
lymphadenectomy, en bloc caudate resection and extended he-
patic resection. All patients were operated on by an individual
HPB surgeon (AKS). Statistical analyses were undertaken by
non-parametric tests.
Results: A total of 20 patients underwent attempted resection.
15 (75%) were tertiary referrals. During period A (n=11), 2
(18%) had bypass for failed resection and 4 (36%) had biliary re-
section alone. During period B (n=9), all had extended resection
with en bloc caudate resection and radical lymphadenectomy.
Overall there were 2 in-hospital deaths (one in each group) – 10%
overall mortality. Median survival in Group A was 10 (0-90)
months and in Group B, 5 are still alive and disease-free with me-
dian survival of 15 months overall [P = NS; Mann-Whitney U
test].
Conclusion: Modern HPB care combined with radical operative
technique can achieve promising results in the surgery of hilar
cholangiocarcinoma.
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THE EFFECT OF NEOADJUVANT
CHEMOTHERAPY OF COLORECTAL LIVER
METASTASES BEFORE SURGICAL
TREATMENT
A.Perrakis, N. Vassos, V. Schellerer, K. Weber, R. Croner,
W. Hohenberger, V. Muller
Surgical Department University of Erlangen-Nuremberg, Germamy
Purpose: Colorectal cancer is one of the most common maligna-
cies in the Western World and the liver is the most frequent site
of haematogen metastasis of colorectal cancer. 40-50% of all pa-
tients develops liver metastases in their cause of disease, while
15-25% has hepatic metastasis at diagnosis. However using the
current indications of surgery only 15-25% can be considered for
primary resection. By use of neoadjuvant chemotherapy the pro-
portion of patients eligible for surgical treatment can be increased
by downstaging of initially unresectable liver metastases. Under
this aspect the question arises, whether an application of
chemotherapy before operation increases the rate of postopera-
tive complications.
Methods: A retrospective study was undertaken of 68 patients,
who were subdivided into 2 groups of 34 patients each: noeadju-
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vant chemotherapy before liver resection (Group 1) vs. primary
resection (Group 2) matched according to following criteria: age,
number of metastases und surgical technique.
Results: All patients underwent a R0-resection.
The overall rate of postoperative complications (seroma, pneu-
monia, pleura effusion, blood loss) in group 1 was 23% (8 of 34
patients) and in group 2 26% (9 of 34). Major complications such
as liver failure and renal insufficiency were registered in 6% in
both groups.
Conclusions: Generally liver resection following neoadjuvant
treatment is a safe procedure. As far as the chemotherapy related
liver damage (steatohepatitis, venous occlusive syndrome) is con-
cerned, the optimal interval between end of chemotherapy and
resection has to be found in order to minimize such complica-
tions.
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LIVER MOBILISATION DURING LIVER
RESECTION AS STANDARDIZED
TRANSLATIONAL MODEL TO STUDY
INTRA-OPERATIVE INTERVENTIONS IN
HUMANS
M. van de Broek, V. Nguyen, M. van de Poll, M. Bemelmans,
R. van Dam, W. Buurman, C. Dejong, S. Olde Damink
Department of Surgery Maastricht University Medical Centre, The
Netherlands
Background: Innovations in liver surgery aiming at a reduction of
hepatocellular injury to prevent liver failure and need to be
tested. However, variations in e.g. ischemic time or blood loss are
founding factors hampering their translation.
Aims: To validate liver mobilization during liver surgery as re-
producible, standardized model to study interventions in humans.
Patients and methods: Consecutive patients undergoing liver
surgery requiring liver mobilization were included. Arterial
plasma samples were obtained just after induction, directly after
exposure and prior to and directly after liver mobilization and
after liver transection. Liver Fatty Acid Binding Protein (L-
FABP) was analyzed as marker of hepatocyte injury and inter-
leukin-6 (Il-6) as marker of inflammation. Wilcoxon’s signed rank
test was used to analyse differences.
Results: Nineteen patients were included (11M/8F, median age
64 years [30 – 79]) who underwent a right hemihepatectomy
(n=11), central liver resection (n=4) or segmental resection
(n=4). Liver mobilization took 60 minutes (25-180). L-FABP lev-
els increased significantly during liver mobilization (from 91.7
ng/mL [11.4 – 2212.5 ng/mL] to 1014.4 ng/ml [141.4 – 8986.1
ng/mL], p<0.001) and didn’t increase significantly thereafter
(1315.2 ng/mL [67.0 – 20099.2 ng/mL], p=0.75). When mobiliza-
tion time was ≥ 60 minutes, L-FABP levels were significantly
higher after mobilization (645.9 ng/mL versus 1679.7 ng/mL,
p=0.04) and Il-6 levels at the end of surgery (297.0 ng/L versus
763.7 ng/L, p=0.03).
Conclusion: Liver mobilization during liver surgery induced pro-
found hepatocyte injury, which did not significantly increase
thereafter. Therefore, liver mobilization offers a good standard-
ized model to study interventions aiming to reduce hepatocellu-
lar injury during liver surgery.
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PREDICTIVE FACTORS OF HEPATECTOMY
IN THE MANAGEMENT OF POST-
CHOLECYSTECTOMY BILIARY INJURY
S. Truant1, E. Boleslawski1, G. Sergent2, L. Gambiez1, F. Pruvot1
1. Service de Chirurgie Digestive et Transplantations CHRU LILLE
2. Service de radiologie CHRU LILLE, France
Objective: To analyze through our experience and a literature re-
view the predictive factors of hepatectomy in the management of
post-cholecystectomy bile duct injuries (BDI).
Summary Background Data: In this setting, indications for hepa-
tectomy are variable from one center to the other.
Methods: The literature review was obtained by searching
PubMed database and bibliographies of extracted articles. He-
patectomies performed for BDI in our Department were ex-
tracted from a prospective computerized database. To avoid bias
selection, predictive factors of hepatectomy were analyzed in two-
way series reporting both cases of hepatectomy (group hepatec-
tomy) and cases of biliary repair without hepatectomy (group no
hepatectomy). Variables of interest were: complex injuries (he-
patic artery and/or portal vein and/or Strasberg E4-E5 injury), la-
parotomy before referral and previous biliary reconstruction.
Results: Among 460 potentially relevant publications, only 31
met eligibility criteria. A total of 99 hepatectomies were reported
among 1756 (5.6%) patients referred for post-cholecystectomy
BDI, including our 3 own cases. Variables of interest were in-
formed in 7 two-way series comprising 232 patients. In logistic re-
gression multivariate analysis, hepatic arterial and Strasberg
E4-E5 injuries were independent predictive factors for hepatec-
tomy. Patients with combined arterial and Strasberg E4-E5 in-
jury were 43.3 times as likely to undergo hepatectomy (95% CI:
8 – 234.2) in comparison with patients without complex injury.
Despite a high postoperative morbidity, hepatectomies provided
a good long-term outcome in two thirds of patients.
Conclusions: Hepatectomies were performed mostly in cases of
complex concurrent Strasberg E4-E5 and hepatic arterial injuries
and provided good long-term outcome despite high postopera-
tive morbidity.
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LIVER-UPTAKE OF INTERLEUKIN-6 IN
HUMANS DURING LIVER RESECTION
S. Dello, J. Bloemen, M. van de Poll, J. Stoot, M. van den Broek,
V. Nguyen, S. Olde Damink, W. Buurman, C. Dejong
Surgery Maastricht University Medical Center, The Netherlands
Background: Liver resection causes an inflammatory response
which leads to increased systemic levels of interleukin-6 (IL-6). It
has been proven that the hepatosplanchnic area is responsible for
IL-6 uptake. The aim of this study was to investigate which of the
splanchnic organs (portal drained viscera and liver) are respon-
sible for IL-6 uptake during liver resection.
Methods: 13 Patients who underwent liver resection for liver
metastases were included. During surgery blood was sampled se-
lectively from the radial artery and the hepatic and portal vein at
different time points during the operation. IL-6 concentrations
were measured with a commercially available ELISA-kit. Arteri-
ovenous gradients were calculated to assess IL-6 exchange across
the liver, gut and splanchnic area. The hepatic inflow was con-
sidered to consist of 30% arterial blood and 70% portal blood.
Results: Thirteen patients (m:f, 6:7) with a median age of 64 (51-
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74) were included. Arterial plasma IL-6 markedly increased after
start of the transection until 480 min after start of surgery; 36 (11)
ng/l to 810 (230) ng/l (p<0.05) respectively. Net release from the
gut was 194 (44) ng/l, whereas the net IL-6 uptake by the liver
equalled 93 (38) ng/l (p<0.05). Splanchnic IL-6 release was 42
(32) ng/l (p>0.05).
Conclusion: We have demonstrated for the first time that the gut
is responsible for release of IL-6 and that the liver is responsible
for uptake of IL-6 in humans during liver resection. The removal
of IL-6 by the liver may constitute a mechanism limiting possible
negative effects of excessive IL-6 levels.
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ADDING PARACETAMOL FOR PAIN RELIEF
AFTER LIVER RESECTION. A RANDOMIZED
CONTROL TRIAL
E. Kapota1, L. Baltatzi1, A .Hatziperi1, V. Aroni1, A. Kouta2
1. Konstadopouleio General Hospital
2. Department of Anaesthesia Konstadopouleio General Hospital,
Athens, Greece
Background of study: Postoperative pain control for liver resec-
tion is a controversial issue (1).
Aim: In this randomized control trial, we evaluated the effect of
adding paracetamol to a standard morphine regimen on postop-
erative quality of analgesia and return of bowel function.
Methods: 20 patients undergoing liver resection were randomly
allocated in two equal groups. At peritoneal closure, Group P
(paracetamol) received a loading dose of morphine 0,15 mg/kg
plus paracetamol 1 gr intravenously where as group C (control)
received just morphine. On arrival at the postanaesthesia care
unit, patients were connected to the PCA (patient control anal-
gesia) morphine pump. In group P, paracetamol 1 gr every 6
hours was continued post-operatively.
Results: Patients did not differ significantly regarding sex, age,
weight and ASA score. Pain scores at rest and during coughing at
1, 8 and 16 postoperative hours were not significantly different.
At 24 h, patients in group P experienced less pain during cough-
ing (p: 0,024). We also observed that PCA morphine consump-
tion was significantly less in group P at 8, 16 and 24 h. (p: 0,01,
p<0,001, p<0,001 respectively). Episodes of nausea and vomit
were less frequent in group P but not at a significant level. How-
ever, time to first passage of flatus was significantly reduced in
group P (p: 0,012). Prothrombin time and total bilirubin were in-
creased equally in both groups at 24 h postoperatively.
Conclusions: In our study, paracetamol at a dose of 1gr every 6
hours has a morphine sparing effect without causing any adverse
effects.
References:
1) Remy C, Marret E, Bonnet F. Effects of acetaminophen on
morphine side-effects and consumption after major surgery:
meta-analysis of randomized controlled trials. Br J Anaesth 2005;
94:505–13
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BLUNT LIVER TRAUMA: EVOLUTION AND
EFFECTIVENESS OF NON OPERATIVE
MANAGEMENT IN 99 CONSECUTIVE CASES
G. La Greca, S. Gagliardo, M. Sofia, F. Sparatore, A. Ricotta,
S. Latteri, G. Castello, A. Di Stefano, D. Russello
University of Catania, Italy
BACKGROUND: All patients haemodynamically stable, with
blunt abdominal trauma, can be managed conservatively by non-
operative management (NOM) that represents the treatment of
choice in 80% of liver trauma. When feasible NOM leads to very
good results in terms of survival, morbility and reduction of hos-
pital stay. METHOD. The Authors retrospectively analysed their
recent experience with liver trauma. RESULTS. In the period
1998-2008 among 99 patients with blunt liver trauma, 45 (45.4%)
underwent a surgical treatment whereas 54 (54.6%), haemody-
namically stable had a NOM. After CT scan all patients with
NOM (61.1% ≥ III degree) underwent a monitoring by US and
blood examinations. We recorded a mortality of 0 %, 1.8% (1 pa-
tient) morbidity and only 3 patients (5.5%) underwent a haemo-
transfusion. Effectiveness of NOM has been 100 % and only 1
patient underwent a successive surgical treatment (to effected 4
days later owing to the continual hepatic haemorrhage). CON-
CLUSIONS. Our clinical experience demonstrated that NOM is
feasible and effective even for higher degree trauma, but it al-
ways needs a severe clinical monitoring and a good selection of
patients. This experience confirms the importance of the initial
valutation for the choise of NOM and to achieve optimum suc-
cess, even in 100% of cases, is due to correct application of se-
lection’s criteria. Furthermore, in the last five years (2003-2008)
we observed an increasing in NOM (75% vs 36.4% in the period
1998-2003) due to a better knowledge of fisiopathological mech-
anisms and improvement in diagnostic examinations. Further
studies will probably lead to a spreading of NOM in liver trauma.
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SAFETY OF MAJOR LIVER RESECTION IN THE
ELDERLY: INSTITUTIONAL EXPERIENCE
O. Damrah, V. Pamecha, R. Koti, S. Rahman, D. Sharma,
K. Rolles, B. Davidson, G. Fusai
Royal Free Hospital, London, United Kingdom
Background: Liver resection has traditionally been thought to
have a high morbidity and mortality rate among the elderly. We
hereby analyze the impact of patient age on postoperative out-
come and long term survival following major hepatic resection.
Methods: Between December 1998 and April 2006, 109 patients
underwent major liver resection (≥3 liver segments) for colorec-
tal metastasis. Portal vein embolization preceded resection in
cases of insufficient predicted remnant liver volume. Patients
were divided into 2 groups; group I (Age<70 years), and group II
(age>70 years).
Results: Group I included 75 patients, aged 58±8.3 years (range:
32-69 years), and group II included 34 patients, aged 74 ± 3.2
years (range: 70–83 years). Both groups were comparable with
regard to sex distribution, site, number and size of liver metasta-
sis, as well as the percentage of patients who underwent preop-
erative portal vein embolization and who received adjuvant
chemotherapy. The length of hospitalization was similar ( me-
dian, range: 18 days, 8–60 days in group I and 16 days, 7–53 days
in group II ) (P=0.8). Postoperative complications occurred in
Abstracts 69
23% and 24% of patients in group I and group II respectively
(P=1.0). Patients in group I had a mortality rate of 1.3%, which
was similar to group II; 2.9% (P=0.5). Survival analysis revealed
a mean survival of 68 months for patients from group I and 59
months for group II patients (P = 0.2). The 1-, 3-, and 5-year sur-
vival rate for patients in group I and II were 88%, 62%, and 48%,
and 84%, 64% and 43% respectively (P=0.5).
Conclusion: In appropriately selected patients, age is not a con-
traindication when major liver resection is indicated.
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C-VITAMIN STATUS IN THE PATIENTS WITH
ACUTE PANCREATITIS
D.B Demin
Orenburg State Medical Academy, Orenburg, Russia.
Initiation of lipoperoxcidation in acute pancreatitisis (AP) one
of the key patogenetic moments that leads to the quick exhaus-
tion of antioxidant system, first of all ascorbic acid (AA), the main
blood plasma antioxidant. Severe AP is known by tens times drop
in AA concentrated in blood.
Goal. Study C-vitamin status of the patients with the acute pan-
creatitisis
Methodology. 90 patients with the AP were splited into 2 groups
of 45 people each. People in Group 1 received standard therapy
(nfusions, blockade of the pancreatic secretion, spasmolytics and
antibiotics). At Group 2 was daily performed 2000 mg. intra-
venous drop injection of 5% AA solution. AA concentration in
blood serum of both groups was tested by method with the
reagent Folin on the 1st, 3rd, 5th, 7th, 10th, and 20th day of the
illness. The results of blood tests of 20 practically healthy people
blood-donors 27 - 40 years of age were taken as a model. The nor-
mal concentration of AA in blood serum was 3,4±0,29 mg\%.
Results. When being brought to hospital all patients had AA
concentration in blood 4 - 6 times lower than normal (p<0,01).
Patients of Group 1 had AA deficit all experiment long, and the
tendency to reconstruction was not noticed. In Group 2 the level
of AA began to grow since the 5th day of treatment. It became 2
times higher (p<0,01) than in Group 1 by 10 – 14th day. But it
was still less than normal. Progress of AP was testified in 19 per-
sons (42,2%) of Group 1 and in 10 persons (22,2%) of Group 2,
and that made evident the necessity of laparoscopic treatment..
The extent of laparoscopic treatment is the examination, drainage
of belly cavity and omental bursa, 12 patients of Group 1 (42,2%)
had pancreatic necrosis, 7 (15,6%) - oedomatic pancreatitis, the
same had 7(15,6%) and 3 (6,6%) people in Group 2. After oper-
ation all patients received treatment provided in their groups. La-
parotomy was performed at 8 people (17,8%) of Group 1 for
purulent process in omental bursa and retroperitoneum. Lethal
outcome in 4 (8,8%) persons, by all was carried out laparotomy.
The reason of death is pancreatic abdominal sepsis with multiple
organ failure. In Group 2 laparotomy was performed at 1 person
(2.5%) a month after laparoscopy because of the break of the
forming cyst of pancreas into the belly cavity. There were no pu-
rulent complications nor lethal outcome. In 6 people (13.3%) of
Group 2 postnecrotic cysts of big size were formed and they were
drainaged under ultrasonographic examination.
Conclusions. This shows that the AP is accompanied by clearly
seen reduce of AA level in blood, that is the serious factor of the
disease progress. Using the high dose of the AA improves the re-
sults of the AP treatment by getting in some cases the phenome-
non of break, localization of the process and providing it in the
aseptic way.
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PANCREATODUODENECTOMY IS A SAFE
PROCEDURE IN ELDERLY
M. Frasson1, M. Braga1, A. Zerbi2, G. Balzano2, A. Beneduce1,
V. di Carlo3
1. San Raffaele University, Milan, Italy
2. Pancreas Unit, Dept. of Surgery S. Raffaele Scientific Institute,
Milan, Italy
3. San Raffaele University IRCCS San Raffaele,Milano
Background: Pancreatoduodenectomy is still a challenging sur-
gical procedure, because of technical difficulties, high morbid-
ity and mortality rate, especially in low-volume hospitals.
Therefore, elderly patients are often not considered eligible to
pancreatoduodenectomy, depriving them of a chance for cure.
Aim: To assess the impact of advanced age on short-term out-
come after pancreatoduodenectomy.
Methods: Between January 2000 and April 2008, 573 patients un-
derwent pancreatoduodenectomy, either for benign or malignant
disease. In all patients demographics, nutritional parameters, pre-
operative haemoglobin, ASA score, intraoperative blood loss,
pancreatic stump features, transfusions, length of stay, cancer
stage, morbidity and mortality were registered prospectively. Ac-
cording to age, patients were divided into four groups: < 70 years
old (n=370), 70-74 years old (n=113), 75-79 years old (n=54),
≥ 80 years old (n=36).
Results: Lower preoperative haemoglobin levels ( p= 0.04 ),
higher malignancy rate ( p< 0.001), higher ASA score (p< 0.001)
and greater Wirsung duct diameter ( p= 0.04) were associated
with increasing age. Other preoperative and intraoperative pa-
rameters were not different among the four groups. In the four
groups postoperative mortality rate was 3.0%, 3.5%, 5.5% and
2.8%, respectively (p=0.79), overall morbidity rate was 53.8%,
61.9%, 63.0 and 58.3%, respectively
( p=0.34), mean length of stay ( days) was 16.7, 17.9, 17.9, and
19.8, respectively (p=0.38) .
To assess independent morbidity and mortality risk factors, a
multivariate regression analysis was carried out in the whole co-
hort of patients. Perioperative transfusion rate ( p= 0.001), pan-
creatic stump texture ( p = 0.001) and Wirsung duct diameter (
p= 0.01) were correlated to morbidity. Only pancreatic stump
texture (p= 0.03) was correlated to mortality.
Conclusions: Pancreatoduodenectomy is a safe procedure in eld-
erly patients and should be considered as a therapeutic option
even in octogenarians.
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THE CLINICAL MANAGEMENT AND
OUTCOME OF HEMORRHAGE AFTER
PANCREATICODUODENECTOMY: RESULTS
IN A CONTINUOUS SERIES OF 755 PATIENTS
M. Dal Molin1, G. Butturini2, S. Partelli1, L. Casetti1,
G. Mansueto3, F. Scopelliti1, C. Bassi1, P. Pederzoli1
1. Surgical Department, Verona University
2. Surgical and Gastroenterological Department, Verona University
3. Radiological Department, Verona University, Italy
Background: Hemorrhage after Pancreaticoduodenectomy (PD)
may be a dramatic complication and a standardized management
is still unavailable.
Aim: To assess the risk factors involved in the development of
hemorrhage, the outcome of surgical or conservative approach
or the combined use of both techniques, the impact of hemor-
rhage in favour further complications.
Methods: Perioperative features of patients undergone PD from
1996 to 2006 were prospectively collected. Success rate of inter-
ventional angiography and surgery in arresting the hemorrhage
were analyzed as well as hemorrhage-related overall outcome.
Results: Postoperative hemorrhage occurred in 48 out of 755 pa-
tients (6.3%). Among 30 severe hemorrhages 16 had an early
bleeding. Hemorrhage was closely related to the occurrence of
pancreatic fistula. Surgical reintervention, which was performed
in all patients with severe early bleeding, was successful in all
cases but one. All patients with delayed hemorrhage underwent
to surgical reexploration and 6 of them had also interventional
angiography, but a subsequent surgical procedure was necessary
to treat a recurrence or an infected collection. Overall mortality
rate of PD was 1.3%, but among the hemorrhagic group of pa-
tients rises to 10%. Both early and delayed forms prolonged the
duration of the hospital stay, compared to non-hemorrhagic pa-
tients (median 20.5 and 33 days respectively vs. 12 days).
Conclusion: Prognosis of hemorrhage after PD depends on a
prompt diagnostic devices such as CT scan and an aggressive ther-
apeutical strategy with interventional angiography and surgery
combined. Even if successfully treated they are often productive
of further complications and a prolonged in-hospital stay.
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QUALITY OF LIFE AFTER ADJUVANT
INTRA-ARTERIAL CHEMOTHERAPY AND
RADIOTHERAPY IN RESECTABLE
PANCREATIC AND PERIAMPULLARY CANCER
C. Pek1, M. Morak2, E. Kompanje3, W. Hop4, G. Kazemier2,
C. Eijck van1
1. Surgery Erasmus Medical Center
2. Dep Surgery Erasmus Medical Centre
3. Intensive Care Erasmus Medical Center
4. Dep Statistics Erasmus Medical Centre, Rotterdam, The Nether-
lands
Background: Adjuvant therapies in pancreatic and periampullary
cancer have been shown to achieve only marginal survival bene-
fit. In a randomized controlled trial, 120 patients with pancreatic
or periampullary cancer after surgery received either adjuvant
celiac axis infusion and radiotherapy (CAI/RT) or no adjuvant
treatment.
Aim of the study:To compare Quality of Life (QoL) in patients
receiving intra-arterial chemotherapy and radiotherapy
(CAI/RT) after pancreatoduodenectomy with QoL in patients
without postoperative adjuvant treatment.
Methods: During and after CAI/RT, QoL was assessed using the
European Organization for Research and Treatment of Cancer
Quality of Life Questionnaire C30 (EORTC QLQ-C30) every 3
months during the first 24 months after randomisation.
Results: Eighty-six per cent (n=103) of the patients completed
one or more questionnaires, 51 in the treatment arm and 52 in
the observation arm. In total, 355 questionnaires were completed.
CAI/RT did not impair physical, emotional or social functioning.
During and after CAI/ RT, patients had significantly less pain
(p=0.02; mean difference 9.7 points) and significantly less nausea
and vomiting (p=0.01; mean difference 5.9 points). Overall QoL
(global functioning) tended to be better (p=0.08; mean differ-
ence 6.5 points) after CAI/RT.
Conclusion: CAI/RT did not impair QoL after pancreatoduo-
denectomy for pancreatic or periampullary tumours and was even
improved during the second half of the follow-up.
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TNM STAGING OF NEUROENDOCRINE
TUMORS - CLINICO-PATHOLOGICAL
ANALYSIS OF INSULINOMAS
C. Eisenberger1, A. Raffel1, M. Krausch1, K. Cupisti1, M. Schott2,
W. Knoefel1
1. University Hospital Duesseldorf Department of General Surgery
2. University Hospital Duesseldorf Department of Endocrinology,
Germany
Aims: Insulinomas are the most common pancreatic endocrine
neoplasms. The 2004 WHO - classification established criteria
wich define prognostic subgroups of pancreatic endocrine tumors
(PET) as insulinomas. Although the classification is quite new,
further efforts are necessary to improve the prognostic assess-
ment. The first TNM classification was proposed and published
in 2006 by a consensus conference in Rome. The aim of our study
was to validate the classification by a larger series of insulinomas.
Methods: A series of 142 patients suffering from persistent hy-
poglycemic hyperinsulinism (PHH) caused by sporadic PET was
analyzed.
Results: Metastatic disease and tumour survival statistically corre-
lated with the TNM classification. The antigen Ki-67-level (MiB-
1), as one of the important markers of the grading system (G1-3),
was highly significant in a series of statistical analysis in our study
(Cox regression – p = 0.00016; Likelihood ration test – p = 0.00339;
Wald test – p = 0.00159; Lok-rank test – p = 0.000271).
Conclusions: Our results from 142 patients suggest the new TNM
classification for sporadic insulinomas. So far the new TNM sys-
tem of PET`s is a valuable tool for staging of insulinomas.
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REFINING THE ROLE OF LAPAROSCOPIC
ULTRASOUND FOR THE STAGING OF
PANCREATIC CANCER
M. Barabino1, R. Santambrogio2, A. Pisani Ceretti1, R. Scalzone1,
M. Costa1, E. Opocher1
1. HPB Surg Unit san paolo hospital University Milan
2. HPB Surg Unit San Giuseppe Hospital University Milan, Italy
Aim of the study: To compare our laparoscopic ultrasonography
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(LUS) - experience in the resectability evaluation of pancreatic
tumours in two different periods: the first period (Step 1) be-
tween 1995-1999 in which we performed LUS to all patients with
pancreatic tumours, and the second period (Step 2) between
2002-2007 in which only selected patients with a suspect of unre-
sectability underwent LUS.
Methods: In Step1 40 patients were enrolled and studied with
monodetector cross sectional imaging. Twenty-two cases were
considered to have resectable tumors, and 18 to have suspect un-
resectable tumors. In Step 2, 64 patients were enrolled and stud-
ied with multidetector CT imaging (MDCT). LUS was performed
to 9 patients with suspect of unresectable disease according to
Pister’s criteria [1] (suspect of liver or peritoneal metastases, tu-
mour larger than 4cm, tumour of the pancreatic body and tail, as-
cites).
Results: LUS was satisfactory performed in all cases. The first
STEP LUS’sensitivity, specificity and accuracy in prediction of
resectability, was respectively 100%, 91-94% and 95-96%. Oth-
erwise LUS was not effective in predicting vascular encasement
when there was a contact between vein and tumour with a sensi-
bility of 57%. In the second study, selective LUS was performed
in 9/64 patients (14%). LUS confirmed unresectability based on
MDCT data, in 8/9 cases (88,9 %) and allowed curative resection
in 1 case (11,1 %). In patients not submitted to LUS only 1/55 of
them (1.8%) would have benefied of procedure. The yield of
LUS, meant to its capacity in identification of radiographically
occult unresectable disease, decreased during the time of the
study (from 45% to 2.2% before and after MDCT). Moroever
pancreatic cancer primary site was the only factor associated with
a marked higher percentage of yield of the LUS.
Conclusion: The current high performance of Multidetector CT
scanners contributed to the incoming downward trend in the yield
of LUS in this last decade [2]. Thus when there are no re-
sectability MDCT doubts, routinary application of LUS is un-
justified and cost-uneffective. On the contrary in front of suspect
of unresectability according to manifold criteria (Pister’s criteria,
pancreatic primary site, high level of CA 19.9), LUS plays an im-
portant role [3]. Up against close vascular contact neither MDCT
nor LUS seem to be diriment and laparotomy reveals yet to be
the only keystone.
Pisters PWT, Lee Je, Vauthey Jn, et al. Laparoscopy in the stag-
ing of pancreatic cancer. Br J Surg Vol 88 :325-337; 2001
White R, Winston C, Gonen M, D’Angelica M, Jarnagin W, Fong
Y, MD Conlon K, Brennan M, Allen P. Current Utility of Stag-
ing Laparoscopy for Pancreatic and Peripancreatic Neoplasms. J
Am Coll Surg Vol. 206: 445-450; 2008
Thomson BNJ, Parks RW, Redhead DN, Welsh FKS, Madhavan
KK, Wigmore SJ and Garden OJ. Refining the role of la-
paroscopy and laparoscopic ultrasound in the staging of pre-
sumed pancreatic head and ampullary tumours. British Journal of
Cancer. 2006;94:213-217
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POLY(A) CDNA REAL-TIME PCR IN
PANCREATIC DUCTAL JUICE IN PATIENTS
UNDERGOING PANCREATICODUODENECTOMY
M. Oliveira-Cunha1, A. Sheen1, R. Byers1, A. Siriwardena2
1. Hepatobiliary Surgery Unit, Manchester Royal Infirmary, Man-
chester, UK
2. Department of Histopathology, Manchester Royal Infirmary,
Manchester, UK
Background: Currently there is much emphasis on earlier diag-
nosis of pancreatic cancer. Pancreatic juice collected during
ERCP may be a potentially useful biological fluid.
Aim: to explore the feasibility of cancer genome study by the iso-
lation of RNA from ductal juice.
Methods: With informed consent, intra-operative sampling of
pancreatic juice was undertaken in 27 patients undergoing pan-
creaticoduodenectomy for suspected tumour. Total RNA was ex-
tracted using proprietary system: Isogen LS ® (Wako) and
Rneasy ® (Qiagen). The RNA isolated was then quantified by
Nanodrop analysis and RNA integrity by Bioanalyzer. We per-
formed Poly(A) PCR on RNA isolated following standard pub-
lished protocols. Finally real-time PCR was performed for genes
in a subset of samples. Samples were normalized for 3 reference
genes (GAPDH, PSMB6 and B2M). The genes of interest were:
TFF2, CPB1 and KLK3).
Results: The median volume of pancreatic juice obtained by
intra-operative aspiration was 1245µl (range from 50 to 5000µl).
The median RNA yield was 3.90 hg/ml (range from 4ρg/µl to
57hg/ml). RNA Integrity Number ranged from 1.9 to 10. RT-PCR
was positive for pancreas specific genes (TFF2 and CPB1) and
negative for PSA in all samples.
Conclusions: These results demonstrate that RNA analysis of
pancreatic juice can be further investigated using PolyA cDNA
technique. Once PolyA PCR has been applied, the resulting
PolyA cDNA can be expanded to produce an essentially perma-
nent archive of representative cDNA suitable for screening with
multiple gene-specific probes, thereby representing a “molecular
block”, of importance for future research.
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GEMCITABIN, CISPLATIN AND
TEGAFUR-URACIL FOLLOWED BY
TEGAFUR-URACIL BASED CHEMORADIATION
FOR LOCALLY ADVANCED PANCREATIC HEAD
ADENOCARCINOMA
N. Legall1, R. Brunet1, L. Votron1, A. Rault2, B. Masson2,
A. Sa Cunha2
1. Institut bergonié
2. CHU BORDEAUX, France
Purpose: We conducted a phase II trial of gemcitabine, cisplatin
and Tégafur-uracil chemotherapy in addition to chemoradiation
(Tégafur-uracil- radiotherapy) for patients with T3/T4 pancreatic
adenocarcinoma.
Patients and methods: Chemotherapy consisted of gemcitabine
(1000 mg/m2 day 1 and 15), cisplatin (60 mg/m2 day 2) and tega-
fur-uracil (300mg/m2 day 1 to day 7) given every to weeks for
twelve doses. Chemoradiation consisted of tegafur-uracil
(250mg/m2 day 1 to day 5) combined with standard-fractionation
radiation therapy (50-54 Gy during 5 weeks). Patients underwent
restaging after completion of chemotherapy and 4 weeks after
completion of chemoradiotherapy. In the absence of disease pro-
gression, patients underwent surgical exploration to determine
whether the tumor was resectable.
Results: The study enrolled 25 patients (T4: n=21, T3 (portal or
superior mesenteric vein encasement): n=4). Twenty-three
(92%) patients completed chemotherapy and chemoradiation.
Nineteen (76%) of 25 patients were taken to surgery and 12
(48%) of 25 underwent PD. Eight patients (38%) of 21 patients
with initially no resectable tumor (T4) underwent PD.
The median overall survival of all 25 patients was 15.4 months.
Median survival for patients who underwent PD was 25 months
and 11 months for the patients who did not undergo surgical re-
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section of their pancreatic adenocarcinoma. (P=0.029).
Conclusion: This trial confirmed that locally advanced, unre-
sectable pancreatic adenocarcinoma, may be downstaged by
chemotherapy following by chemoradiotherapy to allow for sur-
gical resection. The encouraging resection rate and overall sur-
vival observed in this trial supports the investigation of
chemotherapy following by chemoradiotherapy in locally ad-
vanced pancreatic adenocarcinoma.
P 069
LEAKAGE OF GASTRO-ENTERIC AND
ENTERO-ENTERIC ANASTOMOSIS AFTER
PANCREATIC SURGERY
W. Eshuis1, N. van der Gaag1, C. Nio2, O. Busch1, T. Van Gulik1,
D. Gouma1
1. Department of surgery Academic Medical Center
2. Department of Radiology Academic Medical Center, The Nether-
lands
Background: Common anastomotic complications after pancre-
atic surgery are leakage from the pancreaticojejunostomy or he-
paticojejunostomy. Leakage from enteric anastomosis after
pancreatic surgery is rarely described.
Aim: To evaluate the incidence, presentation, treatment and out-
come of enteric anastomosis leakage.
Methods: Between 1992 - September 2008, 1141 consecutive pa-
tients underwent exploration in our hospital for pancreatic head
or periampullary tumor. Discharge notes, radiologic investiga-
tions and relaparotomy operation notes were evaluated to iden-
tify patients with leakage of gastrojejunostomy (GJ),
duodenojejunostomy (DJ) or jejunojejunostomy (JJ). Clinical
presentation, radiological findings, treatment and outcome were
analyzed.
Results: Eight (0.7%) patients had enteric anastomosis leakage;
six (DJ 5, GJ 1) of 764 pancreatoduodenectomy patients, and two
(GJ 1, JJ 1) of 377 palliative bypass patients. Median postoperative
day of diagnosis was 9 (range 2-23). Clinical signs included tender
abdomen, fever, high (enteric) drain output and enterocutaneous
fistula. Median peak white blood cell count before diagnosis was
14.6 x109/L (range 8.4-28.0). Radiological findings included pneu-
moperitoneum and free or localized fluid. Three pancreatoduo-
denectomy patients developed gastro-enteric leakage in association
with pancreatic fistula. Four patients underwent relaparotomy: two
pylorus-preserving pancreatoduodenectomies were converted to
‘classic’ pancreatoduodenectomy; others had anastomotic revision
or primary closure. Three patients were treated by percutaneous
drainage. One palliative bypass patient refused intervention and
died on postoperative day 19.
Conclusions: A 0.7% enteric leakage rate caused one death. Clin-
ical deterioration, tender abdomen and high (enteric) drain out-
put should raise suspicion of enteric leakage. Treatment depends
on index surgery, time to diagnosis, clinical situation and extent
of defect.
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SECOND-LOOK OPERATION IN PREVIOUSLY
ESTIMATED UNRESECTABLE PANCREATIC
CARCINOMA
P. Warnick, M. Glanemann, M. Bahra, D. Jacob, P. Neuhaus
Charite - Universitatsmedizin Berlin, Department of General-, Vis-
ceral- and Transplant Surgery, Berlin, Germany
Backround: The only curative therapy for patients with pancre-
atic carcinoma is the complete surgical tumor resection. The pre-
diction of tumor resectability strongly depends on the surgeon’s
experience.
Aim: We report retrospectively about patients who were estimated
unresectable in an exploratory laparotomy elsewhere and who un-
derwent a second look operation after referral to our clinic.
Methods: All patients with malign pancreatic tumors, who had
underwent an exploratory laparotomy elsewhere and who were
estimated unresectable because of various reasons, were included
in our analysis. All demographic and clinical data were analysed
with the patient’s files.
Results: In 15 patients (median age 56.9 years) a second look op-
eration was performed. In 11 patients (73%) the tumor could be re-
sected whereas in 4 patients (27%) the tumor remained
unresectable. A R0-resection could be obtained in 8 and a R1-re-
section in 3 patients. An operation by Kausch-Whipple was per-
formed in 3 patients, a PPPD in 4 patients and a left pancreatic
resection in another 4 patients. In 4 patients with unresectable tu-
mors exploratory laparotomy (n=2) and bypass operation (n=2)
were performed. Postoperatively, 6 of 15 patients developed com-
plications with 2 patients requiring surgical reintervention. The me-
dian survival in patients with resectable tumors was 17.6 months
and 3.7 in patients with an unresectable tumor.
Summary/ Conclusions: Our results suggest that second look op-
erations are reasonable in selected patients. In this analysis 73%
of our patients were resectable with a high percentage (53%) of
R0 resections. The prediction of resectability seems to depend
on the surgeon’s experience and may be positively affected by re-
sponse to previous chemotherapy. Thus, complex visceral opera-
tions like resections of pancreatic carcinoma should be performed
in high volume centre.
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LAPAROSCOPIC ENUCLEATION OF
PANCREATIC INSULINOMA
G. Zografos1, J. Karoumpalis2, A. Katseli1, G. Vasiliades1,
A. Douma3, D. Georgiadou1, S. Avlonitis1, G. Papastratis1
1. 3rd Department of Surgery General Hospital of Athens “ G.Gen-
nimatas”
2. Department of Gastrenterology Athens General Hospital
3. Department of Αnaesthesiology Athens General Hospital
BACKROUND: Insulinoma is a rare but curable disease. Non-
invasive preoperative investigations may help to locate the
tumor. Laparoscopic resection of insulinomas may reduce mor-
bidity and length of hospitalization and offer to the patient all the
benefits of laparoscopic surgery.
METHODS: We report a case of 37 year-old woman with in-
sulinoma, identified on computerized tomography but missed on
magnetic resonance imaging. Endoscopic ultrasonography (EUS)
revealed a small insulinoma located at the tail of pancreas which
was confirmed with cytological examination.
RESULTS: Preoperatively, a further EUS was performed and the
tumor was injected with blue dye. Subsequently the patient was
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transferred to the operative theatre and the tumor was resected
laparoscopically. Technical aspects are highlighted.
Histology confirmed the presence of an endocrine tumor staining
for chromogranin A and insulin.
CONCLUSIONS: Laparoscopic resection of insulinoma is feasi-
ble and safe. Preoperative localization facilitates the procedure
and limits pancreatic mobilization.
P 072
LAPAROSCOPIC RIGHT HEPATECTOMY
FOR BENIGN DISEASE
M. Goergen, P. Fabiano, A. Juan
Surgeon Centre Hospitalier, Luxembourg
The authors present a right hepatectomy by a full laparoscopic
approach for a large adenoma in a young woman. An extra-he-
patic vascular control of the right glisonian pedicle sheath as well
as right supra-hepatic vein was performed. Without clamping, the
hepatotomy was done by the Ligasure Advance device (Valleylab/
Covidien) and laparoscopic vascular staplers. The specimen was
removed by a Pfanenstiel incision.
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CHEMORADIOTHERAPY (GEMOX PLUS
HELICAL TOMOTHERAPY) FOR
UNRESECTABLE LOCALLY ADVANCED
PANCREATIC CANCER: A PILOT STUDY
A. Gardini1, C. Milandri2, G. La Barba1, A. Passardi2, R. Polico3,
D. Amadori2, D. Garcea1
1. Department of Endocrine Gastrointestinal and General Surgery
G.B. Morgagni – L. Pierantoni Hospital, Forl - Italy
2. Medical Oncology Unit (IRST) Meldola (Forl ) – Italy
3. Radiotherapy Unit (IRST) Meldola (Forl ) – Italy
Background: To evaluate the feasibility of a neoadjuvant chemo-
radiotherapy regimen in the treatment of non-resectable pancre-
atic cancer.
Patients and Methods: Patients with inoperable (by radiological
criteria), locally advanced pancreatic cancer were prospectively
enrolled into the trial. Patients received chemo-radiotherapy, the
former consisting of the GEMOX regimen: Gemcitabine (GEM)
1000 mg/m2 on day 1 and Oxaliplatin (OX) 100 mg/m2 on day 2
every two weeks for 3-4 cycles. Radiotherapy (25 Gy in 5 frac-
tions) was administered 15 days after the 3rd or 4th chemother-
apy cycle. Patients then received a further 3-4 cycles of GEMOX,
underwent restaging and were evaluated for surgery. Potentially
resectable patients were submitted to surgery, while unresectable
responders received 3-4 more cycles of GEMOX and further ra-
diotherapy (total of 15 Gy in 3 sessions).
Results: From August 2004 to November 2007, thirty patients were
enrolled and received a median of 6.5 cycles of GEMOX (range: 1-
12). GEMOX toxicity was similar to that reported in the literature,
radiotherapy was well tolerated. After chemo-radiotherapy, 14 pa-
tients obtained a partial tumor response (48%), 7 showed stable dis-
ease, 6 progressed, and 3 were not evaluable. Nine patients (30%)
underwent surgey: 7 radical pancreatic resections and 2 explorative
laparotomy. Vascular resection were performed in 2 patients. R0
margin was achieved in 6 cases. Four patients are alive after 19
months of median follow up from pancreatectomy.
Conclusions: Our results show the feasibility and potential effi-
cacy of the chemo-radiotherapy increasing number of patients
suitable of surgical treatment. We designed a phase II trial to con-
firm these data in a larger population.
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INCREASE IN ANNUAL NUMBER OF
PANCREATIC HEAD RESECTIONS DOES NOT
AFFECT MORTALITY OF PANCREATIC
CANCER IN THE UNITED KINGDOM
E.Ypsilantis, E. Courtney, H. Warren
Queen Elizabeth Hospital, King’s Lynn, UK
Background: Carcinoma of the head of the pancreas remains a
disease with a poor overall prognosis. Diagnosing the disease at
an early stage together with surgical resection may increase the
chance of cure.
Aims : To identify trends in the annual numbers of pancreatic
head resections in the UK and any potential effect on the overall
disease mortality.
Methods: Retrospective review of the National Hospital Admis-
sion Episodes Database provided by the National Health Service
Statistical Authority.
Results: The incidence of pancreatic cancer has remained un-
changed between 1999 and 2007, with a mean 10.3/100,000 males
and 7.9/100,000 females per year (Figure 1). The number of resec-
tions performed increased from 594 in 1999-2000 to 1,015 in 2006-
2007, representing an annual average increase of 27% (Figure 2).
Despite this increase, the annual mortality rate has not changed
appreciably during the same period of time, mounting to an an-
nual mean of 9.6/100,000 for males and 7.4/100,000 for females
(Figure 1). Conclusion: The increase in the number of pancreatic
head resections has not yet appreciably reduced the mortality as-
sociated with cancer of the head of the pancreas in the UK.
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RADICAL SURGICAL TREATMENT FOR PAN-
CREATIC BODY MALIGNANCIES WITH CELIAC
AXIS INVOLVEMENT: LIVER RE-ARTERIALIZA-
TION TECHNIQUES AND RESULTS
E. Vicente1, Y. Quijano1, E. Esteban1, P. Galindo1,
R. Díaz Conradi1, H. Durán1, C. Loinaz1, M. Marcello1,
B. Morató2, C. Corbacho3, U. López de la Guardia4, E. Conde5,
M. Hidalgo6, O. Hernando7, G. López-Nava8
1. General Surgery Service Hospital Madrid Norte Sanchinarro
2. Intensive Care Unit Hospital Madrid Norte Sanchinarro
3. Anesthesiology Service Hospital Madrid Norte Sanchinarro
4. Radiology Service Hospital Madrid Norte Sanchinarro
5. Pathology Service Hospital Madrid Norte Sanchinarro
6. Oncology Service Hospital Madrid Norte Sanchinarro
7. Radiotherapy Service Hospital Madrid Norte Sanchinarro
8. Gastroenterology Service Hospital Madrid Norte Sanchinarro.
Centro Oncol gico Clara Campal. Universidad San Pablo CEU,
Facultad de Medicina, Spain
INTRODUCTION: Pancreatic body tumors are associated with
a low resectability, mainly due to major vessels involvement.
AIM: To present our experience in radical pancreatectomy with
en bloc resection of the celiac axis and different liver rearterial-
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ization techniques.
METHODS: 7 patients with pancreatic carcinoma of the body
(3) or head-body (4) and arterial involvement underwent radical
resections. Encasement of the celiac axis (5), common hepatic ar-
tery (7) and splenic artery (4) was found. Complete resection
(R0) was achieved by corporocaudal (4) and total pancreatoduo-
denectomy (3) with en bloc resection of the celiac axis and its
branches. Combined resection of superior mesenteric vein was
required (4). 2 patients showed no necessity of revascularization
because of preserved hepatic arterial flow through the pancre-
atoduodenal arcade (Appleby operation). 4 patients underwent
arterial reconstruction: end-to-end anastomosis (common hepatic
artery-celiac axis stump) (2) or PTFEt grafting (1).
RESULTS: Operative time: 350-820 minutes. Intraoperative red
blood transfusions: 3-8 units. AST-ALT postoperative day one:
210-620 and 130-590 (arterial reconstruction); 1200 and 1080
(Appleby). Abdominal pain was relieved after surgery in all cases.
Mortality (30 days): 1/7 (no vascular or digestive complications
demonstrated). Four patients are alive and disease free 3, 8, 20
and 24 months after surgery. 1 patient is alive 43 months after
surgery with tumoral recurrence. 1 patient died two months after
surgery.
CONCLUSIONS: An extremely selected population of patients
could benefit from radical pancreatectomy with celiac axis resec-
tion in terms of quality of life (relief of pain). Late outcome
should be further studied.
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SURGICAL AMPULLECTOMY: INDICATIONS,
TECHNIQUE AND OUTCOME IN 51
CONSECUTIVE PATIENTS
T. Hackert1, W. Hartwig1, U. Hinz2, L. Schneider1, M. Büchler1,
J. Werner1
1. University of Heidelberg, Germany Department of Surgery
2. Department of Surgery Ruprecht-Karls-University/Dept. of Sur-
gery, Germany
Background: Ampullectomy of the duodenal papilla represents
a surgical therapy especially for benign tumors and stenosis of the
papilla. However, in tumors with dysplasia or large adenomas,
decision between ampullectomy as a rather small operation and
more aggressive approaches such as pancreatico-duodenectomy
may be difficult. Aim of the study was to define indications, sur-
gical approaches and outcome for ampullectomy compared with
pancreatico-duodenectomy.
Methods: Data analysis of 51 patients undergoing open ampul-
lectomy was performed with regard to epidemiology, indication,
endoscopic pre-treatment, preoperative diagnostic findings, sur-
gical intervention, histology and outcome. Data were compared
to pancreaticoduodenectomy in a matched-pair analysis
(n=51/102) with regard to operative parameters, morbidity and
mortality.
Results: 51 patients (18 male, 33 female, 60±14y) underwent am-
pullectomy. Indications included benign tumors in 75%, high
grade dysplasia or malignant tumors in 11% and inflammatory
stenosis in 14%. Overall morbidity was 28% including fistula, in-
traabdominal abscess and need for reoperation due to bleeding.
No deaths occurred. Compared to Whipple resections morbidity
(41%), reoperation rate (9,3%) and mortality (3,6%) were re-
duced, while fistula rate (7% vs. 5,6%) was comparable. Mostly,
type A fistulas occurred that did not require invasive therapy. Re-
garding surgical parameters, blood loss and operation time were
significantly reduced in ampullectomy as well as occurrence of
major perioperative complications.
Conclusion: Surgical ampullectomy is a feasible procedure of lim-
ited extent for the treatment of inflammatory stenosis and ade-
nomas of the papilla, especially for suspected high-grade
dysplasia and intraductally extending lesions. Severe surgical
complications as well as mortality are reduced in comparison to
pancreatico-duodenectomy.
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MULTIVISCERAL RESECTION FOR
PANCREATIC MALIGNANCIES: RISK ANALYSIS
AND LONG TERM OUTCOME
W. Hartwig1, T. Hackert1, U. Hinz2, M. Hassenpflug1,
M. Büchler1, J. Werner1
1. University of Heidelberg, Germany Department of Surgery
2. Department of Surgery Ruprecht-Karls-University/Dept. of Sur-
gery, Germany
Background: Curative resection is the only potential cure for pa-
tients with pancreatic cancer. However, advanced tumors may not
be resectable by standard approaches. Data on risk and survival
analysis of extended pancreatic resections is limited. Aim of the
study was to evaluate safety and outcome of multivisceral pan-
creatic resections for primary pancreatic malignancies.
Methods: 101 patients underwent multivisceral pancreatic resec-
tions between 10/2001 and 12/2007. Perioperative and long-term
results were compared to those of 202 matched patients with stan-
dard pancreatic resections. Uni- and multivariate regression
analysis were performed to identify parameters associated with
perioperative morbidity. Long-term survival was evaluated.
Results: Colon, stomach, adrenal gland, liver, hepatic or celiac
artery, kidney, or small intestine were resected in 37.6%, 33.7%,
27.7%, 18.8%, 16.8%, 11.9%, and 6.9% of the 101 patients with
multivisceral resection, respectively. Additional portal vein re-
section was performed in 20.8% of patients. Overall (55.5% vs.
42.8%) and surgical (37.6 vs. 25.3%) morbidity but not mortality
(3.0% vs. 1.5%) was significantly increased compared to standard
pancreatic resections. Uni- and multivariate analysis identified a
long operation time and the extended multivisceral resection of
2 or more additional organs as independent risk factors for in-
traabdominal complications or need for relaparotomy. Median
survival was comparable to that of standard pancreatic resections.
Conclusions: Multivisceral resections can be performed with in-
creased morbidity but comparable mortality and long-term prog-
nosis compared to standard pancreatic resections at high volume
centers. Increased morbidity is related to extended multivisceral
resections with a long operative time.
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P 078
INCOMPLETELY CLOSED DUODENAL LOOP
PANCREATITIS MODEL IN RATS: THE SEVERITY OF
PANCREATITIS IS NOT AFFECTED BY THE DUODENAL
LOOP LENGTH
K. Psarras1, S. Meditskou2, K. Papanikolaou1, N. Symeonidis1,
S. Rafailidis1, D. Pissas1, A. Triantafyllou1, K. Mpallas1,
T. Pavlidis1, G. Marakis1, A. Sakantamis1
1. 2nd Propedeutical Department of Surgery Aristotle University,
Thessaloniki, Greece
2. Department of Histology and Embryology Aristotle University,
Thessaloniki, Greece
Background and Aim: Incomplete closure of duodenum on ei-
ther side of the biliopancreatic duct entry in rats, creates a po-
tentially reversible pancreatitis model, imitating the whole
spectrum of lesions which progressively appear in human acute
pancreatitis. The lesions range from edema to hemorrhagic
necrosis, while a number of animals survive the disease. We
thought to investigate any changes in the severity of pancreatitis
and mortality rates in relation to the length of the partly closed
duodenal loop.
Methods: The duodenum was ligated over half its circumference
at 1 cm, 1.5 cm and 2 cm on either side of the duodenal entry of
the biliopancreatic duct in Wistar rats, and the severity of estab-
lished pancreatitis was assessed biochemically and histopatho-
logically, at 24 h, 48 h, 96h, 1 week and 2 weeks time. Investigated
parameters were serum amylase, edema, inflammation, necrosis,
thrombosis, hemorrhage and fibrosis.
Results: Small differences in the degree of established pancreatitis
were detected between groups, which were not proved to be statis-
tically significant. Mortality differences were not significant.
Conclusion: The length of the partly closed duodenal loop does
not affect the severity of experimental pancreatitis. This poten-
tially reversible pancreatitis model may be very useful to test the
effectiveness of several therapeutic approaches for this serious
disease.
P 079
ORGAN PRESERVING SURGERY FOR LOW
AND BORDERLINE CYSTIC NEOPLASMS IN
PANCREAS HEAD
H. Hwang, J. Kim, J. Park, W. Lee, D. Yoon, S. Cho, H. Chi
Department of Surgery, Yonsei University College of Medicine,
Seoul, Korea
BACKGROUND: According to the development of diagnostic
tools, it is increasing to diagnosis small cystic lesions of pancreas
with asymptomatic patients. A cystic lesions of the pancreatic
head larger than 2cm is considered to be an indication for surgi-
cal resection. Possible treatment modalities for cystic lesions of
the pancreatic head have included pancreaticoduodenoectomy,
organ preserving pancreatic head resection, and enuculation.
AIMS: The authors of this study attempted to compare the effi-
cacy of enuculation to pancreaticoduodenectomy in patients with
small cystic lesions of pancreatic head
MATERIALS & METHODS: We retrospectively reviewed the
medical records of 39 patients underwent pancreatic surgery for
cystic lesions only in the pancreas head between January 2000
and February 2008. Among the 39 patients, 25 patients had cys-
tic lesions of whitch size was between 2cm and 3cm. All patients
were followed-up for more than 6 months and mean duration of
follow-up was 52.0 months. Correlation of the variables was ana-
lyzed using Student t-test, Chi-square test, and Fisher’s Exact Test
(SPSS Window 14.0.). P-values less than 0.05 were considered as
statistically significant.
RESULTS: 25 patients were found to have cystic lesions in the
pancreas head(2cm<size<3cm). The average age of these 25 pa-
tients was 61.2 years (±6.5 years) and consisted of 14 men and
11 women. 20 patients(80%) underwent pancreatic resec-
tion(pancreaticoduodenectomy or pylorus preserving pancreati-
coduodenectomy, PD group), while 5 patients(20%) underwent
enucleation(enucleation group). The mean operation time, in-
traoperative blood loss and starting day of soft diet were signifi-
cantly shorter in the enuculation group compared to the PD
group. Length of hospital stay was shorter in the enuculation
group, but there was no statistical significance. During follow up,
One patients developed recurrence in the PD group. The patient
was borderline IPMN (branch duct type) and recurred in rem-
nant pancreas 8 years after PD. The recurrence lesions are mul-
tifocal with less than 1.5cm and we decided to observe. and There
was no recurred case in enucleation group.
CONCLUSION: It is not easy to confirm accurate diagnosis of
cystic neoplastic lesion of pancreas in preoperatively. So we have
dilemma whether or not operation is necessary, and which is
proper method between local excision and pancreatic resection.
This study suggests that enucleation for small cystic neoplasm in
the pancreas head can be performed safely and can provide the
opportunity not to miss cystic tumor with malignant potential
early when treatment is still possible.
P 080
DISTAL PANCREATECTOMY-POSTOPERATIVE
MORBIDITY WITH SPECIAL FOCUS ON
PANCREATIC FISTULA FORMATION
A. Morad Bakhti1, R. Andersson2, B. Tingstedt2, G. Lindell1
1. University Hospital Malmö Lund University
2. University Hospital Lund, Sweden
Background and aims: Distal pancreatectomy is associated with
high postoperative morbidity. The objective of this study was to
identify potential risk factors associated with postoperative mor-
bidity and mortality after distal pancreatectomy, with special
focus on the development of pancreatic fistulas.
Methods: Patients undergoing distal pancreatic resection from
February 2000 to March 2008 at the University Hospitals in
Malmö and Lund were identified in hospital registers (n=83).
Clinico-pathological perioperative and postoperative data were
collected from files and analysed using uni- and multivariate
analysis. Different techniques for closing the pancreatic remnant
were compared and risk factors were analysed.
Results: Surgical indications were pancreatic and non-pancreatic
tumours in 52 and 37% respectively. In 9.6% chronic pancreati-
tis was the indication and additional organ resection was per-
formed in 52%. The spleen was preserved in 19 %. Complications
were seen in 43% with a total pancreatic fistula rate of 30%. Uni-
variate and multivariate analyses indicated that the use of fibrin
glue and/or collagen patch with fibrin and thrombin decreased
the fistula rate (p=0.023). In addition, an increased fistula rate
was related to the number of intraoperatively placed drains
(p=0.034) and a longer postoperative hospital stay was seen in
patients with complications (p=0.0001).
Conclusion: Pancreatic fistula is a common complication after
distal pancreatic resection. The postoperative fistula rate de-
creased when sealing the pancreatic remnant with fibrin glue
and/or a collagen patch, and was also related to the use of in-
traabdominal drains. The results clearly indicate the need for ran-
domized controlled studies.
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THE LAPAROSCOPIC APPROACH TO DISTAL
PANCREATECTOMY. RESULTS AND
OUTCOMES OF A SINGLE UK HPB CENTRE
G. Ayiomamitis, R. Date, J. Low, B. Ammori
Department of Surgery, Manchester Royal Infirmary, Manchester,
UK
Background: Advances in operative techniques and technology
have facilitated laparoscopic distal pancreatectomy (LDP).
Methods: All distal pancreatectomies were attempted laparo-
scopically. Data were collected prospectively. The results shown
represent median (range) unless otherwise stated.
Results: Eleven patients aged 62 (32-72) years underwent LDP
with (n=5) and without (n=6) splenic preservation. All proce-
dures but one were completed laparoscopically, except for one
which was converted to open due to widespread liver metastasis
and the surgery was considered palliative. Operative mortality
was 9% in a patient with widespread liver metastases and rapid
disease progression. The operating time for LDP was 260 (160-
190) minutes with a blood loss of 300 (50-800) ml. The morbid-
ity, pancreatic fistula, re-admission, re-operation, and in-hospital
mortality rates were 36%, 27%, 27%, 0% and 9% respectively.
The postoperative hospital stay was 7 (5-15) days. Tumours were
1.0-10.5 cm in diameter and included endocrine (n= 8), adeno-
carcinoma (n=1), cystadenoma (n=1) and pseudopapillary tu-
mour (n=1). At a follow up of 12 (2-50) months, one patient died
from brain metastases, one developed new neuroendocrine tu-
mours in the head of the pancreas that required an open pancre-
aticoduodenectomy while the remainder remained disease-free.
Conclusions: The laparoscopic approach to distal pancreatec-
tomy offers favourable results compared with those observed
after the classical open surgery in terms of hospital stay, operative
blood loss, spleen preservation, and morbidity. This LDP series is
in keeping with the literature and can be considered as the gold
standard approach for both benign and malignant diseases.
P 082
PANCREATICODUODENECTOMY COMBINED
WITH VENOUS RESECTION - PRELIMINARY
RESULTS
B. Lien, B. Edwin, A. Foss, I. Gladhaug, A. Rosseland, B. Røsok,
T. Scholz, O. Villanger, P. Line, Ø. Mathisen
Division of Surgery, Oslo University Hospital, Rikshospitalet, Nor-
way.
Background: In surgical treatment of cancer in the pancreatic
head, vascular tumor-involvement usually excludes resection.
Since 2005 we have performed 13 pancreaticoduonenectomies
combined with resection of the portal- or superior mesenteric
vein. The aim of this study was to define patient selection and to
evaluate the safety of the procedure.
Methods: All patients operated with pancreaticoduodenectomy
and venous resection in the period 1.1.2005-1.12.2008 were iden-
tified. 4 patients (30%) used curative anticoagulation therapy pre-
operatively. A major part (54%) of vascular reconstructions were
done with allograft vein.
Results: Median age at operation: 61 years (41-75). Median op-
erating time: 426 min (275-760). Median peroperative transfu-
sions of blood-units: 3 (0-10). Standard postoperative
anticoagulation was Dalteparin 7500 U x 1.
Mortality: 1 patient died within 30 days due to pulmonary em-
bolism.
Complications: 5 patients required reoperations, 4 due to hem-
orrhage, 1 due to bile-leakage. The latter patient also had sepsis,
successfully treated with antibiotics. 1 patient had hemorrhage
from the gastrojejunal anastomosis, treated endoscopically with
clips. Asymptomatic graft thrombosis was diagnosed in 1 patient
after 3 months.
R0-resection was achieved in 8 of 13 patients. Median tumor-di-
ameter was 3,3 cm. In the R1-resection group, free microscopical
margin was not achieved in choledochus (1), posterior pancreatic
margin (2) and portal vein (2). All patients had adenocarcinoma,
12 of pancreaticobiliary type, 1 of intestinal type.
Conclusion: Pancreaticoduodenectomy combined with venous re-
section is associated with increased risk of postoperative hemor-
rhage. Patients receiving curative anticoagulation therapy
represent a challenge. Perioperative mortality and morbidity in
our study is acceptable. Further studies are required to establish
guidelines for inclusion and postoperative antithrombotic treat-
ment.
P 083
ROLE OF D-DIMER IN PREDICTION OF ORGAN
FAILURE IN ACUTE PANCREATITIS
D. Radenkovic, D. Bajec, N. Ivancevic, V. Jeremic, P. Gregoric,
B. Karadzic
Center for Emergency Surgery, Clinical Center of Serbia and School
of Medicine, University of Belgrade Serbia
Aim: Studies on the clinical value of parameters of haemostasis
in predicting pancreatitis-associated complications are still scarce.
Aim of this prospective study was to identify the useful haemo-
static markers for accurate determination of the subsequent de-
velopment of organ failure (OF) during very early course of acute
pancreatitis (AP).
Methods: In 91 consecutive primarily admitted patients with AP,
prothrombin time (PT), activated partial thromboplastin time,
fibrinogen, antithrombin III (AT III), protein C, plasminogen ac-
tivator inhibitor-1, D-dimer, and plasminogen were measured in
plasma within the first 24 hours of admission and 24 hours there-
after. Two study groups comprising 24 patients with OF and 67
patients without organ failure (NOF) were compared. Results:
Levels of PT, fibrinogen, d-dimer on admission were significantly
different between the OF and NOF groups and all these param-
eters plus AT III were significantly different 24 h latter. An d-
dimer value of 414.00 µg/l on admission was the best cut-off value
to predict development of OF with sensitivity, specificity, posi-
tive and negative predictive values of 90%, 89%, 75%,and 96%,
respectively. Conclusions: Measurement of plasma levels of d-
dimer on the admission is an accurate method for identification
of patients who will develop organ failure in the further course of
AP.
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P 084
OUTCOME OF SEVERE ACUTE PANCREATITIS
ADMISSIONS TO A CRITICAL CARE UNIT:
AN 18 YEAR ANALYSIS
N. Pawa1, M. Jadidi2, W. Konarzewski3, M. Tutton1
1. Colchester University Hospital
2. Dept of Anaesthesia and Critical Care Colchester Hospital
3. Dept of Laparoscopic and GI Surgery Colchester Hospital, UK
Background: Severe acute pancreatitis is a dynamic progressive
disease with an extremely poor prognosis. A majority of patients
require critical care support for multi organ dysfunction. Over
the last few years guidelines from various consensus groups have
been introduced, together with more tailored organ specific ther-
apy and care bundles to manage such patients.
Aim: The aim of this study was to analyse whether such advances
have affected the outcome of patients admitted to critical care
departments with severe acute pancreatitis.
Methods: A retrospective review was performed of a database of
admissions between 1990 and 2007. To assess the impact of these
advances the population was split into three historic periods
(1990-1995, 1996-2001, 2002-2007). The primary outcome meas-
ured was 30 day mortality: secondary outcomes including the ad-
mission APACHE II score and its predicted mortality, and length
of stay on the unit. Mortality statistics were compared between
historical groups using the T-test.
Results: A total of 128 patients were admitted during this time
period (male-73, female-55). A decrease was noted in the 30 day
mortality between 1990-1995 and 2002-2007 (56.8% vs. 39.0%, p-
0.31). No significant difference was identified in the mean
APACHE scores over the time period, however marked differ-
ences were noted in the predicted and observed mortalities in
each historic period. No significant difference was identified in
the length of stay across the years.
Conclusion: The introduction of such guidelines has led to an in-
crease in the number of patients admitted to the critical care de-
partment, with some improvement in the 30 day mortality.
P 085
POSTPANCREATECTOMY HAEMORRHAGE
(PPH): RISK FACTORS AND MANAGEMENT
BY INTERVENTIONAL RADIOLOGY
P. Sanjay, A. Fawzi, C. Kulli, I. Tait, I. Zealley, F. Polignano
Hepatobiliary Unit, Ninewells Hospital and Medical School,
Dundee, UK
Background: Haemorrhage after pancreatoduodenectomy is a
serious complication.
Aim: This study aimed to assess their incidence, risk factors and
outcome following management by radiological intervention.
Methods: All consecutive pancreatoduodenectomies (PD) over a
4- year period were reviewed. Main endpoints for analysis were
incidence and site of haemorrhage, incidence of pancreatico-je-
junal anastomosis leak, incidence of drain MRSA infection and
mortality. Univariate and multivariate analysis were performed.
Results: 67 patients underwent PD of which 7 patients (10.4%)
developed postpancreatectomy haemorrhage. The median age
was 71 years. The median time for haemorrhage after surgery was
23 days (range 3-35). The sites of haemorrhage were: hepatic ar-
tery psuedoaneurysm (n=4), psuedoaneurysm of branches of
SMA (n=1), jejunal branch of SMA (n=1), splenic artery
aneurysm (n=1). Successful angiographic treatment was achieved
in all patients by embolisation (n=5) or stent grafting(n=2).
Fistula rate was not statistically different between patients who
sustained PPH and those who did not (4 Vs 24; P=0.4). 4/7 pa-
tients with PPH had drain MRSA infection vs. 10/60 with no PPH
(P=0.03).
3/7 patients (43%) with PPH died from cardio-respiratory failure
despite successful haemostasis. Univariate and multivariate
analysis identified drain MRSA infection as a risk factor for PPH.
Conclusion: Postpancreatectomy haemorrhage is life threaten-
ing complication and presence of MRSA infection in the drain
fluid is a significant risk factor. Aggressive treatment of MRSA
and high index of suspicion may be indicated. Radiologically
guided endovascular treatment is the treatment of choice in our
department and has excellent success rate.
P 086
RADIOLOGICAL TREATMENT STRATEGIES IN
ACUTE PANCREATITIS WITH INFECTED
NECROSIS
S. James, R. Dimitri, I. Charles, O. Steven, M. Malago,
A. Shankar
Department of Hepatopancreaticobiliary Surgery, University College
London Hospital, London, UK
Background and Aims: The standard approach to acute pancre-
atitis with infected necrosis (APIN) is surgical necrosectomy, a
procedure carrying a high incidence of morbidity and mortality.
We aimed to assess the use of a radiological approach to the man-
agement of APIN.
Methods: All patients with acute pancreatitis admitted between
1996 and 2004 were assessed by retrospective case-notes review.
All patients with microbiologically-proven infected necrosis
(drain effluent/blood cultures) were further reviewed. Patients
were managed via a standardised regime of radiologically-guided,
peripancreatic drain-insertion, regular drain-aspiration and ad-
ministration of intravenous antibiotics.
Results: 65 patients (43M:23F) were admitted with APIN. Mean
age was 49.4 years (17-83 yrs) and mean length of stay 68.7 days
(9-240 days).
CT revealed that 18 (27.7%) patients had <30% necrosis, 25
(38.5%) 30-50% necrosis and 22 (33.8%) >50% necrosis.
Organ failure occurred in 45 (69.2%) patients, 30 (46.2%) with
>1 system failure. 62 (95.4%) patients developed in-patient com-
plications including 32 (49.2%) pseudocysts, 6 (9.2%) pseudoa-
neurysms, 4 (6.2%) venous thromboses, 1 (1.5%) PE and 13
(20%) diagnoses of diabetes. There were no drain-related com-
plications. 26 (40%) patients were admitted to ITU, mainly for
respiratory support (mean ITU stay 30.1 days (1-124 days)).
There were 10 (15.4%) deaths, all from multi-system failure. All
patients that died had pre-existing significant co-morbidities.
Conclusions: Radiologically-guided drains have previously been
considered a holding measure for those too unwell for surgery;
however drain-insertion represents an alternative to surgery, with
similar rates of morbidity and mortality to those series in which
selective surgical necrosectomy is undertaken.
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PANCREATIC NECROSECTOMY FOR SEVERE
NECROTIC PANCREATITIS: THE EXPERIENCE
OF A DISTRICT GENERAL HOSPITAL IN THE
UNITED KINGDOM
E. Ypsilantis, M. Blunt, P. Amato Gauchi, H. Warren
Queen Elizabeth Hospital, King’s Lynn, UK
Background: Surgery for pancreatic necrosis complicating acute
severe pancreatitis carries significant mortality, depending on the
timing of surgical intervention, the degree of organ failure, the
extent of pancreatic necrosis and the presence of infection. Aims:
To evaluate the outcomes and potential determining factors of
pancreatic necrosectomy (PN) for severe necrotic pancreatitis
(SNP) in a District General Hospital in the United Kingdom.
Methods: Retrospective analysis of 19 consecutive patients who
underwent PN for SNP during the last 5-years period (2003-
2008), with emphasis on the mortality rate and overall hospital
stay. Results: The median initial Acute Physiology and Chronic
Health Evaluation (APACHE) II score was 18 (95% C.I. 14.5 to
21.3) with median estimated risk of death 29.2% (95% C.I. 24.7%
to 48.6%). The 1-year mortality was 36.8% (7 patients), with most
deaths during the first 3 months post-operatively. The median
stay in Intensive Care Unit for patients who survived was 8 days
(95% C.I. 2 to 28 days). Their median hospital stay was 68 days
(95% C.I. 31 to 143 days). The total hospital stay positively cor-
related with the patients’ initial APACHE II score (Spearman r
1.0, P = 0.016). Conclusion: The outcome of pancreatic necro-
sectomy for severe necrotic pancreatitis is largely affected by the
patients’ physiological parameters on initial presentation. The
combination of timely surgical intervention and adequate Critical
Care support in District General Hospitals can safeguard mor-
tality rates comparable to those of tertiary centres.
P 088
AGGRESSIVE MULTIVISCERAL PANCREATIC
RESECTIONS FOR LOCALLY ADVANCED
TUMOURS WITH FAVOURABLE PATHOLOGY
M. Abu-Hilal, M. McPhail, C. Jones, C. Johnson, N. Pearce
Southampton University Hospital Southampton, UK
Introduction: Orthodox surgical teaching states that pancreatic
resection should not be contemplated when malignancies arise in
the pancreas and involve other organs. Tumors with favourable
biology such as neuroendocrine tumours (NET) and gastroin-
testinal stromal tumors (GIST) even with significant local spread,
however, may achieve useful palliation and arguably survival by
aggressive surgical resection.
Methods: Eighteen consecutive patients (11 male: 7 female, me-
dian age 63 (37-79) years) underwent multi-visceral en-bloc re-
sections for NET or GIST involving the pancreas between 1994
and 2008 at Southampton General Hospital.
Results: Five patients underwent pancreaticoduodenectomy; thir-
teen patients had left sided pancreatic resections. They had a me-
dian of 3 (range 1-4) additional organs resected over a median
duration of 6 (3-9) hrs, and median postoperative stay of 14 (9-40)
days of which only median 1 (0-13) day was in intensive care.
There was one post-operative death (of aspiration pneumonia
following GIST resection) and one death at 9 months of recur-
rence of GIST. There were no deaths in the NET group after me-
dian 24 month follow up. Six patients experienced a complication
(major in 3 patients). Histologically four patients had positive
lymph nodes while 2 had intravascular invasion detected with
seven patients having free resection margins. Five patients expe-
rienced recurrent disease at 6 (2), 7, 26 and 40 months respec-
tively.
Conclusion: En bloc multi-visceral resection for selected locally
advanced NET and GIST involving the pancreas is technically
feasible and in specialist centers can be achieved with low mor-
tality and acceptable morbidity, offering good disease free and
overall survival.
P 089
REVIEW OF STUDIES ON GASTRIC EMPTYING
ASSESSMENT AFTER PANCREATODUODENEC-
TOMY
W.J. Eshuis, N.A. van der Gaag, O.R.C. Busch, T.M. van Gulik,
D.J. Gouma
Department of surgery, Academic Medical Center, Amsterdam, the
Netherlands
Background: Delayed gastric emptying (DGE) is the commonest
complication after pancreatoduodenectomy. In their consensus
definition, the International Study Group of Pancreatic Surgery
defined DGE by clinical criteria. It has been suggested that diag-
nosis of DGE requires objectivation by a diagnostic test.
Aim: To review the literature of diagnostic tests assessing gastric
emptying early after pancreatoduodenectomy and to derive uni-
versal diagnostic test criteria for DGE.
Methods: A systematic search using the MESH terms ‘pancre-
atoduodenectomy’, ‘(delayed) gastric emptying’, ‘diagnostic tech-
niques and procedures’ of Medline and Embase was performed.
Results: In twenty-six identified papers, six different tests were
used. Nine studies (n=384 patients) used gastric emptying scintig-
raphy. Six of these formulated (different) reference values of nor-
mal emptying. Contrast passage studies were used in six studies
(n=164 patients), of which one formulated objective criteria of
delayed passage. Paracetamol absorption test was used in six stud-
ies (n=122 patients), of which one provided reference values for
delayed emptying. Six studies (n=109 patients), four from one
center, assessed gastric function by manometry. Two studies
(n=124 patients) used H2 breath test, another two electrogas-
trography (n=9 patients). The studies’ heterogeneous method-
ology and definitions, and lack of correlation with the clinical
situation hampered defining criteria for the different tests.
Conclusions: Gastric emptying scintigraphy seems the most ac-
knowledged test to identify DGE after pancreatoduodenectomy.
Universal criteria could not be deducted due to heterogeneous
methodology and lack of correlation with the clinical situation.
Further studies are needed for that and to determine the exact
role of diagnostic studies in defining DGE.
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SIMILARITIES BETWEEN TOTAL
MESODUODENAL AND MESORECTAL
EXCISION IN THE TREATMENT OF
PANCREATIC HEAD CARCINOMA: THE NEED
FOR EFFECTIVE LOCOREGIONAL
LYMFADENECTOMY
F. Berrevoet1, F. Goudsmedt2, L. Libbrecht3, S. Laurent4,
X. Rogiers1, R. Troisi5, B. De Hemptinne1
1. HB Surgery UZ Ghent
2. HPB Surgery UZ Ghent
3. Pathology UZ Ghent
4. Abdominal Oncology UZ Ghent
5. HB Surgery Ghent University Hospital & Medical School, Bel-
gium
Introduction: The overall 5-year survival rate of pancreatic head
carcinoma is less than 10%. Although the benefit from extended
lymfadenectomy during pancreaticoduodenectomy has been ques-
tioned and R0 resections are difficult to obtain, both local and dis-
tant spread through lymf node dissemination around the superior
mesenteric artery are the main reason for recurrence. We assessed
the effectiveness of both R0 resections and the number of lymf
nodes resected comparing a standard operative strategy with a new
mesoduodenal excision during pancraeticoduodenectomy.
Methods: For this study 26 concecutive patients who underwent
an pancreatoduodenectomy with mesoduodenal excision between
march 2007 and oktober 2008 were included. The included indi-
cations were resectable tumoral laesion in the common bile duct,
the pancreatic head, the processus uncinatus or the ampulla.
These results were compared using a case-control approach with
previous patients in which the traditional pancreatic head resec-
tion with lymfadenectomy was used. Both quality of life and sur-
vival were prospectively examined.
Results: Considering mesoduodenal excision, a mean of 12.6±4
lymf nodes were resected in the specimen, of which 14.3% had
tumorous involvement in 57.7% of all investigated patients. After
pathological examination R0 margins were obtained in 84.6% of
patients. This number was significantly higher than in the previ-
ously used technique.
Postoperative complications, including pancreatic fistula, chyle
leak, cholangitis, acute renal failure, pneumonia and wound in-
fections were not different between the groups.
Conclusions: Pancreatoduodenectomy using a mesoduodenal ex-
cision technique facilitates the complete skeletonization of the
superior mesenteric artery and consequently increases the num-
ber of lymph nodes removed. Whether these data lead to an im-
proved patient survival or to an increased perioperative morbidity
needs confirmation in further analyses.
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P 091
LONG TERM OUTCOME FOLLOWING
LAPAROSCOPIC LIVER RESECTION OF
COLORECTAL METASTASES: FIRST 100
PATIENTS
A. Kazaryan, I. Pavlik Marangos, B. Røsok, A. Rosseland,
T. Mala, O. Villanger, Ø. Mathisen, B. Edwin
Rikshospitalet University Hospital Oslo, Norway
Background: Laparoscopic liver resection has been reported safe
and feasible and has been shown to improve the postoperative
course for the patient. The oncologic outcomes following la-
paroscopic resection of colorectal liver metastases are poorly re-
ported.
Aim: To evaluate the surgical and late oncologic outcomes fol-
lowing laparoscopic liver resection.
Methods: All patients with colorectal liver metastases undergoing
laparoscopic resection at Rikshospitalet (referral centre) between
August 1998 and December 2008 were included. Median post-
operative follow up was 20 (0,5-92) months.
Results: 131 liver resections were performed in 100 patients dur-
ing 107 procedures with a 4.6 % conversion rate. We performed
101 non-anatomic and 30 anatomic liver resections (24 left lobec-
tomies, 5 right and 1 left hemihepatectomies). The median oper-
ative time was 191 (64-488) min. The median blood loss was 400
(<50-4000) ml. The median resection margin was 6 (0-40) mm. A
negative resection margin was achieved in 94 % of the resections.
Eight cases of positive margins represented 4 primary and 4 re-re-
sections. There were 8 intraoperative complications and 13 post-
operative complications. The median postoperative stay was 3
(1-42) days and postoperative opoid medication 1 (1-11) day. One
patient with severe co-morbidity (ASA 4) died on the 2nd post-
operative day (0.9%) due to multi organ failure. 5 year estimated
actuarial survival and 5 year actual survival was 46 % and 43.5%
respectively.
Conclusions: Laparoscopic liver resection is a favorable alterna-
tive to open liver resection for patients with colorectal metastases.
It provides oncologic outcomes comparable with open surgery.
P 092
REGENERATION OF HUMAN EXTRAHEPATIC
BILIARY EPITHELIUM: THE ROLE OF
PROGENITOR CELLS
M. Sutton1, T. Lisman1, A. Gouw2, R. Porte3
1. Surgical Research Laboratory University Medical Center Gronin-
gen
2. Department of Pathology University Medical Center Groningen
3. Section of Hepatobiliary Surgery and Liver Transplantation Uni-
versity Medical Center Groningen, The Netherlands
Background: Few studies have focussed on regeneration of the
extrahepatic bile duct (EHBD). We aimed to identify the origin
of EHBD regeneration and investigate the role of progenitor cells
(PC) in the EHBD.
Methods: Normal EHBD specimens were obtained from human
donor livers (n=12). Mildly diseased EHBD from patients with
cholangitis (n=5) and severely injured EHBD from patients with
ischemic-type cholangiopathy (ITC) (n=5).
Double immunostaining for CK-19 and Ki-67 was performed to
identify proliferating cells. Using conventional RT-PCR, normal
EHBD specimens were analyzed for the hepatobiliary PC mark-
ers (c-Kit, Thy-1, Musashi-1, alpha-fetoprotein (AFP)) and for
albumin and CK19. In addition, immunohistochemical analysis
on these markers was performed on normal and diseased EHBDs
Results: In EHBDs with cholangitis, proliferation was mainly lo-
cated in the basal layer of the lumen, whereas in case of ITC, pro-
liferation was mainly observed in the peribiliary glands. In all
specimens of normal EHBD, mRNA transcripts for c-Kit, Thy-1,
CK19, albumin were present. AFP and Musashi-1 expression was
detected in 7/12 and 11/12, respectively. c-Kit immunostaining
was localized in single cells throughout the EHBD wall, and Thy-
1 was abundantly present. No Thy-1+ epithelial cell was detected.
Conclusions: In EHBD with ITC and loss of epithelial cells, pro-
liferation was observed in the peribiliary glands, suggesting that
they serve as a reservoir for PCs and epithelial regeneration. Al-
though mRNA transcripts of c-Kit and Thy-1 were present in
EHBD, immunohistochemistry demonstrated that these markers
were expressed by a variety of cell types. These cells were not
likely to be PCs.
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FACTORS PREDICTING PERIOPERATIVE
DEATH AND EARLY OUTCOME IN
HEPATOPANCREATICOBILIARY CANCER
SURGERY: A SYSTEMATIC REVIEW
C. Mann1, T. Palser2, C. Briggs3, C. Neal1, J. Buckles4, I. Cameron5,
M. Rees6, D. Berry7
1. University of Leicester Leicester General Hospital
2. Royal college of Surgeons of England
3. University of Leicester
4. Birmingham Teaching Hospitals
5. Sheffield Teaching Hospitals
6. Basingstoke and North Hampshire NHS Foundation Trust North
Hampshire Hospital, Basingstoke
7. Leicester Teaching Hospitals Leicester General Hospital
Introduction – Risk adjustment is the retrospective adjustment
of a provider or surgeon’s results for case mix and or hospital vol-
ume and allows accurate, meaningful inter-provider comparison.
It is therefore an essential component of any audit and quality-
improvement process. The aim of this study was to systematically
review the literature to identify those factors known to affect
prognosis in hepatobiliary and pancreatic cancer surgery. This
would ensure collection of appropriate datafields and creation of
a hepatopancreaticobiliary cancer risk-adjustment model, allow-
ing meaningful interpretation of the data collected from multi-
ple institutions in the United Kingdom.
Methods – Pubmed was used to identify studies assessing risk in
patients undergoing resectional surgery for hepatobiliary and
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pancreatic cancer, rather than bypass surgery. Information col-
lected included patient numbers, tumour type, operation per-
formed, morbidity rate, mortality rate, complications, hospital
stay, and predictors of peri-operative outcome on multivariate
analysis.
Results – 63 and 68 papers, pertained to a total of 24,609 and
63,654 patients having undergone hepatic or pancreatic resection
for malignancy, respectively, were identified. 22 generic pre-op-
erative factors predicting outcome on multivariate analysis, in-
cluding demographics, blood results, pre-operative biliary
drainage and comorbidities were identified, with tumour charac-
teristic proving disease-specific factors. Operative duration,
transfusion, operative extent, vascular resection and additional
intra-abdominal procedures were also found to have predicted
early-outcome.
Conclusions – Development of a risk-adjustment model will allow
identification of those factors with most influence on early out-
come and therefore potential targets for pre-operative optimisa-
tion, and allow development of a multi-centre risk prediction
model which may play a role in preoperative risk assessment and
allocation of resources.
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BILIARY HEAVY METAL EXCRETION AND ITS
ASSOCIATION WITH PANCREATO-BILIARY
MALIGNANCY
G. Sen1, S. Mansfield1, P. Green2, D. Rimmer2, D. Manas1,
R. Charnley1
1. Department of Hepatobiliary and Pancreatic Surgery, Freeman
Hospital, Newcastle upon Tyne, UK
2. Department of Agriculture, University of Newcastle Upon Tyne,
UK
Introduction: Studies Egypt, USA and India have reported pos-
sible association of heavy metals like lead and cadmium and pan-
creatobiliary malignancy.
Aim: To look at association between biliary heavy metal excretion
and pancreatobiliary malignancy in North-East of England.
Materials and Methods: Patients admitted to a tertiary centre
with malignant biliary obstruction were identified and bile was
collected during endoscopic cholangiography, percutaneous
cholangiography or during surgery. Bile was collected from pa-
tients with benign biliary disease as controls. The bile samples
were analyzed for concentrations of zinc, copper, lead & cad-
mium using atomic absorption spectrometry. The mean levels of
every metal in the study groups and the control group were com-
pared by using SPSS 16© (SPSS Inc) statistical software.
Results: 127 bile samples from 98 patients (43 male, 55 female,
mean age 62.18 years) were analyzed. The study and control
groups were sex matched but there was significant difference in
age distribution between the groups (p<0.001). Mean concen-
tration of every metal in each subgroup of the patients were com-
pared and copper was present in significantly higher level in the
benign control group (p=0.004) and cadmium was present in sig-
nificantly higher level in the malignant groups (p=0.02). There
was no difference amongst the groups for other heavy metals.
Conclusion: Studies have shown association between pancreatic
cancer and cadmium from areas of high environmental pollution.
Present study supports this association from an area of relatively
low pollution. Further research is needed to establish carcino-
genic role of heavy in pancreatobiliary malignancies.
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STAGING, RESECTABILITY, AND OUTCOME IN
106 PATIENTS WITH CHOLANGIOCARCINOMA:
INSTITUTIONAL EXPERIENCE
A. Lauretta, O. Damrah1, N. Katsoulas, A. Almoudaris,
R. Canelo, N. Habib, L. Jiao
HPB Surgery Hammersmith Hospital, London, UK
Introduction: Cholangiocarcinoma is a devastating malignancy
that present late and is associated with a high mortality.
AIM: The authors analyze and assess the management and out-
come in patients with cholangiocarcinoma in a single tertiary re-
ferral centre.
Methods: Between 2002 and 2005, database of all patients with
bile duct cancer treated at our institution was reviewed. Demo-
graphics, results of imaging studies, pathology, and survival were
analyzed. Patients who were deemed unresectable on pre-opera-
tive imaging were managed with metallic stent and, if having good
performance status, treated with further chemotherapy. Curative
resections included hepatectomy, pancreaticoduodenoectomy
and extra-hepatic biliary ducts excision.
Results: There were 106 patients with a mean age of 65.8. Seventy
(66%) patients had hilar cholangiocarcinoma, twenty-four
(22.6%) had intrahepatic cholangiocarcinoma, seven (6.6%) mid-
dle cbd and five (4.7%) low cbd cholangiocarcinoma. Seventy-
nine (74%) patients had unresectable disease; 43 patients
underwent surgical exploration with curative intent. Sixteen pa-
tients were found to have unresectable disease, whereas twenty-
seven (26%) underwent resection: 12 had a concomitant partial
hepatic resection. The overall survival was 15±14 months. Pa-
tient who underwent curative resection (R0) had 1- and 3-year
survival rates significantly longer than those with histological pos-
itive margin (P <0.05) There was no significant difference in
term of survival between patients who underwent resection with
histologically positive margin and patients who had not any sur-
gical treatment. The most favourable outcome has been recorded
in those patients with middle and especially low cbd tumors.
Conclusion: Only complete tumor resection, including hepatic re-
section, enables long survival for patients with cholangiocarci-
noma.
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ASSESSMENT OF THE GALLBLADDER
MOTILITY IN PATIENTS FOLLOWING TOTAL
GASTRECTOMY (ROUX-EN-Y) BY INFUSION
CHOLESCINTIGRAPHY
M. Petrovic, V. Artiko, V. Obradovic, P. Pesko, M. Milicevic
First Surgical Clinic, Clinical center of Serbia
Purpose: The aim is evaluation of the gallbladder (GB) motor
function, by infusion cholescintigraphy, in patients after total gas-
trectomy (Roux-en-Y).
Patients and methods: The study was done in controls (C), 12 pa-
tients early (EPG), and 14 late after the surgery (LPG). Imaging
was performed during three-hours’ infusion of 150 MBq of
99mTc-EHIDA with meal stimulation.
Results: Obtained GB filling time values are significantly in-
creased in EPG (97.0±13.0 min) in comparison with C
(74.5±10.4, p<0.05) and LPG (64.4±9.5, p<0.01), which do not
differ between themselves (p>0.05). There are no differences in
GB emptying time between the groups (C:37.8±8.0,
EPG:27.3±7.9, LPG:39.6±11.0 min, p>0.05), although it is the
shortest in EPG. GB filling and emptying rate ratio are signifi-
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cantly higher in EPG (2.6±1.2) than in C (0.8±0.5, p<0.01) and
LPG (1.0±0.7, p<0.05), without any difference between the lat-
ter two groups (p>0.05). EF values are significantly decreased in
EPG (28.7±10.9) in comparison to C (76.7±17.9) and LPG
(73.3±11.3, p<0.01). Also, ER is lower in EPG (1.05±0.51) than
in C (2.03±0.72) and LPG (1.85±0.63, p<0.05). EF and ER val-
ues between C and LPG patients do not differ (p>0.05).
Conclusion: Early after surgery, GB filling is prolonged and emp-
tying impaired, while after several months GB motor function is
normalized. Thus this method is recommended in the patients
after such surgery to decide on the specific treatment introduc-
tion in order to prevent GB calculosis and other complications.
References:
1. Petrović M, Milićević M, Artiko V, Obradović V, Pesko P, Ko-
vacević N, Bulajić P, Kostić K, Obradović V. Gallbladder motor
function studied by modified infusion cholescintigraphy method
after gastric and duodenal surgery. Acta Chir Iugosl. 42:21-7,
1995.
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ROUTINE DRAINAGE DOES NOT PROVIDE A
BENEFIT AFTER OPEN CHOLECYSTECTOMY
V. Zaydfudim, R. Russell, I. Feurer, J. Wright, C. Pinson
Vanderbilt University Medical Center Division of Hepatobiliary
Surgery and Liver Transplantation Nashville, Tennessee,
Background: According to randomized trials, use of closed-suc-
tion drain after uncomplicated open cholecystectomy provides no
recovery benefit. However, drainage after open cholecystectomy
continues, perhaps as a result of more complicated patient pres-
entation.
Aim: We examined reasons for drain use in patients undergoing
open cholecystectomy and evaluated the effect of abdominal
drainage on surgical outcomes.
Methods: Univariate and multivariate analyses compared pre-
and intra-operative factors leading to drain placement and post-
operative outcomes in patients undergoing open cholecystectomy
at our institution between 2002 and 2007.
Results: In 160 patients who underwent open cholecystectomy as
primary operative procedure, 92 (58%) patients had a drain
placed. In 22% of the cases, the surgeon stated in the operative
report that hemorrhage, abscess, non-identification of critical
structures, bile spillage, or concern for bile leak was reason for
drain placement. In 78% of the cases no reason was provided.
Multivariate analysis revealed diagnoses of acute, chronic or gan-
grenous cholecystitis (n=120, 75%), intra-operative bile spillage
(n=60, 38%), and high intra-operative blood loss (median=200,
IQR: 100-400) as independent predictors of drain use (all
p≤0.04). Patients with drains had increased length of hospital
stay, post-operative ICU admissions, rates of hospital re-admis-
sion, and use of post-operative endoscopy (all p≤0.04). Patients
with and without drains had similar incidence of bile leaks, intra-
abdominal abscesses, wound infections, and deaths (all p>0.12).
Conclusions: Use of drains after open cholecystectomy was asso-
ciated with complicated patient presentations such as acute,
chronic, or gangrenous cholecystitis, intra-operative bile spillage,
and high intra-operative blood loss. These patients had longer
and more complicated post-operative course and more re-ad-
missions. However, there was no documented clinical improve-
ment in bile leaks, abscesses, wound infections, or deaths with use
of drains.
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SURGICAL MANAGEMENT OF SECTORAL BILE
DUCT INJURY AFTER LAPAROSCOPIC
CHOLECYSTECTOMY: CENTER EXPERIENCE
J. Li1, A. Frilling, A. Paul1, S. Nadalin2, S. Raduenz, J. Treckmann,
M. Malago3, C. Broelsch1
1. Department of General, Visceral and Transplantation Surgery
University Hospital Essen
2. Department of Surgery Univeristy of Essen
3. University College London Hospital, NHS Foundation Trust De-
partment of Hepatobiliary and Pancreatic Surgery
Background Injury to sectoral bile duct is a rare event in laparo-
scopic cholecystectomy (LC), challenging in its difficult diagnosis
and management.
Patients and Methods Of 73 consecutive patients with LC-related
biliary injuries referred to the author’s tertiary centre between
April 1998 and December 2006 for surgical management, 10 had
sectoral duct injury (SDI). The authors proposed that there be
two types of SDI, according to the drainage territory. The repair
was carried out according to the two types of SDI and concomi-
tant injury.
Results Precise surgical exploration is the only effective method
to identify the SDI. Type 1 SDI was found in eight and type 2 SDI
in two patients. Most of the patients had concomitant biliary or
vascular injuries. Besides management of the concomitant in-
juries, type 1 SDI was treated by biliary-enteric anastomosis while
type 2 SDI was managed by overstitching. One patient died due
to sepsis before any definitive treatment. The median length of
treatment in the author’s centre was 26 days. During the mean
follow-up of 43 months, two out of nine patients needed re-in-
tervention due to anastomotic stricture at 11 and 28 months re-
spectively.
Conclusion Surgical repair, guided by the type of SDI, has been
shown to be effective. Early diagnosis is a prerequisite for a fa-
vorable outcome.
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KLATSKIN-MIMICKING LESIONS:
DIAGNOSTICAL AND THERAPEUTICAL
DILEMMA?
B. Juntermanns1, T. Jurgen2, V. Spiridon2, H. Matthias2,
P. Andreas1, K. Gernot-Maximilian1
1. Department of General, Visceral and Transplantation Surgery
University Hospital Essen, Germany
2. Transplantation Surgery Hospital Essen, Germany
Background: The preoperative as well as the intraoperative dif-
ferentiation between benign (Klatskin-mimicking tumors) and
malignant hilar tumors (Klatskin-tumors) is problematic.
Patients and Methods: Therefore we retrospectively analysed our
prospectively established bile duct tumor database. From 1999 to
2008 Patients (n=209) with the preoperative Diagnosis of a hilar
cholangiocarcinoma (Klatskin-tumor) underwent surgery. The
postoperative histological diagnosis showed in 21 out of the 209
patients a benign tumour, a so called Klatskin mimicking lesion.
Results: The histological report from 17 out of the 21 patients
showed a chronic inflammatory transformation of the bile ducts.
The histology of 3 patients showed a primary sclerosing cholan-
gitis. In 1 patient a sarkoidosis of the extrahepatic bile ducts has
been demonstrated. 7 out of the 21 patients underwent hemi-
hepatectomy. In 1 patient a resection of the hilar bifurcation with
additional liverresection of section IVa has been performed. 13
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patients underwent resection of hilar bifurcation alone.
Nevertheless a reassessment of the preoperative diagnostics like
computed tomography (CT), magnetic resonance imaging (MRI)
or endoscopic retrograde cholangiopancreatography (ERCP) did
not deliver any change of the tumors dignity that has been as-
sumed preoperatively.
Conclusions: The clinical presentation and the preoperative di-
agnostics of hilar tumors do not establish a clear differentiation
between hilar cholangiocarcinoma (Klatskin tumor) and
Klatskin-mimicking lesions. Therefore an aggressive operative
therapy of suspect hilar tumors still seems to be the appropriate
therapy.
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BIOCHEMICAL PREDICTORS OF ABSENCE
OF COMMON BILE DUCT STONES
Y. Shyr
Taipei Veterans General Hospital, China
Background: We evaluated simple, noninvasive biochemical pa-
rameters as screening tests to predict the absence of common bile
duct stones prior to laparoscopic cholecystectomy.
Methods: A total of 1002 patients underwent laporoscopic chole-
cystectomy. Five biochemical parameters were measured preop-
eratively: gamma glutamyl transferase (GGT), alkaline
phosphatase (AP), total bilirubin(TB), alanine aminotrans-
ferase(ALT), and aspartate aminotransferase(AST). Conven-
tional diagnostic tests were also evaluated. Along with the five
biochemical tests above, these diagnostic tests were scrutinized
and compared as potential predictors for common bile duct
stones.
Results: Eighty-eight (8.8%) patients with gallstone disease who
underwent laparoscopic cholecystectomy had concurrent com-
mon bile duct stones. Among all diagnostic tests, endoscopic ret-
rograde cholangiopancreatography had highest sensitivity
(96.0%), specificity (99.1%), probability ratio (107.3), accuracy
(98.0%), and positive predictive value (98.8%) in detecting com-
mon bile duct stones. At least one abnormal elevation among the
five biochemical parameters had highest sensitivity (87.5%). TB
had highest specificity (87.5%), highest probability ratio (3.9),
highest accuracy (84.1%) and highest positive predictive value
(27.4%). All five biochemical predictors had high negative pre-
dictive values; GGT was highest (97.9%), lowest was TB (94.7%).
Multivariate analysis showed only GGT, AP and TB to be inde-
pendent predictors; GGT appeared to be the most powerful pre-
dictor.
Conclusion: We suggest that unnecessary, costly, or risky proce-
dures such as endoscopic retrograde cholangiopancreatography
can be omitted prior to laparoscopic cholecystectomy on patients
without abnormal elevation of these biochemical values.
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INTRAHEPATIC CHOLANGIOCARCINOMA.
PROGNOSTIC SIGNIFICANCE OF TUMOR
GROSS TYPE
R. Andrea1, P. Silvia1, C. Tommaso1, C. Paola2, M. Giulio1,
C. Iacono1, V. Alessandro1, P. Gianluca1, G. Alfredo1
1. General Surgery A Dipartment of surgical and gastroenterological
sciences
2. Department of pathology University of Verona
Introduction: Intrahepatic cholangiocarcinoma (ICC) is the sec-
ond most common primary liver tumor. Curative surgical resec-
tion is the most effective treatment and the only therapy
associated with prolonged disease-free survival. According to the
gross appearance of the tumor the Liver Cancer Study Group of
Japan (LCSGJ) defined three different types: mass-forming type
(MF), periductal infiltrating type (PI) and intraductal growth
(IG) type.
The aim of this study is to analyse the prognostic significance of
tumor gross type according to LCSGJ.
Patients and Methods: Between 1990 and 2007 81 consecutive
patients with ICC were submitted to surgery. Fifty-two patients
who underwent surgical resection with curative intent were in-
cluded into this study. Tumors were classified according to TMN
stage (6th edition 2002) and LCSGJ gross type classification.
Results: During the study period 52 patients were submitted to
surgical resection with curative intent whereas in 29 patients sur-
gery was limited to exlorative lapatotomy. Curative resection (R0)
was achieved in 43 patients (83%) and in 63% (33/52) of patients
a major hepatic resection was performed. Extrahepatic bile duct
resection was carried out in 36% (19/52) of cases. According to
LCSGJ classification, the MF type was present in 34 patients
(65%), the MF+PI type in 13 (25%), the PI type in 3 (6%) and
the IG type in 2 (4%).
Overall median survival time was 40 months, with a 1-, 3- and 5-
year actuarial survival of 83%, 50%, 20%, respectively. Survival
was significant related with the macroscopic gross type with a me-
dian survival of 50 months for patients with MF type, 19 months
for MF+PI type, 15 months for PI type and 17 months for IG
type. We identified that the MF+PI type tumors were signifi-
cantly associated with negative prognostic factors such as the in-
volvement of extrahepatic bile ducts, the presence of lymph nodes
metastases, the presence of macroscopic vascular invasion, the
presence of perineural invasion and higher T stage.
Conclusions: The curative resection of ICC is the only therapy
that can achieve long term survival. The tumor gross type is one
of the most important prognostic factor. The MF+PI tumors
were associated with negative prognostic factors and overall sur-
vival was significantly shorter compared to the others gross type.
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FACTORS ASSOCIATED WITH ADMISSION TO
HOSPITAL FOLLOWING OUTPATIENT ERCP
S. Thomasset1, C. Briggs1, G. Garcea2, T. Hall, C. Mann1,
A. Dennison2, D. Berry2
1. University of Leicester Leicester General Hospital
2. Leicester Teaching Hospitals Leicester General Hospital
Introduction: Outpatient endoscopic retrograde cholangiopan-
creatography (ERCP) is widely practiced, however, little data ex-
ists on factors which are associated with admission to hospital
following the procedure. The aim of this study was to identify fac-
tors which are associated with admission to hospital following
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outpatient ERCP.
Methods: A retrospective study of outpatient ERCPs undertaken
in a tertiary referral centre in 2006 and 2007. Data was extracted
from available case notes and seven factors were analysed to as-
certain whether they were associated with admission to hospital
following ERCP. Statistical analysis was undertaken using the
Student’s t-test and Fisher’s exact test. P values of less than 0.05
were deemed significant.
Results: Data from 154 outpatient ERCPs were reviewed. Ten
patients were admitted to hospital following the procedure due to
aspiration (n=1), a cardiovascular event (n=1), bleeding from a
sphinterotomy site (n=1) and post-procedural pain (n=7). One
patient was diagnosed with mild pancreatitis but pain resolved
spontaneously in all those admitted. Median hospital stay was 4
days (range 1 to 14 days) and there were no deaths in-hospital or
within 30 days of ERCP. Factors associated with admission to
hospital following ERCP were endoscopic sphinterotomy (p =
0.003), ERCP duration (p = 0.032), an ASA grade >2 (p =
0.043) and the dose of sedative administered (p = 0.048). Patient
age, disease aetiology and stent insertion were not associated with
admission to hospital following ERCP.
Conclusion: These data confirm that outpatient ERCP can be per-
formed safely with low rates of admission to hospital. Factors asso-
ciated with admission include endoscopic sphinterotomy, ERCP
duration, ASA grade and the dose of sedative administered.
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IATROGENIC BILE DUCT INJURY: SHORT AND
LONG-TERM RESULT AFTER SURGICAL OR
ENDOSCOPIC MANAGEMENT
A. Lauretta, O. Damrah, N. Katsoulas, R. Canelo, N. Habib, L. Jiao
HPB Surgery Hammersmith Hospital, London, UK
Introduction: Iatrogenic bile duct injury may have severe effects
on the health of patients. To determine appropriate management,
it is essential to define the type of bile duct injury.
AIM: The aim of this study was to analyze the management, and
short- and long-term results of ercp-ptc stenting and Roux-en-Y
hepaticojejunostomy reconstruction.
Methods: All patients with iatrogenic biliary injury managed at
our institution between 2002 and 2007 were included in this study.
Patients were treated surgically and/or endoscopically according
to the degree and the level (Strasberg classification) of the stric-
ture and of the leak.
Results: Eighteen patients with iatrogenic biliary injuries were
treated. 7 (38.8%) patients had only endoscopic interventions
whereas 6 (33.4%) patients underwent only surgical treatment. 5
(27.8%) patients needed to be treated with both surgical and in-
terventional procedure: in two cases the recurrent stricture after
surgery was successfully managed by repeated interventional
treatments while in two patients the recurrent stricture after re-
peated interventional procedures was successfully treated by he-
paticojejunostomy; only in one case, initially treated with surgery,
was necessary, after repeated interventional procedures which
failed, the re-fashioning of the anastomosis. Repeated interven-
tional treatments resulted in less complications (14.2%) than sur-
gery alone (50%) or surgery and interventional procedure
together (80%); as well as were correlated to a less initial hospi-
tal stay (P<0.01) and total hospital stay (P<0.01).
Conclusion: Multidisciplinary approach provides the best man-
agement for patients with bile duct injuries. Combination of sur-
gical and interventional techniques provides the best results in
the most complex cases.
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INFLUENCE OF BILIRUBIN AND CRP ON
CA19-9 LEVELS IN OBSTRUCTIVE JAUNDICE.
A PRELIMINARY STUDY
G. La Greca, M. Sofia, R. Lombardo, F. Barbagallo, S. Gagliardo,
S. Latteri, .D Russello, S. Puleo
Department of Surgical Sciences, Organ Transplantation, and Ad-
vanced Technologies, University of Catania, Catania, Italy
BACKGROUND. Discrimination between benign and malignant
obstructive jaundice could not be made on the basis of a solitary
elevated CA19-9 measurement. Inflammation and jaundice mod-
ify the specificity. We analysed a possible relation between in-
flammation and CA19-9 value to find a ratio or a corrective factor
for predictivity and specificity. METHOD. Patients with ob-
structive jaundice were recorded about all routine laboratory tests
including bilirubin, CRP and CA19-9. The adjusted CA19-9 value
was obtained by dividing it by the values of bilirubin and CPR.
RESULTS. Eighty-four patients were studied, 45(53.6%) had be-
nign disease and 39(46.4%) had a pancreaticobiliary malignancy.
In malignancies the mean value of bilirubin and CA19-9 were sig-
nificantly higher than in benigne (respectively P<0.01 and
P<0.05), the CRP was higher in the benigne (P<0.01). Sensitiv-
ity, specificity, PPV of CA19-9> 32 U/ml were 79.5%, 44.4% and
55.3%; when the cut-off is CA19-9>100 U/ml they were respec-
tively 61.5%, 80% and 72.7%, when the CA19-9 value was ad-
justed by diving it by the bilirubin or CRP they become 48.7%,
77.7%, 65.5% and 74.3%, 68.8% and 67,4% respectively. CON-
CLUSIONS. We conclude that 55.5% of patients with benign
jaundice had a pathological CA19-9, and using a cut off of
100U/ml, the specificity increased, with limited decrease in sen-
sitivity. The most part of benign patients have a CA19-9 value
<100U/ml, so by adjusting this value with the CRP it is possible
to increase the attendibility of the test. Other studies concerning
these markers are needed to improve knowledge for diagnosis of
malignant tumors when jaundice is present.
REFERENCES.
Qin XL, Wang ZR, Shi JS, et al. Utility of serum CA19-9 in di-
agnosis of cholangiocarcinoma:in comparison with CEA. W J
Gastroenterol 10:427; 2004.
Mann DV, Edwards R, Ho S, et al. Elevated tumor marker
CA19-9: clinical interpretation and influence of obstructive jaun-
dice. Eur J Surg Oncol 26:474; 2000.
Goonetilleke KS, Siriwardena AK. Systematic review of carbo-
hydrate antigen (CA19-9) as biochemical marker in the diagno-
sis of pancreatic cancer. Eur J Surg Oncol 33:266; 2007.
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CHOLECYSTECTOMY AND POLYPOID
LESIONS OF THE GALLBLADDER
M. Papoulas, P. Hadjicostas, C. Christophorides, K. Neophytou,
S. Petros, L. Sakis, A. Charalampos, N. Malakounides
Surgical Department, Nicosia General Hospital, Cyprus
Background: Gallbladder polyps (GP) are usually found inci-
dentally on U/S examination or after cholecystectomy. Due to
their malignant potential, surgeons tend to perform cholecystec-
tomy or close follow up with repeated U/S examinations. Opti-
mal strategies for evaluating those lesions have not been
established yet.
Aim: To report the frequency and clinicopathological features of
polypoid lesions of the gallbladder (PLG) after cholecystectomy
Method: A retrospective study was performed of 1080 patients
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who underwent cholecystectomy between January 2004 and No-
vember 2008 at the Nicosia General Hospital. Clinicopathologi-
cal features (age, gender, presence of symptoms, histopathologic
type) of patients presented with PLG have been assessed.
Results: PLG were detected on U/S examination in 28 patients
(2,6%) preoperatively. Of these, 16 benign GP (57,2%) and 3 ma-
lignant GP (10,7%) were identified on histopathologic analysis.
However, 9 patients (32,1%) did not have PLG upon histopatho-
logic analysis. 4 patients with GP had concomitant gallstones
(21%). The presence of cholesterolosis and adenomyomatosis of
the gallbladder is also assessed.
Conclusion: Size of polyp more than 1cm and age more than 65
years are the two most important factors predicting malignancy in
PLG. The histological finding of chronic cholecystitis (another
risk factor for cancer?) was present in all gallbladder polyps (both
symptomatic and asymptomatic). The presence of GP should be
reassessed with a second U/S examination before any elective
cholecystectomy.
The only effective treatment for GP is cholecystectomy which
should be considered in symptomatic patients, coexistence of gall-
stones or as prophylaxis to prevent malignant transformation.
Size of GP should always be evaluated.
References
Lee KF, Wong J, Li JC, Lai PB. Polypoid lesions of the gallblad-
der. Am J Surg. 2004; 188:186-90
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TREATMENT OF HEPATITIS C REINFECTION
AFTER LIVER TRANSPLANTATION WITH AN
ANTIVIRAL COMBINATION THERAPY
A. Perrakis, S. Schuhmann, N. Vassos, V. Schellerer, R. Croner,
K. Weber, W. Hohenberger, V. Muller
Surgical Department University of Erlangen-Nuremberg
Introduction: The sustained virological response (SVR) in patients
with chronic hepatitis C after liver transplantation is so low, so that a
hepatitis C recurrence with signs of acute or chronic hepatitis comes
in 55-75% of all recipients. To a graft loss resulting from recurrent cir-
rhosis comes in 10 to 40% of the cases. Today an antiviral combina-
tion therapy of interferon and ribavirin is feasible, which shows
sustained virological response (SVR) in approximately 20 to 40% of
the patients. The aim of the study was to evaluate the efficacy of the
interferon (IFN-a2b,peg interferon) and ribavirin (RIBA) treatment.
We report the course of biochemical parameters and the histological
course of recipients after achievement of SVR.
Methods: 21 patients with recurrent Hep C were treated with the
combination therapy consisted of IFN.a2b/peg-Interferon and
RIBA 6 months after OLTx. Hep C RNA was determined every
3 month after starting the therapy. Liver biopsy was taken before
begin and at the end of therapy. All patients were followed up a
mean of 24 +/- 5 months.
Results: Sustained virological response was achieved in 40%, in
25% of the treated patients there was no response to the therapy.
We saw also a statistically significant improvement of the histo-
logical activity index for inflammation activity and fibrosis. Re-
jection episodes were not to register.
Conclusion: The combination therapy with Interferon (INF a2b or
peg-interferon) and Ribavirin is an effective treatment in patients
with recurrent chronic Hep C after OLT. It results in a rate up to 40
% with a sustained virological response and leads furthermore to an
inhibition of inflammation and fibrosis progression.
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COMPARISON OF THE PRETRANSPLANT
IMAGING FINDINGS WITH THE LIVER
EXPLANT PATHOLOGIC FINDINGS, IN CASES
OF LIVER TRANSPLANTATION FOR
HEPATOCELLULAR CARCINOMA
N. Antoniadis1, D. Giakoustidis1, V. Pappanikolaou2,
K. Patsiaoura3, E. Katsiki3, G. Imvrios1, I. Fouzas1, G. Tsoulfas2,
D. Vrochides2, N. Ouzounidis1, S. Iosifidou2, N. Papachrisos4,
A. Giakoustidis2, D. Takoudas1
1. Organ Transplant Uni Aristotle University
2. Department of Transplantation Surgery, Aristotle University of
Thessaloniki, Greece Hippokratio General Hospital
3. Department of Pathology Aristotle University
4. Department of Internal Medicine, Aristotle University of Thessa-
loniki, Greece Hippokratio General Hospital
BACKROUND: Clinical staging and selection criteria for liver
transplantation of patients with cirrhosis and hepatocellular car-
cinoma (HCC) are based on pretransplant imaging.
AIMS: To evaluate the correlation of the pretransplant radio-
logical, spiral CT findings, with the pathologic findings of the ex-
plant liver in our liver transplant patients.
METHODS: We reviewed 41 cirrhotic patients with HCC diag-
nosis, who underwent liver transplantation between 1992-2006.
Pretransplant staging was based on triphasic helical-CT findings
and in serum alpha-fetoprotein levels. Imaging findings, regard-
ing size, number and location of HCC nodules, were compared
with the liver explant pathologic findings.
RESULTS: Identical findings between imaging and pathologic
examination was found in 10(24.4%) patients. In 10(24.4%) pa-
tients HCC diagnosis was given only by the pathologic examina-
tion and not by the preoperative imaging. Six patients (14.63%)
had false-positive pretransplant diagnosis of HCC. Pretransplant
underestimation of the number of tumors was found in 13(31.7%)
patients, in 7 of them by 1-2 missed tumors and in 6 by > 3 tu-
mors. One of these patients had also underestimation of the size
of the tumor (< 1 cm difference). In 2(4.8%) patients there was
pretransplant overestimation of the number of the tumors (by 1
tumor < 1 cm). Pretransplant staging classified 39(95%) within
Milan criteria, while in pathologic staging only 28(68.3%) full-
filled the criteria. The sizes of the undiagnosed tumors were: in
13 patients <1.5cm, in 7 patients 1.5cm-2cm and in 3 patients >
2 cm.
CONCLUSIONS: In cirrhotics accurate pretransplant HCC stag-
ing is problematic, specially for tumors <2cm.
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INDICATING LIVER TRANSPLANTATION FOR
FULMINANT HEPATIC FAILURE - THE APACHE
III SCORE IS SUPERIOR TO MELD SCORE AND
KINGS COLLEGE HOSPITAL CRITERIA
P. Fikatas, F. Ulrich, J. Lee, S. Chopra, A. Pascher,
O. Guckelberger, G. Puhl, U. Neumann, P. Neuhaus, J. Pratschke
Dept. of General, Visceral and Transplantation Surgery Campus Vir-
chow Clinic
Whilst the MELD score and the King`s College Hospital (KCH)
criteria are accepted evaluation models in patients with fulmi-
nant hepatic failure (FHF), the impact of the APACHE III score
on outcome after orthotopic liver transplantation (OLTX) has
not been defined yet. Aim of this study is to compare these early
indicators for liver transplantation and investigate their predictive
efficacy.
Patients and Methods: The study included 111 patients with FHF,
listed for OLTX between 1996 and 2007. MELD score, KCH cri-
teria and APACHE III score were retrospectively defined for the
day of listing for transplantation.
Results: We devided the cohort according the 1-year outcome.
Group 1 consisted 11 patients who were taken fron transplant
waiting list due to improving clinical condition and 73 patient
who survived OLTX. The nonsurvivors group (group 2) included
11 patients who died while waiting for a suitable graft and 16 pa-
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tients who died after transplantation. In Group 1 compared to
group 2 the mean MELD score was 32 8 vs. 34 7 and the
APACHE III was 61 17 vs. 75 21, respectively. In group 2 the
KCH criteria were positive in 56% of the cases. The ROC analy-
sis revealed that compared to MELD score and KCH criteria, the
APACHE III score was a better indicator of prognosis in patients
with FHF (AUC: 0.66, 0.55 and 0.83 respectively).
Conclusion: This study is the first that showes that the APACHE
III score is superior to MELD score and the KCH criteria in ac-
cessing prognossis in patients with FHF.
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NON-ANASTOMOTIC BILIARY STRICTURES
AFTER LIVER TRANSPLANTATION. A SINGLE
CENTRE EXPERIENCE
J. Pine, M. Reddy, M. Davies, G. Toogood, S. Pollard, P. Lodge,
R. Prasad
Department of Organ Transplantation, St James’s University Hos-
pital, Leeds, United Kingdom.
Introduction: Non-anastomotic biliary strictures (NABS) are im-
portant complications after liver transplantation.
Methods: Data was collected by case note review. 22 patients
(1.7%) were diagnosed to have NABS.
Results: Seven (32%) patients had received non-heart-beating
grafts. 4 patients had early hepatic artery thrombosis (HAT) and
underwent emergency revascularization. Ten (45%) patients pre-
sented within 3 months of transplant. Four patients had involve-
ment of the extra-hepatic bile ducts alone, 6 of intra-hepatic bile
ducts alone and 12 had involvement of both. Intra-hepatic duct
involvement varied from single sectoral duct (2), multiple duct
strictures (11) and diffuse involvement (5). CT angiography iden-
tified 3 with late HAT and 7 with hepatic artery stenosis (5 an-
gioplastied). All patients received oral ursodeoxycholic acid and
antibiotics. This was the definitive treatment in four patients.
ERCP was carried out in 11 patients with suggestion of a domi-
nant extra-hepatic stricture. Of these, 5 patients had trial stent
placement and 2 had stricture dilation (1 success). Percutaneous
stricture dilation was attempted in two patients (1 success). Bil-
iary reconstruction was carried out in 4 (2 successes). 2 further
patients await biliary reconstruction. Re-transplant was not pos-
sible in 3 patients (2 were unfit, one refused). 10 (45%) were re-
transplanted due to late HAT or failure of other therapies. At
median follow up of 56 months graft survival was 9/22 (41%) and
patient survival was 16/22 (73%).
Conclusion: NABS have an ischaemic aetiology. Management
should be multi-disciplinary and tailored to each patient. Opti-
mum use of all therapeutic modalities including re-grafting im-
proves patient survival.
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PROCALCITONIN AS DIAGNOSTIC MARKER
FOR CLINICALLY SIGNIFICANT INFECTIONS
IN LIVER TRANSPLANT RECIPIENTS ON THE
INTENSIVE CARE UNIT
M. van den Broek1, S. Olde Damink1, B. Winkens2, C. Broelsch3,
M. Malago4, A. Paul3, F. Saner3
1. Surgery Maastricht University Medical Center
2. Department of Methodology and Statistics Maastricht University
3. Department of General, Visceral and Transplant Surgery Univer-
sity of Essen
4. University College London Hospital, NHS Foundation Trust De-
partment of Hepatobiliary and Pancreatic Surgery
Background: Clinically significant infections (CSI) are life threat-
ening but difficult to diagnose in liver transplant (LTx) recipients.
Aims: To assess the value and accuracy of procalcitonin (PCT)
additional to C-reactive protein (CRP) and leukocyte count (LC)
as independent predictor of CSI in LTx recipients on the ICU.
Patients and methods: The course of LTx recipients transplanted
in a University Hospital between 2006 and 2008 was studied. CSI
were defined as pulmonary, blood stream or intra-abdominal in-
fections proven by culture. Peak values were compared using
Mann-Whitney U test. Independent predictors for CSI were eval-
uated using Cox proportional hazard analysis. ROC curves were
constructed to determine diagnostic accuracies.
Results: 135 recipients were eligible, of whom 30 experienced a
CSI. Recipients with and without CSI showed significant differ-
ences in peak PCT (27.2 ng/mL [1.8–415.0] versus 12.7 ng/mL
[0.7–241.3], p=0.01) and peak CRP (13.7 mg/dL [3.5–31.5] versus
9.9 mg/dL [1.5–28.3], p<0.001), but not peak LC (19.3/nL [5.1–
54.0] versus 14.2/nL [5.1–53.9], p=0.05). Independent predictors
of CSI were male sex, acute liver failure, duration of cold is-
chemia and peak CRP. Peak PCT had no additional predictive
value (-2 Log Likelihood p=0.346). The diagnostic accuracy of
peak CRP was superior to peak PCT and peak LC (AUCCRP
0.725 versus AUCPCT 0.650 and AUCLC 0.617).
Conclusions: Peak PCT and peak CRP, but not peak LC, differed
significantly between LTx recipients with and without CSI. Peak
PCT was of limited value in predicting CSI and had inferior di-
agnostic accuracy compared to peak CRP.
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URINARY AMMONIA EXCRETION ACUTELY
INCREASES DURING LIVING DONOR LIVER
TRANSPLANTATION
L .Mpabanzi1, M. van den Broek2, M. van de Poll2, S. Nadalin3,
C. Dejong1, M. Malago4, S. Olde Damink2
1. Department of Surgery Maastricht University Medical Centre
2. Surgery Maastricht University Medical Center
3. Department of Surgery Univeristy of Essen
4. University College London Hospital, NHS Foundation Trust De-
partment of Hepatobiliary and Pancreatic Surgery
Introduction: We recently showed that renal ammonia handling
is of pivotal importance in determining ammonia concentrations
in patients with cirrhosis. No data exist on the potential contri-
bution of altered renal ammonia handling to peri-transplantation
ammonia homeostasis.
Aim: The present study was designed to study the consequences
of living donor liver transplantation (LDLTx) on arterial ammo-
nia concentration and urinary ammonia excretion.
Patients and Methods: Eleven patients with cirrhosis of the liver
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underwent LDLTx (7M/4F, median age 53 yrs [range 28 – 67 yrs],
median MELD 13 [range 7 – 28], median graft-to-recipient-
weight ratio 1.06 [range 0.73 – 1.53] with a median warm ischemic
time of 40 minutes [range 30 – 59 minutes]). Urinary flow and
samples of arterial blood and urine were taken prior to, during
and 2 hours after the anhepatic phase of the LDLTx. Data are
expressed as median with range. Differences were tested using
Wilcoxon’s test. A p<0.05 was considered statistically significant.
Results:
Legenda: significance from pre-anhepatic value, #p<0.05,
##p<0.001; significance from anhepatic, **p<0.01.
Conclusion: The anhepatic phase induces hyperammonemia that
returned to normal 2 hours after the reperfusion of a partial liver
graft. The kidneys significantly increased urinary ammonia ex-
cretion during the anhepatic phase which sustained after reper-
fusion, thereby contributing to the rapid normalization of
ammonia homeostasis, confirming the pivotal role of the kidney
in interorgan ammonia metabolism.
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DEFINING TRANSPLANTATION SUCCESS
A. IJtsma1, C. van der Hilst2, D. Nijkamp1, J. Bottema1, M. Slooff1
1. Department of Hepatobiliary Surgery and Liver Transplantation
University Medical Center Groningen
2. Department of Medical Technology Assessment University Med-
ical Center Groningen, The Netherlands
Usual methods of providing survival data on liver transplant pa-
tients focus on either waiting list mortality or post-transplanta-
tion survival. Since these two concepts are strongly related,
combined pre- and post-transplantation survival figures would
allow optimal assessment of the quality performance of different
liver transplant programs.
This study presents a relatively simple and uniformly applicable
view on assessing the outcome of patients listed for liver trans-
plantation, combining pre- and post-transplant survival figures.
All 542 patients having spent any time on the waiting time for
liver transplantation in the Netherlands between September 2004
and December 2006 are included in this study.
Of 312 patients removed from the waiting list during the study
period, 252 were transplanted, 46 died, 19 were removed due to
contra-indications and subsequently died, 12 patients improved
and four were lost to follow-up. The death rate per patient year
on the waiting list was 10.4% as calculated in concordance with
UNOS definitions. Mean waiting time for transplantation was
0.84 years.
The expected value for pre-transplantation mortality was 0.84 *
10.4% = 8.7%.
One year post-transplantation patient and graft survival were
87.7% and 80.0% respectively.
Therefore, transplantation success, defined as the chance to sur-
vive up to transplantation and one year thereafter, without re-
transplantation, was estimated at 91.3% * 80.0% = 73.0%.
In conclusion, this study presents a combined method of pre-
senting pre- and post-transplantation survival data, allowing for
quality assessment of the performance of different liver trans-
plant programs.
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VERY EARLY HEPATIC ARTERY THROMBOSIS
AFTER LIVER TRANSPLANTATION MAY NOT
BE DETECTED BY POST-OPERATIVE
TRANSAMINASE ELEVATION
V. Papanikolaou1, D. Vrochides1, G. Imvrios1, D. Giakoustidis1,
I. Fouzas1, N. Antoniadis1, A. Ntinas1, D. Kardasis1, E. Akriviadis2,
T. Vasiliadis2, I. Goulis2, E. Anagnostara3, E. Katsiki4,
N. Ouzounidis1, G. Tsoulfas5, A. Tatiana1, A. Tsitlakidis1,
D. Takoudas1
1. Organ Transplant Unit Aristotle University
2. Department of Internal Medicine Aristotle University
3. Department of Anesthesiology Aristotle University
4. Department of Pathology Aristotle University
5. Harvard Medical School Massachusetts General Hospital
Purpose: To study the liver enzyme elevation secondary to very
early HAT after liver transplantation.
Methods: A total of 231 primary, adult, single-organ liver trans-
plants were performed from 1990 to 2007. Fifteen patients
(6.49%), were diagnosed with very early HAT either by Doppler
of by contrast enhanced computed tomography (ceCT) scan. As-
partate aminotransferase (AST) value ≥ 800 IU/ml within the
first two postoperative days predicted early graft failure (within
90 days post-transplant) with 90% sensitivity and 100% specificity
(s=0.960, p=0.005). Group A’ patients (n=9) reached this
threshold, whereas group B’ patients (n=6) did not.
Results: All liver grafts with very early HAT finally failed, lead-
ing to either re-transplantation or patient’s demise. Mean graft
survival was 32.78 ± 22.82 and 221.17 ± 171.80 days for groups
A’ and B’ respectively (p=0.006). Mean AST value two days after
transplantation was 2688 ± 1226.18 and 375 ± 169.65 IU/ml for
groups A’ and B’ respectively (p=0.001).
Conclusions: Very early HAT after liver transplantation has two
distinct patterns of presentation. The first one is associated with
high post-operative AST values and leads to rapid graft failure.
The second is associated with mildly elevated post-transplantion
AST values and leads to a much slower graft failure.
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THE EFFECT OF RECIPIENT RENAL
FUNCTION ON SURVIVAL FOLLOWING
ORTHOTOPIC LIVER TRANSPLANTATION
(OLT)
V. Papanikolaou1, G. Tsoulfas2, G. Imvrios1, D. Giakoustidis1,
N. Antoniadis1, I. Fouzas1, T. Vasiliadis3, I. Goulis4,
G. Moutsianos5, D. Vrochides6, N. Ouzounidis1, A. Ntinas1,
P. Agorastou4, D. Takoudas1
1. Organ Transplant Unit Aristotle University
2. Harvard Medical School Massachusetts General Hospital
3. Hepatology Ippokrateio General Hospital
4. Department of Internal Medicine Aristotle University
5. Anesthesiology Ippokrateio General Hospital
6. Transplantation Surgery Ippokrateio General Hospital, Greece
Background: One of the goals of the MELD system has been to
give priority to patients with pre-transplantation renal insuffi-
ciency.
Aim: To evaluate the effect of recipient renal function on sur-
vival following liver transplantation.
Methods: This is a retrospective study of 138 patients that un-
derwent OLT at a University Transplant Center in Greece dur-
ing a period of 15 years. The demographic and clinical data of
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donors and recipients were analyzed. The renal function, pre-
and post-transplantation, and survival were compared between
the following two groups: group A (123 patients with pretrans-
plant Cr ≤ 1.5) and group B (15 patients with pretransplant Cr >
1.5).
Results: The mean pretransplant Cr value for group A was 0.9,
whereas for group B it was 1.8. There were no statistically sig-
nificant differences between the two groups regarding donor and
recipient age, quality of donor based on the DRI and cold is-
chemia time. One and five year patient survivals were 80% and
78% for group A, whereas they were respectively 70% and 60%
for group B (statistically significant differences). There was also
a statistically significant difference in the one-year post trans-
plantation Cr level, which was higher in group B at 2.1, versus 1.2
in group A.
Conclusions: The presence of renal dysfunction or renal insuffi-
ciency pre-transplantation can affect survival in a negative man-
ner following orthotopic liver transplantation. This raises the
question of whether these patients should be considered for com-
bined liver-kidney transplantation.
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THE VALUE OF CUSA AND ARGON BEAM
COAGULATION IN LIVING DONOR LIVER
TRANSPLANTATION: EXPERIENCE OF 188
CASES
D Raptis1, F Prete2, J Skipworth1, S Olde Damink3, C Imber4,
A Shankar4, M Malago4
1. University College London Department of Surgery and Interven-
tional Science
2. University College Hospital, London Department of Hepatopan-
creaticobiliary Surgery
3. Surgery Maastricht University Medical Center
4. University College London Hospital, NHS Foundation Trust De-
partment of Hepatobiliary and Pancreatic Surgery
Introduction: Limited and inconsistent data are currently avail-
able concerning the efficacy and safety of the various liver
parenchymal transection techniques available for living donor
liver transplantation (LDLT). This study aimed to compare the
Clamp Crushing (CC) with the Cavitron Ultrasonic Dissector
(CUSA) transection techniques for LDLT-related hepatectomy.
Methods: Data from all LDLT, performed by a single surgeon in
a single centre, were prospectively collected over a 6-year period.
Data included demographics, type of procedure, transection tech-
nique, peri-operative blood-loss (actual measured blood loss, cell-
saver replacement and transfusion requirements), total operative
time, length of ICU and hospital stay, and morbidity and mortal-
ity. The CC technique was utilised for LDLT between June 1998
and February 2000; and the CUSA between February 2000 and
June 2007. Standardised operative resection techniques and peri-
operative management protocols were utilised in all patients.
Results: A total of 188 patients underwent LDLT over the study
period, 40 via the CC technique and 148 utilising CUSA. 101 pa-
tients were male, mean age was 35 (±10) years and mean BMI 24
(±3) kg/m². Procedures performed included 30 left lateral, 12 left
and 146 right hepatectomies. Comparison of the CC and CUSA
groups revealed no significant differences in demographics, pro-
cedure type, length of ICU and hospital stay, or morbidity and
mortality. Total operative time was significantly longer in the
CUSA group [390 (CUSA) vs. 298 (CC) min, p<0.0001] but was
associated with a significantly lower mean blood loss [314
(CUSA) vs 846 (CC) ml, p<0.0001].
Conclusions: This large series demonstrates that, despite signifi-
cantly longer total intra-operative times, the bloodless parenchy-
mal transection facilitated through the use of CUSA significantly
reduces peri-operative blood loss and transfusion requirements,
in patients undergoing LDLT.
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DE NOVO HEPATOCELLULAR CARCINOMA
(HCC) OF DONOR ORIGIN IN A LIVER
ALLOGRAFT, 3 YEARS AFTER LIVER
TRANSPLANTATION. A CASE REPORT
S. Vernadakis, M. Poetsch, F. Weber, E. Malamutmann,
M. Troullinakis, E. Christodoulou, G. Kaiser, A. Paul
Department of General, Visceral and Transplantation Surgery, Uni-
versity Hospital Essen, Germany
Background: De novo HCC in liver transplants without preced-
ing HCC have rarely been reported. We report of a de novo HCC
of donor origin, determined by molecular DNA-analysis, in a liver
allograft 3 years after LTx without preexisting HCC and no his-
tory of hepatitis associated or other type cirrhosis.
Case report: A 59 year-old male with a history of alcoholic cir-
rhosis underwent an orthotopic-LTx. The native liver was free of
HCC. The donor was a 67 year-old man, with no history of can-
cer, who died of intracerebral hemorrhage. The recipient’s im-
munosuppression consisted of CSA, prednisone and MMF. After
the LTx the patient developed ischemic type intra biliary lesions
with cholangitis. He was medical treated and repeated endoscopic
interventions were performed. Under these regimens transplant
function remained stable. 3 years after the LTx, U/S revealed an
echogenic mass in the liver allograft. A biopsy was performed
and the histology was compatible with HCC. The patient under-
went atypical partial liver graft resection of segment 7. The re-
section margins were free of tumour. Hepatic resection was
considered a graft saving option. The donor origin of the tumour
was confirmed based on genotype match on the DNA from the
donor and recipient, compared with the tumour tissue.
Conclusion: Organ transplant recipients are considered at a
greater risk of de novo malignancies related to immunosuppres-
sion. Donor transmitted malignancies are theoretically prevent-
able by meticulous donor evaluation. Surveillance would allow
early detection of such tumours which, in turn, would enable graft
saving therapeutic methods to be performed.
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PANCREAS TRANSPLANT WITH ENTERIC
DRAINAGE IN TAIPEI VETERANS GENERAL
HOSPITAL
Y. Shyr
Taipei Veterans General Hospital, China
Objectives: Insulin-dependent diabetes mellitus (IDDM) even-
tually leads to nephropathy, neuropathy, retinopathy and an-
giopathy. Nowadays, pancreas transplantation is the treatment of
choice in tight control of blood sugar for IDDM patients. S
Methods: From September 2003 to November 2008, 34 cases of
pancreas transplant were performed. The clinical courses includ-
ing blood sugar, C-peptite and HbA1 C levels and renal function
after operation were fully recorded and presented. The compli-
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cations were also evaluated.
Results: The success rates for both pancreas and kidney trans-
plants are 100%. The blood sugar returned to normal level 3
hours (median) after revascularization of the pancreas graft. The
fasting blood sugar maintained within normal range thereafter
throughout the whole clinical course for all patients, except case
2 who experienced grade 3 isolated pancreatic rejection which
was eventually reversed by 5 days thymoglobulin. The complica-
tions included 1 pancreatic graft bleeding, 2 isolated pancreas re-
jection, 4 intestinal obstruction, 1 pulmonary embolism and 1
acute myocardial infarction. Most of these 34 patients presented
hyperinsulinemia after pancreas transplant. The HbA1C returned
to normal level 1 month after pancreas transplant, except 1 SPK
patient who was found to have concurrent type II DM with in-
sulin receptor resistance after IDDM was resolved by SPK trans-
plant. All of our 34 patients are free from insulin injection and
hemodialysis.
Conclusions: SPK transplant provided an ideal insulin-free and
dialysis-free solution for IDDM and uremia. Pancreas transplan-
tation could be performed with similar successful rate of kidney
transplant if they were done simultaneously.
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LAPAROSCOPIC DISTAL PANCREATECTOMY
L. De Cecchis, A Rosignoli, V Durastante, M Zuccolo, R Petri
Department of Abdominal Surgery, University Hospital “Santa
Maria della Misericordia” of Udine, Italy
Background: Since the increasing demand for laparoscopic sur-
gical procedures, the authors show a video presentation of distal
pancreatectomy based on their experience of 25 cases in the last
5 years. The aim of this report is to confirm and support the pre-
vious series of the literature that described this mini invasive ap-
proach believing in the future of this new procedure. Considering
the results: in 25 distal pancreatectomies there was no mortality,
1 conversion due to major bleeding of the splenic vessels that re-
quired 4 unit of RBCs in the first postoperative day, 1 fluid col-
lection wider than 5 cm in diameter with clinical relevance was
detected in a patient that was treated by a CT-drainage with com-
plete resolution otherwise no pancreatic fistula persisted for
more than 7 days. Regard the technique only 3 spleen were pre-
served for both technical problems and oncological radicality.
The pancreas resection was carried out by harmonic scalpel. The
mean operative time was 180 minutes. The mean hospital stay
was of 10 days without including the patient with the postopera-
tive fluid collection that was discharged in the 30th postoperative
day. Conclusions: the hope of this approach is targeted at mini-
mizing the surgical impact preserving the oncological radicality
and safety. With our series we want to share with the HPB pop-
ulation of surgeons the feasibility of this procedure, the surgical
skills and the weak point such as the management of the pancre-
atic stump.
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THE ROLE OF LIVER RESECTION FOR
NONCOLORECTAL, NONNEUROENDOCRINE
HEPATIC METASTASES
G. Ercolani, G. Vetrone, G. Graz, M. Cescon, P. Di Gioia,
M. Ravaioli, M. Del Gaudio, M. Zanello, A Pinna
Hospital Sant’Orsola, Bologna, Italy
Background: Liver resection is treatment of choice for colorectal
hepatic metastases. Aim: indications and results were retrospec-
tively reviewed in 134 resected patients for non-colorectal, non-
neuroendocrine liver metastases (NCRNNE) to evaluate the role
of liver resection in these patients.
Methods: The site of primary tumor was: breast in 44, gastroin-
testinal in 26, genitor-urinary in 20, soft tissue sarcoma in 14, and
other sites in the remaining 30. Mean tumor number was 1.57 cm.
Mean tumor diameter was 55 mm. Mean age was 56 year old.
Chi-square test was used to evaluate prognostic factors. Cox re-
gression test was used to analyze significantly variables at the uni-
variate analysis.
Results: Operative mortality was 3%. Operative morbidity was
23.1%. Major hepatectomies were required in 56 (41.8%) pa-
tients. In 90 (67.2%) patients there was no need of blood trans-
fusion.
Overall 3 and 5-year survival were 56.4% and 40%, respectively.
The 3 and 5-disease-free survival were 44% and 30%. Thitynine
patients (27%) survived more than 60 months. At the univariate
analysis, diameter less than 5 cm, disease-free interval superior to
1 year, metastases non from gastrointestinal tumor and minor he-
patectomies were significantly related to long term survival
(p<0.05 for each one). At the multivariate analysis, the diameter,
disease-free interval and site of primary tumor were significantly
related to outcome.
Conclusions: liver resection is a safety and effective treatment in
patients with NCRNNE liver metastases and should be included
within the multimodal treatment of these patients. Excluding
metastases from gastro-intestinal tumor, satisfying long term re-
sults can be obtained.
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PREDICTION AND EARLY DETECTION OF
POST-HEPATECTOMY LIVER FAILURE BY
PERIOPERATIVE USE OF THE LIMON
METHOD OF INDOCYANINE GREEN
ELIMINATION
N. de Liguori Carino1, D. O’Reilly2, K. Dajani1, P. Ghaneh1,
G. Poston2, A. Wu1
1. Hepatobiliary Unit University Hospital Aintree, Liverpool, UK
2. Supra-Regional Hepatobiliary Unit University Hospital Aintree,
Liverpool, UK
Introduction: A non-invasive liver function monitoring system,
the LiMON®, has been developed that measures indocyanine
green (ICG) elimination by pulse spectrophotometry.
Aims: to assess the relationship between pre and post-operative
ICG plasma disappearance rate (ICG PDR %/min) values and
the onset of post-hepatectomy liver dysfunction in non-cirrhotic
patients.
Methods: 37 patients scheduled for major liver resections were
selected. None had chronic liver disease. IGC PDR was meas-
ured preoperatively and on days 1, five and 10 postoperatively.
On the same day, serum liver function tests were measured.
Results: The median preoperative and post-operative day 1 ICG
PDR for the patients who developed liver dysfunction was sig-
nificantly lower compared to the one of those who did not
(p=0.044, p=0.014). Significant correlation was found between
ICG PDR measurement taken on postoperative day 1 and biliru-
bin level on day 1 (p=0.002), 5 (p=<0.001) and 10 (p= 0.001).
The same was true for IGC PDR on post-operative day 1 and al-
bumin level on day 5 and 10 (p= 0.003, p<0.001).
Discussion: LiMON ICG PDR measured by pulse spectopho-
tometry is a quick, non-invasive and reliable liver function test in
patients undergoing liver resection that aids in the prediction and
early detection of post-hepatectomy liver dysfunction.
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THE REMOTE RESULTS OF PORTOCAVAL
SHUNTING AND THE PREDICTORS OF
SURVIVAL RATE, AT PATIENTS WITH
CIRRHOSIS
I. Dzidzava, B. Kotiv, A. Smorodsky, A. Kochatkova
Medical Military Academy, Saint-Petersburg, Russia
Goal: to reveal the basic predictors of survival rate of patients
after portocaval shunting.
Materials and methods. There were 107 patients with a portal hy-
pertension caused by cirrhosis in research. Distal splenorenal
anastomosis (DSRA) was executed to 46 patients, mesenterico-
caval H-anastomosis (H-MCA) – 53, splenorenal H-anastomosis
(H-SRA) – 8 patients. Degree of hepatic dysfunction estimated
under biochemical tests, a clearance of indocyanine green (ICG)
and by Child-Pugh scales (the A class– 30,8%, B – 50,4%, C -
19,8%) and MELD (a mean score – 8,54±3,31). E. Kaplan – P.
Meier method and regressive analysis Cox were used at statistic
analysis of the data.
Results. Relapses of esophago-gastric bleedings and thromboses
of anastomosis weren’t in the remote period of supervision. The
hepatic encephalopathy was diagnosed after DSRA in 15,2%,
after partial anastomosis at 8 (15,1%) patients. The cumulative
survival rate in supervision about one year has made 89,3±3,2%,
3, 5 and 10-year survival - 82,9±4,1%, 60,1±5,9% and
23,1±6,9%, accordingly. The median survival - 60±5,1 months.
Life expectancy after PCS was defined by degree of hepatic de-
compensation. The plasma disappearance rate of ICG
( =0,0001), expressiveness of ascites ( =0,045), whey albumin
( =0,032), mno ( =0,05) were included in definitive model as pre-
dictors of survival rate. The estimation of practical value of model
has shown that the area under a ROC-curve made 0,791 whereas
for scales Child-Pugh and MELD this indicator has made 0,64
and 0,61, accordingly.
Conclusion. Selective and partial portocaval shunting at the com-
pensated and subcompensated function of a liver at patients with
cirrhosis allow to achieve satisfactory indicators of survival rate.
Major predictors of survival rate are PDR ICG, ascites, albumin
and mno.
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REHEPATECTOMY FOR COLORECTAL LIVER
METASTASES: ARE MORBIDITY AND
SURVIVAL INFLUENCED BY THE EXTENT
OF THE FIRST RESECTION ?
M. Seblini1, E. Boleslawski2, S. Truant2, P. Zerbib1, O. Romano3,
F. Pruvot2
1. Chirurgie Digestive et Transplantations CHRU DE LILLE
2. Service de Chirurgie Digestive et Transplantations CHRU LILLE
3. Oncologie Médicale CHRU DE LILLE, France
Introduction: Sixty percent of patients operated for colorectal
liver metastasis (LM), have recurrence after the first hepatectomy
(RSX1), of whom 20% will benefit a second hepatectomy
(RSX2). This study analyses the impact of RSX1 extent on RSX2
morbidity and survival.
Patients and Methods: January 2000 till May 2008: 307 hepatec-
tomies for LM, of which 53(17, 3%) were RSX2 (two stage pro-
cedure excluded); (23F/30M; mean age 61.7 years); LM
synchronous in 35(66%), bilobar in 16 (30%); Eight patients had
associated extra-hepatic procedure. Two sequences of hepatec-
tomies compared: Sequence1 = RSX1 were major
(n=23;43.4%); Sequence2 = RSX1 were minor (n=30; 56.6%).
In Sequence2, minor RSX1 were followed by major RSX2 in 19
patients (63.3%) and by minor RSX2 in 11 patients (37.7%).
Results:
There was no postoperative mortality in both groups. Eighteen
patients died from recurrence and 3 with no recurrence. Nine-
teen patients are alive with no recurrence. Thirteen patients are
alive with recurrence. Comparison between Sequence1 and Se-
quence2 showed no difference in overall and RSX2 morbidity as
well as 3-year survival. Three-year survival was better when the
margins at RSX1 were greater than 10mm (67.5% vs 36.8%.
p<0.05).
Conclusion:The sequence of resection had no impact on mor-
bidity and survival. Only the chance of exceeding a 10 mm mar-
gin at the first resection should influence the preoperative
decision of performing a minor or a major resection first.
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INTRAHEPATIC CHOLANGIOCARCINOMA:
PRIMARY LIVER RESECTION AND
AGGRESSIVE MULTIMODAL TREATMENT OF
RECURRENCE SIGNIFICANTLY IMPROVE
SURVIVAL
G. Ercolani1, G. Vetrone, G. Grazi, M. Cescon, M. Ravaioli,
G. Brandi2, C. Serra3, M. Del Gaudio, M. Zanello, A. Principe4,
A. Cucchetti, A. Pinna
1. Hospital Sant’Orsola
2. Department of Oncology
3. Department of Internal Medecine
4. Dept. of Surgery and Trasplantation University of Bologna, Italy
Background: intrahepatic cholangiocarcinoma (IC) is often diagnosed
in advanced stage and recurrence rate is high after partial hepatectomy.
Aim: two periods with different approach were analyzed to evaluate
long term results, incidence and management of recurrence
Methods: Seventy-four resected patients for IC were divided into
2 groups according to the year of operation (before and after
1999). Patients characteristics, overall and disease-free survival,
management of recurrence and related survival were analyzed.
Results: The 3 and 5 year overall survival was 62% and 48%,
while the 3 and 5 year disease free survival was 30% and 25%.
There was a significant better 5-year survival among patients op-
erated after 1999 (56% vs 33%), with node negative (52% vs 0),
without blood transfusion (62% vs 22%), and who received adju-
vant chemotherapy (65% vs 40%).
The recurrence rate was comparable in the 2 groups (38.9% and
50%, p=0.49). The most frequent site of recurrence was the liver.
After 1999, a more aggressive approach in the management of
recurrence was applied based on re-resection or ablation plus
chemotherapy. The patients treated for recurrence were signifi-
cant higher after 1999 (81% vs 14.2%).
The overall 3-year survival was 46% after recurrence (median sur-
vival time: 25.2 months). After 1999 there was a significant im-
provement in 3 year survival after recurrence (56%, median: 36
months) compared to patients operated before 1999 (0%, me-
dian 16 months , p=0.004).
Conclusions: liver resection is the gold standard for IC; despite
recurrence rate remains still high, an aggressive multimodal ap-
proach could significantly improve survival.
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RIGHT HEPATECTOMY EXTENDED TO
SEGMENT 4A FOR HEPATOCELLULAR
CARCINOMA
D. Cherqui, L. Vigano’, A. Laurent, C. Tayar.
Departments of General and Hepato-Biliary Surgery, Hôpital Henri
Mondor, Créteil, France
The video shows a right hepatectomy extended to segment 4a for
hepatocellular carcinoma in a 50 year-old woman with HBV+
chronic hepatitis A2F1.
In March 2008, screening abdominal US and MRI showed a 4 cm
HCC in segment 8 in contact with the right and the middle he-
patic veins. AFP was 26.9 ng/mL and liver function tests were nor-
mal. Liver resection was planned.
A J-shaped incision was performed. The confluence of the he-
patic veins and the space between the right and the middle he-
patic veins were dissected. A tape was passed between the liver
and the IVC in order to perform a hanging maneuver. Right por-
tal branch and right hepatic artery were taped and divided. Is-
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chemic demarcation along the Cantlie’s line was obtained.
Cautery incision of Glisson’s capsule was performed along the
right side of the upper part of falciform ligament. The middle he-
patic vein was exposed along its final 4 cm up to its confluence
into the inferior vena cava. Transection line was then conducted
along the Cantlie’s line between segments 5 and 4b, and then
transversally between segment 4a and 4b to reach transection line
along falciform ligament previously marked. Parenchymal tran-
section was performed with bipolar coagulation and ultrasonic
dissector. Encountered structures were treated with the applica-
tion of clips or sutures according to their size. In the horizontal
part of transection plane, the middle hepatic vein was identified
and divided between ligatures. The right hepatic duct and the
portal pedicles of segment 4a were intraparenchymally divided.
The scissural vein was exposed along transection line and pre-
served. At the end of parenchymal transection the middle and
the right hepatic veins were divided by linear stapler. The hepa-
tocaval ligament was divided between clips. Right hepatectomy
was completed by mobilisation of the specimen.
Operative time was 210 minutes. A single session of pedicle
clamping (20 minutes) was needed during the final part of
parenchymal transection. Blood loss was 250 mL and no transfu-
sions were required. Postoperative course was uneventful and the
patient was discharged on postoperative day 10.
Final pathology confirmed diagnosis of hepatocellular carcinoma
infiltrating the right hepatic vein. Surgical margin was 2 mm.
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FEASIBILITY OF RADICAL SURGERY FOR
LIVER HYDATIDOSIS. A PROSPECTIVE SERIE
J. Ramia, P. Veguillas, R. De La Plaza, J. Quiñones, M. Marqueta,
J. Garcia-Parreño
Department of Surgery Hospital Universitario de Guadalajara, Spain
Non radical surgery (NRS) has been performed usually to treat liver
hydatidosis (LH). NRS is less demanding than radical surgery (RS)
but associated with higher percentages of morbidity and relapses.
HPB surgeons can offer nowadays RS to LH patients.
AIM: To measure feasibility, morbimortality and relapse of RS in
LH. To identify cases less suitable for RS.
PATIENTS&METHODS: Prospective study: May07-Oct08. 25
patients with 29 cysts. 14 male/11 female. Age: 48.5 (range: 23-
81). Main symptom: cyst infection: 2; jaundice: 5; cutaneous fis-
tula: 1, abdominal pain: 17. Four patients are relapsed cases.
Mean cyst diameter 8.14 cm (range: 3-20).
RESULTS: RS procedures were: left hepatectomy (3), left lat-
eral sectionectomy (6), total cystectomy (10), near total cystec-
tomy (>90% cyst) (3). NRS procedures: subtotal cystectomy (4),
Lagrot (2). Reasons for NRS were: central lesions (2), wall cyst
sticked to cava vein (5) A 81 year-old patient with infected cyst
treated by Lagrot died. Mean hospital stay: 9.1 (4-50). Jaundiced
patients presented higher morbidity.
*Clavien level I.
CONCLUSIONS: In our prospective serie, RS in LH is feasible
(72 % of cysts and 84% of patients) and safe (no mortality and
low morbidity). The worst cysts for radical surgery are big cen-
tral cysts or those very closed to cava vein..
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LIVER RESECTION AND PERCUTANEOUS
RADIOFREQUENCY ABLATION OF LIVER
COLORECTAL METASTASES: LONG-TERM
RESULTS
V. Vishnevsky, D. Ionkin, M. Efanov, A. Gavrilin, R. Ikramov,
O. Zhavoronkova
Vishnevsky Institute of Surgery, Moscow, Russia
Aim: to asses the long term results of liver resection and RFA in
patients with liver colorectal metastases.
Materials and methods: 176 patients with colorectal liver metas-
tasis had undergone surgical treatment from 2002 to 2007. There
were 62 males and 114 females; mean age – 53,2 (25-83) years.
Liver resections were performed in 84 patients (55% – parcial he-
patectomy, 45% - major liver resections). Simultaneous liver re-
section and removing of the primary colon tumor were performed
in 5 patients. Percutaneous Radiofrequency Ablation (PcRFA)
was performed in 88 patients. The most common indication for
PcRFA was I-II stage of liver metastases (Gennery). III-IV
stages of liver metastases were diagnosed in more than 65% of
patients who underwent liver resections. All the patients received
postoperative chemotherapy. Repeated liver resections were per-
formed in 5 patients (5,9%), PcRFA - in 67 patients (76,1%).
Results: After liver resection 1, 3 and 5 year survival was 76%,
27% и 13% respectively. The median survival time was 18 (2-53)
months. After PcRFA - 1, 3 and 5 year survival was 84,2%; 39,7%;
и 16,3% respectively. Median survival time - 30 months. PcRFA
was more cost-effective procedure in comparison with liver re-
section. Economical expenses were five times more in patients
after liver resection even with uneventful postoperative course.
Conclusions: PcRFA is more cost-effective but not more radical
procedure than liver resection. The possible reason for better
long-term results after PcRFA is advanced stage of disease in pa-
tients that underwent liver resection.
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THE USE OF A VESSEL SEALING SYSTEM IN
HEPATIC RESECTION
C. Polat, Y. Yavas, A. Kilincaslan, Y. Arikan
Afyon Kocatepe University, Turkey
Background: Today, intraoperative severe blood loss remains a
major problem for surgeons operating on the liver. Most of them
occur during parenchymal transection. A variety of different sur-
gical techniques such as unipolar cautery, bipolar cautery, stan-
dard bipolar cautery, harmonic scalpel, ultrasonic dissectors,
water jet dissection, stapling devices, laser systems, and the float-
ing ball apparatus system have been described for limiting blood
loss.
Aims: In this study, we aimed to present our experience with the
bipolar vessel-sealing device (BVSD) during hepatic resection
with 25 patients.
Methods: Between May 2002 and December 2008, 25 patients
underwent hepatic surgery for different surgical pathologies. The
Brisbane 2000 terminology of the International Hepato-Pancre-
ato-Biliary Association has been used for liver anatomy and re-
section. Patient characteristics, indications, surgical procedures
and complications were assessed.
Results: The patients were 17 females and 8 males. Indications
were as follows: 7 echinococcal cysts, 5 metastatic colorectal can-
cers, 4 metastatic gallblader carcinomas, 3 hepatocellular carci-
nomas, 3 hemangiomas, and 1 each blunt hepatic trauma,
metastatic gastric carcinoma, cholangiocarcinoma. There were
one intraoperative and four postoperative complications. Vena
cava rupture occured intraoperatively. Postoperatively, hemor-
rhagia, incisional hernia, intrabdominal abscess and right pleural
effusions associated with pneumonia occured. Mean intraopera-
tive total blood loss was 200 minutes (range: 150-800 minutes).
Summary/Conclusions: We may say that the use of the LigaSure
vessel sealing system for hepatic surgery is an effective and safe
method.
References:
1. Saiura F, Yamamoto J, Koga R, Sakamoto Y, Kokudo N, Seki
M, Yamaguchi T, Yamaguchi T, Muto T, Makuuchi M. Useful-
ness of LigaSure for liver resection: analysis by randomized clin-
ical trial. Am J Surg 2006;192(1):41-5.
2. Romano F, Franciosi C, Caprotti R, Uggeri F, Uggeri F. He-
patic surgery using the Ligasure vessel sealing system. World J
Surg 2005;29(1):110-2.
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RFA ASSISTED RESECTION FOR HCC:
MORBIDITY, MORTALITY AND LONG TERM
SURVIVAL
E. Felekouras, E. Prassas, K. Michael, P. Athanasios,
P. Emmanouil, P. Efstathios
A’ Department of surgery University of Athens Laiko General Hos-
pital, Athens, Greece
Background: Hepatic resection is the mainstay of the curative
treatment of primary hepatic tumours, with constantly improving
short and long term results. RFA assisted liver resection is a rel-
atively new method of transection of the liver parenchyma with
favorable intra- and perioperative results.
Aim: To investigate the oncological efficacy (long term overall
and disease free survival) and confirm the favorable short term
morbidity and mortality.
Methods: Between May 2004 and January 2007, 19 patients un-
derwent 23 resections for 32 HCC. The technique of parenchymal
transection has been described previously as RFA-assisted liver
resection (Felekouras et al World J Surg).
Results: Thirty-day morbidity and mortality were 42.1 and 0%
respectively. Blood transfusion requirement was 37%. The me-
dian length of stay in the hospital was 17.3 days (5-45). The one-
and three-year overall survival was 89.5% and 61.7% respectively.
The one- and three-year disease free survival was 71% and 65.2%
respectively. No patients developed metastatic disease or local
recurrence at the margin site. Six patients (31.5%) developed in–
the–liver recurrence away from the resection area.
Conclusions: RFA-assisted liver resection is a safe and oncolog-
ically efficient method for the surgical treatment of HCC with
results comparable to other surgical techniques.
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THE ROLE OF RFA ASSISTED LIVER
RESECTION IN OBTAINING NEGATIVE
MARGINS
E. Prassas, M. Kontos, A. Petrou, I. Papaconstantinou,
N. Basios, N. Demetriou, A. Papalambros, E. Felekouras
A Department of surgery University of Athens Laiko General Hos-
pital, Athens, Greece
Background: The surgical margin status in liver surgery is recog-
nized as a significant risk factor for local failure.
Aim: To prove that RFA-assisted liver resection can offer satis-
factory local control through achieving sufficient negative mar-
gins.
Methods: Forty three patients underwent 62 RFA assisted liver
resections for primary or metastatic liver tumours with curative
intent (R0 resection). The technique of parenchymal transection
has been described previously as RFA-assisted liver resection
(Felekouras et al World J Surg). Upon completion of routine re-
section, an additional 1cm-wide slice of liver tissue along the ab-
lated cut surface was excised and sent to pathology (specimen M).
Results: On final pathology specimen M was positive in 7/62
(11.3%) cases. RFA assisted liver resection achieved negative
margins in 55/62 (88.7%) of the cases. Specifically for liver pri-
maries, specimen M was positive in 4/23(17.4%) cases and nega-
tive margins were achieved in 19/23 (82.6%) cases. For metastatic
lesions the respective figures are 3/39 (7.6%) and 36/39 (92.4%).
Conclusions: Our results suggest that RFA assisted liver resec-
tion is efficient in achieving negative surgical margins. In com-
parison with historic non-RFA assisted hepatectomies in our unit,
the difference appears to be statistically significant in non-
anatomic resections and in metastatic tumours in favour of RFA
technology.
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LAPAROSCOPIC TREATMENT OF FOCAL
LIVER TUMOURS
J. Pósán, Z. Szentkereszty, I. Takács, R. Kot n, L. Sasi Szabó,
P. Sápy, L. Damjanovich
Department of Surgery, University of Debrecen Medical and Health
Science Center, Hungary
BACKGROUND: Recently the laparoscopic approach to liver
reection has been more frequently and this technique is becom-
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ing widespread mainly for benign neoplasms.
AIM: We would like to show our experiances in this surgical
tehnique.
METHODS: 40 liver resections were performed between 2001
and 2007 in our department. There were 29 female and 11 male.
The indications were benign lesisons in 37 cases -focal nodular
hyperplasia in 9 cases, haemangioma in 8 cases, simplex cyst in 4
cases, echonococcus cyst in 3 cases, adenoma in 1 case, biliaris
dysplasia in 2 cases, other benign tumour in 10 cases- and col-
orectal metastases in 3 cases. The average size of tumour was 3.5
(1-9) cms. There were performed anatomical segment resection
in 7 cases, pericystectomy in 3 cases and non anatomical resection
in 30 cases. The average operating time was 55 minutes.
RESULTS: There were conversion during the operation in 3
cases. The postoperative morbidity was 17% and the mortality
was 0%. One reoperation was performed because of bile likeage.
The average nursing time was 5.6 days.
CONCLUSIONS: Laparoscopic liver resection is recommended
in cases of small, peripherial and primarily benign lesions. Ap-
plying the proper surgical technique the laparoscopic liver recec-
tion can be performed safely, the postoperative complication can
be minimised.
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RADIOFREQUENCY ABLATION OF
COLORECTAL LIVER METASTASES CLOSE
TO MAJOR HEPATICA VESSELS: SAFETY
AND EFFICACY
N. Snoeren, M. Nijkamp, I. Borel Rinkes, R. van Hillegersberg
Surgical Oncology University Medical Centre Utrecht, The Nether-
lands
Background: Hepatic tumors close to the major vessels pose a
treatment predicament. These tumors could be treated with re-
section of the tumor together with resection and reconstruction
of the adjacent major vessels. Such an extensive resection has a
high complication rate and is limited to the very experienced sur-
geon. Until now, the location of these tumors is often seen as a
contraindication for Radiofrequency ablation (RFA) as it may
damage vessels and thereby compromise perfusion of the liver.
We hypothesize that the existing blood flow protects vessels
against thermal damage.
Aim: To demonstrate that patients with tumors adjacent to any of
the major hepatic vessels can effectively undergo bipolar RFA
with local tumor control.
Methods: Six consecutive patients with intrahepatic metastases
adjacent to a large hepatic vessel were entered in our prospec-
tive database. Patient-, tumor and RFA characteristics were
recorded. Mean follow up in this study was 11 months (median
14.5).
Results: All 6 patients were treated with open procedure. Intra-
operatively there were no complications. Postoperatively one pa-
tient suffered form respiratory insufficiency and atelectasis. Local
tumor control was achieved in all tumors abutting the large ves-
sels. No patient experienced a local recurrence. Lesion size was
1.5 x the original volume of the lesion.
Conclusion: It is safe to treat patients with tumours abutting any
of the large hepatic vessels with Radiofrequency ablation. How-
ever in order to prevent thrombosis and total vascular destruc-
tion, the pringle manoeuvre should be used selectively.
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TREATMENT OF LIVER TRAUMA AND
ACCOMPANYING INJURIES. OUR
EXPERIENCE IN THE LAST 6 YEARS
O. Vergos, N. Kosmadakis, M. Tsoukalas, D. Stithos, E. Palli,
D. Carrer, M. Askoxylaki, N. Christodoulopoulos
Surgical Department and Anesthesiology Department General Hos-
pital of Zakynthos, Greece
Objective: Presentation of our experience and outcomes on treat-
ing liver trauma and accompanying injuries in a district hospital
in the last 6 years (2003-2008).
Materials and Methods: 60 patients have been treated (47 M, 13
F), 6-71 years old (median age: 28,8), who were brought to the
hospital mostly after a car accident, or a fall (50), and injury from
a sharp instrument or a firearm (7). 53% of the patients (n=31)
had only liver trauma, while the rest (n=27, 47%) also had ac-
companying injuries, such as rupture of the spleen (n=7),the
mesentery (n=6), the jejunum (n=4), the stomach (n=3), the
gallbladder (n=4), the portal vein (n=1), the chelodechus (n=2),
injury of the pancreas (n=4), the duodenal (n=2), the epiploon
(n=5), retroperitoneal hematoma (n=5), KEK (n=8), hemoth-
orax or pneumothorax (n=6), and more. 12 patients with exclu-
sive liver trauma (stage I-III) were treated, during the past 3
years, in a conservative way, based upon the clinical signs and
symptoms as well as the imaging studies (U/S, CT), whereas the
other 46 patients underwent a laparotomy.
Among the 46 patients that underwent a laparotomy some where
treated with συραφή (n=19), συραφή and epiplooplasty (n=8),
tamponade and placement of hemostatic sponges (n=14), and in
the cases of 5 patients non typical liver excision. The accompanying
injuries were also treated at the same time, either via συραφή (epi-
ploon, stomach, mesentery), either via excision (spleen, gallbladder).
Results. Immediate post-operative complications were observed
in 18 out of the 46 patient tht were operated (39%), those were,
hemorrhage (n=3), xolorroia (n=2), ileum (n=3), infection of
the respiratory tract or pleural effusion (n=2) , trauma purulence
(n=8), all of which were treated conservatively. 11% (n=5) of
the patients that underwent laparotomy died after their being
moved to an ICU due to serious head injuries, while the other 41
fully were recuperated after a hospitalization period of 6 to 22
days (M.D. 14,8 ). Angeiography and embolism of a branch of
the median hepatic vein was performed in the case of 1 patient
immediately after the tamponade.
Conclusions. Treatment of liver trauma and its accompanying in-
juries remains a great problem due to the critical state of the pa-
tients and especially for the hospitals of the district. In the past
few years there is a clear tendency for a more conservative ap-
proach, as long as the imaging means exist and the clinical state
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of the patient allows so, as both the hospitalization period being
long ad the post-operative complications being important, jeop-
ardize the final outcome.
Keywords, Liver trauma, accompanying injuries, conservative
treatment.
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RESULTS OF MULTIDISCIPLINARY
TREATMENT OF PATIENTS WITH
NON-ENDOCRINE LIVER METASTASES
W. Polkowski, J. Mielko, M. Skorzewska, M. Lewicka
Department of Surgical Oncology Medical University of Lublin,
Ploland
Liver metastases are major cause of death in colorectal cancer, as
well as in many other non-endocrine adenocarcinomas. Surgical
resection remains the only treatment that can ensure long-term
survival and cure in some patients. Recent progress including new
chemotherapeutic regimens and ablative techniques may increase
the percentage of patients that can be treated with a curative in-
tent. The management should be used in the multidisciplinary
team setting.
The aim of the study is to assess the results of multidisciplinary
treatment of patients with liver metastases from non-endocrine
solid tumours.
Materials and methods: Analysis was performed in 95 consecutive
patients operated on for liver metastases from non-endocrine
solid tumours. In all patients (neo-)adjuvant chemotherapy
(FOLFOX/FOLFIRI for colorectal cancer) was administered pe-
rioperatively. Mean age mean of patients (male:female ratio:
1:1.2) was 57,8 years (SD 12.7). Survival rate was calculated using
Kaplan-Meier method. The influence of the type of surgical pro-
cedure (resection vs thermoablation), primary tumour localiza-
tion and histology, gender and age of patients on the survival was
assessed retrospectively. All treatment planning and decisions
were made in the multidisciplinary team setting consisting of ra-
diologist, pathologist, medical oncologist and surgical oncologist.
Results: Liver resections were performed on 65 patients. Non-re-
sective ablative procedures by means of RF generator (ther-
moablation) were done through laparotomy (n=23), laparoscopy
(n=2) or percutaneously under CT or USG guidance (n=2).
Combined operations of resection and thermoablation were con-
ducted in 6 patients. In a period of time when RF generator was
not available in 1 patient chemical destruction (ethanol injection)
of the metastatic lesions was performed. Postoperative mortality
was 1.9%. Cumulative 5-year survival is 33%. Differences in sur-
vival in respect of the type of operation (p=0.44), gender or age
(both p=0.26) were not significant (log rank test). However, there
was significant survival advantage in patients with colorectal car-
cinoma (66% 5-year survival) as compared to patients with breast,
ovarian, gastric or gall bladder carcinoma (12% 5-year survival;
p=0.012 log-rank test).
Conclusions: In the field of combined treatment of patients with
liver metastases, multidisciplinary discussion and repeated eval-
uations are crucial in order to achieve good late results, especially
in patients with metastatic colorectal cancer.
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INTRA AND POSTOPERATIVE CLINICAL
OUTCOME FOLLOWING REPEAT
HEPATECTOMY FOR PRIMARY OR
METASTATIC LIVER CANCER
E. De Raffele, M. Mirarchi, S. Vaccari, A. Cavallari, B. Cola
Dipartimento di Chirurgia Generale e Trapianti Policlinico S.Or-
sola-Malpighi, Bologne, Italy
Background and aims. Recurrence after hepatectomy for liver
cancer is frequent and may be confined to the liver. Repeat he-
patectomy is indicated in selected cases. The aim of this study was
to clarify the perioperative outcome of repeat hepatectomy.
Methods. Intra and postoperative parameters of 275 liver resec-
tions (October 2000 - October 2008) performed by one of the au-
thors were reviewed; 110 hepatectomies were done for
hepatocellular carcinoma and 165 for colorectal metastases. 197
were first hepatectomies (FH) and 78 were repeat hepatectomies
(RH), including 56 second, 19 third and 3 fourth hepatectomies.
Chi-square and Student’s t tests were used for statistics; signifi-
cance was defined as p<0.05.
Results. Group FH included 132 males and 65 females aged
64.22+11.28 (range 21-86) yrs; Group RH included 54 males and
24 females aged 64.20+9.75 (range 39-85) yrs (p=ns). Intraop-
erative blood transfusions were 215.10+446.14 (range 0-3300) ml
and 296.79+470.24 (range 0-2250) ml in FH and RH, respectively
(p=0.179). Duration of surgical procedure was 293+114 (range
110-705) min and 359+136 (range 195-800) min in FH and RH,
respectively (p<0.0001). Postoperative complications were 18.8%
and 19.2% in the two groups, respectively (p=1.000). There was
no postoperative death. Postoperative hospital stay was
10.60+6.36 (range 4-72) days and 10.96+7.95 (range 4-68) days
in FH and RH, respectively (p=0.695).
Conclusions. Repeat hepatectomy had similar perioperative re-
sults than first resection in our experience, but should be reserved
to experienced liver surgeons because is usually more challenging.
Surgery should remain the treatment of choice for selected pa-
tients with recurrent liver cancer.
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HEPATIC HYDATID DISEASE REQUIRING
URGENT SURGICAL TREATMENT DURING
PREGNANCY
C. Erçetin¹, . Özden¹, C. yibozkurt2, K. Güven3, K. Serin¹,
O. Bilge¹, Y. Tekant¹, K. Acarlı¹, A. Alper¹, A. Emre¹
¹. Departments of General Surgery (Hepatopancreatobiliary Surgery
Unit),
2. Obstetrics and Gynecology,
3. Radiology, Istanbul Faculty of Medicine , Istanbul, Turkey
Background: Pregnant women may experience acute presenta-
tion of hepatic hydatid disease. The published experience is lim-
ited to case reports.
Objective: To analyze the institutional experience on urgent treat-
ment for hepatic hydatid disease during pregnancy.
Patients and methods: The charts of 7 patients treated between
1992 and 2008 were reviewed.
Results: Median (range) patient age was 27 (23-39) years and
median (range) gestational age 18 (13-24) weeks. The symptoms
were severe abdominal pain (4), vomiting (2), jaundice (2),
pruritus (2); in the asymptomatic patient, a closed intraperitoneal
rupture had been detected during gynecologic ultrasonography.
Drainage of the cysts was performed in all cases. Two patients
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with frank biliary rupture underwent choledochoduodenostomy
or Roux-Y hepaticojejunostomy. Two patients had major cysto-
biliary communications but no hydatid material in the common
bile duct; primary repair and tube choledochostomy were per-
formed. Four patients required postoperative tocolysis. One pa-
tient had a biliary fistula and another had an unexplained
episode of postoperative hepatitis, both of which resolved spon-
taneously. Albendazole was not used. All mothers gave birth to
healthy babies. Six patients could be followed for median (range)
86 months (10-199). Two patients developed recurrences which
were treated with drainage and albendazole; they have had no
other recurrence during 2 and 4 years of follow up.
Conclusions: This entity entails the responsibility of two human
being. Although it imposes limitations on the routine diagnostic
and therapeutic options due to risk of premature labor or ter-
atogenicity, acceptable results can be obtained in collaboration
with the department of obstetrics and gynecology.
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ASSESSMENT OF HEPATOCELLULAR
FUNCTION IN PRIMARY SCLEROSING
CHOLANGITIS USING GD-EOB-DTPA-
ENHANCED LIVER MRI
H. Nilsson1, A. Nordell2, L. Douglas2, J. Viberg2, L. Blomqvist3,
E. Jonas1
1. Karolinska Institutet; Department of Clinical Sciences, Danderyd
Hospital, Division of Surgery, Stockholm, Sweden
2. Department of Medical Physics, Karolinska University Hospital,
Stockholm, Sweden
3. Department of Diagnostic Radiology, Karolinska University Hos-
pital Solna, Institution for Molecular Medicine and Surgery Karolin-
ska Institutet, Stockholm, Sweden & Department of Diagnostic
Radiology, Danderyd Hospital, Stockholm Sweden
Background: To date, we lack a method to reliably monitor liver
function, global or segmental, in patients with liver diseases. Gd-
EOB-DTPA is a gadolinium-based contrast agent developed for
MRI, in clinical use for detection and characterization of focal
liver lesions. About 50% of the administered dose is extracted by
the hepatocytes with subsequent elimination by biliary excretion.
The remaining 50 % is eliminated through the renal pathway1.
Due to this hepatocyte-specific property of the contrast agent,
dynamic Gd-EOB-DTPA enhanced MRI has been tested in ani-
mal models to evaluate hepatic dysfunction 2.
Aim: The aim of this study was to assess if the uptake of Gd-
EOB-DTPA differs between patients with Primary Sclerosing
Cholangitis (PSC) and healthy controls, and if this difference can
be quantified using MRI.
Methods: T1-weighted dynamic Gd-EOB-DTPA-enhanced liver
MRI was performed on 20 healthy volunteers and 12 patients
with PSC. Informed consent was obtained prior to inclusion and
the study was approved by the Regional Ethical Review Board.
The hepatic extraction fraction (HEF) of Gd-EOB-DTPA was
calculated as described by Brown et al3.
Results: The mean Child-score for the patients was 5.55 (range 5
to 7). Median HEF was 12% lower in patients compared to con-
trols (0.176 vs 0.201, Mann-Whitney U-test p<0.001) If only seg-
ments with abnormal morphological appearance were included,
median HEF was 0.136.
Conclusions: A difference in global and segmental hepatocellu-
lar function between healthy subjects and patients with PSC was
identified using Gd-EOB-DTPA-enhanced liver MRI.
References:
1. Hamm B, Staks T, Muhler A, et al. Phase I clinical evaluation
of Gd-EOB-DTPA as a hepatobiliary MR contrast agent:
safety, pharmacokinetics, and MR imaging. Radiology
1995;195(3):785-792.
2. Ryeom HK, Kim SH, Kim JY, et al. Quantitative evaluation
of liver function with MRI Using Gd-EOB-DTPA. Korean J
Radiol 2004;5(4):231-239.
3. Brown PH, Juni JE, Lieberman DA, Krishnamurthy GT. He-
patocyte versus biliary disease: a distinction by deconvolutional
analysis of technetium-99m IDA time-activity curves. J Nucl
Med 1988;29(5):623-630.
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THE GOOD, THE BAD AND THE UGLY:
LIVER RESECTION OF METASTASIS FROM
NON-COLORECTAL NON-NEUROENDOCRINE
TUMORS
M. Sacchetti, H. Sousa, G. Faria, M. Oliveira, M. Almeida,
R. Melo, E. Martins, J. Costa-Maia
Unidade Hepato-Bilio-Pancreática e Esplénica, Serviço de Cirurgia
Geral, Hospital de S. João, Porto, Portugal
INTRODUCTION – Given the overall bad prognosis, hepatic
resection (HR) in metastasis of non-colorectal non-neuroen-
docrine tumors (NCNET) is still a subject of debate. In the last
few years, some reports have suggested an improvement in sur-
vival and in quality of life.
OBJECTIVE – To report the results of HR in patients with liver
NCNET metastases.
MATERIAL AND METHODS – Analisys of the clincal records
of patients submitted to surgery between September 2006 and
October 2008.
RESULTS – We report a series of 10 patients (6 males, 4 fe-
males) with a mean age of 58 years. Primaries were of gastric (5),
duodenal (1), pancreatic (2), ocular melanoma (1) and breast (1)
locations. Metastases were metachronous in all cases, solitary in
60% and under 4 in the remainder. Anatomical resections were
performed in 7 patients and metastasectomies in 3.
In 80% of the patients, a complete resection with negative mar-
gins was achieved. In the remainder, intra-operative ablation pro-
cedures were associated. One patient was reoperated for
hemorrhage and there was no operative mortality.
The clinical follow-up is 6 months on average and there are no
other complications to report. One patient died 16 months after
surgery due to disease progression.
CONCLUSION – In spite of a short follow-up, HR in NCNET
seems, in our experience, to be usefull in selected patients, and as-
sociated with low morbidity and no mortality in this series. Pa-
tient selection is of paramount importance.
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SIMULTANEOUS RESECTIONS OF
COLORECTAL CANCER AND SYNCHRONOUS
LIVER METASTASES
C. Avgoustou, T. Kakavoulis, H. Coniaris, P. Marangoudakis,
A. Tsakpini
District General Hospital of N. Ionia “Constantopouleio” Hospital,
Athens, Greece
The aims of this study were to review our experience with surgi-
cal treatment of primary colorectal cancer (PCC) and synchro-
nous resectable colorectal liver metastases (SRCLM).
During period 1/2000 – 10/2008, among 504 patients who under-
went colectomy for PCC, 22 (15 males, 7 females/mean age 62.5
years) underwent a simultaneous resection of SRCLM. The se-
lection criteria they met were: a)Good health status, b)Metas-
tases 1-2 in one lobe without ascites, metastatic disease confined
to liver, c)High probability of achieving negative hepatic resec-
tion margins, d) PCC not in lower rectum, colectomy not emer-
gent. Hepatic lesions were detected via computed tomography or
magnetic resonance imaging. Types of liver resection were:
Wedge resection/metastasectomy (1 or 2 metastases) in 11 pa-
tients, segmental resection in 8, left hepatic lobectomy in 3. In-
traoperative blood loss was 120-350ml. Colectomies were right in
12 patients, left in 9 and transverse colon excision in 1. All pa-
tients received postoperative chemotherapy for PCC.
Histology detected negative hepatic resection margins in 20 pa-
tients. The 30 day mortality was zero. Mean postoperative hospi-
talization was 9.6 days (8-15). Not serious complications occurred
in 9 patients: bile leakage treated conservatively (5), wound in-
fection (5), pleural effusion (3), atelectasis (3).
Simultaneous colon and live resection is safe and effective in the
treatment of patients with PCC and SRCLM. Metastatic disease
confined to the liver is resected in well selected patients as part of po-
tentially curative strategy. Advantages are the avoidance of a second
laparotomy and the earlier initiation of adjuvant chemotherapy.
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CAN THE NHS CANCER PLAN TIMELINE BE
APPLIED TO HEPATIC COLORECTAL
METASASES?
C. Jones, J. McClements, S. Badger, M. Taylor, L. McKie,
T. Diamond
Mater Hospital, Belfast Health and Social Care Trust, Crumlin
Road, Belfast
Introduction: The National Health Service (NHS) Cancer Plan
guidelines recommend a maximum two-week wait from referral
to first appointment, and two months from referral to treatment
for primary cancers. However, there are currently no guidelines
available for metastatic disease.
In the UK, nearly half of all colorectal cancer patients develop
hepatic metastases. Timely surgical resection offers the poten-
tial for cure.
Aim: The aim of this study was to audit current practice for col-
orectal liver metastases in a regional hepatobiliary unit, and com-
pare this to the NHS Cancer Plan standards for primary disease.
Methods: A prospective review of the unit database was per-
formed for all hepatic metastases referrals from January 2006 to
October 2008. The date of referral, first appointment, investiga-
tions and initiation of treatment, along with patient’s age and sex,
were recorded on Microsoft Excel and analysed. Time was ex-
pressed as mean (±standard deviation) in days.
Results: Ninety-three patients with hepatic metastases were re-
viewed. Five were excluded due to incomplete data. The average
time from referral to first appointment was 12.2 days (±10.4) and
the average time from referral to treatment was 41.7 days (±28.0).
Of the 88 referrals included, 64 (72.7%) had surgical intervention,
of which 15 (23.4%) had pre-operative chemotherapy.
Conclusion: The data compare favourably to the NHS Cancer
Plan guidelines for primary malignancy, demonstrating a regional
hepatobiliary unit is capable of delivering a service for colorectal
liver metastases that adheres to the NHS Cancer Plan. There-
fore, the NHS Cancer Plan can be applied to this cohort.
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PYOGENIC LIVER ABSCESS: SAME DISEASE
DIFFERENT TREATMENTS
M. Almeida, M. Oliveira, H. Sousa, G. Faria, I. Romero, R. Melo,
E. Martins, J. Costa-Maia
Unidade Hepato-Bilio-Pancre tica e Esplénica, Serviço de Cirurgia
Geral, Hospital de S. Jo o, Porto, Portugal
BACKGROUND: Pyogenic Liver Abscess (PLA) is a uncommon
disease with a high mortality rate, despite treatment.
OBJECTIVE: To review clinically-oriented therapeutic options
in PLA.
METHODS: Analysis of 32 patients (17 F, 15 M) with PLA ad-
mitted to our Unit between June 2006 and October 2008.
RESULTS: Mean patient age was 66 years (41-86). The abscesses
were divided into 3 categories: A <3cm (n = 3); B simple> 3cm
(n = 17); C multilocular> 3cm (n = 9).
62% of the abscesses were located in the right lobe. Most com-
mon etiology was biliary (31%); in 25% of cases no cause was
identified. Five patients had coexisting hepato-biliary malignancy.
Treatment was: medical therapy alone in Group A; guided per-
cutaneous drainage in Group B; and percutaneous or surgical
drainage in Group C.
Results from microbiological examination was obtained in 25 pa-
tients and most frequent microorganisms were Gram-negative
bacilli (36%); in 7 patients cultures were sterile.
Average length of stay was 40 days, 17 days in Group A; 41 days
in Group B, and 46 in Group C. Five patients - 3 in Group B and
2 in Group C - died of septic complications or cancer progres-
sion, for an overall mortality of 15.6%.
CONCLUSIONS: PLA is a disease of varying severity that re-
quires agressive, multidisciplinary treatment. Most abscesses are
simple and solitary, located inthe right lobe and resolved by an-
tibiotics and / or percutaneous drainage. Abscesses> 3cm, mul-
tilocular or relapsing, may need surgical drainage and carry an
increased mortality risk.
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MECHANISMS OF SPLENIC HYPERTROPHY
FOLLOWING HEPATIC RESECTION
S. Truant1, S. Lemaire2, G. Sergent2, D. Buob3, F. Pruvot1
1. Service de Chirurgie Digestive et Transplantations CHRU LILLE
2. Service de Radiologie CHRU LILLE
3. Service d’ Anatomopathologie CHRU LILLE
Background: Following hepatic resection, the liver regeneration
has been associated with concurrent splenic hypertrophy. The
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mechanisms of this phenomenon are unknown and may be mul-
tiples: splanchnic sequestration due to a reduction in the hepatic
mass, hepatic growth factors that may indirectly act on the spleen,
splenic reaction to endotoxinemia.
Patients and method: We prospectively monitored serial changes
in liver and spleen volumes following hepatectomy using com-
puted tomography (CT). Exclusion criteria: fibrosis>F1, steato-
sis>40%, associated extra-hepatic resection, previous
hepatectomy (major / minor within 3 months) and preoperative
splenomegaly.
Results: Forty patients (19F/21M) who underwent minor (<3
Couinaud Segments; N=10) or major hepatectomy (N=30) be-
tween February 2005 and June 2007 were included. Mean rem-
nant liver volume (RLV) increased from 1007cc postoperatively
to 1221cc at 1 month (+32%; p<0.00001), while mean splenic
volume increased from 253cc to 310cc (+24%; p<0.00001).
These liver and spleen hypertrophy were significant after major
hepatectomies (+ 42% and + 29%, respectively; p<0.00001) but
not after minor ones (+3% and +8%, respectively). Liver hy-
pertrophy was inversely correlated to the postoperative RLV, but
not the spleen hypertrophy (correlation coefficient =-0.690 and
-0.277, respectively). Chemotherapy did not impact neither he-
patic nor splenic hypertrophy. Splenic hypertrophy increased by
two fold in patients showing infectious complications (N=5)
(+49% vs +20% if no complication, p=0,045).
Conclusion: Spleen hypertrophy occurred mainly after major he-
patectomy, but was not linearly correlated with the RLV. These
results suggested that spleen hypertrophy was related to reduc-
tion in the portal bed rather than indirect action of hepatic growth
factors.
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MANAGEMENT OF OBSTRUCTIVE JAUNDICE
IN HEPATIC HYDATID DISEASE.
D. Yahya, D. Ekheil, D. Thoboot, D. Shuwerief, D. Najla
Department of Surgery, University Teaching Hospital, Zliten, Libya
350 patients with hydatid liver cysts were operated in our hospi-
tal over a period of
(17) years from 1991 to 2008 .Out of these (35) patients presented
with obstructive jaundice. Pre- operative investigations done
(USG, CT Scan) and pre-operative preparation including I.V.
Fluids, Antibiotic, manitol were given before operations. Patients
underwent open surgery usually through right sub-costal incision.
Intra operative ultra sound was done for all patient. Usually in
patients with obstructive jaundice (O,J), it was observed that, the
CBD is not obviously dilated. Trans cyst cavity exploration of bil-
iary communication in residual cavity, with use of Fogarthy
catheter and flushing with normal saline. In such cases no need to
open CBD.
Small visible communications were sutured without exploration.
In the patients with huge cysts near the hilum, no communica-
tion with CBD was found. On excision of cyst, the jaundice was
cleared completely.
The out come of thirty five (35) patients with O,J. Out of
these,(20)patient had O,J. due to extra mural compression of
CBD by huge hydatid cyst lying near the hilum and arising from
the right lobe of liver they were cured by simple excision of cyst
and none of them had communication with CBD.
Fifteen (15) patients their jaundice due to obstruction of the com-
mon bile duct by daughter cysts. Jaundice was cleared by trans-
cyst cavity exploration with use of Fogarthy catheter and flushing
with amount of normal saline through the communication. The
patients were cured completely by this procedure and bilirubin
dropped to normal level.
Those patients with O.J. need an urgent surgical intervention to
prevent the hazards of jaundice.
Conclusion:
1- From our experience dealing with hydatid disease of the liver,
we found that obstructive jaundice can be due to cyst com-
pressing on bile ducts or daughter cyst in the duct causing the
obstruction of the bile duct.
2- In huge cysts causing obstruction by compression, the jaundice
is cleared with excision of the cyst.
3- We found there is no need to open the common bile duct in pa-
tients with obstructive jaundice due to daughter cyst in the
common bile duct and exploring the biliary tree through the
cyst cavity is enough. In such cases patients can be discharged
early
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IS THERE A ROLE FOR ENDOSCOPIC
ULTRASONOGRAPHY IN EVALUATION OF
LEFT LIVER IN COLORECTAL LIVER
METASTASES SELECTED FOR RIGHT
HEPATECTOMY?
C. Sabbagh1, D. Fuks1, J. Joly2, T. Yzet3, A. Hanes1, J. Duchman2,
J. Prevost2, F. Demuynck3, P. Verhaeghe1, J. Regimbeau1
1. Department of Digestive disease Amiens North Hospital
2. Department of Gastroenterology Amiens North Hospital
3. Department of Radiology Amiens North Hospital, France
Background: Assessment of the left liver for patients scheduled
for right hepatectomy is essential. Endoscopic ultrasonography
(EUS) is used for the locoregional staging or biopsy of pancreatic
tumours.
Methods: We prospectively enrolled 24 consecutive patients who
were scheduled for at least a right hepatectomy and who under-
went laparotomy for colorectal liver metastases (CLMs). The left
liver was assessed pre-operatively with standard techniques (CT
scan, percutaneous ultrasonography) and EUS. These results
were compared with those of intraoperative ultrasonography
(IOUS).
Results: There were 12 men and 12 women (mean age: 64±18).
A standard preoperative evaluation detected 28 lesions in the left
liver; EUS detected just 17 lesions, IOUS detected 30 lesions in
the left liver. For the left lobe of the liver (segments II and III),
the standard evaluation had a sensitivity of 85%, a specificity of
64%, a PPV of 50% and an NPV of 91%; EUS had a sensitivity
of 55%, a specificity of 86%, a PPV of 71% and an NPV of 76%;
IOUS had a sensitivity of 85.2%, a specificity of 92%, a PPV of
96.6% and an NPV of 75%. In terms of the left liver (i.e. seg-
ments II, III and IV), the results of EUS are less good than for the
left lobe. EUS changed our therapeutic strategy in three cases.
Conclusion: Even though EUS can provide some valuable infor-
mation, the technique is not accurate enough to merit systematic
performance as part of a standard pre-operative evaluation.
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ARE REPEAT LIVER RESECTIONS A SAFE AND
EFFECTIVE TREATMENT FOR RECURRENT
COLORECTAL LIVER METASTASES?
C. Dopazo, I. Bilbao, G. Sapisochin, R. Rodriguez, A. Ganchegui,
L. Blanco, M. Caralt1, J. Lazaro1, J. Balsells1, R. Charco
HPB Surgery and Liver Transplant Hospital Vall d Hebron,
Barcelona, Spain
Aim.To analyse the results of re-hepatectomies as treatment of
liver tumour recurrence after hepatectomy due to colorectal liver
metastases(CRLM).
Material and Methods.From 1987 to 2007, 230 hepatectomies for
CRLM were performed in our Unit. Two-hundred twelve pa-
tients underwent one hepatectomy (Group H1) and 18 under-
went a second hepatectomy(Group H2).All data were
prospectively collected and retrospectively analysed.
Results.No differences were found in either groups regarding age,
sex, stage of colorectal tumour, adjuvant chemotherapies after
first liver resection, intraoperative blood transfusion, surgical
time and hospital stay.Tumour size was larger in H1 compared
with H2 (4.3±2.5cm vs 2.5±0.9cm, p<.003) and major hepatec-
tomy was performed in 52% of the patients in H1 vs 17,6% in
H2, p<.004. Postoperative morbidity and mortality were 27% and
2.8%(6/212) in H1 vs 22% and 5.5%(1/18) in H2 respectively,
p=ns.During follow-up (median:13 months (r:1-134)), recurrence
was detected in 130 patients (61.3%) of H1 group (liver:48,
lung:14, liver+lung:51 and a distant site:17) while during follow-
up (median:15 months (r:6.5–52.7)), recurrence was found in 10
patients (55.6%) of group H2 (liver:4, lung:4 and liver+lung:2),
p=ns. Significant differences in 1-, 3- and 5- actuarial year sur-
vival were found when 18 of 48 patients with solitary liver recur-
rence underwent second hepatectomy was compared with the
remaining 30 patients underwent other palliatives treatments
(100%, 92%, 72% vs 87%, 29%, 24% respectively,p<.0001).One-
, 2-, and 3- year disease-free survival were 76%,46%,38%, vs
82%,49%,21% for a H1 vs H2 group, respectively. (p=ns).
CONCLUSION.Repeat hepatectomies are a safe and effective
approach for recurrent colorectal liver metastases.
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EXPERIENCE OF HEPATOBILIARY TRAUMA
IN A SINGLE ISTITUTION
A. Frena, G. La Guardia, F. Martin
General Surgery Central Hospital of Bolzano, Italy
Background: liver injuries are the most frequent cause of death in
the field of abdominal traumas. The increase in road accidents
and sports injuries makes discussion of the treatment modalities
increasingly relevant in this area.
Aim: In recent years we have witnessed an evolution in the ther-
apeutic management of such injuries with the increasingly fre-
quent use of non-operative procedures for the management of
non-complex lesions.
Methods: a retrospective study was conducted in 111 cases of liver
injuries observed in our department over a 20-year period (1985-
2005). The mean age of the patients was 31 years. The most fre-
quent causes were road accidents (48%), followed by sports
injuries (23%) and occupational accidents (11%).
Results: 82 patients (74%) were treated surgically and 29 con-
servatively. In 58 cases (35 of which treated surgically), the liver
injury was isolated, while in the other 53 cases lesions were also
present in other abdominal organs. The liver injuries, classified
according to the AAST, were grade I in 47 cases, grade II in 30
cases, grade III in 19 cases, grade IV in 5 cases, and grade V in 10
cases. Thirty-five percent of grade I-II lesions were treated con-
servatively, while 94% of grade III-IV-V lesions received surgical
treatment. The overall operative mortality was 12.5%.
Conclusions: the evolution of the management of liver injuries
has witnessed an increase in conservative treatment, particularly
for grade I and II lesions. There is no alternative to surgical treat-
ment when the injury involves the major hepatic vessels or sub-
stantial amounts of parenchyma. The mortality rate is high
compared to that of elective liver surgery, but this is due to the
frequent associated lesions in other organs and apparatuses.
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INTERVENTIONAL ULTRASONOGRAPHY
IN MANAGING BIG AND GIGANTIC
NONPARASITIC LIVER CYSTS
O. Zhavoronkova, A. Gavrilin, V. Vishnevsky
The Vishnevsky Institute of Surgery, Moscow, Russia
Objective. Assessment of interventional ultrasonography capac-
ity in managing big and gigantic nonparasitic liver cysts (B and G
NPLC).
Design. A prospective one-centre study with an assessment of the
outcomes of percutaneous sclerosing procedures under US con-
trol (PSP), conventional (CS) and laparoscopic surgery (LS) for
B and G NPLC.
Patients. The mean diameter of big (n=39) and gigantic (n=24)
NPLC was 105 ± 7.5 and 149 ± 33 (120 - 260 mm) accord-
ingly. Out of 95 patients 42 (44,2%) had a single, 45 (47.4%) -
two and more cysts and 8 (8.4%) had polycystic disease.
PSP was performed in 55 patients with a high operative risk. 20
patients were operated on conventionally (CS): total (5) and
subtotal (9) cystectomy, unroofing (3) and anatomical liver re-
section (3), 20 – laparoscopically (LS): 4 (20%) unroofings, 16
(80%) subtotal cystectomies and 4 atypical liver resections..
Results: Complications after PSP were registered in 17 (30.9%),
after CS – in 7 (35%), and LS - in 10 (50%) cases, two patients
from the last group were operated on urgently. PSP for infected
residual cavities after CS and LS was performed in 5 (25%) and
4 (20%) cases. After PSP in 49 (89,1%) cases an excellent result
was achieved. Good stage result was achieved in all cases of poly-
cystic disease. All the patients made a complete recovery.
Conclusion: The PSP management of B and G NPLC can be even
more effective than surgery if it is handled by an interventional ul-
trasonography expert.
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LAPAROSCOPIC POSTERIOR LIVER
SEGMENTOMY. THE WAY FORWARD
G. Ayiomamitis, J. Low, A. Hamoudi, B. Ammori
Department of Surgery, Manchester Royal Infirmary, Manchester,
UK
Background & Aims: Advancements in surgical technique and
technology have facilitated safe laparoscopic liver resection
(LLR) in selected patients. The aim of this study is to describe
our new approaches to posterior liver segments and evaluate the
feasibility and outcome of LLR.
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Methods: Resections of lesions situated in any liver segment
(with the exception of segment eight, right hemihepatectomy and
extended hemihepatectomy) were selected for laparoscopic re-
section. Data were collected prospectively.
Results: Between 2003 and 2008, 32 patients underwent LLR.
The resections included left hemihepatectomy and segmectomies
of all the anterior liver segments 2,3,4b,5,6. We have recently ex-
tended the resections to include posterior liver segments (4a and
7). In the two patients (6.25%) with liver lesion in segment 7, we
performed 6 and 7 liver segmentectomy with the patient in left
lateral position. In two patients (6.25%) with liver lesion in seg-
ment 4a, a left hemihepatectomy (segments 2-4) was carried out.
All procedures were completed laparoscopically. The median op-
erating time was 147 minutes. The estimated median blood loss
was 100ml. The overall morbidity rate was 9.4%, and there were
no operative deaths. The median post-operative hospital stay was
3 days. At a median follow up of 16 months, 5 patients (15.6%)
had disease recurrence and 20 patients (91%) remain alive.
Conclusions: In selected patients with lesions in any liver seg-
ment including the posterior segments 4a and 7 (and with the ex-
ception of segment eight, right hemihepatectomy and extended
resections) LLR is feasible, achieves adequate cancer resection,
and is associated rapid recovery. Long-term follow up data are
required for oncological results.
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LIVER VOLUMETRY AND AMINOPYRINE
BREATH TEST TO PREDICT LIVER FUNCTION
AFTER LIVER RESECTION?
I. Hollander, R. van Dam, J. van der Vorst, G. Koek,
W. Wodzig, B. Pulinx, C. Dejong
Department of surgery, Maastricht University Medical Centre, The
Netherlands
Background: Small remnant liver volume (RLV) and reduced
liver function (LF) resulting from extended indications for liver
resection (LR) increase the risk for post resectional liver failure.
Preoperative assessment of RLV and LF is important. Currently,
the predictive value of LF tests is poor. CT volumetry and the
aminopyrine breath test (ABT) can be valuable to predict post
resectional LF.
Aim: To determine the correlation between liver volume (LV)
and microsomal liver function (MLF), tested with ABT, in pa-
tients undergoing LR.
Methods: Patients planned for LR received an ABT and CT-scan
preoperatively and an ABT on day 1 postoperatively and were di-
vided into two groups: Patients undergoing LR (n=7, group I),
and patients undergoing laparotomy without LR (n=4, group II).
Preoperative total liver volume (TLV) and prediction of RLV
were assessed using CT-volumetry. Correlations were assessed
using intercorrelation coefficient.
Results: 11 patients with a mean age of 63 (48-75) years (group I)
and 55 (35-71) years (group II) were studied. 71% of group I and
50% of group II had a normal preoperative ABT (mean
6.96/5.30). All patients had a low 1-day postoperative ABT
(mean1.53/1.73). These results were significantly lower than the
preoperative ABT (p<0.001/p=0.046 Fischer’s exact test.) No
correlations were found between TLV and preoperative ABT
(R20.091), and between RLV and 1-day postoperative ABT in
group I (R20.123).
Conclusion: No correlations have been found between TLV,
RLV and MLF using the ABT. Low 1-day postoperative results
in both groups suggest intestinal aminopyrine uptake is impaired.
References
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OUTCOME OF RADIOFREQUENCY ABLATION
FOR LIVER METASTASES FROM GASTRIC
CANCER
N. Benetatos, G. Pappas-Gogos, K. Tsimogiannis, D. Tsironis,
P. Mavridou, E. Tsimoyiannis
Departments of Surgery and Anaesthesia, G. Hatzikosta General
Hospital, Ioannina, Greece
Background: The indication of liver resection for gastric cancer
metastases remains controversial. The efficacy of RFA treatment
has not been established as in colorectal cancer.
Aim: To investigate the beneficial or no effect of RFA treatment
in patients with liver metastases from gastric cancer.
Μethods: A retrospective analysis was performed on the outome
of 10 patients with synchronous (n=7), and metachronous (n=3)
gastric cancer liver metastases that were resected or ablated.
Results: From August 2002 to January 2007, 10 patients with gas-
tric cancer liver metastases underwent RFA treatment. Nine men
and one woman with mean age 64,4 years (52-80). In 6 pa-
tients RFA was applied for total 25 metastases. In 3 patients
bloodless liver resection using RF energy was performed. In 1 pa-
tient RFA was applied in 2 tumors and wedge resection using RF
energy in 1 tumor. The overall 1, 3 and 5 year survival rates were
70%, 20%, 10% respectively, and the median survival was 20
months. Univariate analysis revealed that survival wasn’t signifi-
cantly different between cases of solitary and multiple metastases.
There was no statistical significance between synchronous and
metachronous metastases. Two patients (RFA only) are disease
free alive, one with multiple synchronous metastases (5 tumors)
is alive for 76 months and the other with solitary synchronous
metastasis is alive for 36 months.
Conclusion: RFA treatment through laparotomy or combination
with bloodless resection by using RF energy, for liver metastases
from gastric cancer, may be beneficial for patients with a solitary
or multiple metastases, synchronous or metachronous.
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THE USE OF THE RADIOFREQUENCY
SALINE-LINKED DEVICE (TISSULINK) IN
HEPATIC SURGERY
N. Michalopoulos, I. Kesisoglou, T. Papavramidis, I. Pliakos,
K. Sapalidis, S. Papavramidis
3rd Department of Surgery AHEPA University Hospital, Aristotle
University of Thessaloniki, Greece
Introduction: Surgical resection represents the treatment of
choice for liver tumors. Factors that influence the operative mor-
tality and morbility, except the tumor’s features and behavior, are
the intraoperative blood loss and the need for transfusion. The
use of new devices and new sources of energy in the liver surgery
reduce operation’s duration and intraoperative blood loss. The
aim of this study is to present ours experience of the radiofre-
quency device Tissuelink Dissecting Sealer 3.5 (Tissuelink D.S.
3.5) in the liver resection.
Methods: Nine patients underwent liver resection for malignant
and benign lesions of liver with the saline-linked radiofrequency
device Tissuelink D.S. 3.5. We analyzed the duration of liver tran-
section, blood loss, duration of hospital stay and complications.
We compare the preoperative values of Hct, Hgb and liver func-
tion enzymes with the corresponding postoperative values.
Results: All patients underwent successfully liver resection with
Tissuelink D.S. 3.5. The mean intraoperative blood loss was
196.7ml (range 50ml – 600ml) and blood transfusion was needed
during the operation in one patient. The liver function was near
normal at the time of discharge (mean hospital stay: 12.8 days).
Conclusions: The saline-linked radiofrequency device Tissuelink
D.S. 3.5 is simple and easy to use. The device permitted excellent
coagulation of liver surface. Small vessels (<5mm) sealed and
the intraoperative bleeding is avoided. The device isolates larger
vessels which can easily ligated.
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DIAGNOSIS AND TREATMENT OF HYDATID
LIVER DISEASE IN CHILDREN
I. Paraian1, C. Ordeanu2, A. Budusan3
1. University of Medicine ‘Iuliu Matieganu’
2. Childrens Hospital Cluj-Napoca
3. University of Medicine Cluj, Romania
Background: Hydatidosis is a parasite infection and still a prob-
lem of public health in some countries, as Romania. The disease
can affect many organs, but most of the cysts appear in the liver.
Aim: Authors present results of a retrospectiv study involving pa-
tients admited and treated in our deparment of pediatric surgery
between 1995-2006.
Methods: We studied medical files of 83 patients with liver hy-
datidosis and analyzed epidemiology, clinical presentation, diag-
nosis tools, medical and surgical treatment, complications,
hospital stay, and outcome.
Results: From 83 patients, 45 were girls (54%) and 38 boys
(46%). Almost half of the cases were teenagers (39 cases – 47%).
Mean age was 9.75 years. 70% of cases (58 patients) came from
countryside. 83 patients presented with 105 liver cysts, 13% of
them having more than one. 84% of liver cysts were in right lobe.
16 patients had other associated cyst (involving lungs, peri-
toneum, brain, spleen). 14 cysts were huge (more than 10 cm di-
ameter), 42 were large (between 6 and 10 cm). Clinical
presentation was not specific in 42 cases (abdominal pain, nausea,
fever) and abdominal tunor in 5 cases. Surgery was associated
with medical treatment with albendazol in 37 cases. We per-
formed laparoscopic treatment in 4 cases. Mean hospital stay was
16 days. Our patients had uneventful recovery, no mortality and
one case of relapse after 1 year.
Conclusions: Clinical presentation may vary and be not specific,
which makes this very difficlut for diagnosis. Abdominal ultar-
sound should be a routine tool diagnosis for children with ab-
dominal pain. Laparoscopic treatment remains an option for
some of the patients.
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COMPLICATED LIVER HYDATID DISEASE
I. Baloyiannis, K. Tepetes, V. Kouritas, M. Spyridakis,
G. Christodoulides, K. Karagiannis, E. Sioka, K. Hatzitheofilou
Department of Surgery, Larissa University Hospital, Larissa, Greece
Background/Aim: The profile of complicated hydatid cases may
identify the proper type and time of treatment.
Methods: The records of 13 patients who underwent surgery for
complicated liver hydatid disease were retrospectively reviewed.
Data collected included; age, gender, clinical presentation, labo-
ratory findings, imaging modalities, ERCP, hospitalization, sur-
gery performed and complications.
Results: 6 patients had rupture in the biliary tree (RBT), 4 com-
munication (CBT), 2 broncho-biliary fistula (BBF) while 1 had
rupture in the abdomen. The main symptom was right hypochon-
drium pain while 2 had acute cholangiitis. Bilirubin was increased
in 1/6 RBT while cholestatic enzymes were abnormal in 5/6 RBT
and in all CBT and BBF cases. U/S was diagnostic in 2/6 RBT
and in 2/4 CBT cases. CT was diagnostic in 2/6 RBT, in 1/4 CBT
and in both BBF cases. MRI/MRCP was diagnostic in 2/6 RBT
and in 1/2 BBF cases. ERCP preoperatively was performed in 1/6
of RBT, in 1/4 CBT and in all BBF cases. Postoperative ERCP
due to bile leakage was performed in 2/6 RBT and in 2/4 CBT
cases. Surgery mainly performed was partial cystectomy, common
bile duct exploration, suture of the biliary tree communication
and omentoplasty (6/10). For BBF, partial cystectomy and sutur-
ing of the fistula was performed.
Conclusion: Complicated cases mainly include RBT that may not
present as acute cholangiitis. Laboratory and imaging may be in-
conclusive and diagnosis is established after multimodality imag-
ing or intraoperatively. ERCP preoperatively may decrease bile
leakage postoperatively. Suturing of the bronho-biliar fistula was
efficacious.
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CLINICAL AND MORPHOLOGICAL
PROGNOSTIC FACTORS IN PORTOSYSTEMIC
SHUNT SURGERY
A. Kochatkova, B. Kotiv, V. Chirsky, I. Dzidzava
Medical Military Academy, Saint-Petersburg, Russia
Backgrounds Searching for the optimal way to treat the manifes-
tations of portal hypertension is still issue of the day in surgical
hepatology. One of the most frequent causes of forming the por-
tal hypertension syndrome is intrahepatic block. As the world ex-
perience implies the most radical way to correct complications of
portal hypertension is to perform different variants of portocaval
shunts (mesentericocaval, distal splenorenal shunts and etc).
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However the high rates of lethal outcomes because of hepatocel-
lular insufficiency and esophagogastric bleeding in postoperative
period require more careful choice of patients with cirrhosis for
this way of treatment. It seems to be more successful results in
portocaval shunting can be reached by searching more informa-
tive criteria for choosing the patients.
Methodology A total of 78 patients with cirrhosis complicated
with portal hypertension syndrome who underwent for portocaval
shunt (38 - mesentericocaval, 31 - distal splenorenal shunts, 9 –
another variants of portocaval shunts) were analyzed. All patients
were fully examined. We also studied cumulative postoperative
survival taking into account Child-Pugh scale and the intensity of
morphological changes in liver. Liver biopsy was evaluated by
using qualitative (the presence/absence of morphological
changes), semiquantitative (histological activity count, Knodell
R.G., 1981) and quantitative (specific volume of parenchyma
components) analyses.
Results According to Child-Pugh scale patients were divided in
the next way: Child A – 16, Child B – 46 and Child C – 16 pa-
tients. Three-year cumulative postoperative survival was: in class
A - 83,3 ± 15,2 %, in class B - 76,8 ± 8,4 % and in class C - 24,8
± 6,2 %. Five-year survival in patients with compensated and sub-
compensated liver functions was: 62,5 ± 10,2 % and 69,1 ± 11,3
%, accordingly. Comparing cumulative postoperative survival
with Histological Activity Count there were no statistically reli-
able results. At the same time decrease of postoperative survival
was characterized by increasing the volume of conjunctive tissue
in liver parenchyma (86,2 ± 1,2 % in one-year and 40 ± 1,4 %
in two-year) and decreasing the volume of healthy hepatocytes
(61,8 ± 2,8% and 72,6 ± 5,6%, accordingly).
Conclusions The most determinant factors in results of porto-
caval shunting were: decompensate liver function (Child C) in
combination with morphological changes in liver (reduction the
volume of healthy hepatocytes < 72 ± 5,6%, increasing the vol-
ume of conjunctive tissue > 55,9 ± 5,6% and nucleocytoplasmic
ratio < 0,9 ± 0,2. Histological Activity Count and the activity of
fibrogenesis in liver are not significant as prognostic markers in
portosystemic shunt surgery.
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RIGHT HEPATECTOMY WITH SELECTIVE
VASCULAR EXCLUSION
M. Oliveira, R. Melo, A. Pinho, I. Romero, M. Almeida,
E. Martins, J. Costa-Maia4
Unidade Hepato-Bilio-Pancreática e Esplénica, Serviço de Cirurgia
Geral, Hospital de S. João, Porto, Portugal
Introduction: One of the most significant advances in liver sur-
gery, has been the recognition of the importance of the liver rem-
nant and the development of techniques of parenchymal
expansion and protection, of which vascular exclusion selectivity
is one of the most important examples.
Case presentation: The authors present a right hepatectomy with
selective inflow and outflow control, in a 61 year-old female with
intra-hepatic cholangiocarcinoma. Intra and post-operative
courses were uneventful, with no blood products transfused peri-
operatively. The patient was discharged on day 5. Options on vas-
cular control, parenchymal transection and liver surface
treatment are presented.
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MESOHEPATECTOMY FOR CYSTIC MASS OF
THE BILIARY CARREFOUR: A CASE REPORT
U. Cillo, M. Polacco, A. Carraro, G. Zanus, A. Brolese,
F. DAmico, A. Vitale, M. Valmasoni, F. D’Amico
Hepato-biliary and Liver Transplant Unit Università degli Studi di
Padova, Italy
Background/Aims: We report a case of a 59 year-old caucasian
man, with incidental finding of increased liver function test with-
out any symptom or clinical sign except for slight subicterus.
Antiechinoccocal antibodies, neoplastic and viral markers for
hepatitis B and C were negative; ultrasound finding of complex
cystic lesion in the right hepatic lobe with left biliary tract com-
pression led to a CT-scan that showed a 6 cm multiloculated avas-
cular cystic lesion with calcifications, septa and a biliary
communication. The brushing during ERCP was negative for
neoplastic cells. A 3-D CT demonstrated an insufficient remnant
liver after a potential right extended hepatectomy; then the pa-
tient was referred to our attention for a surgical second-opinion.
Methods: The patient underwent laparotomy and mesohepatec-
tomy with bilio-jejuno-anastomosis.
Results: The histological findings deposed for hepatobilary cys-
toadenocarcinoma confined within the margin of exeresis with
mitotic index of 18-20 HPF; no vascular invasion. The patient un-
derwent a follow-up every 3 months.
Conclusions: Biliary cystadenomas are a rare benign cystic he-
patic neoplasm with premalignant potential and slow growing
that arise from the bile ducts with a high recurrence. Approxi-
mately 100 cases of cystadenomas and 50 cases of cystadenocar-
cinomas have been reported in the literature. These lesions
account for less than 5% of intrahepatic cysts and approximately
85% of them arise from the intrahepatic biliary tracts. [1]
References:
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LIVER RESECTION FOR TRANSPLANTABLE
HEPATOCELLULAR CARCINOMA
A. LAurent, M. Nicolas, T. Claude, C. Daniel
Dept of Surgery Hopital Henri Mondor Creteil France
Objectives: The aim of this study is to report the results of liver
resection (LR) in transplantable patients, with special reference
to recurrence rate and salvage transplantation.
Background data: Liver transplantation (LT) is the best theoret-
ical treatment of HCC fulfilling the Milan Criteria (TNM stages
1-2). However, LT is limited by organ availability and progres-
sion on the waiting list. LR may represent an alternative in these
patients.
Methods: From 1990 to 2007, 274 patients underwent liver re-
section for HCC. 61 were within Milan Criteria on pathologic
study of the specimen. 10 were stage 1 and 51 stage 2. There were
51 men and 10 women with an mean age of 62. LR included 3
right hepatectomies, 4 central hepatectomies, 10 bisegmentec-
tomies, 13 segmentectomies and 31 non anatomic resections. 34
resections were performed through a laparoscopic approach and
there were only 8 open resections since 1998.
Results: Three patients died postoperatively (4.9%), none after
laparoscopic resection. Morbidity rate was 28% : grade
I/II/IIIa/IIIb/IVa/IVb in 2/4/2/1/3/3, respectively. After a mean
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follow up of 4.3 years, 31 patients (51%) developed intrahepatic
tumor recurrence. 24 were again transplantable of which 15 were
transplanted, 1 is on the waiting list, 2 refused LT and 6 had a
medical contraindications. Other treatments for recurrence (out-
side LT) included, alone or in combination, ablation (13), TACE
(14) and repeat resection (1). Overall and disease free 5-year sur-
vival rates were 72% and 47%, respectively. Survival was identi-
cal in stage 1 and 2 patients. Overall 5-year survival was 85% in
patients who underwent salvage transplantation.
Conclusions: LR for transplantable HCC offers an efficient al-
ternative to LT and yields an overall survival rate comparable to
upfront LT. Close screening is recommended after resection be-
cause efficient treatment of recurrences are available, especially
salvage LT which is possible in 77% of the cases in theory and in
50% on intention to treat analysis.
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HAND-ASSISTED LAPAROSCOPIC RIGHT
HEPATECTOMY FOR METASTASES OF
CARCINOMA OF THE BREAST
C. Loinaz, J. Fernandez, C. Garcia, F. Ochando, M. Ramos,
J. Rueda, D. Vega, C. Fiuza, P. Hernandez, A. Quintans
Unidad de Cirugía General, Hospital Universitario Fundaciόn Al-
corcόn, Alcorcόn, Madrid, Spain
AIM: Laparoscopic right hepatectomy is not a widely spread
technique yet. The volume of the specimen leads to the use of a
moderately sized incision for its retrieval. An incision for hand
assistance may be useful during the dissection time and makes
possible extracting the liver. This film shows how we do the tech-
nique in our centre.
MATERIALS AND METHODS: 63 y old woman with carcinoma
of the left breast operated on in 1999 and right breast in 2006 (stage
IIB). Treated with radiotherapy and chemotherapy afterwards. A
single liver metastases appears, responsive to chemotherapy ini-
tially with size reduction, to regrow afterwards. Surgical treatment
is decided. An exploratory laparoscopy is decided, as the patient
had not any abdominal operation and the preoperative study did
not find any problema. Preoperative image studies located the
metastases in the right posterior section, but at intraoperative la-
paroscopic ultrasonography there was not a clear delineation of
the lesion due to the heterogeneous liver echogenicity. A hand-as-
sisted right hepatectomy with a lap-disc was decided. A chole-
cystectomy was done, dissection and section of the right elements,
and right lobe liberation. Parenchymal transaction was performed
by electrocoagulation, vascular sealers and endostaplers.
RESULTS: Surgery went uneventful. Estimated blood loss was
around 500 cc, the patient entering the OR with 13 g of haemo-
globin and went out with 9,8 g. Surgical time was 5 ½ h. Postop-
erative evoluction was correct, the patient being discharged on
the 6 th PO day.
The resected lobe showed two tumours, on a liver parenchyma
with 35% macrovacuolar steatosis, with fibrosis, hyalinosis nad
etensive microcalcifications, with chemotherapy related changes.
CONCLUSIONS: Hand-assisted laparoscopic right hepatectomy
is a good alternative in the intent ro reduce surgical invasiveness
ans improving postoperative recovery. Combination of instru-
mentation through the trocars and manipulation through the
hand port, with adequate palpation appears to be useful to per-
form the procedure.
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RESULTS OF RESECTION AND
TRANSPLANTATION FOR HCC IN CIRRHOSIS
AND NON CIRRHOSIS
F. Rayya1, M. Bartels2, J. Hauss2, J. Fangmann3
1. Klinikum- Merseburg
2. University Leipzig
3. Karl-Olga Krankenhaus, Germany
Hepatocellular carcinoma (HCC) is one of the most common
cancers worldwide. Both resection (LR) and transplantation
(OLT) are surgical treatment options depending on the size of
tumours and the presence of cirrhosis. Liver cirrhosis is the main
reason for the high early postoperative mortality after resection.
Even in the Child A stage, extensive resections are not recom-
mended. This study presents the results of the surgical treatment
(LR or OLT) for HCC in cirrhotic- and non cirrhotic livers.
We analysed the data of 76 patients who underwent LR or LT
for HCC from January 2001 to December 2006.
In non cirrhotic livers the following resections were performed: 30
right and extended right hemihepatectomies (54, 5%), 11 left hemi-
hepatectomies (20%) and 14 mono- or bisegmentectomies (25, 5%).
In cirrhotic livers the following procedures were performed: in Child
A stage one right hemihepatectomy, one extended right hemihepa-
tectomy, one extended left hemihepatectomy and four mono- or
bisegmentectomies and in Child B stage, three mono- or bisegmen-
tectomies. In 11 patients who underwent transplantation, tumors in
two patients with exceeded the Milan criteria. Five patients of the
LR group were treated with TACE before transplantation.
Liver resection for HCC in cirrhosis should be performed with
caution (no long-term survival in our data). Our study confirms
that transplantation shows good long- term survival in early HCC
stages. However, this may also be true for stages above the Milan
criteria. For HCC in non-cirrhotic livers resection remains the
treatment of choice, justifying an extensive surgical approach.
Such an approach achieves favourable long term survival as
demonstrated in the study presented
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THE REPEATED HEPATECTOMY FOR
RETROPERITONEAL LEIOMYOSARCOMA
E. Dulundu, E. Ozkan, C. Akyuz, Y. Ozel, K. Yildiz,
U. Topaloglu
5th Department of Surgery Haydarpasa Numune Education and Re-
serach Hospital
Background: Leiomyosarcoma are malignant tumors of the soft
tissues. It is most commonly found in the stomach, small intes-
tine and retroperitoneum.
Aim:Although repeated hepatic resection for colorectal liver
metastases has shown good results the place of same policy for
sarcoma’s metastases its still debate.
Case report: We report herein a case of liver metastases from
leiomyosarcoma arising from the retroperitoneum after one year
of its resection in 43 year old women. Liver metastases recurred
5 times during the period of 2005 and 2008. Therefore, the pa-
tient underwent a total of fore liver resection and one RF abla-
tion. Liver resection comprised twenty-two metastasectomy. All
the resection accomplished with R0 resection. She is currently
well and asymptomatic, with no signs of recurrence.
Conclusion: Repeated liver resection is a safe and applicable pro-
cedure for the patient with recurrent liver metastases from
retroperitoneal leiomyosarcoma with providing a survival benefit.
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SYNCHRONOUS INTRA- AND EXTRAHEPATIC
CHOLANGIOCARCINOMA IN TWO PATIENTS
I. Popescu1, S. Ciurea1, D. Hrehoret1, L. David1, P. Petrisor1,
M. Boros2, V. Herlea3, A. Croitoru4
1. Center of General Surgery and Liver Transplantation,
2. Department of Medical Imaging,
3. Department of Pathology
4. Center of Gastroenterology and Hepatology, Fundeni Clinical In-
stitute – Bucharest – Romania
Background: Cholangiocarcinoma (CC) is generally classified as
intrahepatic (ICC) or extrahepatic (ECC). There are few reports
presenting metachronous association of the two types (1) or,
more frequently, synchronous ECC (2). Intrabileduct extension
of ICC has also been reported (3). Methods: Between January
1995 and October 2008, 87 patients underwent liver resections
for ICC in our center. Results: In one patient, with a 6.5 cm tumor
located in segments V, VIII and IV, with hilar invasion, resected
by trisectionectomy, frozen section examination of the common
bile duct (CBD) revealed multiple foci of CC. Another patient,
with a 9 cm tumor located in segments II-III and a tumoral
thrombus in the CBD, underwent a left lateral sectionectomy and
resection of the supraduodenal CBD; frozen section examination
of the CBD also revealed multiple foci of CC. In both patients
resection of the CBD was extended until reaching negative mar-
gins. Bile drainage was done through a Roux-en-Y anastomosis.
Synchronous ICC and ECC was confirmed by final pathological
examination (poorly differentiated adenocarcinoma and well-
moderately differentiated adenocarcinoma, respectively) and im-
munohistochemical staining (positivity for CA 19-9 and CK 7).
Both patients had an uneventful postoperative course and are
alive free of disease at 4 and 2 months, respectively. Conclusions:
Synchronous ICC and ECC are rarely diagnosed preoperatively.
When suspected intraoperatively, aggressive surgical approach
and frozen examinations are essential for the successful manage-
ment of these rare cases.
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EFFECTIVENESS OF FONG S SCORE AND
LAPAROSCOPIC EXPLORATION TO ASSESS
THE RESECTABILITY OF METACHRONOUS
COLORECTAL LIVER METASTASES
M. Sofia1, G. Li Destri1, F. Di Benedetto2, T.R. Portale3,
G. La Greca1, D. Russello1, S. Puleo1
1. Department of Surgical Sciences, Organ Transplantation, and Ad-
vanced Technologies, University of Catania, Catania, Italy
2. Liver and Multivisceral Transplant Centre, University of Modena
and Reggio Emilia, Modena, Italy
3. Department of Surgery, University of Catania, Catania, Italy
BACKGROUND. The resectability of liver metastases is usually
assessed by imagine techniques, intraoperative ultrasonography
or preoperative ultrasound laparoscopic exploration, and the
Fong’s clinical score can be used to predict the prognosis of pa-
tients. Aim of this retrospective study was to establish the effec-
tiveness of the Fong’s risk score to predict the rate of resectability
and if laparoscopic exploration with ultrasonography can consid-
erably reduce the number of useless laparotomies. METHODS.
In the period 1997-January in all patients with colorectal liver
metastases was calculated the Fong’s clinical score and a statisti-
cal analysis was performed to evaluate the relation score-re-
sectability, the probability of unless laparotomy in related to the
score and the Fong’s factor that better predict the resectability.
None of the patients was submitted to preoperative laparoscopic
exploration. RESULTS. Forty-seven patients were eligible for
liver resection. All patients with score 0 were submitted to liver
resection, 76.9% with score 1, 58.3% with score 2, 66.6% with
score 3. No patient had score 4 o 5. The statistical analysis showed
not relationship between the score and the resectability
(p=0.4056), but the probability of useless laparotomy range from
0.07 for score 0 to 29.4 for score 2. The best parameter that in-
fluence the irresectability is the CEA. The use of laparoscopic
exploration could spared 12% of unless laparotomies in patients
with score 0-1, and 39% in score 2-3. CONCLUSIONS. Our
study show that a high Fong’s score, especially the CEA positiv-
ity should be considered in the evaluation of not resection of col-
orectal liver metastases. Moreover the preoperative laparoscopic
exploration could avoid useless laparotomies.
REFERENCES.
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currence after hepatic resection for metastatic colorectal cancer:
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EARLY POST-OPERATIVE OUTCOMES
FOLLOWING HEPATIC RESECTION FOR
BENIGN LIVER DISEASE IN 79 CONSECUTIVE
PATIENTS
J. Lordan, T. Worthington, N. Quiney, W. Fawcett, N. Karanjia
The Royal Surrey County Hospital, Guildford, Surrey, UK
Background: Liver resection is an accepted practice for malig-
nant disease of the liver. However, due to the potential morbid-
ity and mortality, liver resection for benign disease is more
controversial. This study was designed to assess the early out-
comes of consecutive liver resections for benign disease over a 12
year period and compare these to early outcomes of liver resec-
tions for metastatic colorectal cancer (MCRC) during the same
time period.
Methods: Consecutive liver resections (79 for gynaecological ma-
lignancies and 390 for MCRC) were undertaken in a single HPB
centre between 1996 and 2008. Patients’ demographics and early
outcomes were recorded. Statistical analyses were carried out
using SPSS (version 15). P<0.05 was considered to be signifi-
cant.
Results: There was no difference in median age between the be-
nign group (53.6 years) versus the MCRC group (65.9 years,
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p=0.18). However, there was a significant trend towards a lower
ASA in the benign group (p<0.001). There was no difference in
median blood loss (200ml versus 250 ml, p=0.14) or hospital stay
(10 days versus 9 days, p=0.26). The morbidity rate was 8.9% in
the benign group compared with 20.5% in the MCRC group
(p=0.002). The rate of serious complications was 1.3% in the be-
nign group compared with 4.4% in the MCRC group (p=0.04).
There were no post-operative deaths in the benign group com-
pared with 8 (2%) in the MCRC group (p=0.004).
Conclusion: In conclusion, liver resection for benign disease can
be undertaken with a mortality rate approaching zero and mini-
mal morbidity in specialist HPB units.
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SURGICAL INTERVENTION FOR
HEPATOCELLULAR CARCINOMA WITH
OBSTRUCTIVE JAUNDICE DUE TO BILIARY
TUMOR THROMBUS
P. Silvia, R. Andrea, I. Calogero, C. Tommaso, G. Alfredo
Department of Surgery and Gastroenterology, University of Verona,
General Surgery “A” Medical School, Verona, Italy
ABSTRACT: Obstructive jaundice as the main presenting clini-
cal feature is uncommon in hepatocellular carcinoma (HCC) and
only 1-12% of HCC patients manifest obstructive jaundice as the
initial complaint. Such cases are clinically classified as “icteric
type hepatoma” or cholestatic type of HCC”.
We presented a case of 61 year-old man, with history of hepatitis
virus B infection and liver chirrosis, referred to our hospital with
obstructive jaundice. On admission laboratory studies showed el-
evated α-fetoprotein and bilirubin. US, CT and MRI showed a
mass involving the left lobe of the liver, with tumour thrombus in
the common bile duct. After carefull preoperative assessment of
the future liver remnant volume and function we considered that
resection was possible and the patient underwent a successful left
hepatectomy and caudate lobectomy with extra-hepatic bile duct
resection.
It is important to differentiate the hepatocellular type from the
icteric type of HCC in patients presenting with jaundice. The he-
patocellular type of HCC has a very dismal prognosis. In contrast,
patients with the icteric type of HCC have a survival rate compa-
rable to those of HCC patients without jaundice if they are prop-
erly managed. The curative treatment of patients with the icteric
type of HCC is complete extirpation of the tumour by surgical re-
section. In patients with biliary tumour thrombi involving the ex-
trahepatic ducts, the involved ducts can be resected en bloc with
the liver tumour followed by reconstruction with biliary enteric
anastomosis. Early detection, diagnosis and surgical treatment
are the key points to prolong survival of these patients.
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HEPATOCELLULAR CARCINOMA (HCC) WITH
NEOPLASTIC THROMBOSIS OF THE HEPATIC
DUCT (BDT)
E. De Raffele, M. Mirarchi, S. Vaccari, A. Cavallari, B. Cola
Dipartimento di Chirurgia Generale e Trapianti Policlinico S.Or-
sola-Malpighi, Bologna, Italy
Background. The biliary tract involvement in patients with HCC
usually occurs in advanced stages. Sometimes however a tumour
thrombus may grow into the biliary ducts. Surgical treatment may
be beneficial in selected cases.
Case Report. A 69-year-old man was admitted in our unit in May
2002 after repeated sessions of RFTA of 3 nodules of HCC. At
admission the nodule in S5-S8 was still viable and a BDT had in-
vaded the right and the common hepatic ducts. S5-S8 sub-seg-
mentectomy, S6 wedge resection and removal of the BDT were
performed. 17 months later the BDT recurred in the hepatic duct
without evidence of intra-hepatic recurrence and was removed. In
June 2004, a metastatic lymph node appeared at the hepatic
hilum, without evidence of liver or distant metastases, and the pa-
tient underwent limphadenectomy. In June 2007, a new HCC ap-
peared in segment S8, along with a neoplastic seeding at the right
diaphragm, in the site of the previous RFTA. The patient under-
went S8 wedge resection and excision of the diaphragmatic nod-
ule. He is at present alive without recurrence.
Conclusions. The appearance of BDT in the natural history of
HCC does not necessarily involve an unfavourable prognosis. Re-
moval of BDT and curative resection of the HCC car result in oc-
casional long-term survival. Also in presence of intra-biliary,
hepatic or limited extra-hepatic recurrence, surgical exeresis is
the best therapeutic choice in selected cases. Repeated sessions
of RFTA may predispose to malignant seeding, which can de-
velop also many years later.
P 165
HEPATIC RESECTION IN THE ELDERLY
E. Dulundu, E. Ozkan, S. Yardimci, Y. Ozel, K. Yildiz
5th Department of Surgery Haydarpasa Numune Education and Re-
serach Hospital, Istanbul, Turkey
Background: The aim of this study was to evaluate the impact of
patient age on hepatic resection.
Aim: To analyze the influence of age on surgery for hepatic re-
section
Patients and Methods: Between January 2004 and December
2008, 56 patients underwent hepatic resection for primary and
metastatic liver disease. Elderly patients were defined as those
aged 65 years or more. Clinicopathological data and outcomes
after hepatectomy for 12 (21.4%) elderly and 44 (78.6) younger
patients were retrospectively collected and compared.
Results: Operation time and hospital stay was 300 + 183 min.,
287 + 183 min., and 17 + 14 day, 20 + 11 day for young and eld-
erly patients respectively. The rate of major resections (> 3 liver
segments) was 25% in both groups. Postoperative complications
were recorded in 25% of older patients and 20.4% in the younger
group. Postoperative mortality was 0% in both groups.
Conclusion: Advanced age should not be considered as a med-
ical contraindication for hepatic resection in elderly patients. Our
result indicates that even older patients should be regarded as
potential candidates for hepatic resection.
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RETROPERITONEAL LEIOIMYOSARCOMA
LIVER METASTASIS
A. Padilla Rosciano, C. Melo Martínez, I. David, D. Luis
Instituto Nacional de Cancerolog a México
Backround: Soft Tissue sarcoma liver metastasis is an uncommon
presentation of scattered disease. The role of surgical resection of
metastasis represents a point of discussion, and part of the avail-
able data is provided from the studies realized in pulmonary
metastasectomy field
Aim: To exemplify a case of young woman with retroperitoneal
pleomorphic leiomyosarcoma with metastasic disease to left liver,
who was managed with two step surgery, with primary tumor con-
trol at first, and metastasectomy in the second one. After that the
patient underwent to a Chemoteraphy regimen, demonstrating
good reponse al the moment
Methods: Case report diagnosed and treated at our Institution,
with full image and clinical file of a female patient 25 years old
con retroperitoneal mass with metastasic disease involving 80%
of left liver lobe
Conclusions: Surgical treatment of metastasic liver disease is stan-
dard treatment when resectable tumor is documented, this con-
dition has been stablished. Nevertheless, in the point of sarcoma
metastasis to liver, the impact on over all survival and free dis-
ease period need to be studied, since data available comes from
lung metastasectomy procedures
References:
Surgical Oncology Clinics of North America, Volume 17, Issue
3, July 2008
Surgical Clinics of North America, Volume 88, Issue 3, June 2008
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A COMBINED TREATMENT OF LIVER
COLORECTAL METASTASES
B. Kotiv, S. Alientiev, I. Dzidzava
Medical Military Academy, Saint-Petersburg, Russia
Aims: to evaluate the results of combined treatment of liver col-
orectal metastases.
Methodology We included 92 patients with solitary liver colorec-
tal metastases. In 25 (27,2%) cases the metastases were accepted
as synchronous and in the rest cases were metachronous metas-
tases. A volume of an affected liver was 25-70%. By L.Gennary
(1984) classification, I stage was revealed in 22 cases, II stage – in
28, III stage – 42, accordingly.
Results. We performed simultaneous operations (ablation the
tumor of a large intestine and liver resection with postoperative
adjuvant polychemotherapy (regional chemotherapy with oxal-
lyplatin and Xeloda per os - mean 6 courses) in cases with syn-
chronous colorectal metastases with volume of affected liver less
than 50%, without invasion into caval and portal gates (n=7). In
the rest cases we performed 3 courses of postoperative adjuvant
regional chemotherapy after removal the primary tumor with
subsequent liver resection. In postoperative period all patients
are underwent to a course of treatment with adjuvant chemother-
apy. A program of combined treatment of metachronous col-
orectal metastases in liver included: in the first stage -
chemoembolizations into hepatic artery (n=24) and into portal
vein (n=3), and in the second stage - liver resection with the sub-
sequent adjuvant regional chemotherapy. Preoperative adjuvant
chemotherapy (regional - oxallyplatin, per os – xeloda) gave a
partial response in 53% cases. A cumulative postoperative sur-
vival in patients after treatment the liver colorectal metastases in
one-year was 87,9±3,2%, three-year - 48,5±4,3% and five-year
survival 33,3±5,6%, accordingly. The median survival was 46,6
months.
Conclusion. The combined treatment of liver colorectal metas-
tases allows to increase an effort an opportunity of liver resection
and to increase duration of life in this category of patients.
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HYPERNATREMIA AFTER LIVER HIDATIDOSIS
SURGERY
J. ramia1, E. Sancho2, J. Santos2, F. Garrido2
1. Department of Surgery Hospital Universitario de Guadalajara
2. Department of Surgery Hospital Santa Barbara, Madrit Spain
Hypernatremia due to hypertonic saline used as scolicide in hi-
datidosis liver surgery is extremely rare. It is very important to
perform a quick diagnosis because it could provoke neurological
non-reversible complications. We presented a new case and dis-
cuss causes and treatment.
CASE REPORT: Male, 44 years-old, came to Emergency De-
partment with pain in right hypocondrium and jaundice. ALT:
362; GGT: 584; LDH: 164; Alkaline ph: 288, Bilirrubin: 6,8. Hi-
datidosis serology: + (1/4096). In CT, two liver hydatid cysts were
present: segment III (5 cm), and segment IV-V-VIII (15 cm). We
operated on performing total closed cystectomy of segment III
cyst but the other was too big and central to take out closed and
decided to open for performing surgery in a safer way. We
opened the cyst (no bile was present), aspirated (liquid and sco-
lices) and filled with hypertonic saline twice and finally performed
total open cystectomy. We used about 2000 cc of hypertonic
saline. 6 hours after surgery, the patient was confused and dis-
oriented without neurological causes that justified clinical symp-
toms and blood pressure was high (157/95 mmHg). Analysis
showed a sodium of 157 mEq. Preoperative sodium was normal.
We started a hypotonic intravenous therapy to decrease slowly
sodium levels and neurological symptoms disappeared. 48 hours
later sodium was 142 mEq. Hypernatremia no provoked any late
neurological consequence.
CONCLUSIONS: If acute neurological symptoms appear after
using hypertonic saline in liver hydatidosis surgery is mandatory
to rule out hypernatremia. There is not consensus why hyperna-
tremia occurs: total amount of hypertonic saline, frank biliary
rupture, special sensibility,..
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LIVER RESECTION FOR SOLITARY LIVER
METASTASIS FOLLOWING AGGRESSIVE
SCC OF THE PENIS
J. Lordan, J. Kennedy, S. Gant, N. Grant, A. Nigam,
J. Money-Kyrle, N. Karanjia, T. Worthington
The Royal Surrey County Hospital, Guildford, Surrey, UK
Background: The prognosis for squamous cell carcinoma (SCC)
of the penis significantly falls following local lymph node spread.
Few studies have investigated the management of patients with
distant metastatic spread. Liver resection is common place for
metastatic colorectal cancer (MCRC) but, to the authors’ knowl-
edge, has not been described for metastatic SCC of the penis. We
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describe an unusual case who presented with a solitary liver
metastasis from a SCC of the penis which was treated by liver re-
section.
Case Report: In 2006 a 39 year old man underwent a circumcision
and bilateral groin lymphadenectomy followed by local radio-
therapy for SCC of the penis. In 2008 he developed an occipital
lobe infarct and investigation revealed a patent foramen ovale
and an incidental liver metastasis in segment 7. PET-CT showed
increased FDG activity in this lesion which was localised. After
discussion in the regional HPB MDT he underwent a right hemi-
hepatectomy and recovered uneventfully. 3 month follow-up CT
and MRI showed no evidence of disease.
20 years prior, he was diagnosed with ‘prune belly’ syndrome and
associated renal hypoplasia for which he underwent renal trans-
plant.
6 months post-liver resection he developed a lump over his right
shoulder. Subsequent imaging revealed multiple lesions in the
liver, the hilum of the left lung and abutting the transplanted kid-
ney.
Conclusion: We present an unusual case of liver metastasis from
aggressive SCC of the penis treated by liver resection. To the au-
thors’ knowledge this has not been described before.
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RIEDEL THYROIDITIS IN A PATIENT WITH
A HISTORY OF SCLEROSING CHOLANGITIS
N. Michalopoulos1, A. Xydakis2, E. Evagelidakis2,
H. Markogiannakis1, E. Lagoudianakis1, A. Manouras1, P. Kekis1
1. Department of Endocrine Surgery, 1st Department of
Propaedeutic Surgery, Hippokration Hospital, Athens Medical
School, University of Athens, Athens, Greece
2. Athens Medical Center, Athens, Greece
Background: Riedel thyroiditis is an extremely uncommon form
of chronic thyroiditis in which the thyroid gland is replaced by fi-
brous tissue. Its etiology is unclear; the prevailing view, though,
is that it is part of a generalized fibroinflammatory process that
can extend beyond the thyroid capsule, invading adjacent cervical
structures, and may also involve other organs. It is well-docu-
mented that a third of these patients ultimately develop at
least one extracervical manifestation of multifocal fibrosclerosis
such as retroperitoneal or mediastinal fibrosis or sclerosing
cholangitis.
Case presentation: We report a case of a 38-year-old woman who
presented with a diffusely enlarged thyroid gland and hypothy-
roidism. She complained of intermittent neck pain for 3 months.
Physical examination revealed a hard, tender thyroid gland. Ul-
trasound showed a homogeneously hypoechoic pattern, with loss
of clear demarcation of the gland from the adjacent anatomic
structures. The patient’s history included wedge resection of a
3cm liver tumor 2 years ago that was diagnosed as sclerosing
cholangitis characterized by inflammation and fibrosis of the in-
trahepatic bile ducts. Immunohistochemical profile of the tumor
included CD34(-), Bcl-2(-), CD99(-), SMA(+), and Desmin(-).
The patient underwent total thyroidectomy. The specimen was
characterized by fibrous bands which infiltrated the whole gland
and lymphocytes, plasma cells and eosinophils accompanying the
fibrosis. Riedel thyroiditis with no sites of malignancy was diag-
nosed.
Conclusion: Fibroinflammatory disorders, including Riedel thy-
roiditis and sclerosing cholangitis, constitute heterogeneous clin-
ical conditions with largely unknown cause and pathogenesis.
Although rare, they may be present at the same patient.
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PORTAL HYPERTENSIVE BILIOPATHY
COMPLICATING PORTAL VEIN THROMBOSIS
AFTER LIVER RESECTION FOR
HEPATOCELLULAR CARCINOMA (HCC)
E. De Raffele, M. Mirarchi, S. Vaccari, B. Cola
Dipartimento di Chirurgia Generale e Trapianti Policlinico S.Or-
sola-Malpighi, Bologna, Italy
Background: PHB is a rare condition that refers to abnormalities
of the biliary tract in patients with portal hypertension. Herein
we describe a case of obstructive jaundice originating from a PHB
associated with portal vein thrombosis after liver resection for
HCC.
Case Report: A 72-year-old man was admitted in our unit with
HCC on cirrhosis. He underwent wedge resection of segments
S7-S8 and was discharged on 18th post-operative day (p.o.d.) with
a biliary leak; the abdominal drain was removed on 30th p.o.d.
Three weeks later the patient developed obstructive jaundice and
was readmitted in our unit. A CT scan demonstrated a bile col-
lection near the hepatic stump, a complete thrombosis of the right
portal branch and a partial thrombosis of the portal vein (Figure
1). The bile collection was drained percutaneously and Fonda-
parinux was administered subcutaneously. On 66th p.o.d. a ERCP
demonstrated a stricture of the hepatic duct extending to the right
duct, a stricture with upstream dilatation of the left duct and a
small fistula near the hepatic stump (Figure 2). A biliary stent
was placed in the right duct and a naso-biliary drainage in the left
duct, but the levels of serum bilirubin continued to rise slowly.
On 79th p.o.d. a CT scan demonstrated the progression of the
thrombosis to the left portal branch. The patient died two months
later of liver failure.
Conclusions: PHB may represent the first expression of throm-
bosis of intra-hepatic portal branches and may complicate the
clinical course of liver resection in cirrhotic patients.
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REGIONAL VARIATION IN REFERRAL FOR
POTENTIALLY CURATIVE RESECTION
OF COLORECTAL HEPATIC METASTASES
J. Tiernan, C. Briggs, G. Irving, M. Swinscoe, M. Peterson,
I. Cameron
Department of Hepatobiliary and Pancreatic Surgery, Royal Hal-
lamshire Hospital, Sheffield Teaching Hospitals NHS Trust,
Sheffield, UK
Background: Surgical resection is now widely accepted as the gold
standard therapy for colorectal liver metastases. In the UK re-
gions are divided into cancer “networks”, where colorectal teams
at district hospitals refer patients with hepatic metastases to a
specialist hepatobiliary multidisciplinary team (MDT) for further
management. A survey in our region in 2004 demonstrated a wide
variation in referral practice from our four regional hospitals. A
network-wide referral, staging and follow-up protocol was intro-
duced in 2005 in an attempt to standardise resection rates across
the network.
Aim: To compare resection rates for colorectal hepatic metas-
tases by region, following introduction of a standardised referral
policy.
Methods: A prospective audit was conducted form 2005 onwards.
All Sheffield patients are discussed at the specialist hepatobiliary
MDT, whereas the four regional hospitals only refer potentially
resectable candidates based on the follow-up protocol.
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Results
Table 1. Colorectal liver metastases resection rates per 100,000
population per year. Age standardised incidence taken from the
Trent Cancer Registry, 1999.
Table 2. Comparison of outcome, as assessed by CT imaging and
CEA measurement, between patients originating from Sheffield
and regional hospitals 2005-2008. (P=Chi square test)
Introduction of the protocol has increased the resection rate from
three of the four regional hospitals. All resection rates are now
similar but remain significantly lower than Sheffield, despite
Sheffield having the lowest incidence of colorectal cancer in the
region. There was no significant difference in disease-free sur-
vival at 6 months and 1 year (P=0.396 and 0.553 respectively) be-
tween the Sheffield and regional patients.
Conclusion: Introduction of a referral protocol standardised re-
section rates outside the specialist centre. The widespread adop-
tion of the policy to discuss all patients with liver metastases at a
specialist Hepatobiliary MDT may increase resection rates across
the UK.
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STAPLER HEPATECTOMY FOR COLORECTAL
METASTASES CAN BE SAFELY PERFORMED
WITH EXCELLENT ONCOLOGICAL OUTCOME:
A MULTIVARIATE SINGLE-CENTRE ANALYSIS
L. Fischer, H. Bruns, U. Hinz, M. Narimanidze, J. Weitz,
M. Büchler, P. Schemmer
Department of Surgery, University of Heidelberg, Germany
Introduction. Surgical resection offers the best chance for cure
in patients with liver metastasis of colorectal cancer. A 5-year sur-
vival of about 40% with standard resection techniques is reported.
Thus, this analysis was performed to investigate the oncological
results after stapler hepatectomy.
Material and Methods. From October 2001 to August 2008 226
prospectively documented patients underwent liver resection for
colorectal metastases. More than 70% of which underwent sta-
pler hepatectomy, a novel liver resection technique.
Results. The median age of patients was 64.4 years (IQR 57.9-
69.9). There were 65.5% male patients. In 56.5% of cases more
than 2 liver segments were resected. In 79.2% of all cases a R0-
resection was performed while 12.4% and 6.6% of all cases un-
derwent R1- and R2-resection, respectively. In 31.2% of patients
a Fong-score of 2 or less was present at the time of resection. The
mean operation time was 202 minutes (IQR 160-255 min). The
average blood loss was 600 ml (IQR 300-1200 ml). The mean
ICU- and hospital-stay was 1 day (IQR 1-1day) and 11 days (ICR
8-14 days), respectively. The overall 5-year survival was 36.3%
(CI 27-45.6%), being the highest in patients with R0-resection
(41.8%; CI 31.0-52.2%). The multivariate analysis revealed that
an operative time of more than 300 minutes and Fong-scores of
more than 1 had negative impact on survival (p<0.02).
Conclusion. Stapler hepatectomy for colorectal metastasis can be
performed safely with excellent survival. The multivariate analy-
sis revealed that a short operative time and low Fong-score of less
than 2 correlates with improved survival.
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IMPACT OF PRINGLE MANEUVER ON
SURVIVAL OF PATIENTS WITH COLO-RECTAL
LIVER METASTASES: RESULTS OF A
RANDOMIZED CLINICAL TRIAL
A. Ferrero, N.Russolillo, L. Viganò, R. Lo Tesoriere,
A. Muratore, L. Capussotti
HPB Unit Ospedale Mauriziano, Torino, Italy
Background. Experimental studies reported that ischemia/reper-
fusion damage stimulates the outgrowth of pre-established mi-
crometastases and consequently may adversely influence the
prognosis of colorectal cancer patients.
AIMS. To evaluate the impact of Pringle maneuver on survival of
patients with colo-rectal liver metastases who underwent liver re-
section.
Methods. Eighty patients with colo-rectal liver metastases were
randomized to undergo hepatectomy with (39 patients, HPC
group) or without (41 patients, NHPC group) pedicle clamping.
Results. The two groups were homogeneous in terms of age,
tumor presentation and preoperative hepatic biochemistry. Mor-
tality was nil and morbidity rates were similar (35.8% vs. 31.7%,
p 0.692). Median follow-up was 56.0±18.2 months in HPC group
and 54.3±13.2 months in NHPC group (p 0.717). Overall survival
at one-, three- and five-years was 100%, 81.5% and 50.4% in HPC
group vs. 92.6%, 73.1% and 52.4% in NHPC group (p 0.686). Dis-
ease-free survival was similar: one-, three-and five-years survival
rates were 81.8%, 52.7% and 36.4% in the HPC group vs. 85.0%,
56.6% and 34.7% in NHPC group (p 0.618). Twelve patients ex-
perienced hepatic recurrence in both groups (p 0.883). Median
time to hepatic recurrence was 35.2±28.1 months in HPC group
and 27.4±21.5 months in NHPC group (p 0.482). Overall and dis-
ease-free survival were similar even when Pringle maneuver was
longer than 45 minutes (p 0.606 and 0.718, respectively). No dif-
ference was observed in the overall and disease-free survival rates
between patients with and without liver steatosis (p 0.506 and
0.409, respectively)
Conclusions. Pringle maneuver does not influence survival of pa-
tients undergone hepatectomy for colo-rectal liver metastases.
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NOVEL PREDICTION SCORE FOR
POSTOPERATIVE ACUTE RENAL FAILURE
(ARF) FOLLOWING LIVER RESECTION
S. Breitenstein1, K .Slankamenac1, M. Puhan2, U. Held3,
B. Beck-Schimmer1, P. Clavien1
1. Department of Visceral and Transplantation Surgery University
Hospital Zurich, Switzerland
2. Department of Epidemiology Johns Hopkins University, USA
3. Horten Centre for patient-oriented research University Hospital
Zurich, Switzerland
Background: Postoperative acute renal failure (ARF) is feared be-
cause it is a major source of postoperative morbidity and mortality
following major surgery. The frequency of ARF following hepatec-
tomy is unknown. The aim of this study was to evaluate the incidence
of ARF and to develop and validate a score to accurately predict
postoperative acute renal failure (ARF) after liver resection.
Methods: Postoperative ARF was prospectively assessed in 569
consecutive patients undergoing liver resection (2002 to 2007).
In 380 randomly selected patients (2/3 of total sample), multi-
variate logistic regression analysis was used to predict ARF based
on preoperative parameters (age, gender, pre-existing chronic
renal dysfunction, cardiovascular disease, diabetes, malignancy,
bilirubin and alanine aminotransferase (AST) levels). In the re-
maining 189 patients, the new score was validated by assessing
the accuracy of the score for predicting ARF (calibration). (Clin-
icalTrials.gov ID NCT 00743132)
Results: Postoperative ARF occurred in 86 out of 569 patients
(15.1%) and was highly associated with mortality (22.5% vs. 0.8%
without ARF, p>0.001), prolonged ICU (p<0,001) and hospital stay
(p<0,001). In the 380 patients selected for the development of a pre-
diction score, pre-existing cardiovascular disease, pre-existing renal
dysfunction and preoperatively elevated AST were the strongest pre-
dictors of ARF. Including all eight predictors the score-system
ranges between 1 (very low risk) and 19 (very high risk). The pre-
dicted mean absolute risk for ARF was 12.0% in the validation pop-
ulation (n=189), while the observed risk for ARF was 14.8%.
Predicted and observed risks were similar throughout different risk
categories (p=0.50) validating the accuracy of the score.
Conclusions: ARF is a frequent and relevant complication after
liver resection. This novel and simple score (range from 1 to 19)
based on preoperative parameters accurately predicts postoper-
ative ARF. The availability of such a score may have important
clinical application with a focus in developing protective strate-
gies for intra- and postoperative procedures.
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IMPACT OF ISCHEMIC PRE- AND
POSTCONDITIONING ON GENE EXPRESSION
LEVELS IN THE RAT LIVER USING DNA
MIKROARRAYS
A. Riegels Knudsen1, A. Kannerup2, P. Funch-Jensen2,
M. Kruh ffer3, F. Viborg Mortensen1
1. Department of Surgical Gastroenterology L, Aarhus University
Hospital NBG
2. Dept. of Surgery Gastroenterology L Aarhus University Hospital,
Denmark
3. Molecular Diagnostic Laboratory, Department of Clinical Bio-
chemistry, Aarhus University Hospital SKS
Background and aims: Ischemic pre- and postconditioning in-
crease the ability of the liver, to tolerate ischemia/reperfusion in-
juries. The mechanism behind this phenomenon is unknown. The
aim of the present study was to examine how ischemic pre- and
postconditioning affects the whole genome expression using
DNA microarray analysis.
Methods: Twenty-eight male Wistar rats were randomized into
five groups: (A) control; (B) ischemic; (C) ischemic precondi-
tioning; (D) ischemic postconditioning; and (E) combined is-
chemic pre- and postconditioning. All rats except the control
group were subjected to 30 min of liver ischemia. Ischemic pre-
conditioning consisted of 10 min of inflow occlusion and 10 min
of reperfusion. Ischemic postconditioning consisted of three cy-
cles of 30 sek inflow occlusion and 30 sek of reperfusion. Liver
biopsy and blood samples were collected after 30 min of reper-
fusion. Total RNA was extracted from the biopsy and used to de-
termine the full genome expression.
Results: ALAT increased significantly in groups B-E compared to
group A (p = 0.010). Between groups B-E no significant difference
was observed with regard to ALAT. Expression levels were signifi-
cantly changed in 308 genes in group (A) vs. (B); 1212 genes in (A)
vs. (C); 4331 genes in (A) vs. (D) and 5015 genes in (A) vs. (E).
Conclusion: Ischemic conditioning appears to affect a large
amount of genes in up and down regulating of the expression lev-
els. Further subgroup analyses and cluster analyses are currently
being performed and will be ready for poster presentation.
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PARTLY LIVER ISCHEMIA INDUCES
COMPENSATORY METABOLIC CHANGES
IN THE NORMAL PERFUSED PART DURING
REPERFUSION
A. Kannerup1, H. Gønbæk2, P. Funch-Jensen1, S. Karlsen1,
F. Mortensen1
1. Dept. of Surgery Gastroenterology L Aarhus University Hospital,
Denmark
2. Dept. of Medical Gastroenterology V Aarhus University Hospital,
Denmark
Background: Temporary vascular in- and outflow occlusion is an
effective technique for bleeding control during liver resections.
However, occlusion can result in ischemia/reperfusion (I/R) in-
jury to the liver. The aim of this porcine study was to investigate
how the metabolism in normal perfused liver parenchyma was af-
fected by in- and outflow occlusion of another part of the organ,
measured by microdialysis.
Methods: Eight pigs underwent laparotomy. Two microdialysis
catheters were inserted into the liver in the left and right part, re-
spectively. Microdialysis samples were collected every 30 minutes.
Occlusion of the left part of the liver was achieved for 60 minutes
followed by 5 hours of reperfusion. Samples were analyzed for
glucose, lactate, pyruvate, and glycerol. Blood samples were
drawn for determination of standard liver parameters.
Results: Comparing the ischemic part of the liver with the normal
perfused part, significant differences in levels of lactate, pyruvate
and glycerol were found. During reperfusion a similar, and con-
tinuously decrease below baseline levels was observed for lactate
and pyruvate in both the ischemic- and normal perfused part of
the liver. No significant changes in liver parameters were seen.
Conclusions: Temporary in- and outflow occlusion of a part of the
liver is without effects on metabolism in the normally perfused part.
Metabolic changes in the ischemic part of the liver were reversible.
Similar continuously decrease in lactate and pyruvate levels during
reperfusion in both the ischemic- and normal perfused liver indicate
a compensatory metabolic action in the normal perfused part.
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RADIOFREQUENCY ABLATION OF
HEPATOCELLULAR CARCINOMA-DOES SIZE
AND APPROACH MATTER? RETROSPECTIVE
STUDY IN A REGIONAL HOSPITAL IN HONG
KONG
K. Lai, T. Lai, T. Li, S. Li
Princess Margaret Hospital, Hospital Authority, HKSAR
Background: Radiofrequency ablation (RFA) is gaining popu-
larity as a modality of local ablation for unresectable hepatocel-
lular carcinoma (HCC) or for patients who are not operative
candidates. Previous studies suggested superior local control for
open surgical approach [1] while others found no difference in
long-term survival or local recurrence rate among treatment
groups of various approach [2].
Aim: To evaluate influence of tumour size and approach on out-
comes of radiofrequency ablation of liver hepatocellular carci-
noma.
Methods: Patients with hepatocellular carcinoma underwent ra-
diofrequency ablation between Jan 2003 and Dec 2007 were an-
alyzed retrospectively. Local-recurrence-free survival and
disease-free-survival were estimated using Kaplan-Meier analysis
and compared by log-rank test.
Results: During the study period, 107 patients with liver tumours
(HCC 87) underwent RFA in our centre. Of the 87 patients with
HCC, RFA were performed with percutaneous (65) or surgical
(laparoscopic and open) (22) approach. No differences in local-
recurrence-free survival (p= 0.820) and disease-free-survival (p=
0.708) were found between percutaneous and surgical group. Sur-
gical route had a superior complete ablation rate (p=0.027).
There was no difference in major complication among different
approach (p= 0.744). Statistically significant difference was ob-
served in disease-free survival (median 17.12 months vs 8.64
months, p= 0.009) but not in local-recurrence-free-survival (p=
0.089) between groups of largest lesion £3cm and >3cm.
Conclusions. Percutaneous and surgical approaches of radiofre-
quency ablation of hepatocellular carcinoma have comparable
outcome in term of local-recurrence-free survival and disease-
free-survival, while surgical route achieved a superior complete
ablation rate. Size of tumour is a significant factor associated with
disease-free-survival.
References:
1. Kuvshinoff and Ota Radiofrequency ablation of liver tumors:
Influence of technique and tumor size132:605-12 SURGERY
2002
2. S. Garrean et al. Radiofrequency ablation of primary and
metastatic liver tumors: a critical review of the literature 195:
508–520 THE AMERICAN JOURNAL OF SURGERY 2008
3. C.Raut et al. Significant Long-Term Survival After Radiofre-
quency
Ablation of Unresectable Hepatocellular Carcinoma in pa-
tients with Cirrhosis 12(8): 616-628 ANNALS OF SURGICAL
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MINIMAL INVASIVE SURGERY OF ACUTE
PANCREATITIS
D.B. Demin
Orenburg State Medical Academy, Russia
The minimization of an operational trauma is one of key direc-
tions of the modern surgical philosophy. All greater value get
minimal invasive interventions at an acute pancreatitis (AP).
The purpose of research. To estimate efficiency of laparoscopic
and navigating technologies at AP.
Materials and methods. Since 2002 in clinic of faculty of hospital
surgery on treatment there were 107 patients with AP by which
are executed minimal invasive surgical interventions. From them
90 person with peritoneal syndrome are executed laparoscopic
operations (drainage of belly cavity and bursa omentalis), 17 pa-
tients are executed drainage of parapancreatic liquid congestions
under the ultrasonic control.
Results. At a laparoscopy the oedematous pancreatitis is revealed
at 22 patients (group I), pancreatic necrosis - at 68 person (group
II). After operation all patients received standard multicompo-
nent treatment.
In I group weight AP on scale Glasgow (1984) has made 1,6, se-
vere pancreatitis was not. The index of weight of a condition
(SAPS II, 1993) has made 24,4. The progression of process and
complications were not detected, all patients have recovered.
In II group average weight AP has made 2,6, including at 34 sick
(50,7 %) – severe AP. Average index SAPS II - 38,6.
Laparotomia it is executed at 10 sick (14,7 %), at all at reception
severe AP. Term of intervention - 5 - 23 days from the moment
of a laparoscopy, indications – infected AP. A lethal outcome at
9 (13,2 %) patients (initially Glasgow - 3,7; SAPS II - 37,6), by all
it was carried out laparotomia.
The reason of death at 1 patient (1,5 %) – is the massive trom-
boemolic complication, at 8 (11,8 %) – a pancreatic abdominal
sepsis with poliorganic insufficiency. General mortality (all pa-
tients AP) has made 10 %, mortality in patients with pancreatic
necrosis - 13,3 %.
At 17 patients it is executed navigating drainage of parapancre-
atic liquid congestions under the ultrasonic control, including
over three (17,6 %) - with a suppuration. Four patients (23,5 %)
had been exposed to a laparoscopy concerning pancreatic necro-
sis earlier. In the subsequent at one patient (5,9 %) has arisen ex-
piration a contents of cyst in a belly cavity, it is executed
laparoscopic drainage. To one patient endoscopic cystogastros-
tomia was made, to one - it is imposed cystojejunostomia by la-
parotomia. There were not lethal outcomes.
The conclusion. Minimal invasive technologies allow to improve
considerably the results of treatment of the given category of pa-
tients.
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PANCREATODUODENECTOMY IN PATIENTS
WITH ESTABLISHED CHILD A LIVER
CIRRHOSIS
D. Fuks1, C. Sabbagh1, F. Browet2, T. Yzet3, R. Delcenserie4,
F. Mauvais2, M. Riboulot5, P. Verhaeghe1, J. Regimbeau1
1. Department of Digestive Disease Amiens North Hospital
2. Department of Digestive Surgery Amiens North Hospital
3. Department of Radiology Amiens North Hospital
4. Department of Gastroenterology Amiens North Hospital
5. Department of Anesthesiology Amiens North Hospital, France
Aim. Liver cirrhosis is usually considered as a contraindication
of pancreaticoduodenectomy (PD). The aim of our study was to
analyse retrospectively the characteristics of patients with cir-
rhosis discovered during the initial work-up, planned for PD.
Methods. Between 2004 and 2008, Child A cirrhosis was discov-
ered in 6 patients during the initial work-up before PD for pan-
creatic tumour. The liver cirrhosis was confirmed histologically
in 5 cases (fibroscan n=1). The demographic characteristics,
tumor, postoperative outcomes and survival were analyzed.
Results. There were 3 males and 3 females (median age of 64±7).
Median WHO status was 0 (0-2). Cirrhosis was alcoholic (n=5)
or HCV virus (n=1). Cirrhosis was classified Child A in all pa-
tients. One patient with severe portal hypertension was not se-
lected for PD. The median MELD score was 8 (4-12). Indication
of the CPD was adenocarcinoma (n=3) or malignant ampulloma
(n=2). The median operative time was 540±84 minutes and
blood loss of 750ml (150-2000). Three patients had intraopera-
tive blood transfusion. All patients had postoperative complica-
tions: ascites (n=2), pancreatic fistula (n=3), mesenteric
ischemia after portal reconstruction (n=1). No liver failure or
postoperative bleeding occurred. Two patients required re-oper-
ation for mesenteric ischemia and pancreatic fistula. The median
length of stay was 48 days (35-74). The mortality was zero. The
median survival was 8.5 months.
Conclusion. Child A liver cirrhosis does not modify much the post
operative course after PD. Postoperative complications are not
specific to the liver cirrhosis but are responsible of a prolonged
length of stay.
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PANCREATIC HEAD MASS: IS RESECTION
THE KEY-WORD?
G. Vasiliades, A. Koliopanos, N. Kopanakis, A. Katseli,
A. Katopodi, H.Tsipras, E. Margaris
3rd Surgical Department, General Hospital of Athens, “G.Genni-
matas”, Athens, Greece
BACKGROUND: Pancreatic head mass represents a challenge,
as various pathologies can lead to this entity and an accurate di-
agnosis is therefore very important as therapeutic strategies range
from observation to a total pancreatectomy. Whether differenti-
ation between benign and malignant lesions is possible by using
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all available diagnostic modalities or is crucial for surgical deci-
sion making remains controversial.
METHODS: Between June 1996 and November 2008, 114 pa-
tients (74 male, 38 female, mean age 64.5 years, range 34-82), un-
derwent a resection for a “potentially malignant” pancreatic head
mass in our department. In the present study we retrospectively
reviewed the patient’s files regarding the preoperative diagnostic
work-up (history, clinical examination, laboratory testing, tumor
markers index, CT, MRI, EUS/FNAB) in comparison with the
final established histopathological diagnosis in order to evaluate
the accuracy of the preoperative investigation in suspicious tu-
mors. Patients with non-resectable tumors or by-pass operations
performed for any other reason were excluded from the study.
RESULTS: All 114 patients received a pancreatic resection as
follows: 60 classical Whipple resection, 51 pylorus preserving pan-
creaticoduodenectomy and 3 total pancreatectomy. In 100 cases
(87.71%) the histopathological examination showed adenocarci-
noma whereas in the remaining 14 patients histology revealed
chronic pancreatitis in 5 cases (4.38%), cystadenoma in 3 cases
(2.63%), IPMN in 2 cases (1.75% ), lymphoma in 1 case (0.87%),
sarcoma in 1 case (0.87%), neuro-endocrine tumor in 1 case
(0.87%) and sclerosing cholangitis in 1 case (0.87%).
CONCLUSIONS: An accurate preoperative diagnosis may be
beneficial for the correct treatment decision making and avoids
unnecessary pancreatic resections. However, a substantial num-
ber of cases remains obscured despite improved diagnostic
modalities and therefore surgical resection still remains the only
option in cases of doubt.
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LAPAROSCOPIC
PANCREATICODUODENECTOMY.
IS IT WORTHWHILE?
G. Ayiomamitis, B. Alkari, A. Hamoudi, B. Ammori
Department of Surgery, Manchester Royal Infirmary, Manchester,
UK
Background: Recent advances in technology and techniques al-
lowed to a wide range of applications of minimally invasive sur-
gery to be applied in patients with benign and malignant diseases
of the head of the pancreas.
Methods: In this early experience with Laparoscopic Pancreati-
coduodenectomy (LPD) we adopted a cautious approach toward
patient selection. Data shown represent median (range).
Results: Five patients with a median (range) age of 64 (55-79)
years underwent LPD. All procedures were completed laparo-
scopically (hand-assisted, n=1; totally laparoscopic, n=4). The
operating time for LPD was 660 (600-720) minutes with a blood
loss of 300 (300-500)ml. The stay in high dependency unit was for
2 (1-3) days. There were no intraoperative complications,
whereas postoperative complications were encountered in 40% of
the patients (pancreatic fistula, n=1; bilateral below calf deep ve-
nous thrombosis, n=1). The postoperative hospital stay was 11
(7-23) days. All tumours were adenocarcinomas (pancreatic,
n=4; ampullary, n=1) of less than 3 (range, 2-3,5) cm in diame-
ter. At a follow up period of 18 (6-20) months, two patients died
(myocardial infarction, n=1; disease recurrence, n=1), whereas
all the remainder (60%) remain disease-free.
Conclusions: In selected patients and in the hands of the skilled
laparoscopic HPB surgeon, laparoscopic pancreatoduodenec-
tomy is feasible and safe. Growth of experience, technique re-
finements and long-term follow up data are needed.
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SURGICAL TREATMENT OF RARE
CONGENITAL AND ACQUIRED CONDITIONS
OF THE PANCREAS: CASE SERIES
W. Polkowski1, B. Wakowicz2, J. Mielko3
1. Dept of Surgical Oncology Medical University of Lublin
2. Department of Pathology Lublin University Hospital No 1
3. Department of Surgical Oncology Medical University of Lublin,
Poland
Indications of pancreatectomy for benign and malignant diseases
and a better knowledge of natural history of rare congenital and
acquired conditions of the pancreas need precise evaluation of
results of pancreatic surgery. Pancreaticoduodenectomy is the
correct operation when carcinoma of the head of the pancreas is
suspected. The operation should be performed as an oncologic
procedure, assuming that cancer may be present. Pylorus-pre-
serving pancreaticoduodenectomy represents an important ad-
vance in the history of pancreatic surgery. The operation can be
performed with a low operative mortality and morbidity and it
minimizes the long-term physiological disturbance to the patient.
When suspected cancer is not an issue, the Frey procedure is a
very versatile procedure for chronic pancreatitis. Limited pan-
createctomies are rarely indicated. Aim of this study is to present
a case series of rare congenital and acquired conditions of the
pancreas treated with appropriately selected operation. The fol-
lowing disorders are presented:
Pancreaticoduodenectomy for ampullary carcinoma following se-
vere necrotizing post-stenting pancreatitis
Chronic pancreatitis associated with pancreas divisum
Duodenal obstruction due to annular pancreas associated with
carcinoma of the duodenum
Groove pancreatitis
Giant haemangioma of the pancreatic head
Cystic neoplasm of the pancreatic neck
Bifocal neuroendocrine tumor of the pancreatic head
There was no postoperative mortality, and no major complica-
tions necessitating relaparotomy. All patients are alive and free of
symptoms from 18 to 64 months following pancreatic resection.
Conclusion: the excellent results reported with major pancreatic
surgery, are not simply related to improvements in surgical tech-
nique but to establishment of specialist pancreatic surgery.
P 184
TREATMENT OF PANCREATIC ANASTOMOSIS
LEAKAGE AFTER
PANCREATICODUODENECTOMY
G. Capretti1, A. Zerbi1, G. Balzano1, N. Pecorelli2, R. Angiolini2,
V. di Carlo3
1. Pancreas Unit, Dept. of Surgery S. Raffaele Scientific Institute,
Milan, Italy
2. MD IRCCS San Raffaele,Milano
3. San raffaele university IRCCS San Raffaele,Milano, Italy
Background: Postoperative pancreatic fistula is still regarded as
the major complication after pancreatic resection and is a poten-
tially life-threatening event. Aim: To asses indication and type of
treatement for pancreatic fistula requiring re-intervention in a
high-volume center. Methods: We retrospectively collected data
from 718 patients undergoing pancreaticoduodenectomy (PD)
from 1999 to 2008 in our department. 143 patients (19.9%) de-
veloped a pancreatic fistula, 36 of them (25.2%) underwent re-
operation. Results: there were 26 males and 10 females, median
Abstracts 115
age was 66 years. Indication to reoperation were: bleeding in 25
patients (22 for intraabdominal bleeding and 3 for gastrointesti-
nal haemorrhage), peritonitis and/or sepsis in 11 patients. Me-
dian day of reoperation was 12th postoperative day (range 10-28
days). Surgical procedures were: duct occlusion in 21 patients,
simple peripancreatic drainage in 7, completion pancreatectomy
in 5 (1 with islets autotransplantation), stump suture in 3. Twelve
patients died (mortality rate:33.3%): 6 of them in duct occlusion’s
group, 2 in drainage’s one, 3 in completion pancreatectomy’s
group and 1 in stump suture. Causes of death were: sepsis (4),
respiratory insufficiency (5), MOF (2), acute myocardial infarc-
tion (1). Conclusions: Leakage of pancreatic anastomosis after
PD remains a serious complication, it’s management is multidis-
ciplinar and mainly conservative. When reoperation is necessary,
duct occlusion is a good option. If completion pancreatectomy is
required, islets autotransplantation should be considered.
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GREEN TEA POLYPHENOL EXTRACT
AMELIORATES PANCREATIC INJURY IN
CERULEIN-INDUCED MURINE ACUTE
PANCREATITIS
G. Malleo1, B. Babu2, T. Genovese3, E. Mazzon4, R. Di Paola4,
C. Crisafulli3, A. Siriwardena5, S. Cuzzocrea4
1. Department of Surgical and Gastroenterological Sciences; Gen-
eral Surgery B, “G.B. Rossi” Hospital, Verona - Italy Department of
Surgical and Gastroenterologica Sciences, University of Verona, Italy
2. Hepatobiliary Unit Department of Surgery, University of Man-
chester, UK
3. Section of Pharmacology Department of Clinical, Experimental
Medicine and Pharmacology, University of Messina, Italy
4. Department of Clinical, Experimental Medicine and Pharmacol-
ogy, Torre Biologica, Policlinico Universitario, Messina - Italy De-
partment of Clinical, Experimental Medicine and Pharmacology,
University of Messina, Italy
5. Regional Hepatobiliary Surgery Unit, Manchester Royal Infirmary
Department of Surgery, University of Manchester, UK
Background: Green tea is rich in polyphenols, naturally occur-
ring anti-oxidants with powerful anti-inflammatory properties
mediated by actions at a variety of pathways including reactive
oxygen species (ROS) and nuclear factor kappa B (NF-kB).
Aim: To investigate the effects of Green Tea Extract (GTE) in a
cerulein-induced murine model of acute pancreatitis (AP).
Methods: AP was induced in mice by serial intraperitoneal ad-
ministration of cerulein (hourly x6, 50µg/kg); in another group of
animals GTE (25µg/kg) was administered intraperitoneally at 1,
3 and 6 hours after the induction of AP. Animals were sacrificed
at 24 hours after the first administration of cerulein. We analyzed
histological and biochemical features of AP; the levels of IkB-α,
phospho-NF-kB and p65 subunit (nuclear); the expression of ad-
hesion molecules; neutrophil infiltration (myeloperoxidase activ-
ity); the levels of TNF-α, TGF-β and VEGF; the formation of
oxygen and nitrogen-derived radicals; lipid peroxidation and the
expression of the enzyme poly-(ADP ribose) Synthetase (PARS).
Furthermore, we evaluated the presence of apoptosis by TUNEL
assay and the expression of Fas-ligand, Bax and Bcl-2 proteins.
Results: Treatment with GTE reduced histologic and biochemi-
cal features of AP. Western Blot analysis showed significant NF-
kB inactivation. Immunostainings for P-selectin and ICAM-1,
TNF-α, TGF-β, VEGF nitrotirosine and PARS, along with neu-
trophil accumulation and malondialdheide levels were signifi-
cantly reduced. Similarly, apoptosis was down-regulated.
Conclusion: GTE ameliorates pancreatic injury in cerulein-in-
duced murine AP. The effects of GTE influence various path-
ways, including NF-kB, oxidative stress and apoptosis, but require
– in our opinion – independent verification in other models.
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INTRA-ABDOMINAL PRESSURE INDICES
IN DESTRUCTIVE
T. Dyuzheva, A. Shefer
I.M. Sechenov Moscow Medical Academy, Moscow. Russia
Backround: 31 examined AP patients admitted on 1 - 3 day after
the onset of the disease. In 10 patients the MOF was not detected
(group 1). 21 patients presented different MOF symptoms, in-
cluding: respiratory failure (RF) - 10 patients (group 2), RF and
cardiovascular insufficiency (CI) - 6 patients (group 3), CI + RF
and acute renal failure (ARF) - 5 patients (group 4).
Aim: investigation of the intra-abdominal pressure (IAP) level in
acute pancreatitis (AP) patients and variable signs of multi-organ
failure (MOF).
Methods: For IAP evaluation of transvesical measurement
method was applied (Kron, 1984).
The indices were measured in centimeters of water column. The
mesurements were carried out on the days 1, 3, 5, and 7 after the
onset of the disease. The severity of illness was estimated using
APACHE II score system. The abdominal perfusion pressure
(APP) and filtration grade (FG), reflecting tissue perfusion and
renal excretion, were studied also.
Results: IAP level and APACHE II indices in the patients of
group 1 on days 1, 3, 5, and 7 after the onset of disease were 15,9
+ 2,0 and 10 + 1,0; 15,45 + 1,8 and 9,3 + 1,0; 12,1 + 1,2 and 6,4
+ 0,5; 11,6 + 0,8 and 5,1 + 0,1 respectively.
In the patients of group 2: 18,9 + 2,1 and 14,1 + 1,4; 15,5 + 3,6
and 11,7 + 1,5; 12,3 + 1,3 and 14,5 + 2,4*; 10,2 + 1,6 and 16,8 +
5,2*.
In the patients of group 3: 20,4 + 2,8 and 14,1 + 2,2; 21,2 + 1,8
and 14,9 + 1,4; 22,5 + 3,5 and 16,8 + 3,1*; 23,3 + 3,8 and 21,0 +
3,7*.
In the patients of group 4: 27,3 + 2,6* and 21,0 + 2,0*; 24,8 +
2,7* and 21,0 + 3,3*; 32,5 + 8,9* and 26,0 + 2,6*; 61,0 + 20,4*
and 27,7 + 2,6*.
(*-p<0,05 versus indices in group1)
The correlation coefficient between APACHE II indices and IAP
came to r= 0,53.
The correlation coefficient between IAP and APP came to r= -
0,59.
The correlation coefficient between APP and FG came to r=
0,89.
In early postoperative period in groups 1 and 2 nobody died. In
the 3-rd group died 4 patients. In 4-th group died all patients.
Conclusion: Elevated IAP is a sign of the severe AP. Decrease of
APP and FG in patients with elevated IAP substantially defines
MOF progression.
References: 1. Pupelis G, Austrums E, Snippe K, Berzins M
(2002) Clinical significance of increased intraabdominal pressure
in severe acute pancreatitis. Acta Chir Belg 102:71–74
2. De Waele JJ, Hoste E, Blot SI, Decruyenaere J, Colardyn F
(2005) Intra-abdominal hypertension in patients with severe
acute pancreatitis. Crit Care 9:R452–457
3. Tao HQ, Zhang JX, Zou SC (2004) Clinical characteristics and
management of patients with early acute severe pancreatitis: ex-
perience from a medical center in China. World J Gastroenterol
10:919–921
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INTRADUCTAL PAPILLARY MUCINOUS
NEOPLASMS OF THE PANCREAS: TOWARDS
EUS/FNAB GUIDED SURGERY
G. Vasiliades, A. Koliopanos, N. Kopanakis, A. Katseli,
D. Georgiadou, H. Tsipras, E. Margaris
3rd Surgical Department, General Hospital of Athens, “G.Genni-
matas”
BACKGROUND: Intraductal papillary mucinous neoplasm
(IPMN) of the pancreas is diagnosed with increasing frequency
worldwide due to the widespread use of modern imaging modal-
ities. IPMNs exert diverse biological behavior and therefore much
controversy on diagnostic work up and optimal therapeutic man-
agement still exists.
METHODS: Between January 2000 and November 2008, 6 pa-
tients (4 male, 2 female, mean age 59.6 years, range 31-75), un-
derwent a pancreatic resection for IPMNs in our department.
Preoperative diagnosis was made in the last 3 cases with EUS-
FNA due to availability of the method in our institution. Tumor
localization and pathologic FNA characteristics were the main
criteria for surgical resection extent. Mortality, morbidity and
long term outcome were monitored for all patients.
RESULTS: 3 patients were treated with partial resection (2 whip-
ples, 1 distal pancreatectomy) due to localized lesions and 3 with
total pancreatectomy due to a multifocal disease. One patient
who received initially a distal pancreatectomy was diagnosed with
positive histologic margins and was re-operated for a total pan-
createctomy. Operative time, morbidity and complications were
similar with patients operated for adenocarcinomas of the pan-
creas. Histology revealed 1 borderline carcinoma, 3 in situ and 2
infiltrating adenocarcinomas. In long term follow-up (18-102
months) all patients are alive, disease free and with good quality
of life.
CONCLUSIONS: Preoperative EUS/FNA strategies should be
used for determination of the histology nature of IPMNs and
tumor extent throughout the pancreatic gland which determines
the type of resection. Organ preserving surgery represents the de-
finitive treatment of the disease.
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SURGICAL TREATMENT OF PANCREAS
ADENOCARCINOMA: AN EXPERIENCE FROM
CENTRAL ANATOLIA
Z. Yılmaz, F. Mutlu, T. Artş
Erciyes University Medical Faculty General Surgery Department
HPB Division Turkey
Background and Aim: Pancreas adenocarcinoma is still chal-
lenging disease with its high periopertaive morbidity and mortal-
ity rates and limited long term survival. In this study we
prospectively analyzed our results of the patients with pancreatic
head adenocarcinoma at Erciyes University Department of Gen-
eral Surgery HPB surgery division. Method: At our recently es-
tablished unit, between January 2005 and December 2008, 82
patients underwent pancreaticoduodenectomy-Whipple proce-
dure. Only patients (n=35) whom underwent Whipple procedure
for pancreas adenocarcinoma were included in the study. Patients
were followed up for 46 months for operative morbidity, mortal-
ity and long term survival. Standart Whipple procedure were per-
formed for 24 patients and pylorus preserving Whipple for 11
patients. Postoperatively patientes receieved adjuvant
chemotherapy with Gemcitabin and Cisplatin or chemo-radio-
theraphy combination with gemcitabin and radiotheraphy . Pa-
tients were seen by the same surgical team at the first month after
the operation and following every 3 months. Survival was ana-
lyzed with Kaplan Meier test Results: Of 35 patients 23 (65.7%)
were male and 12 (34.2%) were female. Mean age was
59.45±1.18 yrs (r, 26-81). Perioperative (first 30 days, postoper-
atively) mortality and morbidity were 9% and 21%, respectively.
Mean survival was 17.8± 2.18 months and 1 year, 2 year and 3
year survivals were 63%, 52% and 11% respectively. Conclusion:
Establishment of hepato-pancretao-biliary subdivisons at general
surgery departments will increase patient volume.With experi-
enced high volume centers long term results of pancreas head
adenocarcinomas will be more promising.
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CLOSURE OF TRANSECTED PARENCHYMAL
SURFACE CONTROLS THE OUTBREAK OF
INFECTION IN PANCREAIC FISTULA AFTER
DISTAL PANCREATECTOMY
I. Ohsawa, H. Kato, N. Kuriyama, M. Kishiwada, S. Mizuno,
M. Usui, H. Sakurai, M. Tabata, S. Isaji
Department of Hepatobiliary Pancreatic and Transplant Surgery,
Mie University Graduate School of Medicine, Japan
Background: In distal pancreatectomy (DP), to diminish the rate
of pancreatic fistula (PF) nearly to zero is not prospective. We
speculated that preventing outbreak of infection might have the
highest priority in the management of PF in DP.
Aim: To identify the factors which affect the outbreak of infection
in PF after DP.
Methods: We retrospectively analyzed the data on 45 patients un-
dergoing DP in our institution during 10 years, including 10 pa-
tients in whom no operative drain was placed. All cases were
reviewed from background, operative procedure and postopera-
tive course. We divided operative procedure into four processes;
location of transection, device, main pancreatic duct (MPD) and
parenchyma; and then compared the factors in each process. As
to postoperative courses, we divided the complications into two
categories; PF and infection, according to the definition1).
Results: There was mortality in one patient (2.2%). Sixteen pa-
tients (35.6%) developed PF, and 10 patients (22.2%) developed
infection in relation to pancreas. In univariate analysis, identifi-
cation of MPD (p=0.007) and ligation of MPD (p=0.010) were
the two highest risk factors for PF, while non-closure of parenchy-
mal surface (p=0.001) and closure with stapler (p=0.005) were
the two highest risk factor for infection. Besides, operative
drainage helped to detect PF but didn’t any influence on the in-
fection.
Conclusion: Even in the case of PF, we can manage the compli-
cation easily if only the infection doesn’t break out. In DP, we
should consider that the closure of transected parenchymal sur-
face controls the outbreak of infection in PF.
References: 1) Bassi C, et al. Postoperative pancreatic fistula: an
international study group (ISGPF) definition. Surgery 138:8-13,
2005.
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SERUM INTERLEUKIN-6 AND
INTERLEUKIN-8 IN EARLY PREDICTION OF
THE SEVERITY OF ACUTE PANCREATITIS
K. Biliri, G. GIannopoulos, I. Katsoulis, A. Stathoulopoulos,
M Digalakis
1st Surgical Department, “Asklepieio Voulas” General Hospital,
Athens, Greece
Background-Aims: Severe form of acute pancreatitis is associated
with substantial morbidity and mortality. Early identification of se-
vere disease would lead to prompt intensive treatment resulting in
improvement of the outcome. Based on correlation of cytokines
and acute reactant proteins with the extent of pancreatic damage
and development of a systemic inflammatory response syndrome
(SIRS) we investigated the use of interleukins IL-6 and IL-8 as
prognosticators for early detection of severe pancreatitis.
Methods: Twenty-six patients with acute pancreatitis were stud-
ied (15 men and 11 women - mean age 64 years). Two groups of
patients were identified. Those with 3 or more criteria of Ran-
son’s classification within 48 hours from admission formed the
severe pancreatitis group, while the mild pancreatitis group con-
sisted of patients with less than 3 criteria. Serum samples of both
IL-6 and IL-8 were collected on the day of admission and addi-
tionally on the 2nd, 3rd and 7th day. All patients were closely fol-
lowed for the development of local (peripancreatic collection,
ascites, pseudocyst formation, necrosis) or systemic complications
and appropriate intervention was performed as needed (ERCP,
CT guided drainage, surgery). Receiver operating characteristic
(ROC) analysis was used in order to define the optimal cut-off
of IL-6 and IL-8 for the discrimination of severe from mild group.
Results: Significantly higher levels of both IL-6 and IL-8 were
found in patients with severe acute pancreatitis compared to
those with mild disease. IL-6 levels were significantly higher for
the severe group at the second (P = 0.038) and seventh day (P =
0.035), while the optimal cut-offs of IL-6 for the discrimination of
severe from mild disease were 10.9 pg/ml and 3.6 pg/ml, respec-
tively. IL-8 levels were significantly higher for the severe group
at the second (P = 0.001) and third day (P = 0.014), while the
optimal cut-offs for the discrimination of severe form mild dis-
ease were 25.4 pg/ml and 14.5 pg/ml, respectively.
Conclusions: Interleukins IL-6 and IL-8 on early phase of acute
pancreatitis (<48 h) are very useful markers in distinguishing pa-
tients with severe disease in order to achieve an aggressive treat-
ment and prevent lethal complications.
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SHORT-TERM RESULTS OF
PANCREATICODUDENECTOMIES EXTENDED
AT THE EXPENCE OF LYMPHADENECTOMY,
VASCULAR AND EXTENSIVE PANCREATIC
BODY RESECTION
V. Egorov, V. Vishnevsky, I. Kozlov, T. Shevchenko,
O. Melekhina
The Vishnevsky Institute of Surgery, Moscow, RF
Objective: Assessment of an early postoperative course follow-
ing standard (SPD) and extended pancreaticoduodenectomies
(EPD).
Methods: Short-term results of 60 SPD and 30 consecutive EPD
for periampulary tumors have been prospectively assessed taking
into consideration a similar nosology, the age, stage, and GI re-
construction.
Results: There were 22 radical and 8 extended radical operations
among the EPD. Vessel resections and extensive resection of the
pancreatic body were performed in 8 extended procedures (27%).
The number of excised lymph nodes was significantly higher in
the group of extended procedures (14 for SPD vs 27 for EPD). A
comparison of mortality (4.4% vs. 6.6%), the mean operating
time (5.1 vs. 6.5 h), general morbidity, the re-operation rate (8.3%
vs. 13.3%) and blood loss (7.3 vs. 8.1 dl) has shown that only the
difference in the operating time was significant. Specific compli-
cations of extended resections were diarrhea and lymphorrhea
(20%). The main complications of SPDs were pancreatic fistula
(18.3% vs. 3.3% in the extended group) and bile leakage (11.6%
vs. 4%). Nine (30%) cases of ductal adenocarcinoma were
restaged from stage II to IV owing to the involvement of para-
aortic lymph nodes.
Conclusion. The Whipple procedures extended at the expense of
lymphadenectomy, vascular and extensive pancreatic body resec-
tion are technically and time demanding operations but they are
as safe as standard ones. Nearly one third of cases in the extended
group were postoperatively restaged from stage II to IV, which
makes a comparison of long-term results of standard and ex-
tended procedures problematic.
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DECOMPRESSIVE LAPAROTOMY VERSUS
PERCUTANEUS PUNCTURE IN ABDOMINAL
COMPARTMENT SYNDROME DURING ACUTE
PANCREATITIS: BACKGROUND AND DESIGN
OF MULTICENTER, RANDOMISED
(DECOMPRESS) STUDY
D. Radenkovic1, Dj. Bajec1, N. Ivancevic1, V. Jeremic1,
P. Gregoric1, V. Djukic1, D. Radovanovic2, D. Bilanovic3,
D. Mirkovic4, V. Cijan5, B. Kardzic1, A. Karamarkovic1
1. Center for Emergency Surgery, Clinical Center of Serbia and
School of Medicine, University of Belgrade, Belgrade, Serbia
2. Surgical Department, Clinical Center “Dr. Dragisa Misovic” and
School of Medicine, University of Belgrade, Belgrade, Serbia
3. Surgical Department, Clinical Center “Bezanijska Kosa” and
School of Medicine, University of Belgrade, Belgrade, Serbia
4. Surgical department, Military-Medical Academy, Belgrade Serbia
5. Surgical Department, Clinical Center “Zvezdara“, Belgrade, Serbia
Aim: Development of abdominal compartment syndrome (ACS)
in patients with severe acute pancreatitis (SAP) has a strong im-
pact on the course of disease. Number of patients with this com-
plication increases during the years due more aggressive fluid
resuscitation, much bigger proportion of patients who is treated
conservatively or by minimal invasive approach, and efforts to
delay open surgery. There have not been standard recommenda-
tions for a surgical or some other interventional treatment of pa-
tients who develop ACS during the SAP. The aim of
DECOMPRESS study is to compare decompresive laparotomy
with temporary abdominal closure and percutaneus puncture
with placement of abdominal catheter in these patients. Meth-
ods: One hundred patients with ACS will be randomly allocated
to two groups: I) decompresive laparotomy with temporary ab-
dominal closure or II) percutaneus puncture with placement of
abdominal catheter. Patients will be recruited from five university
hospitals in Belgrade during two years period. The primary end-
point is the mortality rate within hospitalization. Secondary end-
points are time interval between intervention and resolving of
organ failure and multi organ dysfunction syndrome, incidence
of infectious complications and duration of hospital and ICU stay.
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A total sample size of 100 patients was calculated to demonstrate
that decompresive laparotomy with temporary abdominal closure
can reduce mortality rate from 60% to 40% with 80% power at
5% alfa.
Conclusion: DECOMPRESS study is designed to reveal a re-
duction in mortality and major morbidity by using decompresive
laparotomy with temporary abdominal closure in comparison
with percutaneus puncture in patients with ACS during SAP.
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THE ROLE OF INTRAOPERATIVE
ULTRASONOGRAPHY (IOUS) IN PANCREATIC
SURGERY FOR MULTIFOCAL INTRADUCTAL
PAPILLARY MUCINOUS NEOPLASMS (IPMNS)
E. De Raffele, M. Mirarchi, L. Calculli, D. Santini, S. Vaccari,
B. Cola
Dipartimento di Chirurgia Generale e Trapianti Policlinico S.Or-
sola-Malpighi, Bologna, Italy
Background and aims. IPMNs are neoplasms of the pancreas with
malignant potential and can be multifocal. The aim of the study
was to define the role of IOUS in guiding the surgeon in patients
with multifocal IPMNs undergoing surgery.
Methods. Five patients with multifocal IPMNs candidated to sur-
gery were included in the study. All underwent pre-operative CT-
scan and MRCP for staging. Patient 1 and patient 2 had had an
invasive carcinoma of pancreatic head and of pancreatic tail, re-
spectively, with multiple BD IPMNs; patient 3 had a BD IPMN
of 30 mm with mural nodules of pancreatic head and multiple
small BD IPMNs; patient 4 had a main duct type IPMN of pan-
creatic head and multiple small BD IPMNs; patient 5 had a mixed
MD and BD type IPMN of pancreatic head and multiple small
BD IPMNs.
Results. IOUS confirmed the preoperative staging of the multi-
focal tumor and the planned pancreaticoduodenectomy in pa-
tient 1, 3 and 5 respectively. Patient 2 underwent distal
pancreatectomy: IOUS showed a 20 mm cystic neoplasm near the
mesenteric vein which was included in the resected specimen and
resulted to be a IPMN with non-invasive carcinoma at histology.
Patient 4 underwent the planned pancreaticoduodenectomy: the
IOUS clearly showed the extension of the cystic dilatation of the
main pancreatic duct and was determinant in obtaining a free
margin.
Conclusion. IOUS is of clinical utility in selected patients with
IPMNs undergoing pancreatic surgery. IOUS should be routinely
used in planning and guiding the resection of pancreatic multifo-
cal neoplasms.
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PROBLEM IN INTRAOPERATIVE DECISION
MAKING IN CASE OF RARE PERIPANCREATIC
TUMORS
G. La Greca, M. Sofia, F. Sparatore, S. Primo, A. Chisari,
A. Ricotta, S. Latteri, D. Russello
Department of Surgical Sciences, Organ Transplantation, and Ad-
vanced Technologies, University of Catania, Catania, Italy
BACKGROUND. Surgical resection of pancreatic tumors is still re-
lated with relevant risk of morbility and mortality so that it is to per-
form only if really needed. The rate of blind resection should be min-
imized. An intraoperative diagnosis often does not clear the doubts.
In rare situations like the present one extremely rare tumors could
be resected without pancreasectomy. CASE REPORT. A 62 years
old man was admitted at our Department for head trauma due to in-
cidental fall. Brain CT scan and blood exams were normal, but ab-
dominal ultrasound revealed a mass in the upper abdomen, large 11
x 14 cm pressing and shifting the neighbouring organs. Thorax-ab-
dominal CT scan confirmed the mass suggesting its origin in the
retroperitoneum from the head of the pancreas. No invasion of or-
gans or the portal vein was apparent. No distant metastases were
identified. Serum tumoral markers, oesophagusgastroduode-
numscopy and colonoscopy were normal. Elective surgery was per-
formed. On laparotomy, a round tumor 15 cm in diameter was
encountered in the upper abdomen. The entire tumor was curatively
resected leaving wide the pancreas. The mass were hardly stuck to
the port vein and hepatic artery so it was needed to resect the artery
and to suture the portal vein. The final histopathological analysis re-
vealed after a second opinion, a well differentiated neuroendocrine
tumor of the retroperitoneum with unclear malignancy. During the
follow-up the Cromoganina A level was normal and the Octreoscan
revealed a doubt area of capture and for this reason the patient, after
12 months is in narrow follow-up without signs of recurrence. CON-
CLUSION. The diagnosis of a retroperitoneal mass involves several
problems about the origin especially if it seem to develop from the
pancreas. In these cases pancreatic resection could be the best sur-
gical option, but in some case a planned pancreatico-duodenectomy
could be result in an over treatment.
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SOLID PSEUDOPAPILLARY TUMORS OF THE
PANCREAS: 3 CASES AND TYPICAL ASPECTS
T. Papavramidis1, K. Sapalidis1, S. Apostolidis2,
N. Michalopoulos1, I. Ntokmetzioglou1, S. Papavramidis1
1. 3rd Department of Surgery AHEPA University Hospital, Aristotle
University of Thessaloniki
2. Department of Anatomy AHEPA University Hospital, Aristotle
University of Thessaloniki
Solid pseudopapillary tumor (SPT) of the pancreas is a rare tu-
mour of uncertain histogenesis characterized, as the name sug-
gests, by a cystic and solid pattern of growth with formation of
pseudopapillae. Accounting for only a small percentage of pan-
creatic neoplasms. SPT occurs primarily in young women and is
thought to have low-grade malignant potential.
The authors report three cases of three young female patients
who underwent surgery for solid pseudopapillary tumour of the
pancreas. Two of those patients were scheduled to be operated
and had typical characteristics, permitting to describe the typical
aspects of those tumours. The third patient was operated on an
urgent basis, due to upper gastrointestinal haemorrhage and per-
mits to refer to rare presentation of the tumor.
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IMPACT OF METHICILLIN RESISTANT
STAPHYLOCOCCOUS AUREAS (MRSA)
INFECTION ON OUTCOME AFTER
PANCREATODUODENECTOMY (PD)
P. Sanjay, A. Fawzi, C. Kulli, F. Polignano, I. Tait
HPB unit, Ninewells Hospital and Medical School, Dundee, UK
Background: There is no data on the impact of MRSA infection
in patients undergoing PD.
Aim: This study evaluated the impact of MRSA infection on pa-
tient outcome after PD.
Methods: 79 patients who underwent PD were monitored for hos-
pital acquired MRSA preoperatively, day 1 postoperatively, and
then every 3 days until discharge. Patients were grouped as, (1)
no MRSA infection, (2) skin colonization with MRSA (3) sys-
temic MRSA infection.
Results: 40/79 (51%) patients were MRSA positive. 14/40 pa-
tients were swab positive only (colonization), whilst 26/40 patients
developed systemic MRSA infection. In the systemic MRSA
group, the sites of infection were (i) abdominal drain fluid only
(42%), (ii) chest only (15%), (iii) wound only (4%), (iv) wound
and sputum (8%), and (v) a combination of sites (31%). Patients
with systemic MRSA infection had longer postoperative stay
(31Vs 22 days, P=0.005), and increased incidence of wound and
chest infections compared with non MRSA (14 Vs 4, P=0.02).
16/79 patients had MRSA in abdominal drain fluid. Patients with
MRSA in drain fluid had drains for a longer duration that non-
MRSA (26Vs19 days P=0.01). 4/16 patients with MRSA in drain
developed delayed massive haemorrhage compared to 3/63 pa-
tients with no MRSA in drain fluid (p=0.02).
Conclusion: 51% of patients admitted for PD became colonized
with MRSA infection. Systemic MRSA infection (33%) after PD
was associated with prolonged postoperative stay, increased
wound & chest infections, and an increased risk of delayed mas-
sive haemorrhage. Hospital acquired MRSA infection is a major
cause of morbidity after PD.
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PANCREATIC AND PERIAMPULLARY CANCER:
A COMPARATIVE GENOMIC HYBRIDISATION
STUDY
J. Erdmann, M. Morak, H. van Dekken, R. van Marion,
W. Hop, C. van Eijck
Department of Surgery, Erasmus Medical Centre, Rotterdam, The
Netherlands
Background: Pancreatic cancer is a major cause of cancer related
death. Periampullary cancers (distal common bile duct, ampulla
of Vater and duodenum) have a more favourable prognosis. Al-
though histologically they appear to be very similar, evidence is
increasing that periampullary cancers have a different biological
basis.
Aim: To find distinct genetic differences between periampullary
and pancreatic cancer as an origin for the evident survival differ-
ence.
Methods: We randomly selected 50 fresh-frozen samples of both
pancreatic and periampullary cancers (25/25). After isolation of
DNA, samples were analyzed by means of a BAC-CGH array.
Results: Both groups had comparable baseline characteristics.
Median overall survival in pancreatic cancer was 17 months vs.
31 months in periampullary cancer (p=0.026). A frequent loss of
locus 9q12-q22.31 and 9q32-q33.2 was found in periampullary but
not in pancreatic cancer (p<0.001). The presence of these losses
was not related to survival, neither were losses or gains at any
other locus. Overall, more gains were related to a significantly
worse median survival in all patients (31 months in the lowest
third vs. 13 months in the highest third; p=0.045), while more
losses were not related to survival. The number of gains and
losses was evenly distributed between periampullary and pancre-
atic cancer (p=0.798) .
Conclusion: CGH analysis revealed significantly more losses at
arm 9q in periampullary cancer than in pancreatic cancer. No sin-
gle gain or loss was associated with survival, however the number
of gains was associated with diminished survival in all patients.
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TEACHING IN PANCREATIC SURGERY:
THE EXPERIENCE OF A UNIVERSITY HIGH
VOLUME CENTER
G. Colucci1, G. Butturini2, A. Casarotto1, M. Dal Molin1,
R. Salvia1, C. Bassi1, P. Pederzoli1
1. Department of Surgery University of Verona, Italy
2. Surgical and Gastroenterological Dept Verona University, Italy
Background: How to teach complex hepato-pancreatic-biliary
procedures without jeopardazing patients’ level of care is a hot
topic. Even if there is a foreseable future for virtual reality and
simulation, the OR is still the main area where teaching takes
place.
Aim: We analysed if an increased “involvement” of resident dur-
ing pancreaticoduodenectomy (PD) can effect on patient out
come.
Methods: We reviewed all PD performed from January 2000 to
September 2007. The operation was divided into 5 steps ( chole-
cystectomy,resection, pancreatic anastomosis, biliary anastomo-
sis, intestinal anastomosis) and we recorded who had performed
each step (consultan or resident). We also recorded surgical com-
plications. Data were analysed using SPSS 13.
Result: During the study period, 633 PD were performed, with a
continuos increase of the annual workload (from 44 in 2000 to 92
in the first nine month of 2007). There has been a rise in num-
ber of PD performed by a cunsultant helped by a resident (from
11% to 63%). We had the same trend for all the steps of the op-
eration: pancreatic anastomosis (from 0 to 27%), biliary anasto-
mosis (from 2.2 to 46.8%), cholecystectomy (0% to 74.6%) and
intestinal anastomosis (from 67% to 69%). During the same pe-
riod, biliary leak rate has been stable while pancreatic fistula has
reduced (31,8% to 13%)
Conclusion: Although PD is a complex procedure it offers a good
opportunity for the training of the resident. Teaching should be
an active process based on a careful selection of the patients man-
ageable by the residents.
Helling, T. S. and A. Khandelwal. “The challenges of resident
training in complex hepatic, pancreatic, and biliary procedures.”
J Gastrointest.Surg. 12.1 (2008): 153-58.
Smith, C. P., et al. “Pancreaticoduodenectomy in a community
general surgery residency program.” Am.Surg. 72.8 (2006): 750-
53.
Fischer, C. P. and J. C. Hong. “Early perioperative outcomes and
pancreaticoduodenectomy in a general surgery residency train-
ing program.” J Gastrointest.Surg. 10.4 (2006): 478-82.
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POSTOPERATIVE COMPLICATIONS AFTER
PANCREATODUODENECTOMY ARE
ASSOCIATED WITH EARLY DEATH DUE TO
RECURRENCE IN PANCREATIC BUT NOT
IN PERIAMPULLARY CARCINOMA
N. van der Gaag, K. Harmsen, S. Lagarde, O. Busch,
T. van Gulik, D. Gouma
Surgery Acadmic Medical Center, Amsterdam, The Netherlands
Background: Pancreatoduodenectomy (PD) for suspected pan-
creatic/periampullary (distal bile duct, ampullary) malignancy is
associated with high postoperative morbidity. In spite of the cur-
ative intent the majority of patients die of recurrent disease after
resection.
Aim: To determine the association between postoperative com-
plications and disease specific survival, and timing of death due
to recurrence.
Methods: Between Jan/1994–Dec/2006 448 consecutive patients
underwent PD for a pathology proven pancreatic or peri-
ampullary adenocarcinoma, which were reviewed for the occur-
rence of postoperative complications. Follow-up data was
collected.
Results: Of the 448 patients 304 (68%) died due to recurrent dis-
ease. Median disease specific survival was 26 months, split by ori-
gin; pancreatic 20 months (215 patients), distal bile duct 30
months (82 patients), ampullary adenocarcinoma 42 months (151
patients). For pancreatic adenocarcinoma, but not for peri-
ampullary adenocarcinoma the occurrence of postoperative com-
plications was independently associated with death due to
recurrence (HR 1.69, 95% CI 1.19-2.38). Other independent fac-
tors were moderate (HR 2.23, 95% CI 1.07-4.65) or poor (HR
3.68, 95% CI 1.73-7.61) tumor differentiation grade, residual
tumor (R1) at resection margin (HR 1.47, 95% CI 1.05-2.04). For
pancreatic adenocarcinoma the occurrence of postoperative com-
plications was independently associated with early death [before
the median disease specific survival threshold of 20 months] due
to recurrence (HR 1.64, 95% CI 1.08-2.49).
Conclusions: In patients that underwent a PD for pancreatic ade-
nocarcinoma the occurrence of postoperative complications, be-
sides established prognosticators like tumor differentiation grade
and microscopically residual tumor, is independently associated
with disease specific survival and early death due to recurrence.
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EFFECTS OF TIMING OF ENTERAL
NUTRITION ON OUTCOME IN PATIENTS WITH
PREDICTED SEVERE ACUTE PANCREATITIS
O. Bakker1, H. van Santvoort1, M. Besselink1, K. Fischer2,
T. Bollen3, M. Boermeester4, H. Gooszen1
1. Dept. of Surgery, UMC Utrecht, Utrecht, Netherlands
2. Julius Center for Health Sciences and Primary Care, UMC
Utrecht, Utrecht, Netherlands
3. Dept. of Radiology, St. Antonius Hospital, Nieuwegein, Netherlands
4. Dept. of Surgery, Amsterdam Medical Center, Amsterdam,
Netherlands
Background: Recent insights suggest that an early start of enteral
nutrition (EN) in patients with predicted severe pancreatitis po-
tentially reduce infectious complications.
Methods: During 2003-2007, all patients with predicted severe
acute pancreatitis (Acute Physiology and Chronic Health Evalu-
ation [APACHE-II] score ≥8, or Imrie/modified Glasgow score
≥3, or C-reactive protein [CRP] >150 mg/L) were prospectively
included in 15 hospitals in the Dutch ‘probiotics in acute pancre-
atitis trial’ (PROPATRIA). All patients received EN via a naso-
jejunal feeding tube. Two groups were retrospectively defined as
1) the ‘early EN group’ (start of EN within 48 hours after admis-
sion) and 2) the ‘standard EN group’ (start after 48 hours after
admission). Groups were compared for the total number of in-
fectious complications: pneumonia, bacteremia and infected
necrosis. Multivariate logistic regression was used to adjust for
differences at baseline (p<0.2) and predicted disease severity
(APACHE-II score).
Results: The early (n=184) and standard (n=112) EN groups
were highly comparable at baseline for APACHE-II score, Imrie
score, CT severity index and presence of organ failure. Infectious
complications occurred in 49 patients (27%) in the early EN group
versus in 38 patients (34%) in the standard EN group (adjusted
odds ratio [OR] 0.659, 95%-confidence interval [CI] 0.33-1.33,
p=.244). Early EN was associated with a reduction in bacteremia
(14% versus 27%; adjusted OR 0.389, 95%-CI 0.17-0.88, p=.024).
No reduction of infected necrosis (11% versus 13%, p=.853) or
pneumonia (16% versus 14%, p=.861) was observed.
Conclusion: In this subgroup analysis of the PROPATRIA trial,
an early start of enteral nutrition reduced bacteremia in patients
with predicted severe acute pancreatitis, but without clear effects
on infected necrosis. However, the trial was not designed to com-
pare timing of EN. The Dutch Pancreatitis Study Group has re-
cently started a nationwide randomized controlled trial
comparing an early start of EN with standard timing of EN in pre-
dicted severe acute pancreatitis.
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EVALUATION OF MODIFIED
RECONSTRUCTION METHOD AFTER
PANCREATODUODENECTOMY
S. Osada, Y. Sanada, Y. Tokuyama, K. Yoshida
Surgical Oncology Gifu University School of Medicine
Background: Based on the enzyme theory, which lysolecithin and
phospholipase A are cooperated to active for each strongly, a newly
reconstruction method after pancreatoduodenectomy (PD) was
designed due to controlling the mixture of these enzymes. Surgical
Technique: The separated jejunal loop method (SL) is created as
the following. The proximal jejunum is used for end-to-side chole-
dochojejunostomy. The cut proximal jejunum is led to pancreatic
stump, and pancreatojejunostomy is performed for end-to-end
anastomosis. Approx. 20 cm jejunum is created with side-to-end
to stomach, and end-to-side jejuno-jejunostomy for Y-reconstruc-
tion. Study Method: SL (n=38) was evaluated by comparing pan-
creatogastrostomy (PG, n=31) and Imanaga method (IM, n=26)
about postoperative patient condition due to comparing pre-oper-
ative state about body weight and serum factors on post-operative
days (POD). Results: On SL, PG and IM cases, the high amylase
level in drainage fleuid was noted in 2.6%, 6.5% and 19.2%, re-
spectively. The delayed gastric emptying was seen in 12.9% and
5.7% on PG and IM, but the gastric drainage tube was removed at
1.8 POD on SL. The body weight on 28th POD and ALB levels
of 14th POD were similar on each methods. By contrast, on 28th
POD, CHE levels represent for 87.2±3.2%, 75.3±2.9% and
68.1±6.2%, and T-CHO levels were 92.9±9.8%, 64.9±12.7% and
62.1±9.8%. These values on SL cases were better than the other
methods. Conclusion: SL method is safety after PD and might
bring a favorite outcome in postoperative patient conditions.
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IS IT POSSIBLE TO PREDICT R1
INVOLVEMENT OF RETROPORTAL ARTERIAL
MARGIN ON CT-SCAN IN RESECTABLE
ADENOCARCINOMA OF THE PANCREATIC
HEAD?
D. Fuks1, M. Lamotte2, T. Yzet3, F. Demuynck3, D. Chatelain4,
C. Sabbagh1, J. Regimbeau1
1. Department of Digestive Disease Amiens North Hospital
2. Department of Digestive Surgery Amiens North Hospital
3. Department of Radiology Amiens North Hospital
4. Department of Pathology Amiens North Hospital, France
Aim. Invasion of retroportal pancreatic margin (RPM) around
the superior mesenteric artery (SMA) decreases the survival time
of patients resected for pancreas adenocarcinoma (PA). The aim
of this work was to determine predictive factors of R1 surgical
margins with preoperative CT-scan.
Methods. Data of patients who underwent pancreaticoduo-
denectomy (PD) for proved adenocarcinoma between 2002 and
2008 for PA were retrospectively reviewed. We excluded ampul-
lomas, IPMN and patients with macrovascular contact with SMA.
All patients had a recent (<2 months) preoperative multidetec-
tor CT-scan analysed on computer by 2 double-blind radiologists.
Postprocessing techniques were used. All PD were performed by
a single surgeon with ink of the posterior retroperitoneal pan-
creatic. Size, distance between posterior pancreatic head and
SMA, density of the fatty layer around SMA and lymph nodes
were analysed.
Results. Twenty-three patients were included (15 males, 8 fe-
males, median age: 56±10). Median diameter of the tumour was
23±9mm. Tumour enhanced in portal-phase CT in 11 (48%) pa-
tients. Mean distance between the tumour and SMA was 9.8mm.
There was a microinfiltration of the fatty layer around the SMA
in 5 (22%) patients without direct invasion of SMA. There was
lymph node involvement in 15 (65%) patients. At pathology, mi-
croscopic (R1) infiltration was confirmed in 6 (26%) cases. There
was no statistic correlation between infiltration of the fatty layer
around the SMA with CT-scan and microscopic (R1) infiltration
of the RPM (p=0.81).
Conclusion. Preoperative multidetector CT-scan doesn’t seem to
predict microscopic invasion of RPM before PD for PA in this
small series.
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CYSTIC NEOPLASMS AND CYSTIC
FORMATIONS OF THE PANCREAS AND
PARAPANCREATIC AREA. OPPORTUNITIES
OF RADIOLOGICAL DIAGNOSTICS IND
DIFFERENTIAL DIAGNOSTICS
J. Stepanova1, G. Karmazanovsky2
1. Radiology Department A.V. Vishnevsky Institute of Surgery
2. A.V. Vishnevsky Institute of Surgery, Moscow, Russia
Background. To determine the opportunities of radiological ex-
amination in diagnostics/differential diagnostics of cystic neo-
plasms (CN) and formations of the pancreas and parapancreatic
area.
Methods. 157 patients (22-72 years old) were examined by US,
helical CT and MRI with bolus enhancement. 55 were operated
on, 17 - cytological verification.
Results. The patients with suspicion on presence of CN were di-
vided: I group - potentially benign tumors (34). II group – tu-
mors with not determined malignant potential tumors (19). III
group - tumors with high grade of malignancy (31). Pathology: I
– serous (25) and mucinous (7) cystadenomas, pseudocyst (2), II
- mucinous cystadenoma (7), mucinous cystadenocarcinoma (11),
pseudocyst (1); III – mucinous cystadenocarcinomas.
The chronic pancreatitis with pseudocyst/pseudocysts was diag-
nosed in 66 cases. In 1 case of pseudocyst, diagnosed on a back-
ground of the expressed chronic pancreatitis at morphology -
mucinous cystadenocarcinoma.
Bleeding in a cavity of pseudocyst (arrosion) from a near located
vessel has been diagnosed in 13 cases.
Pseudocyst in 5 cases was combined with changes of the wall of
duodenum as a thickening of a wall with liquid neoplasm with a
thin capsule and avascular septas - cystic form of duodenal dys-
trophy (DD). In 1 case diagnosed an atypical case of DD.
Intraductal papillary mucinous tumor were diagnosed in 6 cases
(tumors started with the main pancreatic channel - 5, from seg-
mentary pancreatic channels – 1).
Conclusion. The sensitivity, specificity and accuracy of radiolog-
ical examination in differential diagnostics of CN and pseudo-
cysts of the pancreas were 96%, 100% and 95%, respectively.
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COMPLEX ULTRASOUND SCANNING
ASSESSMENT OF PANCREATIC HEAD
CANCER VASCULAR INVASION
J. Stepanova1, A. Kochatkov2, G. Karmazanovsky1, V. Kubyshkin3
1. Radiology Department A.V. Vishnevsky Institute of Surgery
2. Abdominal Surgery A.V. Vishnevsky Institute of Surgery
3. Abdominal Surgery Moscow State Medical and Dental University
Purpose. To evaluate the accuracy of Complex Ultrasound Scan-
ning (CUS), including B-mode, DS, 3D-mode in identifying vas-
cular invasion of pancreatic head cancer.
Methods and Materials. There were 66 patients (38 males and 28
females; mean age 57,8±11,2 years) with pancreatic head ade-
nocarcinoma were investigated with CUS. Investigation was full-
field on VIVID-7, VOLUSON-780 («General Electric»).
Extension of the tumor to large blood vessels and retroperi-
toneum were defined as criteria for assessment of vascular inva-
sion. All of the patients were operated on. Whipple procedures
were performed on 44 (66,7%) patients and palliative operations
were performed on 22 (33,3%) patients.
Results. The patients were grouped into three classes of re-
sectability: I – resectable tumors (27 [40,91%] patients), the
tumor does not contact to a vessel; II – questionably resectable tu-
mors (27 [40,91%] patients), the tumor contacts to a vessel with-
out seen germination; III – non-resectable tumors (12 [18,18%]
patients), the tumor contacts to a vessel with seen germination. A
correlation between the classification of vascular invasion and in-
traoperative findings was found in 51 of 66 cases (77,3%). The
sensitivity, specificity and accuracy of CUS in identifying large
blood vessels invasion were 85,2%, 83,3% and 84,6%, respec-
tively.
The greatest number of diagnostic mistakes was in II group.
The cumulative survival of the patients was: I group - 16,06±3,6;
II - 8,65±4,09 and III - 5,45±2,96 months. The differences were
statistically significant (p<00,5).
Conclusion. The use of CUS with DS and 3D in evaluation of
pancreatic tumors may provide valuable and exact enough pre-
operative assessment of surgical resectability.
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THE SUCCESFULL SURGICAL TREATMENT
OF CHRONIC PANCREATITIS IN THE VIEW
OF TGF BETA AND IL-8 POLYMORHISM
G. Farkas Jr.1, Y. Mándi2, G. Farkas1, G. Lázár1
1. Department of Surgery
2. Institute of Immunology and Microbiology, University of Szeged,
Hungary
BACKGROUND:Cytokine regulation may be important as con-
cerns the susceptibility to the development of chronic pancreati-
tis; transforming growth factor-β1 (TGF-β1) plays a central role
in the pathogenesis of pancreatic fibrogenesis.
AIMS: The aim of our study was to analyse the relevance of
TGF-β1, interleukin-8 (IL-8) polymorphisms in patients with
chronic pancreatitis.
METHODS: Of the 95 patients enrolled in the study, 43 were
treated medically and 52 patients underwent surgical interven-
tion. Healthy blood donors (n = 75) served as controls. The poly-
morphisms of TGF-β1 +869 T C and IL-8 -251 T A were
determined by the ARMS method, serum TGF-β1 levels were
detected by ELISA.
RESULTS: No correlation was found between the genotipes and
the histological varietes of chronic pancreatitis. There was a
higher frequency (50%) of the TT genotype of TGF-β1 +869
with a concomitant higher TGF-β1 level in the plasma (5.2 ± 1.7
ng/ml ) in patients with chronic pancreatitis than in healthy blood
donors ( 28 %, and 2.8 ± 0.9 ng/ml respectively). The number of
TT homozygotes differed significantly between the patients who
underwent surgical intervention and the controls, and even be-
tween the operated and the non operated patients. Those patients
who had TT genotipe with high serum levels of TGF-β1 were re-
hospitalized or underwent further operations. The frequency of
the T/C genotype with higher IL-8 production was significantly
higher in both groups of patients than in the controls (58 %, and
58% vs 40%). Successfully treated patients were found only with
T/C or C/C genotipes and low serum levels of TGF-β1.
CONCLUSION: The correlations of the TGF-β1 and IL-8 sin-
gle nucleotide polymorphisms (SNPs) with chronic pancreatitis
underline the importance of these cytokines in the pathomech-
anism of the disease. Moreover, it seems that the TT genotype of
+869 TGF-β1 might be a risk factor for the development of a se-
vere form of chronic pancreatitis, as a prognostic sign for a fu-
ture surgical intervention or even reoperation. Further studies on
a larger group of patients, including a follow-up study, are nec-
essary to confirm this preliminary observation.
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TRANSLUMBAR PERCUTANEOUS
VIDEO-CONTROLLED RETROPERITONEAL
NECROSECTOMY IN SURGICAL TREATMENT
OF ACUTE NECROTISING PANCREATITIS
I. Khomyak, K. Kopchak
National institute of surgery and transplantation, Kiev, Ukraine
Backround. In spite of recent advances in treatment of acute
necrotising pancreatitis, the mortality in this group of patients is
rather high.
Methods. There were 177 patients with pancreatic necrosis (PN)
treated in our clinic in the period of 2006- October, 2008. In 93
patients (52,5%) aseptic PN was diagnosed. Infected PN was di-
agnosed in 84 patients (47,5%). In 8 patients (4,5%) we used
translumbar percutaneous video-controlled retroperitoneal
necrosectomy and retroperitoneal drainage. Indications for the
procedure were inefficacy of the US-guided percutaneous
drainage in patients with local septic complications of PN.
Results. Postoperative mortality in patients with infected PN was
8,1%. In patients after percutaneous video-controlled retroperi-
toneal necrosectomy mortality was zero. There were no proce-
dure- depended complications in this group.
Conclusion. Translumbar percutaneous video-controlled
retroperitoneal necrosectomy could be applied in selected group
of patients with infected PN.
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LAPAROSCOPIC DISTAL PANCREATECTOMY:
CRITICAL ANALYSIS OF PRELIMINARY
EXPERIENCE FROM A TERTIARY REFERRAL
CENTRE
G. Jain, H. Al Bern, T. ScabillI, M. Abu Hilal
Hepato-biliary and pancreatic surgery unit, Southampton General
Hospital, Southampton, UK
Background: Laparoscopic pancreatic surgery has been slow to
gain wide acceptance because of the complex pancreatic anatomy
and physiology.
Aim: The aim of this study was to analyze the preliminary results
and to highlight the impact of centralization of pancreatic sur-
gery on surgeons workload.
Methods: A retrospective analysis was performed on all patients,
who underwent laparoscopic distal pancreatectomy from May
2007 to Nov 2008.
Results: Laparoscopic distal pancreatectomy was performed in
18 patients during that period. The median operative time was
180 minutes (range 120- 300). The median blood loss was 100 ml
(range 50 -500). Splenectomy was performed in 12 patients. Post
operative recovery was uneventful in 14 patients, while 4 patients
had pancreatic leak.
One pancreatic leak was observed in last 12 patients, since we
started to oversew the pancreatic stump after stapling. In three
patients pancreatic leaks (PL) were minor and settled with con-
servative management, while one patient needed a CT guided
drainage and subsequent mini laparotomy for wash out of the
intra abdominal collection. No conversion or mortality was ob-
served in this series. Median hospital stay was 5 days (range: 4-
7days).
Conclusions: Laparoscopic distal pancreatic resection is feasible,
safe and efficient.
However, this surgery should only be performed in specialized
centres with extensive experience in pancreatic and laparoscopic
surgery. Oversewing the pancreatic stump after transaction with
Endo stapler may reduce the incidence of pancreatic leak. Cen-
tralization of pancreatic surgery has a positive impact in buliding
up surgical experience resulting in obvious benefits for both pa-
tients and institutions.
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SHOULD WE EXTEND THE INDICATION FOR
PROPHYLACTIC PANCREATECTOMY IN
PATIENTS WITH MAJOR VESSEL RESECTIONS
IN PANCREATIC CARCINOMA?
M. Bockhorn1, C. Burdelski1, G. Cataldegirmen1, A. Marx2,
J. K. Vashist1, E. F. Yekebas1, J. R. Izbick1
1. Department of General, Visceral and Thoracic Surgery
2. Institute of Pathology University Medical Centre Hamburg-Ep-
pendorf, University of Hamburg, Germany
Introduction: Pancreatic cancer can often involve the common
hepatic artery and/or the celiac axis and is regarded as an unre-
sectable disease. The benefit of resection in these cases is still a
matter of discussion. Aim of our investigation was to analyze a)
perioperative morbidity and mortality rates between patients with
and without arterial en-bloc resection (AEBR), 2. morphologi-
cal “at risk” conditions such as the texture of the pancreas
parenchyma, elevating the likelihood of surgical complications
and 3. long-term survival.
Material and methods: Of 1099 patients subjected to pancreas-
resection, 29 patients (3%) underwent an AEBR (Group A).
These were compared to 449 patients (41%) (Group B) without
vascular reconstruction.
Results: 18 patients received a reconstruction of the hepatic ar-
tery (HA), 8 a reconstruction of the celiac trunc (CT) and 3 a re-
construction of the superior mesenteric artery (SMA). Among
these, 15 patients needed an additional reconstruction of the por-
tal vein. Group A patients had significantly longer operative times
(P<0.0001), required more blood units (P<0.0001), and had
longer hospital stay than had group B patients (P=0.049). Mor-
bidity and mortality in group A (28% and 17%, respectively) were
significant higher than in group B (15% and 4%; P<0.03). Pa-
tients in group A with a soft pancreatic tissue had a statistically
higher risk of developing an arrosive bleeding after a pancreatic
fistula. The median overall survival time of 12.2 months
(Range:7.7-16.7) in group A was shorter than that in group B
(Median: 14 months, Range:11.5-16.5), but significantly longer
than in patients treated with an palliative bypass, who survived
only 7.5 months (P<0.014).
Conclusion: Despite higher morbidity and mortality rates in pa-
tients with AERB, satisfying overall survival justifies extended re-
sections in individual cases. Due to the elevated risk of fatal
arrosion bleeding in patients with multi-vessel reconstruction and
soft pancreatic tissue, the indication for prophylactic pancreate-
ctomy should be extended.
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LONG TERM RESULTS AFTER SURGICAL
RECECTION AND ADJUVANT CHEMOTHERAPY
FOR GALLBLADDER CARCINOMA
C. Avgoustou, T. Kakavoulis1, A. Tsakpini, B. Schizas,
A. Belegris, P. Penlidis
District General Hospital of N. Ionia “Constantopoulion –Ag. Olga”
Surgical management of gallbladder carcinoma (GC) is contro-
versial regarding indications for radical resection.
A retrospective review of 60 patients aged 34-88 (mean 68) years
with GC treated from 1991 to 2008 was performed. Group I con-
sisted of 24 patients who underwent cholecystectomy for gallstone
disease (GD) and had incidental GC. Among 36 patients with ad-
vanced disease consisting Group II, preoperative diagnosis of GC
was made in 14 and of “suspicious” GD in 22. Cancers classified
using Nevin classification: Stage I - 11 patients (18.33%), II -
11(18.33%) , III - 24 (40%), IV - 8 (13.33%), V - 6 (10%). Pa-
tients of stages I-II and 3 of stage V underwent simple cholecys-
tectomy. Patients of stages III-IV and 3 of stage V underwent
extended cholecystectomy with regional lymphadenectomy. Two
patients (stage IV) had bile duct resection with biliary-enteric re-
pair.
Adenocarcinomas were detected in 58 patients, undifferentiated
carcinomas in 2 (stage V). Fourteen patients (23.33%) had post-
operative complications including wound infection (8), biliary fis-
tula (5), pleural effusion (4). Twenty patients of group II received
adjuvant chemotherapy (cisplatin, etoposide, 5-fluorouracil, leu-
covorin).
With the exception of 4 died from unrelated disease and 5 lost,
patients of stages I-II suvived for more than 5 years (8) and 10
years (5). Survival for remaining with advanced disease was 7
months (5-8.5) for those having had only surgery and 18 months
(12-41) for those who also received chemotherapy.
Combination of radical surgery and chemotherapy for patients
of stages III-IV increases survival rate and improves quality of
life.
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PERI-OPERATIVE MORBIDITY MAY EFFECT
LONG-TERM SURVIVAL FOLLOWING
RESECTION FOR HILAR
CHOLANGIOCARCINOMA
C. Mann1, C. Briggs1, C. Neal1, C. Pattenden2, G. Garcea2,
M. Metcalf2, A. Dennison2, D. Berry2
1. University of Leicester Leicester General Hospital
2. Leicester Teaching Hospitals Leicester General Hospital
Introduction – Resection is the only potential cure for hilar
cholangiocarcinoma, however it involves major surgery with its
associated morbidity. Recent evidence suggests that post-opera-
tive morbidity may be associated with adverse long-term outcome
following hepatic resection for colorectal liver metastases, how-
ever this has not been investigated following resection for hilar
cholangiocarcinoma. The aim of this study was to assess the im-
pact of peri-operative morbidity on long-term outcome of pa-
tients following resection for hilar cholangiocarcinoma.
Methods – Clinicopathological data were obtained from a
prospectively maintained database for patients who underwent
resection for hilar cholangiocarcinoma between July 1995 and
December 2004 at a single United Kingdom tertiary referral he-
patobiliary centre. Patients who died of peri-operative compli-
cations were excluded. Pre- and peri-operative variables,
including morbidity and clinicopathological variables were
analysed, and their effect on long-term survival determined.
Results – 35 patients underwent resection for hilar cholangiocar-
cinoma over the study period, with a median follow-up of 20.5
months. 18 were male, and the median age was 61 years. The
overall peri-operative morbidity rate was 51%. The overall sur-
vival was poorer in patients who suffered post-operative compli-
cations; 1- and 3-year survival rates were 44.4% and 22.2% in
patients who suffered peri-operative morbidity, compared to
87.5% and 37.5% in patients who did not, although this did not
reach statistical significance (p=0.16).
Conclusions – Peri-operative morbidity may adversely affect long-
term outcome following resection for hilar cholangiocarcinoma,
therefore efforts aimed at reducing peri-operative complications
may improve patient survival. Larger studies are required to val-
idate these findings.
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CHOLEDOCAL CYSTS IN ADULTS IN A GREAT
SOUTH AMERICAN MEDICAL CENTER
F. Levino, A. David, R. Dagher, A. de Moricz, R. Altenfelder,
A. Pacheco, T. de Campos
Santa Casa de São Paulo – São Paulo, Brazil
Introduction: Choledocal cysts (CC) are rare congenital non-fa-
milial anomalies that may strike both intra and extra-hepatic bil-
iary tract and was classified by Todani in five groups1. Its
incidence varies geographically, being 1:1000 in Asian countries,
and from 1:100000 to 1:150000 in Occidental countries2. Most
cases are diagnosed in pediatric patients, 60% within the first
decade of life. CC in adults is therefore often rare3. Cases Re-
port: We report a series of 7 adults carrying CC, 6 Todani type I
and 1 type IV-B, 3 male and 4 female, with a mean age of 42.3
years, surgically managed by our team from 1992 to 2008. The
mean history of clinical signs was 19 months. All patients had ab-
dominal pain, 5 (71.4%) presented jaundice and ascitis was not
found. Serum alkaline phosphatase and gamma-glutamyltrans-
ferase were above limits in all cases with an average 98 UI/L and
631 UI/L respectively. The cysts width varied from 4 to 12.4 cm.
In 6 patients we could see intra-hepatic ducti dilation at the sono-
gram. In two cases we found complications after surgery; one pa-
tient shocked and another had a left leg thrombosis. Both patients
died. In a mean follow up of 12.4 months 5 patients are alive and
show no signs of relapse. Conclusion: CC in adults is so rare a
disease in our country that never before was it formally related.
Cholecistectomy and choledocal cyst excision followed by a Roux-
en-Y hepatic-jejunostomy was a successful treatment to most of
our patients.
References
1. Todani, T et al. .Congenital bile duct cysts: classification, op-
erative procedures, and review of 37 cases including cancer aris-
ing from choledochal cyst. Am J Surg 1977;134:2639.
2. Singham, J. et al. Choledochal cysts:analysis of disease pattern
and optimal treatment in adult and pediatric patients.
HPB,2007;9:383387.
3. Liu, C.L. et al. Choledochal Cysts in Adults. Arch Surg
2002;137: 465-468.
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SURGICAL TREATMENT OF HILAR
CHOLANGIOCARCINOMA: A SINGLE
INSTITUTION EXPERIENCE
A. Katseli, A. Koliopanos, N. Kopanakis, A. Katopodi,
S. Loggos, E. Margaris
3rd Department of Surgery General Hospital of Athens “G.Genni-
matas”, Athens, Greece
INTRODUCTION: Hilar cholangiocarcinoma has recently been
recognised as a unique entity requiring special diagnostic modal-
ities and individual treatment. The clinical practice involves a
multidisciplinary approach and emphasizes the role of surgery as
primary treatment in surgically fit patients.
METHODS: During the last 10 years, 23 patients (15 male and 8
female, age 54-78, mean age 70 years old) with bile duct cancer
underwent surgery in our department. Complete staging of the
patients was accomplished using a combination of US, CT scan
and endoscopic US. All patients suitable for surgery were
planned for an explorative laparotomy in the absence of evidence
of cancer dissemination and the final decision making was made
intraoperatively.
RESULTS: In three cases, exploratory laparotomy revealed peri-
toneal metastasis and no further surgery was performed. The re-
maining 20 patients received either a palliative (8 patients) or a
therapeutic R0 resection (12 patients). In 2 cases with intrahepatic
bile duct cancer a hemi-hepatectomy was performed. The biliary
tree reconstruction after resection was accomplished by bilioen-
teric roux en Y anastomosis with primary or secondary bile ducts.
Mortality included one patient with left hepatectomy who died 30
days after surgery from pulmonary insufficiency in the ICU. In 5
patients a bile leakage was treated conservatively for 20-30 days.
All patients received adjuvant chemotherapy. Three patients died
19, 25, 29 months after surgery from disease recurrence. The re-
maining patients are alive, 3-24 months after surgery.
CONCLUSIONS: Advanced diagnostic approach may increase pa-
tients who potentially benefit from surgery. Aggressive resection in-
cluding hepatic tissue when necessary may improve patient’s long
term survival although with increased mortality and morbidity.
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EXPERIENCE IN SURGICAL TREATMENT OF
MID AND DISTAL TRACT BILE DUCT CANCER
A. Frena, G. La Guardia, F. Martin
General Surgery Central Hospital of Bolzano, Italy
Introduction: carcinoma of the mid or distal third of the common
bile duct is a fairly rare nosological entity in the Western world,
accounting for 13-23% of tumours of the extrahepatic bile ducts.
The surgical treatment varies in relation to the site: in the case of
carcinomas of the distal common bile duct the operation of
choice is duodeno-pancreatectomy, whereas for tumours of the
mid common bile duct there is still no unanimous consensus of
opinion regarding the type of surgery.
AIM: The prognosis of these tumours is, on the whole, better
than that of carcinomas of the proximal choledochus.
Methods: we retrospectively assessed 37 patients with non-hilar
extra-hepatic bile duct tumours observed in our surgery depart-
ment from 1985 to 2005. The patient series comprised 21 men
and 16 women, with a mean age of 71 years. The presenting symp-
tom was jaundice in 95% of cases. In 23 cases the carcinoma af-
fected the distal common bile duct and in 14 cases the mid
common bile duct.
Results: 15 patients were treated with a radial intent by either
duodenopancreatectomy (13 cases) or by resection of the com-
mon bile duct (2 cases). Ten patients with local inoperability or
liver metastases were treated with a palliative biliodigestive anas-
tomosis. Twelve patients were excluded from surgery and treated
endoscopically. Postoperative staging identified 1 patient as stage
Ia, 2 patients as stage Ib, 8 patients as stage IIa, 3 patients as stage
IIb, and 1 patient as stage III according to the new TNM classifi-
cation. There was no operative mortality. Survival at 1, 2 and 5
years was 51%, 27% and 14%, respectively.
Conclusions: carcinoma of the mid or distal portion of the com-
mon bile duct is a tumour that offers fairly good prospects of sur-
vival. Surgical radicality is achieved essentially by obtaining ductal
and radial margins which are free of microscopic infiltration and
by means of a thorough lymphadenectomy. These conditions can
be achieved more easily in carcinomas of the distal portion of the
duct owing to the extent of the duodeno-pancreatectomy they re-
quire. In carcinomas of the mid common bile duct the anatomi-
cal contiguity with the portal vein is responsible for a lower
resectability rate.
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CONVERSION RATE OF ELECTIVE
LAPAROSCOPIC CHOLECYSTECTOMY IN
A COMMUNITY HOSPITAL
P. Gkanas, J. Massalis, E. Papadema, G. Efthimiou,
C. Konsolas, J. Moysis, J. Kritselis
Department of Surgery, General Hospital of Nafplion, Greece
Background: Laparoscopic cholecystectomy(LC) has become a
very common procedure in community hospitals. The risk of con-
version from LC to open cholecystectomy(OC) is related with
various technical difficulties and should be explained to every pa-
tient preoperatively.
Aims: To evaluate the preoperative risk factors of conversion
from LC to OC
Methods: Preoperative and intraoperative data were collected
from 210 patients(138 female, 72 male), who underwent LC by
two surgeons in 3 years time(2005 –2007). Seven parameters, (ab-
dominal tenderness, recent- multiple biliary colic attacks, white
blood cells, gall bladder wall thickness ultrasonography, previous
abdominal surgery, BMI(Body Mass Index), history of acute
cholecystitis) were regarded as preoperative risk factors and
formed the risk score from 0-9. Exclusion criteria were history of
Jaundice, cholangiitis, dilated common bile duct.
Results: 210 patients underwent LC. There were not common
bile duct injuries or other major complications and low morbid-
ity rate(5,5%). Overall 15 patients required conversion to
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OC(7%),12 of them(5,7%) had score higher than 3. The ideal
cut-off point for preoperative score was 3. Under this score only
3 patients (1,4% ) underwent convertion, mainly because diffi-
culties related with BMI.
Conclusions: Preoperative risk factors could be used to define the
difficult LC and assist the operating team in selecting the most
appropiate procedure. An experienced surgeon must operate pa-
tients with high preoperative score.
G Belli1, L Cioffi1, C Fantini1, A DAgostino1, P Limongelli1, G
Russo1, A Belli1
1. Loreto Nuovo Hospital S.Maria Loreto Nuovo Hospital Naples
- Dept of General and HPB Surgery
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REVISION SURGERY FOR INCIDENTALLY
DETECTED GALLBLADDER CANCER.
OPEN AND LAPAROSCOPIC APPROACH
G. Belli, L. Cioffi, C. Fantini, A. DAgostino, P. Limongelli,
G. Russo, A. Belli
Loreto Nuovo Hospital S.Maria Loreto Nuovo Hospital Naples -
Dept of General and HPB Surgery
Background: gallbladder carcinoma is found in 0.2 to 2.9% of all
cholecystectomies. Incidental detected gallbladder carcinoma
(IDGC) is identified when is found in histopathology analyses
after removal of gallbladder for benign disease. Data from the lit-
erature recommend a tailored approach based on pT category.
Early tumors (Tis and T1a) are curable with simple cholecystec-
tomy alone; tumors invading muscle layer (T1b) demonstrated
better outcomes with extended cholecystectomy+ lymphadenec-
tomy + port-site excision (PSE) with no different outcomes com-
paring early vs referred treatment; for T2-T3 is recommended
S4b-S5 resection + lymphadenectomy. In literature is remarked
that gallbladder carcinoma laparoscopically treated is no worse
than that for patient undergoing conventional surgery in terms
of preoperative and oncological survival.
In this paper we compared our perioperative outcomes of la-
paroscopic vs open surgical revision for IDGC.
Methods: a total of 400 consecutive laparoscopic cholecystec-
tomies for benign disease were performed in our institute be-
tween January 2001 and August 2008; 6 incidental gallbladder
carcinoma (1.5%) were detected and underwent to surgical revi-
sion based on tailored approach above mentioned. Procedures
were: 2 port-site excision (Tis, T1a), 2 extended cholecystec-
tomies + PSE (1 open and 1 laparoscopic for T1b), 1 laparo-
scopic resection of segment IVB and V+ PSE (T2).
Results: No significant differences had been observed in blood
loss, hospital stay, postoperative mortality and morbidity between
laparoscopic and open approach.
Conclusions: according to literature, mininvasive surgical treat-
ment of IDGB is feasible, safe and seems to be comparable to
open approach in terms of perioperative outcomes.
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MUIR-TORRE SYNDROME ASSOCIATED WITH
INTRAHEPATIC CHOLANGIOCARCINOMA
H. Sousa, T. Almeida, R. Melo, J. Teixeira, E. Martins,
J. Costa-Maia
Uindade HBPE - Serviço de Cirurgia Geral Hospital S. João, Por-
tugal
Muir-Torre syndrome (MTS) is a rare cancer-predisposing syn-
drome with autosomal dominant transmission, and characterized
by the development of sebaceous skin lesions (adenomas, ep-
itheliomas, basaliomas and carcinomas). These lesions are typi-
cally associated with tumors that belong to the spectrum of
hereditary nonpolyposis colorectal cancer. We report a case of
Muir-Torre syndrome associated with intrahepatic cholangiocar-
cinoma, a location described only once previously, and associated
with a novel missense mutation of the hMLH1 gene.
Case Report: A 75-year-old Caucasian male was admitted in our
Unit with liver tumor suggestive of cholangiocarcinoma, detected
during the investigation of weight loss with a 3 week evolution. He
also present a skin nodule in the left retro-auricular area. Family
history indicated that the patient’s father had died from colon
cancer at the age of 50.
He was submitted to a left hepatectomy with bilio-enteric anasto-
mosis and resection of the skin lesion. Microscopic examination
showed a poorly differentiated intra-hepatic cholangiocarcinoma.
The left retro-auricular nodule corresponded to a sebaceous ep-
ithelioma. Considering family history and these results, MTS was
suspected and genetic testing was performed, revealing the pres-
ence of missense mutation of the hMLH1 gene, that confirmed the
clinical suspicion of MTS.
Conclusion: We report what is, to our knowlege, the second case
of Muir-Torre syndrome, associated with intra-hepatic cholan-
giocarcinoma, and we present evidence that a novel germline mu-
tation of the hMLH1 gene is the underlying cause of this severe
cancer.
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THE ANALYSIS OF HUMAN BILIARY
CALCULUS TYPES BY MEANS OF DAMAGE
CAUSED BY LASER
S. Mijatovic, A. SIjacki, B. Stefanovic
Emergency centar of Clinical Centar of Serbia
Background. Cholelitiasis is a common surgical problem. The his-
tory of choledocholitiasis does not necessarily have to be related
to the history of cholelitiasis. Stones in choledoch and Vater
papilla can be either primary or secondary which can be the con-
sequence of migration from gall bladder and they differ in their
structure. Gall bladder concrements have a compact structure
and they vary in size, shape and compostion which develops in
the lithogenic cholecyst in the biliary calculus. There are three
types of calculuses: cholesterinal, pigmentary and combined.
Methods. Nowadays, stone testing within human body, and espe-
cially in gall bladder, is a significantly less invasive procedure due
to a number of non-invasive methods which have been developed.
This analysis shows the results of gall bladder calculus fragmen-
tation research in vitro for which CO2 laser in impuls > power
level output 5W, in continuous regime, power level output 15W,
and diodic laser, 808nm, were used. The total of 15 gall bladder
human calculus of the known size, collected during surgical pro-
cedures, was tested. The damages caused by the laser were
analysed visually and by means of stereo microscope, magnifying
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10 to 20 times. Depending on the type and the applied radiation
and the parameters, it can be noticed on the stones the different
types of damages, such as machanical injuries, plastic deformity,
erosion developed by material depostion, evaporation traces,
burning effects and material melting. Every tested group shows
some of the mentioned effects of a laser beam activity.
Results. The demonstrated gall bladder damages developed by
the activity of two types of lasers are mutually very different, al-
though the functioning effects were the same. The radiation of
the applied diodic laser whose wavelength is one-tenth the wave-
length of CO2 laser has a greater ability of penetration, which
also resulted in a greater profundity of the damages.
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MALIGNANT SCHWANNOMA OF THE
COMMON HEPATIC DUCT. A CASE REPORT
M. Sabol, V. Straka, M. Straka
St. Elisabeth Cancer Institute, Bratislava, Slovenia
Introduction. Malignant schwannoma represents approximately
10% of all soft tissue sarcomas but primary malignant schwan-
noma of hepatic duct is extremely rare. Only 10 cases of extra-
hepatic biliary tract Schwannoma have been reported in the
literature. Peripheral nerve sheath tumors account for
2%- 6% of gastrointestinal stromal tumors.
Case report. We report an unusual case of 65-year-old white male
who presented with obstructive jaundice due to common hepatic
duct obstruction. Prior to admission to our department a duo-
deno-biliary stent was inserted and patient suffered from recur-
rent cholangitis. MRCP revealed common hepatic duct stenosis
with extension to hepatic duct confluens and dilation of intra-
hepatic biliary tree. PET/CT fusion disclosed pathologic meta-
bolic activity in the area of common hepatic duct and enlarged
paracaval and coeliac lymphnodes. Massive tumorous infiltration
comprising hepatic confluens and hepatoduodenal ligament was
found at laparotomy. Resection of both hepatic ducts proximal
to the confluens was performed, common bile duct was resected
at retroduodenal level and regional lymphadenectomy was done.
Reconstruction by hepaticojejunostomy Roux –en-Y was per-
formed. Gross inspection showed an intramural submucosal le-
sion with a diameter of 4 cm. Histologic examination disclosed
malignant mesenchymal peripheral nerve sheath tumor G1 low
grade(Broders G1) with assymetric spindle cells without mucosal
infiltration. Imunohistochemic staining was positive for S-100, vi-
mentin and CD68 and negative for desmin, CD34 and CD117. 15
removed lymphnodes were negative. As R0 resection was
achieved no adjuvant therapy was indicated.
Conclusion. Preoperative diagnosis is often difficult, differentia-
tion from cholangiocarcinoma can be done only histologically.
Resection remains the only curative modality.
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NEONATAL CHOLECYSTITIS - CASE REPORT
T. Syriopoulou1, E. Fourlani2, E. Michael1
1. Kalamata General Hospital
2. «Agia Sofia» University Children Hospital of Athens
Backround: Neonatal cholecystitis is an acute inflammation of
the cholecyst, sometimes associated with the appearance of cal-
culi. The disease appears acutely with abdominalgia which is usu-
ally accompanied by vomiting, fever and icterus. It is reported the
case of an infant with cholecystitis.
Methods: Neonatal full term female, with birth weight 2830 gr,
born with caesarian section by primara mother with an obstetri-
cal history of gestagional diabetes, presented necrotizing entero-
colitis during its third day that was conservatively treated shows
while being 23 days of age alimentary vomit after meals, anxiety
and growl. The objective examination of the infant showed tym-
panism and sensitivity during abdominal palpation. Laboratory
testing was performed: blood and biochemical testing, haemo-
urine-fecal cultures. Imaging evaluation (abdominal x-ray, cere-
brum u/s, kidney-urinary bladder u/s and pylorus u/s) was also
performed.
Results: Biochemical testing revealed increased index of infec-
tion (CRP 30.8 mg/lt) while the rest of the test results were within
normal ranges. X-ray abdominal film showed multiples aerial
masses. Imaging evaluation of cerebrum and kidney-urinary blad-
der showed no pathological finding, however pylorous u/s re-
vealed fully oedematous cholecyst, with increased heamatosis,
incrassation of the paries (cholecystitis compatible findings).
Feeding was paused and total parenteral nutrition was given.
Treatment with intravenous antibiotics (meropenem and metron-
idazole) gradually decrudescented the symptoms and improved
the clinical presentation (tympanism regression).
Conclusions: The case is reported due to its rarity and to empha-
size the necessity of including cholecystitis in diagnostic differ-
ential of neonatal incidents with similar simiology.
References: 1. Riddlesberger MM Jr: Diagnostic imaging of the
hepatobiliary system in infants and children. J Pediatr Gas-
rtroenterol Nutr 3: 653, 1984
2. Andres JM, Mathis RK, Walker WA: Liver disease in infants:
Part I. Developmental hepatology and mecanisms of liver dis-
function. J Pedietr 90 : 686, 1977
P 220
GALLBLADDER PERFORATION: ANALYSIS
OF 5 CASES
K. Spyridakis1, G. Panagiotakis2, G. Krasonikolakis2,
M. Grigoraki2, E. Chronakis2, T. Papadakis1, T. Kokkinakis1,
S. Kandylakis3
A Surgical Department – General Hospital “ Venizelio – Pananio”
Iraklion Crete
Gallbladder perforation is a rare condition even in patients af-
fected by acute cholecystitis. It’s difficult to be diagnosed and is
associated with significant morbidity and mortality. The aim of
this study is to present our clinical experience on gallbladder per-
foration as a complication of acute cholecystitis.
MATERIALS AND METHODS: Perforation of gallbladder oc-
cured in 5 cases (0,77%) of 643 patients with acute cholecystitis
treated in our surgical department in a 10-year period. The mean
age of the patients was 79 years and the male:female ratio was
3:2. Most patients had a coexisting history of cardiorespiratory
and/or metabolic(diabetes mellitus) desease.
RESULTS: Abdominal Ultrasound (U/S) revealed gallstones in
4 patients. In 3 patients abdominal U/S did not reveal free in-
traperitoneal fluid and in all patients revealed pericholecystitic
free fluid. CT scan was performed in 2 patients,and in one case
showed extensive free intraperitoneal fluid. 4 patients underwent
surgical intervention 24-48 hours after the initial symptoms. In 1
patient we had a late decision for surgical intervention. The post-
operative hospitalisation period for the first 4 patients was 15
days. The last patient presented with acute abdomen and under-
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went surgical intervention 6 days later.
CONCLUSION: Early diagnosis of gallbladder perforation is
very important, late operative intervention is associated with in-
creased morbidity, mortality and prolonged postoperative hospi-
tal stay. We notify that U/S and CT scan has a limited diagnostic
valve for detection the gallbladder perforation, after acute chole-
cystitis, but they have a significant role in preoperative diagnosis
even if sometimes these examinations failed to established the di-
agnosis.
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MAJOR OPERATIVE AND POSTOPERATIVE
COMPLICATIONS AFTER LAPAROSCOPIC
CHOLECYSTECTOMY
D. Daskalaki, S. Paraskakis, A. Anastasiou, K. Daskalakis
Surgical and Gastroenterological Department University of Verona
Policlinico G.B Rossi
Background (Aim): Laparoscopic cholecystectomy is the gold
standard technique for the treatment of gallbladder diseases. The
aim of this retrospective study is to present the major complica-
tions during and after LC.
Methods: The last 5 years, 671 patients underwent LC for un-
complicated cholelithiasis ( 587 patients, 87,48%) or acute chole-
cystitis ( 84 patients 12,52% ). Males were 211 ( 31,45%) mean
age 58,3 years and 460 females ( 68,55 %) mean age 56,2 years
Low molecular heparin and perioperative antibiotics were used
routinely. A subhepatic drain was placed in all patients for 24h
or more if necessary.
Results: The conversion rate was 4,02% (27 patients) . The fol-
lowing major complications recorded intraoperatively in 16 pa-
tients ( 2,38%).
Common bile duct injury (2 patients-0,3%),small bowel injury
(3patients-0,45%), haemorrhage from gallbladder bed ( 7 pa-
tients 1,04%), haemorhage from the cystic artery (2patients), cut-
ting of the short cystic bile duct by the clip (1patient) and
pneumothorax caused by right hemidiafragm injury ( 1 patient ).
All complications were recognized intraoperatively and managed
immediately. Ten of them laparoscopically and 6 by conversion.
Postoperative complications observed in 11 patients (1,64%).
Haemorrhage from the drainage (4 patients), bile fistula (4 pa-
tients ) and biloma (3 patients). These complications were man-
aged: Conservatively in 8 patients, by percutaneus drainage in 1,
by ERCP and stent placement in 1 and surgically in 1 patient.
Overall perioperative morbidity : 4,02%
Perioperative mortality : 0%
Mean postoperative hospital stay : 2,8 days.
Conclusions: LC is a safe procedure for the management every
stage of symptomatic cholelithiasis. The injury of the bile ducts
still remains a serious and potentially lethal complication.
The critical point is to recognize the lesion during the laparo-
scopic procedure and treat this laparoscopically or by conversion
to open surgery during the initial operation.
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BIOCHEMICAL MARKERS IN SURGICAL
PATIENTS WITH EXTRAHEPATIC
CHOLESTASIS
S Zajic, R. Zdravkovic, M. Jovanovic
Health Center Krusevac, Serbia
Cholestasis is characterized by regurgitation of bile and its con-
stituents to liver and circulation. Obstruction of ductus hepati-
cus, choledochus or papilla Vateri, are the causes of extrahepatic
cholestasis and jaundice. The most important toxic constituents
are hydrophobic bile salts and unconjugated bilirubin.
The purpose of this work was to analyse biochemical markers
such as activity of GGT and AF, concentration of bilirubin, and
albumin in patients with different kinds of extrahepatic cholesta-
sis, for the purpose of choosing the adequate method of treat-
ments.
The 100 patients were examined and divided into 4 groups. Con-
trol group (20 healthy volunteers), I group (20 patients-intralu-
minal cholestasis), II group (20 patients-intramural cholestasis),
III group (40 patients-extraluminal cholestasis).
There are significant increases in GGT and AF activity in blood
of cholestatic patients compared to control (p<0,001). In III
group, GGT activity is increased compared to I group (p<0,05),
while AF activity was reduced in I group compared to II (p<0,05)
and III group (p<0,01). The bilirubin concentrations were higher
in patients with cholestasis (p<0,001) compared to control. Con-
centration of bilirubin in blood of patients with cholestasis from
II and III were significantly higher compared to I group. Albumin
concentration was significantly lower in patients with cholestasis
compared to control group.
In patients there are significant increasing of cholestatic mark-
ers-III group. Cholestasis induces reduction of liver function no-
ticeable in patients with intramural and extraluminal cholestasis.
Patients with extrahepatic cholestasis and jaundice should be
treated conservatively and surgically as soon as possible after the
first symptoms appear.
Alvaro D, Benedetti A, Marucci L, Delle Monache M, Mon-
terubbianesi R, Di Cosimo E, Perego L, Macarri G, Glaser S, Le
Sage G, Alpini G. The function of alkaline phosphatase in the
liver: regulation of intrahepatic biliary epithelium secretory ac-
tivities in the rat. Hepatology 2000;32(2):174-84.
Glasova H, Beuers U. Extrahepatic manifestations of cholesta-
sis. Journal of Gastroenterology and Hepatology 2002;17:938-48.
Phillips J, Poucell S, Oda M. Mechanisms of Cholestasis. Labo-
ratory Investigation 1986;54(6): 593-608.
Kullak-Ublick G and Maier P. Mechanisms of cholestasis. Clin
Liver Dis 2000; 4(2):357-85.
Pasanen P, Pikkarainen P, Alhava E, Partanen K, Penttila I.
Value of serum alkaline phosphatase, aminotransferases, gamma-
glutamyl transferase, leucine aminopeptidase, and bilirubin in the
distinction between benign and malignant diseases causing jaun-
dice and cholestasis: results from a prospective study. Scand J
Clin Lab Invest. 1993;53(1): 35-9.
Trauner M, Meier P, Boyer J. Molecular Pathogenesis of
Cholestasis. N Engl J Med 1998;339:1217-27.
Valls C. Obstructive Jaundice: diagnostic and therapeutic man-
agement. J Radiol 2006;87(4 Pt 2):460-78.
Benjamin IS. Biliary tract obstruction-Pathophysiology. In: LH
Blumgart (ed.) Surgery of teh liver and biliary tract. London:
Churchil Livingstone, 1988. pp. 111-9.
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ALMOST A SURGICAL CATASTROPHE:
POLYARTERITIS NODOSUM PRESENTING
AS ACUTE ACALCULUS CHOLECYSTITIS AND
COMPLICATED BY CORONARY VASCULITIS
G. Irving1, C. Briggs2, R. Stevens3, C. Kelty3
1. Sheffield Teaching Hospitals
2. University of Leicester
3. Doncaster Royal Infirmary, UK
Introduction: Inflammation of the gallbladder in the absence of
gallstones (Acalculus cholecystitis) is unusual and may be a
marker of other pathology. We present a case of gallbladder vas-
culitis, complicated by life-threatening coronary arteritis, which
could have led to a surgical catastrophe.
Case report: A 17 year old male presented with right upper quad-
rant pain. Past medical history included asthma. Clinical exami-
nation revealed tachycardia and severe RUQ tenderness. Serum
CRP was 66.1 mg/l, WBC 20.6 x 109/l, neutrophils 7.6 x 109 /l and
eosinophils 10.1 x 109/l (0.01-0.7). Liver function was normal. Dif-
ferential diagnosis included visceral perforation or acute chole-
cystitis.
CT revealed thickened and oedematous gallbladder consistent
with acute cholecystitis. Urgent cholecystectomy was arranged
pending ultrasound scan. USS confirmed oedema of the gall-
bladder wall, normal biliary tree, but no gallstones. A conserva-
tive approach was adopted.
24 hours later the patient developed pleuritic chest pain and dys-
pnoea. ECG changes were diagnostic of pericarditis. The patient
was transferred to coronary care. Further investigations con-
firmed elevated creatine kinase and troponin T. Thoracic CT con-
firmed vascular lung nodules. Rheumatological assays lead to a
diagnosis of polyarteritis nodosum (PAN). Intravenous steroid
therapy was commenced and the patient recovered.
Discussion: PAN is a rare systemic vasculitis associated with
asthma and eosinophilia. Acalculus cholecystitis is an uncommon
and rarely reported presentation of this condition. A high degree
of clinical suspicion is needed when gallbladder inflammation oc-
curs without the presence of gallstones. In this case, urgent chole-
cystectomy could have been fatal due to concurrent coronary
arteritis.
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CASE REPORT: EXTREMELY LARGE RARE
BILIARY CYSTADENOCARCINOMA
S. Smeaton, R. Washburn III, L. Harrell, C. Walters,
J. Martinie, D. Iannittie
Carolinas Medical Center, Charlotte, NC, USA
BACKGROUND: Biliary cystadenomas are rare tumors that are
often misdiagnosed as other benign cystic lesions of the liver. The
malignant counterpart, biliary cystadenocarcinoma, is even more
rare. Differentiating between the two by imaging modalities or
needle biopsy has proven difficult. Evidence also suggests that
benign lesions have a propensity for malignant degeneration. For
these reasons resection is recommended when either is suspected.
We present a case of a patient who underwent resection for a rare
28 lb biliary cystadenocarcinoma.
REPORT: The patient is a 43 year old female with 14 months of
progressive abdominal distention and difficulty breathing. Ab-
dominal tri-phase CT demonstrated multiple cystic lesions within
the liver. She was diagnosed with adenocarcinoma after FNA
biopsy. Due to the apparent multiple lesion sites she was deter-
mined to be inoperative and started on seven months of
chemotherapy (Gemzar, Xeloda, Avastin, Oxaloplatin) and then
maintenance Avastin.
At the time of evaluation at this institution, tri-phase abdominal
CT (Fig 1) demonstrated massive tumor filling most of the liver
(30 x 20 cm cross sectional size) with multiple areas of cystic
degradation. There was preserved right portal and right hepatic
vein blood flow to noninvolved hepatic segments VI and VII.
There was no evidence of extrahepatic metastases.
Laparotomy and right hepatic trisegmentectomy were performed.
A multicystic mass with areas of hemorrhage and necrosis weigh-
ing 28 lbs was resected with negative margins (Fig 2). Final diag-
nosis was biliary cystadenocarcinoma. On 30 day follow-up the
patient is ambulatory and doing well. Follow-up CT shows no re-
sidual tumor.
Fig 1 Large cystic lesion of liver on CT
Fig 2 Resection of 28 lb biliary cystadenocarcinoma
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LAPAROSCOPIC FENESTRATION OF
MULTIPLE GIANT BILIARY MUCINOUS
CYSTADENOMAS OF THE LIVER
L. Alevizos1, E. Lagoudianakis2, H. Markogiannakis2,
A. Larentzakis1, I. Papailiou1, H. Kantsos1, N. Pararas1,
K .Toutouzas1, V. Katergiannakis1, A. Manouras2
1. 1st Department of Propaedeutic Surgery, Hippokration Hospital,
Athens Medical School, University of Athens, Athens, Greece
2. Department of Endocrine Surgery, 1st Department of Propaedeu-
tic Surgery, Hippokration Hospital, Athens Medical School, Uni-
versity of Athens, Athens, Greece
Background-Aim: Biliary cystadenomas of the liver are rare, cys-
tic neoplasms of the biliary ductal system. We report a case of
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synchronous multiple huge biliary mucinous cystadenomas with
unique features. This is, to our knowledge, the first report in the
literature of three synchronously occurring hepatobiliary cys-
tadenomas.
Case presentation: A 70-year-old woman presented with a one
year history of low back pain. Blood tests were normal. Abdom-
inal ultrasonography revealed the presence of multiple hepatic
cysts (the largest one measuring 17 cm in diameter) and
cholelithiasis. Subsequent CT scan showed two cysts in the right
and one cyst in the left hepatic lobe. The cysts were unilocular,
well-defined, with homogeneous content and had no irregular
thickness, mural nodules or papillary projections. The patient un-
derwent laparoscopic fenestration of the cysts and cholecystec-
tomy. She had an uneventful postoperative period and was
discharged two days after surgery. Pathologic evaluation revealed
that the cyst wall was comprised of a single layer of cuboidal-to-
columnar epithelium, a moderately cellular stroma and an outer
dense layer of collagenous connective tissue. These findings were
consistent with cystadenoma without evidence of malignancy.
Conclusion: Differential diagnosis of cystic lesions of the liver
should always include hepatobiliary cystadenoma. Due to the rar-
ity of this entity, there are no major reports addressing the treat-
ment and outcome of laparoscopic surgery for hepatobiliary
cystadenomas. Since they have a strong tendency to recur and a
potential of malignant transformation, a lifelong follow-up is nec-
essary.
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ANALYSIS OF LONG TERM RESULTS OF
CHOLEDOCHOLITIASIS TREATMENT BY
MEANS OF T DRAINAGE AND
TRANSDUODENAL SPHINCTEROPLASTY
S. Mijatovic, A. SijackI, B. Stefanovic
Emergency centar of Clinical Centar of Serbia
Background. Symptomatic cholelitiasis is a common surgical
problem, and choledocholitiasis represents an additional com-
plication and it increases morbidity. The incidence of choledo-
cholitiasis is 15%-20% among the patients with biliary calculus.
The stones in choledoch and in Vater papilla can be primary and
secondary and they differ in their structure.
Methods. The study was conducted on the surgically treated pa-
tients who were all divided into two groups: the first group was
the control group including 30 patients with choledocholitiasis
who underwent T drainage surgical method, whereas the second
group included 30 patients treated with the transduodenal sphinc-
teroplasty surgical method. The clinical, laboratory, radiographic
and surgical methods, coupled with the HIDA test, were used in
the analysis.
Results. Both groups of patients were homogeneous, there is not
a statistically significant difference in laboratory results and di-
agnostic procedures. Hepatobiliary scintigraphy shows the sig-
nificant intergroup difference in the radiofarmac secretion time
in favour of the subjects. The long-term results, as well as the
quality of living were significantly superior in the group of sub-
jects.
Conclusions. Transduodenal sphincteroplasy is the method of
choice in the clinical treatment of the patients with choledo-
cholitiasis, complicated dysfunction and/or Oddi’s sphinct, as well
as in the cases when the endoscopic method cannot be performed
for it has not given any results. Choledocholitiasis treatment is a
multidisciplinary process which requires a number of specialists’
expertise.
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UNUSUAL LOCALIZATION OF BILOMA AT
THE ABDOMINAL WALL AFTER
LAPAROSCOPIC CHOLECYSTECTOMY
C. Agalianos, D. Davidis, V. Kontostolis, N. Ivros,
G. Stefanidis, G. Papageorgiou, K. Nastos, I. Kyriazanos
Naval Hospital of Athens, Greece
Bilomas are localized collections of bile occurring usually post-
operatively from an injured cystic or bile duct and present a rare
complication of both open and laparoscopic cholecystec-
tomy.They are usually located at the site of the cholecystec-
tomy.We present a case of a 52-year-old man with a rare
formation of a biloma at the abdominal wall after a laparoscopic
cholecystectomy,due to bile leak from the cystic duct.
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DEFINING DUCTAL ANATOMY USING
CT-CHOLANGIOGRAPHY IN GALLBLADDER
DUPLICATION
C. Mann1, C. Briggs1, C. Neal1, A. Khanna2, A. Rajesh, D. Berry2
1. University of Leicester Leicester General Hospital
2. Leicester Teaching Hospitals Leicester General Hospital
A 55-year old woman presented with intermittent right upper quad-
rant pain radiating into the back, associated with nausea. The pa-
tient had no history of jaundice, pale stools, or dark urine.
Abdominal ultrasonography identified a gallbladder containing sev-
eral stones, with an intrahepatic cystic area also containing stones.
A MRCP confirmed the presence of two gallbladders, one intra-
hepatic, however the cystic duct could not be identifed from the in-
trahepatic gallbladder. A CT cholangiogram demonstrated the two
gallbladders, one in the gallbladder fossa with a cystic duct draining
into the common hepatic duct, the other intrahepatic, with the cys-
tic duct draining into the right hepatic duct. The patient underwent
successful operative removal of both gallbladders followed by an
uneventful post-operative recovery.
Duplication of the gallbladder is a rare congenital anatomical
anomaly. Defining ductal anatomy is important preoperatively
in planning surgery and reducing the risk of iatrogenic biliary in-
jury. ERCP is gold standard, however associated with significant
complications. Contrast-enhanced MRCP has been reportedly
used to define the ductal anatomy in a patient with gallbladder
duplication, however in this case the cystic duct from the acces-
sory gallbladder was very thin and not seen on MRCP. Spatial
resolution on multidetector-row helical CT is superior to that of
MRCP. Whilst MRCP may be able to evaluate the ductal
anatomy without the use of ionising radiation, CT-cholangiogra-
phy should be used where there are any contraindications to
MRCP, or where it is unable to adequately identify the biliary
anatomy in patients with gallbladder duplication prior to surgery.
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EXPERIENCE WITH THE INTRODUCTION
OF DAYCASE LAPAROSCOPIC
CHOLECYSTECTOMY IN A DISTRICT
GENERAL HOSPITAL
N. Henley, M. Palliyil, F. Baldwin, A. Agwunobi
Stepping Hill Hospital, Stockport, UK
Aims: Day case laparoscopic cholecystectomy (LC) has been
shown to have overnight admission rates are as low as 20%.
These can be achieved safely without excess morbidity. We have
recently introduced day case LC in our unit. We aimed to see if
we could achieve acceptable readmission rates without any ad-
verse morbidity and with high patient satisfaction.
Methods: Patients requiring elective LC who were considered
medically fit for day case surgery were included. Patients were
counselled pre-operatively. They were discharged with a stan-
dard discharge pack containing anti-emetics and opiate analgesia.
Patients were followed up by phone call at day 1 and 7 post-op-
eratively. They were then reviewed at 6 weeks
Results: Of the 25 patients in the study, there were 19 women and
6 men. 24 had biliary colic and one had a non-functioning gall-
bladder. There were no intra-operative or post-operative com-
plications. 17 (68%) patients were discharged the same day, 8
(32%) required overnight stay. 14 were followed up at day 1, 11
(79%) reported no problems, 1 had shortness of breath, 2 had
pain. 3 were subsequently readmitted but all investigations were
normal. 10 patients were followed up at 7 days and all were symp-
tom free, satisfied with their treatment and would recommend it
to others. 16 patients were seen at 6 week follow up, all were back
to full activity but 2 reported slight pain.
Discussion: In our pilot study, 15 patients (60%) successfully un-
derwent day case LC without the need for overnight stay or read-
mission. They all reported satisfaction with their treatment.
Despite our relatively high overnight stay and readmission rate,
there were no operative complications. Day case LC is a safe pro-
cedure with a high satisfaction rate among patients. The higher
than expected readmission rate in this series may be due to a lack
of experience.
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LAPAROSCOPIOC CHOLECYSTECTOMY:
EXPERIENCE OF ONE-SINGLE CLINIC
AFTER 5202 OPERATIONS
G. Velimezis, V. Patrikakos, S. Deverakis, G. Koukis, E. Perrakis
Surgical Ward Western Attica General Hospital, Athens- Greece
Aim: The aim of this study is to present our experience of
one surgical team on laparoscopic cholecystectomy (l.c.)
Methods:The records of 5202 patients who underwent la-
paroscopic cholecystectomy in our ward from 1.1. 1992 to
30.11.2008 were analyzed .
Results: In 5001 cases (96.2%) operation were completed la-
paroscopically but 201 converted into open procedure ( 3.9%).
Acute inflammation noticed in 981 cases (16.3%).We had se-
vere postoperative complications in 215 cases (4%) but in
63(1.25%) required reoperation:52 open procedure, 11 rela-
paroscopy.Main reason of reoperation were bleeding 26/63
(41.2%) and bile leaking 14/63 (22.3%).There were 9 bile
duct injuries (0.18%) treated surgically. The mean duration of
procedure reduced from 85 min (1992) to 27 min (2008) but
mean postoperative stay was 2.3 days, because we still use
subhepatic drainage. In these serie there were 3 deaths
(0.05%), one due to operation,the other two due to other
causes.
Conclusions: Laparoscopic cholecystectomy remains the golden
standard for treatment of chololithiasis.Major role plays not
o0nly the experience of the surgeon but of all the members
of the surgical team. We believe that there is plenty room to
improve new technologies on patients benefit
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SOLITARY ASYMPTOMATIC SPLENIC
METASTASIS FROM CARCINOMA OF
THE BREAST
K. Giannoulis, K. Savidou, T. Boutsiadou, C. Stavraka,
D. Kiskinis
1st Department of Surgery, Papageorgiou General Hospital, Aris-
totle University of Thessaloniki, Greece
Introduction: We report the case of a solitary, asymptomatic
splenic metastasis from carcinoma of the breast in a woman, three
years after mastectomy.
Case Report: A 59-year old woman underwent elective splenectomy
to treat a growing splenic mass. It was discovered two years previ-
ously at computerized tomography, during follow-up after mastec-
tomy for breast cancer. During this period its size increased to 12 x
15 x 9 cm, raising concerns for spontaneous rupture.
At operation, the spleen and part of the diaphragm was removed
through a left subcostal incision. Histology revealed a sizeable,
metastatic, moderately-low differentiated carcinoma, with im-
munohistochemical features characteristic of breast tissue.
Discussion: Although splenic involvement is fairly common in dis-
seminated cancer, solitary splenic metastases are rare and origi-
nate from breast, lung, ovarian, colorectal and gastric
carcinomas1. Usually asymptomatic, they may cause abdominal
discomfort and splenomegaly1,2. An increasing number of
asymptomatic splenic lesions are incidental findings during rou-
tine investigations.
As in the case presented, the treatment of choice for a suspected
solitary splenic metastasis is splenectomy2,3. Postoperative fol-
low-up is necessary to diagnose and treat recurrences.
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INTRAOPERATIVE RADIOTHERAPY WITH
LOW ENERGY PHOTONS COMBINED WITH
SURGERY AND CHEMOTHERAPY FOR THE
TREATMENT OF METASTATIC GALLBLADDER
CARCINOMA
W. Polkowski, M. Jankiewicz, J. Romanek, M. Lewicka
Department of Surgical Oncology Medical University of Lublin,
Poland
Background: Although intraoperative radiotherapy (IORT) is
commonly reported for the treatment of gall bladder tumors, the
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irradiation is usually delivered with high energy electrons (11-20
MeV) using a linear accelerator. We report the case of a patient
with a metastatic liver tumor from gall bladder carcinoma, who
has been effectively treated with aggressive surgery, IORT, and
systemic chemotherapy.
Methods: The treatment is of particular interest because the
IORT was delivered using a mobile low energy (18 keV) X-ray
generator (Intrabeam PRS 500; Carl Zeiss Surgical, Oberkochen,
Germany). The Intrabeam system has not previously been used
for this type of tumor and has mainly been used as a boost fol-
lowing breast cancer surgery. Our case report is therefore unique,
with low energy photons studied to date only in an experimental
model for liver tissue.
Results: The patient was a 55-year old woman underwent chole-
cystectomy, partial liver resection (segments 4b, 5 and 6) with re-
gional lymph node dissection for metastatic gall bladder
carcinoma (pT3,N2,M1). She received six courses of adjuvant
chemotherapy (every four weeks) with low dose cisplatin (15
mg/m2, on days 1–5), 5-fluorouracil (370 mg/m2 bolus), and leu-
covorin (25 mg/m2, on days 1–5). A recurrent liver tumor (4.5 cm
diameter) was detected 10 months after the surgery. During re-
exploration intraoperative ultrasound revealed encasement of the
hilar vascular structures, and therefore the IORT was delivered
using the Intrabeam PRS 500. The upper and central portions of
the tumor were removed in order to insert a spherical applicator
of diameter 3.5 cm. The low energy photons therapy targeting the
unresectable remnants of the tumor was then performed using a
dose prescription of 15 Gy defined at the applicator surface and
given over 16 minutes. To determine the dose profile of the low-
energy x-rays from the Intrabeam PRS 500 system for the 3.5 cm
applicator we used the X-ray dose transmission distribution files
provided by the manufacturer for the 3.5 cm applicator.
The IORT procedure and the immediate post-operative period
were uneventful and the patient was discharged 8 days after treat-
ment. No abdominal symptoms, or liver failure related to irradi-
ation have been observed. Systemic chemotherapy with docetaxel
(100 mg/m2, every three weeks, three cycles) was administered
four weeks post-operatively. Follow-up assessments were made
using CT scanning. Tumor-free progression time was 18 months
after completion of IORT. Then a recurrent tumour was detected
in the bed of the previously irradiated field of the liver. The pa-
tient was again explored to treat the tumour with radiofrequency
thermoablation. Seven cycles of chemotherapy with paclitaxel
(175 mg/m2, 3 hours infusion on day 1) and adriamycin (50
mg/m2, on day 1) was administered four weeks post-operatively.
The patient is currently alive with stable disease at 36 months
after the primary surgical procedure.
Conclusion
We believe that this multimodality approach could be promising
for the treatment of recurrent liver tumors from biliary tract car-
cinoma.
P 233
REPEATED INTRAPERITONEAL INSTILLATION
OF LEVOBUPIVACAINE FOR THE
MANAGEMENT OF PAIN AFTER
LAPAROSCOPIC CHOLECYSTECTOMY
A. Papadima1, E. Lagoudianakis2, P. Antonakis3,
H. Markogiannakis2, K. Filis3, F. Sigala3, V. Katergiannakis3,
A. Manouras2
1. Department of Anesthesiology, Hippokration Hospital, Athens,
Greece
2. Department of Endocrine Surgery, 1st Department of Propaedeu-
tic Surgery, Hippokration Hospital, Athens Medical School, Uni-
versity of Athens, Athens, Greece
3. 1st Department of Propaedeutic Surgery, Hippokration Hospital,
Athens Medical School, University of Athens, Athens, Greece
Background: Laparoscopic cholecystectomy is the treatment of
choice for cholelithiasis. However, postoperative pain may pro-
long hospital stay and lead to increased morbidity. Intraperi-
toneal administration of local anesthetic, in the context of a
multimodal approach to analgesia, may optimize analgesia and
facilitate early postoperative recovery.
Methods: In this prospective randomized placebo-controlled
study, 71 patients scheduled for elective laparoscopic cholecys-
tectomy were randomized to receive either intraperitoneal anal-
gesic (IPA group) or not (controls). In the IPA group, 10ml of
levobupivacaine 0.5% were intraperitoneally infused upon com-
pletion of laparoscopic cholecystectomy and at 8 hours postop-
eratively, whereas in the controls 10ml of N/S 0.9% were
administered in the corresponding points of time. Pain scores dif-
ferences between the two groups were the primary endpoints
while opioid consumption and adverse effects the secondary end-
points.
Results: The two groups were homogenous in respect to age,
gender, BMI, and duration of surgery. No conversion, complica-
tion or mortality was recorded. The IPA group yielded lower
VAS score at rest and at movement compared to controls at all
points of time measured. Moreover, fentanyl consumption was
significantly greater in the control group and the consumption of
meperidine and the percentage of the patients that requested res-
cue analgesia in the ward was significantly greater in the control
group. Local analgesic intraperitoneal injection for postoperative
analgesia had no significant adverse effects.
Conclusions: Intraperitoneally administered levobupivacaine sig-
nificantly reduced postoperative pain and the need for opioids
compared to placebo. This technique is simple, safe, and without
adverse effects.
P 234
LONG-TERM RESULTS AFTER ROUX-EN-Y
HEPATICOJEJUNOSTOMY WITH STOMATIZED
LIMP FOR BENIGN BILIARY STRICTURES
T. Kakavoulis, C. Avgoustou, C. Sioros, V. Schizas,
G. Boumbousis, P. Penlidis, H. Coniaris
District General Hospital of N. Ionia “Constantopoulion –Ag. Olga”
Benign biliary strictures (BBS) pose a surgical challenge as they
require further corrective procedures in 15-35% of cases.
During period 1990-2008, 42 patients (30 females, 12 males) aged
38-76 (mean: 57) years with BBS were surgically managed. Forty
strictures developed as result of common bile duct injury during
cholecystectomy. Two cases had history of penetrating abdominal
injury. All patients had undergone 1-4 (mean: 1.6) biliary opera-
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tions before referral. For the precise localization of obstruction,
percutaneous transhepatic cholangiography (PTC) in first 16
cases and PTC with MRCP in last 26 cases were performed. Ac-
cording to Bismuth classification, stenoses were: level II (23 pa-
tients), III (12), IV (4) and V (3). All patients underwent
Roux-en-Y hepaticojejunostomy with exteriorization of extended
limp of the Roux loop to skin.
No death happened. Complications occurred in 9 patients: anas-
tomotic leak with fistula closed spontaneously (5), wound infec-
tion (5), pleural effusion (2), pulmonary infection (1). The mean
postoperative hospitalization was 9.8 days (7-17). Postoperative
trans-stoma cholangiogram or introduction of endoscope via
stomatized jejunal limp was routinely performed to examine anas-
tomoses and dilate restrictures if needed. Only patients with level
IV and V stenoses required endoscopic dilatations. During mean
follow-up of 9.1 years (2-17), no recurrent stricture or intrahep-
atic stone formation needed further surgery. Limp stomas were
closed at 4 years.
Roux-en-Y hepaticojejunostomy for Bismuth II to V BBS affords
satisfactory long-term outcome. Routine stoma formation of
Roux loop secures access for radiological imagination or endo-
scopic intervention, but it is unnecessary for level II lesions.
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SURGERY FOR HEPATOBILIARY AND
PANCREATIC TRAUMA. A SINGLE
INSTITUTION EXPERIENCE
G. Zografos, D. Georgiadou, G. Vasiliades, S. Avlonitis,
A. Koliopanos, H. Margaris, H. Tsipras, G. Papastratis
3rd Department of Surgery General Hospital of Athens “ G.Genni-
matas”, Greece
BACKGROUND: Management of blunt or penetrating injuries
to the pancreas, biliary tract and the liver remains a significant
challenge. There are relatively uncommon, associated with high
morbidity and mortality, especially if diagnosis is delayed.
AIMS: To present the experience of treating such injuries in 12
years of clinical practice in a single unit.
METHODS: Between January 1997 and November 2008, 24 pa-
tients underwent surgery due to blunt or penetrating injuries to
the pancreas, biliary tract and liver.
The preoperative management, operative details, complications,
length of hospital stay, morbidity and mortality were documented
from the hospital records of 130 patients who underwent surgical
procedures due to abdominal trauma in the same period.
RESULTS: Twenty-four patients, 20 men and 4 women with
mean age 39.6 (range 17-83) operated on urgent basis as a result
of haemo-dynamic instability. Seventeen patients, 16 men and
one woman underwent immediate laparotomy as a consequence
of blunt trauma whereas 7 patients were operated for penetrating
abdominal trauma. Intra-operatively, 12 patients appeared to
have variant grade of liver rupture, handled with direct suture lig-
ation or perihepatic packing or liver resection.
One patient with common bile duct trauma underwent external
biliary drainage with T-tube, 1 patient had liver rupture and both
hepatic ducts rupture which dealt with direct suture ligation and
perihepatic packing and one patient underwent cholecystectomy.
Three patients had pancreatic trauma.
Three patients with liver trauma died during surgery and one died
after reoperation and right hepatectomy for recurrent bleeding.
Two of them were re-operated on due to bile leak and abdomi-
nal collection and one had drainage of subphrenic abscess under
CT guidance.
From the 7 patients, 4 men and 3 women, who underwent imme-
diate laparotomy as a consequence of penetrating trauma one
died intra-operatively and the rest were treated successfully with
suture ligation and/or perihepatic packing.
CONCLUSIONS: Intensive care availability, improved surgical
techniques, and new technologies have contributed to a signifi-
cant reduction in mortality rates from hepato-biliary and pan-
creatic trauma. However these injuries are associated by
significant morbidity and long hospitalization.
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GALLSTONE ILEUS - TWENTY YEARS OF
SURGICAL EXPERIENCE
M. Jovanovic, R. Zdravkovic, S. Zajic
Department of General Surgery, Health Center Krusevac, Serbia
Gallstone ileus is the rare cause (1-3%) of intestinal mechanical
obstruction with a difficult preoperative diagnostics.
We reported a retrospective study from medical histories and op-
erative protocols in which we analyzed clinical pictures, diagnos-
tic procedures, operative treatments and postoperative
complications. From 01.01.1988. to 31.12.2007, 18 patients with
gallstone ileus were treated at our department. In that period we
have 26820 operations, due to 3427 (12,78%) were done because
of intestinal obstruction, and only 18 (0,53%) because of biliary
ileus. The group included 12 (66,67%) women and 6 (33,33%)
men; average age was 70 years (between 57 and 79). Preopera-
tive diagnosis was correctly performed in 8 (44,44%) patients with
several diagnostic procedure: x-rays examination (intestinal ob-
struction, pneumobilia), US, CT, MRI. The main symptoms were:
abdominal pain, nausea, vomiting and abdominal distension. Sur-
gical treatment was performed in all patients. Obstructing stones
were located in duodenum (1 patient- Sy Bouveret), in jejunum
(3 patients), in proximal part of ileum (2 patients) and in termi-
nal part of ileum (12 patients). The smallest stone was 2x1 cm,
and the largest one was 8x4 cm. Enterolythotomy was performed
in 16 (88,89%) patients without biliary tract repairing, and re-
section of small bowel we have done in 2 (11,11%) patients.
Gallstone ileus is a surgical emergency in which the main objec-
tive is to relieve the obstruction. There were frequently in elderly
people, and we think that the biliary tract could be operated later.
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SYSTEMIC INFLAMMATORY RESPONSE DOES
NOT PREDICT SHORT- OR LONG-TERM
OUTCOME FOLLOWING RESECTION
FOR HILAR CHOLANGIOCARCINOMA
C. Mann1, C. Neal1, C. Briggs1, C. Pattenden2, G. Garcea2,
M. Metcalf2, A. Dennison2, D. Berry2
1. University of Leicester Leicester General Hospital
2. Leicester Teaching Hospitals Leicester General Hospital
Introduction – The presence of systemic inflammatory response
has been shown to predict poor long-term outcome following re-
section in patients with several different tumour pathologies. The
aim of this study was to determine the prognostic value of pre-op-
erative systemic inflammatory biomarkers in patients undergo-
ing resection of hilar cholangiocarcinoma.
Methods – Clinicopathological data were obtained from a
prospectively maintained database for patients who underwent
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resection of hilar cholangiocarcinoma between July 1995 and De-
cember 2004 at a single United Kingdom tertiary referral hepa-
tobiliary centre. Inflammatory biomarkers (total and differential
leucocyte counts, neutrophil–lymphocyte ratio, platelet count,
haemoglobin, and serum albumin) were measured from routine
preoperative blood tests. The relationship between these factors,
patient age and sex, upon occurrence of post-operative compli-
cations and long-term survival were examined using Cox regres-
sion analysis.
Results – 35 patients underwent resection for hilar cholangiocar-
cinoma over the study period. 18 were male, and the median age
was 61 years. Post-operative complications occurred in 51%.
There was no relationship between any of the pre-operative vari-
ables and complications. Overall 1-, 3- and 5- year survival rates
were 65%, 32%, and 29%. There was no relationship between
any of the pre-operative variables and overall or disease-free sur-
vival.
Conclusions – The presence of pre-operative systemic inflamma-
tory response does not predict short- or long-term outcome fol-
lowing resection of hilar cholangiocarcinoma.
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STAGING, RESECTABILITY, AND OUTCOME
IN PATIENTS WITH GALLBLADDER
CARCINOMA: INSTITUTIONAL EXPERIENCE
A. Lauretta, O. Damrah, N. Katsoulas, N. Habib, L. Jiao
Imperial College London Hammersmith Hospital, London, UK
Introduction: Carcinoma of gallbladder is the most common bil-
iary tract malignancy. It is usually detected at an advance stage
and the prognosis of patients hence remains poor, as radical sur-
gical treatment is achievable in a small number of them.
AIM: The authors analyze and assess the management and out-
come in patients with gallbladder cancer in a single tertiary re-
ferral centre.
Methods: Between 2002 and 2007, database of all patients with
gallbladder cancer treated at our institution was reviewed. De-
mographics, results of imaging studies, pathology, and survival
were retrospectively analyzed. Depths of tumor invasion (T) and
presence of lymphonode metastasis (N) have been examined as
factors influencing survival.
Results: There were 31 patients with a mean age of 63.9. The
overall survival was 17±16 months. Eighteen (58%) patients had
unresectable disease; 13 were offered a surgical treatment. A total
of eight liver resections has been performed (6 wedge resections
of gallbladder bed, one resection of segments IVa and V and 1
right hepatectomy). No post-operative mortality has been
recorded. The median survival for patients who underwent sur-
gery was significantly longer than that for not-operated patients
(P<0.003). Depth of tumor invasion (T) significantly affected sur-
vival(P<0.01). The 1- and 3-year survival rates for T1/T2, and
T3/T4 were 100%, 67% and 66% and 0% respectively. In absence
of lymphonode metastasis (N0) the 1-and 3-year survival were
100% and 47% respectively. Lymphonode metastasis was a sig-
nificant prognostic factor (P<0.003).
Conclusion: Only complete tumor resection, including hepatic re-
section, enables long-term survival for patients with gallbladder
carcinoma.
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IATROGENIC BILE DUCT INJOURIES
K. Spiridakis, G. Panagiotakis, M. Grigoraki, G. Krasonikolakis,
F. Psarakis, T. Papadakis, T. Kokkinakis, S. Kandylakis
A Surgical Department – General Hospital “ Venizelio – Pananio”
Iraklion Crete
The aim of this study is to present an analysis of 5 patients with
iatrogenic bile duct injury following open or laparoscopic chole-
cystectomy.
MATERIALS AND METHODS: During the last 20 years 4135
cholecystectomies were performed in our surgical departement.
5 patients were treated for iatrogenic bile duct injury following
cholecystectomy; 3 women and 2 men with a mean age of 60,2
years, 2 patients following open procedure and 3 patients follow-
ing laparoscopic procedure.
RESULTS: 3 patients are treated with laparoscopic cholecystec-
tomy and 2 with open procedure. The mean time from the bile
duct injury until the reconstruction surgery was two days in 4
cases and 1 case in one week. All injuries were not recognised at
the time of surgery. There was no death in the postoperative time.
The postoperative complications were: in 1 patient wound infec-
tion and in 1 patient with intraabdominal abscess/biloma. Our in-
terventions included the abscess drainage. The post operative
length of hospitalisation was 16,8 days (median 17 days). One pa-
tient required reoperation in the post operative period. In all pa-
tients the timing of operation was early.
CONCLUSION: A biliary duct iatrogenic injury during laparo-
scopic or open cholecystectomy, is a complication that is difficult
to diagnose, but it’s also difficult to treat. Treatment is regolated
by the time of presentation and the nature of bile duct injuries
and requires a careful approach with experience from the sur-
geon. Radiology and the ERCP procedure have an important role
in the diagnosis of complications and the description of the biliary
injuries.
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GALLBLADDER AGENESIS
A. Dounavis, S. Adamopoulos1, G. Dedemadi2, T. Mihailidis,
I. Sakellariou, E. Anagnostou
1. 2nd Department of Surgery Medical School, Democritus Univer-
sity of Thrace, Alexandroupolis, Greece.
2. Amalia Fleming Hospital, Athens, Greece
The last ten years three cases of gallbladder (GB) agenesis were
encountered in our unit.
The first patient is a woman 40 years old who suffered from atyp-
ical symptoms of the right hypochondrium since three months.
Several ultrasounds (US) failed to detect the GB. A final US de-
tected a small GB filled with stones. The patient was taken to the
operating theatre where during laparoscopy as well as during
open exploration that followed, the GB wasn’t found. A T-tube
was inserted.
The second is a woman of 37 with similar complaints since six
months. One of the many US showed cholelithiasis. The patient
was operated initially laparoscopically elsewhere and two weeks
later in our unit with the open method due to biliary peritonitis.
A T- tube was again inserted. The postoperative period was long
due to various mild complications.
The third patient is a male of 70. He had been hospitalized in the
ICU due to ischemic heart attack. At that time he suffered an
episode of “acute cholecystitis”. US, CT and MRCP all failed to
detect the GB. The patient was treated conservatively.
In conclusion, GB agenesis is very rare. In patients with atypical
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symptoms, when several US are negative in detecting the GB, the
surgeon must have in mind the probability of agenesis, even if a
positive US is available. The operation in such a patient might
turn to a very difficult one with a high probability of severe com-
plications.
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NEUROENDOCRINE TUMOR OF
EXTRAHEPATIC BILIARY TRACT
N. Michalopoulos1, G. Karagiannopoulou2, T. Papavramidis1,
K. Sapalidis1, S. Papavramidis1
1. 3rd Department of Surgery
2. Department of Pathology, AHEPA University Hospital, Aristotle
University of Thessaloniki, Greece
Neuroendocrine tumors (NETs) are distinct neoplasms with
characteristic histological, clinical and biological properties. Car-
cinoma of extrahepatic billiary tract accounts for less than 2% of
all cancers. Extrahepatic bile ducts remain one of the rarest pri-
mary sites of NETs, accounting from 0.2% to 2% of all such tu-
mors.
A 52-year old Greek male referred to our department for ob-
structive jaundice caused by a tumor of biliary tract. The symp-
toms started two months before the administration with general
fatigue, low pain in the upper right quantrant and jaundice. Phys-
ical examination revealed a well-noutrished man with stable vital
signs and mild tenderness to palpation to the right hypohon-
drium. The ultrasonography, CT and the MRI-MRCP revealed
cholelithiasis, dilatation of the intrahepatic bile duct until the
junction of hepatics bile duct and a mass in the common hepatic
duct, probably a cholangiocarcinoma. The patient scheduled for
operation and laparotmy performed through a right subcostal in-
cision. The extrahepatic bile duct was transected above the con-
fluence of the hepatic ducts and the distal common bile duct. A
Roux-en-Y hepaticojejunostomy was performed for reconstruc-
tion. Macroscopically the specimen consisted of a mass measur-
ing 2cm x 1.5cm. Immunostains showed the tumor cells to be
positive for NSE and Synaptophysin.
NETs include the entire spectrum ranging from well-differenti-
ated tumor (classical carcinoid) to a malignant neoplasm. The
only curable treatment for neuroendocrine tumors of biliary tract
is the aggressive surgical resection.
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GALL BLADDER CANCER - THE POSSIBILITIES
OF SURGICAL TREATMENT
V. Treska, T. Skalicky, A. Sutnar, V. Liska
Dept. of Surgery University Hospital, Czech
Background: The effect of radical resection in gallbladder can-
cer is still area of debate.
Aim of study: To determine the criteria of surgery in primary and
incidental gallbladder cancer.
Method: Eighty-four patients with gallbladder cancer were eval-
uated between 1999 and 2008. Sixty patients (72,4%) were symp-
tomatic. Explorative laparotomy was performed in 40 (66,7%),
palliative procedure in 5 (8,3%) patients in stage pT3-4, N1, M 0-
1. Cholecystectomy only or completed with wedge resection of
the gallbladder bed and lymfadenectomy as radical procedure was
performed only in 7 (1,7%) patients in pT1-2, N 0-1,M 0. Twenty
four (28,6%) patients had incidental gall bladder carcinoma. Rad-
ical cholecystectomy was performed in 4 (16,7%) – pT 1a, N0,M0,
palliative cholecystectomy in 3 patients (12,5%) – pT3,N1,M0.
Radical reoperation with wedge gall bladder bed or liver resec-
tion, lymfadenectomy was performed in 15 (62,5%) patients in
stage pT1b-2, N0-1,M0.
Results: Patients survival after explorative laparotomy and pal-
liative procedures was no longer than 7 months. Four from seven
patients died after radical operation 12-18 months after opera-
tion. Six from 15 radically re-operated patients are alive in in-
terval 4 months and 8 years. Nine patients died in interval 9
months and 4 years after re-operation.
Conclusion: Radical surgical procedure is the treatment of choice
for patients with gall bladder carcinoma especially in stage pT1-
2, N0,M0.
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LAPAROSCOPIC HEPATICOJEJUNOSTOMY.
THE OPERATIVE TECHNIQUE
G. Ayiomamitis, B. Ammori
Department of Surgery, Manchester Royal Infirmary, Manchester, UK
The techniques for laparoscopic biliary bypass are now well es-
tablished, and this MIS approach has been shown to be safe and
associated with significant reductions in postoperative pain, hos-
pital stay and recuperation period, compared with open surgery.
Laparoscopic cholecystojejunostomy is the most commonly ap-
plied method for biliary bypass, and benefits from ease of tech-
nique and shorter operative time. Percutaneous transhepatic
biliary stent insertion may be reserved to the small proportion of
patients in whom the cholecystojejunostomy fails during follow
up. Whilst a hepaticojejunostomy is significantly more likely to
remain patent compared with a cholecystojejunostomy, it is tech-
nically more demanding and should be reserved to patients with
occluded cystic duct and perhaps in patients in who the cystic duct
insertion is within less than 1 cm of the upper limit of the biliary
stricture. Surgical, rather than endoscopic, relief of the biliary ob-
struction however is best reserved to patients with life expectancy
exceeding 6 months (with non-metastatic disease) and when at-
tempts at endoscopic biliary stenting have failed or were aban-
doned due to duodenal obstruction. The laparoscopic approach
to biliary bypass may also be applied to the management of be-
nign duodenal and distal biliary strictures that complicate chronic
pancreatitis, and persistent duodenal stenosis that occasionally
complicates acute necrotising pancreatitis.
We demonstrate a video with our laparoscopic approach to bil-
iary reconstruction with a completely hansutured technique which
offers a definite and long-term treatment option.
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OPEN CHOLECYSTECTOMY: IS THERE ANY
PLACE AT THE PRESENT TIME?
G. Dedemadi, G. Sgourakis, A. Dounavis, P. Lazaridis,
S. Theodorou, E. Anagnostou
Department of Surgery “A. Fleming” Hospital, Melissia, Greece
BACKGROUND: 10% to 30% of cholecystectomies are still per-
formed in the open fashion. This study aims to examine current
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indications for open cholecystectomy and conversion from la-
paroscopy, and major complications.
METHODS: The records of 708 consecutive patients who un-
derwent elective or emergency cholecystectomy for benign gall-
bladder disease from November 2003 to November 2008 were
studied retrospectively. Surgical procedures were performed by
five surgical specialists and four residents under supervision. In
order to find the model of predictors for complications we ap-
plied General Discriminant Analysis.
RESULTS: The mean age of the patients was 60.11±15.57 years,
289 were men and 416 women. 527 patients underwent laparo-
scopic cholecystectomy, 130 primary and 48 converted open
cholecystectomies. Conversion rate decreased during the period
2003-2008 from 8.5 to 3.25%. Open cholecystectomy was mainly
employed for gangrenous cholecystitis (34%), previous upper ab-
dominal surgery (29%) and treatment of concomitant diseases
(12%). 14 major complications occurred in the laparoscopic
group (bile leak from cystic duct, Luschka or liver; postoperative
bleeding from gallbladder bed or cystic artery; small or large
bowel perforation; bile duct injury), with 4 procedures requiring
conversion. Only 1 major complication was detected in the open
group (bleeding from liver bed). The model of predictors for
complications in multivariate analysis included surgeon, diagno-
sis and procedure (p=0.001). Complications significantly pre-
dicted by this model are: bleeding from cystic artery (p=0.002),
small and large bowel perforation (p=0.001) and bile duct injury
(p=0.001).
CONCLUSIONS: Primary open cholecystectomy remains an ad-
equate procedure in the treatment of gallbladder disease with
limited indications concerning complicated and difficult cases.
Supervised residents performed surgical procedures equally well
as specialists, achieving a very small complication rate.
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INTRAHEPATIC CHOLANGIOCARCINOMA
ADHERENT TO THE BILIARY CONFLUENCE:
SURGICAL RESECTION WITH BILIARY
RECONSTRUCTION
M. Filauro, D. Dedola, S. Cappato, F. Belli, U. Catrambone
General and Hepatobiliopancreatic Surgery Unit Galliera Hospital,
Genoa. Italy
Intrahepatic cholangiocarcinoma (ICC) is well known to have a very
poor prognosis, expecially in case of large size. Aggressive surgical
strategies in the treatment of ICC, including major hepatectomy,
have been reported to offer the only chance for significant survival.
We describe a case of a 71-years old female patient affected by
large size (12 cm) intrahepatic cholangiocarcinoma developing in
segment 4b-5-8d and 6, with compression and no infiltration of
biliary confluence at preoperative imaging work up.
Computerized tomography examination showed a huge mass in
the right liver extended to the fifth and sixth segments. Preoper-
ative needle biopsy confermed the diagnosis of ICC.
The video shows the surgical treatment , consisting in liver re-
section of segment 4b,5,8d and 6, using ultrasound as a guide
for anatomical dissection.
The biliary confluence was saved and recostructed on Rodney-
Smith intraluminal stent, as a “safe”margin with the mass was
detected intraoperatively.
Post operative course was characterized by biliary fistula from he-
patic stump, treated conservatively.
Histology confermed the diagnosis of ICC and the R0 resection
( N negative).
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DOPPLER US COULD PREDICT VARICES
PROGRESSION AND REBLEEDING AFTER
PORTAL HYPERTENSION SURGERY: LESSONS
FROM 146 EGDS AND 10 YEARS OF
FOLLOW-UP.
F. Ferreira, M. Ribeiro, M. Santos, J. Assef, L. Szutan
Liver Group Santa Casa Medical School and Hospital
BACKGROUND: Surgical treatment in variceal hemorrhagic
complications for patients with schistosomal portal hypertension
in our group comprises esophagogastric devascularization pro-
cedure with splenectomy (EGDS). There are two different kinds
of postoperative follow up: prophylactic or on demand endo-
scopic program of varices eradication. This program implies risks
and costs and only proves necessary in 6 to 29% of cases. The aim
of this study was to assess portal vein Doppler US data in these
patients, and to establish a relationship with the progression of
varices number and size, appearance of red spots and rebleeding
in the postoperative period after EGDS.
PATIENTS AND METHODS: Data on portal vein Doppler US
from 146 patients, with schistosomal portal hypertension and pre-
vious history of upper digestive bleeding due to esophagogastric
varices rupture was analyzed. All subjects underwent EGDS and
were analyzed before and after the procedure and compared
postoperatively at 4 time-points: 1 year, 2 years, until 5 years and
up to 10 years. The following portal hemodynamic parameters
were analyzed: diameter and mean blood flow velocity. Variceal
size and number, presence of red spots and rebleeding all were
determined by endoscopic examination. Patients were divided
into two groups, at the 4 time-points, according to esophagogas-
tric varices progression.
RESULTS: Patients with variceal progression had significantly
higher values of portal blood flow velocity. At time-points I, II, III
and IV, the measured flow velocity from first postoperative year
was 17.64 ± 4.84 vs. 13.81 ± 5.61. p=0.025; 16.74 ± 4.80 vs. 13.75
± 5.80. p=0.039; 16.01 ± 5.00 vs. 13.23 ± 5.86. p=0.036 and
16.01 ± 5.00 vs. 13.23 ± 5.86. p=0.036, respectively.
CONCLUSION: Patients with schistosomal portal hypertension
submitted to EGDS who had portal blood flow velocity above
15.5 cm/s at the 1st postoperative year, presented progression of
esophagogastric varices, with greater chance of rebleeding, and
should therefore be included in the endoscopic program for
varices eradication.
KEY-WORDS: non cirrhotic portal hypertension; esophagogas-
tric devascularization with splenectomy; Doppler ultrasound; por-
tal vein blood flow velocity; esophagogastric varices; rebleeding.
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LIVER RESECTION FOR PRIMARY
INTRAHEPATIC STONES
G. Clemente, A. De Rose, M. Giordano, M. Vellone,
F. Ardito, F. Giuliante, I. Giovannini, G. Nuzzo
Hepatobiliary Unit Catholic University, Rome, Italy
Background. Primary intrahepatic lithiasis occurs frequently in
East Asia, but is rare in Western Countries (1). Liver resection
may be regarded today as an effective method of treatment when
a single liver lobe or segment is involved.
Aim. To evaluate early and late results and to assess indications,
methods and long-term outcomes in a series of patients submit-
ted to liver resection for primary intrahepatic stones.
Methods. Forty patients (25 males and 15 females, mean age 51
years) were treated for primary intrahepatic stones in our unit
between January 1992 and December 2007. Ultrasonography and
magnetic-resonance cholangiography were the preferred preop-
erative investigations. Thirty-eight patients underwent liver re-
section: left hepatectomy (20 patients) and left lateral
segmentectomy (12 patients) were the most frequently performed
procedures. A cholangiocarcinoma was found in 4 patients (10%)
and two of these, found unresectable at surgery, received only an
explorative laparotomy.
Results. There was no postoperative mortality. Morbidity was
22.5 % with prevalence of infectious complications related to bile
leakage. Long-term results, assessed in 30 patients with a follow-
up greater than 12 months, were good or fair in 93.4 % of cases.
Summary/Conclusions. Intrahepatic lithiasis includes different
types of disease, and the choice of the treatment should be based
on the accurate assessment of the intrahepatic biliary tree, of bile
duct strictures and of the location of stones. Primary intrahepatic
stones more commonly involve one single liver segment or lobe:
partial hepatectomy is a safe and effective procedure, allowing
definitive treatment of the disease and prevention of cancer.
References: 1) G. Nuzzo, G. Clemente, I. Giovannini et al: Liver
resection for primary intrahepatic stones: a single-center experi-
ence. Arch Surg. 2008; 143(6):570-4.
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VESEAL CATHETER: A NEW
RADIOFREQUENCY ASSISTED HAEMOSTATIC
DEVICE
D. Zacharoulis1, G. Tzovaras1, E. Sioka1, J. Balogiannis1,
D. Symeonidis1, A. Lahanas1, E. Zahari1, G. Koukoulis1,
K. Hatzitheofilou1, N. Habib2
1. Department of Surgery University of Thessaly, Mezourlo, Greece
4. Hammersmith Hospital of London, UK
Background: Interventional Radiology plays a key role in the
management of active bleeding. Current tools have limitations
and complications
Aim: The Habib™ Veseal Catheter is a 5French catheter used to
coagulate vessels using radiofrequency energy(RF).The efficiency
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and safety of this new device is tested.
Materials and Methods: Five female white pigs were used. The
femoral artery was exposed and an angiographic catheter under
radiological control was advanced until the hepatic, splenic or the
renal artery. Using 5French catheter type Cobra the aforemen-
tioned arteries were subsequently catheterized. Over a
0,14French guide wire the VeSeal was advanced.
Once the VeSeal catheter was in position the electrodes was en-
ergized using the Rita 1500 radiofrequency generator. Parame-
ters such as Watts/Time/Impedance were recorded.
After each delivery of RF energy radio-opaque material was care-
fully injected in the vessel to observe the degree of tissue coagu-
lation and subsequently the vessel lumen occlusion.
When the vessel was completely coagulated the VeSeal was with-
drawn. The pigs were resuscitated and were survived for seven
days.
Results: For the hepatic artery the median watts was 7 range (4-
7) for median time 3 min (2-7). For the splenic artery the median
watts was 4 (3-5) for median time 3 min (1-4).For the renal artery
the median watts was 6 (4-10) for median time 6min ( 4-10) All
the vessels were occluded.
Conclusion: The Habib™ Veseal Catheter is a safe tool for artery
conclusion. There were no complications and the procedure was
well tolerated.
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INTERORGAN SHORT CHAIN FATTY ACID
EXCHANGE IN PATIENTS WITH A CIRRHOTIC
LIVER; IMPLICATIONS FOR PREBIOTICS
TREATMENT
J. Bloemen, S. Olde Damink, K. Venema, W. Buurman,
R. Jalan, C. Dejong
Department of surgery, Nutrition and Toxicology Research Institute
Maastricht, Maastricht, The Netherlands
Rationale: Short chain fatty acids (SCFAs: acetate, propionate
and butyrate) are produced in the colon by bacterial fermenta-
tion and play a role in maintaining integrity of the colonic ep-
ithelium. Part of the SCFAs are released in the portal vein and
are cleared by the liver. Aim of this study was to determine
whether the dysfunctional liver is able to metabolize SCFA. This
information seems relevant for treatment with prebiotics, because
high systemic SCFA concentrations are toxic and if a dysfunc-
tional liver wouldnot scavenge the SCFA, this might adversely af-
fect the patient.
Methods: 12 patients with liver cirrhosis and an intrahepatic por-
tosystemic shunt (TIPSS) were studied. Patients did not use lac-
tulose or antibiotics. Blood was sampled from the femoral artery,
portal and hepatic vein. Organ plasma flow was measured. SCFA
plasma concentrations were measured using LC-MS.
Results: Arterial concentrations were 118±12, 8±1 and 10±1µM
for acetate, propionate and butyrate, respectively. The gut released
542±235, 80±22 and 102±36 nmol/kg bw/min of acetate, propi-
onate and butyrate. Assuming 70% portosystemic shunting, the liver
takes up 53±10 and 87±22 nmol/kg bw/min for propionate and bu-
tyrate. Hepatic uptake of acetate is non-significant (202±169). As
a consequence of shunting, part of total acetate escapes from the
splanchnic bed, which equaled 581± 221 nmol/kg bw/min.
Conclusion: The gut releases SCFA in the portal vein and the liver
is still able to take up propionate and butyrate in patients with a cir-
rhotic liver. Due to portosystemic shunting, splanchnic acetate re-
lease is higher than in patients with normal liver function.
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MELD-BASED ORGAN ALLOCATION
INCREASES TOTAL COSTS OF LIVER
TRANSPLANTATION: A SINGLE-CENTRE
EXPERIENCE
P. Schemmer, N. Hillebrand, T. Schneider, H. Bruns, U. Hinz,
J. Schmidt, M. Büchler
Department of Surgery Ruprecht-Karls-University/Dept. of Surgery,
Germany
Introduction: In December 2006, MELD-based organ allocation
replaced the CTP/waiting-time based system. The impact on costs
of transplantation has not been evaluated yet.
Methods: Total costs for liver transplantations (LTx) before and
after implementation of MELD-based organ allocation were
identified (256 of total 283 cases, 01.01.05 - 08.12.07). 49 cases
were excluded (re-transplantations, HU-listed recipients and pa-
tients with 30-day mortality). For the remaining 207 cases, total
costs were compared to their corresponding MELD-Scores. Fur-
thermore, 84 cases from the pre-MELD-era were compared to
123 cases of MELD-based organ allocation.
Results: Total costs for LTx correlate (r²=0.28) to the recipients’
labMELD-Scores. No significant correlation could be identified
for Child-Pugh Classification and total costs. MELD-Scores can
be stratified in 4 groups (I: 6-10, II: 11-18, III: 19-24, IV: >24)
representing a difference of 15.672 ± 2.233 between each group
(p<0.05). Recipient labMELD-Scores were significantly higher
in the MELD-based allocation system by 9 points and correlated
to a median increase of costs by 11.650 / case (p<0.05). The in-
dication for liver transplantation had no influence on total costs.
For LTx of HU-listed patients, significantly more resources were
needed.
Conclusion: MELD-based organ allocation has led to increased
total costs of LTx. In accordance with other studies, sicker pa-
tients had higher health-care costs.
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ARE THE SHORT AND LONG-TERM
OUTCOMES OF LAPAROSCOPIC
HEPATECTOMY COMPARABLE TO THOSE
OF OPEN HEPATECTOMY FOR COLORECTAL
METASTASES?
F. Welsh1, P. Tekkis2, T. John1, M. Rees1
1. Basingstoke and North Hampshire NHS Foundation Trust North
Hampshire Hospital, Basingstoke, UK
2. The Royal Marsden Hospital, London, UK
Background: There is no prospective randomized data comparing
laparoscopic to open hepatectomy.
Aims: To compare short and long-term outcomes in patients un-
dergoing hepatectomy for colorectal metastases (CRM), who
were suitable for either laparoscopic or open resection.
Methods: Data were prospectively collected from consecutive pa-
tients undergoing hepatectomy for CRM (1987-2007). Patients
suitable for laparoscopic resection (Group 1) were compared with
patients whose tumour characteristics favored an open approach
(Group 2). Patients with distant extra-hepatic disease or who
were having a repeat hepatectomy were excluded.
Results: 1152 hepatectomies were performed for CRM during
the study period, with 266 (23.1%) suitable for a laparoscopic ap-
proach (Group 1). Groups 1 and 2 were matched for age, gender
and Duke’s stage. The median (IQR) number of metastases was
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greater in Group 2 [2(1-20) vs 1(1-10), p<0.001], as was the mean
(SD) tumour size [5.3(3.6)cm vs 3.3(1.2)cm, p<0.001]. The me-
dian (IQR) operation time was faster in Group 1 [210(70)min-
utes vs 240(90)minutes, p<0.001], with less blood loss
[270(265)mls vs 355(320)mls, p<0.001]. There was no difference
in median in-hospital stay, morbidity [24.8% in Group 1 vs 25.6%
in Group 2], 30-day [1.1% vs 1.4%, p=0.53, or 90-day mortality
[1.5% vs 1.7%, p=0.54]. Patients in Group 2 had a higher R1 re-
section rate [14.9%] compared to Group 1 [4.5%, p<0.001] and
lower 5-year survival [37.8% vs 44.2%, p=0.005].
Conclusions: Current criteria for laparoscopic hepatectomy se-
lects patients who have more straight-forward surgery, less in-
volved resection margins and better long-term survival, compared
to patients unsuited to a laparoscopic approach.
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ACCURACY OF PREOPERATIVE AUTOMATIC
MEASUREMENT OF THE LIVER VOLUME BY
CT-SCAN WITH A 3D SURGICAL
PLANIFICATION SOFTWARE
F. Vandenbroucke-Menu1, M. Plasse1, A. Roy1, M. Dagenais1,
R. Letourneau1, L. Soler2, J. Marescaux2, R. Lapointe1
1. Universite de Montreal Hopital Saint Luc - CHUM
2. Universite Louis Pasteur IRCAD
Introduction: The evaluation of the volume of remnant liver is
very important in the case of major hepatectomy. We used a soft-
ware developed for the 3D visualisation and analysis of the liver,
vessels and tumors from a contrast CT-Scan. Therefore, preop-
erative hepatectomy simulation can be done and different vol-
umes of the liver are automatically calculated before surgery.
The aim of this study were first, to compare different hepatic vol-
umes between automatic (AC) and manual (MC) calculation
techniques, and secondly operative or postoperative data.
Material and methods: This prospective study included 34 pa-
tients (16 females and 18 men; mean age : 55 years +/- 13). Pre-
operative total, resected, remnant liver and tumor volumes were
calculated by both techniques and compared. The volume of re-
sected liver was obtained by its weight at surgery. A Ct scan was
performed on the 2nd postoperative day in order to evaluate the
real remnant liver volume. Wilcoxon’s test and Pearson’s corre-
lation were used for statistical analysis.
Results: Resected AC liver volume was significantly correlated
to the resected MC volume (943 cm3 vs 1010 cm3, difference of
4%, r=0.971) and to the weight of the liver specimen (943 cm3 vs
748 cm3, r=0.734). Resected AC and MC volumes were signifi-
cantly more important than the weight of the liver specimen (748
cm3) (p<0.0001).
The mean of percentage of remnant AC and MC liver volume
was not significantly different (54.6% vs 52.8%, p=0.5, r=0.926).
The difference between preoperative AC and MC tumor volumes
(194 cm3 vs 189 cm3) was 2.6% (p=0.395). These volumes were
not significantly different from the pathological tumor volume
(217 cm3) (p=0.381).
Pre and postoperative AC remnant volume were not significantly
different (971 cm3 vs 1047 cm3; p=0.182; r=0.854), but the post-
operative AC width of the remnant liver was 2.6 cm more than the
preoperative AC width (p=0.005).
Conclusions: The automatic calculation of liver volume by this
software is accurate and reliable with a good correlation to the
manual technique of liver volume measurement. It allows an easy
and fast calculation of different liver volumes and a 3D visualisa-
tion of the foreseen liver resection. This software appears to be
very useful for a better planning of hepatic surgery. The full po-
tential of this tool is still under assessment.
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CASE CONTROL COMPARISON OF
MICROWAVE ABLATION USING A 915 MHZ
SYSTEM OR A 2.45 GHZ SYSTEM
S. Smeaton, E. Kubek, J. Martinie, S. Padma, M. Meadows,
D. Iannitti
Carolinas Medical Center, Charlotte, U.S.A.
We present preliminary results from an upcoming prospective,
non-randomized comparison of patients with liver tumors treated
with either a 915 MHz or a 2.45 GHz microwave ablation system.
Results from this institution using a commercially available 915
MHz microwave ablation system (ValleyLab, Boulder, CO) for
malignant tumors in the liver have been previously published,
using both open or transcutatious antennae. Treatment with a
2.45 GHz system (Microsulis, Denmead, UK) has primarily been
available in Europe and, until recently, a transcutaneous antenna
was not available. With the arrival of this newer 2.45GHz system
in the United States, we are now able to study the unique char-
acteristics of both systems in the research and clinical settings.
This study aims to determine differences in the length of time and
number of ablations needed to achieve complete tumor thermo-
coagulation in patients matched for lesion size and type. Efficacy
of ablation and size of ablation site were based on follow-up im-
aging. Any complications were also documented.
Methods. Patients with either a primary or metastatic liver tumor
were treated with either a 915 MHz MWA system with three 13
gauge 22cm surgical antennae in a clustered array or a 2.45GHz
MWA system with a single 5.6mm diameter surgical antennae.
Data for the number of treatments, time of each treatment, and
power measured in watts were collected for each lesion. Follow
up CT with contrast was performed at 30 days from date of op-
eration and presence or absence of residual tumor documented.
Any complications were also documented.
Results. 20 patients with 38 liver lesions received ablation of each le-
sion with either 915 MHz or 2.45 GHz. The power used for each
system was the same for all lesions, 45W for the 915MHz system
and 100W for the 2.45 GHz system. For the 915 MHZ system the
average primary liver lesion was 3.1cm (range 1.6 to 7) and the av-
erage treatment time was 9.5min (range 5-10). For non primary le-
sions the average size was 2.1cm (range 0.5-5) and treatment time
9.1min (range 5-10). For the 2.45 GHz system the average primary
liver lesion was 2.7cm (range 0.8 to 6.5) and the average treatment
time was 4.25min (range 3-6). For non primary lesions the average
size was 2.2cm (range 0.5-6) and treatment time 4.5 min (range 2-
8). For the 915 MHz system treatment time averaged 3.1min/cm
primary tumor and 4.3 min/cm non primary tumor. For the 2.45
GHz system treatment time averaged 1.6min/cm primary tumor and
2.1 min/cm non primary tumor. 15 patients (5/11 treated with 2.45
GHz) have had follow up CT and none of those had evidence of
residual disease. Complications were a liver abscess in a patient
treated with 2.45 GHz and a biloma in the 915 MHz.
Conclusions: As this is a preliminary report a large enough sam-
ple size to determine significance has not been obtained. It ap-
pears, however, that the data is leaning towards significance in
demonstrating the treatment time and number of applications re-
quired to treat a liver tumor of a given size and type are less for
the 2.45 GHz system than the 915 MHz system. Efficacy and com-
plication rates appear to be similar. This study will continue to
evaluate the 2.45 GHz system, including the new transcutaneous
1.8mm diameter antenna.
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HEPATIC RESECTION OF INITIALLY
UNRESECTABLE LIVER METASTASES FROM
COLORECTAL CANCER AFTER HEPATIC
ARTERIAL INFUSION OF OXALIPLATIN AND
SYSTEMIC 5-FLUOROURACIL AND
LEUCOVORIN
D. Goéré, I. Deshais, T. de Baere, D. Malka, S. Bonnet,
F. Dumont, V. Boige, C. Dromain, M. Ducreux, D. Elias
Department of Surgical Oncology- Institut Gustave Roussy – Ville-
juif France
Background: About 80% of patients (pts) presenting colorectal
liver metastases (CRLM) are initially unresectable. A subgroup
will become eligible for surgery after chemotherapy administra-
tion. Efficacy of hepatic arterial infusion (HAI) of oxaliplatin with
systemic 5-Fluorouracil and leucovorin (LV5FU2) in with unre-
sectable CRLM was previously demonstrated. This study was per-
formed to evaluate the resection rate of pts with initially
unresectable CRLM after oxaliplatin HAI and systemic LV5FU2.
Methods: Patients treated in our hospital with oxaliplatin HAI
and systemic LV5FU2 for unresectable CRLM from May 1999
to May 2007 were analyzed. Inclusion criteria were : unresectable
CRLM, no extensive extrahepatic disease, HAI performed in our
hospital, minimal follow up of 24 months. Eighty-seven pts were
selected from a prospective database
Results: Hepatic arterial infusion was delivered after previous
systemic chemotherapy failure in 69 pts (80%). Main criterion
for unresectability was massive liver involvement (80%). CRLM
were synchronous and bilateral in respectively 85% and 90% of
pts. The median number of oxaliplatin HAI cycles was 8 (0-25).
Thirty-one pts experienced technical problems with the arterial
catheter, which was responsible for HAI withdrawal in seven.
A total of 23 pts (26.4%) were operated, leading to resection
and/or radiofrequency ablation of CRLM in 21 pts. No post-op-
erative mortality was observed and the morbidity rate was 30%.
The 3-year overall survival for patients operated was 72.5% ver-
sus 12% for non operated pts (p<0.0001). After a median follow-
up of 75 months [24-118], intra-hepatic recurrence occurred in
10 pts.
Conclusions: Hepatic artery infusion of oxaliplatin and systemic
LV5FU2 increase the resectability rate in pts with advance
CRLM even after previous systemic chemotherapy failure. Fu-
ture studies combining oxaliplatin HAI and recent IV chemother-
apy are needing to achieve an increase disease-free survival.
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INCIDENCE AND RISKS FACTOR OF
PULMONARY EMBOLISM AFTER LIVER
SURGERY
E. Melloul, F. Dondero, S. Dokmak, J. Belghiti
Department of Hepato-Bilio-Pancreatic Surgery and Transplanta-
tionHospital Beaujon, Clichy, France
Background: The risk of pulmonary embolism (PE), which is es-
timated between 1% and 5% after abdominal surgery, is un-
known after liver surgery.
Patients & Method: We retrospectively analyzed all patients with
liver surgery who developed a postoperative symptomatic PE con-
firmed at angiographic spiral CT (PE group). A prospective data-
base of 660 hepatectomies performed during the same period,
without postoperative PE was used as a control group. The two
groups were similar in term of age, ASA score and co-morbidities.
Results: Among 1188 hepatectomies, 29 patients (2.4%) with a
mean age of 55 years (range 24-77), including 20 (69%) males
developed a postoperative symptomatic PE. These 29 patients
underwent a liver resection for malignant tumours in 18 (62%)
cases. Symptoms of PE appeared in a mean time of 5 days (range
1 to 10) and included tachyarrhythmia (25%), dyspnoea (25%),
hypoxemia and chest pain. In the PE group, the incidence of deep
venous thrombosis (DVT) was 27%, and 16/16 postoperative
thrombophilia tests collected were negative. Comparisons be-
tween patients with PE and control group showed that 72% of
hepatectomies were major in the PE group vs 60% in the control
group (p=0.18). Statistical analysis of perioperative variables be-
tween the PE and control groups revealed that BMI (27 vs 25
kg/m2, p=0.012), non-oncological disease (40% vs 32%,
p=0.006), and F0-F2 liver parenchyma (90% vs 76%, p=0.002)
were strongly associated with PE.
Conclusions: The risk of pulmonary embolism after liver surgery
is increased in patients with BMI>25 kg/m2 who underwent an
hepatectomy on a normal parenchyma liver.
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OUTCOME OF SYNCHRONOUS
HEPATECTOMY AND COLECTOMY FOR
COLORECTAL CANCER CO-PRESENTING
WITH HEPATIC METASTASES
N. Henley, F. Reid, P. Petras, J. Hill, A. Siriwardena,
A. Watson, A. Sheen
Regional Hepatobiliary Surgery Unit and Colorectal Surgery Unit,
Manchester Royal Infirmary, Manchester, UK
Introduction: Conventional practice for patients with synchro-
nous colorectal hepatic metastases is colorectal resection fol-
lowed by hepatectomy (with or without adjuvant chemotherapy).
Synchronous major hepatectomy has the attraction of reducing
the number of surgical interventions and potentially of present-
ing a patient without macroscopic residual disease for chemother-
apy.
Methods: 12 (10 male: 2 female) patients presenting April 2006
- November 2008 with surgically operable colorectal tumours with
synchronous liver metastases constitute the population. Col-
orectal tumours were distributed as follows: 5 right sided primary
tumours, 7 sigmoid/ rectal tumours. 8 patients underwent major
liver resection ( 4 segments), 4 patients had metastatectomy/ seg-
mentectomy only.
Results: Mean operating time was 462 (270-813) minutes in the
major group and 439 (270-646) minutes in the minor group. There
were no in-hospital deaths. In the major group, 3 patients experi-
enced complications (one bile leak, one collection, one post-oper-
ative intestinal obstruction). Median length of stay was 20 days. At
follow up (mean 21 months: range 1-70) all patients were alive.
Conclusions: This preliminary experience indicates that with con-
temporary colorectal surgery and liver resection techniques, syn-
chronous major resection appears to be a feasible option.
Further experience and more prolonged survival data are re-
quired before wider acceptance.
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RADIOFREQUENCY-ASSISTED LIVER
RESECTION: INITIAL EXPERIENCE ON 110
CONSECUTIVE PATIENTS FROM A REGIONAL
ANTICANCER INSTITUTE
D. Korkolis1, C. Aggeli1, G. Plataniotis1, E. Gontikakis1,
D. Xinopoulos2, P. Vassilopoulos1
1. First Department of Surgery Hellenic Anticancer Institute, “Saint
Savvas”Hospital, Athens, Greece
2. Department of Gastroenterology Hellenic Anticancer Institute,
“Saint Savvas”Hospital, Athens, Greece
Background: Parenchymal liver transection using radiofrequency
energy represents an evolving surgical field.
Aim: Retrospective evaluation of the safety and feasibility of the
method in curative resection of primary and metastatic liver tumors.
Materials and Methods: During the last 48 months, 110 consec-
utive patients suffering from primary and metastatic liver tumors
were surgically treated for cure. These were 57 men and 53
women with a mean age of 67 years (range 30-81). Primary liver
tumors were treated in 33 and secondary ones in 77 patients, in-
cluding metastatic colorectal cancer in 46 (60%) and non-col-
orectal, non-endocrine metastases in 28 (36%) patients. Formal
right hepatectomy was performed in 21 patients, extended right
in 3, formal left in 20, extended left in 3, central hepatectomy in
6, caudate lobectomy in 3, bisegmentectomy in 17, and anatomi-
cal segmentectomy in 37 patients. In 23 patients simultaneous in-
traoperative RF tumor ablation was performed. In all cases,
intraoperative ultrasound was used. Whenever necessary, major
portal branches and hepatic veins where secured before resection
using endoscopic stapling devices. Hepatic parenchymal transec-
tion was always performed by using the Cooltip RF Single Nee-
dle System (Radionics Inc., Burlington, MA, USA).
Results: Median duration of major hepatectomies was 150±100
min whereas median intraoperative blood loss was 175±125 ml.
Disease-free margins of resection was achieved in 93% of cases.
ICU support lasted less than 24 hours and median hospital stay
was 8 days (range 4-35). Postoperative mortality was 2.7% and
was mainly attributed to non-reversible hepatic failure. Postop-
erative complications were seen in 30% of patients and included
hemorrhage in 1, transient liver insufficiency in 5, biliary fistula in
9, intraabdominal fluid collections in 12, pleural effusion in 3, and
extrahepatic biliary injury in 2 patients.
Conclusions: Radiofrequency-assisted liver resection is an effec-
tive approach in the surgical management of liver malignancies.
It may decrease operative time, minimize blood loss and achieve
high rates of disease-free margins of hepatic resection, with an
adequate safety profile.
P 258
IMPROVING LONG-TERM OUTCOME
EXPANDS THE ROLE OF LIVER RESECTION
IN MANAGAMENT OF COLORECTAL
METASTASES
C. Pulitan 1, L. Aldrighetti2, S. Wigmore1, R. Parks1, G. Ferla2,
J. Garden1
1. Clinical and Surgical Sciences (Surgery), University of Edinburgh,
Royal Infirmary Edinburgh, UK
2. Liver Unit, Department of Surgery, Scientific Institute San Raf-
faele, Vita-Salute San Raffaele University, Milan, Italy IRCCS San
Raffaele Hospital – Milan – Italy
Background: As hepatic resections have become safer and indi-
cations have broadened, there are increasing expectations re-
garding assessment of trends in long-term patient outcomes. Al-
though a variety of retrospective studies have demonstrated
improvements in short-term outcomes in recent years, changes
in long-term survival over time are less well-established. AIM: To
examine outcomes in patients undergoing hepatic resection for
colorectal metastases during a 20-year period and, in particular,
to address temporal trends in long-term survival.
Methods: Data from 582 consecutive patients undergoing poten-
tially curative liver resection for CLM between 1985 and 2005 in
two different institutions were analyzed. This entire period was
split into three intervals each lasting 6 years. Actuarial survival
rates related to prognostic determinants were analyzed using the
log-rank test.
Results: Ninety-nine patients operated on between 1985 and 1991
were found to have an overall survival of 32% at 5 years, com-
pared to 43% for the 153 patients operated from 1992 to 1998,
and 55% for the 330 patients operated from 1999 and 2005. The
survival differences between these three time frames reached sta-
tistical significance
(P < 0.05). CLM severity assessed using the Fong_s clinical risk score,
as well repeat resections, the presence of bilateral disease, and neoad-
juvant chemotherapy increased significantly throughout the three
time periods. Time period was identified to have a statistically signif-
icant influence on survival at multivariate analysis.
Conclusions: Long-term survival following liver resection for
CLM has improved significantly over the years, despite the pres-
ence of more severe diseases in the more recent periods.
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HEPATIC RESECTION FOR COLORECTAL
LIVER METASTASES: THE VALUE OF
PROGNOSTIC SCORING SYSTEMS
C. Pulitanό, R. Parks, S. Wigmore, J. Garden
Clinical and Surgical Sciences, University of Edinburgh, Royal In-
firmary Edinburgh
BACKGROUND: Several investigators have proposed risk scor-
ing systems to predict the outcome of liver resection for colorec-
tal liver metastases (CLM). However the value of these scoring
system remain to be determined. AIM: To validate and compare
existing scoring systems.
METHODS: In this study we compared the validity of four dif-
ferent scoring systems developed on large patient populations:
the clinical risk score (CRS) defined by Fong et al., the score sys-
tem defined by Nordlinger (NSI), the Basingstoke Predictive
Index (BPI) defined by Ree set al. and the score system defined
by Minagawa et al (MSI). Medical records of 191 liver resections
for CLM performed from 1985-2004 in our institution were ana-
lyzed. To validate these scoring models, our data set was applied
to each risk scoring system. Discriminatory ability for death at
one, three, and five years for each score were evaluated by re-
ceiver operating characteristic curve (ROC) area.
RESULTS: The calculated CRS, NSI, BPI and MSI were ana-
lyzed with respect to patient survival and were found to be highly
predictive of long-term outcome (P=0.0001, P=0.0043, and
P=0.0001, respectively).
Discriminatory ability for death at 5-years evaluated by ROC
curve area analysis, were higher for CRS (0.720) compared with
NSI (0.6700), BPI (0.662) and MSI (0.690).
CONCLUSIONS: This study validates the proposed scores as
predictive of patient outcome. However, the CRS seems to be the
most effective in predicting patients survival.
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CHANGES IN BLOOD COAGULATION AND
INFLAMMATORY CYTOKINE PROFILE IN
LAPAROSCOPIC AND OPEN LIVER
RESECTION: A PRELIMINARY STUDY
E. Guzzetti1, F. Cipriani1, C. Pulitan 1, F. Ratti1, L. Aldrighetti2,
M. Catena1, R. Finazzi1, G. Ferla1
1. General and Specialistic Surgery Department, UOC Hepatobil-
iary Surgery IRCCS San Raffaele Hospital, Milan, Italy
2. Liver Unit, Department of Surgery, Scientific Institute San Raf-
faele, Vita-Salute San Raffaele University, Milan, Italy IRCCS San
Raffaele Hospital, Milan, Italy
Background: Liver surgery is known to induce a hypercoagula-
bility state because of the inflammatory response, mainly med-
icated by inflammatory cytokines. [1] Laparoscopic surgery may
help to maintain coagulation homeostasis because of the reduced
inflammatory response [2-3]
Aim: The aim of this prospective study was to investigate haemo-
static and inflammatory system alterations in patients undergoing
open or laparoscopic liver resection.
Methods: Between 2006 and 2008, 20 patients were assigned to
laparoscopic liver resection (LPS Group, 10 patients) or open
liver resection (Control Group, 10 patients) or liver tumors. In-
terleukin-6 (IL-6), tumor necrosis factor- (TNF- ), C-reactive
protein (CRP), white blood cells (WBC), platelets, prothrombin
time ratio (PT ratio), fibrinogen (FG), antithrombin III (ATIII),
D-dimer levels (XDP) were measured at baseline and on post-
operative day 1, 2 and 5.
Results: Postoperative plasma levels of inflammatory cytokines
IL-6, TNF- , CRP and XDP showed a lower rise in LPS Group;
ATIII and FG were significantly higher in LPS group. Alteration
were greater on immediate postoperative days, the first and the
second. No difference was observed for WBC, PT-ratio and
platelets.
Conclusions: Laparoscopic technique showed a lower impact on
systemic homeostasis, in terms of inflammatory response and co-
agulation alterations. Further studies are required to investigate
these issues.
[1] Pulitan C, Aldrighetti L, Arru M, Finazzi R, Catena M,
Guzzetti E, Soldini L, Comotti L, Ferla G.
Preoperative methylprednisolone administration maintains co-
agulation homeostasis in patients undergoing liver Resection: im-
portance of inflammatory cytokine modulation.
Shock (2007) 28: 401-405.
[2] Schietroma M, Carlei F, Mownah A, Franchi L, Mazzotta C,
Sozio A, Amicucci G.
Changes in the blood coagulation, fibrinolysis, and cytokine pro-
file during laparoscopic and open cholecystectomy.
Surg Endosc (2004) 18: 1090–1096.
[3] Shimada M, Harimoto N, Maehara S, Tsujita E, Rikimaru T,
Yamashita Y, Tanaka S, Shirabe K.
Minimally invasive hepatectomy: Modulation of systemic reac-
tions to operation or laparoscopic approach? Surgery
2002;131:S312-7
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VARIABILITY OF MICROWAVE ABLATION
DIAMETERS IN METASTATIC LIVER CANCER
R. Hompes, R. Aerts, B. Topal
Department of Abdominal Surgery, University Hospital Leuven, Bel-
gium
Introduction: In patients with hepatic malignancies radiofre-
quency ablation (RFA) has become an established treatment
modality. Microwave ablation (MWA) is the most recent devel-
opment in the field of local ablative techniques. Opposed to RFA
it has several theoretical advantages that may increase its effec-
tiveness in the treatment of hepatic cancer. The aim of current
study was to evaluate the ablation diameters obtained after MWA
vs. RFA in patients with metastatic liver tumours.
Methods: From August 2008 until November 2008, single-probe
MWA (laparoscopy 5; percutaneous 1) was used to treat 16 liver
metastases in 6 patients without cirrhosis. All data were entered
in a prospective database. MWA ablation diameters were com-
pared with those of RF ablated tumours in patients matched for
tumour size and localisation. Ablation diameters (D1 transverse;
D2 antero-posterior; D3 cranio-caudal; mm) were assessed using
a CT-scan within 7 days after MWA.
Results: No mortality occurred. In 1 patient haemobilia devel-
oped after MWA, which was resolved conservatively. The mean
transverse diameter after MWA was smaller than after RFA, i.e.
26 (range 12-64; standard deviation SD 14) vs 32 (range 16-41;
SD 7) mm. The other diameters were similar after MWA and
RFA (D2 35mm; D3 32mm), though with higher SD after MWA
vs. RFA. No statistically significant differences were found be-
tween the diameters in both groups (p>0.09). Immediate post-
MWA CT-scan showed seemingly complete tumour ablation,
whereas the zone of ablation extended until the liver capsule at
the site of MWA-probe introduction (“comet” effect).
Conclusion: Ablation diameters after single-probe MWA of
metastatic liver tumours are unpredictable, with high variability
and high coefficient of variation. The relatively small transverse
diameter raises concerns about the completeness of destruction
in tumours measuring larger than 20mm in diameter. The
“comet” effect may cause unwanted collateral damage to neigh-
bouring organs or structures. Improvements to better control and
accurately predict the ablation zone after MWA are needed be-
fore it can be implemented routinely in daily clinical practice.
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A SUTURELESS RADIOFREQUENCY-ASSISTED
DEVICE FOR TRANSECTION OF THE LIVER.
PRELIMINARY RESULTS OF CLINICAL TRIAL
IN REAL PATIENTS
M. Martínez-Serrano1, F. Burdio2, I. Poves1, E. Berjano3,
A. Navarro4, A. Güemes4, L. Grande1
1. Department of Surgery, Hospital del Mar, Barcelona, Spain
2. Hospital del Mar Service of Surgery
3. Department of Electronic Engineering, Polytechnic University of
Valencia, Spain
4. Department of Surgery, Hospital Cl nico Universitario Lozano
Blesa, Zaragoza, Spain
BACKROUND: The optimal surgical tool for performance of
liver resection would achieve, with a single device, both hemo-
stasia and rapid procedure1. Actually, several medical radio-fre-
quency devices have been designed and they’re being tested so
far.
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AIMS: Our purpose is to reproduce and confirm in real clinical
cases previous results obtained in pig liver2 with a new radiofre-
quency assisted-device –RFAD- (485 KHz), and demostrate its
safety.
PATIENTS AND METHODS: After approval by the Local Eth-
ical Committee and National Medicament Agency, clinical trial in
real patients (code: 312/08 EC) is actually ongoing and expected
to be concluded in 2009. The approved clinical protocol includes
18 patients with liver metastases from colorectal cancer to be re-
sected by RFAD in two phases: 1) Phase (I) (n=8), in order to
demonstrate its safety and 2) Phase II (n=10) to study efficacy. At
this moment, three partial hepatectomies have been performed
on two patients with RFAD as single method for both transec-
tion and hemostasia. The main outcome measures were transec-
tion time, blood loss, transection area, transection speed, blood
loss per transection area, haemodynamic parameters during pro-
cedure and analytic parameters in post-surgery period.
RESULTS: So far, three non-anatomic liver transections without
any need of sutures have been performed in two patients. Oper-
ating time were 130 and 174 minutes for the whole operations
whereas transection time were 53 and 87 minutes, respectively.
The blood loss per transection area was 7.37mL/cm2 and
5.16mL/cm2, respectively. Both patients demonstrated an un-
eventful postoperative course. Nevertheless, in one of them
wound infection was observed after discharged but he didn’t need
hospital treatment.
CONCLUSION: Preliminary results of this clinical trial with the
proposed RFAD have demonstrated to be safe in both transec-
tion and hemostasia without any need of sutures in non-anatomic
liver resections.
REFERENCES:
1.- A. Navarro, F. Burdio, E.J. Berjano, et al. Laparoscopic blood-
saving liver resection using a new radiofrequency-assisted device:
preliminary report of an in vivo study with pig liver. Surg Endosc
2008; Mar 6 [Epub ahead of print].
2.- F. Burd o, A. Navarro, E. Berjano et al. A radiofrequency-as-
sisted device for bloodless rapid transection of the liver: A com-
parative study in a pig liver model. EJSO 2008(34);599-605.
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COLOR DOPPLER ULTRASOUND PROVIDES
REAL TIME MEASUREMENT OF MICROWAVE
FIELD IN ABLATION THERAPY
S. Smeaton, P. Nguyen, J. Martinie, J. Heath, D. Iannitti
Carolinas Medical Center, Charlotte, NC, USA
Microwave generators create an energy field around the active
tip of an antenna via pulsed electromagnetic waves. Tissue ther-
mocoagulation is achieved as water molecules within the field os-
cillate according to energy delivered. This study demontrates that
the visualized field seen in color Doppler US during MWA cor-
relates with measured zone of thermocoagulation.
METHODS: Microwave ablations with a single needle 915 MHz
surgical antenna (ValleyLab, Boulder, CO) at 45W for 6 minutes
were performed in ex-vivo bovine liver. Ultrasound (BK Pro
Focus 2202, BK Medical, Denmark) was used to monitor the ab-
lation using color Doppler mode. A clear demarcation was ob-
served at the edge of the microwave field which was marked
circumferentially with methylene blue utilizing US guidance. The
tissue was transected along the needle plane and the distance be-
tween each mark and the edge of thermocoagulation zone was
measured.
RESULTS: Twenty MW ablations were performed with 5 mark-
ings per ablation. Measured distance from the markings to the
edge of the thermocoagulation zone averaged 1.62mm (Range
0.00 - 5.5, SD 1.34). The field seen on Doppler US correlated in
size with the thermocoagulation zone seen in the liver tissue.
CONCLUSIONS: The visualized field observed in the color
Doppler mode of US during MWA correlates with the MW field
as well as the zone of thermocoagulation. To date this has not
been described. Live feedback of the treatment area during mi-
crowave ablation can be used to create target specific probes, gen-
erator modulated ablations, and more efficient methods for
shielding.
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OUTCOME OF RESECTION OF BILIARY
CANCER IN PATIENTS WITH PRIMARY
SCLEROSING CHOLANGITIS
N. de Liguori Carino, P. Goldsmith, S. Farid, G. Toogood,
J. Lodge, K. Prasad
HPB and Transplant Surgery, St James’s University Hospital, Leeds,
UK
Aims: to discuss the feasibility, clinical course, management and
outcome of resection of biliary malignancies on a background of
primary sclerosing cholangitis(PSC).
Methods: Between January 2003 and December 2008, 7 patients
(6 male, and 1 female) with biliary cancer on a background of his-
tologically con rmed PSC underwent resection. 5 were hilar
cholangiocarcinoma, 1 intrahepatic cholangiocarcinoma and 1
gallbladder carcinoma. Three patients had preoperative biliary
drainage (2 ERCP, 1 PTC). Protocol follow-up was based on se-
rial total body CT scan and tumor markers.
Results: All except the last patient underwent caudate lobe re-
section and lymphadenectomy. In addition three patients under-
went right hemihepetectomy, one patient underwent a right
trisectionectomy following preoperative portal vein embolisation,
one underwent left hemihepatectomy and left portal vein recon-
struction and one patient with a gallbladder cancer underwent
resection of segments IVb and V. Finally one patient with intra-
hepatic cholangiocarcinoma underwent right anterior sectionec-
tomy. Postoperative complications were seen in 2 cases. Three
patients had positive resection margin and 3 had lymph-node
metastases. Follow-up ranged from 6 to 38 months. Five had re-
currence within the liver. The longest overall and disease free sur-
vivals were 38 and 24 months respectively.
Conclusions: This series is the largest reported on resection of
biliary cancer in patients with PSC. Despite being technically fea-
sible, long term results are poor. More effort should focus on
screening for early stage detection of cholangiocarcinoma in pa-
tients with PSC.
P 265
RESULTS OF PERCUTANEOUS
RADIOFREQUENCY ABLATION OF LIVER
COLORECTAL METASTASES
V. Vishnevsky, D. Ionkin, M. Efanov, A. Gavrilin,
O. Zhavoronkova
Vishnevsky Institute of Surgery, Moscow, Russia
Aim: Improvement of the treatment results in the patients with
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colorectal liver metastasis.
Technique, materials and methods: we have being accumulated
the experience of Percutaneous Radiofrequency Ablation
(PcRFA) since 2002. PcRFA was performed in 88 patients with
colorectal liver metastasis. There were 37 males and 51 females;
mean age – 51,6 (27-83) years. All the patients had primary
tumor removal as the first stage of treatment. We used Radion-
ics Cool-Tip® Ablation System with set of needle water cooling
electrodes. The treatment was being performed under Ultra-
sound control. Totally 168 applications of PcRFA had been per-
formed. Average number of applications was 2,2+1,7 (from 1 to
8). Completeness of the tumor destruction was controlled by Ul-
trasound, MRT starting from the first 24 hours after surgery.
Results: The most common postoperative complication was ex-
sudative pleuritis (22,5%). Five patients died (5,6%) within first
3 months after surgery. In 61% of patients we registered new
metastasis in spite of chemotherapy and repeated applications of
PcRFA. The sites of disease recurrence were: liver (26%), extra-
hepatic (mostly in lungs, 34%), liver and extrahepatic (45,8%).
After PcRFA 1, 2, 3, 4 and 5-year survival were 84,2%; 55,7%;
39,7%; 29,7% and 16,3% respectively. Mean time survival was
30 months.
Conclusions: MRI was the most effective in control of complete-
ness of tumor destruction in comparison with Ultrasound and CT.
Incomplete destruction is the main cause of relapse of disease.
PcRFA may be considered as radical treatment method if tumor
destruction zone exceeds tumor size in at least 1 cm.
P 266
SURGICAL MANAGEMENT OF HYDATID
DISEASE OF THE LIVER AND SPLEEN
D. Daskalaki, S. Paraskakis, G. Stamatakis, K. Daskalakis
Surgical and Gastroenterological Department University of Verona
Policlinico G.B Rossi, Italy
Background (Aim): Treatment of hydatid disease of the liver and
spleen is primarily surgical. Several surgical techniques have been
used for the treatment of hepatic hydatidosis.
The aim of this study is to see how will select the appropriate
technique in each case.
Methods: Seven patients with hydatid disease of the liver or
spleen were operated in our department during the last 5 years.
Two were males and 5 females, mean age 50,4 years. Five patients
had hydatid cysts in the liver, 1 in spleen and 1 in both. Three pa-
tients had solitary liver cysts and 3 multiple (2,4,15 respectively).
Solitary spleen cyst had 1 patient double cysts the other one. The
cysts were located in the right hepatic lobe in 2 patients, in the
left lobe in 3 and 1 were bilobar.
Cholecystectomy was added in all patients. Two splenectomies
were performed in spleen hydatidosis.
Total pericystectomy was performed in 2 paqtients and partial
cystectomy plus omentoplasty in another 2.
In 2 patients with multiple liver cysts, combination of several tech-
niques were performed. Two total pericystectomies and 2 partial
cystectomies plus omentoplasty in the patient with 4 cysts and
total pericystectomies, atypical hepatic lobectomies, partial cys-
tectomies plus omentoplasty and partial cystectomies with
drainage in the other with 15 cysts.
Results: No deaths and no serious postoperative complications.
There was 1 biliary fistula which healed spontaneously after 2
months. The mean hospital stay was 15,2 days. The follow up in-
dicate no recurrencies until now.
Conclusions: The surgical treatment of hepatic hydatidosis, es-
pecially when the cysts are multiple, is sometimes difficult re-
quires operative experience. The choice of operative technique
must be based on number, size and location of cysts, nature of
complications and previous surgery.
Splenectomy is the treatment of choice for hydatid cysts of the
spleen.
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INTRAOPERATIVE RADIOFREQUENCY
ABLATION (IRFA) AND REPEAT
HEPATECTOMY TO TREAT SECOND
GENERATION OF LIVER METASTASES
M. Isambert1, L. Etchechoury1, T. Razafindratsira1, C. Lalet2,
S. Mathoulin-Pelissier2, S. Evrard2
1. Digestive Tumour Unit Institut Bergonie
2. Department of Biostatistics Institut Bergonie
Background: Repeat liver surgery provides special issues like dif-
ficult adhesiolysis, important bleeding. Evaluation of the remnant
liver volume and preservation of the supra hepatic drainage may
be critical. IRFA may spare healthy liver parenchyma.
Aim: To assess the feasibility of IRFA in combination with re-
peat hepatectomy.
Methods: Patients with second generation liver metastases were
retrospectively reviewed, selected on chemo responsiveness1,2.
Data were prospectively registered. 44 patients were included: 37
with colorectal metastases and 7 with non colorectal metastases.
After complete mobilisation of the liver, intraoperative ultra-
sound allowed us to choose between resection and IRFA: neces-
sity to spare liver parenchyma or supra hepatic veins, existence
of CASH or SOS, lesions up to 25 mm were in favour of IRFA.
Resection was chosen whenever possible.
Results: 14 patients were treated by IRFA alone, 10 by IRFA +
resection, 20 by resection alone. Median number of metastases
was for IRFA: 2 [1-5] ; IRFA + resection: 7 [2-13] ; resection
alone 2 [1-6]. Mortality was zero. Complications were 2 blood col-
lections and 1 abscess to be reoperated on. Median follow up was
30 months [24-36]. Total hepatic recurrence (new lesions + re-
currences of treated lesions) was 53% at 2 years. Overall survival
was 73% at 2 years and 49% at 3 years.
Conclusion: IRFA may be usefully added to resection for the
treatment of second generation of liver metastases, without in-
creasing morbidity. Combined strategy provides survival similar
to rehepatectomy in the literature and allows R0 treatment for
selected unresectable patients.
1 Adam R et al, Ann Surg, 244:524-35, 2006.
2 Reddy et al, JACS, 204:372-82, 2007.
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INITIAL CLINICAL RESULTS OF A NEW
BIPOLAR RADIOFREQUENCY ABLATION/
ASPIRATOR DEVICE (HEXABLATE) IN THE
MANAGEMENT OF PRIMARY AND
SECONDARY LIVER CANCERS
D. Zacharoulis, G. Tzovaras, E. Sioka, J. Balogiannis,
D. Symeonidis, A. Lahanas, K. Karagiannis, E. Zahari,
G. Koukoulis, K. Hatzitheofilou
Department of Surgery University of Thessaly Mezourlo, Larissa,
Greece
Background and Aims: Surgical resection is the standard treat-
ment for primary/secondary liver cancer but only 10-20% of pa-
tients are suitable. Increasingly, radiofrequency (RF) energy has
been used to ablate liver tumours when surgery is inappropriate.
The workload of thermal ablation for cancer involving the liver is
predicted to more than double in the next 5 years. A novel bipo-
lar RF ablation/aspirator device (Hexablate) was designed to ad-
dress the limitations of the present technology.
Methods: A multicentre, non randomised, prospective clinical
trial of a novel bipolar RF ablation/aspirator device (Hexablate)
in the treatment of primary and secondary cancers of the liver
was undertaken.
Results: A total of 34 lesions in 16 patients were ablated at la-
parotomy and followed up at 4 weeks after discharge. The me-
dian diameter of the lesion before ablation was 2.75 (range 1-10)
cm, median volume aspirated during ablation 10 (range 0-25) mls
and median operative time was 150 (range 100 - 215) minutes.
Three patients had minor complications: two patients developed
a pleural effusion and one a wound infection. Median length of
stay was 7.5 (range 3 - 14) days. In 11 patients the ablated tumour
was resected. Histological assessment showed no evidence of vi-
able cancer at the tumour edge and average ablation was 90%.
No local complications relating to ablation was demonstrated on
CT scan at two weeks post operatively.
Conclusions: Initial analysis of the data shows this approach to
ablation to be safe and effective.
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PORTUGUESE CENTER EXPERIENCE WITH
A NEW HEMOSTATIC PRODUCT
H. Sousa, M. Sacchetti, G. Faria, I. Romero, M. Oliveira,
M. Almeida, R. Melo, E. Martins, J. Costa-Maia
Uindade HBPE - Serviço de Cirurgia GeralUindade HBPE -
Serviço de Cirurgia GeralUindade HBPE - Serviço de Cirurgia
Geral Hospital S. João, Portugal
Introduction: Reduction of morbidity and mortality in HPB sur-
gery has always been linked to hemorrhagic control, that, among
others, include technical developments such as hemostatic
sealants. The ideal hemostatic should be safe, effective even in
areas with active bleeding, with no potential for disease trans-
mission, easy to prepare and use and economical. The authors re-
port their experience with a recently introduced device that
consists of a collagen matrix coated with a layer of fibrinogen and
thrombin (TachoSil ), with sealing properties encompassing var-
ious organic fluids.
Methods: Revision of HPB surgical patients in whom TachoSil
was used, between April and November 2008.
Results: We reviewed 51 procedures in 50 pts: 42 liver resections,
5 pancreatic resections, 3 biliary anastomosis and a splenic iatro-
genic lesion.
The hemostatic patch was easy to prepare and apply, efficient in
achieving rapid and adequate hemostasis and no complications
were attributable to it’s usage.
One patient died in the post-op period from multiorgan failure
following a pancreatoduodenectomy for ampulary carcinoma.
One patient was reoperated for hemorrhage, unrelated to the
liver resection margin, and another developed an intra-abdomi-
nal collection resolved by percutaneous drainage.
Conclusions: TachoSil provided fast, effective hemostasis, was
well tolerated and it’s sealing properties justify, in our experience,
it’s use beyond the hemorrhagic context, in liver, biliary and pan-
creatic surgery.
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IS RADIOFREQUENCY ASSISTED LIVER
RESECTION A GOOD OPERATIVE TECHNIQUE
FOR HEPATOCELLULAR CARCINOMA IN
CIRRHOTIC LIVER?
D. Galun, M. Milicevic, P. Bulajic, M. Zuvela, Z. Raznatovic,
D. Basaric
First Surgical Clinic, Clinical Center of Serbia, Belgrade
Background. Although the treatment of hepatocellular carci-
noma (HCC) is evolving, hepatic resection remains the treatment
of choice for many patients. Liver cirrhosis is the main reason for
high early postoperative mortality after resection. Any technique
performed without interference with liver blood supply may be
beneficial to avoid perioperative injury of the hepatic
parenchyma.
Aim. To assess the postoperative morbidity and overall survival in
patients with HCC in cirrhotic liver who underwent liver resection
using radio frequent sequentional ‘coagulate-cut liver resection
technique’.
Methods. 32 patients underwent liver resection from November
2001 to November 2007 in First surgical clinic, Clinical Center of
Serbia. According to Barcelona-Clinic Liver Cancer staging clas-
sification 5 patients were in group A (early stage), 20 patients
were in group B (intermediate stage) and 7 patients were in group
C (advanced stage).
Results. The following resections were performed (without
Pringle maneuver): 4 subsegmentectomies, 4 segmentectomies,
4 left bisegmentectomies, 2 right bisegmentectomies, 4 triseg-
mentectomies, 2 central resections, 11 right hepatectomies and 3
left hepatectomies (34 resections, 2 patients were re-operated).
Only one patient required intraoperative transfusion (530ml of
blood). Tumor size ranged from 2 to 25cm in diameter. Postop-
erative complications included portal vein thrombosis in 1 patient
(3%), respiratory complications in 9 (28%) and biliary fistula in
1 patient (3%). The 1 year survival was 100, 65 and 57% for
groups A, B and C respectively.
Conclusions. Radio frequent sequentional ‘coagulate-cut liver re-
section technique’ may be one of preferred solutions for man-
agement of patients with HCC in cirrhotic liver.
© The Authors
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PHARMACOLOGICAL PREVENTION OF THE
ISCHEMIA/REPERFUSION INJURY IN HEPATIC
SURGERY. AN EXPERIMENTAL STUDY
M. Trovato, R. Lanteri, M. Santangelo, M. Sofia, G. La Greca,
A. Di Cataldo, S. Puleo
Department of Surgical Sciences, Organ Transplantation and Ad-
vanced Technologies, University of Catania, Italy
Background: Since complete inflow occlusion is still one of the
more commonly performed techniques to prevent intraoperative
blood loss, a solution must be found to the ischemia reperfusion
(I/R) injury which follows the clamping of the portal triad. This
solution would involve the pathways of Nitric Oxide (NO) and
Heme Oxygenase (HO). Aims: The aim of this study was to find
out how the NO and the HO systems work and how to interact
pharmacologically with them using natural antioxidant drugs.
Methods: A rat model of hepatic ischemia (30 min) and reperfu-
sion (180 min) was used. As indicators of hepatocyte ossidative
damage and liver function, plasma concentrations of liver marker
enzymes, lipid hydroperoxides (LOOH), total thiol groups (RSH)
and liver histology were assessed. In addiction, hepatic LOOH
and RSH levels, DNA fragmentation and the expression of HO-
1, NOS (NO- sinthase) inducible and endothelial, DDAH 1 (di-
methylarginine dimethylaminohydrolase) were evaluated. The
I/R rats were distinguished among different groups that under-
went the administration of rutine (a natural antioxidant) or
placebo. A sham operation rat group was included. There is still
a test in progress evaluating the liver expression of TRAIL
(Tumor necrosis factor-related apoptosis inducing ligand). The
ANOVA and the Bonferroni t-tests were performed. Results:
Our data suggest that rutine treatment improves liver function
reducing the impairment of liver marker enzymes and of liver
tissue caused by I/R injury, increasing the expression of HO-1
and ADMA, cutting down the activity of DDHA 1, of iNOS, and
DNA fragmentation. Conclusions: The previous administration
of antioxidant drugs should improve the outcome of patients who
underwent hepatic major resections or transplantations, reduc-
ing the hepatic failure due to the ischemia reperfusion injury.
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LIVER RESECTION IN CIRRHOTIC PATIENTS
IS SAFE AND FEASIBLE WITH MODERN
RESECTION TECHNIQUES - A SINGLE
CENTER ANALYSIS
M. Kremer, U. Hinz, J. Weitz, J. Schmidt, M. Büchler,
P. Schemmer
Department of Surgery, University of Heidelberg, Germany
Due to new surgical techniques and devices like vascular staplers
as well as improved multimodal perioperative treatment, the in-
dication for liver resection is given more and more also in cir-
rhotic patients. This is a prospective analysis of 55 cirrhotic
patients who underwent liver resection between October 2001
and August 2008 for both primary (n=46; 84%) and metastatic
(n=5; 9%) liver cancer, and benign liver disease (n=4; 7%). GIA
vascular staplers for parenchymal transection were used in about
70% of cases. All patients suffered from Child A cirrhosis mainly
due to chronic viral hepatitis or alcohol consumption. There were
15 (27%) major resections (³ 3 segments) and 40 minor hepatic
resections. Most frequent surgical complications were relaparo-
tomy (n=5; 9%), wound infection (n=4; 7%) and bilioma (n=2;
3%). Most frequent non-surgical complications were pleural ef-
fusion (n=4; 7%) and pneumonia (n=2; 3%). Although major
hepatic resections were associated with a significant increase in
duration of surgery time, blood loss and postoperative stay in the
intensive care unit, mortality did not differ significantly between
major and minor resections. Total mortality was 9%, 3 patients
died after minor resection whereas 2 patients died after major re-
sections.
In unison with other centres using conventional resection tech-
niques these results clearly indicate that stapler hepatectomy is
feasible with acceptable mortality and morbidity in cirrhotic pa-
tients in the absence of alternative treatment regimens.
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EL IN TREATMENT AND PREVENTIVE
MAINTENANCE OF BLEEDINGS FROM
VARICOSIS AT PATIENTS WITH CIRRHOSIS
I. Dzidzava, B. Kotiv, V. Belevich, A. Smorodskii
Medical Military Academy, Saint-Petersburg, Russia
Goal: to estimate the efficiency of endos opic ligation (EL) of
varicosis of esophagus at patients with cirrhosis.
Materials and methods. 88 patients with cirrhosis complicated
with portal hypertension were included in research. Varicosis of
esophagus of IV degree was diagnosed at 39 (44,3%), III degree
– 49 (55,7 %) patients. On Child-Pugh scale patients were dis-
tributed as follows: the class A has made – 16 (18,2%), B and C
on 36 (40,9%) patients. The indication to performance EL was a
acute bleeding from varicses in 28 (31,8%) cases, recidivating
esophagus bleedings in the anamnesis - in 37 (42 %). EL was ex-
ecuted with the preventive purpose in connection with presence
of red markers to 23 patients.
Results. Efficiency of EL in a control of a acute bleeding has
made 82,1%, re urrence of hemorrhage in the first 5 days of su-
pervision took place in 5 cases. Recidivating bleeding in the early
postoperative period had developed at 12,5% of patients as a
whole. Lethality was 4,5%. Re urrence of bleeding from varicses
of esophagus has developed at 15 (20,5%) patients in the remote
period. The maximum number of cases of recidivation of hemor-
rhage were during the first 2 months after EL. The survival rate
of patients with cirrhosis after EL in supervision till 1 year has
made 75,2±5,1%, 3 and 5-year - 54±6% and 45,2±6,2%, ac-
cordingly. Life expectancy was defined by expressiveness of he-
patic insufficiency. So the one-year survival rate of patients of the
class A, B and C on Chid-Pugh scale was 77,4±111, %, 76±7,9%,
73,5±8,1%, and 5-year – 56,4±15,3%, 54,1±9,5%, 30,9±9,1%,
accordingly ( ≤0,05).
Conclusion. EL is an effective method of a stop of a sharp bleed-
ing from varicosis of esophagus, but frequency of relapses of hem-
orrhage in the nearest and kept away periods of supervision
reaches 32,7%.
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CLEARANCE TEST WITH ICG IN AN
ESTIMATION OF WEIGHT OF HEPATIC
DYSFUNCTION
I. Dzidzava, B. Kotiv, A. Kochatkova
Medical Military Academy, Saint-Petersburg, Russia
Goal: to estimate the possibilities of the clearance-test with in-
Abstracts 147
docyanine green in estimations of weight of hepatic insufficiency.
Materials and methods. There were 53 patients with histological
confirmed cirrhosis of a virus etiology in research. Patients were
distributed by Child-Pugh criteria s as follows: the A class –
43,5% (20), B – 39,1% (19), C – 17,4% (14). An index of histo-
logical activity (IHA) was estimated by results of biopsy. It was
calculated as the sum of the periportal and intralobar necrosis
degree and expressivenesses of inflammatory infiltration of por-
tal paths. Average value of the IHA was 8,3±3,4 a point. The cor-
relation analysis with Spirmen’s criterion was used at statistical
processing.
Results. Decrease in plasma disappearance rate (PDR) of ICG
and increase of its residual concentration (R
15
) in blood was
marked at all patients. Average values of PDR and R
15
were
10,2±6,6%/min and 28,3±15,4%, accordingly. PDR ICG de-
creased according to degree of hepatic dysfunction on Child-Pugh
(r
pdr
=-0,62, <0,001). Statistically significant correlation commu-
nication between plasma disappearance rate and albumin and
bilirubin was revealed at two-factorial analysis (r=0,64, <0,001
and r=-0,54, =0,002, accordingly). There were no correlations
between indicators of the clearance-test and AlT, AsT, alkaline
phosphatase, creatinine, a prothrombin index and mno. Authen-
tic correlation communication between an IHA and PDR, R
15
was
defined (r
pdr
=-0,64, r
r15
=0,64, <0,001). The correlation between
Child-Pugh scale and IHA was less strong and doubtful at the
same time (r=0,35, =0,052). Inclusion of parameters of the
clearance-test in CTP scale increased it prognostic value (the area
under a ROC-curve was 0,827 and 0,743, accordingly).
Conclusion. Indicators of the clearance-test with indocyanine
green surpass Child-Pugh criteria’s in an objective estimation of
a functional condition of a liver at patients with cirrhosis. Their
combination improves value and accuracy of the forecast.
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PROGNOSTIC FACTORS FOR SURVIVAL
AFTER LIVER RESECTIONS IN PATIENTS WITH
COLORECTAL CANCER LIVER METASTASES
V. Vishnevsky, M. Efanov, R. Ikramov, V. Egorov,
N. Nazarenko, D. Ionkin, T. Shevchenko
A.V.Vishnevsky Institute of surgery, Moscow, Russia
Background: hepatic resection is the most effective therapeutic
modality for colorectal cancer liver metastases (CLM) but hepa-
tectomy can only be performed in 15–25% of patients with CLM.
Aim: to estimate the influence of different prognostic factors on
survival time after hepatic resection in patients with CLM. Ma-
terial and methods: the long-term results were analyzed in 101
patients with CLM who underwent liver resections from 1996 to
2007. Partial liver resections were performed in 55 patients, major
liver resections – in 46. 77 (76%) patients were followed-up. Mul-
tiple large (>5 cm) metastases were in 75 patients. 42 of them
had bilobar lesions. Cox model and univariate logistic regression
were used to evaluate the relationship between survival and fol-
lowing prognostic factors: type of liver resection (major or par-
tial), diameter of the largest metastasis, stage of primary tumor
(TNM), stage of metastatic tumor (mTNM by Gayowski T.J. et al,
1994), lobar distribution of the hepatic lesions (bi- or unilobar),
time of liver metastases diagnosis (meta- or synchronous),
chemotherapy, number of metastases (multiply or single), tumor
differentiation of metastatic lesions, volume of blood loss, dura-
tion of Pringle maneuver, primary tumor localization (colon or
rectum), postoperative complications. Results: multivariable
analyses revealed that only stage of metastatic tumor had signif-
icant influence on survival. Univariate regression showed that
stage of metastatic tumor, lobar distribution of the hepatic lesions
and number of metastases were independently associated with
survival after hepatectomy.
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LIVER RESECTION FOR HCC IN NON-
CIRRHOTIC LIVER WITHOUT UNDERLYING
VIRAL HEPATITIS: A SINGLE CENTRE
EXPERIENCE
S. Farid, G. Morris-Stiff, G. Toogood, P. Lodge, R. Prasad
Department of Organ Transplantation St James University Hospi-
tal, UK
Increasing numbers of HCCs arising in normal liver parenchyma
are being observed but outcomes of surgical resection for HCC
arising in such non-cirrhotic, non-fibrotic livers are not widely
published.
Methods: A review of departmental database identified all pa-
tients undergoing resection for HCC with non-cirrhotic, non-fi-
brotic livers without underlying viral hepatitis between February
1994 and August 2007. Primary end points of the analysis were
disease-free (DFS) and overall survival (OS).
Results: A total of 62 patients were identified with a median age
at diagnosis of 65 years (range: 15-85 years). The median tumour
size was 11cm and only 31% expressed AFP. A major resection
was required in 46 cases. The median follow-up post-resection
was 30 months (range: 6-152 months). The 1- and 5-year overall
survival rates were 80% and 60% respectively. Univariate analy-
sis identified the presence of microvascular invasion, and R1 re-
section margin as adverse predictors of OS, however on
multivariate analysis, a positive resection margin was the only in-
dependent predictor for OS. The 1- and 5-year DFS rates were
74% and 55% respectively. Pre-operative tumor biopsy, multiple
tumors, microvascular invasion, and R1 resection margin were all
predictors of poorer DFS on univariate analysis. Multivariate
analysis showed that only multiple lesions, tumour biopsy and an
R1 resection margin were independent predictors of poorer DFS.
Conclusions: The tumours were large, the majority not express-
ing AFP and required major resections but the results were com-
parable results to those expected for HCCs in cirrhosis/fibrosis
supporting an aggressive policy ensuring clear resection margins.
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LONGTERM OUTCOME OF HEPATIC
RESECTION FOR NONCOLORECTAL
NONNEUROENDOCRINE LIVER METASTASES
G. Sapisochin, C. Dopazo, I. Bilbao, M. Caralt, L. Blanco,
J. L zaro, J. Olsina, J.Balsells, R. Charco
Department of HBP Surgery and Transplant. Hospital Universitario
Vall D Hebron, Barcelona, Spain
INTRODUCTION: The place of liver resection (LR) for non-
colorectal nonendocrine liver metastases (NCNELM) remains
controversial.
AIMS: To asses the outcome of patients that underwent LR for
NCNELM.
MATERIAL AND METHODS: From 1989-2006,695 LR were
performed at our Department, 44 (6.3%) for NCNELM. Primary
tumor was breast 12 (27%), gynaecologic 9 (21%), genitourinary
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5 (11%), choroid 5 (11%), gastrointestinal 4 (9%) and miscel-
lanous 9 (21%). The most common histologies were adenocarci-
noma (59%), sarcoma (16%) and melanoma (14%).
Metachronous metastases (76%) appeared with a median time
of 58 (7-252) months. Median follow-up was 33 (7-192) months.
A multivariate analysis was performed to identify risk factors of
death.
RESULTS: Hepatic metastases were solitary in 54% and unilat-
eral 63%; median diameter 4 (2-13) cm. Minor hepatectomy was
performed in 50%. R0 resection was achieved in 88% with a post-
operative mortality of 0% and morbidity of 25%. Tumor recur-
rence was observed in 77% (34% hepatic recurrence, 9%
extrahepatic recurrence and 34% of both hepatic and extrahep-
atic). Actuarial and disease-free survival at 1,3 and 5-years was
91%, 54%, 34% and 65%, 36% and 25% respectively. No signif-
icant differences on survival were observed according to tumor
primary site. In multivariate analysis factors associated with re-
currence were vascular invasion, bilobar metastases and simulta-
neous resection of primary tumor and metastases (p<0.05).
Factor associated with significant poor prognosis was early re-
currence (<12months)(p<0.05).
CONCLUSIONS: LR for NCNELM is safe but with a high rate
of recurrence. Patients with recurrence during the first year of
follow-up have a high risk of mortality.
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ANGIOGRAPHIC EMBOLIZATION IN SEVERE
BLUNT HEPATIC TRAUMA
N. Varsamidakis1, M. Kanakis1, G. Karidas2, E. Brountzos3,
E. Kostopanagiotou1
1. 1st Department of Surgery, General Hospital of Athens, Greece
2. Department of Interventional Radiology, General Hospital of
Athens, Greece
3. Department of Interventional Radiology, Attikon Hospital,
Athens, Greece
Background. Angiographic embolization in a young patient with
severe liver injury.
Methods - Results. A 16-year-old female was admitted to the
emergency department, after a motorbike accident. Clinical ex-
amination showed hemodynamic instability. There were no ex-
ternal wounds or bone fractures. After intravenous resuscitation,
the patient was able to undergo a computerized tomography (CT)
scan of her abdomen. Enhanced CT examination revealed a
grade V right liver injury according to the American Association
for the Surgery of Trauma grading system (1). Four hours after
later, hemodynamic instability was occurred again (Hb: 6.8 g/dl)
and 2 units of red packed cells were administered. The patient
stabilized and was transferred to the interventional radiology de-
partment. Superior mesenteric angiography showed multiple con-
trast pooling during the early arterial phase involving segments
VII and VIII. No supplementary contrast pooling was detected
during the portal phase. Selective catheterizations of involved ar-
terial branches were effective using a coaxial microcatheter. Ar-
terial embolization was performed by metal microcoils.
Technical success was demonstrated subsequently by angiograms.
The patient became hemodynamic stable and no more blood
transfusion was needed. She mobilized on the 3rd day and 5 days
later was discharged with Hb: 12.3 g/dl. Three months later, the
patient is well and her hemoglobin stable (Hb: 12.4 g/dl).
Conclusion. Angiographic embolization is valuable in managing
severe blunt injury non operatively.
References
Moore EE, Cogbill TH, Jurkovich GJ, et al. Organ injury scal-
ing: spleen and liver (1994 revision). J Trauma 1995; 38: 323-324.
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TOTALLY LAPAROSCOPIC EXTENDED RIGHT
HEPATECTOMY
A. Gumbs1, B. Bar-Zakai2, B. Gayet2
1. Columbia University, New York, U.S.A.
2. Institut Mutualiste Montsouris
INTRODUCTION: Laparoscopic resection of peripheral hepatic
segments has become increasingly more common in the surgical
treatment of both benign and malignant tumors. This video will
demonstrate the relevant technical maneuvers in the perform-
ance of a totally laparoscopic extended right hepatectomy. Com-
mon pitfalls and areas of concern will also be discussed.
METHOD: This video will illustrate the pertinent issues regarding
pre-operative patient selection, necessary minimally invasive equip-
ment, trochar placement, intra-operative monitoring and steps nec-
essary to perform a right hepatectomy including control and
transection of the middle hepatic vein using totally laparoscopic tech-
niques. The five principal steps of this procedure include: mobiliza-
tion of the liver, control of hepatic inflow, division of hepatic
parenchyma, control of hepatic outflow and removal of the specimen.
RESULTS: The patient underwent embolization of the right
branch of the portal vein followed by a laparoscopic extended
right hepatectomy. Due to concerns of adequate post-operative
hepatic reserve the left half of segment IVb was not resected and
all of segment IVa was preserved. At our institution a total of 5
extended left hepatectomies have been performed with totally la-
paroscopic techniques. Our long-term results have been similar to
our open historical controls. No mortalities have been observed.
CONCLUSION: Minimally invasive techniques in right hepatic
resections are feasible, and high volume centers that specialize in
these procedures can have results similar to historical open se-
ries. Totally laparoscopic extended right hepatectomy should cur-
rently only be performed by surgeons with expertise in
laparoscopy and hepatobiliary surgery.
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ADVANCED IMAGE GUIDANCE FOR ABLATION
PROBE PLACEMENT IN OPEN SURGERY
J. Martinie, S. Smeaton, P. Nguyen, I. McKillop, D. Iannitti
Carolinas Medical Center, Charlotte, NC, USA
This video demonstrates the use and placement accuracy of a mi-
crowave ablation antenna when using an advanced image guid-
ance device, the InVision System (IVS), for open surgical hepatic
ablation. Using infrared cameras, IVS tracks the positions of the
ultrasound transducer and the ablation antenna. It continually
determines the spatial relationship between the two instruments
and presents a visual representation of them, in real time in 3D.
Our previous studies have shown that 3D stereoscopic visualization
offers measurably improved needle placement in phantoms. Three
users of different US experience levels _ novice, amateur and expert
– made a series of microwave ablation antenna placements into
phantoms with and without the advanced guidance system. Users
Abstracts 149
made twenty placements of the needle – ten with IVS guidance, ten
without – at each of three different angles to the ultrasound slice: 0
degrees (or the traditional in-plane approach); 45 degrees; and 90
degrees (or perpendicular to the plane of the US). Each physician
made a total of sixty (60) placements, for a total number of 180 place-
ments, and the success of the attempt was recorded.
The results indicate that all users’ performance significantly im-
proved with the IVS. The novice using the system demonstrated
a performance improvement of over 60%; the amateur’s per-
formance improvement was over 50%; and the expert’s perform-
ance improvement was over 40%. The performance of the novice
using the system was better than the expert’s without it.
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RIGHT HEPATECTOMY FOR A TUMOUR
INVOLVING THE RIGHT LIVER VEIN USING
THE LIVER HANGING MANEUVER
K. Oldhafer, G. Stavrou
Department of General, Visceral and Thoracic Surgery Celle Gen-
eral Hospital, Germany
BACKROUND: The standard approach to right hepatectomy re-
quires complete mobilization of the right liver lobe. This can be
sometimes difficult in cases where the patient is very sensitive to
changes of the blood flow in the Vena Cava due to underlying
cardiac disease.
More importantly, mobilization requires manipulation of the tu-
mour with possible oncologic consequences for longtime survival.
Belgithi has proposed a liver hanging maneuver to allow for a safe
anterior approach to resection without the need for mobilization
of the right lobe.
Method: We used the Liver Hanging Maneuvre in a case where
the right hepatic vein was infiltrated to spare any manipulation of
the tumour.
Results: With this technique it was much easier to approach the tu-
mour and manage to resect the tumour completely with a part of the
V. cava followed by reconstruction with a patch. No unnecessary ma-
nipulation of the tumour was necessary during the operation.
Summary: The method is safe and well applicable for surgeons
with experience in liver surgery. Especially in a case with infiltra-
tion of the right vein this approach is very helpful in achieving a
successful resection.
Belghiti, J et al., Liver hanging maneuver: a safe approach to right
hepatectomy without liver mobilization. J Am Coll Surg 2001 vol.
193 (1) pp. 109-11
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LAPAROSCOPIC LIVER RESECTION FOR
RUPTURED LIVER ABSCESS
H. Lee, H. Hwang, J. Park, S. Cho, D. Yoon, H. Chi
Department of Surgery, Yonsei University College of Medicine,
Seoul, Korea
BACKGROUD: The combination of antibiotics and closed per-
cutaneous drainge has been shown to be safe and effective and
non-operative approach has become the first choice of treatment
for liver abscesses. Laparoscopic drainage has been reported and
considered to be a good option. Open operation is indicated
when there is a rupture of liver abscess and those with concomi-
tant intrahepatic or biliary pathology. Laparoscopic resection of
liver for ruptured pyogenic liver abscess has been rarely reported.
AIMS: This case report describes a 73-year-old diabetic man who
presented with spontaneous rupture of liver abscess and has been
treated with laparoscopic lateral sectionectomy.
MATERIALS & METHOD: A 73-year-old man with history of
diabetes mellitus for 10 years and laparoscopic cholecystectomy
due to gall bladder empyema at our hospital 2 month ago was ad-
mitted again because of sudden epigastric pain. Computed to-
mography of the abdomen showed hypodense lesion, 9cm in
diameter, in the lateral segment of left lobe of the liver. Small
amount of free peritoneal air in anterior portion of abdomen with
moderate amount of high density ascites was also shown. These
findings were consistent with a diagnosis of peritonitis due to rup-
tured liver abscess. Laparoscopic left lateral sectionectomy of
liver was performed.
RESUTS: Intra-operatively, there was a severe soiling and pus-
like fluids in whole abdomen. Large abscess was found in the left
lobe of the liver involving segments 2 and 3, which had ruptured
both anteriorly and posteriorly. Two silastic drain was inserted
into abdominal cavity. An abdominal CT scan was done 1 week
later for follow-up which revealed no immediate complication.
He was discharged on POD 22. At the out-patient clinic, he re-
mained well without recurrence of liver abscess.
CONCLUSION: Rupture of a pyogenic liver abscess is uncommon,
with an incidence of 7.1-15.1%, but it carries a mortality as high as
42.8%, because of the greater potential for generalized peritonitis,
septicemia and septic shock. Although prompt percutaneous
drainage and appropriate antibiotics is now the treatment of choice
for most pyogenic liver abscess, surgical intervention has to be car-
ried out for ruptured liver abscess, particularly when generalized
peritonitis is present. The laparoscopy in emergency situation is now
well established. Although current standard treatment of ruptured
liver abscess is surgical drainage of abscess followed by peritoneal
lavage, laparoscopic resection of liver could be another option with
shorter duration of antibiotics and hospital stay.
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THE USE OF AN IMPREGNATED COLLAGEN
SPONGE (TACHOSIL) FOR LAPAROSCOPIC
RADIOFREQUENCY ABLATION OF LIVER
TUMOURS
S. Robinson, D. Manas, S. Noormohamed, R. Lochan,
A. Al-Mukhtar, S. White
Department of HPB and Transplant Surgery, Freeman Hospital,
Newcastle, UK
Background: Radio-frequency (RFA) ablation of liver tumours is
an acceptable treatment for liver tumours particularly in those pa-
tients who are unfit for resection or those with underlying cirrhosis.
RFA is also used in the authors unit as a bridging treatment for
HCC in those patients listed for liver transplantation. The potential
complications of RFA include haemorrhage and bile leak. This
video illustrates the use of an impregnated collagen sponge to seal
the abalation tract after RFA of a liver tumour.
Method and Results: A standard pneumoperitoneum is achieved
using a blunt 12mm port at the umbilicus. A further 12mm work-
ing port is placed to enable laparoscopic ultrasound localisation
of the liver tumour. A RITA Starburst TM XL (Angiodynamics)
is then carefully introduced into the liver parenchyma directly
into the liver tumour. A tumour ablation is then performed at the
appropriate temperature and for an appropriate duration. The
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track is then ablated. At the end of the procedure if there is still
any bleeding a Tachosil ® sponge is then prepared on the back
table. The Tachosil ® is rolled into a small parcel with the active
(yellow) side on the inside to avoid fracturing. The parcel is se-
cured with an appropriate suture and delivered onto the liver sur-
face. The suture is divided and the Tachosil is unravelled with the
active (yellow) side in contact with the liver parenchyma directly
over the ablation track. A small infant feeding tube is then intro-
duced down one of the laparoscopic ports and the surface of the
Tachosil ® is flushed with saline to activate the sponge. The ab-
lation track is then sealed.
Discussion: This technique is quick and reproducible requiring
no specialist equipment to facilitate track sealing after RFA.
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LIVER HISTOPATHOLOGICAL FEATURES OF
HBEAG NEGATIVE CHRONIC HEPATITIS B
IN YOUNG BANGLADESHIS
M. Al-Mahtab1, S. Rahman1, F. Karim1, M. Kamal2
1. Department of Hepatology Bangabandhu Sheikh Mujib Medical
University, Dhaka, Bangladesh & Viral Hepatitis Foundation
Bangladesh
2. Department of Pathology Bangabandhu Sheikh Mujib Medical
University, Dhaka, Bangladesh.
Background: HBV infection is common in Bangladesh, but char-
acteristics of young patients incidentally detected with HBeAg
negative chronic hepatitis B (CHB) is yet to be studied in this
country.
Aim: The aim of this study was to study the characteristics of
young Bangladeshis incidentally detected with HBeAg negative
CHB.
Methods: We did percutaneous liver biopsies of 36 CHB patients
aged between 8 to 20 years. They were all HBeAg negative with
persistently normal or raised serum ALT values.
Results: 56% patients had significant necro-inflammation, while
significant fibrosis was seen in 17.6%. Serum ALT was raised in
38.2%, while high HBV DNA load was observed only in 26.5%.
Conclusion: HBeAg negative CHB is an entity that can be seen
in young population and a significant percentage of such patients
may have considerable hepatic involvement.
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ETIOLOGIC FRACTION OF HOSPITAL-
ADMITTED ACUTE HEPATITIS LIKELY
ATTRIBUTABLE TO HEV INFECTION:
EXPERIENCE FROM A TERTIARY HOSPITAL
IN BANGLADESH
M. Al-Mahtab, S. Rahman, F. Karim
Department of Hepatology Bangabandhu Sheikh Mujib Medical
University, Dhaka, Bangladesh & Viral Hepatitis Foundation
Bangladesn
Background: Acute hepatitis is seen sporadically round the year
in Bangladesh. The incidence of acute viral hepatitis E rises after
floods as this allows sewerage contamination of supply and
ground water.
Aim: The aim of this study was to assess the burden of hepatitis
E virus HEV infection in Bangladesh.
Methods: This study is a retrospective study. Patients attending
Hepatology Unit III, BSMMU were included in the study. All
viral markers were tested by ELISA. The study population was
divided in 4 groups. Group 1 included 144 [84/144] patients with
acute viral hepatitis. Inclusion criteria included nausea and/or
vomiting, loss of appetite, serum bilirubin >200 µmol/L, raised
serum transaminases and prothrombin time >3 sec prolonged
beyond control value. In group 2, there were 31 pregnant women
with acute viral hepatitis. All patients had prodrome, icterus,
raised serum bilirubin and raised serum transaminase levels. In
group 3, 23 patients presenting with fulminant hepatic failure
were included. Finally in group 4, 69 patients with cirrhosis of
liver were included. They presented with features of decompen-
sation for the first time. Inclusion criteria were patients with es-
tablished cirrhosis with jaundice and/or ascites and/or hepatic
encephalopathy.
Results: In group 1, 58.33% had acute viral hepatitis E. In group
2, 45.16% pregnant women had acute viral hepatitis E also. HEV
was found responsible for 56.52% cases of FHF in group 3. Fi-
nally in group 4, in 21.7% cases, decompensation of cirrhosis was
due to HEV. Acute viral hepatitis E in 3rd trimester of pregnancy
and HEV induced FHF was associated with 80% mortality de-
spite best possible care.
Conclusion: In this clinical context acute viral hepatitis E is the
leading cause of wide spectrum of liver disease ranging from se-
vere acute viral hepatitis, fulminant hepatic failure and decom-
pensation of liver in cirrhotics in Bangladesh. Sewerage
contamination of water supply following floods may contribute
to the higher incidence of HEV infections.
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AETIOLOGY OF ACLF: EXPERIENCE FROM
A TERTIARY CENTRE IN BANGLADESH
M. Al-Mahtab, S. Rahman, F. Karim, M. Khan
Department of Hepatology Bangabandhu Sheikh Mujib Medical
University, Dhaka, Bangladesh & Viral Hepatitis Foundation
Bangladesh
Background: Acute on chronic liver failure (ACLF) is common
in Bangladesh. Acute viral E hepatitis is sporadically encountered
in this country round the year, with incidence rising during the
rainy season.
Aim: The aim of this study was to identify the aetiology of ACLF
in Bangladesh.
Methods: In this retrospective study, 69 ACLF patients were in-
cluded. They presented to our Department at the Bangabandhu
Sheikh Mujib Medical University in Dhaka. History was recorded
and appropriate investigations done in all patients.
Results: Acute hepatitis E virus (HEV) infection was positive in
21.7% (15/69) patients, while 14.5% (10/69) had septicaemia.
Upper gastro-intestinal tract haemorrhage was present in 4.3%
(3/69), while another 4.3% (3/69) gave positive history for alcohol
or drugs. None of the patients tested positive for hepatitis A virus
(HAV) infection and no evidence of hepatitis B virus (HBV) flare
was evident in any patient. No specific cause for ACLF could be
identified in the rest.
Conclusion: Acute HEV infection is a leading cause of ACLF in
Bangladesh. Many of these cases were previously thought to be
decompensation of cirrhosis, but subsequently recognized as
ACLF on retrospective review following the APASL Working
Party on ACLF Meeting in New Delhi early this year.
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DISTAL PANCREATIC RESECTION:
EXPERIENCE VERSUS COMPLICATIONS
N. Kopanakis, A. Koliopanos, G. Vasiliadis, A. Katseli,
G. Zografos, H. Tsipras, H. Margaris
3rd Department of Surgery, General Hospital of Athens, “G.Genni-
matas”
BACKGROUND: Pancreatic fistula is the most common com-
plication after distal pancreatectomy. We review hereby our 11-
years experience in order to evaluate the techniques and the post
operative results.
METHODS: Between January 1997 and November 2008, 43 pa-
tients (24 female, 19 male, mean age 50 years) received a distal
pancreatectomy in our department and pathology included 26
cases of adenocarcinoma of the pancreas, 7 cases of tumors infil-
trating distal pancreas, 4 cases of chronic pancreatitis, and 6 cases
of rare pancreatic non-adenocarcinoma tumors. In all cases, pan-
creatic stump was closed with monofilament non-absorbable su-
tures and an effort was made to identify and separately secure
the main pancreatic duct. Operative time, mortality, intra and
early postoperative complications as well as time to recovery and
hospital stay were closely monitored in all patients.
RESULTS: Mean operative time was 133 min (range from 78-
380 min) and was not found to be associated with more compli-
cating postoperative course. Associated procedures were
performed in 8 cases (3 total gastrectomies, 2 esophago-gastrec-
tomies, 1 partial gastrectomy and left colectomy and 2 adrena-
lectomies). There where no intra-operative complications.
Mortality included 2 patients, one with a locally advanced tumor
of the esophagus who died a month after the operation in the
ICU, due to generalized sepsis and another one with pancreatic
cancer who died three weeks after the operation due to respira-
tory failure. Thirteen patients (30,2 %) developed a low output
pancreatic fistula that was treated conservatively and closed spon-
taneously within a period from 3 weeks to 3 months in all but one
cases. A female patient with a pancreatic fistula developed an ab-
dominal abscess that was drained percutaneously under U/S guid-
ance. Fistula was associated with infiltrating tumors, multiple
organ resections and soft pancreas.
CONCLUSION: Distal pancreatectomy may be performed with
low mortality and morbidity rates. The most common complica-
tion after distal pancreatectomy is a low outflow pancreatic fistula
that may be treated conservatively in most of the cases.
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A COMPARATIVE STUDY OF THE EFFECT OF
TIMING OF REFERRAL AND TREATMENT ON
RESECTABILITY AND SURVIVAL OF PATIENTS
WITH PANCREATIC AND AMPULLARY
CANCER
D. Raptis1, C. Fessas2, P. Belasyse-Smith3, J. Skipworth1,
T. Kurzawinski2
1. University College London, Department of Surgery and Interven-
tional Science
2. University College Hospital, London Department of Hepatop-
nacreaticobiliary Surgery
Aim: Prognosis in patients with pancreatic cancer (PC) is worse
than in ampullary (AC) cancer. The aim of this study was to eval-
uate relation between the delay of treatment and prognosis in
these cancers.
Methods: Data on all patients referred to Pancreatic Unit (1997-2002)
were collected prospectively and analysed (SPSS 15®) regarding the
impact of time to treatment (symptoms-referral-investigations-
treatment) on operability, resectability and survival.
Results: Of a total of 433 patients, 355 (82%) had PC and 78
(18%) AC. The median time from symptoms to referral for PC
and AC was 65(3-401) and 64(3-385), from referral to investiga-
tions 28(1-334), 26(1-155) and overall median time from symp-
toms to treatment was 101(3-792), 97(33-386) days (p>0.05). PC
patients had a significantly lower operability rate [101/355 (29%)
vs 74/78 (95%), p<0.0001] and resectability rate 33/101 (33%)
vs63/74 (85%), p<0.0001] compared to AC patients. PC patients
who had surgery had a significantly higher median time from
symptoms to treatment when compared to AC (347 vs 86 days,
p<0.0001). PC patients had a significantly lower 1, 3 and 5 -year
survival rates when compared to AC (26%, 5% and 1% vs 90%,
66% and 52% respectively, p<0.0001). Time from initial symp-
toms to treatment had no effect on survival in either of the groups
(p=0.116). PC patients who were operated and those who had a
resectable tumour had a significantly higher 5-year survival rate
than those who had no surgery (9% vs 2%, p<0.0001) and (25%
vs 5%, p<0.0001).
Conclusion: The delay of treatment may adversely affect both op-
erability and resectability rates in a small number of patients with
pancreatic cancer however it has no effect on survival of patients
with pancreatic and ampullary cancer.
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OUTCOME FROM PANCREATIC SURGERY
FOR BENIGN DISEASE IS SIMILAR TO
THAT FROM MALIGNANT DISEASE
J. Skipworth, D. Raptis, F. Prete, C. Imber, S. Olde Damink,
A. Shankar, M. Malago
Department of HPB Surgery University College London Hospital, UK
Background: Literature series reveal mortality rates of 3-4.8%
and morbidity rates of 15-73% for pancreatic surgery. We aimed
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to assess outcome following pancreatic surgical procedures for
benign and malignant disease, in our large, hepatopancreatico-
biliary tertiary centre.
Methods: Data were retrospectively collected from hospi-
tal/ICU/theatre databases for all patients undergoing pancreatic re-
section. All patients were pre-operatively discussed in a
multi-disciplinary meeting and post-operatively admitted to the In-
tensive Care Unit (ICU). All complex patients/procedures involved
an operative strategy incorporating >1 Consultant hepatopancre-
aticobiliary surgeons.
Results: 104 operations for primary pancreatic disease were per-
formed January 2007-December 2008; 76(73%) for malignant
disease and 28(27%) for benign disease (cohorts well-matched).
41(39.4%) Whipple’s procedures, 19(18.3%) distal pancreatec-
tomies, 13(12.5%) duodenal-preserving resections, 23(22.1%) by-
passes and 8(7.7%) miscellaneous procedures were performed.
27(26.0%) patients developed in-patient complications;
20(26.3%) in the malignant group and 7 (25.0%) in the benign
group(p>0.05). Complications included 6(5.8%) non-pancreatic
anastomotic leaks (5 Malignant/1 Benign), 4(3.8%) pancreatic
fistulae (2 Malignant/2 Benign) and 9(8.7%) re-admissions to
ICU (6 Malignant/3 Benign). In-hospital mortality was
0.96%(1/104); 1.3%(1/76) for patients with neoplastic disease and
0%(0/28) for benign disease(p>0.05).
Median hospital stay was 20 days for the malignant group and 14
days for the benign group(p>0.05).
Conclusions: This case-series reveals that benign and malignant
pancreatic surgery carry similar morbidity and mortality rates.
Benign pancreatic surgery should be considered carefully and
only following thorough pre-operative investigation/optimisation.
Multi-disciplinary input and the use of operative strategies in-
corporating >1 consultant surgeon may be capable of improving
outcome, as compared to traditional series described in the liter-
ature.
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POST PANCREATICODUODENCTOMY
PANCREATITIS: PREDICTORS AND OUTCOME
A. Tank, A. Prakash, R. Singh, A. Behari, A. Kumar, R. Saxena,
V. Kapoor
Department of Surgical Gastroenterology Sanjay Gandhi Post Grad-
uate Institute of Medical Sciences, India
Introduction: Pancreatic anastomotic leak is one of the compli-
cations of PD leading to high morbidity and mortality. Post pan-
creatic resection pancreatitis may be the underlying cause for
pancreatic anastomotic leak. There is only one published report
in English literature regarding predictors and outcome of post-
PD pancreatitis.
Methods: Thirty one (31/387, 8%) patients were diagnosed as
post-operative pancreatitis based on clinical, laboratory and
CECT finding. Retrospective analysis was done with regards to
predictors and outcome.
Results: “Post PD pancreatitis” was more frequent in undilated
pancreatic duct (4 mm or less) (90% Vs 69%, p=0.012) and in
ampullary tumor (87% Vs 70%, p=0.037).
Patients with ‘post-PD pancreatitis’ group had overall more com-
plications: Overall complications (93% Vs 44%, p=0.000), more
anastomotic leaks: pancreatico-jejunal anastomotic leak (45%
Vs 9%, p=0.000), hepatico-jejunostomy anastomotic leak (26%
Vs 5%, p=0.000), duodeno-jejunal or gastro-jejunal anastomotic
leak (13% Vs 13%), p=0.04); more overall bleeding (36% Vs
12%, p=0.016): intraluminal bleed (19% Vs 12%, p=0.019) and
extra-luminal bleed (26% Vs 12%, p=0.035); intra-abdominal ab-
scess (26% Vs 12%, p=0.000), delayed gastric emptying (26% Vs
12%, p=.022), wound infection (42%) Vs 24%, p=0.027), pneu-
monia (38% Vs 12%, p=0.000), need for re-operation (48% Vs
15%, p=0.000), prolonged post-operative hospital stay (mean
days, 23 Vs 17 days, p=0.002) and mortality (39% Vs 7%,
p=0.000).
Conclusion: Soft pancreas and ampullary tumor are predictors of
“post PD pancreatitis”. Post operative course of this group of pa-
tients should be continuously monitored as these patients have
more risk of most of the post operative complications and mor-
tality.
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PRE-OPERATIVE AND PATHOLOGICAL
PREDICTORS OF SURVIVAL AFTER CURATIVE
RESECTION FOR AMPULLARY CARCINOMA:
ANALYSIS OF 193 CONSECUTIVE PATIENTS
S. Partelli1, H. Kocher2, M. Falconi1, R. Salvia1, G. Butturini3,
A. Abraham2, R. Hutchins2, S. Bhattacharya2, G. Barugola1,
S. Crippa1, C. Bassi1, P. Pederzoli1
1. Department Of Surgery University Of Verona
2. Hpb Surgery Royal London Hospital
3. Surgical and Gastroenterological Dept Verona University
Background: Carcinoma of the ampulla of Vater (CAV) repre-
sents a relatively uncommon disease that has favourable progno-
sis compared to pancreatic ductal adenocarcinoma.
Aim: To describe a large series of resected, pathologically con-
firmed, CAV from two high-volume centres for pancreatic sur-
gery and to determine predictive factors for long-term survival.
Methods: The combined databases from the Department of Sur-
gery of the University of Verona, Verona and Barts & the Lon-
don HPB Centre, London were analyzed in order to identify
patients with CAV (1990 and 2008). Survival rates and recurrence
were evaluated and predictors were identified.
Results: We identified 193 patients who underwent pancreatico-
duodenectomy (PD) for CAV. Jaundice (n=127) was the most
common presenting symptom. Postoperative morbidity and mor-
tality rates were 49.7% and 5.7% respectively. Sixty-eight patients
were treated with adjuvant therapy. At a median follow up of 20
months, the 5-years disease specific survival rates was 59.2%.
Jaundice, resection type (Whipple’s PD versus pylorus-preserving
PD), differentiation (G3 versus G1/G2), stage, lymph node
metastases, number of lymph node resected (<16), the number of
metastatic lymph nodes (>3), lymph node ratio (LNR)
(0,2<LNR≤ 0,4 and LNR>0,4) were significant predictors of re-
currence on univariate analysis.
Only jaundice, poor differentiation, number of lymph nodes re-
sected (<16) and number of metastatic nodes (>3) were signifi-
cant predictors on multivariable analyses.
Conclusion: Presence of jaundice is the most powerful pre-oper-
ative and the poor differentiation, the number of resected and
metastatic nodes postoperative, adverse prognostic factors after
PD for ampullary carcinoma. These factors should identify po-
tential candidates for adjuvant therapy.
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AGGRESSIVE APPROACH TO ACINAR CELL
CARCINOMA OF THE PANCREAS: A SINGLE
INSTITUTION EXPERIENCE AND A
LITERATURE REVIEW
G. Butturini1, M. Pisano2, M. Donofrio3, A. Auriemma4,
P. Capelli5, A. Scarpa5, C. Bassi2, P. Pederzoli2
1. Surgical and Gastroenterological Dept Verona University
2. Department of Surgery University of Verona
3. Radiological Dept Verona University
4. Oncological Dept Verona University
5. Pathological Dept Verona University, Italy
Background: Acinar cell carcinomas (ACCs) account for 1% of
primary pancreatic tumors; not standardized treatment is avail-
able. Pancreatoblastomas and endocrine tumors share some his-
tological patterns with ACCs.
Aim: To analyze clinically and pathologically a series from a high
volume pancreatic center and to review the Literature to mis-
match our experience.
Patients and Methods: Retrospective review of prospective col-
lected data from 1990-2007 included patients underwent curative
pancreatic resection of neoplasm having features of pure ACCs.
Pathological specimens were reviewed. Follow-up ended on April
2008. Literature search was performed by Pubmed and
COCHRANE library.
Results: We observed 9 patients (6 males) with a median age of
53 years. R0 resection was possible for all but one R1. We had
no major complications and no mortality. All 9 specimens were
pure ACCs. Follow up is complete for all patients with a median
of 31 months. 56% of patients received chemotherapy. We ob-
served 7 deaths; median overall survival is 31 months, disease free
survival was 19,2 months. Seven patients had postoperative liver
metastases treated by modification of chemotherapeutic schema,
ablation techniques or reiterate surgery: in this group one patient
is alive without disease 67 months from pancreatic resection. Sim-
ilar results with aggressive treatment are reported in the two
largest series published by Johns Hopkins and Memorial Sloan-
Kettering Cancer Center groups accounting for 14 and 18 resec-
tions respectively.
Conclusion: ACCs represent a rare and poor prognosis tumor of
the pancreas. Aggressive approaches could guarantee good re-
sults also in distant recurrences patients
Holen KD, Klimstra DS, Hummer A, Gonen Mithat, Conlon K,
Brennan M, Saltz LB. Clinical characteristic and outcomes from
an institutional series of acinar cell carcinoma of the pancreas
and related tumours. J Clin Oncol 2002; 20:4673-4678.
Seth AK, Argani P, Campbell KA, Cameron JL, Pawlik TM,
Schulick RD, Choti MA, Wolfang CL. Acinar cell carcinoma of
the pancreas: an institutional series of resected patients and re-
view of the current literature. J Gastrointestinal Surg 2008; 12
(6): 1061-1067.
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LAPAROSCOPIC RESECTION OF PRIMARY
CARCINOMAS OF THE PANCREAS,-
POSTOPERATIVE OUTCOME AND SURVIVAL
B. Røsok, I. Pavlik Marangos, A. Kazaryan, A. Rosseland,
O. Villanger, I. Gladhaug, Ø. Mathisen, B. Edwin
Division of Surgery Rikshospitalet, Norway
Background: The laparoscopic approach has gained increased ac-
ceptance for resections of pancreatic neoplasms. There are lim-
ited data with regards to the long term results of laparoscopic sur-
gery for pancreatic malignancies as most studies describe results
following resection of benign lesions in selected patients.
Aim: To study postoperative outcome and survival following la-
paroscopic resection of primary pancreas carcinomas.
Methods: Since 1997, 148 patients have undergone surgery for
pancreas lesions in our institution. 25 patients (15 female, 10
male, median age 63 years) were diagnosed with primary carci-
nomas of the pancreas (17% of the total). 20 patients underwent
laparoscopic resection.
Results: 17 patients had distal resection with splenctomy (in-
cluding combined, èn bloc resections of adjacent organs). Other
resections included 1 Whipple procedure, 1 subtotal distal resec-
tion and 1 resection of ectopic pancreas. 5 patients were deter-
mined non-resectable. 2 procedures were converted. There were
17 ductal adenocarcinomas, 2 IPMN carcinomas, 2 cystadeno-
carcinomas, 1 sclerosing adenocarcinoma, 1 adenosquamous car-
cinoma, 1 acinary cell carcinoma and 1 pancreatobiliary
carcinoma.
Median operative time for distal resections with splenectomy was
227 minutes (150-313). Median hospital-stay was 5 days (1-30).
One patient had an R1 resection. Median tumour diameter was
50 mm (4-180) and median number of retrieved lymph nodes
were 5 (0-21). 1 patient developed a grade B fistula. 30 day mor-
tality was 4% (n=1).
Estimated 5 year survival following distal resection with splenec-
tomy was 34%.
Conclusion: Laparoscopic resection in patients with malignant
lesions in the distal pancreas can be performed safely and with
acceptable 5-year survival.
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SURGERY FOR PANCREATIC MATASTASES:
CLINICAL AND LONG-TERM OUTCOME WITH
ANALYSIS OF PROGNOSTIC FACTORS.
O. Strobel1, T. Hackert1, W. Hartwig1, F. Bergmann2, M. Wente1,
U. Hinz1, S. Fritz1, L. Schneider1, M. Büchler1, J. Werner1
1. General, Visceral and Transplantation Surgery
2. Institute of Pathology, University Hospital Heidelberg, Heidelberg,
Germany
Purpose: Pancreatic metastases are uncommon and little is
known about long-term outcome after resection or about prog-
nostic parameters. We aimed to evaluate perioperative and long-
term results after surgery for pancreatic metastases and to define
prognostic factors. Patients and Methods: From a prospective
database all consecutive operations performed for pancreatic
metastases between 10/2001 and 07/2008 at our institution were
identified. Clinicopathological details, perioperative and long-
term results were analyzed. Uni- and multivariate analysis were
performed to identify parameters associated with overall and dis-
ease-free survival. Results: Forty-six operations were performed
for pancreatic metastases in 44 patients. Primary tumors included
31 (67%) renal cell carcinomas and 15 other entities. Pancreatic
resections were performed in 44 cases and include 18 multivis-
ceral resections. Two patients underwent palliative bypass pro-
cedures. Morbidity was 33% and mortality 4.3%. Pancreatic
metastases occurred after a median interval of 7.1 months after
the primary tumors. 27 patients (59%) presented with additional
extrapancreatic disease. With a median follow-up of 32.1 months,
overall 3- and 5-year survival were 69.1% and 56.7%, disease-free
3- and 5-year survival were 37.2% and 33.0%, respectively. Non-
RCC primary tumors, a disease-free interval of less than 36
© The Authors
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months and additional extrapancreatic disease were associated
with shorter overall survival. Additionally, a prior recurrence was
associated with shorter disease-free survival. Conclusions: Re-
section for pancreatic metastases can be performed safely and
with good long-term results and can thus be recommended as
treatment of choice. Especially in patients with isolated pancre-
atic metastases, long-term survival can be expected.
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DIAGNOSIS AND MANAGEMENT OF
HAEMORRHAGE AFTER
PANCREATICOGASTROSTOMY. A SINGLE
CENTER EXPERIENCE
F. Scopelliti1, G. Butturini2, M. Dal Molin1, R Salvia3, C. Bassi1,
P. Pederzoli1
1. Surgical Dept., Verona University
2. Department of Surgical and Gastroenterological Verona Univer-
sity, Italy
BACKGROUND/AIMS – Haemorrhage after pancreatic resec-
tion is a life-threatening complication. It can be defined by 3 pa-
rameters: onset, location, and severity. Nevertheless, the most
frequent source of bleeding is pancreatic anastomosis. Early di-
agnosis and correct management of bleeding arising from the
pancreatic anastomosis is mandatory in order to preserve the
anastomosis and the pancreatic remnant. Surgery still remains
the best choice in the management of massive haemorrage, es-
pecially in the early postoperative period.
Pancreatogastrostomy is an option in managing the pancreatic
remnant, associated with low morbidity and mortality rate. In
pancreatogastrostomy performed through anterior gastrotomy,
diagnosis and management of bleeding arising from the pancre-
atic anastomoses is easy, safe and effective to avoid damage to
the anastomosis and the pancreatic remnant.
METHODS – From January 2002 to November 2008 153 pan-
creatic resections with pancreaticogastrostomy were performed
in our Institution. Patients who developed postoperative bleeding
were analyzed.
RESULTS – A severe postoperative haemorrhage occurred in 7
patients (4,6%). Four patients had early and three had late bleed-
ing. Easy and quick diagnosis was obtained by CT scan and/or
EGDS. Two patients had extraluminal bleeding successfully
treated by immediate relaparotomy. In five patients the bleeding
source was the pancreaticogastrostomy: one patient was treated
endoscopically and four underwent anterior gastrotomy with con-
trol of bleeding without undoing pancreatic anastomosis.
CONCLUSIONS – Severe haemorrhage after pancreaticogas-
trostomy is a relatively rare event, safely manageable by rela-
parotomy and anterior gastrotomy. This approach allows to
prevent damage to the pancreatic remnant and pancreatic and
biliary anastomoses. Endoscopy is a valid option in late bleeding.
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CYSTIC FIBROSIS DISEASE PRESENTING AS
PANCREATIC ASCITES IN AN ADULT PATIENT.
A CASE REPORT
N. Kopanakis, A. Koliopanos, A. Katseli, G. Vasiliadis,
S. Avlonitis, H. Tsipras, H. Margaris
3rd Department of Surgery General Hospital of Athens “ G.Genni-
matas”, Athens, Greece
INTRODUCTION: Acute pancreatitis (AP) may rarely be the
presenting symptom in adolescent or adult patients with cystic fi-
brosis (CF). We report hereby a case of a 19 years old male who
initially presented with recurrent episodes of AP and subse-
quently developed a pancreatic pseudocyst and pancreatic ascites
requiring surgical intervention.
CASE PRESENTATION: A 19 years old male was admitted in
our hospital with fever, mild abdominal tenderness and a pro-
gressive abdominal distension one month prior to admission. The
MRI scan demonstrated 2 large pancreatic pseudocysts commu-
nicating with the main pancreatic duct. One of the pseudocysts
presented signs of rupture in the peritoneal cavity and ascites for-
mation. Due to the uncommon age presentation of the symptoms,
a detailed history, lung MRI, sweat test and genetic testing with
a known mutation (621+1G>T) lead to a subsequent diagnosis
of CF. Due to the increase of the ascites volume and failure of
conservative treatment the patient underwent an explorative la-
parotomy. A distal pancreatectomy was performed, including
pseudocysts excision and ascites fluid evacuation. A drain was left
in left subdiaphragmatic space draining large amounts of amy-
lase-free ascetic fluid for a month postoperatively and thereafter
the patient was dismissed in a good general condition.
CONCLUSION: CTFR mutations should be considered in cases
of chronic or recurrent pancreatitis in young patients. Pancreatic
ascites is a rare complication of acute pancreatitis with pseudocyst
formation and despite endoscopic and/or minimally invasive ra-
diologic modalities a definitive surgical treatment is sometimes
unavoidable.
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PANCREATIC-DUODENAL INJURY AFTER
BLUNT ABDOMINAL TRAUMA: TWO STEPS
SURGICAL MANAGEMENT
P. Mezzatesta, G. Toia, A. Messina, G. Barranco, P. Marchesa
Chirurgia Generale e d’Urgenza, Ospedale Civico, Palermo, Italy
We present a case of complicated hepatic and pancreatic-duode-
nal trauma secondary to blunt abdominal trauma.
A 25 yo man arrived at AE conscious but hypotensive after blunt
abdominal trauma. He was resuscitated and taken for emergency
CT scan that showed free air in abdomen, massive haemoperi-
toneum secondary to lesion of the 4° segment of the liver, a dis-
rupted pancreatic head with active bleeding from sma. There was
a large retroperitoneal haematoma due to multiple right kidney
fractures and an aortic dissecation from ima to right iliac artery.
He underwent emergency exploratory laparotomy. We found a
massive hemoperitoneum with active bleeding from the disrupted
pancreatic head with complete trans-section of the 3° portion of
the duodenum.
On the liver there was a laceration of the 4° and I° segment.
We achieve a temporary haemostasis with gauzes and after
Pringle manoeuvre, we achieved haemostasis on the liver by
means of prolene sutures. After releasing the Pringle, a DCP was
necessary to obtain complete haemostasis on the duodeno-pan-
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creatic region.
Since the patient showed acidotis, hypothermia and required 7 U
of PRBC and 10 U of FFP, we decided to delay reconstructive
surgery draining the pancreatic and biliary duct externally and
patient was transferred to ICU. After 4 hrs he became extremely
hypotensive and required 2 more u of PRBC and inotropic sup-
port was started. At that time there were 700 ml of blood in the
drainage. The pt went back to the OR but no source of active
bleeding was found.
After 5 days in the ICU the reconstructive surgery was completed
successfully and pt was discharged home 21 days after initial sur-
gery.
He was readmitted 15 days later for fever and leucopenia. At CT
a 10 cm collection on 4° segment was found and treated percu-
taneously with success.
Conclusion: complicated Pancreatic trauma represent a challenge
for surgeons dealing with emergencies. Mortality for pancreatic
trauma has remained unchanged, at least in the last 30 years,
ranging from 17% to 46%. (1,2). Pancreatic injury is a rare oc-
currence. The pancreas is involved in 0.2 % to 3 % of all abdom-
inal traumas (2, b). many experienced trauma surgeons will have
minima exposure to these challenging injuries(a). We think that
delayed two step surgery represent a safe option, allowing
haemostasis at first time and safe reconstruction in the second
step with pt in better general conditions and pancreas has an in-
creased firmness allowing a better anastomosis as reported by
Yong.
References:
1. Jones, R.C., Management of Pancreatic Trauma, Ann.Surg.,
Vol. 187, 555-562, 1978
2. Scollay, J.M., A Population-Based Study of Pancreatic Trauma
in Scotland, World J Surg. 30: 2136-2141, 2006
3. De Kerpel, W., Whipple Procedure after Blunt Abdominal
Trauma, J Trauma., 53: 780-783, 2002
P 298
SURGICAL MANAGEMENT OF PANCREATIC
PSEUDOCYSTS
M. Karavalaki, C. Mirelis, T. Liappis, G. Kapoutsis,
A. Katsourakis, E. Hatzitheoklitos
Surgical Department, General Hospital “O AGIOS DIMITRIOS”,
Thessaloniki, Greece
Background: Elective surgical drainage of pancreatic pseudocysts
is performed only in symptomatic patients.
Aim: The aim of this study is to present a series of patients oper-
ated for pancreatic pseudocysts, being unable undergo to endo-
scopic drainage.
Patients – Methods: This retrospective study concerns to 9 cases
of pancreatic pseudocysts, from 2006 to 2008. General charac-
teristics of the patients, the anatomical and topographical data
of the pseudocysts, their etiology, their management and in-hos-
pital morbidity and mortality were recorded.
Results: The male: female ratio was 8:1 and the mean age was
52.1±4.7 (33-75) years. Calculus pancreatitis was the cause of 7
cases of pseudocysts while alcoholic pancreatitis was present in 2
cases. The mean diameter of pseudocysts was 7.8 ±1.3 (5.6-12.3)
cm. The precise anatomical positions of the pseudocysts as well as
their correlation with pancreatic duct were studied before sur-
gery by ultrasound, CT and MRI. In 6 cases the pseudocysts were
drained into a Roux en Y jejunal loop and in the other 3 into the
stomach. The mean in-hospital stay was 12±3 (7-18) days and
morbidity 22.2% (2 patients). CT follow up in 3 and 12 months
showed no recurrence.
Conclusions: Surgical drainage of pancreatic pseudocysts into al-
imentary tract performed in symptomatic patients is recognized
as safe and effective method, presenting also the lowest incidence
of recurrence.
References
1. Andren – Sandberg A, Dervenis C. Pancreatic pseudocysts in
the 21st century. Part II: natural history. JOP 2004 Mar; 5(2):
64-70.
Andersson B, Nilsson E, Willner J, Andersson R. Treatment and
outcome in pancreatic pseudocysts. Scand J Gastroenterol 2006
Jun; 41(6): 751-6.
Bhasin DK, Rana SS, Singh K. Clinical usefulness of a treatment
algorithm for pancreatic pseudocysts. Gastrointest Endosc. 2008
Sep; 68(3): 612-3.
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TRANSCUTANEOUS TRANSHEPATIC
ENDOBILIARY AND ENDOSCOPIC
INTERVENTIONS IN THE TREATMENT OF
AN OBSTRUCTIVE JAUNDICE RESULTING
FROM TUMOROUS GENESIS
B. Kotiv, S. Ivanusa, S. Alientiev, I. Dzidzava, D. Shershen
Medical Military Academy, Saint-Petersburg, Russia
Aims: to evaluate the effectiveness of less invasive interventions
in the treatment of an obstructive jaundice resulting from tu-
morous genesis.
Methodology: We included 155 patients with obstructive jaun-
dice of tumorous genesis: 88 patients with a head of pancreas
cancer, 48 patients with primary and metastatic liver tumors, in 19
cases – tumors of biliary tract. We performed the next less inva-
sive interventions: transcutaneous transhepatic external catch-
ment - 15, transcutaneous transhepatic external and internal
catchment of bile-ducts and stenting of bile-ducts – 66, endo-
scopic stenting of bile-ducts – 69. A control group was presented
by 53 patients with biliodigestive anastomoses or with cholecys-
tostomy.
Results. An adequate catchment was achieved by using the tran-
scutaneous transhepatic internal catchment of bile-ducts and
stenting of bile-ducts. The transcutaneous transhepatic external
catchment could not eliminate a hyperbilirubinemia efficiently.
The most patients in control group had a recurrence of jaundice
(72,4% - with cholecystostomies, 50% of performed biliodiges-
tive anastomoses). The best results in endobiliary and endoscopic
interventions we got in cases with obturation of common bile duct
coupled with volume of affected liver less than 50%. In cases with
more extensive liver affection the transcutaneous transhepatic ex-
ternal and internal catchment of bile-ducts was less effective and
endoscopic interventions were not expedient considering a mul-
tilayer block. An adequate transcutaneous transhepatic external
and internal catchment of bile-ducts and stenting of bile-ducts se-
cured a long-term remission of jaundice in a period from 6 month
to 2,5 years. In fact it allowed accomplishing a polychemother-
apy. Combining the biliary catchment with polychemotherapy in-
creased the median survival from 6,7 t 15,1 months, in 11 cases
it permitted to performed radical surgical interventions.
Conclusion. The less invasive interventions in the treatment of
an obstructive jaundice resulting from tumorous genesis are more
effective than traditional surgical ones, consequently it allowed
to use polychemotherapy and radical surgery in deferred order.
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A NEW DUPLOCATH MIS TM (MINIMALLY
INVASIVE SYSTEM) TO FACILITATE
PANCREATIC STUMP MANAGEMENT DURING
LAPAROSCOPIC DISTAL PANCREATECTOMY
R. Lochan, J. French, S. Robinson, S. Noormohamed,
K. Oppong, M. Nayar, R. Charnley, S. White
Department of HPB and Transplant Surgery, Freeman Hospital,
Newcastle, UK
Background: Laparoscopic distal pancreatectomy is becoming in-
creasingly recognised as a treatment option for tumours in the dis-
tal part of the pancreas. Potentially it shortens hospital stay and
analgesic requirements when compared to open distal pancreatec-
tomy. One of the drawbacks is the potential for pancreatic leaks
from the cut surface of the pancreatic stump. Fibrin sealants are a
two component biological system consisting of fibrinogen and
thrombin, Tisseel also contains a protease inhibitor Aprotinin which
may facilitate stump management by reducing pancreatic leaks and
inhibiting exocrine enzyme activation. The aim of this study was to
describe the use of a new Duplocath MIS system TM for Tisseel
application during laparoscopic distal pancreatectomy.
Method: All patients underwent preoperative investigations in-
cluding triple phase CT scanning in addition to EUS and FNA of
any cyst aspirate where appropriate. A standard pneumoperi-
toneum is achieved using a blunt 12mm port at either the um-
bilicus or in a supra-umbilical position. Three further working
ports are usually placed and a Pfannenstiel incision is used for re-
moval of the specimen. The pancreas is mobilised in a standard
fashion using the ACE Harmonic. The neck of the pancreas is di-
vided with a 60mm Echelon (Endo-Ethicon) linear stapler. The
pancreas is removed using an endo-2 catch bag through the Pfan-
nenstiel incision. Once haemostasis is achieved the Duplocath
MIS system is used to seal the pancreatic stump.
Results: Overall 7 patients (3F:4M) are included in the series (age
range 35-80yrs). Histology confirmed mucinous cystic tumours
(n=3), IPMN (n=2), insulinoma (n=1) and chronic pancreatitis
with a ductal stone (n=1). Fibrin sealant was applied in 4 patients
as in the early series the Duplocath MIS system was still under de-
velopment. Median hospital stay was 6 days, range (4-29). One
patient developed a pancreatic leak. This patient also had a la-
paroscopic repair of a colo-vesical fistula. Fibrin sealant was not
used in this patient and post-operative complications lead to a
prolonged hospital stay (29 days).
Conclusion: As with open distal pancreatectomy , laparoscopic
distal pancreatectomy can be complicated by a pancreatic leak.
There is still no absolute method to prevent this complication but
the use of a fibrin sealant containing a protease inhibitor may fa-
cilitate stump management by sealing the pancreatic duct and po-
tentially preventing pancreatic enzyme activation.
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GAMMA SECRETASE INHIBITORS AS
PROMISING THERAPEUTIC AGENTS IN
PANCREATIC ADENOCARCINOMA
C. Mann1,2, C. Neal1,2, C. Briggs1,2, M. Cheng1,2, W. Steward1,
M. Manson2, D. Berry2
1. Department of Cancer Studies and Molecular Medicine, Univer-
sity of Leicester, UK
2. Department of Hepatobiliary and Pancreatic Surgery, University
Hospitals of Leicester, UK
Introduction: Pancreatic carcinoma has a dismal prognosis and
is largely resistant to current chemotherapeutic agents. The
Notch signalling pathway plays a role in carcinogenesis of several
solid malignancies. The aim of this study was to determine the
role of Notch in pancreatic carcinoma and investigate its poten-
tial therapeutic modulation by inhibiting gamma secretase, the
enzyme responsible for pathway activation.
Methods: Four pancreatic adenocarcinoma cell lines were used
(ASPC-1, BxPC-3, MiaPaCa-2, PANC-1) to examine the effect
of gamma secretase inhibition (GSI-I, Calbiochem, UK) on cell
proliferation , viability (ATP assay), apoptosis (Annexin V bind-
ing) and cell-cycle.
Results: All cell lines expressed Notch pathway constituents.
GSI-I inhibited activation of Notch-1, -3, and -4, as well as ex-
pression of the target gene Hes-1 in a dose-dependent manner.
Treatment with 0.1-5µM also dose-dependently reduced prolif-
eration in all cell lines, associated with G2-M cell-cycle arrest,
and resulted in reduction in viability and increased apoptosis. All
lines entered apoptosis 4-8 hours after treatment, with >90% of
cells necrotic by 72 hours after treatment with 5µM GSI-I. At
doses as low as 0.1µM, GSI-I induced apoptosis at 24 hours.
Combination of GSI-I and Gemcitabine resulted in an additive
reduction in cell viability and increase in apoptosis, compared to
treatment with either agent alone. Knockdown of Notch 1 with
siRNA significantly decreased viability in the three lines express-
ing this form.
Conclusions: The Notch pathway is important in the pathogene-
sis of pancreatic adenocarcinoma.
This data demonstrates that modulation of this pathway using
gamma secretase inhibitors is a promising therapeutic approach.
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PANCREATIC METASTASES: A DIAGNOSTIC
CHALLENGE
C. Triantopoulou1, C. Avgerinos2, E. Zouros2, A. Sofianidis2,
N. Gouvas2, C. Dervenis2
1. Computed tomography department
2. 1st Surgery department, Konstantopouleion general Hospital,
Athens, Greece
Background: Metastatic lesions of the pancreas are uncommon
accounting for approximately 2% of pancreatic malignancies.
Many tumors involve the pancreas secondarily and may manifest
with different clinical and imaging characteristics. Although many
patients have widespread disease isolated metastases can be
found. Surgical management is associated with improved survival
in these cases. The experience of the pancreatic surgery unit and
imaging department of our hospital in many patients presenting
with pancreatic metastases is displayed.
Aim: To describe the imaging features of pancreatic metastases
and present differential diagnostic criteria from other pancreatic
tumors.
Patients-methods: CT was performed in all patients using a ded-
icated pancreatic imaging protocol. MRI was performed in a
small number of cases presenting diagnostic dilemmas. Synchro-
nous and metachronous cases were encountered.
Results: Hypovascular and hypervascular solitary or multiple le-
sions were found. Imaging appearance was related to the primary
tumor. Metastases from renal cell carcinoma and melanoma were
hyperdense after contrast administration, while metastases form
lung, gastric and colon cancer appeared as hypodense lesions with
a peripheral rim of enhancement. Pancreatic duct showed no di-
latation in all cases. All surgical candidates underwent partial
pancreatectomy or enucleation of metastatic lesions. Imaging
findings correlated well with pathology results. Accurate diagno-
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sis of metastases was possible by imaging in all the patients. No
surgical candidates received chemotherapy with promising results
in cases of colon and renal cancer metastases.
Conclusion: Preoperative diagnosis of a secondary pancreatic
tumor is essential for proper patient management. In certain
cases prolonged survival may be achieved with successful surgical
resection.
References:
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PREDICTION OF INFECTED PANCREATIC
NECROSIS USING A DATA MINING
A. Litvin, O. Jarikov
Gomel Regional Clinical Hospital, Gomel State Medical Univer-
sity, Belarus
Background. Infected pancreatic necrosis (IPN) is associated with
high morbidity and mortality and is mandatory for surgical or ra-
diosurgical intervention.
Aim. The aim of this study was to construct and validate a Data
Mining (DM) to IPN.
Methods. All patients who presented with severe acute pancre-
atitis from January 1996 to December 2007 were reviewed. Pres-
entation data on admission and at 48 hours were collected.
APACHE II and Glasgow severity (GS) score were calculated. A
Data Mining ((artificial neural networks (ANN) and support vec-
tors machine (SVM)) was created and trained to predict devel-
opment of IPN and mortality from AP; 25% of the data set was
withheld from training and was used to evaluate the accuracy of
the DM. Accuracy of the DM in predicting infected pancreatic
necrosis was compared with APACHE II and GS scores.
Results. A total of 1564 patients with acute pancreatitis were
identified of whom 391 (25.0%) fulfilled the clinical and radio-
logical criteria for severe pancreatitis and 91 patients died (5.8%).
Median APACHE II score at 48 hours was 12 (range, 0 to 23).
DM was more accurate than APACHE II or GS scoring systems
at predicting IPN (P < .05 and P < .01, respectively).
Conclusions. A DM (ANN and SVM) was able to predict devel-
opment of infected necrotizing pancreatitis with considerable ac-
curacy and outperformed other clinical risk scoring systems.
Further studies are required to assess its utility in aiding man-
agement decisions in patients with severe acute pancreatitis.
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PROTOCOL-DRIVEN PROGNOSTICATION
OF ACUTE PANCREATITIS
D. Raptis1, J. Skipworth1, Y. Sheena2, N. Patel2, C. Morkane2,
A. Shankar2, C. Imber2, M. Malago2
1. University College London Department of Surgery and Interven-
tional Science
2. University College London Hospital, NHS Foundation Trust De-
partment of Hepatobiliary and Pancreatic Surgery
Background: Acute pancreatitis (AP) is common and its preva-
lence has continued to rise steadily in recent decades. It bears
with it a significant burden of morbidity and mortality. UK na-
tional guidelines recommend the use of validated scoring systems
to assess severity and prognosticate all cases of AP. [1]
Aims: Our objective was to assess local compliance with this stan-
dard and implement strategies to improve early prognostication
of AP.
Methods: In July 2007, our department implemented a protocol
for the standardisation of assessment/management of all patients
with suspected AP, whilst still within the emergency department
(ED). Data collected 7 months before and 6 months after the in-
troduction of the protocol included patient demographics, aeti-
ology, results of laboratory and radiological investigations and
record of prognostic evaluation (Ranson, Glasgow or APACHE-
II).
Results: 120 patients with AP were assessed, prior to protocol in-
troduction and 117 patients after. A significant improvement, fol-
lowing implementation of a protocol-driven strategy, was
observed in the collection of basic blood tests and the use of scor-
ing systems (see Table). No significant differences were seen in
rates of early imaging or diagnosis (within 48 hrs). There is a rel-
atively high proportion of patients being initially diagnosed with
idiopathic AP.
Conclusions: Protocol-driven strategies can lead to improvements
in the management and outcome of potentially serious condi-
tions, such as AP. In this instance, they promote standardisation
of investigation and management, whilst protocol forms, inserted
into the notes, prompt further completion by specialist teams fol-
lowing admission, as well as serving as a formal record of the pa-
tient’s assessment. A possible reason for initial poor management
and prognostication of AP is the reliance upon expert opinion
and sophisticated imaging that are available in large, tertiary cen-
tres.
References
UK Working Party on Acute Pancreatitis. UK guidelines for the
management of acute Pancreatitis. Gut 2005;54;1-9
Table of Results
*ABG: Arterial Blood Gasses
**Initial diagnosis by the admitting Doctors
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PORTAL OR SUPERIOR MESENTERIC VEIN
RESECTION FOR PANCREATIC HEAD
ADENOCARCINOMA: PROGNOSTIC VALUE
OF THE LENGTH OF VENOUS RESECTION
Y. Kaneoka, A. Yamaguchi, M. Isogai
Department of Surgery, Ogaki Municipal Hospital, Japan
Background. The type of vein involvement that is appropriate for
portal (and superior mesenteric) vein resection (PVR) for pan-
creatic cancer has not been discussed adequately.
Aim. Surgical outcome of PVR was investigated and clarified the
validity of PVR.
Methods. Between 1993 and 2006, 84 patients with invasive pan-
creatic head adenocarcinoma were resected by pancreatoduo-
denectomy with macroscopically curative resection. Forty-two
patients received PVR by means of segmental resection with end-
to-end anastomosis in 27 patients and autologous vein graft in 15
patients. Venous involvement was classified macroscopically as
unilateral involvement (180 degree or less, n=27) or circumfer-
ential involvement (n=15) and as short (the length of PVR < 3
cm, n=15) or long (>3 cm, n=27).
Results. Median and 5-year survivals according to PVR status were:
without PVR (n=42), 26 mo and 32%; PVR (n=42), 12 mo and
17% (p= 0.039), and limiting to R0 (histologically curative resec-
tion) patients, those were: without PVR (n=39), 26 mo and 34%;
PVR (n=32), 20 mo and 23% (p= 0.17). In patients with PVR
there were no statistical differences in survival between those re-
sected with or without a venous allograft and those with unilateral
or circumferential involvement; however, short PVR showed better
5 year survival than long PVR (39% vs. 4%, p=0.017) despite sim-
ilar positive rates of histologic venous invasion.
Conclusions. PVR has comparable survival compared to no PVR
only in patients undergoing an R0 resection. PVR less than 3 cm
in length can result in respectable survival rates.
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FACTORS AFFECTING THE LIVER
METASTASIS OF PANCREATIC DUCTAL
ADENOCARCINOMA AFTER SURGICAL
RESECTION
K. Paik1, J. Heo2, S. Choi2
1. Hanil General Hospital Kepco Medical Foundation
2. Samsung Medical Center Sungkyunkwan University, School of
Medicine, Seoul, Korea Republic
Purpose: Most patients who underwent a curative resection for a
pancreatic ductal adenocarcinoma (PDAC) develop recurrence,
usually in the liver and at retroperitoneal area, which has been
associated with the poor prognosis of a PDAC. The aim of this
study is to investigate risk factors affecting the liver metastasis of
PDAC after resection.
Methods: We retrospectively analyzed 101 PDAC patients who un-
derwent surgical resection at the Samsung Medical Center, Seoul,
South Korea, between January 2000 and December 2004. Forty one
patients with liver metastasis were analyzed for the time of metasta-
sis, prognostic factors affecting liver metastasis, and survival.
Results : Liver metastasis were found in 40.6%. The median time
of the liver metastasis(n=41) was 6.0±4.6 month. Almost liver
metastasis occurred within 1 year. In univariate analysis, tumor
size, preoperative CA19-9, perineural invasion were factors af-
fecting the liver metastasis after resection. In multivariate analy-
sis, tumor size was the most important factor for liver metastasis.
In univariate analysis, tumor cell differentiation was significant
to liver metastasis in low-risk group of liver metastasis.
Conclusion: Liver metastasis after resection of PDAC occur early
and show poor survival. Tumor size was the poorest indicator for
liver metastasis after resection.
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GREEN TEA POLYPHENOLS AMELIORATES
PANCREATIC INJURY IN MURINE
EXPERIMENTAL ACUTE PANCREATITIS
B. Babu1, G. Malleo2, E. Mazzon3, R. Di Paola3, A. Siriwardena1,
S. Cuzzocrea3
1. Hepatobiliary Surgery Unit, Manchester Royal Infirmary, Man-
chester, UK
2. Department of Surgical and Gastroenterological Sciences; Gen-
eral Surgery B, “G.B. Rossi” Hospital, Verona, Italy
3. Department of Clinical, Experimental Medicine and Pharmacol-
ogy, Torre Biologica, Policlinico Universitario, Messina, Italy
Introduction: Green tea polyphenols (GTP) are naturally occur-
ring compounds with powerful anti-inflammatory properties me-
diated by inhibition of oxidative stress and nuclear factor kappa
B (NF-kB) pathways. GTP reduce inflammation in experimental
colitis and renal injury. This study investigates the effect of Green
Tea Polyphenols in a cerulein-induced murine model of acute
pancreatitis (AP).
Methods: CD Mice median weight 37.7g (Range 33-41 g) were
allocated to the following groups at random: control, AP, AP +
GTP and GTP alone. AP was induced by serial intraperitoneal
administration of cerulein (hourly x6, 50µg/kg). GTP (25µg/kg)
was administered intraperitoneally at 1, 3 and 6 hours after the in-
duction of AP. Animals were sacrificed at 24 hours after the first
administration of cerulein. Endpoints were histological and bio-
chemical features of AP; levels of IkB-α & phospho-NF-kB (as
indicator of NF-kB activity); expression of adhesion molecules;
neutrophil infiltration (myeloperoxidase activity); TNF-α, TGF-
β and VEGF and the expression of the enzyme poly-(ADP ri-
bose) Synthetase (PARS). Furthermore, we evaluated the
presence of apoptosis by TUNEL assay and the expression of Fas-
ligand, Bax and Bcl-2 proteins.
Results: Cerulein produced severe haemorrhagic AP. Interven-
tion with GTP reduced histologic and biochemical features of AP.
Western Blot analysis showed significant NF-kB inactivation. Im-
munostain showed reduction in ICAM-1, TNF-α, TGF-β, VEGF
and PARS, together reduction in neutrophil accumulation and
myeloperoxidase. All apoptosis markers were down-regulated.
Conclusion: Green Tea polyphenols are potent inhibitors of pan-
creatic injury in experimental acute pancreatitis.
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TOWARDS A NO-LAPAROSCOPY STAGING
ALGORITHM FOR PATIENTS UNDERGOING
PANCREATICODUODENECTOMY
M. Junejo, A. Sheen, A. Siriwardena
Regional Hepatobiliary Surgery Unit, Manchester Royal Infirmary
Department of Surgery, University of Manchester, UK
Introduction: Laparoscopy is a traditional component of the stag-
ing of pancreas cancer. However, modern, high-resolution multi-
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slice computed tomography provides a very accurate assessment
of the local extent of tumour and of small-volume metastatic dis-
ease. This study reports the outcome of a no-laparoscopy man-
agement strategy in the staging of pancreatic cancer.
Methods: During a 6 year period, 130 consecutive patients un-
derwent trail dissection for Whipple pancreaticoduodenectomy
under the care of an individual HPB surgeon (AKS). A prospec-
tively applied staging protocol consisted of high-resolution multi-
slice CT, cardiopulmonary exercise testing (CPEx – since 2007)
plus endoscopic ultrasound with EUS-FNA for cytology and tu-
mour markers for all cystic lesions. Laparoscopic ultrasonogra-
phy was available but not utilised.
Results: Laparoscopy was used selectively in 14 (11%) with large
primary lesions or back pain as presenting symptom. Three pa-
tients in the laparoscopy series (25%) went on to have trial dis-
section without resection. Eleven had negative laparoscopy and
went on to have resection. Overall, 12 patients underwent trial
dissection without Whipple. Reasons for inoperability included
tumour adherence to portal vein in 6, small volume peri-pancre-
atic abscess in 2, adherence to IVC in 2 and liver metastases (con-
firmed on intra-operative frozen section) in 2. 118 underwent
pancreaticoduodenectomy. There were two post-operative in-
hospital deaths in the 118 Whipple patients (1.7% mortality).
Conclusion: Contemporary staging algorithms continue to evolve.
CPEx for co-morbidity, combined with high-resolution CT and
EUS-FNA for cystic tumours is a rapid and sophisticated path-
way. These findings question the validity of the dogma of rou-
tine laparoscopy prior to pancreaticoduodenectomy.
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SYNDROME OF THE DEFERRED DIGESTION
(SDD) AFTER PANCREATOJEJUNOSTOMY
IN CHRONIC PANCREATITIS
V. Chornyi, V. Kopchak, D. Cheverdiuk, V. Serdiuk, A. Duvalko,
A. Zelinsky
National institute of surgery and transplantology, Kiev, Ukraine
Background. Poor long-term results in patients with chronic pan-
creatitis (CP) is associated with poor postoperative digestive func-
tion, result in postoperative morbidity in 30% of patients. We
have noticed, that a linear relationship does not exist between the
secreting level of human pancreatic enzymes in CP and the de-
gree of dyspepsia.
Aims. To find out mechanisms of digestive dysfunction after sur-
gical treatment of CP. To define optimal surgical tactics for pan-
creas draining and resection procedures completion.
Methods. 13C-dipeptide (DBT), 13C-mixed triglyceride (TBT)
breath tests and faecal elastase (FE) analysis were performed in
9 patients with CP. In all patients Frey’s procedure was per-
formed. In 5 patients (group A) a Roux loop standard recon-
struction was executed, in 4 patients (group B)
pancreatico-jejuno-duodenostomy using isolated interposed je-
junum (Moreno-Gonzalez procedure) was performed. Quantita-
tive data on quality of life was survey with EORTC QLQ-C30
questionnaire module.
Results. It was no significant differences of FE level between two
groups. Fundamental difference in 13 respiratory tests results
become apparent in DOBmax peak time values. Time of diges-
tion in group A appeared at 4-5 hours more longly, than in group
B. The quality of life 11 month after surgery show a differ signif-
icantly between the two groups (EORTC-QLQ-C30, group A
55.6% vs. Group B 75.3%).
Conclusion. A Roux loop may occasionally exacerbate digestion
disorders because of low abduction of pancreatic juice in diges-
tion, damaging meal-stimulated neurohormonal reflexes. In re-
sult there is a set of symptoms named us a SDD, shown by aug-
mentation of digestion time up to 5 hours. Inclusion of pancreatic
juice in a duodenal lumen using isolated interposed jejunal loop
is avoiding SDD development.
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LATE SYMPTOMATIC GIANT INSULINOMA
E. Esteban, P. Galindo, C. Loinaz, R. Dίaz Conradi, M. Marcello,
H. Durán, Y Quijano, E. Vicente, Í. Martίnez Gil, C. Corbacho,
M. Allona, E. Conde, L. Ugidos, M. Garcίa Aranda,
M. Rodrίguez
Hospital Madrid-Norte-Sanchinarro. Centro Integral Oncolόgico
Clara Campal (CIOCC). Universidad San Pablo CEU, Facultad
de Medicina. Madrid, Spain
INTRODUCTION: Most insulinomas are smaller than 3 cm
when diagnosed. Tumours larger than 3 cm are frequently ma-
lignant.
CASE REPORT: A 57-year old woman is taken to the emergency
room because an acute onset of low conscience level, confusion,
strange movements, mutism and inability to recognize her rela-
tives. She had been previously diagnosed of panic attacks because
of three episodes of sweating and dizziness during the previous
month.
Physical exam only revealed confusion low conscience. A plasma
glucose of 24 mg/dl was found, so intravenous glucose was infused
and after complete recovery the patient was admitted for study.
An insulinoma was suspected because of high plasmatic insulin,
C-peptide and proinsuline levels. Abdominal CT showed a 12 x 9
x 7 cm mass depending on the tail of the pancreas, and a fine nee-
dle biopsy revealed neuroendocrine tumour cells.
Laparotomy confirmed a 14 cm mass in the tail of the pancreas
with no distant metastasis, so the patient underwent a distal pan-
createctomy with splenic preservation and was discharged on
postoperative day 7 with normal plasma glucose levels, assymp-
tomatic, and after no complications. Histopathological exam of
the specimen revealed a well differenciated beta-cells endocrine
carcinoma with malignant criteria (size, vascular permeation, Ki-
67 over 20%).
CONCLUSIONS: This patient’s insulinoma is one of the biggest
lesions we could find in the literature. In addition, such a big size
with only one month-long symptoms and without distant metas-
tasis when diagnosed are strong points of interest.
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OXIDATIVE STRESS MARKERS IN ACUTE
PANCREATITIS PATIENTS
Z. Dambrauskas1, E. Jansen2, A. Gulbinas1, G. Barauskas3
1. Institute for Biomedical research of Kaunas University of Medi-
cine, Kaunas, Lithuania
2. National Institute for Public Health and the Environment,
Bilthoven, the Netherlands
3. Dept. of Surgery, Kaunas University of Medicine, Kaunas, Lithuania
The participation of oxidative stress in the pathogenesis of acute
pancreatitis has been widely studied in animal and in vitro (with
pancreatic acinar cells) models. However, there are only few re-
ports about the redox or antioxidant status in human acute pan-
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creatitis.
The aim of our study was to evaluate oxidative stress and redox
parameters, and its clinical implications in patients with mild and
severe acute pancreatitis.
Consecutive patients admitted with a diagnosis of acute pancre-
atitis were divided into mild (n=22) and severe (n=17) groups;
age and sex matched volunteers (n= 28) was used as control
group. Oxidative stress markers measured in serum included re-
active oxygen metabolites (ROM) and ferric reducing antioxidant
power (FRAP). In erythrocytes glutathione status, GPX and
SOD have been assessed.
The serum oxidative stress parameters ROM and FRAP showed
a completely unexpected behaviour. Both mild and severe pan-
creatitis groups showed statistically significantly decreased levels
of oxygen metabolites and an increased total antioxidant capac-
ity compared with the control group. No differences have been
observed in the glutathion status.
The present results showed a completely disturbed status of the
general physiology among the pancreatitis patients, but without
any sign of increased oxidative stress or altered redox status. On
the contrary they showed a lower oxidative stress in a number of
serum parameters.
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MULTIFOCAL INTRADUCTAL PAPILLARY
MUCINOUS NEOPLASMS (IPMN) OF THE
PANCREAS FROM MILD DYSPLASIA TO
INVASIVE CARCINOMA: A CASE REPORT
M. Mirarchi, E. De Raffele, L. Calculli, D. Santini, S. Vaccari,
B. Cola
Dipartimento di Chirurgia Generale e Trapianti Policlinico S.Or-
sola-Malpighi, Italy
Background. IPMNs are pancreatic neoplasms characterized by
a wide spectrum of histological lesions ranging from adenoma to
invasive carcinoma. We report the case of an elderly patient who
underwent distal spleno-pancreatectomy for multifocal IPMNs
evolved to invasive carcinoma.
Case report. The patient was a 84-yrs old female in excellent con-
ditions, who came to our observation with aspecific digestive
symptoms. Ultrasonography, CT and endosonography showed
multiple cysts of the whole pancreas and a cancer of the tail with-
out evidence of nodal and distal metastases. The patient under-
went distal spleno-pancreatectomy. The intraoperative
ultrasonography confirmed the preoperative findings of multiple
cystic lesions of the whole pancreas and permitted to include in
the specimen a 2-cm cyst of the isthmus. Histology showed an in-
vasive, moderately differentiated carcinoma of the tail infiltrating
the fibroadipous peripancreatic tissue without evidence of re-
gional nodal metastases; multifocal IPMN was evident in the re-
maining tissue, with broad hystologic spectrum ranging from
dysplasia to non-invasive carcinoma; the 2-cm cyst of the isthmus
near the resection margin was a IPMN with non-invasive carci-
noma. The post-operative course was uneventful ant the patient
was discharged 14 days later. Twenty-four months later the pa-
tient is in excellent conditions without evidence of recurrence.
Conclusion. We report a patient with multiple IPMNs during the
different histological phases of tumoral progression up to infil-
trating carcinoma. Pancreasectomy was considered because of
the limited extension of the neoplasia without nodal metastases
at pre-operative evaluation. In such cases the long term progno-
sis can be favorable, even in properly selected elderly patients.
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A NEW ANATOMICALLY BASED SURGICAL
PROCEDURE FOR TREATMENT AND
PREVENTION OF BILIARY COMPRESSION
IN CHRONIC PANCREATITIS
V. Kopchak, D. Cheverdiuk, K. Kopchak, A. Zelinsky,
B. Tsubera, O. Simonov
National institute of Surgery and Transplantology, Kiev, Ukraine
Background. Biliary duct compression is common complication
of chronic pancreatitis. It appears in up to 45.6% of patients. The
most common procedures in treatment of the chronic pancreati-
tis are local pancreatic head resections (Frey or Berne proce-
dure). With these procedures, the common bile duct can often be
freed up from the structures compressing it doing away with the
necessity of a separate biliary bypass. However, up to 8% of those,
who were not demanded initial biliary bypass presents obstruc-
tive jaundice in long term follow-up.
Aims. To design a safe and effective procedure for treatment and
prevention of biliary compression in chronic pancreatitis without
performing biliary bypass.
Methods. Forty-six patients whom we performed Frey procedure
were studied retrospectively. Prospectively were studied twelve
patients for whom we performed Frey procedure. Seven of them,
at whom pre- and intraoperatively was identified pancreatic lin-
gula, underwent its anatomical resection. In both groups all pa-
tients presented a signs of biliary hypertension in absence of
absolute indications for initial biliary bypass performing. Mean
follow-up in both groups was 18 months.
Results. Four patients in first group presented jaundice in mean
terms of 13.6 months. In second group no one had any signs of bil-
iary compression in mean terms of 18.7 months. Rates of post-
operative morbidity and hospital stay were similar in both groups.
Conclusion. Pancreatic lingula may become a cause of postoper-
ative distal bile duct obstruction. An anatomical resection of the
pancreatic lingula can be a feasible opportunity for prevention of
postoperative jaundice in long-term outcome.
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ANALYSING OF LABORATORY PARAMETERS
IN PATIENTS WITH SEVERE ACUTE
PANCREATITIS AFTER PERCUTANEOUS
DRAINAGE OF STERILE ACUTE FLUID
COLLECTIONS
R. Kotán1, Z. Szentkereszty1, S. Sipka2, J. Pόsán1,
L. Damjanovich1, P. Sápy1
1. University of Debrecen, Medical and Health Science Center, De-
partment of Surgery
2. University of Debrecen, Medical and Health Science Center, Re-
gional Immun Laboratory, Hungary
Background and Aims: The aim of this prospective, study is to
analyse the changes of laboratory parameters after the percuta-
neous drainage of sterile fluid collections in severe acute pan-
creatitis.
Materials & methods: The changes of the level of the serum
TNFα, CRP, Complement 3-4, Amylase, Lipase and Wbc were
analysed after percutaneous drainage of sterile fluid collections in
10 patients treated with severe acute pancreatitis. In the treat-
ment of pancreatitis the well-accepted methods such as naso-je-
junal feeding, Imipenem-Cilastatin antibiotic preventation,
delayed surgery were used. Percutaneous drainage of sterile fluid
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collections was used only in cases when it caused severe com-
plaints. The laboratory parameters and the quantity of the
drained fluid were measured on the day and after the 5th and
10th days of the drainage. The results were statisticallly analysed
with paired T and Wilocoxon probe.
Results: The CRP the WBC and the quantity of the drained fluid
decreased significantly on the 10th day after the drainage. The
other parameters also decreased but not significantly. The TNFα
levels did not correlated with the procedure. The Complement
levels did not decreased during the drainage but on the contrary
elevated in that 3 cases where surgery were needed so it may val-
ued as a prognostic factor on surgery.
Conclusions: The decrease of the measured parameretrs (CRP,
WBC, Amylese, lipase) shows well correlation with the clinical
improvement during the drainage of sterile acute fluid collections
in severe acute pancreatitis. The elevation of Complement 3-4
may be a prognostic factor on necessity of surgery.
P 315
INGUINAL MASS AS A UNIQUE SIGN OF
SEVERE ACUTE PANCREATITIS
J. Ramia, E. Santos, R. Lozoya, F. Garrido J. Santos
Department of Surgery, Hospital Santa Barbara, Puertollano (Ciu-
dad Real), Spain
Inguinal mass as a first and unique sign of asymptomatic acute
pancreatitis (AP) is extremely rare. Only five cases have been de-
scribed in the literature. We present a patient with a painful right
inguinoscrotal swelling due to an asymptomatic AP that we ini-
tially mistook for a incarcerated inguinal hernia
CASE REPORT: A 62 year old male came to our Emergency
Department with a 2-day history of right testicular pain. On ex-
amination, right inguinal area, teste and spermatic cord were en-
larged and painful. We performed a right inguinal US that
showed a painful incarcerated mass of mixed echogenicity. The
patient was operated on with the diagnosis of incarcerated in-
guinal hernia. Inguinal area presented a huge inflammation. In
the sac and a small amount of necrotic debris was present. We
decided to perform a herniorraphy. 48 hours later, the patient
had fever (38.1 C) and a painful hot erithema in right dorsal re-
gion. Patient did not refer any abdominal symptom. A CT showed
a enlarged pancreatic head and a huge collection on the right
retroperitoneal space that emerged from pancreatic head and ex-
tended down in front of the right kidney and arrived to the right
inguinal canal. Analysis: amilase: 532, CRP: 27.2,. We started
NPO and parenteral nutrition. Progressively, the painful hot area
disappeared and CT showed a decreasing of inflammatory mass.
At present, patient is totally asymptomatic.
CONCLUSIONS: Inguinal involvement as only and first mani-
festation of AP are very unfrequent. The correct diagnosis can be
very difficult if the patient has no symptom related to pancreati-
tis.
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METHOD AND TECHNIQUES OF
MANAGEMENT OF PANCREATIC LEAKAGE
IN DEPARTMENT OF SURGERY OF THE
EMERGENCY CENTAR OF SERBIA
D. Stepic, V. Djukic, Z. Loncar, D. Mijaljica, D. Micic,
S. Mijatovic
Emergency centar of Clinical Centar of Serbia, Serbia
During the eight year period, 2000-2007. we performed 74 pan-
creatic resections. There were 60 cephalic resections, 12 distal
pancreatic resections and 2 pancreatic body resections. We had 6
cases with pancreatic leakage( 8.0%).From that number we re-
operated three cases with cephalic pancreatic resections. Other
three cases( 50%) We treated conservative. Two of three cases
that we had to re-operate, we performed total pancreatectomy.
Other one we performed re-anastomosis with transintestinal
drainage and contact drainage. Caudal resection leakage We
managed with conservative procedures.
The conservative procedure was continuous irrigation with suc-
tion, which we starter in early days. Average contained 287ccm
per day. Last leakage stop after 37days.
RESULTS: The mean hospital stay was 27.6 +/- 3.2 days. The in-
cidence of overall surgical complications was 9.6% including bil-
liar leakage.One patient died after reoperation during fifth day
after second operation.
Conclusion: Pancreatic leakage is serious complication after pan-
creas resection. Quality decision how treated and which proce-
dure to follow for managed complication should be result of team
work of highly experienced and skilled surgeons.
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CATACLYSMIC BLEEDING DUE TO ARTERIAL
PSEUDOANEURISMS AFTER RADICAL
HEPATOBILIOPANCREATIC TUMOR
RESECTIONS
E. Esteban, P. Galindo, M. Marcello, R. Dίaz Conradi, H.
Durán, C. Loinaz, Y. Quijano, E. Vicente, B. Waez, F. Machés,
P. Hidalgo, E. Garcίa, A. Cubillo, E. Sánchez, G. Pastor
Hospital Madrid-Norte-Sanchinarro, Centro Integral Oncol gico
Clara Campal (CIOCC). Universidad San Pablo CEU, Facultad
de Medicina, Madrid, Spain
BACKGROUND: Agressive dissection of hepatobiliopancreatic
tumors can weaken supramesocolic arterial walls, which brings
some risk for severe early and late postoperative hemorrhage.
AIM: 2 cases of cataclysmic bleeding after radical surgery for he-
patobiliopancreatic malignancies are presented.
MATERIAL AND METHOD:
Case 1:
A 70-year-old woman with a Bismuth type I cholangiocarcinoma
with portal vein involvement (T4 Nx M0) underwent a radical
celiac trunk, hepatic artery and hepatic hilus lymphadenectomy,
a portal vein resection, and an extrahepatic bile duct resection
with cholecystectomy.
On postoperative day 8 a severe haemodinamic unstability, right
upper quadrant pain and melena appeared, with a severe and re-
fractary haemodynamic shock and death.
Autopsy revealed massive haemoperitoneum due to a right he-
patic artery dissection with parietal necrosis.
Case 2:
A 66-year-old man with a pancreatic head adenocarcinoma with
suspected hepatic artery involvement underwent a total duodeno-
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espleno-pancreatectomy, with a difficult dissection but no resec-
tion of the hepatic artery was necessary.
After 2 episodes of self-limited upper gastrointestinal bleeding
with no endoscopic findings, he was readmitted of postoperative
day 32 because of a new episode of bleeding with haemodynamic
unstability. An angiography showed an aneurismatic dilation of
the common hepatic artery with contrast filling of the bile duct.
An embolization was performed, after which the patient recov-
ered and was discharged in 7 days.
CONCLUSIONS: After aggressive vascular dissections, the risk
for aneurismatic arterial complications must be considered. In
case of bleeding, an angiography can be not only the gold stan-
dard diagnostic tool but also the only useful therapeutic ap-
proach.
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AUTOIMMUNE AND GROOVE PANCREATITIS:
A DIAGNOSTIC DILEMMA
C. Triantopoulou1, C. Avgerinos2, C. Agalianos2, D. Kelgiorgi2,
J. Papailiou1, C. Dervenis2
1. Computed tomography Department Konstantopouleio Hospital
2. 1st Surgical Department, Kostantopouleio-Agia Olga Hospital
Background: Autoimmune (AP) and groove pancreatitis (GP)
represent distinct subsets of chronic pancreatitis showing specific
pathologic characteristics. In both diseases an inflammatory mass
could be identified. Since specific imaging features are not com-
mon, and biopsies are unlikely to be diagnostic, patients may un-
dergo pancreatoduodenectomy for suspected carcinoma.
Aim: To describe the imaging features of AP and GP in cases of
resected lesions.
Patients-methods: Upon review of pathology database in three
years’ period, we have found four cases of resected pancreatic le-
sions that were proved to be AP and five cases representing GP.
Four patients were thought to harbor malignancy, while in the
rest surgery was performed due to persistent and severe clinical
symptoms. A detailed research in patients’ records was retro-
spectively done concerning clinical presentation, laboratory find-
ings and imaging studies.
Results: All patients presented with obstructive jaundice painless
in four of them and painful in the rest. Tumor markers were el-
evated in three cases. Transabdominal ultrasound, contrast en-
hanced computed tomography and magnetic resonance imaging
were performed in all patients, while ERCP was performed in
two. A hypovascular pancreatic head mass was evident in all pa-
tients. There was also a different degree of common bile and pan-
creatic ducts dilatation, while vessels infiltration was obvious in
three patients.
Conclusion: In any case of pancreatic pathology before the diag-
nosis of AP or GP is rendered, the possibility of adenocarcinoma
ought to be carefully excluded. Awareness of the possibility of AP
and GP should influence the surgeon to perform further investi-
gation before radical surgery is attempted.
References:
1. Abraham SC, Wilentz RE, Yeo CJ, et al. Pancreaticoduo-
denectomy in patients without malignancy. Are they all chronic
pancreatis? The American journal of surgical pathology 2003;
27(1); 110-120.
2. Sahani DV, Kalva SP, Farrell J, Maher MM, Saini S, Mueller
PR, Lauwers GY, Fernandez CD, Warshaw AL, Simeone JF. Au-
toimmune pancreatitis: imaging features. Radiology 2004; 233(2):
345-52.
3.Castell-Monsalve FJ, Sousa-Martin JM, Carranza-Carranza A.
Groove pancreatitis: MRI and pathologic findings. Abdom Im-
aging 2008; 33(3): 342-8.
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EMPHYSEMATOUS PANCREATITIS WITH
PNEUMOPERITONEUM AND
RETROPNEUMOPERITONEUM WITHOUT
VISCERAL PERFORATION
J. Ramia1, F. Garrido2, E. Sancho2, J. Santos2
1. Department Of Surgery Hospital Universitario De Guadalajara,
Spain
2. Department Of Surgery Hospital Santa Barbara, Spain
Gas inside the parenchyma of solid organs is known as emphyse-
matous infections. Emphysematous pancreatitis (EP) is extremely
rare. We present a new case of EP due to Kleibsella pneumoniae,
with pneumoperitoneum and retropneumoperitoneum without
visceral perforation.
CASE REPORT: Male, 66 years-old with severe co-morbidities
(obesity, high blood presure, DM II, smoker with COPD). He
presented at ER severe abdominal pain in upper abdomen with
vomiting (Blood pressure 130/80, HR: 96, temp: 36 C). Analisis
(1): 18.000 leukocytes, amilase: 5.900, AST: 169, ALT: 105 y Bi-
liirubin 2.5 gr/dl, CRP: 0.8. In US, we observed cholelitiasis and
an enlarged and hypoechoic pancreas. 12 hours later a worsening
of clinical situation began suddenly (BP 90/60, HR 160). In the
next minutes, the patient suffer hypotension, bad peripheral per-
fussion, bradycardia and finally asystolia. After cardiopulmonary
resuscitation, we needed high levels of noradrenaline to mantain
BP and FiO2 100%. Analisis (3): leukocytes 4.470, creatinine: 2.5
mg/dl, pH 7.23 y bycarbonate 10.9 mmol/l. In CT, we observed
neumoperitoneum, retropneumoperitoneum and gas inside the
pancreas. We performed a laparotomy and found a disorganized,
necrotic and hemorrhagic pancreas rounded by bloddy bad-smell
liquid. No visceral perforation was identified. A cholecystectomy,
necrosectomy with Beger technique was done. Kleibesella pneu-
moniae grew in the liquid. Patient died after 24 hours.
DISCUSSION: Differential diagnosis between visceral perfora-
tion and EP is difficult. No guideline about adequate treatment
has been performed. Surgical procedures is the most frequent ap-
proach but medical treatment is possible if you obtain a correct
diagnosis. EP mortality is very high.
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WALLED OFF PANCREATIC NECROSIS:
A NEW DEFINITION OF AN OLD PROBLEM
J. Ramia1, E. Sancho2, J. Santos2, J. Qui ones1, P. Veguillas1,
J. Garcia Parre o2
1. Department Of Surgery Hospital Universitario De Guadalajara,
Spain
2. Department Of Surgery Hospital Santa Barbara,Spain
In 2006, Walled-off pancreatic necrosis (WOPN) was used by first
time to define a liquified collection containing solid luminal con-
tent that develops as a late consequence of necrotizing pancre-
atitis. We present 3 cases and discuss optimal management.
MATERIAL&METHODS: We have operated on three patients
with WOPN. All of them were male. Age: 41, 44 y 75 years. All
had previously severe acute pancreatitis managed medically.
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ERCP was performed in two cases. Time between pancreatitis
and WOPN were 1, 22 y 26 months. Main clinical problem was
abdominal pain (3) and fever (1). In CT/MRI a peripancreatic
collection in body and tail of pancreas of 8, 20 y 22 cm was seen.
Percutaneous drainage was tried in 2 patients but it did not solve
WOPN. Necrosectomy plus cholecystectomy was done in every
patient. Choledocotomy to extract 3 bile duct stones was done in
the patient without ERCP. No mortality. One patient was reop-
erated due to bowel ischaemia and colon resection was per-
formed. This patient developed a pancreatic fistula treated
conservatively. Bile culture: e.faecalis (3) and necrosis culture:
staph. (2) y sterile (1). Hospital stay was 8, 8 y 21 days. In CT fol-
low-up, a restitutio ad integrum of pancreas is seen.
CONCLUSIONS: In symptomatic patients, a percutaneous
drainage could be useful to obtain material for culture but usually
do not solve WOPN, because it is too dense. Necrosectomy is a
feasible, safe and deffinitive technique to treat these patients.
Mixed endoscopic and laparoscopic techniques has been pub-
lished in patients with WOPN (<15 cm).
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TRUE SOLITARY CYST OF THE PANCREAS:
REPORT OF CASE SERIES
T. Artis, H. Akyildiz, C. Kucuk, Y. Aritas, Z. Yilmaz
Department of General Surgery, Erciyes University Medical School,
Turkey
Background and Aim: Although cystic lesions of the pancreas
have been recognized more frequently with the advanced imag-
ing and diagnostic tools, preoperative differentiation remains dif-
ficult and unreliable. Benign pancreatic cysts are rare entities;
they are subclassified as solitary or simple true cysts, pseudocysts,
and serous adenomas.True solitary cyst of the pancreas is a very
rare pathologic condition in adults. Herein we present three pa-
tients with true solitary pancreatic cyst.
Material and Methods: Three patients were underwent surgery
with diagnosis of pancreatic cystic mass. Patient characteristcs
were depicted in table-1
Table-1(LDP: Laparoscopic distal pancreatectomy, DP: distal
pancreatectomy,
S: splenectomy, C:cholecystectomy)
On pathologic examination, the cysts were serous and lined with
a single layer of normal cuboidal epithelium that was negative for
Periodic-acid-Schiff stain. The final diagnosis’s were true soli-
tary cyst of the pancreas.
Discussion: True solitary cystt of the pancreas is a very rare clin-
ical entity. The differential diagnosis of solitary true cyst from
other cystic lesion of the pancreas usually is based on histology.
Minimally invasive surgery can be performed particularly for well
defined non-invasive tumors of the pancreas.
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LAPAROSCOPIC RESECTION OF A
PANCREATIC HEAD TUMOUR
M. Oliveira, H. Cristino, G. Faria, R. Costa, E. Martins,
J. Costa-Maia
Unidade Hepato-Bilio-Pancre tica e Esplénica, Serviço de Cirurgia
Geral, Hospital de S. João, Porto, Portugal
Pancreatic resections including pancreaticoduodenectomy and
distal pancreatectomy are the standard of care for patients with
malignant tumors of the pancreas. However, patients with benign
disease or unusual tumors may benefit from limited resection or
enucleation.
Laparoscopy is a safe, feasible technique and has been increas-
ingly reported for neuroendocrine tumors located at the body and
tail of the pancreas. However, for tumors in the pancreatic head
(due to its close relation to the duodenum and pancreatic and
bile ducts) few succesfull atempts have been made.
We report a case of enucleation of a 2 cm neuroendocrine tu-
mour located at the uncinate process of a patient with von Hip-
pel-Lindau syndrome.
Enucleation was succesffuly performed after laparoscopic iden-
tification of its location, in close proximity of the superior mesen-
teric vein, but far enough from the pancreatic duct, to allow its
resection.
The patient had no postoperative complications, started oral
feeding on the 1st postoperative day and was safely discharged at
the 7th post-operative day.
CONCLUSION: For selected patients, treated in a center with
expertise on laparoscopic and pancreatic surgery, laparoscopic
resection of neuroendocrine pancreatic tumors is a valid option,
even in cephalic locations.
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LAPAROSCOPIC RADICAL ANTEGRADE
MODULAR PANCREATOSPLENECTOMY
I. Poves, F. Burdio, E. Membrilla, S. Alonso, L. Grande
Hospital del Mar Service of Surgery, Barcelona, Spain
Introduction: Laparoscopic left-sided pancreatectomy (LLP) has
gained popularity among surgeons. LLP is considered appropri-
ate for selected patients with left-sided pancreatic pathology. In
many centers, it has been considered the standard procedure for
benign, pre-malignant and cystic lesions, but not for malignant
tumours. In a recent multicenter comparison study between open
vs laparoscopic approach, the LLP has been associated with less
morbidity and shorter hospital stay than the open approach. In
2003, Strasberg described the concept of radical antegrade mod-
ular pancreatosplenectomy for the treatment of malignant tu-
mours of the body and tail of the pancreas. He introduced the
concept of the adequate radicality attending to the radial mar-
gins. Clinical case: A 76 year-old man was operated of a 4 cm het-
erogeneous cystic-solid lesion in the body of the pancreas. A
totally laparoscopic radical antegrade modular pancre-
atosplenectomy was performed. Lenght of operation was 240
minutes. Postoperatory was uneventfull being discharged at fifth
day. Definitive diagnosis was a mixed ductal-neuroendocrine car-
cinoma of 7 cm of diameter. All 33 removed lymph nodes were
negative. One year after surgery the patient is alive and disease-
free. Conclusions: LLP can be appropriate for the treatment of
malignant tumours of the body and tail of the pancreas. Adequate
oncological radicality can be achieved by laparoscopic approach.
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PANCREATIC BODY AND TAIL
LAPAROSCOPIC RESECTION, PRESERVING
THE SPLENIC VESSELS, FOR A
NEUROENDOCRINE TUMOR
C. Loinaz, R. Conradi, M. Marcello, P. Galindo, E. Esteban,
H. Duran, Y. Quijano, E. Garcia, E. Vicente
Servicio de Cirugia General y Aparato Digestivo. Hospital Madrid
Norte Sanchinarro, Universidad CEU San Pablo, Madrid, Spain
AIM: Laparoscopic approach in the treatment of benign and in-
definite pancreatic lesions is increasingly indicated. In this film
we try to show the technique of pancreatic body and tail resection
in a case of body-tail lesion suspicious of a neuroendocrine tumor.
PATIENT AND METHODS: 58 year old female patient, asymp-
tomatic, with accidental diagnosis of a pancreatic body-tail mass.
The diagnostic-work-up (hormones and tumor markers, ultra-
sonography, CAT scan, MR, octreoscan, PET-CT, EUS) lead to
a possible non-functioning neuroendocrine tumor. A diagnostic
and therapeutic laparoscopy was scheduled.
RESULTS: With the patient in intermediate decubitus position,
the trocars were positioned towards the left upper quadrant. The
colosplenic ligament was taken down, the inferior pancreatic bor-
der was dissected, then the splenic vein, and the splenic artery
with the superior border of the gland. The dissection was com-
pleted taking apart the pancreatic tail and the spleen. An endo-
stapler was used for the transection of the pancreatic parenchyma
at the neck. The specimen was withdrawn through the enlarged
orifice of the 12 mm trocar. Intraoperative biopsy was suspicious
of neuroendocrine tumor.
CONCLUSIONS: Laparoscopic body and tail pancreatic resec-
tion preserving the splenic vessels is a good option for tumors lo-
cated in this area. It entails a careful dissection of the splenic
vessels and their tiny branches, that occasionaly may be difficult.
It has the great advantage of maintaining a good splenic vascu-
larization, and minimal abdominal wall opening.
P 325
LAPAROSCOPIC APPROACHES TO
PANCREATIC PSEUDOCYSTS
G. Ayiomamitis, N. Henley, B. Ammori
Departments of Surgery, Manchester Royal Infirmary, Manchester,
U.K
Backround: Large, persistent, symptomatic, complicated and en-
larging pancreatic pseudocyst require internal drainage.
Methods: We adopted a policy of internal drainage of the pan-
creatic pseudocysts in all patients who required surgical inter-
vention, using varied laparoscopic approaches.
Results: To date, we have performed 22 laparoscopic procedures
in 20 patients without conversion to open surgery (10 transgastric
cyst-gastrostomy, 6 exogastric cyst-gastrostomy, 4 Roux-en-Y
cyst-jejunostomy, 1 cyst-duodenostomy and 1 laparoscopic exter-
nal drainage). The median operating time was 122.5 minutes and
the median postoperative hospital stay was 2 days. There were no
mortalities and no postoperative complications. At follow up
(median 21 months), two patients had developed recurrent pan-
creatic pseudocyst which were re-drained laparoscopically.
Conclusions: In the hands of the pancreatic surgeon who is in pos-
session of advanced laparoscopic skills, laparoscopic drainage of
PP is safe and should be the surgical option of choice. The ap-
proach is tailored according to the pseudocyst location.
We demonstrate a video with the different laparoscopic ap-
proaches for the management of pancreatic pseudocysts.
P 326
GROSSING AND EVALUATION OF THE
RETROPERITONEAL RESECTION MARGIN IN
THE PANCREATICODUODENOECTOMY
SPECIMEN: CONSENSUS IS NEEDED
V. Maksymov1, M. Khalifa2, C. Rowsell2
1. Department of Pathology Eastern Health Science Center,
Torondo, Canada
2. Department of Pathology Sunnybrook Health Science Center,
Toronto, Canada
Background. There is no widely accepted standardized protocol
for grossing and evaluation of the retroperitoneal (RP) resection
margin (RM) of the pancreaticoduodenectomy specimen (PD).
Recently we (1) proposed nomenclature and landmarks for
anatomic mapping of the PR.
Aim. To discuss our approach to grossing and evaluation of the
RP, with radiologic correlation.
Method. Between 2006 and 2008 PD were handled and evaluated
in a similar fashion in two tertiary care Canadian medical cen-
tres.
Result. Several key points are crucial in our method of assess-
ment of the RPRM. 1. The RP, was divided into the following
components: the uncinate process, the groove (vascular bed), and
the medial aspect. 2. The prominence of the vascular groove was
separately identified. 3. The RPRM was submitted in total, ori-
ented, sectioned perpendicular to the RP (It increases the fre-
quency of its positivity and the number of retrieved lymph nodes).
3. Clear distinction was made between RM and dissection margin
(DM). 4. Distance of the tumour from the closest margin was
measured (There is no accepted minimal tumour clearance). 5.
Perineural invasion at the RM versus DM was reported. 6. Pre-
operative CT scan results suggesting proximity or involvement of
the SMA and/or SMV were correlated with histological involve-
ment of the uncinate process and the vascular groove.
Conclusion. Consensus is needed in the grossing and the evalu-
ation of the RPRM in order to determine accurate microscopic
residual tumour rates (R1) in PD specimens. A standardized pro-
tocol may also form the basis of retrospective or prospective stud-
ies to determine preoperative imaging findings which may predict
R1 resections or involvement of the SMV/PV confluence.
References. 1. M A Khalifa, V Maksymov, C Rowsell. Retroperi-
toneal margin of the PD: anatomic mapping for the surgical
pathologist. Virchows Archiv, 2008; 1432-2307 (Online)
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DISTAL SPLENO-PANCREATECTOMY
FOLLOWING PREVIOUS PANCREATIC
NECROSECTOMY
M. Abu Hilal
Hepatobiliary-Pancreatic and Laparoscopic Surgical Unit,
Southampton University Hospital. Southampton, United Kingdom
Introduction: Laparoscopic approach to distal pancreatectomy
has been increasingly favoured following several reports showing
reductions in morbidity and hospital stay compared with open
surgery. Previous major abdominal surgery is a relative con-
traindication for most laparoscopic procedures including distal
pancreatectomy.
This video illustrate finding and techniques in a case where la-
paroscopic distal pancreatectomy was completed in a patient 4
years following major pancreatic necrosectomy
Conclusion: In specializzed centers laparoscopic distal pancrea-
tectomy is safe and feasible even after major pancreatic surgery
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LONG-TERM OUTCOME OF SURGICAL
INTERVENTION FOR CHRONIC PANCREATITIS
N. Shah, A. Siriwardena
Regional Hepatobiliary Surgery Unit, Manchester Royal Infirmary
Department of Surgery, University of Manchester, UK
Introduction: Pancreatic surgery for chronic pancreatitis (cp) can
take the form of resection, duct drainage or more latterly, mini-
mally-invasive destruction of the splanchnic nerves. The evi-
dence-base for surgery is hindered by a critical deficiency in
long-term outcome data. The present study is a comprehensive
analysis of the long-term outcome of pancreatic interventional
surgery.
Patients and Methods: PubMed, and Embase databases were
searched for the period June 1997 to June 2007. The Medical
Subject Headings “Chronic pancreatitis” and “Surgery” were
used. Articles providing original information and pain scores
from before AND after surgery were retained. Exclusions pro-
duced a final population of 20 manuscripts providing data on
1376 patients undergoing elective surgery for CP. Only 1 report
provides long-term outcome of thoracoscopic splanchnic nerve
division and none provide long-term outcome of the duodenum
preserving pancreatic resection. Non-parametric tests were used
for analyses.
Results: Median pre-operative pain scores [range 0-100] were 70
(69-90). At a median follow-up of 40 (6-83 months), median post-
operative pain scores were 18 (3 -70). This difference was signif-
icant [p=0.002; Mann-Whitney U test]. When the data are
restricted to studies providing long-term follow-up of more than
5 years (n=4 reports; n=405 patients), the difference in median
pain scores is 80 pre-op vs. 3 post-op with 2 studies showing pain
scores of 0 post-op. However, this difference failed to attain sta-
tistical significance.
Conclusion: Surgery provides good short-term relief of pain in
CP. Better quality, longer-term follow-up is required to know
whether these benefits are sustained beyond 5 years after surgery.
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HEPATO-PANCRAETICO-BILIARY (HPB)
PROGRAM: IMPACT ON GENERAL SURGERY
RESIDENCY
P. Nguyen, J. Martinie, A. Prabhu, T. Heniford, D. Iannitti
Carolinas Medical Center, Charlotte, U.S.A.
Intro: HPB program is dedicated for the advancement in research
and clinical training in the field of liver, pancreas, and biliary sur-
gery. The purpose of this study is to demonstrate the impact of
a HPB program on liver, pancreas, and biliary procedures for
chief surgical residents.
Methods: Liver, pancreas, and biliary procedures were entered
into ACGME website during the duration of general surgical res-
idency. Resident case logs were reviewed retrospectively using
the ACGME database. The implementation of the HPB pro-
gram was in the 4th quarter of 2006. HPB cases for chief resi-
dents (PGY 5-6) were reviewed from 2001-2006 and compared
to 2007-2008.
Results: Surgical procedures for 25 chief residents included: liver
(n=232), pancreas (n=254), biliary (n=3,227), with total cases
(n=29,671). Residents pre-HPB program (n=18) and post-HPB
(n=7) were compared and the average case load included: liver
(7.9 vs 12.7; p-value 0.03), pancreas (8.8 vs 13.6; p-value 0.05) and
pancreaticoduodenectomy (3.0 vs 5.7; p-value 0.03), biliary (125
vs 139.6; p-value 0.37), total cases (1181 vs 1202; p-value 0.87),
% liver cases (0.68 vs 1.00; p-value 0.04), % pancreas cases (0.76
vs 1.11; p-value 0.05), and % biliary cases (10.74 vs 11.70; p-value
0.34).
Conclusion: Implementation of a HPB program significantly in-
creases the number of liver and pancreas cases, including pan-
creaticoduodenectomy, for chief residents. In addition, this
increase in liver and pancreas cases was not due to an increase of
residents’ case load. Further studies would be to consider HPB
cases for the entire residency to identify an impact on junior res-
idents.
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PRE-OPERATIVE PERCUTANEOUS INSERTION
OF SHORT METAL STENTS AS A BRIDGE TO
SURGERY FOR POTENTIALLY RESECTABLE
OBSTRUCTING PANCREATIC OR DUODENAL
MALIGNANCY
C. Briggs, G. Irving, A. Cresswell, R. Peck, F. Lee, M. Peterson,
I. Cameron
Departments of Hepatobiliary and Pancreatic Surgery and Inter-
ventional Radiology, Royal Hallamshire Hospital, Sheffield Teach-
ing Hospitals NHS Trust, Sheffield, United Kingdom.
Introduction: The role of biliary stenting to correct hyperbiliru-
binaemia prior to surgical resection remains controversial. British
Society of Gastroenterology guidelines (Gut 2005; 54 1-16)(1)
state that an endoscopic approach should be used and self ex-
panding metal stents should be avoided. Between 2002 -2003
three patients in our unit, with apparently operable tumours on
CT scan, experienced significant complications after endoscopic
stenting which then precluded attempted resection. This invoked
a change in practice, with patients needing pre-operative drainage
having attempted insertion of a percutaneous short metal stent.
Methods: Retrospective review of a prospective database of all
patients undergoing operative intervention for tumours of the
pancreas, bile duct and duodenum head.
Results: Since October 2004, we have attempted percutaneous
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placement of short internal metal stents in 67 patients with po-
tentially resectable pancreatic, lower bile duct or duodenal ma-
lignancies and biliary obstruction. Stenting was successful in 53
patients (79%), the remainder receiving external biliary drainage.
Of the stented patients, 5 (9.4%) had complications (3 sepsis, 1
haemorrhage and 1 pancreatitis). All were successfully managed
conservatively and none precluded trial dissection. Mean biliru-
bin was 253 pre-intervention and 33 pre-operatively in stented
patients, and 308 pre-intervention and 102 pre-operatively in
those who needed external drainage. Mean time from stent in-
sertion and external drainage to trial dissection was 36 and 19
days respectively.
Conclusions: Percutaneous insertion of short metal stents pro-
vides a safe and effective method of treating jaundice pre-opera-
tively in patients with potentially resectable tumours around the
pancreatic head, and can be considered as an alternative to en-
doscopic stent placement(2).
1. Guidelines for the management of patients with pancreatic
cancer periampullary and ampullary carcinomas. Gut 2005;54
Suppl 5:v1-16.
2. Mullen JT, Lee JH, Gomez HF, Ross WA, Fukami N, Wolff
RA, et al. Pancreaticoduodenectomy after placement of en-
dobiliary metal stents. J Gastrointest Surg 2005;9(8):1094-104;
discussion 1104-5.
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LAPAROSCOPIC RESECTION IN THE
TREATMENT OF HEPATIC POLYCYSTIC
DISEASE
M. Oliveira, M. Almeida, H. Sousa, E. Martins, J. Costa-Maia
Unidade Hepato-Bilio-Pancre tica e Esplénica, Serviço de Cirurgia
Geral, Hospital de S. João, Porto, Portugal
Introduction: Hepatic polycystic disease of the adult is usually
asymptomatic. However massive hepatomegaly may lead to in-
capacitating symptoms as abdominal pain, bloating, vomiting, as-
citis or biliary obstruction. Surgery remains an option in
symptomatic patients whether fenestration of, at least, 75% of
the cyst wall, or hepatic resection. Laparoscopic approach is in-
creasingly recognized as safe and effective in these cases.
We present a laparoscopic left hepatic lobectomy associated with
cyst fenestration, in a 57 year-old, female patient with policystic
disease. Operative time was 170 min. and no blood products were
transfused intra or post-operatively. The most significant surgi-
cal steps are highlighted, namely the 3 trocar access, security in
parenchymal resection and the reduced blood loss.
Conclusion: In centers with adequate expertise in liver and ad-
vanced laparoscopic surgery experience, minimal access approach
is the first-line option for the treatment of a wide variety of liver
conditions, including adult policystic disease.
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IS THERE ANY ROLE OF DRAIN USE IN
ELECTIVE LAPAROSCOPIC
CHOLECYSTECTOMY? A CONTROLLED
RANDOMIZED TRIAL
G. Tzovaras, P. Liakou, F. Fafoulakis, I. Baloyiannis,
D. Zacharoulis, C. Hatzitheofilou
University Hospital of Larissa, Greece
Backgraound: Although the issue of drain use in open cholecys-
tectomy has been adequately addressed by prospective random-
ized trials, there is lack of evidence on the usefulness of drain in
elective laparoscopic cholecystectomy and the surgeons rather
follow their beliefs and bias on this debate.
Aim/study design: We designed a controlled randomized trial in
order to assess the value of drain in elective laparoscopic chole-
cystectomy.
Material and methods: During a 5 year period (January 2002 –
December 2006) 284 patients were randomized to have a drain
(group A) while 281 were randomized not to have a drain (group
B) in the subhepatic space. Endpoints of this trial were to detect
any differences in morbidity, postoperative pain and hospital stay
between the two groups.
Results: There was no mortality in either group and no statisti-
cally significant difference in morbidity or hospital stay between
the two groups. However, postoperative pain was significantly in-
creased in patients who had a drain – median VAS 5 (1-8) vs 3 (1-
8), p< 0.0001. Interestingly, in 2 out of 3 patients where a drain
was placed against randomization because of bile leak suspicion,
a bile leak occurred.
Conclusion: The routine use of a drain in elective laparoscopic
cholecystectomy has nothing to offer; in contrast, it is associated
with increased pain. It would be reasonable, however, to leave a
drain if there is a worry about an unsolved or potential bile leak,
bearing in mind that drain placement, although sometimes pro-
vides a false sense of security, it does not guarantee either pre-
vention or treatment of postoperative bile collections, bleeding
or bile peritonitis.
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THREE-PORT LAPAROSCOPIC RESECTION
OF LIVER CELL ADENOMA
J. Ramia, R. De La Plaza, P. Veguillas, J. Quiñones, R. Puga,
J. Garcia-Parreño
HPB Unit. Hospital Universitario de Guadalajara, Guadalajara,
Spain
Laparoscopic liver resection is becoming a new gold standard for
some types of liver surgery. Usually, it is performed using 5 tro-
cars and Pringle manouver, but in some selected cases a three-
port approach without portal clamping is possible. We present
the resection of liver cell adenoma in segment IVb with a three
port technique.
CASE REPORT: Female, 34 year-old, no previous intake of con-
traceptive pills. She referred colic pain in right hypocondrium.
Abdominal ultrasound showed cholelithiasis and a solid tumor in
segment IVb that was interpreted as an hemangioma. Laparo-
scopic cholecystectomy was performed and a fatty liver tumor in
segment IVb was seen. We did not resect and preferred to per-
form an abdominal CT postoperatively to see if there were more
lesions and the relationship with liver vessels. Abdominal CT
showed a unique, fatty, well-defined, hipodense lesion (34 x 24
mm.) in segment IVb. We performed a totally laparoscopic liver
resection using only three ports: umbilical (10 mm), left hypocon-
drium (10 mm), and right flank (5 mm). Parenchyma resection
was performed using Ligasure 5 mm without clamping and ob-
taining a 5mm free margin. The lesion was extracted using a en-
dobag. Definitive histology was liver cell adenoma. Postoperative
period was uneventful and the patient was discharged two days
after surgery.
CONCLUSIONS: Three port laparoscopic liver resection with-
out clamping is a safe and feasible technique for peripheral small
tumors in segments III,IV, and V. Classical five port technique
with clamping is only needed for more severe liver resections.
© The Authors
Journal Compilation © 2009 Hepato-Pancreato-Biliary Association, HPB, 11 (Suppl. 2), 1-172
© The Authors
Journal Compilation © 2009 Hepato-Pancreato-Biliary Association, HPB, 11 (Suppl. 2), 1-172
P 334
ADVANTAGES OF THE FIRST-STEP TOTALLY
LAPAROSCOPIC APPROACH IN TWO-STAGED
HEPATECTOMY FOR COLORECTAL
SYNCHRONOUS LIVER METASTASIS
F. Panaro, E. Rosso, P. Pessaux
Hepatobiliary surgery and Transplantation, University Hospital
Hautepierre, France
We present the case of 74 years old male, with unresectable bilo-
bar synchronous liver metastasis secondary to high rectal carci-
noma diagnosed on June 2007. From July 2007 to November
2007, nine cycles of neoadjuvant chemotherapy based on Irinote-
can and Bevacizumab was administered, resulting in a resecabil-
ity of the liver metastasis, in the optic of a future two-staged
hepatectomy (insufficient future remnant liver).On January 17,
2008 we performed a recto-sigmoid resection combined with
three metastasectomies of the left liver and a radiofrequency
thermoablation of another localization in the segment IVa. On
February 7, the chemotherapy with Irinotecan was continued and
a right portal vein embolization was performed. After an ade-
quate hypertrophy of the future left remnant liver, a right open
hepatectomy extended to the segment IVa was successful real-
ized.
After the first step, the patient need to have a faster recovery to
perform as soon as possible the portal vein embolization and the
subsequently ongoing chemotherapy during the hepatic left lobe
hypertrophy process . The laparoscopic exploration also permits
to exclude peritoneal carcinomatosis or undetected liver metas-
tasis frequently presents in patients with such cases of advanced
colorectal carcinoma. The one-step totally laparoscopic proce-
dure permits all these advantages compared to the conventional
open technique. Moreover, the second-stage of hepatectomy is
easier due to reduce incidence of the adherences. Last but not
the least, sometimes it is very hard for the patient to accept two
consecutive stressful procedures, the less invasivity of the first
step laparoscopic procedure is another important advantage for
the patient phycological wellbeing.
In conclusion, the laparoscopic approach should be more con-
sidered and validated in selected patients as the first-step proce-
dure of a two-staged hepatectomy for bilobar synchronous liver
metastasis.
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THE ROLE OF ENDOSCOPIC RETROGADE
CHOLANGIOGRAPHY (ERC)IN THE
MANAGEMENT OF POST CHOLECYSTECTOMY
BILE LEAKS
C. Agalianos, D. Davidis, G. Stefanidis, I. Kotsikoros,
V. Kontostolis, K. Nastos, N. Ivros, I. Kyriazanos
Athens Naval and Veterans Hospital, Surgical and Gastroenterol-
ogy Departments
AIM: Βile leak following after laparoscopic cholecystectomy can
occur in 0.3–2.7% of patients. The aim of this study is to under-
line the role of ERC in the diagnostic algorithm of management
of this severe complication.
METHODS: We reviewed retrospectively the data of the chole-
cystectomies and the ERCs that have been performed at our in-
stitution during 2004-2007.We have performed 587
cholecystectomies.8 post operative bile leaks were occurred. Our
protocol included ERC + stent +/-.sphincterotomy in all patients
with bile leak.
RESULTS: Bile leaks presented as bile flow from the drain left
in situ or as bilomas .All patients underwent ERC as to the pro-
tocol. Percutaneous drainage was performed in a number of pa-
tients. The stents were removed after 6-8 weeks. The bilomas and
the bile leaks were successfully treated in all patients and no fur-
ther complications were met.
CONCLUSIONS: ERC is a safe and effective method not only in
recognizing but in treating bile leaks following cholecystectomy
as well .In the therapeutic algorithm of management bile leaks
ERC can be a safe alternative option.
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THE ROLE OF THE LAPAROSCOPIC NURSE
SPECIALIST IN PATIENT DISCHARGE
FOLLOWING LAPAROSCOPIC
CHOLECYSTECTOMY
L. Bloxham, C. Neal, D. Lloyd, G. Robertson, C. Sutton
Department of Surgery, Leicester Royal Infirmary, Leicester, UK
BACKGROUND: The United Kingdom’s Department of Health
(DoH) has identified reducing delays in patient discharge as a
key aim for Health Service development. To this end, the DoH
advocates nurse-led patient discharge, though support for this
practice is scarce, particularly in the context of surgical patients.
AIM: The aim of this study was to examine the impact of the La-
paroscopic Nurse Specialist (LNS) upon patient discharge and
outcomes following laparoscopic cholecystectomy.
METHODS: A prospective audit of outcomes for patients un-
dergoing laparoscopic cholecystectomy between January 2007
and June 2007 was performed. Prior to surgery, patients were ran-
domly allocated to either nurse-led or doctor-led discharge. The
LNS used set criteria to assess suitability for discharge and, if ap-
propriate, initiated discharge without review by the medical team.
Pre-operative, intra-operative and post-operative variables, in-
cluding time to discharge and readmission rates, were recorded
and compared.
RESULTS: Forty patients undergoing laparoscopic cholecystec-
tomy were included in each group. There was no significant dif-
ference in ASA grade, operative duration, drain placement,
conversion rate (<1% overall) or post-operative complication
rate (<2% overall) between the groups. Patients in the LNS-led
discharge group were significantly more likely to be discharged
home on the same day as their operation than patients in the
doctor-led discharge group (P=0.034). Importantly, there was no
significant difference in readmission rates between the LNS-led
and doctor-led patient groups (n=1 and n=2 respectively,
P=0.56).
CONCLUSIONS: These data suggest that the LNS may enable
safe and rapid discharge of patients following laparoscopic chole-
cystectomy, supporting current DoH policy.
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LAPAROSCOPIC CHOLECYSTECTOMY IN
PATIENTS WITH LIVER CIRRHOSIS AND
SYMPTOMATIC CHOLELITHIASIS
T. Pavlidis, N. Symeonidis, K. Psarras, C. Skouras, T. Kontoulis,
K. Ballas, S. Rafailidis, G. Marakis, A. Sakantamis
2nd Propedeutical Department of Surgery, School of Medicine, Ar-
istotle University, Thessaloniki, Greece
Background: The aim of this study was to investigate the efficacy
and safety of laparoscopic cholecystectomy (LC) in patients with
liver cirrhosis and symptomatic cholelithiasis.
Methods: Medical records of 38 patients with liver cirrhosis who
underwent LC were retrospectively reviewed. Demographic char-
acteristics and other parameters including initial presentation,
conversion rate, complication rate, mortality and duration of hos-
pital stay were investigated and compared to non-cirrhotic pa-
tients of our database.
Results: Cirrhotic patients who underwent LC were older than
non-cirrhotic patients. Both the conversion rate and the duration
of hospital were increased in the cirrhotic group but without sta-
tistical difference. Despite that major complications occurred
more often in cirrhotic group, the mortality was zero.
Conclusions: Results indicate that LC can be safely performed in
cirrhotic patients with symptomatic gallstone disease, with ac-
ceptable complication and conversion rates. However, the in-
creased risk for a major complication, requires more attention
than usual.
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EXPERIENCE IN LAPAROSCOPIC
PANCREATIC SURGERY
M. Oliveira, H. Sousa, M. Sacchetti, I. Romero, M. Almeida,
H. Cristino, R. Melo, E. Martins, J. Costa-Maia
Unidade Hepato-Bilio-Pancre tica e Esplénica, Serviço de Cirurgia
Geral, Hospital de S. João, Porto, Portugal
Introduction: The laparoscopic approach to pancreatic surgery
(LPS), has been increasingly used since the early 1990’s. Main in-
dications are chronic pancreatitis, neuroendocrine and cystic tu-
mors. LPS has been associated with less post-operative pain and
length-of-stay, earlier return to normal activity, better cosmetic
results and increase patient satisfaction.
Objectives: Review of LPS experience in an HBP Surgical Unit
Methods: 10 patients (5F; 5M) submitted to LPS between Octo-
ber 2007 and October 2008, were included in the study. Average
age was 54.8 years (32-78). Data include ASA classification, pro-
cedure and duration, intra-operative transfusion, conversion rate,
histology and resection margins, length-of-stay, morbidity and
mortality.
Results: Procedures included 8 distal and 1 proximal pancreate-
ctomy and 1 tumor enucleation. One case was converted to la-
parotomy. Median postoperative length of stay was 7 days (3-14).
A patient developed a peri-pancreatic collection resolved with
percutaneous drainage. There was no mortality.
Conclusion: LPS is safe and effective when practiced in centers
with experience in pancreatic and advanced laparoscopic surgery.
LPS is currently our first line approach for the treatment of cys-
tic and distal pancreatic lesions.
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TOTALLY LAPAROSCOPIC PERICYSTECTOMY
AND SPLENECTOMY FOR SIMULTANEOUS
LIVER AND SPLEEN HYDATIDOSIS
T. Artis, H. Akyildiz, C. Kucuk, F. Mutlu, Z. Yilmaz
Dept. of General Surgery Erciyes University Medical School, Turkey
Background and Aim: Hydatid disease can occur in all viscera
and soft tissues mainly in liver,lungs and spleen. Surgery has re-
mained the mainstream treatment. Recently advances in laparo-
scopic surgery made it possible to consider laparoscopic
approaches in selected patients with hepatic hydatid disease. We
report a case of simultaneous laparoscopic pericystectomy and
splenectomy performed in a selected patient with hydatidosis.
Case report: A 51-year- old male admitted with diagnosis of liver
and spleen hydatidosis. Major complaint was discomfort at the
right and left upper quadrants of the abdomen. He had a history
of cerebral hydatid operation recently. Physical examination and
routine laboratory tests were normal. Abdominal ultrasound and
computerized tomography showed cystic masses diagnosed as hy-
datidosis in segment 5 of the liver and lower pole of the spleen, 3
cm and 1,5 cm diameter, respectively Considering patients his-
tory of hydatidosis surgery was decided. Lesions were suitable for
laparoscopic approach. Standard approach as in the laparoscopic
cholecystectomy using four trocars were used. Total pericystec-
tomy was performed with use of ligasure for parenchymal tran-
section. Laparoscopic splenectomy was performed with posterior
approach using three trocars. Endovascular stapler was used for
splenic hilum.Operation time was 112 min. and no blood trans-
fusion was needed. Postoperative course was uneventful and pa-
tient discharged at postoperative day 4.
Conclusion: To the best of our knowledge this is the first report
of laparoscopic management for simultaneous liver and spleen
hydatidosis. With appropriate patient selection laparoscopic ap-
proach for both liver and splenic hydatid cysts is feasible and safe
treatment option.
P 340
EFFICACY AND SAFETY OF LAPAROSCOPIC
COMMON BILE DUCT EXPLORATION IN
EMERGENCY SETTING
R. Hompes, R. Aerts, B. Topal
Department of Abdominal Surgery, University Hospital Leuven, Bel-
gium
Introduction: Laparoscopic common bile duct exploration
(LCBDE) for common bile duct stones (CBDS) is well recog-
nised and validated for achieving bile duct clearance from stones.
However, few data are available on the results in an emergency
setting. The aim of the present study is to evaluate the efficacy
and safety of acute LCBDE.
Methods: From January 2001 until october 2008, 142 consecutive
patients with CBDS and galbladder in situ underwent laparo-
scopic cholecystectomi (LCCE) and LCBDE. Patient and surgery
data were recorded in a prospective database. Fourthy-three pa-
tients underwent LCCE and LCBDE in an acute setting. In half
of these patients LCBDE was attempted for CBDS in the pres-
ence of acute cholecystitis. LCBDE was performed via trans-cys-
tic approach in 32 patients and via choledochotomy in 11 patients.
Flexible choledochoscopy was used in all patients.
Results: Laparoscopic stone clearance of the bile duct was suc-
cesful in 95.3% of the patients. In two patients conversion was
necessary to open surgery. Mean duration of surgery was 93
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(range 81-105) minutes. No mortality occured. Postoperative
complications were observed in 4 patients. Median length of hos-
pital stay was 2 (range 0-33) days after trans-cystic LCBDE and
5 days (range 2-34) days after stone clearance via choledo-
chotomy. There were no significant differences in comparison
with LCBDE in an elective setting.
Conclusion: Acute LCCE with LCBDE and stone extraction is
safe and can be performed with high efficacy, without mortality,
and with cmparable morbidity as in elective procedures.
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LAPAROSCOPIC VERSUS OPEN DISTAL
SPLENO PANCREATECTOMY:
A RETROSPECTIVE CASE MATCHED
COMPARATIVE STUDY
G. Jain, I. Panagiotoaoulou, G. Ennew, P. Neil, C. Johnson,
M. Abu Hilal
Hepato-biliary and pancreatic surgery unit, Southampton General
Hospital, Southampton, UK
Background: Laparoscopic pancreatic surgery has been slow to
gain wide acceptance because of the complex pancreatic anatomy
and physiology.
Aim: To compare the short term results of Laparoscopic versus
Open distal pancreatectomy in a Tertiary Pancreatic Centre.
Methods: Since January 1999 a total of 48 distal pancreatectomies
have been performed at our centre. Prior to April 2007, 33 open
procedures (69%) were performed.
Subsequently, pancreatic surgery was centralized at our institu-
tion and the remaining fifteen (31%) procedures were all per-
formed laparoscopically. The Laparoscopic Group (LG) was
retrospectively compared with 15 matched cases from the Open
Group (OG) which by todays criteria would have been consid-
ered feasible by a laparoscopic approach (benign diseases or bor-
derline malignant neoplasms with a diameter ≤ 5 cm.).
Results: There was no difference in the demographic data and
the indication for surgery in both groups. Median time for the
LG and OG was 180 (120-300) and 240 (120-300) minutes re-
spectively. Median blood loss was 100 (50-500) ml for the LG
and 500 (75-2000) ml for OG. Hospital stay was 5 (4-7) days for
LG and 11 (6-32) days for OG. No patient was admitted to ITU
in LG group as compared to one post operative ITU admission in
OG group. No peri-operative mortality was observed in the LG.
Overall morbidity rate was 29% and 33% for LG and OG re-
spectively. In both groups, three cases developed a pancreatic fis-
tula.
Conclusions: In specialized centres laparoscopic distal spleno-
pancreatectomy is feasible, safe and efficient.
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LAPAROSCOPIC LEFT LATERAL
SECTIONECTOMY WITHOUT INFLOW
OCCLUSION: THE GOLD STANDARD
TECHNIQUE IN NON-CIRRHOTIC LIVER
PARENCHYMA?
R. Troisi1, A. Geerts2, I. Colle2, H. Van Vlierberghe2,
J. Van Huysse3, B. De Hemptinne1
1. Dept. of General, Hepato-Biliary and Liver Transplantation Service,
2. Hepato-Gastroenterology,
3. Pathology, Ghent University Hospital & Medical School, Ghent,
Belgium.
Background. Laparoscopic liver resection is increasingly per-
formed. We reviewed medical files of patients undergoing in a
prospective way a laparoscopic left lateral sectionectomy (LLS)
for benign or malignant disease in non-cirrhotic liver
parenchyma. Material and Methods. Between June 2005 and No-
vember 2008, 32 consecutive LLS were performed in our institu-
tion. According to this study LR was performed with ultrasonic
scalpel without interruption of the arterial and portal inflow. End-
point was to investigate overall morbidity in terms of blood loss,
complication rates and hospital stay. Results. All patients are
alive and well after a median follow-up of 22 months (range 1-
42). In all patients LLS was successfully performed for benign dis-
ease (19/32-60%) and for metastases (13/32-40%). Mean
resection time was of 45±12.5 min. and median blood loss of 50
ml (30-100). Fourteen (43.7%) patients had a previous abdomi-
nal operation before LLS. Overall morbidity was 9.4% (n=2
grade 1 and n=1 grade 2). The median hospital stay was of 4 days
(3-10). Histology revealed up to 30% macrovesicular steatosis in
5 pts (28.5%) and a metavir score A2F2 in up to 12 (37.5%) of pa-
tients. Conclusions. Laparoscopic left lateral sectionectomy with-
out partial inflow occlusion can be performed safely in
non-cirrhotic livers with minimal blood loss and a favorable out-
come. According to this prospective study, LLS could be consid-
ered as a gold standard operative technique in patients without
underlying cirrhosis.
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IMPACT OF LAPAROSCOPIC INTRA-
OPERATIVE ULTRASOUND IN
CHOLANGIOCARCINOMA STAGING AND
PREDICTION OF OPERABILITY: RESULTS
FROM A UNITED KINGDOM TERTIARY
REFERAL CENTRE
C. Briggs, C. Mann, C. Pattenden, C. Neal, A. Dennison, D. Berry
Department of Hepatobiliary and Pancreatic Surgery, Leicester Gen-
eral Hospital, Gwendolen Road, Leicester, United Kingdom
BACKGROUND AND AIMS: Identifying candidates for sur-
gery in cholangiocarcinoma (CC) is difficult as many patients
have occult disseminated disease at the time of diagnosis. CT,
PET and MRI have increased detection of extra-abdominal
metastases, but tend to underestimate local disease. This study
assesses the results of staging laparoscopy (SL) alone or with
intra-operative ultrasound (SLIOUS) in the detection of locally
unresectable disease in our unit.
METHODS: Retrospective review of our database of all patients
diagnosed with cholangiocarcinoma up to 2004. Patients under-
going SL or SLIOUS were included.
RESULTS: Seventy three patients underwent laparoscopy. Peri-
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LAPAROSCOPIC TREATMENT OF POLYCYSTIC
LIVER DISEASE AND HAEMANGIOMAS IN
THE SAME PATIENT
J. Ramia, E. Sancho, R. Lozoya, J. Santos
Department of Surgery, Hospital Santa Barbara, Puertollano (Ciu-
dad Real), Spain
Liver polycystic disease type II (multiples cysts of small and big
size) with or without kidney polycystic disease is a low prevalence
inherited disease. Liver heamangioma is the most frequent be-
nign solid liver tumor. The coincidence of liver cysts with liver
haemangiomas in the same patient is extremely rare. Laparo-
scopic liver surgery, when it is feasible, is probably the best option
for the treatment of benign liver diseases. We present a patient
with liver polycystic disease type II and two liver haemangiomas
treated totally by laparoscopy.
CASE REPORT: Female, 49 years, she is referred to us due se-
vere abdominal pain in right hypocondrium and fever. Abdomi-
nal examination was normal. US/CT: Multiple liver and kidney
cysts, two haemangiomas in left lateral section. We perform la-
paroscopic fenestration of liver cysts in segments II, III, IV, V,
VI y VIII (10 cysts), and resection of both hemangiomas of 3 cm
each in segment III. Postoperative course was eventful. Patient is
asymptomatic after a 2-year follow up.
CONCLUSIONS: The coincidence of liver polycystic disease
type II and liver heamangioma in the same patient is extremely
rare. Surgical procedure is only indicated if there is any compli-
cation (pain, haemorrhage,..) or uncertained diagnosis. Laparo-
scopic liver cyst fenestration is the best therapeutical option.
Laparoscopic liver resection for small peripheral lesions is also
becoming the new gold standard. Laparoscopic liver surgery is
feasible, safe and more comfortable for the patient.
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LAPAROSCOPIC CHOLECYSTECTOMY
IN CAPD
J. Ha, H. Chandraratna
Department of General Surgery, St John of God Hospital (Subiaco)
& Royal Perth Hospital, Western Australia
Introduction: Laparoscopy cholecystectomy is the established
procedure for cholelithiasis. There is no consensus on its use in
patients with chronic ambulatory peritoneal dialysis and there is
no clear recommendation in the literature.
With the increased practice of laparoscopic techniques, peri-
toneal dialysis can be resumed soon after the surgical procedure
without interruption with hemodialysis. We present a successful
case of a laparoscopic cholecystectomy in a patient with chronic
ambulatory peritoneal dialysis.
Conclusion: We recommend that laparoscopic cholecystectomy
should be used in these patient population who are often at an in-
creased risk for peri-operative complications and would benefit
from a less invasive surgical technique.
toneal or liver metastases were discovered at SL in 22 patients
(30%). SLIOUS was performed in 44 of the remaining patients,
10 by a specialist radiologist and 34 by surgeons. 7 patients (10%)
were found to have disease precluding resection. 44 patients
(60%) proceeded to laparotomy and 31 (70%) underwent po-
tentially curative resection. The 13 inoperable cases despite
SLIOUS were due to extensive vascular involvement (6), lymph
node metastases (3), liver metastases (3), and peritoneal metas-
tases (1). Overall laparoscopic staging sensitivity for local unre-
sectability was 69% (29 of 42 cases). Specialist radiologist IOUS
had an operability predictive rate of 80%, whereas surgical staff
were correct in 72% of cases.
CONCLUSIONS: Staging laparoscopy is essential in the staging
of cholangiocarcinoma as a third of patients will be saved from an
unnecessary laparotomy. IOUS increased diagnostic yield by ap-
proximately 10%. However, 21% of patients still have unre-
sectable disease detected only at laparotomy.
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STAPLER LAPAROSCOPIC HAND ASSISTED
RIGHT HEMIHEPATECTOMY BY
ULTRASOUND DIRECTED INTRAHEPATIC
APPROACH WITHOUT PRINGLE MANOEUVRE
G. Belli, C. Fantini, A. DAgostino, A. Belli, L. Cioffi,
P. Limongelli, G. Russo
Loreto Nuovo Hospital S.Maria Loreto Nuovo Hospital Naples -
Dept of General and HPB Surgery, Italy
Background: Laparoscopic hepatic resection is a promising sur-
gical option for patients affected by liver mass and is progressively
gaining popularity. Minor resections have been reported by var-
ious authors and are becoming a routine approach for many sur-
gical indications. On the contrary laparoscopic major
hepatectomies have been performed only in a limited number of
cases by few skilled surgeons, who have acquired expertise in the
advanced laparoscopic approach and have sufficient training in
open liver surgery to allow rapid conversion when necessary. So
that a standardized technique is not yet available. Hand-assisted
laparoscopic liver surgery has been developed to facilitate hepatic
resection in order to improve liver exposure and the vascular con-
trol thus increasing the safety of the procedure.Transparenchi-
mal en-bloc stapler transection of the inflow blood supply and
bile ducts to the right lobe of the liver has been referred to be
safe and useful in open surgery in order to minimize periopera-
tive bleeding, reduce transfusion requirement, and to limit warm
hepatic ischemia and overall operative time.
Methods: In this video we show a personal technique for hand
assisted right hemihepatectomy by ultrasound directed intrahep-
atic approach without Pringle manoeuvre.
Conclusion: To the best of our knowledge, this is the first report
in which right hemihepatectomy with en-bloc intrahepatic portal
triad transection has been performed by an hand assisted la-
paroscopic approach.
